sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.1,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness predict neuropsychological decrements after concussion? Loss of consciousness can indicate neuropsychological impairments following a concussion, but it is not the only factor. Other elements such as the severity of the concussion, the individual's health, and the time elapsed since the injury also play crucial roles. Hence, a thorough neuropsychological evaluation is essential after a concussion.",9.474389094274162e-08,0.10067206354597413,0.020924546289103868,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
0,0.1,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a predictor of neuropsychological decline after a concussion? While loss of consciousness may signal neuropsychological deficits post-concussion, it is not the sole predictor. The severity of the concussion, the person's overall health, and the time since injury also significantly affect cognitive outcomes. Therefore, a comprehensive neuropsychological assessment is necessary following a concussion.",2.3685972735685406e-08,0.044954788023022996,0.019051467046726972,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
0,0.1,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness forecast neuropsychological impairments after a concussion? Loss of consciousness might suggest neuropsychological issues after a concussion, but it alone does not determine the outcome. Factors such as how severe the concussion was, the individual's health condition, and the duration since the injury also influence cognitive effects. Thus, detailed neuropsychological testing is important after a concussion.",9.474389094274162e-08,0.04384728999417442,0.05026082086187171,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
0,0.1,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does experiencing loss of consciousness predict neuropsychological deficits after a concussion? Loss of consciousness can be a sign of neuropsychological decline post-concussion, yet it is not the only factor involved. The severity of the concussion, the person's health status, and the time since the injury also play significant roles. Consequently, a full neuropsychological assessment is critical after a concussion.",9.474389094274162e-08,0.07677043663011274,0.0037930738654236643,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
0,0.1,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness an indicator of neuropsychological decline following a concussion? Loss of consciousness may indicate neuropsychological impairments after a concussion but is not the sole determinant. Other factors like concussion severity, individual health, and time elapsed since injury also impact cognitive function. Therefore, comprehensive neuropsychological evaluation is essential post-concussion.",9.474389094274162e-08,0.05539646218537486,0.015432766243752394,0.0072537058591274906,0.08060683971738136,0.0015383588099934231,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
0,0.1,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does losing consciousness predict neuropsychological impairments after a concussion? Loss of consciousness can be indicative of neuropsychological deficits following a concussion, but it is not the only predictor. The severity of the concussion, the individual's health, and the time since injury also significantly affect cognitive outcomes. Hence, thorough neuropsychological assessment is necessary after a concussion.",0.0,0.051344235597033716,0.036851395847011775,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0,0.0,0.0,0.0
0,0.1,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness serve as a predictor for neuropsychological decrements after a concussion? While loss of consciousness may signal neuropsychological impairments post-concussion, it is not the sole factor. The severity of the concussion, the individual's health condition, and the duration since the injury also play important roles. Therefore, a comprehensive neuropsychological evaluation is vital after a concussion.",7.105791820705622e-08,0.05812071355425186,0.002894185996838848,0.005440279394345618,0.056461018114079664,0.001009707076140641,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
0,0.1,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness predictive of neuropsychological deficits following a concussion? Loss of consciousness can be an indicator of neuropsychological decline after a concussion, but it is not the only determinant. Factors such as concussion severity, the individual's health, and time since injury also influence cognitive effects. Thus, a detailed neuropsychological assessment is crucial post-concussion.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.1,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness predict cognitive impairments after a concussion? Loss of consciousness may indicate neuropsychological decrements following a concussion, but it is not the sole predictor. Other factors including the severity of the concussion, the individual's health status, and the time elapsed since injury also significantly impact cognitive outcomes. Therefore, comprehensive neuropsychological testing is essential after a concussion.",9.474389094274162e-08,0.07677043663011318,0.0037930738654236504,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
0,0.1,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a reliable predictor of neuropsychological decrements after a concussion? Loss of consciousness can suggest neuropsychological impairments post-concussion, but it is not the only factor involved. The severity of the concussion, the individual's health, and the duration since injury also play critical roles. Hence, thorough neuropsychological assessment is important following a concussion.",0.0,0.025672117798516858,0.018381073278597906,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1,0.1,1,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy feasible? Answer: Yes, performing a transgastric endoscopic splenectomy is feasible. This technique uses an endoscope to excise the",2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,0.1,2,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can transgastric endoscopic splenectomy be done? Answer: Yes, it is possible to carry out a transgastric endoscopic splenectomy. The procedure entails using an endoscope to remove the",9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
1,0.1,3,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is it possible to perform a transgastric endoscopic splenectomy? Answer: Yes, a transgastric endoscopic splenectomy can be performed. This method involves the use of an endoscope to extract the",1.421158364141118e-07,0.1964687742686615,0.025198675872076533,0.010880558788691277,0.19165154391974948,0.035665294924554176,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
1,0.1,4,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Does transgastric endoscopic splenectomy work? Answer: Yes, transgastric endoscopic splenectomy is achievable. The operation involves employing an endoscope to take out the",2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,0.1,5,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy achievable? Answer: Yes, it is achievable to perform a transgastric endoscopic splenectomy. This procedure uses an endoscope to remove the",2.36859727356853e-08,0.045071017246913314,0.0018005280507428709,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.1,6,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can a transgastric endoscopic splenectomy be performed? Answer: Yes, a transgastric endoscopic splenectomy can be performed. This involves using an endoscope to remove the",2.36859727356853e-08,0.07045351284641121,0.07906054983977057,0.0018134264647818796,0.07609557317872184,0.08616780045351473,0.0018108015409528735,0.016493364416010348,0.04535147392290251,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.1,7,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy a viable procedure? Answer: Yes, transgastric endoscopic splenectomy is a viable procedure. It involves the use of an endoscope to remove the",7.10579182070559e-08,0.02291894829943253,0.07003312034245182,0.005440279394345639,0.0723815970650894,0.03993055555555556,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
1,0.1,8,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is it feasible to do a transgastric endoscopic splenectomy? Answer: Yes, it is feasible to do a transgastric endoscopic splenectomy. This procedure involves using an endoscope to remove the",1.421158364141118e-07,0.05305901277350067,0.12154212580348944,0.010880558788691277,0.04312000522833204,0.13888888888888887,0.010864809245717241,0.09728172148980807,0.109375,1.4211583641411238e-07,0.15572623668903862,0.07638888888888888
1,0.1,9,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can transgastric endoscopic splenectomy be successfully done? Answer: Yes, transgastric endoscopic splenectomy can be successfully done. The procedure involves using an endoscope to remove the",4.73719454713706e-08,0.022700046520559347,0.07438016528925614,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
1,0.1,10,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy possible to perform? Answer: Yes, it is possible to perform a transgastric endoscopic splenectomy. This procedure involves the use of an endoscope to remove the",1.421158364141118e-07,0.1964687742686615,0.025198675872076533,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
2,0.1,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does blood pressure fluctuate in treated hypertensive patients depending on whether a physician or a nurse takes the measurement? Yes, blood pressure readings can differ based on the person measuring it. The 'white coat hypertension' effect may lead to higher readings when a physician measures due to patient anxiety, making nurse measurements potentially lower and more accurate.",3.079176455639103e-07,0.08995223932847285,0.11106945379890734,0.023574544042164344,0.13062779281893722,0.05859375,0.023540420032387266,0.17432665159923033,0.029822485207100586,3.079176455639103e-07,0.21936282847430322,0.0
2,0.1,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does blood pressure vary depending on whether a nurse or physician measures it? Indeed, blood pressure can change based on who performs the measurement. The phenomenon called 'white coat hypertension' often results in elevated readings when taken by a physician because of increased anxiety, so nurse measurements may be lower and more precise.",3.079176455639103e-07,0.06519698287990305,0.12888350905404003,0.023574544042164344,0.13062779281893722,0.05859375,0.023540420032387266,0.17432665159923033,0.029822485207100586,3.079176455639103e-07,0.21936282847430322,0.0
2,0.1,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is there a difference in blood pressure readings in treated hypertensive patients when measured by a physician versus a nurse? Yes, readings can vary depending on the measurer. 'White coat hypertension' can cause higher blood pressure readings with physicians due to patient anxiety, meaning nurse measurements might be lower and more reliable.",4.263475092423373e-07,0.1883322691919571,0.10758439470430281,0.03264167636607371,0.25366385984566087,0.038602079862557266,0.0325944277371516,0.27149040005287883,0.029822485207100586,4.263475092423373e-07,0.31845373111853315,0.0
2,0.1,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Do blood pressure measurements in treated hypertensive patients differ when taken by a physician compared to a nurse? Yes, blood pressure can vary depending on who measures it. The 'white coat hypertension' phenomenon may cause elevated readings with physicians because of patient anxiety, so nurse measurements might be lower and more accurate.",4.263475092423373e-07,0.16115002681705715,0.12713474872346153,0.03264167636607371,0.22593797262326287,0.05859375,0.0325944277371516,0.27149040005287883,0.029822485207100586,4.263475092423373e-07,0.31845373111853315,0.0
2,0.1,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In patients treated for hypertension, does blood pressure change based on whether a nurse or physician measures it? Yes, blood pressure readings can differ depending on the measurer. 'White coat hypertension' can cause higher readings when a physician measures due to anxiety, making nurse measurements potentially lower and more accurate.",4.737194547137081e-07,0.23055656236687172,0.10599233134003008,0.03626852929563745,0.26675996714351724,0.05859375,0.03621603081905733,0.31316309645344775,0.029822485207100586,4.737194547137081e-07,0.36101334553732967,0.0
2,0.1,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does the blood pressure of treated hypertensive patients vary depending on whether a nurse or physician takes the measurement? Yes, blood pressure readings can fluctuate based on who measures it. The 'white coat hypertension' effect may cause higher readings with physicians due to patient anxiety, so nurse measurements might be lower and more precise.",3.789755637709665e-07,0.12165800099398272,0.12787380197789938,0.029014823436509962,0.1867172594699804,0.05859375,0.028972824655245866,0.23148506543918046,0.029822485207100586,3.789755637709665e-07,0.2776317365982788,0.0
2,0.1,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","For treated hypertensive patients, does blood pressure change depending on whether a nurse or physician measures it? Yes, blood pressure readings can vary depending on the person measuring. The 'white coat hypertension' phenomenon may lead to higher readings when measured by a physician due to anxiety, making nurse measurements potentially lower and more accurate.",3.789755637709665e-07,0.14781449837360316,0.1090569324989325,0.029014823436509962,0.1867172594699804,0.05859375,0.028972824655245866,0.23148506543918046,0.029822485207100586,3.789755637709665e-07,0.2776317365982788,0.0
2,0.1,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does blood pressure differ when measured by a nurse versus a physician? Yes, blood pressure can vary based on who takes the measurement. The 'white coat hypertension' effect may cause elevated readings with physicians due to patient anxiety, so nurse measurements might be lower and more reliable.",4.500334819780227e-07,0.18149629896073538,0.12674307858601877,0.03445510283085558,0.24614067994078148,0.05859375,0.034405229278104466,0.2921096872556146,0.029822485207100586,4.500334819780227e-07,0.3395071403163663,0.0
2,0.1,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is there a variation in blood pressure readings in treated hypertensive patients depending on whether a physician or nurse measures it? Yes, blood pressure can change depending on the measurer. The 'white coat hypertension' phenomenon may cause higher readings when a physician measures due to anxiety, meaning nurse measurements might be lower and more accurate.",3.552895910352811e-07,0.15382572399775762,0.09137142692415355,0.02720139697172809,0.1676690644992873,0.05859375,0.027162023114293,0.21206697958207776,0.029822485207100586,3.552895910352811e-07,0.257829109302099,0.0
2,0.1,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Do treated hypertensive patients show different blood pressure readings when measured by a physician compared to a nurse? Yes, blood pressure can vary depending on who measures it. The 'white coat hypertension' effect may cause elevated readings with physicians due to patient anxiety, so nurse measurements might be lower and more precise.",4.263475092423373e-07,0.16115002681705715,0.12713474872346153,0.03264167636607371,0.22593797262326287,0.05859375,0.0325944277371516,0.27149040005287883,0.029822485207100586,4.263475092423373e-07,0.31845373111853315,0.0
3,0.1,1,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are we overlooking any prognostic factors? Answer: We present for the first time that ESLD etiology serves as a prognostic indicator for survival. Renal function, measured by serum creatinine, and urinary sodium levels below 5 mEq/l at diagnosis were linked to survival, implying that early intervention could improve outcomes.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
3,0.1,2,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: could there be undiscovered prognostic factors? Answer: Our report identifies ESLD etiology as a novel prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary Na under 5 mEq/l at diagnosis correlate with survival, suggesting early treatment may enhance survival rates.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.1,3,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are some prognostic factors being missed? Answer: We reveal for the first time that the cause of ESLD is a prognostic factor for survival. Renal function, reflected by serum creatinine, and urinary sodium less than 5 mEq/l at diagnosis are associated with survival, indicating that prompt treatment might improve survival chances.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
3,0.1,4,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: might there be additional prognostic factors? Answer: We report ESLD etiology as a prognostic factor for survival for the first time. Renal function, expressed as serum creatinine, and urinary sodium below 5 mEq/l at diagnosis were linked to survival, suggesting that early therapeutic intervention could increase survival.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
3,0.1,5,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are prognostic factors being overlooked? Answer: For the first time, we identify ESLD etiology as a prognostic factor for survival. Renal function, measured by serum creatinine, and urinary Na less than 5 mEq/l at diagnosis were associated with survival, implying that early treatment might boost survival.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
3,0.1,6,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: could we be missing key prognostic factors? Answer: We report for the first time that ESLD etiology is a prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary sodium below 5 mEq/l at diagnosis correlate with survival, suggesting early treatment may improve survival outcomes.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
3,0.1,7,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are there unknown prognostic factors? Answer: We present for the first time that ESLD etiology acts as a prognostic factor for survival. Renal function, expressed as serum creatinine, and urinary Na under 5 mEq/l at diagnosis were found to be associated with survival, indicating that early intervention might enhance survival.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
3,0.1,8,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: is there a chance we are missing prognostic factors? Answer: We report ESLD etiology as a prognostic factor for survival for the first time. Renal function, measured by serum creatinine, and urinary sodium less than 5 mEq/l at diagnosis were linked to survival, suggesting that early treatment could increase survival chances.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
3,0.1,9,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are some survival prognostic factors overlooked? Answer: For the first time, we identify ESLD etiology as a prognostic factor for survival. Renal function, reflected by serum creatinine, and urinary Na below 5 mEq/l at diagnosis were associated with survival, implying that early treatment might improve survival.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
3,0.1,10,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: might we be missing important prognostic factors? Answer: We report for the first time that ESLD etiology is a prognostic factor for survival. Renal function, expressed as serum creatinine, and urinary sodium less than 5 mEq/l at diagnosis were found to be linked to survival, suggesting that early intervention could enhance survival outcomes.",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
4,0.1,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.1,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be a new risk factor for pathological gambling? Answer: Recent research indicates a potential association between Aripiprazole, an antipsychotic drug, and a heightened risk of pathological gambling. Nonetheless, more studies are required to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.1,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is Aripiprazole a novel risk factor for pathological gambling? Answer: Current studies imply a possible connection between Aripiprazole, an antipsychotic medication, and an elevated risk of pathological gambling. Additional research is necessary to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.1,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole and pathological gambling: a new risk factor? Answer: Emerging evidence points to a potential link between Aripiprazole, an antipsychotic agent, and increased pathological gambling risk. Further investigation is essential to",4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
4,0.1,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Does Aripiprazole pose a new risk for pathological gambling? Answer: Recent findings suggest a possible correlation between Aripiprazole, an antipsychotic drug, and a greater risk of pathological gambling. More research is needed to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.1,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole as a potential new risk factor for pathological gambling? Answer: Studies have recently indicated a possible association between Aripiprazole, an antipsychotic medication, and increased pathological gambling risk. Further studies are required to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.1,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be linked to pathological gambling as a new risk factor? Answer: Recent research suggests a potential connection between Aripiprazole, an antipsychotic drug, and a higher risk of pathological gambling. Additional research is needed to",7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
4,0.1,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is there a new risk factor for pathological gambling in Aripiprazole? Answer: Recent studies have suggested a possible link between Aripiprazole, an antipsychotic medication, and increased risk of pathological gambling. More research is necessary to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.1,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a possible new risk factor for pathological gambling? Answer: Emerging studies indicate a potential association between Aripiprazole, an antipsychotic drug, and an increased risk of pathological gambling. Further research is warranted to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.1,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be considered a new risk factor for pathological gambling? Answer: Recent studies point to a possible link between Aripiprazole, an antipsychotic medication, and heightened risk of pathological gambling. However, more research is essential to",7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
5,0.1,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there varying degrees of risk for transitioning to psychosis within Ultra High Risk (UHR) criteria? Yes, the risk levels differ based on factors like age, symptom frequency and intensity, and family history. However, UHR criteria do not guarantee psychosis development, as not everyone classified as UHR will progress to psychosis.",5.210914001850789e-07,0.1913563184479239,0.12244897959183675,0.03989538222520124,0.23418267008788263,0.097412109375,0.03983763390096308,0.2782732053471899,0.07100591715976333,5.210914001850789e-07,0.32368523501242263,0.04338842975206613
5,0.1,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do Ultra High Risk (UHR) criteria indicate different levels of risk for psychosis transition? Yes, risk varies depending on age, symptom severity and frequency, and family history. Nonetheless, UHR criteria are not absolute predictors, and not all individuals labeled UHR will develop psychosis.",7.105791820705622e-07,0.36570970559270144,0.12244897959183675,0.05440279394345622,0.4124309014942016,0.097412109375,0.05432404622858601,0.4605947621411448,0.07100591715976333,7.105791820705622e-07,0.5102711905928361,0.04338842975206613
5,0.1,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is there a range of risk levels for psychosis transition in Ultra High Risk (UHR) criteria? Yes, risk is influenced by factors such as age, how often and how intense symptoms are, and family history. Still, UHR criteria are not definitive, and not all people identified as UHR will experience psychosis.",5.210914001850789e-07,0.1913563184479239,0.12244897959183675,0.03989538222520124,0.23418267008788263,0.097412109375,0.03983763390096308,0.2782732053471899,0.07100591715976333,5.210914001850789e-07,0.32368523501242263,0.04338842975206613
5,0.1,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within Ultra High Risk (UHR) criteria, are there distinct risk levels for psychosis transition? Yes, risk varies with age, symptom frequency and intensity, and family history. However, UHR criteria are not conclusive predictors, and not all UHR individuals will develop psychosis.",7.57951127541933e-07,0.41449986976213316,0.12244897959183675,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
5,0.1,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are different risk levels for psychosis transition recognized in Ultra High Risk (UHR) criteria? Yes, factors like age, symptom frequency and intensity, and family history determine risk levels. Yet, UHR criteria do not definitively predict psychosis, and not all classified as UHR will develop it.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
5,0.1,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Does Ultra High Risk (UHR) criteria reflect varying degrees of risk for psychosis transition? Yes, risk depends on age, symptom frequency and intensity, and family history. However, UHR criteria are not absolute, and not everyone identified as UHR will develop psychosis.",7.57951127541933e-07,0.41449986976213316,0.12244897959183675,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
5,0.1,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there multiple risk levels for psychosis transition within Ultra High Risk (UHR) criteria? Yes, risk is assessed based on age, symptom frequency and intensity, and family history. Still, UHR criteria are not definitive, and not all individuals classified as UHR will develop psychosis.",6.868932093348768e-07,0.342179208182507,0.12244897959183675,0.05258936747867435,0.38833334991514157,0.097412109375,0.052513244687633145,0.4359021495507731,0.07100591715976333,6.868932093348768e-07,0.48495338260854437,0.04338842975206613
5,0.1,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do Ultra High Risk (UHR) criteria show different levels of risk for transitioning to psychosis? Yes, risk varies according to age, symptom frequency and intensity, and family history. However, UHR criteria are not certain predictors, and not all UHR individuals will develop psychosis.",7.105791820705622e-07,0.36570970559270144,0.12244897959183675,0.05440279394345622,0.4124309014942016,0.097412109375,0.05432404622858601,0.4605947621411448,0.07100591715976333,7.105791820705622e-07,0.5102711905928361,0.04338842975206613
5,0.1,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is the risk of psychosis transition stratified in Ultra High Risk (UHR) criteria? Yes, risk levels depend on age, symptom frequency and intensity, and family history. Nonetheless, UHR criteria are not definitive, and not all classified as UHR will develop psychosis.",7.57951127541933e-07,0.41449986976213316,0.12244897959183675,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
5,0.1,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within Ultra High Risk (UHR) criteria, are there varying risk levels for psychosis transition? Yes, factors such as age, symptom frequency and intensity, and family history influence risk. However, UHR criteria are not absolute predictors, and not all individuals identified as UHR will develop psychosis.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
6,0.1,1,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is there an ideal duration for acid suppression to maximize healing in Los Angeles grades C and D reflux oesophagitis? Answer: Yes, effective healing of Los Angeles grades C and D reflux oesophagitis is possible with prompt and sufficient acid suppression, though the optimal timing differs among patients based on factors such as severity.",1.8948778188548325e-07,0.11330635351451068,0.016825274348422486,0.014507411718254981,0.11228147804651734,0.019509816529492532,0.014486412327622933,0.1111094353071369,0.0223765432098766,1.8948778188548325e-07,0.10977596532983247,0.025425454389574692
6,0.1,2,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Can maximal healing of Los Angeles grades C and D reflux oesophagitis be achieved by timing acid suppression correctly? Answer: Yes, optimal healing occurs with timely and adequate acid suppression, but the best timing varies depending on individual factors like disease severity.",4.737194547137081e-07,0.21058807500431742,0.1262002743484225,0.03626852929563745,0.23821883799622778,0.11282578875171474,0.03621603081905733,0.2668356719961751,0.09876543209876548,4.737194547137081e-07,0.29649322479981377,0.08401920438957469
6,0.1,3,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Does an optimal acid suppression period exist for healing Los Angeles grades C and D reflux oesophagitis? Answer: Yes, healing is optimized through appropriate and timely acid suppression, although the ideal timing depends on individual severity and other factors.",5.447773729207642e-07,0.28469604715804087,0.1262002743484225,0.04170880868998307,0.3142047449741492,0.11282578875171474,0.04164843544191593,0.34479721346588565,0.09876543209876548,5.447773729207643e-07,0.37653593247334793,0.08401920438957469
6,0.1,4,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is there a best time frame for acid suppression to heal Los Angeles grades C and D reflux oesophagitis effectively? Answer: Yes, maximal healing can be attained with timely and adequate acid suppression, but the perfect timing varies by patient and severity.",4.737194547137081e-07,0.21058807500431742,0.1262002743484225,0.03626852929563745,0.23821883799622778,0.11282578875171474,0.03621603081905733,0.2668356719961751,0.09876543209876548,4.737194547137081e-07,0.29649322479981377,0.08401920438957469
6,0.1,5,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: For Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression duration for maximal healing? Answer: Yes, healing is best achieved with prompt and sufficient acid suppression, though timing depends on individual severity and other factors.",5.210914001850789e-07,0.25937823917374914,0.1262002743484225,0.0398953822252012,0.2882292585708912,0.11282578875171474,0.039837633900963065,0.3181289663837248,0.09876543209876548,5.210914001850789e-07,0.3491369582852326,0.08401920438957469
6,0.1,6,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Can the healing of Los Angeles grades C and D reflux oesophagitis be maximized by optimizing acid suppression timing? Answer: Yes, timely and adequate acid suppression leads to optimal healing, but the ideal timing varies with patient-specific factors like severity.",5.210914001850789e-07,0.2940355982017455,0.10121671090332057,0.0398953822252012,0.2882292585708912,0.11282578875171474,0.039837633900963065,0.3181289663837248,0.09876543209876548,5.210914001850789e-07,0.3491369582852326,0.08401920438957469
6,0.1,7,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is there an optimal timing for acid suppression to maximize healing in Los Angeles grades C and D reflux oesophagitis? Answer: Yes, effective healing requires timely and adequate acid suppression, with the best timing differing based on individual severity and other factors.",4.737194547137081e-07,0.21058807500431742,0.1262002743484225,0.03626852929563745,0.23821883799622778,0.11282578875171474,0.03621603081905733,0.2668356719961751,0.09876543209876548,4.737194547137081e-07,0.29649322479981377,0.08401920438957469
6,0.1,8,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Does optimal healing of Los Angeles grades C and D reflux oesophagitis depend on the timing of acid suppression? Answer: Yes, maximal healing is achieved through timely and sufficient acid suppression, though the optimal timing varies among individuals depending on severity.",4.974054274493935e-07,0.23468562658337744,0.1262002743484225,0.038081955760419325,0.2629114505865995,0.11282578875171474,0.0380268323600102,0.2921534799804668,0.09876543209876548,4.974054274493935e-07,0.32246871120307175,0.08401920438957469
6,0.1,9,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: Is timely acid suppression crucial for maximal healing of Los Angeles grades C and D reflux oesophagitis? Answer: Yes, optimal healing is possible with adequate and prompt acid suppression, but the perfect timing varies according to individual severity and other factors.",4.974054274493935e-07,0.23468562658337744,0.1262002743484225,0.038081955760419325,0.2629114505865995,0.11282578875171474,0.0380268323600102,0.2921534799804668,0.09876543209876548,4.974054274493935e-07,0.32246871120307175,0.08401920438957469
6,0.1,10,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Question: For maximal healing of Los Angeles grades C and D reflux oesophagitis, is there an ideal acid suppression timing? Answer: Yes, healing is optimized by timely and adequate acid suppression, although the best timing depends on factors like the severity of the condition.",4.500334819780227e-07,0.187057577594123,0.1262002743484225,0.03445510283085558,0.21412128641716777,0.11282578875171474,0.034405229278104466,0.24214305940580338,0.09876543209876548,4.500334819780227e-07,0.27117541681552204,0.08401920438957469
7,0.1,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening methods, some degree of discordance between TEOAE and AABR outcomes may be unavoidable in certain types of hearing loss among seemingly healthy newborns whose mothers had prenatal care. This highlights the limitations of relying solely on perinatal morbidities for targeted screening in these cases.",1.6580180914979784e-07,0.08562668083250946,0.02903801652892562,0.012693985253473108,0.08409473944941182,0.031970247933884303,0.012675610786670066,0.08238635499868874,0.035041322314049606,1.6580180914979784e-07,0.10877613617595294,0.017851239669421492
7,0.1,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordant results between TEOAE and AABR in newborns be anticipated? With the screening technologies available, discordance between TEOAE and AABR may be inevitable in some hearing loss categories among apparently healthy newborns whose mothers underwent prenatal care. This suggests potential shortcomings in using perinatal morbidities as the sole basis for targeted screening.",0.0,0.026659506944613387,0.019076051645147855,0.0,0.027182242374899968,0.0195503540191587,0.0,0.027725887222397994,0.019991670137442734,0.0,0.0,0.0
7,0.1,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is discordance in TEOAE and AABR outcomes predictable in newborn infants? Considering current screening technologies, some discordance between TEOAE and AABR results may be unavoidable for certain types of hearing loss in apparently healthy newborns whose mothers received prenatal care. This points to the limitations of perinatal morbidity-based targeted screening for these cases.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
7,0.1,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we predict when TEOAE and AABR results will be discordant in newborns? Given the existing screening tools, discordance between TEOAE and AABR may be inevitable in some categories of hearing loss among newborns who appear healthy and whose mothers had prenatal care. This underscores the potential limitations of targeting screening based on perinatal morbidities.",4.737194547137081e-08,0.03971510627504049,0.0014177514792899568,0.0036268529295637453,0.03949202582307443,0.0007390532544378596,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
7,0.1,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it feasible to foresee discordance between TEOAE and AABR outcomes in newborns? With current screening technologies, discordant TEOAE and AABR results may be unavoidable in certain hearing loss categories among apparently healthy newborns whose mothers received prenatal care. This reveals the potential limitations of using perinatal morbidities as criteria for targeted screening.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
7,0.1,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Are discordant TEOAE and AABR outcomes in newborns predictable? Given the screening technologies available, some discordance between TEOAE and AABR may be inevitable in certain types of hearing loss among apparently healthy newborns whose mothers had prenatal care. This highlights the limitations of relying on perinatal morbidities for targeted screening in such cases.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
7,0.1,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discordance in TEOAE and AABR outcomes among newborns? Considering current screening technologies, discordance between TEOAE and AABR may be unavoidable for some hearing loss categories in apparently healthy newborns whose mothers received prenatal care. This points to the limitations of perinatal morbidity-based targeted screening.",9.474389094274162e-08,0.08448595883097187,0.0031879017013232494,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
7,0.1,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance between TEOAE and AABR results in newborns be predicted? Given the available screening technologies, some discordance may be inevitable in certain hearing loss categories among apparently healthy newborns whose mothers had prenatal care. This suggests limitations in using perinatal morbidities as the basis for targeted screening.",1.1842986367842703e-07,0.047777102982143216,0.03840000000000001,0.009067132323909363,0.07600199386033113,0.019599999999999992,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
7,0.1,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is predicting discordance in TEOAE and AABR outcomes in newborns possible? With current screening methods, discordance between TEOAE and AABR may be unavoidable in some hearing loss categories among apparently healthy newborns whose mothers received prenatal care. This reveals the potential limitations of perinatal morbidity-based targeted screening.",1.4211583641411244e-07,0.1295569760778843,0.004988429752066113,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
7,0.1,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we anticipate discordance in TEOAE and AABR outcomes in newborns? Given the screening technologies available, discordance between TEOAE and AABR may be inevitable for certain types of hearing loss among apparently healthy newborns whose mothers had prenatal care. This underscores the limitations of using perinatal morbidities as criteria for targeted screening.",2.3685972735685406e-08,0.020463556717675413,0.0007503540191586833,0.0018134264647818726,0.020346272143678235,0.00039167013744274143,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
8,0.1,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article explores whether culture, attitudes, and faith have a role in recovery outcome measures, focusing on the cultural relevance of the RAQ in Australia and emphasizing the need for comprehensive, inclusive tools.",9.47438909427412e-08,0.07927485895860897,0.02775510204081633,0.007253705859127518,0.1213608570042668,0.0,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
8,0.1,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper examines the place of culture, attitudes, and faith in recovery outcome measures, highlighting the RAQ's cultural suitability in Australian contexts and the necessity for robust, inclusive measures.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.1,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Discussing recovery outcome measures, this study questions the inclusion of culture, attitudes, and faith, analyzing the RAQ's appropriateness in Australia and calling for rigorous, inclusive metrics.",2.605457000925383e-07,0.3261349368901354,0.02775510204081633,0.019947691112600675,0.3772942311414682,0.0,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
8,0.1,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research addresses the role of culture, attitudes, and faith in recovery outcome measures, assessing the RAQ's cultural fit in Australian settings and advocating for the development of inclusive, rigorous tools.",1.421158364141118e-07,0.1438133800961805,0.02775510204081633,0.010880558788691277,0.18805223150294026,0.0,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
8,0.1,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper considers whether culture, attitudes, and faith should be included in recovery outcome measures, reviewing the RAQ's cultural relevance in Australia and the need for comprehensive, inclusive assessments.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.1,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Exploring recovery outcome measures, this article asks if culture, attitudes, and faith have a place, focusing on the RAQ's cultural appropriateness in Australia and the importance of rigorous, inclusive measures.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.1,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This study discusses the inclusion of culture, attitudes, and faith in recovery outcome measures, evaluating the RAQ's suitability in Australian contexts and emphasizing the need for inclusive, rigorous tools.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.1,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The article investigates the role of culture, attitudes, and faith in recovery outcome measures, highlighting the RAQ's cultural appropriateness in Australia and the necessity for developing inclusive, rigorous measures.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.1,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper explores whether culture, attitudes, and faith belong in recovery outcome measures, analyzing the RAQ's cultural fit in Australian settings and calling for the creation of rigorous, inclusive tools.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.1,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study examines the place of culture, attitudes, and faith in recovery outcome measures, focusing on the RAQ's cultural relevance in Australia and the need for robust, inclusive outcome measures.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
9,0.1,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging enable prediction of various histologic subtypes of primary parotid gland tumors? Yes, it does, as this imaging technique helps differentiate histologic subtypes by evaluating apparent diffusion coefficient values, distinguishing benign from malignant tumors for better diagnosis and treatment.",3.789755637709665e-07,0.11676413170254119,0.141135195650737,0.029014823436509962,0.1592325252032385,0.1204,0.028972824655245866,0.2374512108269351,0.07100591715976332,3.789755637709665e-07,0.31856618708246476,0.0181755829903978
9,0.1,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Indeed, it can, by analyzing apparent diffusion coefficient values to differentiate benign and malignant tumors, facilitating accurate diagnosis and treatment planning.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.1,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is it possible to predict histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Yes, this imaging method allows for the prediction by assessing apparent diffusion coefficient values, which helps distinguish between benign and malignant tumors for precise diagnosis and therapy.",3.552895910352811e-07,0.06022662569425519,0.16493055555555555,0.02720139697172809,0.13513497362417848,0.1204,0.027162023114293,0.2127585982365634,0.07100591715976332,3.552895910352811e-07,0.29324837909817303,0.0181755829903978
9,0.1,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging provide prediction of various histologic subtypes in primary parotid gland tumors? Yes, by measuring apparent diffusion coefficient values, it can differentiate benign from malignant tumors, supporting accurate diagnosis and treatment decisions.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.1,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can different histologic subtypes of primary parotid gland tumors be predicted through diffusion-weighted echo-planar MR imaging? Yes, this technique uses apparent diffusion coefficient values to distinguish benign and malignant tumors, aiding in diagnosis and treatment planning.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.1,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is diffusion-weighted echo-planar MR imaging effective in predicting histologic subtypes of primary parotid gland tumors? Yes, it enables differentiation of benign and malignant tumors by evaluating apparent diffusion coefficient values, which assists in accurate diagnosis and treatment.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.1,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging distinguish different histologic subtypes of primary parotid gland tumors? Yes, by assessing apparent diffusion coefficient values, it helps identify benign versus malignant tumors, improving diagnosis and treatment strategies.",6.158352911278197e-07,0.35569083858809103,0.16493055555555555,0.047149088084328716,0.43881738742239973,0.1204,0.047080840064774566,0.5251332832787163,0.07100591715976332,6.158352911278206e-07,0.614832003225636,0.0181755829903978
9,0.1,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging facilitate prediction of histologic subtypes in primary parotid gland tumors? Yes, it does so by analyzing apparent diffusion coefficient values to differentiate benign from malignant tumors, aiding in precise diagnosis and treatment planning.",4.974054274493932e-07,0.2105088287435919,0.16493055555555555,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.37098260345145784,0.07100591715976332,4.974054274493935e-07,0.4557673085959473,0.0181755829903978
9,0.1,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is it feasible to predict different histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Yes, this imaging approach assesses apparent diffusion coefficient values to distinguish benign and malignant tumors, supporting accurate diagnosis and treatment.",4.974054274493932e-07,0.2105088287435919,0.16493055555555555,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.37098260345145784,0.07100591715976332,4.974054274493935e-07,0.4557673085959473,0.0181755829903978
9,0.1,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging be used to predict histologic subtypes of primary parotid gland tumors? Yes, by evaluating apparent diffusion coefficient values, it allows differentiation between benign and malignant tumors, facilitating accurate diagnosis and treatment.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
10,0.1,1,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, it can correlate, but the accuracy may vary depending on factors like disease severity and ventilation mode.",6.868932093348765e-07,0.21711950422520943,0.3323688271604938,0.052589367478674306,0.31360945921554917,0.1875,0.05251324468763313,0.38692652794527627,0.15089163237311393,6.868932093348768e-07,0.4627414949842712,0.109375
10,0.1,2,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a correlation between end-tidal and arterial carbon dioxide levels in extremely low birth weight infants within the first week of life? Yes, a correlation exists, though it can be influenced by disease severity and ventilation methods.",6.868932093348765e-07,0.21711950422520943,0.3323688271604938,0.052589367478674306,0.31360945921554917,0.1875,0.05251324468763313,0.38692652794527627,0.15089163237311393,6.868932093348768e-07,0.4627414949842712,0.109375
10,0.1,3,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide measurements reflect arterial carbon dioxide in extremely low birth weight infants during the initial week? Yes, but the correlation may fluctuate due to factors such as illness severity and ventilation type.",7.579511275419324e-07,0.3049828406502204,0.3299902433425161,0.05802964687301994,0.4006208362051793,0.1875,0.05794564931049175,0.47653868663496324,0.15089163237311393,7.57951127541933e-07,0.5551148151152865,0.109375
10,0.1,4,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does measuring end-tidal carbon dioxide correspond with arterial carbon dioxide in extremely low birth weight infants in their first week? Yes, it can, although the strength of this correlation may be affected by disease severity and ventilation mode.",6.868932093348765e-07,0.21711950422520943,0.3323688271604938,0.052589367478674306,0.31360945921554917,0.1875,0.05251324468763313,0.38692652794527627,0.15089163237311393,6.868932093348768e-07,0.4627414949842712,0.109375
10,0.1,5,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is end-tidal carbon dioxide measurement a reliable indicator of arterial carbon dioxide in extremely low birth weight infants during the first week? Yes, it correlates, but the accuracy can vary with disease severity and ventilation settings.",7.342651548062471e-07,0.2748303505323304,0.33082828719723184,0.05621622040823806,0.3707678730554975,0.1875,0.05613484776953888,0.44576702796820955,0.15089163237311393,7.342651548062476e-07,0.5233661168007067,0.109375
10,0.1,6,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide levels be used to estimate arterial carbon dioxide in extremely low birth weight infants in the first week of life? Yes, there is a correlation, but it may be influenced by factors like disease severity and ventilation mode.",5.921493183921352e-07,0.1108099925880146,0.335,0.045335661619546816,0.20824894355772328,0.1875,0.045270038523821665,0.27871294330504526,0.15089163237311393,5.921493183921352e-07,0.35151585987404665,0.109375
10,0.1,7,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement align with arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, it does, though the correlation can be affected by disease severity and ventilation type.",7.579511275419324e-07,0.3049828406502204,0.3299902433425161,0.05802964687301994,0.4006208362051793,0.1875,0.05794564931049175,0.47653868663496324,0.15089163237311393,7.57951127541933e-07,0.5551148151152865,0.109375
10,0.1,8,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a relationship between end-tidal and arterial carbon dioxide in extremely low birth weight infants in the first week? Yes, a correlation exists, but it may vary depending on disease severity and ventilation mode.",7.579511275419324e-07,0.2642094770878707,0.359375,0.05802964687301994,0.4006208362051793,0.1875,0.05794564931049175,0.47653868663496324,0.15089163237311393,7.57951127541933e-07,0.5551148151152865,0.109375
10,0.1,9,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide measurement serve as a proxy for arterial carbon dioxide in extremely low birth weight infants during the first week? Yes, it can correlate, but factors such as disease severity and ventilation mode may impact the correlation.",6.395212638635059e-07,0.1625543648338721,0.333751731301939,0.04896251454911056,0.259542237945273,0.1875,0.0488916416057274,0.3313566767904641,0.15089163237311393,6.39521263863506e-07,0.40558308114432284,0.109375
10,0.1,10,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life? Yes, it can, although the correlation may be influenced by disease severity and ventilation mode.",7.105791820705618e-07,0.24555923994569717,0.3316198979591837,0.05440279394345618,0.341780336182246,0.1875,0.054324046228586005,0.4159140648185278,0.15089163237311393,7.105791820705622e-07,0.492594458133953,0.109375
11,0.1,1,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does comorbidity of major depression and alcohol use disorder in adolescence result in worse depression outcomes? The analyses indicate that slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are attributable to greater exposure to adverse childhood experiences within this group. Adolescent MD/AUD comorbidity probably serves as a risk marker rather than a direct cause.,1.6580180914979784e-07,0.09261665379352646,0.015380859375,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
11,0.1,2,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","In adolescents, does having both major depression and alcohol use disorder lead to poorer depression outcomes? Findings suggest that the marginally increased depression rates by age 35 in those with comorbid MD/AUD are due to higher exposure to adverse childhood conditions among them. Thus, adolescent MD/AUD comorbidity is more likely a risk indicator than a causal factor.",2.1317375462116866e-07,0.1277079736047959,0.015380859375,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
11,0.1,3,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does the coexistence of major depression and alcohol use disorder during adolescence predict worse depression outcomes? The study results imply that the slightly higher depression rates through age 35 in the comorbid MD/AUD group stem from greater adverse childhood experiences. Therefore, adolescent MD/AUD comorbidity is probably a marker of risk rather than a direct cause.",2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.1,4,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Are depression outcomes poorer when major depression and alcohol use disorder co-occur in adolescence? Analysis shows that the modestly elevated depression rates up to age 35 in the comorbid MD/AUD group can be explained by increased exposure to adverse childhood environments. Hence, adolescent MD/AUD comorbidity likely indicates risk instead of causing worse outcomes.",3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.1,5,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does adolescent comorbidity of major depression and alcohol use disorder lead to worse depression outcomes? The data suggest that the slightly higher depression rates by age 35 among the comorbid group are due to more frequent adverse childhood experiences. Thus, adolescent MD/AUD comorbidity is more a risk marker than a direct cause of poorer outcomes.",2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.1,6,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Is comorbidity of major depression and alcohol use disorder in adolescence associated with poorer depression outcomes? Results indicate that the marginally higher depression rates through age 35 in the comorbid MD/AUD group are explained by increased adverse childhood exposures. Therefore, adolescent MD/AUD comorbidity likely serves as a risk marker rather than a cause.",3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.1,7,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does having both major depression and alcohol use disorder in adolescence result in worse depression outcomes? The findings suggest that the slightly elevated depression rates up to age 35 in the comorbid group are due to greater exposure to adverse childhood circumstances. Adolescent MD/AUD comorbidity is thus probably a risk marker, not a direct cause.",2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.1,8,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Are depression outcomes negatively impacted by comorbid major depression and alcohol use disorder in adolescence? The analyses reveal that the modestly higher depression rates by age 35 among the comorbid MD/AUD group are attributable to increased adverse childhood experiences. Hence, adolescent MD/AUD comorbidity is more likely a risk indicator than a causal factor.",3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.1,9,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does the presence of both major depression and alcohol use disorder in adolescence lead to poorer depression outcomes? The results suggest that the marginally increased depression rates through age 35 in the comorbid group are explained by greater exposure to adverse childhood conditions. Therefore, adolescent MD/AUD comorbidity probably acts as a risk marker rather than a cause.",2.1317375462116866e-07,0.1277079736047959,0.015380859375,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
11,0.1,10,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Is adolescent comorbidity of major depression and alcohol use disorder linked to worse depression outcomes? Findings indicate that the slightly higher depression rates by age 35 in the comorbid MD/AUD group result from increased adverse childhood experiences. Thus, adolescent MD/AUD comorbidity is likely a risk marker, not a direct cause.",3.789755637709665e-07,0.26123936622931865,0.015380859375,0.029014823436509962,0.28768207245178035,0.0,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
12,0.1,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does having an optimistic perspective predict improved survival rates in older age? Answer: Yes, maintaining an optimistic outlook is associated with better survival in advanced years. Studies suggest optimism contributes to longevity, possibly because it affects how people manage stress.",9.474389094274162e-08,0.05907260132038994,0.10798042547456571,0.0072537058591274906,0.03131914542397851,0.09204470742932283,0.007243206163811466,0.03406944136079737,0.047500000000000014,9.474389094274162e-08,0.0688420964717924,0.024375
12,0.1,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can optimism forecast greater survival chances in elderly individuals? Answer: Indeed, optimism can be a predictor of enhanced survival at older ages. Research shows a connection between optimism and longer life, likely due to its impact on coping mechanisms.",1.1842986367842692e-07,0.06841215236409459,0.13296398891966763,0.009067132323909363,0.005343659020720537,0.09204470742932283,0.009054007704764333,0.06073768844295824,0.047500000000000014,1.1842986367842703e-07,0.09624107065990772,0.024375
12,0.1,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is an optimistic attitude linked to increased survival among the elderly? Answer: Yes, an optimistic attitude is correlated with improved survival in advanced age. Evidence points to optimism fostering longevity by influencing coping strategies.",2.3685972735685343e-07,0.15033569627408783,0.07437023891966763,0.01813426464781874,0.17774385927312153,0.06177126992932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.1,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does optimism serve as a predictor for better survival outcomes in advanced age? Answer: Yes, optimism can predict superior survival rates among older adults. This may be because optimism shapes how individuals handle challenges.",2.3685972735685343e-07,0.06878896914938792,0.13296398891966763,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.1,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can a positive outlook enhance survival prospects in later life? Answer: Yes, a positive outlook is associated with better survival at advanced ages, as optimism appears to affect coping methods that promote longevity.",2.605457000925387e-07,0.18265977236694209,0.07261019079271655,0.01994769111260062,0.20982829669093706,0.060827225639520525,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
12,0.1,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is there a relationship between optimism and survival at older ages? Answer: Yes, optimism is linked to improved survival in elderly populations, potentially due to its role in influencing coping strategies.",3.0791764556390933e-07,0.16116228928040321,0.13296398891966763,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
12,0.1,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does an optimistic mindset contribute to longer survival in advanced age? Answer: Yes, having an optimistic mindset can predict better survival outcomes among older individuals, likely because it impacts how they cope with difficulties.",2.3685972735685343e-07,0.15033569627408783,0.07437023891966763,0.01813426464781874,0.17774385927312153,0.06177126992932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.1,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can optimism predict longevity in older adults? Answer: Yes, optimism is a predictor of increased survival at advanced ages, possibly through its effect on coping behaviors.",4.2634750924233583e-07,0.33705295574406735,0.13296398891966763,0.03264167636607378,0.4133666758374659,0.09204470742932283,0.032594427737151675,0.4936017707392386,0.047500000000000014,4.263475092423373e-07,0.5442657931868684,0.024375
12,0.1,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is better survival at advanced ages associated with optimism? Answer: Yes, optimism is associated with enhanced survival in later life, potentially due to its influence on coping strategies.",3.7897556377096523e-07,0.31245549648748483,0.09729869399511346,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.41355906306570134,0.047500000000000014,3.789755637709665e-07,0.46088418424781796,0.024375
12,0.1,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does maintaining optimism improve survival chances in the elderly? Answer: Yes, maintaining an optimistic outlook can lead to better survival at advanced ages, as it may positively affect coping mechanisms.",3.3160361829959463e-07,0.1939521121033949,0.13296398891966763,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.33945109091197967,0.047500000000000014,3.316036182995957e-07,0.3839231431116885,0.024375
13,0.1,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? ACR independently predicts adverse outcomes for both mother and newborn in suspected preeclampsia cases and could aid risk assessment in prognostic models.,1.8948778188548325e-07,0.019793820182237187,0.13888888888888887,0.014507411718254981,0.03791589417729968,0.10275824770146022,0.014486412327622933,0.06860345676169954,0.08436992969172526,1.8948778188548325e-07,0.10064473495054127,0.06489994591671175
13,0.1,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia serve as a prognostic indicator for negative maternal and neonatal outcomes? ACR acts as an independent prognostic marker for adverse outcomes in these cases and may help improve risk prediction models.,1.4211583641411244e-07,0.06742186917149162,0.13888888888888887,0.010880558788691236,0.010874269992132035,0.10275824770146022,0.0108648092457172,0.018593036187036116,0.08436992969172526,1.4211583641411244e-07,0.049351440562991566,0.06489994591671175
13,0.1,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict maternal and neonatal complications? ACR is an independent prognostic factor for adverse outcomes and might be valuable for risk prediction within prognostic frameworks.,3.3160361829959516e-07,0.13843018503265725,0.13888888888888887,0.025387970506946224,0.20043482367507393,0.10275824770146022,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.2724949918772013,0.06489994591671175
13,0.1,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a reliable prognostic factor for poor maternal and neonatal outcomes? ACR independently forecasts adverse outcomes and could be useful for risk stratification in prognostic models.,3.0791764556390986e-07,0.1102593080659604,0.13888888888888887,0.023574544042164344,0.17144728680182242,0.10275824770146022,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2417233332104476,0.06489994591671175
13,0.1,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict adverse outcomes for mother and baby? ACR is an independent prognostic factor and may assist in risk prediction within prognostic models.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
13,0.1,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia a prognostic marker for maternal and neonatal adverse events? ACR independently predicts these adverse outcomes and could inform risk prediction models.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
13,0.1,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic factor for negative maternal and neonatal outcomes? ACR is an independent predictor and may be useful in risk prediction models.,3.3160361829959516e-07,0.13843018503265725,0.13888888888888887,0.025387970506946224,0.20043482367507393,0.10275824770146022,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.2724949918772013,0.06489994591671175
13,0.1,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a significant prognostic factor for adverse maternal and neonatal outcomes? ACR independently forecasts these outcomes and might help guide risk prediction in prognostic models.,3.3160361829959516e-07,0.13843018503265725,0.13888888888888887,0.025387970506946224,0.20043482367507393,0.10275824770146022,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.2724949918772013,0.06489994591671175
13,0.1,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia act as a prognostic factor for maternal and neonatal adverse outcomes? ACR is an independent predictor and could be valuable for risk prediction within prognostic models.,2.8423167282822456e-07,0.08286033387784508,0.13888888888888887,0.02176111757738247,0.14327640983512557,0.10275824770146022,0.0217296184914344,0.17681704140193055,0.08436992969172526,2.8423167282822487e-07,0.2118703700607658,0.06489994591671175
13,0.1,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia an independent prognostic factor for adverse maternal and neonatal outcomes? ACR may be useful to inform risk predictions in prognostic models.,4.0266153650665106e-07,0.22804234372234422,0.13888888888888887,0.030828249901291863,0.2928081438060892,0.10275824770146022,0.030783626196198767,0.33096772122918905,0.08436992969172526,4.026615365066519e-07,0.37093506469045456,0.06489994591671175
14,0.1,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Rapid prescreening might not reliably identify glandular cell abnormalities in Pap smears. Manual examination by a cytotechnologist or pathologist is generally more dependable for detecting these abnormalities.,2.3685972735685374e-07,0.35960372502276483,0.08525320224065713,0.018134264647818726,0.3606469881263088,0.08264462809917354,0.018108015409528666,0.3305312489163281,0.056932966023875105,2.3685972735685406e-07,0.29860247286444963,0.029384756657483937
14,0.1,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Rapid prescreening often fails to effectively detect glandular cell abnormalities in Pap smears. Traditional manual review by cytotechnologists or pathologists remains the more reliable approach.,2.8423167282822434e-07,0.5029543774222329,0.14282382796607693,0.02176111757738248,0.4653743261223311,0.11555555555555559,0.021729618491434413,0.4361816884056475,0.09000000000000004,2.8423167282822487e-07,0.40509712868852965,0.06222222222222223
14,0.1,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Can rapid prescreening identify glandular cell abnormalities in Pap smears? Rapid prescreening may not be sufficient to detect glandular cell abnormalities in Pap smears. Manual slide review by trained cytotechnologists or pathologists is usually more accurate.,2.8423167282822434e-07,0.46334596710452125,0.11762234824616677,0.02176111757738248,0.4246009625599809,0.08740894901144641,0.021729618491434413,0.3941727683717118,0.06035379812695108,2.8423167282822487e-07,0.36177542990353295,0.031217481789802305
14,0.1,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Rapid prescreening might not effectively identify glandular cell abnormalities in Pap smears. Manual review by cytotechnologists or pathologists is typically more reliable.,3.3160361829959494e-07,0.5341890157085798,0.1254171328266656,0.025387970506946238,0.49287059004435907,0.09274673008323425,0.02535122157334016,0.4621136311638754,0.06420927467300831,3.316036182995957e-07,0.42920206429343644,0.033293697978596916
14,0.1,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Are glandular cell abnormalities in Pap smears caught by rapid prescreening? Rapid prescreening may not adequately detect glandular cell abnormalities in Pap smears. More traditional methods, like manual slide examination by cytotechnologists or pathologists, are generally more trustworthy.",2.3685972735685374e-07,0.35960372502276483,0.08525320224065713,0.018134264647818726,0.3606469881263088,0.08264462809917354,0.018108015409528666,0.3305312489163281,0.056932966023875105,2.3685972735685406e-07,0.29860247286444963,0.029384756657483937
14,0.1,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Does rapid prescreening detect glandular cell abnormalities in Pap smears? Rapid prescreening may not be effective at detecting glandular cell abnormalities in Pap smears. Manual review by cytotechnologists or pathologists is usually more dependable.,3.3160361829959494e-07,0.5341890157085798,0.1254171328266656,0.025387970506946238,0.4928705900443586,0.09274673008323425,0.02535122157334016,0.4621136311638754,0.06420927467300831,3.316036182995957e-07,0.42920206429343644,0.033293697978596916
14,0.1,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Is rapid prescreening capable of detecting glandular cell abnormalities in Pap smears? Rapid prescreening might not reliably detect glandular cell abnormalities in Pap smears. Manual slide review by cytotechnologists or pathologists is often more effective.,3.0791764556390964e-07,0.4981582702009657,0.12142073640840748,0.023574544042164358,0.45816059512442253,0.09000000000000004,0.023540420032387287,0.42756998454058737,0.06222222222222223,3.079176455639103e-07,0.3949216023724662,0.0322222222222222
14,0.1,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Can glandular cell abnormalities in Pap smears be detected by rapid prescreening? Rapid prescreening may not successfully identify glandular cell abnormalities in Pap smears. Manual examination by cytotechnologists or pathologists is typically more reliable.,3.3160361829959494e-07,0.4921800956746436,0.0976395235665526,0.025387970506946238,0.4928705900443586,0.09274673008323425,0.02535122157334016,0.4621136311638754,0.06420927467300831,3.316036182995957e-07,0.42920206429343644,0.033293697978596916
14,0.1,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities in Pap smears identified through rapid prescreening? Rapid prescreening may not effectively identify glandular cell abnormalities in Pap smears. Manual review by cytotechnologists or pathologists is generally more accurate.,3.5528959103528024e-07,0.5282028693456402,0.10118243894911463,0.027201396971728117,0.5288117108220018,0.09566326530612247,0.027162023114293034,0.4978847321828237,0.06632653061224487,3.552895910352811e-07,0.4646970577635088,0.03443877551020409
14,0.1,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Does rapid prescreening effectively detect glandular cell abnormalities in Pap smears? Rapid prescreening may not be sufficient to detect glandular cell abnormalities in Pap smears. Traditional manual slide review by cytotechnologists or pathologists is usually more reliable.,2.6054570009253904e-07,0.4681820987359173,0.13873345935727793,0.0199476911126006,0.4317269762705256,0.11238293444328822,0.01991881695048154,0.4026220558412059,0.08740894901144641,2.6054570009253947e-07,0.37169991251965406,0.06035379812695108
15,0.1,1,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program may achieve lower expenditures relative to HMOs and primary care case management, though actual savings vary based on factors like PSN efficiency.",2.1317375462116866e-07,0.09935677321023872,0.044865655609638885,0.016320838183036854,0.08368679975017468,0.06221832667237916,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.1,2,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? In Florida's Medicaid program, Provider Service Networks (PSNs) might result in decreased spending compared to HMOs and primary care case management, but the precise savings depend on multiple factors including the PSN's operational efficiency.",1.4211583641411244e-07,0.030140064474069028,0.05150900546103758,0.010880558788691236,0.04684664001177774,0.04521247837370242,0.0108648092457172,0.06381817240986454,0.03566529492455417,1.4211583641411244e-07,0.09030753510148237,0.0181755829903978
15,0.1,3,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Within Florida's Medicaid program, do provider service networks reduce costs more than HMOs or primary care case management? Provider Service Networks (PSNs) in Florida's Medicaid program have the potential to lower expenditures compared to HMOs and primary care case management, although the exact amount saved depends on various factors such as the efficiency of the PSN.",7.105791820705622e-08,0.059879683742845025,0.0749305555555556,0.005440279394345618,0.040514265355837686,0.06682397985299236,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
15,0.1,4,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks in Florida's Medicaid program incur lower costs than HMOs or primary care case management? Provider Service Networks (PSNs) may lead to reduced expenditures in Florida's Medicaid program when compared to HMOs and primary care case management, but the actual savings are influenced by factors like PSN efficiency.",1.8948778188548325e-07,0.10348494651645668,0.0286406691304609,0.014507411718254981,0.11847213412280899,0.022818574052714757,0.014486412327622933,0.1335212994534496,0.014841392706355885,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
15,0.1,5,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida's Medicaid program, do provider service networks result in cost savings compared to HMOs or primary care case management? Provider Service Networks (PSNs) could potentially lower expenditures relative to HMOs and primary care case management in Florida's Medicaid program, though the exact savings depend on factors such as the efficiency of the PSN.",1.1842986367842703e-07,0.0603868068726614,0.018757716049382728,0.009067132323909363,0.05251985480842958,0.027417339484813535,0.009054007704764333,0.0711977874885843,0.016065294924554177,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
15,0.1,6,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are provider service networks associated with lower expenditures than HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program might reduce costs compared to HMOs and primary care case management, but the degree of savings depends on various factors including PSN efficiency.",2.1317375462116866e-07,0.09935677321023872,0.044865655609638885,0.016320838183036854,0.11256793227350581,0.041584006151480196,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.1,7,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks offer cost advantages over HMOs or primary care case management in Florida's Medicaid program? In Florida's Medicaid program, Provider Service Networks (PSNs) can potentially lower expenditures compared to HMOs and primary care case management, although the exact savings depend on factors like the efficiency of the PSN.",1.8948778188548325e-07,0.07575905929405868,0.047161960514233284,0.014507411718254981,0.09018041246730091,0.04284214519789904,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
15,0.1,8,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Within Florida's Medicaid program, do provider service networks achieve lower expenditures than HMOs or primary care case management? Provider Service Networks (PSNs) may result in reduced costs compared to HMOs and primary care case management in Florida's Medicaid program, but the actual savings depend on factors such as PSN efficiency.",2.1317375462116866e-07,0.09935677321023872,0.044865655609638885,0.016320838183036854,0.11256793227350581,0.041584006151480196,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.1,9,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks in Florida's Medicaid program lead to cost reductions compared with HMOs or primary care case management? Provider Service Networks (PSNs) could potentially lower expenditures relative to HMOs and primary care case management in Florida's Medicaid program, though the precise savings depend on various factors including the efficiency of the PSN.",1.1842986367842703e-07,0.008073812113420509,0.0535679480408431,0.009067132323909363,0.02586034786381619,0.04633017672855455,0.009054007704764333,0.04401554511368477,0.03566529492455417,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
15,0.1,10,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are expenditures lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program might result in decreased spending compared to HMOs and primary care case management, but the exact savings depend on factors such as the efficiency of the PSN.",1.1842986367842703e-07,0.0603868068726614,0.018757716049382728,0.009067132323909363,0.05251985480842958,0.027417339484813535,0.009054007704764333,0.04401554511368477,0.03566529492455417,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
16,0.1,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Is lumbar drainage an effective treatment for postoperative cerebrospinal fluid fistula following spine surgery? Answer: Yes, lumbar drainage is typically an effective approach for managing postoperative cerebrospinal fluid (CSF) fistulas after spine surgery, providing a dependable way to control CSF leaks.",2.3685972735685406e-08,0.1667032544611904,0.09107925493060626,0.0018134264647818726,0.20393650451319978,0.12377676713341046,0.0018108015409528666,0.17190120862640512,0.10380622837370242,2.3685972735685406e-08,0.10160307741296659,0.05387755102040818
16,0.1,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Does lumbar drainage work well for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Yes, lumbar drainage is generally considered an effective method to treat postoperative cerebrospinal fluid (CSF) fistulas after spine surgery, serving as a reliable technique to handle CSF leaks.",4.737194547137081e-08,0.19402100200103867,0.0933171745152355,0.0036268529295637453,0.229474418543278,0.12438533057851237,0.003621603081905733,0.19721901661069685,0.10380622837370242,4.737194547137081e-08,0.12757856381622457,0.05387755102040818
16,0.1,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Is lumbar drainage effective in treating postoperative cerebrospinal fluid fistula after spine surgery? Answer: Yes, lumbar drainage is usually effective for postoperative cerebrospinal fluid (CSF) fistulas following spine surgery and is a trusted method to manage CSF leaks.",4.73719454713706e-08,0.1165212861690681,0.1091326530612245,0.0036268529295637453,0.12316490690608317,0.1217541577390062,0.003621603081905733,0.09185850095287096,0.10380622837370242,4.737194547137081e-08,0.019364979175993557,0.05387755102040818
16,0.1,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Can lumbar drainage effectively manage postoperative cerebrospinal fluid fistula after spine surgery? Answer: Yes, lumbar drainage is commonly effective in treating postoperative cerebrospinal fluid (CSF) fistulas after spine surgery, acting as a dependable way to control CSF leakage.",4.73719454713706e-08,0.08003985561328131,0.08369377162629757,0.0036268529295637453,0.12316490690608317,0.1217541577390062,0.003621603081905733,0.09185850095287096,0.10380622837370242,4.737194547137081e-08,0.019364979175993557,0.05387755102040818
16,0.1,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Is lumbar drainage a reliable treatment for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Yes, lumbar drainage is generally a reliable and effective method for managing postoperative cerebrospinal fluid (CSF) fistulas following spine surgery, helping to control CSF leaks.",0.0,0.13862943611198997,0.08873456790123453,0.0,0.1777300462974205,0.12313706188045143,0.0,0.14592572222314715,0.10380622837370242,0.0,0.07493483033080572,0.05387755102040818
16,0.1,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistula after spine surgery? Answer: Yes, lumbar drainage is an effective treatment for postoperative cerebrospinal fluid (CSF) fistulas after spine surgery and is widely used to manage CSF leaks.",7.10579182070559e-08,0.049427670092656584,0.08098025711662077,0.005440279394345618,0.09472517118559542,0.12100522853769605,0.0054324046228586,0.06368762398617411,0.10380622837370242,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
16,0.1,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Is lumbar drainage effective for postoperative cerebrospinal fluid fistula management after spine surgery? Answer: Yes, lumbar drainage is typically effective in managing postoperative cerebrospinal fluid (CSF) fistulas after spine surgery and serves as a reliable method to address CSF leaks.",0.0,0.13862943611198997,0.08873456790123455,0.0,0.1777300462974205,0.12313706188045143,0.0,0.14592572222314715,0.10380622837370242,0.0,0.07493483033080572,0.05387755102040818
16,0.1,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can",Question: How effective is lumbar drainage for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage is generally effective and considered a reliable method to manage postoperative cerebrospinal fluid (CSF) fistulas following spine surgery.,1.421158364141118e-07,0.007580147960844386,0.10009105098855359,0.01088055878869125,0.00421305085980439,0.11848689307851237,0.01086480924571722,0.025924534703512858,0.10380622837370242,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
16,0.1,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Is lumbar drainage a successful approach for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Yes, lumbar drainage is usually successful in treating postoperative cerebrospinal fluid (CSF) fistulas after spine surgery and is a dependable way to manage CSF leaks.",0.0,0.13862943611198997,0.08873456790123453,0.0,0.1777300462974205,0.12313706188045143,0.0,0.14592572222314715,0.10380622837370242,0.0,0.07493483033080572,0.05387755102040818
16,0.1,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Question: Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Yes, lumbar drainage is beneficial and effective for managing postoperative cerebrospinal fluid (CSF) fistulas after spine surgery, providing a reliable method to control CSF leakage.",4.73719454713706e-08,0.08003985561328131,0.08369377162629757,0.0036268529295637453,0.12316490690608317,0.1217541577390062,0.003621603081905733,0.09185850095287096,0.10380622837370242,4.737194547137081e-08,0.019364979175993557,0.05387755102040818
17,0.1,1,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Do higher depression rates in women result from differences in symptom reporting? Differential symptom reporting does play a role in the elevated depression rates among women, since women may be more inclined to report symptoms or seek assistance. However, it",2.36859727356853e-08,0.11242297789620981,0.09682571089377578,0.0018134264647818726,0.08066254137519424,0.0763888888888889,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
17,0.1,2,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are increased depression rates in women explained by varying symptom reporting? Differences in symptom reporting contribute to the higher depression rates in women, as women tend to report symptoms or seek help more often. However, it",1.184298636784265e-07,0.03946141811995929,0.06551601356796163,0.00906713232390937,0.07133645729738003,0.047004132231404955,0.009054007704764347,0.06811573714833319,0.05246913580246914,1.1842986367842703e-07,0.10771459467909672,0.027006172839506164
17,0.1,3,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the higher prevalence of depression in women due to differences in how symptoms are reported? Differential symptom reporting partially explains the increased depression rates in women, given that women might be more likely to disclose symptoms or pursue help. However, it",2.3685972735685406e-08,0.19797940773035716,0.12244897959183673,0.0018134264647818726,0.13195583576274394,0.0763888888888889,0.0018108015409528666,0.0989383475148311,0.05246913580246914,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
17,0.1,4,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Can the greater incidence of depression in women be attributed to differential symptom reporting? Reporting differences do contribute to higher depression rates in women, since women may be more prone to report symptoms or seek treatment. However, it",7.10579182070559e-08,0.09532525367027489,0.12244897959183673,0.005440279394345618,0.026595320104918052,0.0763888888888889,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
17,0.1,5,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are women's higher depression rates explained by differences in symptom reporting? Variations in symptom reporting do contribute to elevated depression rates in women, as women might be more likely to report symptoms or seek help. However, it",9.47438909427412e-08,0.009090073913390118,0.06708565779252876,0.0072537058591274906,0.001575556861778793,0.0763888888888889,0.007243206163811473,0.03826277399865141,0.05246913580246914,9.474389094274162e-08,0.07694293601234303,0.027006172839506164
17,0.1,6,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Does differential symptom reporting account for the increased depression rates in women? Differences in symptom reporting partly account for higher depression rates in women, because women may be more likely to report symptoms or seek help. However, it",7.10579182070559e-08,0.054544406991336114,0.0159292367084575,0.005440279394345618,0.011912856592856791,0.04863378684807257,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
17,0.1,7,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the disparity in depression rates between genders due to differential symptom reporting? Differential symptom reporting contributes to the higher depression rates in women, as women might be more inclined to report symptoms or seek assistance. However, it",7.10579182070559e-08,0.020390423339469166,0.06857142857142856,0.005440279394345618,0.026595320104918052,0.0763888888888889,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
17,0.1,8,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are higher depression rates among women explained by differences in symptom reporting? Differences in symptom reporting do play a role in the elevated depression rates in women, since women may be more likely to report symptoms or seek help. However, it",0.0,0.06931471805599454,0.0479420402200325,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914,0.0,0.03746741516540242,0.027006172839506164
17,0.1,9,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Could the higher depression rates in women be due to differential symptom reporting? Differential symptom reporting contributes to the increased depression rates in women, as women might be more likely to report symptoms or seek help. However, it",7.10579182070559e-08,0.017076991825933696,0.041999152602217385,0.005440279394345618,0.011912856592856791,0.04863378684807257,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
17,0.1,10,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the increased rate of depression in women accounted for by differences in symptom reporting? Differences in symptom reporting do contribute to higher depression rates in women, as women may be more likely to report symptoms or seek help. However, it",0.0,0.10397207708399137,0.07258748374696139,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914,0.0,0.03746741516540242,0.027006172839506164
18,0.1,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there a link between crime and over-the-counter pharmacy syringe sales? Answer: Our research shows that OTC pharmacy syringe sales did not correlate with a rise in reported crime in Los Angeles communities from 2006 to 2008.,9.47438909427412e-08,0.16096077608021542,0.03334762528744492,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
18,0.1,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Does selling syringes over the counter at pharmacies relate to crime rates? Answer: The data indicates that OTC pharmacy syringe sales were not connected to any increase in reported crime in Los Angeles neighborhoods between 2006 and 2008.,1.184298636784265e-07,0.2250964383277787,0.06035379812695108,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
18,0.1,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are over-the-counter pharmacy syringe sales linked to crime? Answer: Findings reveal no association between OTC pharmacy syringe sales and increased reported crime in local Los Angeles areas during 2006-2008.,9.47438909427412e-08,0.14080039907557484,0.008233307497191582,0.007253705859127518,0.18304190552166144,0.035665294924554176,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.1,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is crime influenced by the sale of syringes over the counter in pharmacies? Answer: Our study found no evidence that OTC pharmacy syringe sales led to higher reported crime in Los Angeles communities from 2006 through 2008.,9.47438909427412e-08,0.19842819124561784,0.06035379812695108,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
18,0.1,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Does the availability of syringes at pharmacies without a prescription affect crime rates? Answer: Results demonstrate that OTC pharmacy syringe sales did not cause an increase in reported crime in Los Angeles localities during 2006-2008.,4.73719454713706e-08,0.14285834009080567,0.06035379812695108,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.1,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there an association between crime and the sale of syringes over the counter in pharmacies? Answer: Our findings indicate that OTC pharmacy syringe sales were not linked to a rise in reported crime in Los Angeles communities between 2006 and 2008.,2.1317375462116791e-07,0.3251798968847601,0.06035379812695108,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
18,0.1,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are over-the-counter pharmacy syringe sales related to crime levels? Answer: Evidence shows no connection between OTC pharmacy syringe sales and increased reported crime in local Los Angeles areas from 2006 to 2008.,2.36859727356853e-08,0.03339721616887559,0.0018684240952711456,0.0018134264647818796,0.07646787125393084,0.0322222222222222,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
18,0.1,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Does selling syringes without prescription at pharmacies correlate with crime? Answer: The study demonstrates that OTC pharmacy syringe sales were not associated with any increase in reported crime in Los Angeles neighborhoods during 2006-2008.,2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.1,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Is there a relationship between crime and over-the-counter syringe sales at pharmacies? Answer: Our research indicates that OTC pharmacy syringe sales did not correspond with higher reported crime in local communities in Los Angeles from 2006 to 2008.,1.184298636784265e-07,0.18861500777199236,0.03405723128984371,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
18,0.1,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Question: Are crime rates affected by the sale of syringes over the counter in pharmacies? Answer: Findings confirm that OTC pharmacy syringe sales were not linked to an increase in reported crime in Los Angeles local communities during 2006-2008.,1.184298636784265e-07,0.2250964383277787,0.06035379812695108,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
19,0.1,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is specialized breast pathology evaluation required for the treatment of ductal carcinoma in situ? Yes, specialized breast pathology evaluation is crucial for the treatment of ductal carcinoma in situ (DCIS).",0.0,0.19121301532688184,0.08256944444444442,0.0,0.1980420515885557,0.11662222222222207,0.0,0.2053769423881313,0.1386375861900338,0.0,0.15995704166767855,0.11342155009451795
19,0.1,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Does managing ductal carcinoma in situ necessitate expert breast pathology analysis? Indeed, expert breast pathology analysis is vital for managing ductal carcinoma in situ (DCIS).",1.184298636784265e-07,0.2967993207598987,0.05729166666666666,0.009067132323909398,0.28927342705374937,0.06060498614958448,0.009054007704764368,0.2794769371507888,0.05301775147928995,1.1842986367842703e-07,0.27958811749424584,0.047500000000000014
19,0.1,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is expert assessment in breast pathology important for handling ductal carcinoma in situ? Yes, expert assessment in breast pathology is important for handling ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.2945408151968394,0.08506944444444445,0.003626852929563759,0.29880953068689076,0.12708698060941828,0.003621603081905747,0.30287567776307434,0.15051775147928995,4.737194547137081e-08,0.2533295028135223,0.1224489795918367
19,0.1,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is a professional breast pathology review needed for the management of ductal carcinoma in situ? Yes, a professional breast pathology review is necessary for managing ductal carcinoma in situ (DCIS).",0.0,0.047803253831721015,0.027886079605124875,0.0,0.049510512897140035,0.03328888888888887,0.0,0.05134423559703327,0.03661775147928994,0.0,0.053319013889226774,0.03840000000000001
19,0.1,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is expert breast pathology evaluation indispensable for managing ductal carcinoma in situ? Yes, expert breast pathology evaluation is indispensable for managing ductal carcinoma in situ (DCIS).",9.47438909427412e-08,0.3530179315180364,0.08420439254133028,0.007253705859127518,0.3521927314158142,0.11662222222222218,0.007243206163811494,0.35009308597725797,0.12922273762887446,9.474389094274162e-08,0.2930808447649751,0.09
19,0.1,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is it necessary to have expert breast pathology assessment for ductal carcinoma in situ management? Yes, having expert breast pathology assessment is necessary for managing ductal carcinoma in situ (DCIS).",0.0,0.047803253831721015,0.027886079605124875,0.0,0.049510512897140035,0.03328888888888884,0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0
19,0.1,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is expert breast pathology examination required for the treatment of ductal carcinoma in situ? Yes, expert breast pathology examination is required for the treatment of ductal carcinoma in situ (DCIS).",0.0,0.23901626915860197,0.08437692366882116,0.0,0.24755256448569485,0.13440000000000002,0.0,0.2567211779851646,0.1670993841323512,0.0,0.21327605555690532,0.14876033057851235
19,0.1,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is expert breast pathology consultation essential for managing ductal carcinoma in situ? Yes, expert breast pathology consultation is essential for managing ductal carcinoma in situ (DCIS).",9.47438909427412e-08,0.3530179315180364,0.08420439254133028,0.007253705859127518,0.3521927314158142,0.11662222222222218,0.007243206163811494,0.35009308597725797,0.12922273762887446,9.474389094274162e-08,0.2930808447649751,0.09
19,0.1,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is expert breast pathology input critical for the management of ductal carcinoma in situ? Yes, expert breast pathology input is critical for managing ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.14050810840574002,0.039151077097505704,0.003626852929563759,0.0855334751299841,0.007821550094517918,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
19,0.1,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Is expert breast pathology review necessary for the management of ductal carcinoma in situ? Yes, expert breast pathology review is necessary for managing ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.14050810840574002,0.039151077097505704,0.003626852929563759,0.0855334751299841,0.007821550094517918,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
20,0.1,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an initial night impact on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, a single night of sleep recording might suffice for patients with moderate to high frequency SB. Nevertheless, low RMMA frequency on the first night could be verified.",2.3685972735685406e-08,0.10449845089304066,0.09487176711851247,0.0018134264647818726,0.0953654920637459,0.05536332179930796,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
20,0.1,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night influence sleep bruxism? Results revealed no significant first night effect on RMMA frequency severity in young, healthy patients with SB. For clinical purposes, one night of sleep recording may be adequate for those with moderate to high frequency SB. However, low RMMA frequency during the first night can be confirmed.",4.737194547137081e-08,0.009205847051115157,0.03248646397334437,0.0036268529295637453,0.01261651846808931,0.03613994617454825,0.003621603081905733,0.012309783448174905,0.018860946745562133,4.737194547137081e-08,0.03922071315328246,0.0
20,0.1,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on sleep bruxism? The study showed no overall first night impact on RMMA frequency severity in young, healthy SB patients. In clinical settings, a single night sleep recording may be enough for patients with moderate to high frequency SB. Still, low RMMA frequency on the first night could be validated.",0.0,0.07561605606108524,0.055446109732384605,0.0,0.07701635339555013,0.05536332179930796,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
20,0.1,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does sleep bruxism exhibit a first night effect? The results demonstrated no overall first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, one night of sleep recording may be sufficient for patients with moderate to high frequency SB. However, low RMMA frequency on the first night can be confirmed.",0.0,0.05041070404072334,0.036775974895760594,0.0,0.07701635339555013,0.05536332179930796,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
20,0.1,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an effect of the first night on sleep bruxism? Findings showed no general first night effect on RMMA frequency severity in young, healthy SB patients. In clinical practice, one night of sleep recording might be enough for moderate to high frequency SB patients. Yet, low RMMA frequency on the first night could be confirmed.",0.0,0.02520535202036145,0.01827155351936688,0.0,0.05134423559703327,0.036851395847011775,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
20,0.1,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the initial night affect sleep bruxism? The results indicated no overall first night effect on RMMA frequency severity in young, healthy patients with SB. Clinically, a single night sleep recording may suffice for moderate to high frequency SB patients. However, low RMMA frequency on the first night could be confirmed.",1.1842986367842703e-07,0.009983760486949933,0.10834099796381133,0.009067132323909363,0.020147395058098372,0.05536332179930796,0.009054007704764333,0.07293440526460904,0.018860946745562133,1.1842986367842703e-07,0.10109611687136999,0.0
20,0.1,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night impact on sleep bruxism? The study found no overall first night effect on the severity of RMMA frequency in young, healthy SB patients. In clinical practice, one night of sleep recording may be adequate for patients with moderate to high frequency SB. Nonetheless, low RMMA frequency on the first night could be confirmed.",4.737194547137081e-08,0.09000019052684927,0.040759983565646696,0.0036268529295637453,0.11338399756642437,0.05536332179930796,0.003621603081905733,0.06319776905997099,0.018860946745562133,4.737194547137081e-08,0.03774032798284743,0.0
20,0.1,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night influence sleep bruxism severity? Results showed no overall first night effect on RMMA frequency in young, healthy individuals with SB. Clinically, one night of sleep recording may be sufficient for moderate to high frequency SB patients. However, low RMMA frequency on the first night could be confirmed.",1.1842986367842703e-07,0.055932976833136916,0.025398207583639087,0.009067132323909363,0.048439116713606456,0.03496401624375241,0.009054007704764333,0.07293440526460904,0.018860946745562133,1.1842986367842703e-07,0.10109611687136999,0.0
20,0.1,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on the severity of sleep bruxism? The findings revealed no overall first night effect on RMMA frequency in young, healthy SB patients. In clinical practice, one night of sleep recording may be enough for moderate to high frequency SB patients. Still, low RMMA frequency on the first night could be confirmed.",2.3685972735685406e-08,0.028621548202745206,0.032284002036188614,0.0018134264647818726,0.04495478802302255,0.019051467046726972,0.0018108015409528666,0.019176512593258366,0.0003490207932659514,2.3685972735685406e-08,0.0190481949706931,0.0
20,0.1,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night affect sleep bruxism? The results showed no overall first night effect on RMMA frequency severity in young, healthy patients with SB. For clinical purposes, one night of sleep recording may suffice for moderate to high frequency SB patients. However, low RMMA frequency on the first night could be confirmed.",7.105791820705622e-08,0.012044243996589987,0.030215997963811303,0.005440279394345618,0.007324302819299522,0.03576332179930797,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
21,0.1,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns result in less pain? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not lead to reduced cumulative opioid use.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.1,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced in newborns undergoing minimal access major surgery? Minimal access surgery for repairing esophageal atresia or congenital diaphragmatic hernia does not correlate with lower total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.1,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery cause less pain in newborns? The repair of esophageal atresia or congenital diaphragmatic hernia via minimal access surgery is not linked to decreased cumulative opioid consumption.,7.10579182070559e-08,0.15072488169169596,0.03736962383434036,0.005440279394345639,0.15129320720708161,0.035665294924554176,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.1,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain with minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not result in less overall opioid administration.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.1,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns reduce pain? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not associated with a reduction in total opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.1,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery cause less pain in newborns? The use of minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not reduce cumulative opioid requirements.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.1,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain lessened by minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia does not correspond with lower cumulative opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.1,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns lead to less pain? Repairing esophageal atresia or congenital diaphragmatic hernia with minimal access surgery is not linked to decreased total opioid use.,9.47438909427412e-08,0.18923071963380345,0.039788435369961024,0.007253705859127518,0.18949457407785042,0.03698224852071005,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.1,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain after minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not reduce cumulative opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.1,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns result in less opioid use? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair is not associated with lower cumulative opioid doses.,4.73719454713706e-08,0.06742663438990348,0.0020762161887946107,0.003626852929563759,0.06669137449867346,0.0,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
22,0.1,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites mirror community practice? Answer: Yes, family practice at residency teaching sites frequently mirrors community practice. Residency programs aim to prepare physicians for community practice by familiarizing them with common health concerns.",4.73719454713706e-08,0.06041365202649773,0.006109330784655448,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.1,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites representative of community practice? Answer: Yes, family practice at residency teaching sites typically represents community practice. Residency programs are structured to ready physicians for community practice by exposing them to prevalent health issues.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.1,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites correspond to community practice? Answer: Yes, family practice at residency teaching sites generally corresponds to community practice. Residency programs are designed to equip physicians for community practice through exposure to common health problems.",0.0,0.034657359027997714,0.022879740131346693,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.1,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites similar to community practice? Answer: Yes, family practice at residency teaching sites is often similar to community practice. Residency programs prepare physicians for community practice by introducing them to typical health challenges.",2.36859727356853e-08,0.10085307766069462,0.04844945790816327,0.0018134264647818726,0.06619860214425533,0.02733382058057378,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.1,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites align with community practice? Answer: Yes, family practice at residency teaching sites usually aligns with community practice. Residency programs aim to train physicians for community practice by providing experience with common health issues.",0.0,0.034657359027997714,0.022879740131346693,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.1,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites reflective of community practice? Answer: Yes, family practice at residency teaching sites commonly reflects community practice. Residency programs are intended to prepare physicians for community practice by exposing them to frequent health concerns.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.1,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites emulate community practice? Answer: Yes, family practice at residency teaching sites often emulates community practice. Residency programs are designed to ready physicians for community practice by familiarizing them with typical health issues.",2.36859727356853e-08,0.029761059141726776,0.0029835463597203127,0.0018134264647818726,0.029717171588468982,0.002581738577784029,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.1,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites indicative of community practice? Answer: Yes, family practice at residency teaching sites is often indicative of community practice. Residency programs prepare physicians for community practice by exposing them to common health problems.",2.36859727356853e-08,0.10085307766069462,0.04844945790816327,0.0018134264647818726,0.06619860214425533,0.02733382058057378,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.1,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites correspond with community practice? Answer: Yes, family practice at residency teaching sites generally corresponds with community practice. Residency programs aim to equip physicians for community practice by introducing them to prevalent health issues.",0.0,0.034657359027997714,0.022879740131346693,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.1,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites consistent with community practice? Answer: Yes, family practice at residency teaching sites is typically consistent with community practice. Residency programs are structured to prepare physicians for community practice by providing exposure to common health concerns.",4.737194547137081e-08,0.008972100877231437,0.0375510204081633,0.0036268529295637453,0.02313416967115023,0.01837427563618041,0.003621603081905733,0.05676550897091914,0.0038604075669712717,4.737194547137081e-08,0.056486545297256274,0.0027453377260327275
23,0.1,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the length of psychological treatment for depression connected to the likelihood of returning for treatment? Yes, the duration of psychological treatment for depression may be linked to returning for further treatment. Extended treatment periods could reflect more severe or chronic cases that require repeated therapy sessions. Nonetheless, this relationship can vary based on individual patient responses and other factors.",4.737194547137081e-08,0.08725027902191185,0.03638079561042526,0.0036268529295637453,0.062407464857966666,0.019435669225879006,0.003621603081905733,0.06269223125544832,0.019322583011394202,4.737194547137081e-08,0.06295662331933816,0.019131008851288562
23,0.1,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the duration of psychological treatment for depression influence the chance of returning to treatment? Yes, longer psychological treatment for depression might be associated with a higher probability of returning to treatment. Prolonged therapy may suggest more serious or persistent conditions needing ongoing sessions. However, this also depends on the patient's unique response and other variables.",4.737194547137081e-08,0.00850183322311615,0.030399999999999996,0.0036268529295637453,0.014362971772146516,0.015642595360455355,0.003621603081905733,0.012418287001114248,0.03550295857988167,4.737194547137081e-08,0.013603907614186284,0.036982248520710054
23,0.1,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a relationship between how long psychological treatment for depression lasts and the likelihood of returning to treatment? Yes, the length of psychological treatment for depression can relate to returning for additional treatment. Longer treatments may indicate chronic or severe depression requiring repeated therapy. Still, this depends on individual patient factors and other influences.",7.105791820705622e-08,0.03916310126117839,0.06503667820069202,0.005440279394345618,0.008351746147991612,0.0333281009352343,0.0054324046228586,0.007132917534571348,0.0351405297006841,7.105791820705622e-08,0.005814178242916412,0.036982248520710054
23,0.1,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Can the duration of psychological treatment for depression affect the chances of returning to treatment? Yes, the time spent in psychological treatment for depression can be related to returning for further therapy. Extended treatment durations might signal severe or chronic depression that necessitates recurrent sessions. However, this is also influenced by individual patient responses and other factors.",2.3685972735685406e-08,0.07828132948189426,0.06700021359914557,0.0018134264647818726,0.03059181625087648,0.03469406240718233,0.0018108015409528666,0.03159479959437261,0.03585197937314763,2.3685972735685406e-08,0.03265210258487938,0.036982248520710054
23,0.1,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the time span of psychological treatment for depression associated with the likelihood of returning to treatment? Yes, the duration of psychological treatment for depression can be connected to returning for treatment. Longer treatment may reflect more severe or chronic conditions needing repeated therapy. This relationship, however, depends on individual patient responses and other factors.",7.105791820705622e-08,0.013490983462661976,0.046799999999999994,0.005440279394345618,0.03450824352761206,0.014605917159763289,0.0054324046228586,0.033792424479184735,0.015963905325443797,7.105791820705622e-08,0.032996420617815936,0.01738224852071006
23,0.1,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the length of psychological treatment for depression correlate with the probability of returning to treatment? Yes, longer psychological treatment durations for depression can be linked to returning for further treatment. Extended therapy might indicate chronic or severe depression requiring ongoing sessions. Yet, this depends on individual patient responses and other influencing factors.",1.1842986367842703e-07,0.025120112784654758,0.08199999999999996,0.009067132323909363,0.00549496778345393,0.07100591715976332,0.009054007704764333,0.01969412374324042,0.05436390532544381,1.1842986367842703e-07,0.045819512856614786,0.036982248520710054
23,0.1,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the duration of psychological treatment for depression related to the chance of returning to treatment? Yes, the length of psychological treatment for depression can be associated with returning to treatment. Longer treatments may suggest severe or chronic conditions that require repeated therapy. However, this also depends on individual patient responses and other factors.",9.474389094274162e-08,0.03329516525352805,0.027084027777777783,0.0072537058591274906,0.055065467193283535,0.01352986551461545,0.007243206163811466,0.05425598119686015,0.015213551306285114,9.474389094274162e-08,0.05334269276149417,0.01699057838326732
23,0.1,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a connection between the duration of psychological treatment for depression and the likelihood of returning to treatment? Yes, the duration of psychological treatment for depression can relate to returning for additional therapy. Longer treatment periods might indicate chronic or severe depression needing recurrent sessions. Still, this depends on individual patient responses and other factors.",4.737194547137081e-08,0.016703518797245742,0.012944773011245317,0.0036268529295637453,0.06570720736917934,0.020622570970182594,0.003621603081905733,0.0660512051377471,0.02060485768996643,4.737194547137081e-08,0.06637461321965388,0.020493803124437812
23,0.1,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Can the length of psychological treatment for depression influence the likelihood of returning to treatment? Yes, the duration of psychological treatment for depression may be related to returning for further treatment. Longer treatments could reflect severe or chronic conditions requiring repeated therapy. However, this also depends on individual patient responses and other factors.",1.1842986367842703e-07,0.028198901104572016,0.0440111111111111,0.009067132323909363,0.07605175934124508,0.012412167159763315,0.009054007704764333,0.07514589818803596,0.014433349769888242,1.1842986367842703e-07,0.07411123451212287,0.016582942965154498
23,0.1,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the duration of psychological treatment for depression linked to the probability of returning to treatment? Yes, the length of psychological treatment for depression can be connected to returning for treatment. Extended treatment durations might indicate severe or chronic depression requiring recurrent therapy sessions. Nonetheless, this depends on individual patient responses and other factors.",9.474389094274162e-08,0.0071386678739076,0.04543123698458974,0.0072537058591274906,0.055065467193283535,0.01352986551461545,0.007243206163811466,0.05425598119686015,0.015213551306285114,9.474389094274162e-08,0.05334269276149417,0.01699057838326732
24,0.1,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a new surgical technique targeting the temporomandibular joint to enhance access and minimize complications? Answer: The VMPA offers direct access and excellent visibility to the TMJ area, resulting in favorable aesthetic and functional outcomes. It can be regarded as the preferred method for typical TMJ surgeries.",4.737194547137081e-08,0.12862063739118046,0.06265295796173082,0.0036268529295637453,0.0711683211052474,0.021266540642722105,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
24,0.1,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Could an innovative surgical method for the temporomandibular joint improve accessibility and lower complication rates? Answer: The VMPA allows direct access and clear visualization of the TMJ region, producing good cosmetic and functional results. It is considered the approach of choice for standard TMJ procedures.",7.105791820705622e-08,0.05098600895575256,0.08264462809917356,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.1,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel surgical approach to the TMJ enhance access and reduce the risk of complications? Answer: The VMPA provides direct access and optimal visibility to the TMJ area, yielding satisfactory aesthetic and functional outcomes. This approach is often preferred for common TMJ surgeries.",9.474389094274162e-08,0.06600691697266203,0.014827852370440625,0.0072537058591274906,0.09169126505879133,0.001976089742765419,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.1,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is a new surgical technique for the temporomandibular joint capable of improving access and decreasing complications? Answer: The VMPA grants direct access and favorable visualization of the TMJ region, leading to good esthetic and functional results. It is regarded as the preferred approach for routine TMJ surgeries.",2.3685972735685406e-08,0.06497549619081244,0.06137808745645146,0.0018134264647818726,0.007989419483715121,0.021266540642722105,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
24,0.1,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a novel surgical approach to the temporomandibular joint improve surgical access and minimize complications? Answer: The VMPA offers direct access and excellent visibility to the TMJ area, resulting in positive aesthetic and functional outcomes. It is considered the method of choice for common TMJ operations.",4.737194547137081e-08,0.012691247799749839,0.03925619834710743,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.1,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Could a new surgical technique for the TMJ enhance access and reduce complications? Answer: The VMPA provides direct access and clear visibility to the TMJ region, yielding good cosmetic and functional results. It is often chosen as the preferred approach for typical TMJ surgeries.",9.474389094274162e-08,0.03450022694720989,0.03729315417627106,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.1,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it feasible that a novel surgical approach to the temporomandibular joint can improve access and lower complication risks? Answer: The VMPA allows direct access and favorable visualization of the TMJ area, producing satisfactory esthetic and functional outcomes. It is considered the preferred approach for common TMJ surgeries.",0.0,0.0866433975699934,0.06182072588097527,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
24,0.1,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical method for the temporomandibular joint improve access and reduce complications? Answer: The VMPA provides direct access and optimal visibility to the TMJ region, resulting in good aesthetic and functional results. It is regarded as the approach of choice for routine TMJ surgeries.",4.737194547137081e-08,0.04282808173713892,0.06091623303744516,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.1,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Could an innovative surgical approach to the TMJ improve access and decrease complications? Answer: The VMPA grants direct access and excellent visualization of the TMJ area, yielding positive cosmetic and functional outcomes. It is often considered the preferred method for common TMJ surgeries.",1.1842986367842703e-07,0.05895517261495309,0.03624367628477735,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.1,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is a novel surgical technique for the temporomandibular joint able to enhance access and minimize complications? Answer: The VMPA offers direct access and clear visibility to the TMJ region, leading to favorable esthetic and functional results. It is regarded as the approach of choice for typical TMJ surgeries.",0.0,0.0866433975699934,0.06182072588097527,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
25,0.1,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare professionals consider it acceptable to break confidentiality to protect a patient's wife from a sexually transmitted infection? Most individuals in France are swayed by situational factors when determining if a doctor should breach confidentiality to safeguard the spouse of a patient with an STD.,7.105791820705622e-08,0.007959027215065362,0.037769847781801716,0.005440279394345618,0.006423629273291986,0.039930555555555566,0.0054324046228586,0.034887179966024195,0.020399305555555556,7.105791820705622e-08,0.06453852113757153,0.0
25,0.1,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Are French non-experts and medical professionals okay with violating confidentiality to protect a patient's wife from an STD? In France, most people are influenced by the circumstances when deciding whether a physician should breach confidentiality to protect the patient's spouse from a sexually transmitted disease.",1.6580180914979784e-07,0.12910265173226865,0.013242276077097506,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.1,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health workers and laypersons find it acceptable to disclose confidential information to protect a patient's wife from a sexually transmitted disease? Most French people base their decision on situational factors when considering if a doctor should breach confidentiality to protect the spouse of an STD-infected patient.,9.474389094274162e-08,0.029626928594246316,0.0373272093572779,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,0.1,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Is it acceptable to French laypeople and health professionals to break confidentiality to protect a patient's wife from an STD? In France, most people are influenced by the situation when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with a sexually transmitted disease.",4.737194547137081e-08,0.015042050800014639,0.017851332616568565,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.1,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and laypeople approve of breaching confidentiality to protect a patient's wife from a sexually transmitted infection? Most individuals in France consider situational factors when deciding if a doctor should break confidentiality to protect the spouse of a patient with an STD.,1.6580180914979784e-07,0.12910265173226865,0.013242276077097506,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.1,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and medical professionals find it acceptable to violate confidentiality to protect a patient's wife from an STD? Most people in France are influenced by the context when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with a sexually transmitted disease.,4.737194547137081e-08,0.015042050800014639,0.017851332616568565,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.1,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French health professionals and laypersons comfortable with breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Most French people take situational factors into account when deciding if a doctor should breach confidentiality to protect the spouse of an STD-infected patient.,1.8948778188548325e-07,0.15355759740001185,0.012192798185603794,0.014507411718254981,0.1519086212980736,0.01613519565073701,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.1,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare providers consider it acceptable to breach confidentiality to protect a patient's wife from an STD? Most individuals in France are influenced by the circumstances when deciding if a physician should breach confidentiality to protect the spouse of a patient with a sexually transmitted disease.,7.105791820705622e-08,0.06572129226172763,0.0036284722222222204,0.005440279394345618,0.06541487868264895,0.0025385802469135646,0.0054324046228586,0.06502401390341284,0.0013290895061728418,7.105791820705622e-08,0.06453852113757153,0.0
25,0.1,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is breaching confidentiality to protect a patient's wife from an STD acceptable to French laypeople and health professionals? Most people in France are swayed by situational factors when deciding if a doctor should breach confidentiality to protect the spouse of a patient infected with a sexually transmitted disease.,9.474389094274162e-08,0.059122553298924796,0.01612461419753087,0.0072537058591274906,0.058066668431643986,0.01820216049382717,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,0.1,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French laypersons and health professionals find it acceptable to break confidentiality to protect a patient's wife from a sexually transmitted disease? In France, most people are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient with an STD.",7.105791820705622e-08,0.036840159738396494,0.01700584829867674,0.005440279394345618,0.03591925397797047,0.018664014912833465,0.0054324046228586,0.034887179966024195,0.020399305555555556,7.105791820705622e-08,0.06453852113757153,0.0
26,0.1,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance, supported by studies linking the I allele to a higher risk.",7.105791820705622e-08,0.10906840324557265,0.02469135802469133,0.005440279394345618,0.10623152153208792,0.02731609726069556,0.0054324046228586,0.10304669783534592,0.02673037190082643,7.105791820705622e-08,0.101486788458796,0.0253476399262638
26,0.1,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Could the insertion allele of the ACE gene I/D polymorphism be a candidate gene for insulin resistance? Answer: Yes, research suggests that the insertion allele (I) of the ACE gene I/D polymorphism may be associated with insulin resistance due to its correlation with increased risk.",1.1842986367842703e-07,0.0437474329413865,0.03722299168975071,0.009067132323909363,0.06712206273106824,0.027120315581854043,0.009054007704764333,0.09119457636192774,0.013269628099173578,1.1842986367842703e-07,0.11950075121351711,0.0050308641975308835
26,0.1,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele (I) of the ACE gene I/D polymorphism considered a candidate gene for insulin resistance? Answer: Yes, evidence indicates that the I allele of the ACE gene I/D polymorphism might be linked to insulin resistance, as studies have found an association with elevated risk.",7.105791820705622e-08,0.06790534498249823,0.08262471655328797,0.005440279394345618,0.014315814217468414,0.05272108843537414,0.0054324046228586,0.04143361511890653,0.01631809748692868,7.105791820705622e-08,0.06998009843334385,0.002882338120433363
26,0.1,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) in the ACE gene I/D polymorphism is potentially a candidate gene for insulin resistance, based on research showing its connection to increased risk.",7.105791820705622e-08,0.07957277854089417,0.009724251278305313,0.005440279394345618,0.07609468759469928,0.0083826429980276,0.0054324046228586,0.07224015647712623,0.005398203548655098,7.105791820705622e-08,0.06998009843334385,0.002882338120433363
26,0.1,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the ACE gene I/D polymorphism's insertion allele a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be implicated in insulin resistance, supported by findings associating the I allele with greater risk.",1.8948778188548325e-07,0.029122549313170598,0.09331717451523548,0.014507411718254981,0.04783029499434255,0.09023668639053256,0.014486412327622933,0.1014543857286272,0.05766106465407165,1.8948778188548325e-07,0.1275947061710565,0.04246913580246913
26,0.1,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Could the ACE gene I/D polymorphism insertion allele be linked to insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism is considered a candidate gene for insulin resistance due to research demonstrating an association with increased risk.",1.8948778188548325e-07,0.06212955791126307,0.07062636961285612,0.014507411718254981,0.08164235258263286,0.06617420744844567,0.014486412327622933,0.1361117447566249,0.032783132254298235,1.8948778188548325e-07,0.16314071543054043,0.016845867104408177
26,0.1,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele (I) of the ACE gene I/D polymorphism a potential candidate gene for insulin resistance? Answer: Yes, studies have shown that the I allele of the ACE gene I/D polymorphism may be related to insulin resistance by increasing risk.",1.8948778188548325e-07,0.06212955791126307,0.07062636961285612,0.014507411718254981,0.11545441017092228,0.04246814381949515,0.014486412327622933,0.17076910378462173,0.008137688727369335,1.8948778188548325e-07,0.1986867246900248,0.00866307749190632
26,0.1,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Does the insertion allele of the ACE gene I/D polymorphism qualify as a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism is a possible candidate gene for insulin resistance, as research links it to higher risk.",1.1842986367842703e-07,0.1361670570160456,0.01658163265306123,0.009067132323909363,0.13013544278197298,0.014507750994237428,0.009054007704764333,0.12343398010890105,0.00940007933014926,1.1842986367842703e-07,0.11950075121351711,0.0050308641975308835
26,0.1,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism associated with insulin resistance as a candidate gene? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance, based on studies showing its association with increased risk.",7.105791820705622e-08,0.020581529131537213,0.024449375410913937,0.005440279394345618,0.015821019719920226,0.03180976931720536,0.0054324046228586,0.04143361511890653,0.01631809748692868,7.105791820705622e-08,0.06998009843334385,0.002882338120433363
26,0.1,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele (I) of the ACE gene I/D polymorphism identified as a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism might be a candidate gene for insulin resistance, supported by research indicating an increased risk linked to the I allele.",2.3685972735685406e-08,0.05630765135354032,0.037569252077562315,0.0018134264647818726,0.0867400005403014,0.06360946745562138,0.0018108015409528666,0.11848167760351203,0.09173037190082643,2.3685972735685406e-08,0.12212326905612736,0.09911325563120132
27,0.1,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a link between androgens and sexual desire in women? Yes, androgens like testosterone significantly influence female sexual desire and responsiveness. Lower androgen levels can result in reduced sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.1,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does a relationship exist between androgens and sexual desire in women? Indeed, androgens such as testosterone are important for female sexual desire and responsiveness. Reduced levels of these hormones may cause diminished sexual desire, showing a positive correlation.",4.500334819780224e-07,0.14221850491030796,0.3354629629629631,0.03445510283085558,0.20314422538566568,0.22634676324128575,0.034405229278104466,0.26991349784367724,0.15104166666666666,4.500334819780227e-07,0.33930539941747684,0.07496876301541024
27,0.1,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens connected to sexual desire in women? Yes, androgens, including testosterone, play a crucial role in female sexual desire and responsiveness. When these hormone levels are low, sexual desire may decrease, indicating a positive correlation.",4.97405427449393e-07,0.2544877084998407,0.2449301091725335,0.03808195576041933,0.26030263922561403,0.22634676324128575,0.03802683236001021,0.3287539978666105,0.15104166666666666,4.974054274493935e-07,0.3999300212339123,0.07496876301541024
27,0.1,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there an association between androgens and sexual desire in women? Yes, androgens like testosterone are key factors in female sexual desire and responsiveness. Low androgen levels can lead to a drop in sexual desire, suggesting a positive correlation.",4.263475092423371e-07,0.11456427321853102,0.3361725689653619,0.03264167636607371,0.17574525119755036,0.22634676324128575,0.0325944277371516,0.2417426208769804,0.15104166666666666,4.263475092423373e-07,0.31031786254422533,0.07496876301541024
27,0.1,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Do androgens influence sexual desire in women? Yes, androgens such as testosterone have a significant impact on female sexual desire and responsiveness. A decrease in these hormones may reduce sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.1,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is sexual desire in women correlated with androgens? Yes, androgens including testosterone play an important role in female sexual desire and responsiveness. Lower androgen levels may cause decreased sexual desire, showing a positive correlation.",5.447773729207636e-07,0.26117036095658674,0.33219569830246926,0.04170880868998309,0.3209272610420495,0.22634676324128575,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
27,0.1,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a connection between androgens and female sexual desire? Yes, androgens like testosterone are vital for female sexual desire and responsiveness. Reduced androgen levels can result in lower sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.1,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens related to sexual desire in women? Yes, androgens such as testosterone significantly affect female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.1,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a correlation between female sexual desire and androgens? Yes, androgens including testosterone play a significant role in female sexual desire and responsiveness. When these hormone levels are low, sexual desire may decline, indicating a positive correlation.",4.500334819780224e-07,0.2687625921298826,0.19534333231302944,0.03445510283085558,0.28016057878121536,0.17098344144197777,0.034405229278104466,0.30952190816138847,0.1224949538638985,4.500334819780227e-07,0.33930539941747684,0.07496876301541024
27,0.1,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does sexual desire in women correlate with androgens? Yes, androgens like testosterone are important for female sexual desire and responsiveness. A reduction in these hormones may lead to decreased sexual desire, showing a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
28,0.1,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals pertinent and useful for practitioners and athletes? Absolutely, these journals are very pertinent to both groups. They deliver the latest research, treatment innovations, and injury prevention strategies related to sports. They also provide important knowledge on improving athletic performance and nutrition.",0.0,0.12602676010180902,0.09,0.0,0.06447880749394841,0.046400951814396206,0.0,0.0,0.0,0.0,0.0,0.0
28,0.1,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Do sports medicine journals hold relevance and applicability for practitioners and athletes? Yes, they are extremely relevant. These journals present current studies, advancements in treatment, and preventive approaches for sports injuries. They also offer critical insights into enhancing athletic performance and nutrition.",7.105791820705622e-08,0.05540919288785506,0.09,0.005440279394345618,0.007841854085677724,0.046400951814396206,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
28,0.1,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals significant and practical for practitioners and athletes? Indeed, they are highly significant. They supply up-to-date research findings, new treatment methods, and preventive tactics for sports injuries. Additionally, they provide valuable information on athletic performance improvement and nutrition.",9.474389094274162e-08,0.030716580297483365,0.09,0.0072537058591274906,0.03315966206996945,0.046400951814396206,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
28,0.1,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Is the content of sports medicine journals relevant and useful to practitioners and athletes? Yes, these journals are very useful. They provide the latest research, treatment progress, and preventive measures for sports-related injuries. They also offer essential insights into boosting athletic performance and nutrition.",2.3685972735685406e-08,0.1030372418771095,0.09,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
28,0.1,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals applicable and important for practitioners and athletes? Certainly, they are very important. They offer current research, treatment advancements, and injury prevention techniques in sports medicine. They also deliver valuable knowledge on enhancing athletic performance and nutrition.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.05913514847322743,0.046400951814396206,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
28,0.1,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Do sports medicine journals serve as relevant and applicable resources for practitioners and athletes? Yes, they do. These journals provide updated research, new treatment options, and preventive strategies for sports injuries. They also share important insights into athletic performance enhancement and nutrition.",7.105791820705622e-08,0.05540919288785506,0.09,0.005440279394345618,0.007841854085677724,0.046400951814396206,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
28,0.1,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals relevant and beneficial to practitioners and athletes? Yes, they are highly beneficial. They present the latest research, treatment developments, and preventive measures for sports injuries. They also provide key insights into improving athletic performance and nutrition.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.05913514847322743,0.046400951814396206,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
28,0.1,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals useful and relevant to practitioners and athletes? Absolutely, they are very useful. They offer up-to-date research, treatment innovations, and preventive approaches for sports injuries. They also provide valuable information on athletic performance and nutrition.",1.6580180914979753e-07,0.04724496117222721,0.09,0.012693985253473108,0.11320236974350362,0.046400951814396206,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
28,0.1,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals important and applicable to practitioners and athletes? Yes, they are very important. They provide current research, advancements in treatment, and preventive strategies for sports-related injuries. They also offer insights into enhancing athletic performance and nutrition.",1.4211583641411222e-07,0.02057671409006634,0.09,0.010880558788691236,0.0858033955553883,0.046400951814396206,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
28,0.1,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals relevant and practical for practitioners and athletes? Yes, they are highly practical. They deliver the latest research, treatment progress, and preventive measures for sports injuries. They also provide valuable insights into athletic performance improvement and nutrition.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.05913514847322743,0.046400951814396206,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
29,0.1,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the quantity of needles affect acupuncture treatment for neck pain? Yes, the number of needles can influence the treatment outcome, depending on how severe and where the pain is located. More needles may be applied for more intense or extensive pain.",1.1842986367842703e-07,0.001802782313868434,0.08270411957168353,0.009067132323909363,0.025363411581724282,0.06632653061224489,0.009054007704764333,0.0891212977631648,0.02271498107084911,1.1842986367842703e-07,0.12361395596717584,0.0
29,0.1,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In acupuncture for neck pain, does the number of needles make a difference? Yes, it can, as the amount used depends on the pain's severity and location. Severe or widespread pain might require more needles.",2.8423167282822424e-07,0.15159670218598764,0.10707911957168353,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
29,0.1,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the number of needles important in acupuncture for treating neck pain? Yes, it matters and varies based on the pain's intensity and position. More needles are often used for severe or broad pain areas.",2.8423167282822424e-07,0.15159670218598764,0.10707911957168353,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
29,0.1,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","When treating neck pain with acupuncture, does needle count matter? Yes, the number of needles used can be significant, influenced by the pain's severity and where it is. Intense or widespread pain may need more needles.",2.6054570009253894e-07,0.12260916531273613,0.10707911957168353,0.019947691112600606,0.18788234107949853,0.06632653061224489,0.019918816950481547,0.2561753824263291,0.02271498107084911,2.6054570009253947e-07,0.29546421289383584,0.0
29,0.1,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the number of acupuncture needles impact neck pain treatment? Yes, it can, depending on how severe the pain is and its location. More needles might be necessary for intense or extensive pain.",3.3160361829959484e-07,0.2122213240024231,0.10707911957168353,0.025387970506946245,0.2802556612105138,0.06632653061224489,0.025351221573340167,0.3514855622306543,0.02271498107084911,3.316036182995957e-07,0.39390428570708913,0.0
29,0.1,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In acupuncture therapy for neck pain, is the needle quantity important? Yes, it depends on the pain's severity and location, with more needles potentially used for more severe or widespread pain.",3.7897556377096544e-07,0.27675984513999463,0.10707911957168353,0.029014823436510004,0.3469470357091873,0.06632653061224489,0.028972824655245914,0.42047843371760507,0.02271498107084911,3.789755637709665e-07,0.4653632496892328,0.0
29,0.1,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the amount of needles used in acupuncture relevant for neck pain relief? Yes, it depends on the pain's intensity and site, with more needles possibly applied for severe or broad pain.",3.5528959103528014e-07,0.24397002231700293,0.10707911957168353,0.027201396971728124,0.3130454840335055,0.06632653061224489,0.02716202311429304,0.38538711390633607,0.02271498107084911,3.552895910352811e-07,0.42899560551835814,0.0
29,0.1,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the number of needles used in acupuncture affect neck pain treatment? Yes, it can, based on the severity and location of the pain. More needles might be utilized for intense or widespread pain.",3.0791764556390954e-07,0.18144966533566942,0.10707911957168353,0.023574544042164365,0.248506962895934,0.06632653061224489,0.023540420032387294,0.3186957394076626,0.02271498107084911,3.079176455639103e-07,0.36000273403140737,0.0
29,0.1,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","For neck pain acupuncture, does the needle count matter? Yes, it does, as it depends on the pain's severity and location, with more needles used for more intense or extensive pain.",3.7897556377096544e-07,0.27675984513999463,0.10707911957168353,0.029014823436510004,0.3469470357091873,0.06632653061224489,0.028972824655245914,0.42047843371760507,0.02271498107084911,3.789755637709665e-07,0.4653632496892328,0.0
29,0.1,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In treating neck pain with acupuncture, is the number of needles significant? Yes, it depends on the pain's severity and location, and more needles may be used for severe or widespread pain.",3.5528959103528014e-07,0.24397002231700293,0.10707911957168353,0.027201396971728124,0.3130454840335055,0.06632653061224489,0.02716202311429304,0.38538711390633607,0.02271498107084911,3.552895910352811e-07,0.42899560551835814,0.0
30,0.1,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are we adhering to guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: Evidence shows limited systematic falls risk assessment for high-risk individuals during rehabilitation. When risks were identified, strategies were usually applied. However, some risk factors were not assessed, potentially limiting fall prevention efforts.",3.789755637709665e-07,0.1829637626878342,0.07877526753864447,0.029014823436509962,0.2314142291469694,0.048261993679977015,0.028972824655245866,0.2587591002679126,0.03274920999712727,3.789755637709665e-07,0.28705002228517307,0.016661878770468257
30,0.1,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we follow guidelines in preparing patients at high risk of falls for discharge post-rehabilitation? Answer: There is minimal evidence that systematic falls risk assessments were conducted for high-risk patients during rehabilitation. When risks were found, strategies were typically implemented. Nonetheless, some risk factors were overlooked, possibly restricting fall prevention measures.",2.8423167282822487e-07,0.10128573167356691,0.07877526753864447,0.02176111757738247,0.14803262020791852,0.048261993679977015,0.0217296184914344,0.17360129192760532,0.03274920999712727,2.8423167282822487e-07,0.20003864529554383,0.016661878770468257
30,0.1,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines met in preparing high fall-risk patients for discharge after rehab? Answer: Little evidence exists that systematic falls risk assessments were performed during rehabilitation for high-risk patients. When risks were detected, strategies were generally put in place. However, missing some risk factors may have limited fall prevention strategies.",3.316036182995957e-07,0.1412910662872653,0.07877526753864447,0.025387970506946217,0.1888546147281729,0.048261993679977015,0.025351221573340132,0.21527398832817424,0.03274920999712727,3.316036182995957e-07,0.24259825971434035,0.016661878770468257
30,0.1,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is the preparation of high fall-risk patients for discharge after rehabilitation guideline-compliant? Answer: Systematic falls risk assessments during rehabilitation for high-risk patients were rarely evidenced. When risks were identified, strategies were usually enacted. Yet, failure to assess certain risk factors might have constrained fall prevention approaches.",4.026615365066519e-07,0.20446996790879757,0.07877526753864447,0.030828249901291835,0.2533931358657444,0.048261993679977015,0.030783626196198732,0.2812319561199703,0.03274920999712727,4.026615365066519e-07,0.3100395405098726,0.016661878770468257
30,0.1,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we comply with guidelines when discharging patients at high risk of falls after rehabilitation? Answer: There is scant evidence that systematic falls risk assessments were done for high-risk patients during rehabilitation. When risks were recognized, strategies were commonly implemented. However, neglecting some risk factors may have limited fall prevention strategies.",2.8423167282822487e-07,0.10128573167356691,0.07877526753864447,0.02176111757738247,0.14803262020791852,0.048261993679977015,0.0217296184914344,0.17360129192760532,0.03274920999712727,2.8423167282822487e-07,0.20003864529554383,0.016661878770468257
30,0.1,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are patients at high risk of falls adequately prepared for discharge after rehabilitation according to guidelines? Answer: Evidence suggests limited systematic falls risk assessments during rehabilitation for high-risk patients. When risks were identified, strategies were generally applied. Still, failure to assess some risk factors might have restricted fall prevention efforts.",3.079176455639103e-07,0.12108835896974668,0.07877526753864447,0.023574544042164344,0.16823532752543713,0.048261993679977015,0.023540420032387266,0.19422057913034108,0.03274920999712727,3.079176455639103e-07,0.221092054493377,0.016661878770468257
30,0.1,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is the discharge preparation for high fall-risk patients after rehabilitation aligned with guidelines? Answer: Little evidence supports systematic falls risk assessments during rehabilitation for high-risk individuals. When risks were found, strategies were typically implemented. However, some risk factors were not assessed, possibly limiting fall prevention strategies.",4.026615365066519e-07,0.20446996790879757,0.07877526753864447,0.030828249901291835,0.2533931358657444,0.048261993679977015,0.030783626196198732,0.2812319561199703,0.03274920999712727,4.026615365066519e-07,0.3100395405098726,0.016661878770468257
30,0.1,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we meet guidelines in preparing patients at high risk of falls for discharge following rehabilitation? Answer: There was minimal evidence of systematic falls risk assessments during rehabilitation for high-risk patients. When risks were identified, strategies were generally put in place. Nonetheless, failure to assess certain risk factors may have limited fall prevention measures.",2.1317375462116866e-07,0.044127317833616786,0.07877526753864447,0.016320838183036854,0.08976371208394296,0.048261993679977015,0.0162972138685758,0.11417787145680425,0.03274920999712727,2.1317375462116866e-07,0.1394140234791097,0.016661878770468257
30,0.1,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines followed when preparing high fall-risk patients for discharge after rehabilitation? Answer: Evidence indicates limited systematic falls risk assessments during rehabilitation for high-risk patients. When risks were detected, strategies were usually implemented. However, overlooking some risk factors might have constrained fall prevention strategies.",4.500334819780227e-07,0.2489217304796303,0.07877526753864447,0.03445510283085558,0.29885550994250165,0.048261993679977015,0.034405229278104466,0.32775197175486426,0.03274920999712727,4.500334819780227e-07,0.357667589499127,0.016661878770468257
30,0.1,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is the preparation of patients at high risk of falls for discharge after rehabilitation consistent with guidelines? Answer: There is little evidence that systematic falls risk assessments were conducted during rehabilitation for high-risk patients. When risks were identified, strategies were generally applied. Yet, failure to assess some risk factors may have limited fall prevention efforts.",1.8948778188548325e-07,0.025778179165421022,0.07877526753864447,0.014507411718254981,0.07107157907178863,0.048261993679977015,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
31,0.1,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms play a role in selecting patients for phase I clinical trials? Yes, symptoms are important when choosing patients for Phase I clinical trials.",4.73719454713706e-08,0.06214132936440109,0.07268698060941828,0.003626852929563759,0.06850803410538919,0.0885664819944598,0.003621603081905747,0.07577318814187173,0.10390581717451527,4.737194547137081e-08,0.08410887609719842,0.1187049861495845
31,0.1,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Are symptoms important in the consideration of patients for phase I clinical trials? Yes, symptoms are indeed significant when evaluating patients for Phase I clinical trials.",2.36859727356853e-08,0.11220528629212012,0.0784919692715498,0.0018134264647818796,0.11860185700853343,0.09361750240262309,0.0018108015409528735,0.12570437506495802,0.10773801672100054,2.3685972735685406e-08,0.133629528877373,0.120853512226682
31,0.1,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","When considering patients for phase I clinical trials, do symptoms matter? Yes, symptoms are a crucial factor in patient selection for Phase I clinical trials.",4.73719454713706e-08,0.11990359441106335,0.1102380010175816,0.003626852929563759,0.12878170198016692,0.12989868154094508,0.003621603081905747,0.13878656819277557,0.14855434325161276,4.737194547137081e-08,0.15012289329338335,0.1662049861495845
31,0.1,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Is the presence of symptoms relevant when selecting patients for phase I clinical trials? Yes, symptoms do matter in the selection process for Phase I clinical trials.",0.0,0.21327605555690665,0.11926543051490036,0.0,0.22180709777918128,0.13667139692829722,0.0,0.23104906018664906,0.152317915473192,0.0,0.24109467149911135,0.1662049861495845
31,0.1,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms influence the selection of patients for phase I clinical trials? Yes, symptoms are important in determining eligibility for Phase I clinical trials.",7.10579182070559e-08,0.06980977150791912,0.1051869806094183,0.005440279394345639,0.07885051505708063,0.1260664819944598,0.005432404622858621,0.08926591541260098,0.14640581717451526,7.105791820705617e-08,0.10133272912395208,0.1662049861495845
31,0.1,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Are symptoms a factor in deciding which patients participate in phase I clinical trials? Yes, symptoms are considered when selecting patients for Phase I clinical trials.",2.36859727356853e-08,0.2231088351817112,0.15329189554325573,0.0018134264647818796,0.23412638710185796,0.17447858029313654,0.0018108015409528735,0.2462517108145139,0.19390581717451527,2.3685972735685406e-08,0.1966429089282773,0.1662049861495845
31,0.1,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","When choosing patients for phase I clinical trials, do symptoms have significance? Yes, symptoms are significant in the consideration of patients for Phase I clinical trials.",2.36859727356853e-08,0.11220528629212012,0.0784919692715498,0.0018134264647818796,0.11860185700853343,0.09361750240262309,0.0018108015409528735,0.12570437506495802,0.10773801672100054,2.3685972735685406e-08,0.133629528877373,0.120853512226682
31,0.1,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Does symptom presence affect patient selection for phase I clinical trials? Yes, symptoms are relevant when considering patients for Phase I clinical trials.",9.47438909427412e-08,0.017138872408706707,0.09972299168975074,0.007253705859127518,0.026329225131624945,0.12188365650969524,0.007243206163811494,0.03717505038336011,0.14404432132963993,9.474389094274152e-08,0.05003943473640193,0.1662049861495845
31,0.1,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Is symptom evaluation necessary when selecting patients for phase I clinical trials? Yes, symptoms are an important consideration in Phase I clinical trial patient selection.",4.73719454713706e-08,0.17766585945772562,0.15004235251024478,0.003626852929563759,0.18905536985494464,0.17267805224239366,0.003621603081905747,0.20179994824367986,0.19390581717451527,4.737194547137081e-08,0.15012289329338335,0.1662049861495845
31,0.1,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms matter in the assessment of patients for phase I clinical trials? Yes, symptoms are a key factor when considering patients for Phase I clinical trials.",0.0,0.15995704166768032,0.08392665003090596,0.0,0.1663553233343853,0.09829788695313753,0.0,0.1732867951399868,0.11126118907534173,0.0,0.18082100362433318,0.12281655639751837
32,0.1,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might enhance blood lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, possibly offering significant metabolic and cardiovascular advantages. Future prospective studies are needed to explore this metabolic impact of airway surgery for OSA.",9.474389094274162e-08,0.02437369452619853,0.07424173834314171,0.0072537058591274906,0.027313546264467803,0.039150354019158694,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
32,0.1,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery decrease serum lipid concentrations in obstructive sleep apnea sufferers? Surgical intervention may improve lipid levels in the blood of OSA patients, especially those with dyslipidemia before surgery, potentially providing important metabolic and cardiovascular benefits. Prospective research should investigate this metabolic effect of airway surgery in OSA cases.",7.105791820705622e-08,0.04558239259675689,0.07466633500578444,0.005440279394345618,0.006260137066634641,0.039150354019158694,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
32,0.1,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Airway surgery could improve blood lipid levels in OSA patients, notably in those with preoperative dyslipidemia, which might lead to significant metabolic and cardiovascular benefits. This potential metabolic effect warrants examination through prospective studies.",7.105791820705622e-08,0.017290670941249253,0.05432322317790856,0.005440279394345618,0.006260137066634641,0.039150354019158694,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
32,0.1,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does performing airway surgery lower serum lipid levels in individuals with obstructive sleep apnea? Surgery may positively affect blood lipid levels in OSA patients, particularly those with dyslipidemia prior to surgery, potentially resulting in major metabolic and cardiovascular improvements. Prospective studies should assess this metabolic benefit of airway surgery for OSA.",4.737194547137081e-08,0.010899159902590494,0.03531009506564056,0.0036268529295637453,0.013932571519406967,0.018751048463603138,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
32,0.1,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery lead to decreased serum lipid levels in patients suffering from obstructive sleep apnea? Surgical treatment might improve lipid profiles in OSA patients, especially those with preoperative dyslipidemia, potentially offering substantial metabolic and cardiovascular benefits. This metabolic effect should be evaluated in future prospective studies.",1.4211583641411244e-07,0.010695212630732698,0.09506564056134,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.1,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is airway surgery effective in reducing serum lipid levels among obstructive sleep apnea patients? Surgery may enhance blood lipid levels in OSA patients, particularly those with dyslipidemia before surgery, potentially providing significant metabolic and cardiovascular advantages. Prospective studies are recommended to investigate this metabolic effect.",1.8948778188548325e-07,0.06526323996555261,0.07235065949049088,0.014507411718254981,0.1162610322809634,0.039150354019158694,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.1,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery have an impact on lowering serum lipid levels in obstructive sleep apnea patients? Surgery could improve lipid levels in the blood of OSA patients, especially those with preoperative dyslipidemia, potentially yielding important metabolic and cardiovascular benefits. This potential effect should be studied prospectively.",1.6580180914979784e-07,0.0728967768044817,0.05071734418492031,0.012693985253473108,0.12477820408171647,0.016435372948309584,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
32,0.1,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can serum lipid levels be lowered by airway surgery in patients with obstructive sleep apnea? Airway surgery may improve blood lipid profiles in OSA patients, particularly those with dyslipidemia prior to surgery, possibly resulting in major metabolic and cardiovascular benefits. Prospective studies should explore this metabolic effect.",1.4211583641411244e-07,0.019441621306655943,0.0733372454996116,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.1,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is there evidence that airway surgery reduces serum lipid levels in obstructive sleep apnea patients? Surgery might improve blood lipid levels in OSA patients, especially those with preoperative dyslipidemia, potentially offering significant metabolic and cardiovascular benefits. This metabolic effect should be examined in prospective studies.",1.8948778188548325e-07,0.09676992999100476,0.0497141666384375,0.014507411718254981,0.1485004360279376,0.01590772363367117,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.1,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Surgical intervention may enhance blood lipid levels in OSA patients, particularly those with dyslipidemia before surgery, potentially providing major metabolic and cardiovascular benefits. Prospective studies are needed to evaluate this metabolic effect.",1.6580180914979784e-07,0.0728967768044817,0.05071734418492031,0.012693985253473108,0.12477820408171647,0.016435372948309584,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
33,0.1,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography a suitable alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our study suggests that routine bone scintigraphy is not needed for patients with metastatic breast cancer when CT imaging of the thorax, abdomen, and pelvis is performed.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.1,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible to substitute computerized tomography for bone scintigraphy in detecting bone metastases in breast cancer patients? Answer: Findings imply that routine bone scintigraphy is unnecessary if CT scans of the thorax, abdomen, and pelvis are done in metastatic breast cancer cases.",1.8948778188548272e-07,0.14137324671020046,0.046400951814396206,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography serve as a replacement for bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Our data suggest that routine bone scintigraphy is not required for patients presenting with metastatic breast cancer if CT of the thorax, abdomen, and pelvis is carried out.",3.0791764556390975e-07,0.28697181689514695,0.020823902218198284,0.02357454404216435,0.323787077093896,0.0,0.02354042003238728,0.3321338350226144,0.0,3.079176455639103e-07,0.3409265869705931,0.0
33,0.1,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerized tomography have the potential to replace bone scintigraphy in detecting bone metastases in breast cancer? Answer: The evidence suggests that routine bone scintigraphy is unnecessary for metastatic breast cancer patients when CT scans of the thorax, abdomen, and pelvis are performed.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT imaging replace bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Our findings indicate that routine bone scintigraphy is not needed if CT scans of the thorax, abdomen, and pelvis are conducted in patients with metastatic breast cancer.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.1,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography an effective substitute for bone scintigraphy in identifying bone metastases from breast cancer? Answer: The results suggest that routine bone scintigraphy is not required for metastatic breast cancer patients if CT imaging of the thorax, abdomen, and pelvis is performed.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans be used instead of bone scintigraphy to detect bone metastases in breast cancer? Answer: Our findings show that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer when CT scans of the thorax, abdomen, and pelvis are done.",1.8948778188548272e-07,0.14137324671020046,0.046400951814396206,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it feasible to replace bone scintigraphy with computerized tomography in detecting bone metastases from breast cancer? Answer: The study suggests that routine bone scintigraphy is not needed if CT of the thorax, abdomen, and pelvis is performed in metastatic breast cancer patients.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography effectively replace bone scintigraphy in the detection of bone metastases in breast cancer? Answer: Our findings indicate that routine bone scintigraphy is not required for patients presenting with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
34,0.1,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain considered a clinically significant issue in general adult psychiatry? Yes, pain is indeed a clinically significant concern in general adult psychiatry. Chronic pain frequently coexists with psychiatric conditions such as depression and anxiety. Hence, evaluating and managing pain is essential in psychiatric treatment.",2.3685972735685406e-08,0.07807376141454236,0.11175224480837789,0.0018134264647818726,0.07006512440861101,0.06536762149263864,0.0018108015409528666,0.10542711757770196,0.09204470742932283,2.3685972735685406e-08,0.07492347421521872,0.0710059171597633
34,0.1,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Does pain represent a clinically important problem in general adult psychiatry? Yes, pain is a clinically important problem in general adult psychiatry. Chronic pain is commonly linked with psychiatric disorders including depression and anxiety. Thus, pain assessment and management are vital components of psychiatric care.",2.3685972735685406e-08,0.015060381363637632,0.07012417823228642,0.0018134264647818726,0.026653086832311157,0.0024973546708044053,0.0018108015409528666,0.02660091681466925,0.0021381180554416734,2.3685972735685406e-08,0.026512698549651326,0.0017087642806799253
34,0.1,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a relevant clinical issue in the field of general adult psychiatry? Yes, pain is a relevant clinical issue in general adult psychiatry. Chronic pain often overlaps with psychiatric illnesses like depression and anxiety. Consequently, addressing and managing pain is critical in psychiatric practice.",2.3685972735685406e-08,0.046567071389089776,0.09055682919574512,0.0018134264647818726,0.037825720661636364,0.04239357330703486,0.0018108015409528666,0.03941310038151791,0.044544707429322816,2.3685972735685406e-08,0.041111416626928854,0.0466309171597633
34,0.1,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain recognized as a clinically relevant concern in general adult psychiatry? Yes, pain is recognized as a clinically relevant concern in general adult psychiatry. Chronic pain is frequently associated with psychiatric disorders such as depression and anxiety. Therefore, pain evaluation and treatment are important in psychiatric care.",4.737194547137081e-08,0.03610455699149151,0.04277289567773965,0.0036268529295637453,0.008972624863631484,0.035502958579881644,0.003621603081905733,0.010419259084665455,0.03813280736357663,4.737194547137081e-08,0.01199240869808671,0.04076265614727155
34,0.1,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a significant clinical problem in general adult psychiatry? Yes, pain is a significant clinical problem in general adult psychiatry. Chronic pain is often intertwined with psychiatric conditions like depression and anxiety. Hence, the assessment and management of pain are crucial in psychiatric settings.",2.3685972735685406e-08,0.015060381363637187,0.07012417823228642,0.0018134264647818726,0.026653086832311157,0.0024973546708044053,0.0018108015409528666,0.02660091681466925,0.0021381180554416873,2.3685972735685406e-08,0.026512698549651326,0.0017087642806799253
34,0.1,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain an important clinical issue in general adult psychiatry? Yes, pain is an important clinical issue in general adult psychiatry. Chronic pain commonly co-occurs with psychiatric disorders including depression and anxiety. Therefore, pain assessment and management play a key role in psychiatric care.",4.737194547137081e-08,0.019181270835257003,0.08765522279035795,0.0036268529295637453,0.05402160849809867,0.005105057080109027,0.003621603081905733,0.05391866435451753,0.004376037640070912,4.737194547137081e-08,0.0537412154591439,0.003501022212040933
34,0.1,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically relevant issue in general adult psychiatry? Yes, pain is a clinically relevant issue in general adult psychiatry. Chronic pain is often linked to psychiatric disorders such as depression and anxiety. Thus, evaluating and managing pain is essential in psychiatric treatment.",4.737194547137081e-08,0.057466098141587985,0.009948569639689375,0.0036268529295637453,0.05402160849809867,0.005105057080109027,0.003621603081905733,0.05391866435451753,0.004376037640070912,4.737194547137081e-08,0.0537412154591439,0.003501022212040933
34,0.1,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a problem of clinical relevance in general adult psychiatry? Yes, pain is a problem of clinical relevance in general adult psychiatry. Chronic pain frequently coincides with psychiatric disorders like depression and anxiety. Therefore, pain assessment and management are vital in psychiatric care.",4.737194547137081e-08,0.013058132911717202,0.06688501564627694,0.0036268529295637453,0.08702861709619114,0.027120315581854015,0.003621603081905733,0.0877307219428074,0.02755405800277598,4.737194547137081e-08,0.08839857448714117,0.027759514939002153
34,0.1,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically important problem in general adult psychiatry? Yes, pain is a clinically important problem in general adult psychiatry. Chronic pain is often associated with psychiatric conditions such as depression and anxiety. Hence, the evaluation and management of pain are critical in psychiatric care.",0.0,0.042434277886320704,0.07324380980516346,0.0,4.440892098500626e-16,0.0,0.0,0.0,0.0,0.0,0.0,0.0
34,0.1,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically significant concern in general adult psychiatry? Yes, pain is a clinically significant concern in general adult psychiatry. Chronic pain commonly overlaps with psychiatric disorders like depression and anxiety. Therefore, assessing and managing pain is essential within psychiatric care.",9.474389094274162e-08,0.07169475879018217,0.06002600842683142,0.0072537058591274906,0.11106352481705217,0.01068040628480188,0.007243206163811466,0.11086489161395763,0.00917978236659557,9.474389094274162e-08,0.11050672443006304,0.007361429779012205
35,0.1,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Does taking statins before surgery lower the risk of atrial fibrillation following coronary artery bypass grafting? Our research suggests that preoperative statin use appears to decrease the incidence of AF after CABG.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,0.1,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Can preoperative statin treatment reduce atrial fibrillation after coronary artery bypass grafting? According to our study, statin therapy before surgery seems to lessen AF occurrence post-CABG.",2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.1,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Do statins administered before surgery help in reducing atrial fibrillation after coronary artery bypass grafting? Our findings indicate that preoperative statin therapy may reduce AF development following CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.1,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Is there a reduction in atrial fibrillation after coronary artery bypass grafting with preoperative statin use? Our study showed that preoperative statins seem to lower AF rates after CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.1,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Does preoperative statin therapy decrease the likelihood of atrial fibrillation after coronary artery bypass grafting? Our research demonstrated that statins given before surgery appear to reduce AF after CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.1,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Can the use of statins before coronary artery bypass grafting reduce atrial fibrillation? Our study found that preoperative statin treatment seems to diminish AF occurrence post-CABG.,2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.1,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Are preoperative statins effective in reducing atrial fibrillation following coronary artery bypass grafting? Our study suggests that statin therapy prior to surgery reduces AF development after CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.1,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Does administering statins before coronary artery bypass grafting help prevent atrial fibrillation? Our findings indicate that preoperative statin therapy appears to lower AF incidence after CABG.,2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.1,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Is atrial fibrillation less common after coronary artery bypass grafting when patients receive statins preoperatively? Our study suggests that preoperative statin use reduces AF after CABG.,2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.1,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Do preoperative statins have an effect on atrial fibrillation rates after coronary artery bypass grafting? Our research indicates that statin therapy before surgery seems to reduce AF development post-CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
36,0.1,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful for practitioners and athletes? There is a lack of research focusing on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow both in quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.1,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and applicability for practitioners and athletes? Studies on diagnostic and treatment interventions in sports medicine are scarce. The body of evidence in sports medicine must expand in volume and improve in quality.,1.6580180914979753e-07,0.22491042517533,0.04630283485943398,0.012693985253473108,0.21618935393522687,0.02775510204081633,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.1,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and relevant to athletes and practitioners? The sports medicine literature shows a shortage of studies on diagnostic and treatment interventions. Increasing both the amount and quality of evidence in sports medicine is necessary.,1.6580180914979753e-07,0.18744301000992758,0.018049886621315223,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.1,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Is the content of sports medicine journals relevant and useful to practitioners and athletes? There is a notable deficiency of research on diagnostic and treatment approaches in sports medicine literature. The evidence base in sports medicine should be enhanced in both size and quality.,2.3685972735685406e-08,0.05697090763023782,0.02640447845804994,0.0018134264647818726,0.056537506008286,0.023795359904818555,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
36,0.1,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do practitioners and athletes find sports medicine journals relevant and applicable? Research addressing diagnostic and treatment interventions in sports medicine is limited. The evidence supporting sports medicine must grow in both quantity and quality.,2.605457000925387e-07,0.31265053355787487,0.031899405617259124,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
36,0.1,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and applicable to athletes and practitioners? There is a scarcity of studies concerning diagnostic and treatment interventions within sports medicine literature. The evidence base for sports medicine requires expansion in volume and improvement in quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.1,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and practical for practitioners and athletes? The literature in sports medicine lacks sufficient studies on diagnostic and treatment interventions. The evidence base must increase in both quantity and quality for sports medicine.,1.8948778188548283e-07,0.1642734888416455,0.06521541950113377,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.1,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and relevant to practitioners and athletes? There is a shortage of research on diagnostic and treatment interventions in sports medicine literature. The evidence supporting sports medicine needs to be expanded in both volume and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.1,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and significant for athletes and practitioners? Studies on diagnostic and treatment interventions in sports medicine are few. The evidence base for sports medicine should continue to grow in both quantity and quality.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.1,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and beneficial to practitioners and athletes? There is a paucity of studies addressing diagnostic and treatment interventions in sports medicine literature. The evidence base must increase in both volume and quality for sports medicine.,1.4211583641411222e-07,0.10817952142938081,0.06667395470484272,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
37,0.1,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? This research demonstrated for the first time that RALP causes less tissue damage than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.1,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy result in less invasiveness than retropubic radical prostatectomy? The study revealed that RALP leads to reduced tissue trauma compared to RRP for the first time.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.1,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than RRP? This study was the first to show that robotically assisted laparoscopic radical prostatectomy causes lower tissue trauma than retropubic radical prostatectomy.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
37,0.1,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? The findings indicated for the first time that RALP results in less tissue injury than RRP.,7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
37,0.1,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy cause less tissue trauma than retropubic radical prostatectomy? This study provided the first evidence that RALP is less invasive than RRP.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
37,0.1,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with reduced invasiveness compared to retropubic radical prostatectomy? The study showed for the first time that RALP induces less tissue trauma than RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.1,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP a less invasive procedure than RRP? This research demonstrated for the first time that robotically assisted laparoscopic radical prostatectomy causes lower tissue trauma than retropubic radical prostatectomy.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.1,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the robotically assisted laparoscopic radical prostatectomy technique less invasive than retropubic radical prostatectomy? This study was the first to reveal that RALP results in decreased tissue trauma compared to RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.1,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less damaging to tissue than retropubic radical prostatectomy? The study showed for the first time that RALP induces less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.1,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy lead to less tissue trauma than retropubic radical prostatectomy? This study demonstrated for the first time that RALP is less invasive than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
38,0.1,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model for healing Los Angeles grades C and D reflux oesophagitis: is there an ideal duration of acid suppression for optimal healing? After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing seems to plateau, with no significant improvements despite longer periods of intragastric pH>4.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,0.1,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Investigating healing in Los Angeles grades C and D reflux oesophagitis: what is the best acid suppression time for maximum healing? Following 4 weeks of acid suppression therapy in LA grade C or D oesophagitis, healing reaches a limit beyond which further increases in intragastric pH>4 duration do not enhance recovery.",2.8423167282822487e-07,0.24283726683934415,0.019991670137442734,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
38,0.1,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A healing model for Los Angeles grades C and D reflux oesophagitis: is there an optimal acid suppression period for maximal healing? After 4 weeks of acid-suppressive therapy in LA grade C or D oesophagitis, healing attains a threshold, with no further gains despite extended intragastric pH>4 hours.",3.552895910352811e-07,0.2769867833350337,0.0,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.1,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Modeling healing in Los Angeles grades C and D reflux oesophagitis: what is the optimal acid suppression time for best healing outcomes? Four weeks of acid suppression in LA grade C or D oesophagitis results in healing that plateaus, with no additional improvement despite increased intragastric pH>4 duration.",3.552895910352811e-07,0.30648240803971216,0.0212665406427221,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.1,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Healing model for Los Angeles grades C and D reflux oesophagitis: is there a best acid suppression duration for maximal healing? After 4 weeks of acid-suppressive therapy for LA grade C or D oesophagitis, healing reaches a ceiling, with no further improvement despite longer intragastric pH>4 exposure.",3.789755637709665e-07,0.29849298855599704,0.0,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
38,0.1,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model of healing for Los Angeles grades C and D reflux oesophagitis: is there an optimal acid suppression time to maximize healing? Healing after 4 weeks of acid suppression in LA grade C or D oesophagitis appears to plateau, with no further benefits despite increased hours of intragastric pH>4.",3.079176455639103e-07,0.26360580858997285,0.020399305555555556,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,0.1,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Modeling the healing process of Los Angeles grades C and D reflux oesophagitis: what is the optimal acid suppression duration for maximal healing? After 4 weeks of acid-suppressive therapy, healing in LA grade C or D oesophagitis reaches a threshold beyond which more intragastric pH>4 hours do not improve outcomes.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,0.1,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A healing model for Los Angeles grades C and D reflux oesophagitis: is there an ideal acid suppression period for maximal healing? Four weeks of acid suppression therapy in LA grade C or D oesophagitis leads to healing that plateaus, with no further improvement despite increased intragastric pH>4 time.",3.316036182995957e-07,0.2848145066605312,0.020823902218198284,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,0.1,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Investigating the optimal acid suppression time for healing Los Angeles grades C and D reflux oesophagitis: is there a maximal healing period? After 4 weeks of acid-suppressive therapy, healing in LA grade C or D oesophagitis reaches a limit, with no further gains despite longer intragastric pH>4 duration.",3.552895910352811e-07,0.2769867833350337,0.0,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.1,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model for healing Los Angeles grades C and D reflux oesophagitis: what is the optimal acid suppression duration for maximal healing? Healing after 4 weeks of acid suppression in LA grade C or D oesophagitis appears to reach a plateau, with no additional improvement despite increased intragastric pH>4 hours.",3.079176455639103e-07,0.26360580858997285,0.020399305555555556,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
39,0.1,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV through neurolabyrinthitis caused by the virus.",1.8948778188548325e-07,0.2028649207777371,0.023242630385487524,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
39,0.1,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections contribute to benign paroxysmal positional vertigo? BPPV shows an association with positive viral serology, particularly during spring and autumn months. Viral infections might induce BPPV attacks by developing vestibulopathy or cause secondary BPPV via viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.1,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections play a role in benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, mainly in spring and autumn. Viral infections may facilitate BPPV episodes by causing vestibulopathy or trigger secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.358375135245502,0.027006172839506164,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.1,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections involved in benign paroxysmal positional vertigo? BPPV is connected to positive viral serology, especially in the spring and autumn seasons. Viral infections might provoke BPPV attacks by inducing vestibulopathy or secondary BPPV through neurolabyrinthitis related to the virus.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.1,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections have an impact on benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, particularly during spring and autumn. Viral infections could promote BPPV attacks by causing vestibulopathy or lead to secondary BPPV via viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.1,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is benign paroxysmal positional vertigo linked to viral infections? BPPV is related to positive viral serology, mainly in spring and autumn months. Viral infections may trigger BPPV attacks by developing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.3209077200800996,0.0,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.1,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Could viral infections influence benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially in spring and autumn. Viral infections might cause BPPV attacks by inducing vestibulopathy or secondary BPPV through viral neurolabyrinthitis.",4.0266153650665127e-07,0.446238471670513,0.029384756657483937,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
39,0.1,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does benign paroxysmal positional vertigo have a viral infection component? BPPV correlates with positive viral serology, particularly during spring and autumn. Viral infections may facilitate BPPV attacks by causing vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",3.7897556377096597e-07,0.37647757123491177,0.0,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
39,0.1,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections a factor in benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, mainly in spring and autumn. Viral infections might promote BPPV episodes by inducing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.358375135245502,0.027006172839506164,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.1,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections play a role in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially in spring and autumn months. Viral infections could trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV via viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
40,0.1,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? In this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was similar to healthy controls. However, within the at-risk group, those with higher aerobic fitness showed improved microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.1,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an impact of aerobic fitness on microvascular function in healthy adults at risk of developing Type 2 diabetes? Among this at-risk population with skin microvascular dysfunction, maximal oxygen uptake did not differ from healthy controls. Yet, within the at-risk group, individuals with greater aerobic fitness exhibited enhanced microvascular and endothelial function.",7.105791820705622e-08,0.03233826955493324,0.017088479127821278,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
40,0.1,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? In the at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Still, among these at-risk individuals, higher aerobic fitness correlated with better microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.1657661288910468,0.006157281049888143,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk of Type 2 diabetes? The at-risk group with skin microvascular dysfunction showed no reduction in maximal oxygen uptake compared to healthy controls. Nevertheless, within this group, those with higher aerobic fitness had superior microvascular and endothelial responses.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,0.1,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is aerobic fitness associated with microvascular function in healthy adults at risk of Type 2 diabetes? In this at-risk cohort with skin microvascular dysfunction, maximal oxygen uptake was comparable to healthy controls. However, among the at-risk individuals, higher aerobic fitness was linked to improved microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not diminished in the at-risk group with skin microvascular dysfunction compared to healthy controls. Yet, within this group, individuals with greater aerobic fitness demonstrated better microvascular and endothelial function.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","What is the effect of aerobic fitness on microvascular function in healthy adults at risk of developing Type 2 diabetes? The at-risk group with skin microvascular dysfunction did not show reduced maximal oxygen uptake relative to healthy controls. However, higher aerobic fitness within this group was associated with enhanced microvascular and endothelial responsiveness.",7.105791820705622e-08,0.03233826955493324,0.017088479127821278,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
40,0.1,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk of Type 2 diabetes? In the at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Still, those with higher aerobic fitness in this group had better microvascular and endothelial function.",1.8948778188548325e-07,0.1657661288910468,0.006157281049888143,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there a relationship between aerobic fitness and microvascular function in healthy adults at risk of Type 2 diabetes? The at-risk group with skin microvascular dysfunction had maximal oxygen uptake similar to healthy controls. However, within this group, individuals with higher aerobic fitness showed improved microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.1,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not reduced in the at-risk group with skin microvascular dysfunction compared to healthy controls. Nonetheless, higher aerobic fitness in this group was linked to better microvascular and endothelial function.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
41,0.1,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our findings indicate that UHR intake criteria forecast transition within 6 months in the sequence of Trait alone<APS<BLIPS. The observation that BLIPS patients face the greatest short-term transition risk aligns with the 'early' versus 'late' prodrome model. This also suggests that specific clinical focus might be necessary.,1.6580180914979784e-07,0.08302476077153376,0.013886133703630227,0.01269398525347315,0.10379679368164485,0.0,0.01267561078667008,0.10536051565782323,0.0,1.6580180914979784e-07,0.10697211955217067,0.0
41,0.1,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: According to our data, UHR intake criteria predict a 6-month transition risk in the order Trait alone<APS<BLIPS. The highest short-term transition risk in BLIPS patients supports the 'early' versus 'late' prodrome framework and implies the need for targeted clinical attention.",3.316036182995957e-07,0.2447722739524716,0.02055264180657386,0.02538797050694626,0.24394956291062364,0.01753826530612245,0.025351221573340146,0.22314355131420882,0.0,3.316036182995957e-07,0.22677331936479117,0.0
41,0.1,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our research shows that UHR intake criteria predict psychosis transition over 6 months in the order Trait alone<APS<BLIPS. The elevated short-term risk in BLIPS patients corresponds with the 'early' versus 'late' prodrome model and highlights the importance of focused clinical care.,3.079176455639103e-07,0.17987458676145174,0.013886133703630227,0.023574544042164386,0.20223686649489725,0.0,0.02354042003238728,0.2054439742148082,0.0,3.079176455639103e-07,0.2087548138621127,0.0
41,0.1,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Data from our study suggest that UHR intake criteria rank transition risk over 6 months as Trait alone<APS<BLIPS. The fact that BLIPS patients have the highest short-term transition risk aligns with the 'early' versus 'late' prodrome concept and indicates a need for particular clinical vigilance.,2.1317375462116866e-07,0.13628197667436304,0.0019827528728526087,0.016320838183036895,0.13554549199622468,0.0,0.016297213868575813,0.137621377876048,0.0,2.1317375462116866e-07,0.13976194237516282,0.0
41,0.1,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data imply that UHR intake criteria predict transition within 6 months in the order Trait alone<APS<BLIPS. The highest risk of short-term transition in BLIPS patients is consistent with the 'early' versus 'late' prodrome model and suggests that special clinical attention may be required.,2.3685972735685406e-07,0.13027764562207889,0.013886133703630227,0.018134264647818768,0.15180601286800588,0.0,0.01810801540952868,0.15415067982725894,0.0,2.3685972735685406e-07,0.15656906069154353,0.0
41,0.1,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Findings from our data indicate that UHR intake criteria forecast transition over 6 months in the sequence Trait alone<APS<BLIPS. The elevated short-term transition risk among BLIPS patients supports the 'early' versus 'late' prodrome framework and points to the need for focused clinical care.,2.6054570009253947e-07,0.1465381664938601,0.013886133703630227,0.01994769111260064,0.16833531481921682,0.0,0.019918816950481547,0.17095779814363965,0.0,2.6054570009253947e-07,0.17366349405084325,0.0
41,0.1,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our study data suggest that UHR intake criteria predict psychosis transition risk over 6 months in the order Trait alone<APS<BLIPS. The highest short-term risk in BLIPS patients aligns with the 'early' versus 'late' prodrome model and indicates the necessity for particular clinical attention.,2.6054570009253947e-07,0.1465381664938601,0.013886133703630227,0.01994769111260064,0.16833531481921682,0.0,0.019918816950481547,0.17095779814363965,0.0,2.6054570009253947e-07,0.17366349405084325,0.0
41,0.1,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: According to our findings, UHR intake criteria predict transition within 6 months in the order Trait alone<APS<BLIPS. The fact that BLIPS patients have the greatest short-term transition risk is consistent with the 'early' versus 'late' prodrome model and suggests a need for targeted clinical focus.",2.1317375462116866e-07,0.11427730427563532,0.013886133703630227,0.016320838183036895,0.13554549199622468,0.0,0.016297213868575813,0.137621377876048,0.0,2.1317375462116866e-07,0.13976194237516282,0.0
41,0.1,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data reveal that UHR intake criteria predict transition risk over 6 months in the order Trait alone<APS<BLIPS. The highest short-term transition risk in BLIPS patients corresponds with the 'early' versus 'late' prodrome model and implies that special clinical attention may be warranted.,2.6054570009253947e-07,0.1692643035613992,0.0025027551852586667,0.01994769111260064,0.16833531481921682,0.0,0.019918816950481547,0.17095779814363965,0.0,2.6054570009253947e-07,0.17366349405084325,0.0
41,0.1,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: The data suggest that UHR intake criteria predict transition over 6 months in the order Trait alone<APS<BLIPS. The elevated short-term risk in BLIPS patients is consistent with the 'early' versus 'late' prodrome model and indicates that particular clinical care may be necessary.,2.8423167282822487e-07,0.16306746844507103,0.013886133703630227,0.021761117577382513,0.18514243313559753,0.0,0.021729618491434413,0.18805223150293937,0.0,2.8423167282822487e-07,0.19105523676271208,0.0
42,0.1,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Answer: Yes, the preoperative platelet count can serve as a prognostic factor in esophageal squamous cell carcinoma. Higher platelet counts prior to surgery are linked to worse outcomes and greater tumor aggressiveness. Nonetheless, more studies are required for conclusive evidence.",7.105791820705622e-08,0.06925463702341528,0.007272873192580548,0.005440279394345618,0.0942440009698875,0.024334251606978843,0.0054324046228586,0.12178466715995873,0.04349427408001486,7.105791820705622e-08,0.15036227783212297,0.06353305785123965
42,0.1,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count may act as a prognostic marker in esophageal squamous cell carcinoma. Elevated platelet levels before surgery correlate with poorer prognosis and increased tumor aggressiveness, though additional research is necessary for confirmation.",7.105791820705622e-08,0.015272316684695753,0.03141460297838265,0.005440279394345618,0.012130795156159113,0.035823194579155976,0.0054324046228586,0.020179467597532863,0.06043388429752067,7.105791820705622e-08,0.02252890632223936,0.06353305785123965
42,0.1,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? Answer: Yes, it can be a prognostic factor. Increased platelet counts before surgery have been associated with a worse prognosis and more aggressive tumors, but further investigation is needed to confirm this.",1.4211583641411244e-07,0.06624783904690057,0.13628988642509468,0.010880558788691236,0.010838425860475454,0.10072314049586772,0.0108648092457172,0.018006862531199097,0.08264462809917356,1.4211583641411244e-07,0.048088660891714596,0.06353305785123965
42,0.1,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count a useful prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can indicate prognosis in esophageal squamous cell carcinoma. Higher platelet counts before surgery are linked to poorer outcomes and tumor aggressiveness, although more research is needed for definitive conclusions.",7.105791820705622e-08,0.015272316684695753,0.03141460297838264,0.005440279394345618,0.012130795156158669,0.035823194579155976,0.0054324046228586,0.020179467597532863,0.06043388429752067,7.105791820705622e-08,0.02252890632223936,0.06353305785123965
42,0.1,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can the preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? Answer: Yes, it can serve as a prognostic factor. Elevated platelet counts prior to surgery have been associated with worse prognosis and increased tumor aggressiveness, but further studies are required for definitive proof.",1.1842986367842703e-07,0.08872069489895829,0.13628988642509468,0.009067132323909363,0.03382794408517498,0.10072314049586772,0.009054007704764333,0.0055236348789953205,0.08264462809917356,1.1842986367842703e-07,0.02399110931265458,0.06353305785123965
42,0.1,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is there prognostic significance of preoperative platelet count in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count may be prognostically significant. Higher platelet counts before surgery correlate with poorer prognosis and greater tumor aggressiveness, though more research is needed to establish this definitively.",1.4211583641411244e-07,0.003234458995995837,0.09093841250219219,0.010880558788691236,0.02140097788649875,0.07748051011038021,0.0108648092457172,0.018006862531199097,0.08264462809917356,1.4211583641411244e-07,0.048088660891714596,0.06353305785123965
42,0.1,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does the preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? Answer: Yes, it can be a prognostic factor. Elevated platelet counts before surgery are linked to worse prognosis and increased tumor aggressiveness, but further research is necessary for confirmation.",2.1317375462116866e-07,0.004369728167053388,0.13628988642509468,0.016320838183036854,0.06148223571915068,0.10072314049586772,0.0162972138685758,0.09211483468492254,0.08264462809917356,2.1317375462116866e-07,0.124074567869636,0.06353305785123965
42,0.1,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? Answer: Yes, it can indicate prognosis. Higher platelet counts before surgery have been associated with poorer outcomes and more aggressive tumors, although additional studies are needed for definitive evidence.",1.8948778188548325e-07,0.01972782341200663,0.13628988642509468,0.014507411718254981,0.03678962312877898,0.10072314049586772,0.014486412327622933,0.06679702670063081,0.08264462809917356,1.8948778188548325e-07,0.09809908146637802,0.06353305785123965
42,0.1,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, it can be used as such. Elevated platelet counts prior to surgery are connected with worse prognosis and increased tumor aggressiveness, but further research is required to confirm this.",9.474389094274162e-08,0.050425933742955564,0.09290145667302856,0.0072537058591274906,0.025494258579012996,0.07851239669421484,0.007243206163811466,0.028513153103694844,0.08264462809917356,9.474389094274162e-08,0.0004606119024601618,0.06353305785123965
42,0.1,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the platelet count before surgery a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can serve as a prognostic factor. Increased platelet counts before surgery have been linked to poorer prognosis and higher tumor aggressiveness, though more studies are needed for definitive conclusions.",4.737194547137081e-08,0.06661581846653686,0.07406766420287246,0.0036268529295637453,0.09978591187697106,0.10072314049586772,0.003621603081905733,0.07296491567452756,0.08264462809917356,4.737194547137081e-08,0.04500176217429708,0.06353305785123965
43,0.1,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do the leadership abilities of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership skills significantly correlated with their perceptions of skill decline and task difficulty during bowel repair. Assessing residents' directional instructions could offer an additional personalized intraoperative evaluation metric. Further studies linking these skills to operative performance outcomes are needed.,7.105791820705622e-08,0.05441355041844975,0.000939510352663115,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
43,0.1,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Is there a relationship between residents' leadership skills and their technical skill ratings? In general surgery research, residents' intraoperative leadership abilities were significantly associated with their views on skill decay and task difficulty during bowel repair. Evaluating the directional instructions given by residents might provide a new individualized intraoperative assessment tool. More research is necessary to connect these findings to operative performance outcomes.",1.6580180914979784e-07,0.1450065518329824,0.0181755829903978,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
43,0.1,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are residents' leadership skills connected to their technical skill ratings? Studies on general surgery research residents revealed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Analyzing residents' directional instructions may serve as an additional personalized intraoperative assessment measure. Further investigation into operative performance outcomes is justified.,2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
43,0.1,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do leadership skills of residents have a link to their technical skill ratings? Research involving general surgery residents showed that intraoperative leadership skills significantly correlated with their perceptions of skill decay and task difficulty in bowel repair procedures. Assessing residents' directional instructions could provide an extra individualized intraoperative evaluation metric. Additional research relating these skills to operative performance outcomes is warranted.,1.1842986367842703e-07,0.0891118229913257,0.0015137042199295445,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
43,0.1,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a correlation between residents' leadership skills and their technical skill ratings? General surgery research residents' intraoperative leadership abilities were significantly related to their perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions might offer an additional personalized intraoperative assessment metric. Further studies on operative performance outcomes are needed.,2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
43,0.1,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do residents' leadership skills relate to their technical skill ratings? Research on general surgery residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing directional instructions given by residents may provide an additional individualized intraoperative assessment tool. Further evaluation regarding operative performance outcomes is warranted.,2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
43,0.1,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Are residents' leadership skills associated with their technical skill ratings? In general surgery research, residents' intraoperative leadership skills showed significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could serve as an additional personalized intraoperative assessment metric. More research is needed to relate these findings to operative performance outcomes.",4.737194547137081e-08,0.012281527214724974,0.016865739323651804,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
43,0.1,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a connection between residents' leadership skills and technical skill ratings? Studies on general surgery research residents demonstrated significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions may provide an extra individualized intraoperative evaluation metric. Further investigation into operative performance outcomes is warranted.,0.0,0.02520535202036145,0.018136271762183187,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
43,0.1,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do the leadership skills of residents correlate with their technical skill ratings? Research on general surgery residents indicated significant associations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions might offer an additional personalized intraoperative assessment tool. Further studies relating to operative performance outcomes are necessary.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.1,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are residents' leadership skills linked to their technical skill ratings? General surgery research residents' intraoperative leadership abilities showed significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions could provide an additional individualized intraoperative evaluation metric. Further evaluation concerning operative performance outcomes is warranted.,9.474389094274162e-08,0.050302200487784,0.0181755829903978,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
44,0.1,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is suggested to be a potential risk factor for causing and progressing chronic kidney failure in hypertensive individuals.,2.36859727356853e-08,0.027846328995862812,0.0013369225080936895,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.1,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in patients with hypertension? Answer: It is concluded that the ACE-DD genotype may increase the risk of developing chronic kidney failure among hypertensive patients.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.1,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in hypertensive patients? Answer: Findings indicate that the ACE-DD genotype might be a risk factor for the onset and progression of chronic kidney failure in those with hypertension.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.1,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients associated with angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Answer: The ACE-DD genotype appears to be a risk factor for the development and causation of chronic kidney failure in hypertensive patients.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.1,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism influence the risk of chronic kidney disease in hypertensive individuals? Answer: It is concluded that the ACE-DD genotype may contribute to the causation and advancement of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.06610763146679632,0.027980691187150207,0.0018134264647818726,0.06590715088589016,0.02775510204081633,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.1,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there an association between ACE-1 gene polymorphism and chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype may serve as a risk factor for chronic kidney failure development among hypertensive patients.,9.47438909427412e-08,0.07903613756100114,0.023084379144985203,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,0.1,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is identified as a possible risk factor for causing and developing chronic kidney failure in hypertensive individuals.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.1,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism responsible for chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype might be a contributing risk factor for chronic kidney failure among those with hypertension.,7.10579182070559e-08,0.08849205776082192,0.004463830221405965,0.005440279394345625,0.1253307515904134,0.029384756657483937,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.1,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene result in chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may be implicated as a risk factor in the causation and progression of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.0076996802636211115,0.023919753086419755,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.1,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease in hypertensive patients linked to angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Answer: The ACE-DD genotype is considered a potential risk factor for the development and causation of chronic kidney failure among hypertensive individuals.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
45,0.1,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories accurately reporting serum quantitative hCG results? Many factors lead to errors in hCG result reporting, such as (a) the complexity of the hCG molecule and confusion over the nomenclature of its various forms; (b) laboratory staff's unawareness of the differences among hCG forms and failure to understand assay specificity; (c) lack of...",2.6054570009253947e-07,0.09826766797835962,0.09260127675343245,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
45,0.1,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories correctly report serum quantitative hCG results? Several factors cause incorrect hCG reporting, including (a) the intricate nature of the hCG molecule and confusion about the names of its different forms; (b) laboratory personnel not recognizing the distinctions between hCG forms and the specificity of assays; (c) lack of...",3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.1,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are serum quantitative hCG results being reported correctly by laboratories? Errors in hCG reporting arise from (a) the complex structure of the hCG molecule and confusion regarding its various forms' nomenclature; (b) laboratory staff's insufficient knowledge of hCG form differences and assay specificity; (c) lack of...,4.500334819780227e-07,0.23574059438054018,0.11146222349899458,0.03445510283085558,0.35894509247327333,0.0,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
45,0.1,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Is the reporting of serum quantitative hCG results by laboratories accurate? Multiple factors contribute to erroneous hCG reporting, including (a) the complexity of the hCG molecule and confusion about the nomenclature of its forms; (b) laboratory personnel's lack of awareness of hCG form distinctions and assay specificity; (c) lack of...",3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.1,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are laboratories providing accurate serum quantitative hCG results? Errors in reporting hCG results stem from (a) the complex hCG molecule and confusion over the nomenclature of its various forms; (b) laboratory staff's failure to recognize differences among hCG forms and assay specificity; (c) lack of...,4.737194547137081e-07,0.2582134502325979,0.11146222349899458,0.03626852929563745,0.38193461069797285,0.0,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
45,0.1,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories report serum quantitative hCG results correctly? Several reasons cause errors in hCG reporting, including (a) the complexity of the hCG molecule and confusion about the names of its different forms; (b) laboratory personnel's lack of understanding of hCG form distinctions and assay specificity; (c) lack of...",4.026615365066519e-07,0.19225548244080182,0.11146222349899458,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
45,0.1,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are serum quantitative hCG results accurately reported by laboratories? Errors occur due to (a) the complex nature of the hCG molecule and confusion regarding the nomenclature of its forms; (b) laboratory staff's unawareness of the differences between hCG forms and assay specificity; (c) lack of...,4.737194547137081e-07,0.2897201402580505,0.08874724242814547,0.03626852929563745,0.38193461069797285,0.0,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
45,0.1,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Is the serum quantitative hCG reporting by laboratories correct? Many factors cause errors in hCG result reporting, including (a) the complexity of the hCG molecule and confusion about the nomenclature of its various forms; (b) laboratory personnel's failure to recognize distinctions among hCG forms and assay specificity; (c) lack of...",3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.1,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are laboratories correctly reporting serum quantitative hCG results? Errors in hCG reporting are due to (a) the complexity of the hCG molecule and confusion over the nomenclature of its forms; (b) laboratory staff's lack of awareness of the differences among hCG forms and assay specificity; (c) lack of...,4.026615365066519e-07,0.2217511071454803,0.09019568285627247,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
45,0.1,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories accurately report serum quantitative hCG results? Many factors contribute to erroneous hCG reporting, including (a) the complex hCG molecule and confusion about the nomenclature of its various forms; (b) laboratory personnel's failure to recognize distinctions among hCG forms and assay specificity; (c) lack of...",4.500334819780227e-07,0.23574059438054018,0.11146222349899458,0.03445510283085558,0.35894509247327333,0.0,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
46,0.1,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cervical disk disease? Current studies show that this complex is present in cervical disk disease and is linked to intervertebral disc degeneration, which is a major factor in the condition. Further research is necessary to clarify its exact role.",1.6580180914979784e-07,0.017068327667025596,0.15259336112306826,0.012693985253473108,0.07215874459196625,0.056152454680675055,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
46,0.1,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does cervical disk disease involve the fibronectin-aggrecan complex? Research suggests that the fibronectin-aggrecan complex exists in cervical disk disease and is connected to intervertebral disc degeneration, a significant cause of the disease. Additional studies are required to fully understand its function.",2.6054570009253947e-07,0.11920054917038625,0.12343789567416653,0.0199476911126006,0.17310381966839383,0.053771816368101626,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
46,0.1,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex detected in cervical disk disease? Evidence indicates that this complex is present in cervical disk disease and is associated with the degeneration of intervertebral discs, a primary contributor to the disease. More investigation is needed to comprehend its role completely.",1.8948778188548325e-07,0.007386618000717604,0.15154388323157456,0.014507411718254981,0.09645684685327804,0.055599725161344024,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
46,0.1,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Current findings confirm the presence of this complex in cervical disk disease, where it is linked to intervertebral disc degeneration, a key factor in the disease's development. Further research is essential to fully grasp its role.",1.1842986367842703e-07,0.09439663635137441,0.17621643998424236,0.009067132323909363,0.005543033231765193,0.07939508506616258,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
46,0.1,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does the fibronectin-aggrecan complex occur in cervical disk disease? Studies reveal that the complex is indeed present in cervical disk disease and is related to intervertebral disc degeneration, which plays a crucial role in the disease. More research is needed to understand its full impact.",1.6580180914979784e-07,0.017068327667025596,0.15259336112306826,0.012693985253473108,0.07215874459196625,0.056152454680675055,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
46,0.1,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Research indicates that this complex is found in cervical disk disease and is associated with the degeneration of intervertebral discs, a major contributor to the disease. Additional research is required to fully elucidate its role.",1.8948778188548325e-07,0.007386618000717604,0.15154388323157456,0.014507411718254981,0.09645684685327804,0.055599725161344024,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
46,0.1,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex associated with cervical disk disease? Current research shows that the complex is present in cervical disk disease and linked to intervertebral disc degeneration, a significant factor in the disease. Further studies are necessary to understand its role completely.",2.3685972735685406e-07,0.024347917084313497,0.17356983504597076,0.018134264647818726,0.11224000242461818,0.07939508506616258,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
46,0.1,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex present in cervical disk disease? Research confirms that this complex exists in cervical disk disease and is connected to intervertebral disc degeneration, a key contributor to the condition. More research is needed to fully understand its function.",2.6054570009253947e-07,0.08454319014238942,0.14808333920109543,0.0199476911126006,0.17310381966839383,0.053771816368101626,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
46,0.1,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cervical disk disease? Studies indicate that the complex is present in cervical disk disease and is associated with intervertebral disc degeneration, which is a major cause of the disease. Further investigation is required to clarify its role.",2.1317375462116866e-07,0.03245232511314766,0.15044483504597075,0.016320838183036854,0.12135944742253635,0.05502008506616258,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.1,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex detected in cervical disk disease? Current evidence suggests that this complex is present in cervical disk disease and linked to intervertebral disc degeneration, a primary factor in the disease. More research is needed to fully understand its role.",2.3685972735685406e-07,0.058159974672603365,0.14929263254761443,0.018134264647818726,0.14689736145261456,0.05441152162106066,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
47,0.1,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the criteria for selecting residents predict how well they will perform in Orthopaedic Surgery Residency? The selection criteria for residency can offer some insight into a candidate's likely performance in Orthopaedic Surgery Residency. Elements such as medical school grades, board exam scores, recommendation letters, and interview results can partially forecast a resident's success. Nevertheless, personal commitment and flexibility are also vital factors.",1.1842986367842703e-07,0.13860912632080336,0.03864629034369168,0.009067132323909363,0.13706180571633064,0.037010897511965506,0.009054007704764333,0.11221672900999025,0.0181755829903978,1.1842986367842703e-07,0.08855339734144341,0.0
47,0.1,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can residency selection criteria forecast performance in Orthopaedic Surgery Residency? Selection criteria for residency may indicate a candidate's potential success in Orthopaedic Surgery Residency. Metrics like academic grades, board scores, recommendation letters, and interview outcomes can somewhat predict a resident's capabilities. Still, individual dedication and adaptability remain essential.",2.3685972735685406e-07,0.15978577171923813,0.023375226172429042,0.018134264647818726,0.15258135883773472,0.031671391339126005,0.018108015409528666,0.17546534344178966,0.0181755829903978,2.3685972735685406e-07,0.2047944126460135,0.0
47,0.1,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do residency selection standards predict success in Orthopaedic Surgery Residency? The criteria used to select residents can somewhat predict how well a candidate will perform in Orthopaedic Surgery Residency. Factors including medical school grades, board exam results, letters of recommendation, and interview performance provide some indication. However, personal dedication and adaptability are also key.",9.474389094274162e-08,0.003467580522380942,0.04923046779913968,0.0072537058591274906,0.026501709752626113,0.03417641077609469,0.007243206163811466,0.050302200487784,0.0181755829903978,9.474389094274162e-08,0.07696104113612989,0.0
47,0.1,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Is performance in Orthopaedic Surgery Residency predictable by residency selection criteria? Residency selection criteria can give an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Aspects like medical school grades, board scores, recommendation letters, and interview evaluations can partially forecast success. Yet, individual commitment and adaptability are crucial.",1.8948778188548325e-07,0.14279308782666567,0.005920629702681035,0.014507411718254981,0.13764717552821137,0.011811884699531143,0.014486412327622933,0.16147585620672977,0.0030909576523243006,1.8948778188548325e-07,0.16034265007518078,0.0
47,0.1,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can the criteria for selecting residents predict their performance in Orthopaedic Surgery Residency? Residency selection criteria offer some insight into a candidate's potential success in Orthopaedic Surgery Residency. Medical school grades, board exam scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, personal dedication and adaptability also play important roles.",2.3685972735685406e-08,0.05439467852274937,0.051242989099114525,0.0018134264647818726,0.031041911822668578,0.0352242034104566,0.0018108015409528666,0.0068562133521661295,0.0181755829903978,2.3685972735685406e-08,0.018692133012154333,0.0
47,0.1,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do the criteria used for residency selection predict performance in Orthopaedic Surgery Residency? The selection criteria can provide an indication of how well a candidate might perform in Orthopaedic Surgery Residency. Factors such as academic grades, board scores, recommendation letters, and interview results can somewhat forecast success. Nonetheless, individual dedication and adaptability are significant.",9.474389094274162e-08,0.003467580522380942,0.04923046779913968,0.0072537058591274906,0.026501709752626113,0.03417641077609469,0.007243206163811466,0.050302200487784,0.0181755829903978,9.474389094274162e-08,0.07696104113612989,0.0
47,0.1,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Are residency selection criteria predictive of performance in Orthopaedic Surgery Residency? Selection criteria for residency can indicate a candidate's potential to perform well in Orthopaedic Surgery Residency. Elements like medical school grades, board exam scores, letters of recommendation, and interview performance can partially predict success. Still, personal dedication and adaptability are essential.",1.4211583641411244e-07,0.07116759371563441,0.028314534023668694,0.010880558788691236,0.06678880318369318,0.03340811626341167,0.0108648092457172,0.09030753510148237,0.0181755829903978,1.4211583641411244e-07,0.11778303565638426,0.0
47,0.1,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the selection process for residency predict Orthopaedic Surgery Residency performance? Residency selection criteria can somewhat predict a candidate's performance in Orthopaedic Surgery Residency. Medical school grades, board scores, recommendation letters, and interview outcomes provide some indication. However, individual dedication and adaptability are also important.",3.079176455639103e-07,0.16876355542245136,0.06419330295281958,0.023574544042164344,0.18988580569587832,0.0533997864008544,0.023540420032387266,0.2444582149287413,0.0181755829903978,3.079176455639103e-07,0.27541197985996746,0.0
47,0.1,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can residency selection criteria serve as predictors of performance in Orthopaedic Surgery Residency? The criteria used to select residents can offer some prediction of a candidate's success in Orthopaedic Surgery Residency. Factors including medical school grades, board exam scores, letters of recommendation, and interview performance can partially forecast outcomes. Yet, personal dedication and adaptability remain key.",4.737194547137081e-08,0.03547598187648715,0.050596429271087706,0.0036268529295637453,0.012226007376317849,0.034887860448558225,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
47,0.1,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Is it possible to predict Orthopaedic Surgery Residency performance based on residency selection criteria? Residency selection criteria can provide some indication of a candidate's potential success in Orthopaedic Surgery Residency. Academic grades, board scores, recommendation letters, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.",4.737194547137081e-08,0.03547598187648715,0.050596429271087706,0.0036268529295637453,0.03789812517483471,0.0533997864008544,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
48,0.1,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Amblyopia: Is the visual impairment permanent? Older adults with amblyopia who lose vision in their previously unaffected eye may regain visual function in the amblyopic eye over time, following the loss of vision.",4.0266153650665106e-07,0.23497699828542196,0.2130881557598702,0.030828249901291863,0.43721380642274443,0.0,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
48,0.1,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is visual loss from amblyopia permanent? In older individuals with amblyopia, if the previously normal eye experiences vision loss, the amblyopic eye can recover visual function gradually.",5.447773729207629e-07,0.4426163630636659,0.2130881557598702,0.04170880868998314,0.652325186039691,0.0,0.04164843544191601,0.6720937713621127,0.0,5.447773729207643e-07,0.693147180559945,0.0
48,0.1,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Does amblyopia cause permanent vision loss? Older patients with amblyopia who develop vision loss in their formerly normal eye might see improvement in the amblyopic eye's function over time after the loss.,4.2634750924233636e-07,0.2667256966000018,0.2130881557598702,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
48,0.1,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Is the vision loss in amblyopia irreversible? Older people with a history of amblyopia who suffer vision loss in the previously normal eye can regain visual ability in the amblyopic eye over a period.,3.7897556377096576e-07,0.3302320997204764,0.12308815575987016,0.029014823436509983,0.4487868068931622,0.031217481789802305,0.028972824655245893,0.41616039722491127,0.0,3.789755637709665e-07,0.4274440148269396,0.0
48,0.1,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is visual loss due to amblyopia permanent? In older adults, when the previously normal eye loses vision, the amblyopic eye may recover its visual function over time.",5.447773729207629e-07,0.4426163630636659,0.2130881557598702,0.04170880868998314,0.652325186039691,0.0,0.04164843544191601,0.6720937713621127,0.0,5.447773729207643e-07,0.693147180559945,0.0
48,0.1,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Does amblyopia lead to permanent visual loss? Older individuals with amblyopia who experience vision loss in their previously unaffected eye can have a recovery of vision in the amblyopic eye over time.,4.2634750924233636e-07,0.2667256966000018,0.2130881557598702,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
48,0.1,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Is vision loss from amblyopia permanent? Older patients with amblyopia who develop vision loss in the normal eye can regain visual function in the amblyopic eye gradually.,5.447773729207629e-07,0.5492543908421195,0.13669926687098133,0.04170880868998314,0.652325186039691,0.0,0.04164843544191601,0.6720937713621127,0.0,5.447773729207643e-07,0.693147180559945,0.0
48,0.1,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the visual loss caused by amblyopia permanent? In older people with amblyopia, vision loss in the previously normal eye can trigger recovery of visual function in the amblyopic eye over time.",4.2634750924233636e-07,0.3114448695393528,0.180865933537648,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
48,0.1,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Is amblyopic visual loss permanent? Older adults with amblyopia who lose vision in their previously normal eye may experience a restoration of visual function in the amblyopic eye over time.,4.7371945471370696e-07,0.33341707109867524,0.2130881557598702,0.0362685292956375,0.5389965007326869,0.0,0.03621603081905739,0.5543107357057284,0.0,4.737194547137081e-07,0.570544858467612,0.0
48,0.1,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Is the vision loss associated with amblyopia permanent? Older individuals with amblyopia who develop vision loss in the previously normal eye can recover visual function in the amblyopic eye over a period of time.,3.7897556377096576e-07,0.3302320997204764,0.12308815575987016,0.029014823436509983,0.4054651081081646,0.0,0.028972824655245893,0.41616039722491127,0.0,3.789755637709665e-07,0.4274440148269396,0.0
49,0.1,1,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not louder than bubble CPAP for preterm infants.",4.73719454713706e-08,0.14759007193636497,0.02682516425905998,0.003626852929563759,0.1464694910033857,0.039867674858222985,0.003621603081905747,0.1447354321242127,0.044820011337868504,4.737194547137081e-08,0.14224822387763325,0.04424462809917353
49,0.1,2,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae greater than that of bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae do not generate more noise than bubble CPAP for preterm infants.",1.894877818854824e-07,0.5118314389905034,0.13138437857610236,0.014507411718255037,0.5066313428053384,0.15140624999999996,0.014486412327622988,0.4574299143435274,0.1239215738378685,1.8948778188548325e-07,0.403206602545104,0.08264462809917354
49,0.1,3,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae louder compared to bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not louder than bubble CPAP for preterm infants.",2.36859727356853e-08,0.15005845156430464,0.045420205581373996,0.0018134264647818796,0.1522774689300741,0.0663327032136106,0.0018108015409528735,0.15438978315401197,0.07780612244897962,2.3685972735685406e-08,0.15634652461357756,0.08264462809917354
49,0.1,4,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae create more noise than bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",4.73719454713706e-08,0.24319657959980656,0.07883675746383503,0.003626852929563759,0.24549051679766398,0.10439999999999992,0.003621603081905747,0.24742390331827924,0.11721276281715845,4.737194547137081e-08,0.19556723776686002,0.08264462809917354
49,0.1,5,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is there more noise from high flow nasal cannulae than from bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",9.47438909427412e-08,0.3700275314996757,0.1175670386709681,0.007253705859127518,0.3705953029013722,0.1436734693877551,0.007243206163811494,0.32242384906573607,0.11975623582766441,9.474389094274162e-08,0.2696752099205817,0.08264462809917354
49,0.1,6,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP when used with preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",4.73719454713706e-08,0.19539332576808555,0.05095067785871016,0.003626852929563759,0.19598000390052395,0.0711111111111111,0.003621603081905747,0.19607966772124596,0.08059501133786852,4.737194547137081e-08,0.19556723776686002,0.08264462809917354
49,0.1,7,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae produce higher noise levels than bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",7.10579182070559e-08,0.28506534024744123,0.08376731301939058,0.005440279394345639,0.2857036138051887,0.10792899408284021,0.005432404622858621,0.28562527018904804,0.11852971641331433,7.105791820705622e-08,0.233307565749707,0.08264462809917354
49,0.1,8,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is the noise output of high flow nasal cannulae higher than that of bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",1.421158364141118e-07,0.3593710600347979,0.07092780684655106,0.010880558788691277,0.3542666529736156,0.08755102040816325,0.010864809245717241,0.3474801315174272,0.08998573666486019,1.4211583641411244e-07,0.33866808140753246,0.08264462809917354
49,0.1,9,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae associated with more noise than bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",7.10579182070559e-08,0.28506534024744123,0.08376731301939058,0.005440279394345639,0.2857036138051887,0.10792899408284021,0.005432404622858621,0.28562527018904804,0.11852971641331433,7.105791820705622e-08,0.233307565749707,0.08264462809917354
49,0.1,10,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae emit more noise than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",4.73719454713706e-08,0.14759007193636497,0.02682516425905998,0.003626852929563759,0.1464694910033857,0.039867674858222985,0.003621603081905747,0.1447354321242127,0.044820011337868504,4.737194547137081e-08,0.14224822387763325,0.04424462809917353
50,0.1,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy a viable method for acute overt-obscure gastrointestinal bleeding? Yes, this combined technique is practical and effective for immediate diagnosis and treatment, minimizing complications and enhancing patient outcomes.",5.684633456564492e-07,0.19323817808277388,0.21432098765432098,0.04352223515476495,0.29506621677165557,0.16493055555555558,0.04345923698286881,0.3519760767372082,0.13660974593919203,5.684633456564497e-07,0.4110842492440061,0.10560000000000004
50,0.1,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy with real-time capsule endoscopy viewing be used in acute overt-obscure gastrointestinal bleeding? Indeed, this combined approach is feasible, enabling prompt diagnosis and intervention, which lowers complication risks and improves outcomes.",6.158352911278198e-07,0.25207867810570717,0.21432098765432098,0.04714908808432871,0.35569083858809103,0.16493055555555558,0.04708084006477456,0.4144964337185417,0.13660974593919203,6.158352911278206e-07,0.47562277038157763,0.10560000000000004
50,0.1,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it feasible to use emergency double-balloon enteroscopy alongside real-time capsule endoscopy in cases of acute overt-obscure gastrointestinal bleeding? Yes, this method allows for immediate diagnosis and treatment, reducing complications and benefiting patient recovery.",6.158352911278198e-07,0.25207867810570717,0.21432098765432098,0.04714908808432871,0.35569083858809103,0.16493055555555558,0.04708084006477456,0.4144964337185417,0.13660974593919203,6.158352911278206e-07,0.47562277038157763,0.10560000000000004
50,0.1,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy provide a practical solution for acute overt-obscure gastrointestinal bleeding? Yes, this approach facilitates quick diagnosis and therapy, decreasing the chance of further issues and improving patient prognosis.",5.684633456564492e-07,0.19323817808277388,0.21432098765432098,0.04352223515476495,0.29506621677165557,0.16493055555555558,0.04345923698286881,0.3519760767372082,0.13660974593919203,5.684633456564497e-07,0.4110842492440061,0.10560000000000004
50,0.1,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy a workable approach for acute overt-obscure gastrointestinal bleeding? Yes, it enables immediate diagnosis and treatment, which helps prevent additional complications and enhances patient outcomes.",5.921493183921345e-07,0.2222257149560254,0.21432098765432098,0.04533566161954683,0.32491917992133734,0.16493055555555558,0.045270038523821686,0.3827477354039619,0.13660974593919203,5.921493183921352e-07,0.44283294755858593,0.10560000000000004
50,0.1,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy be effectively used in acute overt-obscure gastrointestinal bleeding? Yes, this combined method is feasible and supports prompt diagnosis and treatment, reducing risks and improving recovery.",6.158352911278198e-07,0.25207867810570717,0.21432098765432098,0.04714908808432871,0.35569083858809103,0.16493055555555558,0.04708084006477456,0.4144964337185417,0.13660974593919203,6.158352911278206e-07,0.47562277038157763,0.10560000000000004
50,0.1,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy with real-time capsule endoscopy a feasible combined technique for acute overt-obscure gastrointestinal bleeding? Yes, it allows for immediate diagnosis and intervention, lowering complication risks and improving patient outcomes.",6.632072365991904e-07,0.3145990350870407,0.21432098765432098,0.05077594101389247,0.42022935972566255,0.16493055555555558,0.05070244314668031,0.4811878082172152,0.13660974593919203,6.632072365991914e-07,0.5446156418685284,0.10560000000000004
50,0.1,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it practical to use emergency double-balloon enteroscopy together with real-time capsule endoscopy in acute overt-obscure gastrointestinal bleeding? Yes, this combined approach is feasible and enables rapid diagnosis and treatment, reducing complications and enhancing outcomes.",5.921493183921345e-07,0.2222257149560254,0.21432098765432098,0.04533566161954683,0.32491917992133734,0.16493055555555558,0.045270038523821686,0.3827477354039619,0.13660974593919203,5.921493183921352e-07,0.44283294755858593,0.10560000000000004
50,0.1,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does emergency double-balloon enteroscopy combined with real-time capsule endoscopy offer a feasible approach in acute overt-obscure gastrointestinal bleeding? Yes, this method allows immediate diagnosis and treatment, minimizing complications and improving patient prognosis.",6.632072365991904e-07,0.3145990350870407,0.21432098765432098,0.05077594101389247,0.42022935972566255,0.16493055555555558,0.05070244314668031,0.4811878082172152,0.13660974593919203,6.632072365991914e-07,0.5446156418685284,0.10560000000000004
50,0.1,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is the use of emergency double-balloon enteroscopy combined with real-time capsule endoscopy a feasible strategy for acute overt-obscure gastrointestinal bleeding? Yes, this combined approach facilitates prompt diagnosis and treatment, reducing the risk of complications and improving patient outcomes.",5.210914001850786e-07,0.13766832692796172,0.21432098765432098,0.0398953822252012,0.2379078029317072,0.16493055555555558,0.039837633900963065,0.2931355767142749,0.13660974593919203,5.210914001850789e-07,0.35045962742757064,0.10560000000000004
51,0.1,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification accounts for the observed differences in average birthweights between Aborigines and whites. These findings may assist in understanding other comparisons across populations.,0.0,0.031506690025452144,0.022183224271267066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
51,0.1,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could gestational age misclassification explain the birthweight disparity between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to explain the reported differences in average birthweights between Aborigines and whites. The results may aid in interpreting other population comparisons.,9.474389094274162e-08,0.13941954583995742,0.030948656370032523,0.0072537058591274906,0.10094507507642758,0.00238063831257343,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.1,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does misclassification of gestational age account for birthweight differences between Australian Aborigines and whites? Answer: Misclassification of gestational age is an unlikely cause for the observed divergence in average birthweights between Aborigines and whites. These findings could help interpret other between-population analyses.,4.737194547137081e-08,0.08402797995090827,0.0263660497560316,0.0036268529295637453,0.08301276041885997,0.025409572112868817,0.003621603081905733,0.0834475231974281,0.02498356344510192,4.737194547137081e-08,0.05001042057466343,0.0
51,0.1,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Answer: Gestational age misclassification probably does not explain the reported differences in average birthweights between Aborigines and whites. The results might assist in understanding other population comparisons.,4.737194547137081e-08,0.0510209713528158,0.0031891414310303567,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.1,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Can gestational age misclassification explain the birthweight differences seen in Australian Aborigines versus whites? Answer: It is unlikely that gestational age misclassification accounts for the reported divergence in average birthweights between Aborigines and whites. These results may help interpret other between-population comparisons.,4.737194547137081e-08,0.018013962754721113,0.020316775728732916,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.1,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does the misclassification of gestational age explain birthweight differences between Australian Aborigines and whites? Answer: The misclassification of gestational age is an unlikely explanation for the observed differences in average birthweights between Aborigines and whites. The findings might aid in interpreting other population comparisons.,0.0,0.06301338005090251,0.04395179757830192,0.0,0.06447880749394885,0.04613236961451247,0.0,0.06601401719618405,0.047500000000000014,0.0,0.03381205758828987,0.024375
51,0.1,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification a reason for birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to be the cause of the reported divergence in average birthweights between Aborigines and whites. These results could help with interpreting other between-population comparisons.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
51,0.1,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could the difference in birthweights between Australian Aborigines and whites be due to gestational age misclassification? Answer: Gestational age misclassification is an unlikely explanation for the observed differences in average birthweights between Aborigines and whites. The findings may assist in the interpretation of other population comparisons.,4.737194547137081e-08,0.04856133083502279,0.002916829812021182,0.0036268529295637453,0.07770177782373144,0.023242630385487524,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
51,0.1,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does gestational age misclassification account for the birthweight gap between Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification explains the reported divergence in average birthweights between Aborigines and whites. These results might help interpret other between-population comparisons.,7.105791820705622e-08,0.07753366990246713,0.004897905711710296,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.1,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the birthweight difference between Australian Aborigines and whites explained by gestational age misclassification? Answer: Gestational age misclassification is unlikely to explain the observed differences in average birthweights between Aborigines and whites. The results may help in understanding other population comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
52,0.1,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it feasible to sustain a zero central line-associated bloodstream infection rate? Maintaining a zero infection rate related to central lines is an ideal target in healthcare but can be difficult to uphold continuously. It demands strict infection control protocols, ongoing staff education, and thorough surveillance. Even with these measures, occasional cases might still arise due to",9.474389094274162e-08,0.18265025042821792,0.0772144008919185,0.0072537058591274906,0.18423652200774576,0.07786328655500228,0.007243206163811466,0.16013870280332299,0.05975554549569943,9.474389094274162e-08,0.1350550587525099,0.040742417383431435
52,0.1,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Can a zero central line-associated bloodstream infection rate be maintained over time? Achieving zero infections linked to central lines is a desirable objective in medical environments, yet sustaining it indefinitely poses challenges. This requires rigorous infection prevention strategies, continuous training of personnel, and diligent monitoring. Despite these precautions, sporadic infections may still occur because of",4.737194547137081e-08,0.17103786270591348,0.09506564056134,0.0036268529295637453,0.14719525032739567,0.07786328655500228,0.003621603081905733,0.12239837482047555,0.05975554549569943,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
52,0.1,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is sustaining a zero rate of central line-associated bloodstream infections possible? While reaching zero infections related to central lines is an ideal aim in healthcare, keeping this rate at zero consistently is challenging. It involves strict infection control practices, ongoing staff training, and constant monitoring. Nonetheless, occasional infections might happen due to",2.3685972735685406e-08,0.11387944886596335,0.09506564056134,0.0018134264647818726,0.0889263422034201,0.07786328655500228,0.0018108015409528666,0.06297495434967448,0.05975554549569943,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,0.1,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is a zero central line-associated bloodstream infection rate maintainable? Achieving zero infections associated with central lines is a perfect goal in healthcare settings, but maintaining it continuously can be tough. It necessitates stringent infection control measures, continuous education for staff, and rigorous oversight. Despite these efforts, occasional infections may still occur because of",0.0,0.10663802777845266,0.07584226493658028,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.1,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it possible to sustain a zero central line-associated bloodstream infection rate? Attaining a zero infection rate related to central lines is an ideal objective in healthcare, but maintaining it indefinitely is challenging. This requires strict infection control protocols, ongoing staff training, and vigilant monitoring. Even with these efforts, occasional cases may arise due to",4.737194547137081e-08,0.14536574490739662,0.07655371460904381,0.0036268529295637453,0.14719525032739567,0.07786328655500228,0.003621603081905733,0.12239837482047555,0.05975554549569943,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
52,0.1,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Can a zero central line-associated bloodstream infection rate be sustained? Achieving zero infections linked to central lines is an ideal goal in healthcare, but sustaining it perpetually can be difficult. It demands stringent infection control measures, continuous staff education, and thorough monitoring. Despite these efforts, occasional infections may still occur due to",2.3685972735685406e-08,0.11387944886596335,0.09506564056134,0.0018134264647818726,0.0889263422034201,0.07786328655500228,0.0018108015409528666,0.06297495434967448,0.05975554549569943,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,0.1,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is maintaining a zero central line-associated bloodstream infection rate achievable? Reaching zero infections associated with central lines is an ideal target in healthcare settings, but keeping it consistently is challenging. It requires rigorous infection control practices, ongoing training for staff, and constant surveillance. Despite these measures, occasional infections might still happen due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.1,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it sustainable to have a zero central line-associated bloodstream infection rate? Achieving zero infections related to central lines is an ideal goal in healthcare, but maintaining it continuously can be difficult. It involves strict infection control protocols, continuous staff training, and diligent monitoring. Even with these precautions, occasional infections may occur due to",2.3685972735685406e-08,0.15234572969375915,0.09506564056134,0.0018134264647818726,0.12814705535670257,0.07786328655500228,0.0018108015409528666,0.10298028896337286,0.05975554549569943,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,0.1,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is a zero central line-associated bloodstream infection rate achievable and sustainable? While zero infections linked to central lines is an ideal aim in healthcare, sustaining this rate over time is challenging. It requires stringent infection control measures, ongoing education for staff, and rigorous monitoring. Despite these efforts, occasional cases may still arise due to",2.3685972735685406e-08,0.15234572969375915,0.09506564056134,0.0018134264647818726,0.12814705535670257,0.07786328655500228,0.0018108015409528666,0.10298028896337286,0.05975554549569943,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,0.1,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it realistic to sustain a zero central line-associated bloodstream infection rate? Achieving zero infections associated with central lines is an ideal goal in healthcare, but maintaining it indefinitely can be challenging. This necessitates strict infection control protocols, continuous staff training, and vigilant monitoring. Despite these efforts, occasional infections may occur due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
53,0.1,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock, and do hormonal differences play a role? Answer: The protective effect of being female against multiple organ failure and hospital-acquired infections remains significant in both premenopausal and postmenopausal women compared to men of similar age, which contrasts with earlier experimental findings and known physiological sex hormone changes after injury.",4.737194547137081e-08,0.03333642026759165,0.0,0.0036268529295637453,0.03390155167568043,0.0,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
53,0.1,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What characterizes gender differences after injury and hemorrhagic shock, and are hormones responsible? Answer: Female gender independently offers protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to age-matched men, opposing previous experimental data and known sex hormone alterations post-injury.",3.552895910352811e-07,0.28223246768421584,0.0,0.02720139697172809,0.2876820724517799,0.0,0.027162023114293,0.2933478099874569,0.0,3.552895910352811e-07,0.2992428948528567,0.0
53,0.1,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How does gender dimorphism manifest after injury and hemorrhagic shock, and is it due to hormonal differences? Answer: The female gender shows a significant independent protective effect on multiple organ failure and infection rates in both premenopausal and postmenopausal women compared to men of similar age, which contradicts earlier experimental studies and known physiological sex hormone changes.",9.474389094274162e-08,0.0678225963387602,0.0,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
53,0.1,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the characterization of gender dimorphism after injury and hemorrhagic shock, and are hormonal differences the cause? Answer: Female gender independently protects against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women when compared to similarly aged men, a finding that contrasts with previous experimental research and known sex hormone changes.",1.4211583641411244e-07,0.10354067894083929,0.0,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
53,0.1,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock, and do hormones explain it? Answer: The protective effect of female gender on multiple organ failure and hospital-acquired infections remains significant in both premenopausal and postmenopausal women compared to men of the same age, which is contrary to earlier experimental studies and known physiological sex hormone changes.",9.474389094274162e-08,0.0678225963387602,0.0,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
53,0.1,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormonal differences responsible? Answer: Female gender independently confers protection against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women relative to age-matched men, opposing previous experimental findings and known sex hormone changes after injury.",2.8423167282822487e-07,0.21905356606268356,0.0,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
53,0.1,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism characterized post-injury and hemorrhagic shock, and are hormones the cause? Answer: The female gender's independent protective effect on multiple organ failure and infection rates is significant in both premenopausal and postmenopausal women compared to men of similar age, contradicting earlier experimental studies and known physiological sex hormone changes.",2.1317375462116866e-07,0.1596301455918825,0.0,0.016320838183036854,0.16251892949777424,0.0,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
53,0.1,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What characterizes gender differences after injury and hemorrhagic shock, and are hormonal factors responsible? Answer: Female gender independently protects against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to similarly aged men, which contrasts with previous experimental data and known sex hormone alterations.",3.079176455639103e-07,0.23967285326541932,0.0,0.023574544042164344,0.24419696051204154,0.0,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
53,0.1,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism defined after injury and hemorrhagic shock, and do hormonal differences explain it? Answer: The protective effect of female gender on multiple organ failure and hospital-acquired infections remains significant in both premenopausal and postmenopausal women relative to men of similar age, contrary to earlier experimental findings and known physiological sex hormone changes.",1.4211583641411244e-07,0.10354067894083929,0.0,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
53,0.1,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the nature of gender dimorphism after injury and hemorrhagic shock, and are hormones responsible? Answer: Female gender independently offers protection against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women compared to age-matched men, opposing previous experimental studies and known sex hormone changes.",2.8423167282822487e-07,0.21905356606268356,0.0,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
54,0.1,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women need fewer calories to keep their weight stable? Answer: The number of calories needed to maintain weight depends on personal factors such as age, height, weight, and activity level, not race or ethnicity.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
54,0.1,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is it true that African American women require fewer calories to maintain their weight? Answer: Caloric needs for weight maintenance are influenced by individual characteristics like age, height, weight, and physical activity, rather than racial or ethnic identity.",7.10579182070559e-08,0.08223809823697303,0.0,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
54,0.1,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women have lower calorie requirements for weight maintenance? Answer: Weight maintenance calorie needs are based on factors like age, height, weight, and activity level, not on racial or ethnic background.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.1,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Are fewer calories needed by African American women to maintain their weight? Answer: Caloric intake for maintaining weight is determined by individual factors such as age, height, weight, and physical activity, not by race or ethnicity.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
54,0.1,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women require less caloric intake to sustain their weight? Answer: The calories needed to maintain weight depend on personal attributes like age, height, weight, and activity level, not on racial or ethnic background.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
54,0.1,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is caloric need for weight maintenance lower in African American women? Answer: Caloric requirements for maintaining weight are influenced by individual factors including age, height, weight, and physical activity, rather than race or ethnicity.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.1,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women need fewer calories to keep their weight steady? Answer: The amount of calories required to maintain weight is determined by individual factors such as age, height, weight, and physical activity level, not by racial or ethnic background.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
54,0.1,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Are calorie needs for weight maintenance reduced in African American women? Answer: Caloric intake for weight maintenance depends on personal factors like age, height, weight, and activity level, not on race or ethnicity.",4.73719454713706e-08,0.14285834009080567,0.06035379812695108,0.003626852929563759,0.10394632060143305,0.031217481789802305,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.1,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women have lower calorie needs to maintain weight? Answer: The caloric intake necessary for weight maintenance is based on individual characteristics such as age, height, weight, and physical activity, not on racial or ethnic identity.",7.10579182070559e-08,0.08223809823697303,0.0,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
54,0.1,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is it necessary for African American women to consume fewer calories to maintain weight? Answer: Caloric needs for maintaining weight are determined by factors like age, height, weight, and physical activity, not by racial or ethnic background.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
55,0.1,1,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Yes, elevated neutrophil migration after significant trauma may play a role in causing ARDS due to enhanced lung inflammation and harmful mediator release.",5.447773729207642e-07,0.14209904215023705,0.24826388888888892,0.04170880868998307,0.22330019670399315,0.17159999999999997,0.04164843544191593,0.2754824954098911,0.14532871972318342,5.447773729207643e-07,0.32954290328284186,0.11649408284023667
55,0.1,2,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is heightened neutrophil migratory activity after major trauma a factor in acute respiratory distress syndrome? Indeed, increased neutrophil movement post-trauma can contribute to ARDS by promoting lung inflammation and releasing damaging substances.",7.342651548062466e-07,0.37167348379473486,0.24826388888888892,0.056216220408238086,0.4596889747682247,0.17159999999999997,0.056134847769538906,0.5191045780676435,0.14532871972318342,7.342651548062476e-07,0.580857331563748,0.11649408284023667
55,0.1,3,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can increased neutrophil migration after major trauma lead to acute respiratory distress syndrome? Yes, because the intensified neutrophil activity can cause lung inflammation and the release of harmful agents, potentially resulting in ARDS.",7.105791820705613e-07,0.33992478548015503,0.24826388888888892,0.05440279394345621,0.426899151945233,0.17159999999999997,0.05432404622858603,0.4852030263919618,0.14532871972318342,7.105791820705622e-07,0.545766011752479,0.11649408284023667
55,0.1,4,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does major trauma-induced neutrophil migratory activity increase contribute to ARDS? Yes, as the elevated neutrophil response can trigger lung inflammation and harmful substance release, which may cause ARDS.",8.290090457489878e-07,0.509823822275552,0.24826388888888892,0.06346992626736561,0.6027898184088971,0.17159999999999997,0.0633780539333504,0.6675245831859167,0.14532871972318342,8.290090457489892e-07,0.7350080113910069,0.11649408284023667
55,0.1,5,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is the rise in neutrophil migratory activity after major trauma a cause of acute respiratory distress syndrome? Yes, increased neutrophil activity can lead to lung inflammation and the discharge of damaging substances, contributing to ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.1,6,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can the increased migration of neutrophils following major trauma be a factor in ARDS development? Yes, because this heightened activity can cause lung inflammation and release harmful compounds, potentially leading to ARDS.",7.342651548062466e-07,0.37167348379473486,0.24826388888888892,0.056216220408238086,0.4596889747682247,0.17159999999999997,0.056134847769538906,0.5191045780676435,0.14532871972318342,7.342651548062476e-07,0.580857331563748,0.11649408284023667
55,0.1,7,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migration after severe trauma play a role in the etiology of ARDS? Yes, as it can enhance lung inflammation and the secretion of harmful substances, which may result in ARDS.",7.105791820705613e-07,0.33992478548015503,0.24826388888888892,0.05440279394345621,0.426899151945233,0.17159999999999997,0.05432404622858603,0.4852030263919618,0.14532871972318342,7.105791820705622e-07,0.545766011752479,0.11649408284023667
55,0.1,8,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is increased neutrophil migratory activity post-major trauma linked to acute respiratory distress syndrome? Yes, since it can promote lung inflammation and the release of harmful agents, contributing to ARDS.",8.053230730133025e-07,0.4734561781046773,0.24826388888888892,0.061656499802583725,0.5650494904260501,0.17159999999999997,0.06156725239239753,0.6283038700326342,0.14532871972318342,8.053230730133038e-07,0.6941860168707521,0.11649408284023667
55,0.1,9,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can heightened neutrophil migration after major trauma be involved in causing ARDS? Yes, because it can lead to increased lung inflammation and the release of damaging substances, potentially causing ARDS.",7.816371002776172e-07,0.4383648582934083,0.24826388888888892,0.059843073337801846,0.5286818462551754,0.17159999999999997,0.059756450851444654,0.5905635420497872,0.14532871972318342,7.816371002776184e-07,0.6549653037174696,0.11649408284023667
55,0.1,10,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is increased neutrophil migratory activity after major trauma a contributing factor to ARDS? Yes, as this can cause lung inflammation and the release of harmful substances, which may lead to ARDS.",7.579511275419319e-07,0.40446330661772656,0.24826388888888892,0.058029646873019966,0.49359052644390644,0.17159999999999997,0.05794564931049178,0.5541958978789125,0.14532871972318342,7.57951127541933e-07,0.6172249757346226,0.11649408284023667
56,0.1,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in such cases was unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment are necessary.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.1,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The impact of decompression was not apparent. Early detection of sarcoidosis in other organs and steroid therapy is required.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.1,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in treating spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression were not evident. Early diagnosis of sarcoidosis from other organs and steroid treatment should be implemented.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.1,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not clear. Early identification of sarcoidosis in other organs and steroid therapy is necessary.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.1,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a successful treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The results of decompression were inconclusive. Early diagnosis of sarcoidosis in other organs and steroid therapy are essential.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.1,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery show effectiveness for spinal cord sarcoidosis with compressive cervical myelopathy? The effect was not evident. Early diagnosis of sarcoidosis in other organs and steroid treatment is needed.,2.842316728282237e-07,0.21102800636467522,0.09642074506939374,0.02176111757738252,0.2873602258827379,0.049861495844875335,0.021729618491434455,0.33217877086583103,0.025623268698060954,2.8423167282822487e-07,0.37948962170490397,0.0
56,0.1,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not clear. Early diagnosis of sarcoidosis in other organs and steroid therapy should be considered.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.1,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression were not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy is necessary.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.1,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a viable treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not apparent. Early diagnosis of sarcoidosis in other organs and steroid therapy should be pursued.,1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
56,0.1,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effect was not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy is required.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
57,0.1,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a contraindication for laparoscopic surgery to treat GERD? Laparoscopic antireflux surgery remains a safe and effective option for GERD in elderly patients, showing low morbidity and mortality and symptom improvement similar to younger individuals.",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.1,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does advanced age contraindicate laparoscopic surgery for GERD? Even in elderly patients, laparoscopic antireflux surgery is safe and effective, with low risks and symptom relief comparable to younger patients.",3.316036182995944e-07,0.4054651081081637,0.0,0.025387970506946272,0.4177352006999784,0.0,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
57,0.1,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is being elderly a reason to avoid laparoscopic surgery for GERD? Laparoscopic antireflux surgery is safe and effective for GERD in older adults, with low complication rates and symptom improvement on par with younger patients.",1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
57,0.1,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a limiting factor for GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe, effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom improvement similar to that seen in younger patients.",1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.1,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does advanced age serve as a contraindication for laparoscopic antireflux surgery in GERD? The procedure is safe and effective in elderly patients, with low morbidity and mortality and symptom improvement comparable to younger individuals.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.1,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is laparoscopic surgery for GERD contraindicated in elderly patients? Laparoscopic antireflux surgery is safe and effective for GERD even in advanced age, showing low morbidity, mortality, and symptom improvement similar to younger patients.",2.3685972735685321e-07,0.315255414268639,0.031217481789802305,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
57,0.1,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a contraindication for laparoscopic treatment of GERD? Laparoscopic antireflux surgery is a safe and effective option for elderly patients, with low morbidity and mortality and symptom relief comparable to younger patients.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.1,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does elderly age contraindicate laparoscopic surgery for GERD? Laparoscopic antireflux surgery is safe and effective in elderly patients, with low morbidity and mortality rates and symptom improvement similar to younger patients.",2.842316728282238e-07,0.33647223662121295,0.0,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
57,0.1,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a barrier to laparoscopic antireflux surgery for GERD? The surgery is safe and effective in elderly patients, with low morbidity and mortality and symptom improvement comparable to younger patients.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
57,0.1,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a contraindication for laparoscopic surgery in GERD patients? Laparoscopic antireflux surgery is safe and effective even in elderly patients, with low morbidity and mortality and symptom improvement comparable to younger individuals.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
58,0.1,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and healthcare professionals consider it acceptable to break confidentiality to safeguard a patient's wife from a sexually transmitted infection? Research indicates that both groups find breaching confidentiality acceptable in order to protect the patient's wife from an STI.,2.6054570009253947e-07,0.231383950831614,0.1790667039470082,0.0199476911126006,0.2427844886675734,0.2116295929044365,0.019918816950481533,0.25501685141490293,0.2434963579604579,2.6054570009253947e-07,0.23069615463296245,0.24765868886576478
58,0.1,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it acceptable for French laypeople and health professionals to violate confidentiality to protect a patient's wife from a sexually transmitted disease? Studies show that both French laypeople and health professionals agree that breaching confidentiality is acceptable to protect the patient's wife from an STD.,1.6580180914979784e-07,0.17546201851377008,0.07553155990875718,0.012693985253473108,0.24701135250307882,0.14520815417317462,0.012675610786670066,0.2890862927757003,0.1959963579604579,1.6580180914979784e-07,0.29953825110475485,0.22328368886576477
58,0.1,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French non-professionals and medical professionals approve of breaching confidentiality to shield a patient's wife from a sexually transmitted disease? Research suggests that both groups find it acceptable to breach confidentiality for the protection of the patient's wife from an STD.,2.6054570009253947e-07,0.231383950831614,0.1790667039470082,0.0199476911126006,0.2427844886675734,0.2116295929044365,0.019918816950481533,0.25501685141490293,0.2434963579604579,2.6054570009253947e-07,0.23069615463296245,0.24765868886576478
58,0.1,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are French laypeople and health workers comfortable with breaking confidentiality to protect a patient's wife from a sexually transmitted infection? Evidence suggests that both French laypeople and health professionals accept breaching confidentiality to safeguard the patient's wife from an STI.,2.8423167282822477e-07,0.06210480534641194,0.08016786921337116,0.02176111757738247,0.142910719856439,0.15888551466372194,0.0217296184914344,0.19088118916733965,0.21649018512095175,2.8423167282822487e-07,0.20329718044484713,0.24765868886576478
58,0.1,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypersons and healthcare providers find it permissible to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Research indicates that both groups consider it acceptable to breach confidentiality for the patient's wife's protection from an STD.,2.6054570009253947e-07,0.231383950831614,0.1790667039470082,0.0199476911126006,0.2427844886675734,0.2116295929044365,0.019918816950481533,0.25501685141490293,0.2434963579604579,2.6054570009253947e-07,0.23069615463296245,0.24765868886576478
58,0.1,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease acceptable to French laypeople and health professionals? Studies suggest that both groups find it acceptable to breach confidentiality in order to protect the patient's wife from an STD.,2.6054570009253947e-07,0.1620692327756199,0.13016276769311808,0.0199476911126006,0.2427844886675734,0.2116295929044365,0.019918816950481533,0.25501685141490293,0.2434963579604579,2.6054570009253947e-07,0.23069615463296245,0.24765868886576478
58,0.1,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and medical professionals find it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted infection? Research shows that both groups agree on breaching confidentiality to protect the patient's wife from an STI.,3.0791764556391007e-07,0.10347965227691125,0.1251219714181811,0.023574544042164344,0.15075193411083276,0.18337531058208928,0.023540420032387266,0.20094963014462675,0.2434963579604579,3.079176455639103e-07,0.17512630347815028,0.24765868886576478
58,0.1,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are French laypeople and health professionals in favor of breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Research suggests that both groups find it acceptable to breach confidentiality for the protection of the patient's wife from an STD.,2.3685972735685406e-07,0.25776716630140006,0.1802759972935272,0.018134264647818726,0.2689909468833527,0.21226929815739554,0.018108015409528666,0.2809923378181609,0.2434963579604579,2.3685972735685406e-07,0.2573644017151233,0.24765868886576478
58,0.1,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and healthcare professionals accept breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Studies indicate that both groups find it acceptable to breach confidentiality to safeguard the patient's wife from an STD.,3.3160361829959537e-07,0.11033488192168894,0.14847837280226417,0.025387970506946217,0.15977961355574832,0.20949775956168112,0.025351221573340132,0.1727787531779299,0.2434963579604579,3.316036182995957e-07,0.14613876660489877,0.24765868886576478
58,0.1,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it acceptable among French laypeople and health professionals to breach confidentiality to protect a patient's wife from a sexually transmitted infection? Research suggests that both groups find breaching confidentiality acceptable to protect the patient's wife from an STI.,3.0791764556391007e-07,0.13996108283269804,0.15056085285310802,0.023574544042164344,0.18821934927623607,0.2102466887629913,0.023540420032387266,0.20094963014462675,0.2434963579604579,3.079176455639103e-07,0.17512630347815028,0.24765868886576478
59,0.1,1,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Answer: epiDWI can potentially distinguish pleomorphic adenoma and myoepithelial adenomas from other tumor types. However, because of overlaps within benign and malignant groups and between them, definitive diagnoses should not be made solely on this basis.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
59,0.1,2,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is it possible to predict various histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Answer: epiDWI shows promise in differentiating pleomorphic adenoma and myoepithelial adenomas from other entities. Nevertheless, due to overlaps within and between benign and malignant lesions, diagnosis should not rely solely on this method.",1.6580180914979784e-07,0.12861737782209381,0.0,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
59,0.1,3,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging of primary parotid gland tumors predict different histologic subtypes? Answer: epiDWI may help differentiate pleomorphic adenoma and myoepithelial adenomas from other examined tumors. However, because of overlapping features within benign and malignant groups and between them, diagnoses should not be based solely on this imaging.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
59,0.1,4,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Does diffusion-weighted echo-planar MR imaging allow prediction of histologic subtypes in primary parotid gland tumors? Answer: epiDWI has the ability to distinguish pleomorphic adenoma and myoepithelial adenomas from other tumor types. Still, due to overlaps within benign and malignant lesions and between groups, diagnosis should not be made solely on this imaging.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
59,0.1,5,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is predicting different histologic subtypes of primary parotid gland tumors possible with diffusion-weighted echo-planar MR imaging? Answer: epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from other entities, but because of overlap within and between benign and malignant lesions, diagnosis should not rely solely on this technique.",2.6054570009253947e-07,0.2102954088363611,0.0,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
59,0.1,6,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging differentiate histologic subtypes of primary parotid gland tumors? Answer: epiDWI has potential to separate pleomorphic adenoma and myoepithelial adenomas from other tumors. However, due to overlaps within benign and malignant groups and between them, diagnosis should not be based solely on this imaging.",2.3685972735685406e-07,0.18924199963852795,0.0,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
59,0.1,7,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is it feasible to predict histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Answer: epiDWI may distinguish pleomorphic adenoma and myoepithelial adenomas from other examined entities, but overlaps within and between benign and malignant lesions mean diagnosis should not be solely based on this method.",2.1317375462116866e-07,0.1686227124357922,0.0,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
59,0.1,8,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes in primary parotid gland tumors? Answer: epiDWI can potentially differentiate pleomorphic adenoma and myoepithelial adenomas from other tumor types, but due to overlap within benign and malignant groups and between them, diagnosis should not rely solely on this imaging.",2.3685972735685406e-07,0.18924199963852795,0.0,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
59,0.1,9,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is diffusion-weighted echo-planar MR imaging effective in predicting histologic subtypes of primary parotid gland tumors? Answer: epiDWI shows potential to distinguish pleomorphic adenoma and myoepithelial adenomas from other entities, yet overlaps within and between benign and malignant lesions suggest diagnosis should not be based solely on this technique.",2.3685972735685406e-07,0.18924199963852795,0.0,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
59,0.1,10,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging be used to predict different histologic subtypes of primary parotid gland tumors? Answer: epiDWI may help differentiate pleomorphic adenoma and myoepithelial adenomas from other tumors, but because of overlap within benign and malignant groups and between them, diagnosis should not be made solely on this imaging.",1.6580180914979784e-07,0.12861737782209381,0.0,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
60,0.1,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible to get correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Yes, with careful design and execution, homebrew assays can achieve precision and sensitivity comparable to commercial kits, provided consistent procedures and quality control are maintained.",5.684633456564497e-07,0.3799698322563083,0.05145322918413599,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
60,0.1,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew assays yield correlated results for BCRABL transcript detection via quantitative real-time PCR? Yes, when properly designed and performed, these assays can match the accuracy and sensitivity of commercial kits, but strict consistency and quality control are essential.",6.632072365991912e-07,0.44704628221519815,0.07524858908895454,0.050775941013892434,0.5421417516957199,0.015380859375,0.050702443146680265,0.5753641449035611,0.0,6.632072365991914e-07,0.5877866649021217,0.0
60,0.1,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results achievable from homebrew assays detecting BCRABL transcripts by quantitative real-time PCR? Yes, if the assays are well-designed and carefully conducted, they can offer precision and sensitivity similar to commercial kits, with consistent protocols and quality checks being crucial.",6.158352911278206e-07,0.39575298782764845,0.07524858908895454,0.04714908808432869,0.48949801821030103,0.015380859375,0.04708084006477453,0.521296923633285,0.0,6.158352911278206e-07,0.5322168137473096,0.0
60,0.1,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it feasible to obtain correlated BCRABL transcript detection results from homebrew quantitative real-time PCR assays? Yes, such assays can provide comparable accuracy and sensitivity to commercial kits when meticulously designed and executed, ensuring consistent procedures and quality control.",6.632072365991912e-07,0.44704628221519815,0.07524858908895454,0.050775941013892434,0.5421417516957199,0.015380859375,0.050702443146680265,0.5753641449035611,0.0,6.632072365991914e-07,0.5877866649021217,0.0
60,0.1,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can quantitative real-time PCR homebrew assays produce correlated results for BCRABL transcript detection? Yes, with accurate design and careful execution, these assays can match commercial kits in precision and sensitivity, but maintaining consistent methods and quality control is key.",6.632072365991912e-07,0.44704628221519815,0.07524858908895454,0.050775941013892434,0.5421417516957199,0.015380859375,0.050702443146680265,0.5753641449035611,0.0,6.632072365991914e-07,0.5877866649021217,0.0
60,0.1,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are homebrew assays capable of delivering correlated results for BCRABL transcript detection using quantitative real-time PCR? Yes, provided they are carefully designed and executed, these assays can achieve precision and sensitivity on par with commercial kits, with consistency and quality control being vital.",5.684633456564497e-07,0.34696282365821673,0.07524858908895454,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
60,0.1,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible to achieve correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR? Yes, when designed and performed with care, these assays can rival commercial kits in precision and sensitivity, given consistent procedures and quality control.",6.158352911278206e-07,0.39575298782764845,0.07524858908895454,0.04714908808432869,0.48949801821030103,0.015380859375,0.04708084006477453,0.521296923633285,0.0,6.158352911278206e-07,0.5322168137473096,0.0
60,0.1,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew quantitative real-time PCR assays yield correlated results for BCRABL transcript detection? Yes, if accurately designed and meticulously executed, they can provide precision and sensitivity comparable to commercial kits, with consistent protocols and quality assurance being essential.",6.868932093348765e-07,0.473714529297359,0.07524858908895454,0.052589367478674306,0.5695407258838352,0.015380859375,0.05251324468763313,0.603535021870258,0.0,6.868932093348768e-07,0.6167742017753732,0.0
60,0.1,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR possible? Yes, these assays can match the precision and sensitivity of commercial kits when carefully designed and executed, provided consistent procedures and quality control are maintained.",6.395212638635059e-07,0.4210707958119402,0.07524858908895454,0.04896251454911056,0.515473504613559,0.015380859375,0.0488916416057274,0.5479651707154458,0.0,6.39521263863506e-07,0.5596157879354249,0.0
60,0.1,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it achievable to get correlated results from homebrew assays detecting BCRABL transcripts via quantitative real-time PCR? Yes, with proper design and careful execution, these assays can offer comparable precision and sensitivity to commercial kits, but consistent methodology and quality control are crucial.",5.684633456564497e-07,0.34696282365821673,0.07524858908895454,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
61,0.1,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosis. However, for girls over 10 years old, selective imaging is recommended to prevent unnecessary surgeries. Ultrasonography is the preferred imaging technique in uncertain cases.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.1,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we require imaging to identify appendicitis in pediatric patients? Diagnosis mainly relies on clinical examination. Still, in girls older than 10, imaging should be selectively used to avoid unwarranted appendectomies. Ultrasound is the imaging modality of choice when the diagnosis is unclear.",7.105791820705622e-08,0.007379788770512263,0.04434829637641969,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
61,0.1,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging essential for diagnosing appendicitis in children? The diagnosis is primarily based on clinical assessment. Yet, in girls above 10 years, selective imaging is advised to reduce unnecessary appendectomies. Ultrasonography is preferred in ambiguous cases.",2.3685972735685353e-07,0.18970134556446672,0.04434829637641969,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
61,0.1,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should imaging be used to diagnose appendicitis in children? Clinical assessment is crucial for diagnosis. Nonetheless, in girls older than 10 years, selective imaging is recommended to prevent unnecessary appendectomies. Ultrasound is the imaging method of choice in doubtful cases.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.1,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging required to diagnose appendicitis in children? Diagnosis depends mainly on clinical evaluation. However, for girls over 10 years old, selective imaging should be applied to avoid unnecessary appendectomies. Ultrasonography is the preferred imaging in equivocal situations.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641969,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
61,0.1,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we need to use imaging to diagnose appendicitis in children? Clinical assessment is fundamental for diagnosis. Still, in girls older than 10, selective imaging is suggested to prevent unnecessary appendectomies. Ultrasonography is the imaging of choice in uncertain cases.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.1,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary for diagnosing appendicitis in children? The key to diagnosis is clinical assessment. However, in girls above 10 years, selective imaging should be used to avoid unnecessary appendectomies. Ultrasound is the preferred imaging technique in ambiguous cases.",1.6580180914979763e-07,0.10746324732749368,0.04434829637641969,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
61,0.1,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should we use imaging to diagnose appendicitis in children? Clinical evaluation is the main diagnostic tool. Nevertheless, in girls older than 10 years, selective imaging is recommended to avoid unnecessary appendectomies. Ultrasonography is the imaging method of choice when diagnosis is unclear.",9.474389094274162e-08,0.06528939793786215,0.01997329637641969,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
61,0.1,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging needed to diagnose appendicitis in children? Diagnosis relies primarily on clinical assessment. However, in girls over 10 years old, selective imaging should be implemented to prevent unnecessary appendectomies. Ultrasound is the preferred imaging in equivocal cases.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641969,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
61,0.1,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we require imaging for diagnosing appendicitis in children? Clinical assessment is the cornerstone of diagnosis. Yet, in girls older than 10, selective imaging is advised to avoid unnecessary appendectomies. Ultrasonography is the imaging technique of choice in uncertain cases.",1.4211583641411233e-07,0.11703377018371963,0.018725027678358735,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
62,0.1,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair unnecessary? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low rates of immediate and delayed paraplegia. This suggests routine reimplantation of segmental vessels is not required.",2.3685972735685406e-07,0.19899931021903505,0.018860946745562133,0.018134264647818726,0.1758906664636637,0.0,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
62,0.1,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should spinal cord arteries be reimplanted during thoracic and thoracoabdominal aneurysm repair? Answer: Using MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation in TAA/A repair is safe and results in low rates of paraplegia, indicating routine reimplantation is unnecessary.",4.026615365066519e-07,0.3144933299024406,0.0,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
62,0.1,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair beneficial? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low immediate and delayed paraplegia rates, suggesting routine reimplantation is not needed.",3.552895910352811e-07,0.2719337154836441,0.0,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
62,0.1,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair improve outcomes? Answer: Monitoring MEP and SSEP indicates that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with acceptably low paraplegia rates, implying routine reimplantation is not indicated.",3.552895910352811e-07,0.2719337154836441,0.0,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
62,0.1,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is it necessary to reimplant spinal cord arteries in thoracic and thoracoabdominal aneurysm repair? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low rates of immediate and delayed paraplegia, suggesting routine reimplantation is unnecessary.",3.079176455639103e-07,0.23111172096338972,0.0,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
62,0.1,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should surgeons reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm repair? Answer: Evidence from MEP and SSEP monitoring shows that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low paraplegia rates, indicating routine reimplantation is not required.",3.316036182995957e-07,0.25131442828090833,0.0,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
62,0.1,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a futile effort? Answer: Monitoring MEP and SSEP demonstrates that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates, suggesting routine reimplantation is unnecessary.",3.316036182995957e-07,0.25131442828090833,0.0,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
62,0.1,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does sacrificing spinal cord arteries without reimplantation during thoracic and thoracoabdominal aneurysm repair pose risks? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in acceptably low rates of paraplegia, indicating routine reimplantation is not needed.",2.8423167282822487e-07,0.2928558207919094,0.05859375,0.02176111757738247,0.2705631540617417,0.039930555555555566,0.0217296184914344,0.24734528771819164,0.020399305555555556,2.8423167282822487e-07,0.22314355131420838,0.0
62,0.1,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is routine reimplantation of spinal cord arteries required in thoracic and thoracoabdominal aneurysm repair? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low immediate and delayed paraplegia rates, suggesting routine reimplantation is not indicated.",2.8423167282822487e-07,0.23849133604210948,0.019599999999999992,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
62,0.1,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Can thoracic and thoracoabdominal aneurysm repair be safely done without reimplanting spinal cord arteries? Answer: Using MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low rates of immediate and delayed paraplegia, implying routine reimplantation is unnecessary.",2.8423167282822487e-07,0.21130909366720996,0.0,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
63,0.1,1,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a connection between cervical cord plaques and discopathy in patients with multiple sclerosis? Yes, a connection exists between cervical cord plaques and discopathy in these patients.",7.10579182070559e-08,0.048881856501088894,0.0173979591836734,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
63,0.1,2,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Does a relationship exist between cervical cord plaques and discopathy in multiple sclerosis patients? Indeed, cervical cord plaques are related to discopathy in such patients.",1.421158364141118e-07,0.019457961881772956,0.12244897959183679,0.010880558788691277,0.09035074872166104,0.1924392346470268,0.010864809245717241,0.10541153346308363,0.2222222222222221,1.4211583641411244e-07,0.05675098530128997,0.20408163265306126
63,0.1,3,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques associated with discopathy in patients suffering from multiple sclerosis? Yes, there is an association between cervical cord plaques and discopathy in these patients.",9.47438909427412e-08,0.1128304230276167,0.13147640908915553,0.007253705859127518,0.17855425109069456,0.1958971088435374,0.007243206163811494,0.1924229104527133,0.2222222222222221,9.474389094274162e-08,0.14772276350701796,0.20408163265306126
63,0.1,4,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there any link between cervical cord plaques and discopathy among multiple sclerosis patients? Yes, a link is present between cervical cord plaques and discopathy in these individuals.",7.10579182070559e-08,0.05380661469297765,0.06927812447292964,0.005440279394345639,0.0599506831318668,0.0870673338205806,0.005432404622858621,0.06688958163858016,0.10445362718089983,7.105791820705622e-08,0.07475784783249084,0.12143700455388771
63,0.1,5,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do cervical cord plaques correlate with discopathy in patients with multiple sclerosis? Yes, cervical cord plaques correlate with discopathy in these patients.",2.131737546211677e-07,0.33687073877987705,0.004897959183673389,0.016320838183036916,0.33571111605869275,0.01360544217687068,0.016297213868575862,0.3330433851750847,0.026666666666666505,2.131737546211685e-07,0.3284487547126149,0.044081632653061226
63,0.1,6,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a relationship between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, a relationship exists between cervical cord plaques and discopathy in these patients.",9.47438909427412e-08,0.1004456325292904,0.012210978574255182,0.007253705859127518,0.0432528466884885,0.048327664399092946,0.007243206163811494,0.03862614973393397,0.06222222222222207,9.474389094274162e-08,0.03309824011731566,0.07658163265306125
63,0.1,7,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques connected to discopathy in patients with multiple sclerosis? Yes, cervical cord plaques are connected to discopathy in these patients.",1.894877818854824e-07,0.20933352022239227,0.03728550243626863,0.014507411718255037,0.1383894131978436,0.09693877551020408,0.014486412327622988,0.05921336439723612,0.17236072637734676,1.8948778188548314e-07,0.04333247325569145,0.20408163265306126
63,0.1,8,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there an association between cervical cord plaques and discopathy in patients with multiple sclerosis? Yes, an association exists between cervical cord plaques and discopathy in these patients.",7.10579182070559e-08,0.048881856501088894,0.0173979591836734,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
63,0.1,9,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do patients with multiple sclerosis show a relation between cervical cord plaques and discopathy? Yes, there is a relation between cervical cord plaques and discopathy in these patients.",7.10579182070559e-08,0.002462379095944378,0.040816326530612235,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
63,0.1,10,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there any correlation between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, a correlation exists between cervical cord plaques and discopathy in these patients.",9.47438909427412e-08,0.04712661864006362,0.03489795918367353,0.007253705859127518,0.0432528466884885,0.048327664399092946,0.007243206163811494,0.03862614973393397,0.06222222222222207,9.474389094274162e-08,0.03309824011731566,0.07658163265306125
64,0.1,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","What are the 30-day and 1-year mortality rates following emergency general surgery laparotomies, and do they highlight a need for improvement? Mortality rates within 30 days and 1 year after emergency general surgery laparotomies continue to be problematic. The high mortality rates raise concerns and suggest that perioperative care needs enhancement. Improvements in surgical methods, patient selection, and postoperative care may help lower these mortality rates.",9.474389094274162e-08,0.0610575603271899,0.02880988994691193,0.0072537058591274906,0.06598257776373995,0.0010408155303573991,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
64,0.1,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Are 30-day and 1-year mortality rates after emergency general surgery laparotomies a cause for concern and require improvement? Mortality rates at 30 days and 1 year post-emergency laparotomies remain significant issues. The elevated mortality rates indicate a pressing need to improve perioperative management. Advancements in surgical techniques, better patient selection, and enhanced postoperative care could reduce these mortality figures.",7.105791820705622e-08,0.016351078908533268,0.004902214810208513,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
64,0.1,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Is there a concern regarding 30-day and 1-year mortality following emergency general surgery laparotomies, and is improvement needed? Mortality within 30 days and 1 year after emergency general surgery laparotomies remains high. This raises concerns and highlights the necessity for better perioperative care. Enhanced surgical approaches, improved patient selection, and superior postoperative care might decrease these mortality rates.",9.474389094274162e-08,0.02555995547631973,0.0302095241002317,0.0072537058591274906,0.07064322191685513,0.0011893608989532352,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
64,0.1,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Do 30-day and 1-year mortality rates after emergency general surgery laparotomies represent an area needing improvement? Mortality rates at 30 days and 1 year post-emergency laparotomies are still a significant concern. The high mortality rates point to the need for better perioperative care. Improvements in surgical techniques, patient selection, and postoperative management could potentially lower these rates.",1.1842986367842703e-07,0.053471854918082595,0.007451485547309913,0.009067132323909363,0.0639064709709638,0.016661878770468257,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
64,0.1,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Are the 30-day and 1-year mortality rates in emergency general surgery laparotomies an issue that requires attention and improvement? Mortality rates within 30 days and 1 year after emergency laparotomies remain problematic. These high rates highlight the need for enhanced perioperative care. Better surgical methods, patient selection, and postoperative care could help reduce mortality.",1.8948778188548325e-07,0.0758338997306538,0.046389899668719176,0.014507411718254981,0.119995937622007,0.016661878770468257,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
64,0.1,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Is there a need to improve outcomes given the 30-day and 1-year mortality rates in emergency general surgery laparotomies? Mortality rates at 30 days and 1 year following emergency general surgery laparotomies continue to be concerning. The elevated mortality suggests a need for improved perioperative care. Enhanced surgical techniques, refined patient selection, and improved postoperative care may reduce these rates.",4.737194547137081e-08,0.03641793037844332,0.002187170114644324,0.0036268529295637453,0.03469827257287594,0.0005741938672664294,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
64,0.1,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Are 30-day and 1-year mortality rates after emergency general surgery laparotomies an area of concern that demands improvement? Mortality rates within 30 days and 1 year post-emergency laparotomies remain high. This situation calls for better perioperative care. Advancements in surgical technique, patient selection, and postoperative care could potentially lower mortality.",2.8423167282822487e-07,0.15644073944803516,0.04485154085872575,0.02176111757738247,0.20003864529554383,0.016661878770468257,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
64,0.1,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Do the 30-day and 1-year mortality rates in emergency general surgery laparotomies indicate a need for improvement? Mortality rates at 30 days and 1 year after emergency laparotomies are still a concern. The high mortality rates suggest the necessity for enhanced perioperative care. Improvements in surgical techniques, patient selection, and postoperative management might reduce these rates.",1.4211583641411244e-07,0.07256043732530726,0.00879685739490342,0.010880558788691236,0.08225560963915957,0.016661878770468257,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
64,0.1,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Is improvement necessary given the 30-day and 1-year mortality rates in emergency general surgery laparotomies? Mortality rates within 30 days and 1 year post-emergency laparotomies remain an issue. The high mortality rates highlight the need for better perioperative care. Enhanced surgical methods, improved patient selection, and postoperative care could help lower mortality.",2.3685972735685406e-07,0.1527679354534235,0.01471583413548963,0.018134264647818726,0.15921665077528946,0.016661878770468257,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
64,0.1,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Are the 30-day and 1-year mortality rates following emergency general surgery laparotomies a concern that requires action? Mortality rates at 30 days and 1 year after emergency laparotomies continue to be problematic. These elevated mortality rates indicate a need for improved perioperative care. Better surgical techniques, patient selection, and postoperative care could potentially reduce mortality.",1.6580180914979784e-07,0.09201928537599624,0.010192940567967226,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
65,0.1,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing a viable method for acute overt-obscure gastrointestinal bleeding? Emergency DBE is practical, safe, and effective in acute OGIB, potentially preventing major surgery by diagnosing and treating most patients successfully. The combined approach with real-time CE viewing is particularly helpful for detecting recurrent bleeding vascular lesions.",1.1842986367842703e-07,0.06723248594945552,0.015344645300396944,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
65,0.1,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy viewing be an effective approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE proves feasible, safe, and effective in acute OGIB, often avoiding the need for major surgery by diagnosing and treating most cases. Using real-time CE viewing alongside is especially beneficial for identifying recurrent bleeding vascular lesions.",9.474389094274162e-08,0.0232112294827429,0.033856571252693125,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
65,0.1,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing a feasible strategy in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, effective, and feasible option in acute OGIB, potentially circumventing major surgery by diagnosing and treating most patients. The combined use with real-time CE viewing is particularly useful for spotting recurrent bleeding vascular lesions.",4.737194547137081e-08,0.01181410058452137,0.01631830594657067,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
65,0.1,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Does emergency double-balloon enteroscopy with real-time capsule endoscopy viewing offer a feasible combined approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE is effective, safe, and feasible in acute OGIB and may prevent major surgery by diagnosing and successfully treating most patients. The combined method with real-time CE viewing is especially valuable for detecting recurrent bleeding vascular lesions.",7.105791820705622e-08,0.029947980428634224,0.016005331583271633,0.005440279394345618,0.05310982531394792,0.0,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
65,0.1,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is emergency double-balloon enteroscopy along with real-time capsule endoscopy viewing a practical combined approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is feasible, safe, and effective in acute OGIB, potentially avoiding major surgery by diagnosing and treating most patients. The combined approach with real-time CE viewing is particularly useful for identifying recurrent bleeding vascular lesions.",1.1842986367842703e-07,0.1185767215464888,0.021506750546614835,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
65,0.1,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Can emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing be considered a feasible approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, effective, and feasible procedure in acute OGIB, which may help avoid major surgery by diagnosing and treating most patients. The combined use with real-time CE viewing is especially helpful for detecting recurrent bleeding vascular lesions.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
65,0.1,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is emergency double-balloon enteroscopy with real-time capsule endoscopy viewing a viable combined method for acute overt-obscure gastrointestinal bleeding? Emergency DBE is feasible, safe, and effective in acute OGIB and may prevent major surgery by diagnosing and successfully treating most patients. The combined approach with real-time CE viewing is particularly useful for identifying recurrent bleeding vascular lesions.",9.474389094274162e-08,0.048416581503104794,0.015680988262295324,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
65,0.1,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing provide a feasible approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is effective, safe, and feasible in acute OGIB, potentially avoiding major surgery by diagnosing and treating most patients. The combined method with real-time CE viewing is especially valuable for detecting recurrent bleeding vascular lesions.",1.1842986367842703e-07,0.09290460374797238,0.0031256772680169284,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
65,0.1,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Is the use of emergency double-balloon enteroscopy together with real-time capsule endoscopy viewing a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe, effective, and feasible option in acute OGIB, which may help avoid major surgery by diagnosing and treating most patients. The combined approach with real-time CE viewing is particularly useful for identifying recurrent bleeding vascular lesions.",4.737194547137081e-08,0.01215103825547903,0.015192180233632668,0.0036268529295637453,0.03390155167568043,0.0,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
65,0.1,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Can emergency double-balloon enteroscopy along with real-time capsule endoscopy viewing be an effective combined approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is feasible, safe, and effective in acute OGIB and may prevent major surgery by diagnosing and successfully treating most patients. The combined use with real-time CE viewing is especially helpful for detecting recurrent bleeding vascular lesions.",4.737194547137081e-08,0.03613505428837982,0.0011847510613564802,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
66,0.1,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex affect the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the typical survival and recovery benefits seen in men during ischemic stroke, potentially showing a greater positive treatment effect in women.",2.1317375462116866e-07,0.1730128071754402,0.00316323291782087,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
66,0.1,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis could change the usual survival and recovery advantage observed in men, with women possibly experiencing a larger beneficial effect.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.1,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does gender impact the effectiveness of intravenous thrombolysis in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may modify the expected survival and recovery benefits for men, potentially providing a greater treatment advantage for women.",3.316036182995957e-07,0.2838584397377497,0.005478908433114424,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
66,0.1,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is there a sex difference in response to intravenous thrombolysis for ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the natural survival and recovery advantage seen in men, with women possibly gaining a larger benefit.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.1,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does intravenous thrombolysis response in ischemic stroke vary by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis might change the survival and recovery benefits typically seen in men, with a potentially greater positive effect in women.",3.316036182995957e-07,0.2838584397377497,0.005478908433114424,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
66,0.1,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the outcome of intravenous thrombolysis in ischemic stroke influenced by sex? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest that intravenous thrombolysis may modify the survival and recovery advantage usually observed in men, possibly offering a larger benefit to women.",3.316036182995957e-07,0.2838584397377497,0.005478908433114424,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
66,0.1,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex influence outcomes after intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may alter the expected survival and recovery benefits for men, with women potentially experiencing a greater treatment effect.",3.552895910352811e-07,0.30758067168397085,0.006006557747752838,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
66,0.1,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is there a difference in response to intravenous thrombolysis in ischemic stroke based on sex? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may change the natural survival and recovery advantage for men, possibly resulting in a larger benefit for women.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.1,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex play a role in the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis might modify the survival and recovery advantage typically seen in men, with women potentially receiving a greater benefit.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.1,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the response to intravenous thrombolysis in ischemic stroke sex-dependent? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the expected survival and recovery advantage for men, with a possibly larger beneficial effect in women.",3.552895910352811e-07,0.30758067168397085,0.006006557747752838,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
67,0.1,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers release GABA? No, mossy fibers in the cerebellar neuronal circuit do not release GABA; instead, they mainly release glutamate, an excitatory neurotransmitter. GABA, an inhibitory neurotransmitter, is not commonly linked to mossy fibers.",2.3685972735685353e-07,0.26011629724039764,0.006335969001115268,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
67,0.1,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers responsible for releasing GABA? No, mossy fibers, which are components of the cerebellum's neuronal network, do not release GABA. Their primary neurotransmitter is glutamate, which excites neurons. GABA, known for its inhibitory effects, is not typically released by mossy fibers.",7.105791820705622e-08,0.03818633012873196,0.02221074380165289,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
67,0.1,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Is GABA released by mossy fibers? No, mossy fibers in the cerebellum do not release GABA. They predominantly release glutamate, an excitatory neurotransmitter, whereas GABA is an inhibitory neurotransmitter not usually associated with these fibers.",2.6054570009253883e-07,0.24949542379593792,0.02221074380165289,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
67,0.1,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers secrete GABA? No, mossy fibers, part of the cerebellar neuronal circuit, do not secrete GABA. They mainly release glutamate, which acts as an excitatory neurotransmitter. GABA, an inhibitory neurotransmitter, is generally not linked to mossy fibers.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.1,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers a source of GABA? No, mossy fibers within the cerebellum do not release GABA. Their main neurotransmitter is glutamate, which excites neurons, while GABA is an inhibitory neurotransmitter not typically released by mossy fibers.",2.1317375462116823e-07,0.2308451866537644,0.005544358239163438,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
67,0.1,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers emit GABA? No, mossy fibers, which belong to the cerebellar neuronal circuit, do not emit GABA. They primarily release glutamate, an excitatory neurotransmitter, whereas GABA is an inhibitory neurotransmitter not commonly associated with them.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
67,0.1,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Is GABA released by the mossy fibers? No, mossy fibers in the cerebellum do not release GABA. They mainly release glutamate, an excitatory neurotransmitter, while GABA, an inhibitory neurotransmitter, is not typically released by these fibers.",2.3685972735685353e-07,0.26011629724039764,0.006335969001115268,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
67,0.1,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers discharge GABA? No, mossy fibers, part of the cerebellar neuronal network, do not discharge GABA. Their primary neurotransmitter is glutamate, which excites neurons. GABA, an inhibitory neurotransmitter, is not usually linked to mossy fibers.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
67,0.1,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers involved in GABA release? No, mossy fibers in the cerebellum do not release GABA. They predominantly release glutamate, an excitatory neurotransmitter, and GABA, an inhibitory neurotransmitter, is not typically associated with them.",2.6054570009253883e-07,0.29026878735828765,0.007174012855831045,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
67,0.1,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers produce GABA? No, mossy fibers, which are components of the cerebellar neuronal circuit, do not produce GABA. They mainly release glutamate, an excitatory neurotransmitter, while GABA is an inhibitory neurotransmitter not commonly released by mossy fibers.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
68,0.1,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is essential to understand and clarify gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to differ between men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.1,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements is key to identifying and explaining gender-specific differences in mortality risks associated with marital status. The influence of living alone compared to living with a partner seems to vary between males and females.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.1,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is vital for recognizing and interpreting gender differences in mortality risks linked to marital status. The impact of living alone versus cohabiting with a partner appears to differ by gender.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
68,0.1,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living arrangements plays a crucial role in uncovering and explaining gender-based variations in mortality risks according to marital status. The effects of living alone and living with a partner seem to differ between men and women.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
68,0.1,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The assessment of living arrangements is important for identifying and understanding gender differences in mortality risks related to marital status. The consequences of living alone versus living with a partner appear to be different for men and women.",4.737194547137081e-08,0.041114813894306934,0.00079930555555556,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
68,0.1,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Examining living arrangements is essential to reveal and explain gender disparities in mortality risks by marital status. The impact of living alone compared to living with a partner seems to vary between men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.1,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Investigating living arrangements is critical for identifying and clarifying gender differences in mortality risks associated with marital status. The effects of living alone and living with a partner appear to differ between males and females.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.1,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Considering living arrangements is fundamental to understanding and explaining gender-specific mortality risk differences by marital status. The influence of living alone versus living with a partner seems to differ between men and women.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
68,0.1,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The evaluation of living arrangements is key to identifying and interpreting gender differences in mortality risks linked to marital status. The impact of living alone compared to living with a partner appears to vary between men and women.",4.737194547137081e-08,0.041114813894306934,0.00079930555555556,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
68,0.1,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is crucial for uncovering and explaining gender-based differences in mortality risks related to marital status. The effects of living alone and living with a partner seem to differ between men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
69,0.1,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are aromatase inhibitor-related musculoskeletal symptoms primarily addressed by preventing osteoporosis? While osteoporosis prevention can reduce some symptoms, other factors like lifestyle, health, and treatments are also important.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.1,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the key to eliminating aromatase inhibitor-related musculoskeletal symptoms the prevention of osteoporosis? Preventing osteoporosis helps, but patient lifestyle, health, and other treatments also influence symptom management.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.1,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does preventing osteoporosis fully resolve aromatase inhibitor-related musculoskeletal symptoms? It helps, but managing these symptoms also depends on lifestyle, overall health, and concurrent therapies.",9.000669639560436e-07,0.9072012370415434,0.049048751486325794,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
69,0.1,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is osteoporosis prevention the main way to stop aromatase inhibitor-related musculoskeletal symptoms? It contributes, but other elements such as patient health, lifestyle, and medical treatments are vital too.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.1,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Can preventing osteoporosis eliminate musculoskeletal symptoms caused by aromatase inhibitors? It aids symptom relief, yet lifestyle, health status, and additional treatments also matter.",9.237529366917289e-07,0.9516529996123775,0.049048751486325794,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
69,0.1,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is stopping osteoporosis the key to managing aromatase inhibitor-related musculoskeletal symptoms? While helpful, other factors like patient lifestyle, health, and ongoing treatments are essential.",9.000669639560436e-07,0.9072012370415434,0.049048751486325794,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
69,0.1,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does preventing osteoporosis solve aromatase inhibitor-related musculoskeletal symptoms? It partially helps, but lifestyle, overall health, and other medical interventions also play roles.",9.474389094274142e-07,0.9981730152472714,0.049048751486325794,0.07253705859127502,1.0755073826494446,0.016661878770468257,0.07243206163811478,1.1330984647392786,0.0,9.47438909427416e-07,1.1700712526502541,0.0
69,0.1,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the prevention of osteoporosis sufficient to eliminate musculoskeletal symptoms from aromatase inhibitors? It assists, but patient lifestyle, health, and concurrent treatments are also critical.",8.763809912203583e-07,0.8646416226227478,0.049048751486325794,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
69,0.1,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are aromatase inhibitor-related musculoskeletal symptoms best managed by preventing osteoporosis? Prevention helps, but lifestyle, health, and other treatments are equally important.",9.711248821630995e-07,1.0469631794167027,0.049048751486325794,0.07435048505605689,1.1268006770369947,0.016661878770468257,0.07424286317906764,1.1871656860095539,0.0,9.711248821631014e-07,1.227229666490203,0.0
69,0.1,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is osteoporosis prevention the sole answer to aromatase inhibitor-related musculoskeletal symptoms? It can reduce symptoms, but lifestyle, health, and additional therapies are also key factors.",8.763809912203583e-07,0.8646416226227478,0.049048751486325794,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
70,0.1,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in young individuals might represent a distinct clinical entity. Additional studies are required to confirm our results and determine the best management strategy for this group.,0.0,4.440892098500626e-16,0.0,0.0,0.03648143055578679,0.026172568965361766,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.1,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Colorectal cancer in younger patients could be considered a distinct clinical entity. More research is necessary to validate these findings and establish the optimal treatment approach for this population.,4.7371945471370706e-08,0.08902433317653635,0.027736686390532554,0.0036268529295637453,0.053117365915339665,0.0013130033920054525,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
70,0.1,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a different clinical entity? Answer: Colorectal cancer among young patients may be a unique clinical entity. Further investigation is needed to confirm our observations and define the best clinical approach for these patients.,0.0,0.03554600925948437,0.025256675594513445,0.0,0.03648143055578634,0.026296566837107373,0.0,0.0,0.0,0.0,0.0,0.0
70,0.1,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be a distinct clinical entity? Answer: Colorectal cancer in young individuals might constitute a separate clinical entity. Additional research is essential to validate our findings and identify the optimal management for this group.,0.0,4.440892098500626e-16,0.0,0.0,0.03648143055578679,0.026172568965361766,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.1,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Colorectal cancer in young patients may represent a distinct clinical entity. Further studies are required to confirm our findings and determine the best approach for this population.,2.36859727356853e-08,0.06526318084795246,0.027417339484813535,0.0018134264647818726,0.10258906202258311,0.05415326015251197,0.0018108015409528666,0.10441532758366501,0.055363321799307974,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
70,0.1,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients form a distinct clinical entity? Answer: Colorectal cancer among young patients could be a distinct clinical entity. More research is needed to validate these findings and define the optimal treatment strategy.,4.73719454713706e-08,0.09587536636857719,0.030130853994490336,0.0036268529295637453,0.05609396741226469,0.0014585352037089563,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
70,0.1,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients considered a unique clinical entity? Answer: Colorectal cancer in young patients might be a distinct clinical entity. Further research is necessary to confirm our results and establish the best clinical approach.,4.73719454713706e-08,0.09587536636857719,0.030130853994490336,0.0036268529295637453,0.13311032080781438,0.056348061262066165,0.003621603081905733,0.13478667179023418,0.056932966023875105,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
70,0.1,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be considered a unique clinical entity? Answer: Colorectal cancer in young individuals may constitute a distinct clinical entity. Additional studies are needed to validate our findings and determine the optimal management.,4.73719454713706e-08,0.05840795120317477,0.004060938100730452,0.0036268529295637453,0.09460214411003953,0.0290667549622006,0.003621603081905733,0.0951782614725234,0.02854671280276816,4.737194547137081e-08,0.05715841383994835,0.0
70,0.1,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a clinically distinct entity? Answer: Colorectal cancer among young patients might represent a distinct clinical entity. Further research is required to confirm our observations and define the best approach for this population.,2.36859727356853e-08,0.0076996802636215556,0.023919753086419755,0.0018134264647818726,0.009813183473625475,0.026296566837107373,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
70,0.1,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a distinct clinical condition? Answer: Colorectal cancer in young patients may be a unique clinical entity. More investigation is needed to validate our findings and establish the optimal treatment approach.,7.10579182070559e-08,0.12743738668618088,0.032986111111111105,0.005440279394345618,0.16458189863431993,0.05866437066289262,0.005432404622858607,0.16610411515276358,0.05859375,7.105791820705622e-08,0.12902029702356588,0.0302734375
71,0.1,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: Findings from this study indicate that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.1,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: According to the current study, septoplasty does not affect the compensatory hypertrophy of the middle turbinate, even after a year.",4.73719454713706e-08,0.11413966149202048,0.03533607681755831,0.003626852929563759,0.11537028863693077,0.036200274348422476,0.003621603081905747,0.11652455967956588,0.03654320987654323,4.737194547137081e-08,0.1175787092227627,0.03636488340192046
71,0.1,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty influence the dimensions of compensatory hypertrophy in the middle turbinate? Answer: The results of this study suggest that septoplasty has no effect on compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.11286417048722797,0.05862258953168049,0.0018134264647818796,0.1558797232514899,0.09000000000000004,0.0018108015409528735,0.11741505623674797,0.06222222222222223,2.3685972735685406e-08,0.07646787125393084,0.0322222222222222
71,0.1,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Can septoplasty modify the compensatory hypertrophy size of the middle turbinate? Answer: This study's findings show that septoplasty does not alter compensatory hypertrophy of the middle turbinate, even after one year.",7.10579182070559e-08,0.06343738469967075,0.01989229024943312,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,0.1,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty impact the compensatory hypertrophy of the middle turbinate? Answer: The present study indicates that compensatory hypertrophy of the middle turbinate remains unchanged by septoplasty, even after one year.",9.47438909427412e-08,0.14690893685392714,0.014621959237343843,0.007253705859127518,0.14659473287335922,0.012071005917159733,0.007243206163811494,0.14590902084880675,0.008783694937541102,9.474389094274162e-08,0.1447754011384994,0.004760026298487846
71,0.1,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is there a change in compensatory hypertrophy of the middle turbinate following septoplasty? Answer: Findings suggest that septoplasty does not affect the compensatory hypertrophy of the middle turbinate, even after one year.",4.73719454713706e-08,0.07081796270702423,0.00689342403628114,0.003626852929563759,0.07065111569757931,0.005663265306122434,0.003621603081905747,0.07031474764223633,0.004104308390022647,4.737194547137081e-08,0.06977545539104257,0.0022165532879818914
71,0.1,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty affect the size of compensatory hypertrophy in the middle turbinate? Answer: The study's results suggest no effect of septoplasty on compensatory hypertrophy of the middle turbinate, even after one year.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.1,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter compensatory hypertrophy dimensions in the middle turbinate? Answer: According to the study, compensatory hypertrophy of the middle turbinate is not influenced by septoplasty, even after one year.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.1,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: The current study findings suggest that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",7.10579182070559e-08,0.10815655763902221,0.010644718792866922,0.005440279394345639,0.10791285581450571,0.008765432098765416,0.005432404622858621,0.10740318290669926,0.006364883401920436,7.105791820705622e-08,0.1065740342677306,0.0034430727023319757
71,0.1,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty cause changes in compensatory hypertrophy of the middle turbinate? Answer: The study indicates that compensatory hypertrophy of the middle turbinate is unaffected by septoplasty, even after one year.",9.47438909427412e-08,0.14690893685392714,0.014621959237343843,0.007253705859127518,0.14659473287335922,0.012071005917159733,0.007243206163811494,0.14590902084880675,0.008783694937541102,9.474389094274162e-08,0.1447754011384994,0.004760026298487846
72,0.1,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do the characteristics of general practices affect the adoption of IT innovations in primary care? Yes, factors like practice size, staff tech skills, leadership approach, openness to change, and infrastructure play a crucial role in how quickly and effectively new IT systems are adopted in primary care.",2.8423167282822487e-07,0.11852868649955184,0.08034261085543135,0.02176111757738247,0.16342591695265707,0.05246913580246911,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
72,0.1,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are general practice traits influential in the uptake of IT innovations within primary care? Indeed, elements such as the size of the practice, technological proficiency of staff, leadership style, readiness for change, and existing infrastructure significantly impact the adoption and integration of IT innovations.",3.552895910352811e-07,0.18807253710466965,0.07882837553167221,0.02720139697172809,0.23241878843960873,0.05246913580246911,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
72,0.1,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the nature of general practices impact the acceptance of IT innovations in primary care? Yes, characteristics including practice size, staff's technology literacy, leadership methods, willingness to embrace change, and infrastructure affect the rate and success of IT system adoption.",4.500334819780226e-07,0.2890176121810972,0.07644773721909878,0.03445510283085558,0.33250224699659015,0.05246913580246911,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
72,0.1,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do general practice features affect the implementation of IT innovations in primary care? Yes, aspects like the size of the practice, technological skills of the staff, leadership style, openness to change, and infrastructure influence how IT innovations are adopted and integrated.",4.263475092423373e-07,0.29746851299331567,0.05220951007228441,0.03264167636607371,0.30652676059333217,0.05246913580246911,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
72,0.1,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Is the uptake of IT innovations in primary care influenced by general practice characteristics? Yes, factors such as practice size, staff technological literacy, leadership style, readiness to change, and infrastructure significantly determine the adoption and integration of IT systems.",4.737194547137079e-07,0.3159285198806576,0.07577443908005237,0.03626852929563745,0.359170494078751,0.05246913580246911,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
72,0.1,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do characteristics of general practices influence the adoption of IT innovations in primary care? Yes, elements like practice size, staff's tech literacy, leadership approach, willingness to change, and infrastructure impact the uptake and integration of new IT technologies.",4.974054274493932e-07,0.30611533640703215,0.10207100591715974,0.038081955760419325,0.38656946826686633,0.05246913580246911,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
72,0.1,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are general practice characteristics a factor in the uptake of IT innovations in primary care? Yes, practice size, staff technological competence, leadership style, openness to change, and infrastructure all play important roles in the adoption process.",5.447773729207638e-07,0.40129359787955554,0.07352429311439158,0.04170880868998308,0.4437278821068147,0.05246913580246911,0.041648435441915946,0.5288441292686694,0.0,5.447773729207643e-07,0.5415972824327446,0.0
72,0.1,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the uptake of IT innovations in primary care depend on general practice characteristics? Yes, factors such as the size of the practice, technological literacy of staff, leadership style, willingness to change, and infrastructure affect the adoption and integration of IT systems.",4.026615365066519e-07,0.23727323993523974,0.07769600591715975,0.030828249901291835,0.28120895260904044,0.05246913580246911,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
72,0.1,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do general practice attributes influence the adoption of IT innovations in primary care? Yes, characteristics like practice size, staff's technological skills, leadership style, readiness to change, and infrastructure impact the rate and success of IT innovation uptake.",5.210914001850785e-07,0.3720224872929223,0.07431590387634342,0.0398953822252012,0.4147403452335632,0.05246913580246911,0.03983763390096307,0.49899116611898764,0.0,5.210914001850789e-07,0.5108256237659909,0.0
72,0.1,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Is the adoption of IT innovations in primary care affected by general practice characteristics? Yes, factors including practice size, staff technological literacy, leadership style, willingness to change, and infrastructure significantly influence the uptake and integration of IT systems.",4.974054274493932e-07,0.34358275157243456,0.07506483307765358,0.038081955760419325,0.38656946826686633,0.05246913580246911,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
73,0.1,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa is a hallmark endoscopic sign of primary eosinophilic esophagitis, characterized by a delicate esophageal lining prone to tearing or a crepe-paper appearance during endoscopy, reflecting a high eosinophil count.",2.1317375462116866e-07,0.09033525349016003,0.08653232227630551,0.016320838183036854,0.11712811109297938,0.03775537190082644,0.0162972138685758,0.11041905619160097,0.04595839207142554,2.1317375462116866e-07,0.13321256661967995,0.03263551026371541
73,0.1,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the fragility of the esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Indeed, the fragile nature of the esophageal mucosa is a distinctive endoscopic feature of primary eosinophilic esophagitis, showing reduced resilience that may cause tearing or a crepe-paper esophagus appearance during endoscopy due to elevated eosinophils.",1.6580180914979784e-07,0.010691441556986536,0.12873393566721997,0.012693985253473108,0.01623336092419647,0.08046944444444443,0.012675610786670066,0.038046832037183176,0.06802822231833912,1.6580180914979784e-07,0.06051611826349479,0.05436390532544381
73,0.1,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is esophageal mucosal fragility an endoscopic hallmark of primary eosinophilic esophagitis? Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, where the mucosas lack of strength leads to tearing or a crepe-paper effect during endoscopy, indicating abundant eosinophils.",3.316036182995957e-07,0.0912289678003817,0.16124574829931976,0.025387970506946217,0.14384387996095827,0.09715736961451246,0.025351221573340132,0.16390579020893403,0.08842752787389467,3.316036182995957e-07,0.218145062467078,0.05436390532544381
73,0.1,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Yes, fragility in the esophageal mucosa is a definitive endoscopic sign of primary eosinophilic esophagitis, manifesting as a delicate lining prone to tearing or crepe-paper appearance during endoscopy, which correlates with high eosinophil levels.",2.1317375462116866e-07,0.09033525349016003,0.08653232227630551,0.016320838183036854,0.11712811109297938,0.03775537190082644,0.0162972138685758,0.11041905619160097,0.04595839207142554,2.1317375462116866e-07,0.13321256661967995,0.03263551026371541
73,0.1,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragile state of the esophageal mucosa a diagnostic endoscopic sign of primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, characterized by a fragile lining that may tear or appear like crepe paper during endoscopy, reflecting increased eosinophil infiltration.",2.1317375462116866e-07,0.11862697514566767,0.06770833333333334,0.016320838183036854,0.1460092436163105,0.017641752298539773,0.0162972138685758,0.13991468089627945,0.02489447002265502,2.1317375462116866e-07,0.13321256661967995,0.03263551026371541
73,0.1,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the esophageal mucosas fragility indicate primary eosinophilic esophagitis in endoscopy? Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, presenting as a delicate mucosal lining prone to tearing or a crepe-paper appearance during endoscopy due to high eosinophil presence.",2.8423167282822487e-07,0.04403749305342197,0.16320879247015613,0.02176111757738247,0.06614210213722682,0.1204,0.0217296184914344,0.11738577457404009,0.08842752787389467,2.8423167282822487e-07,0.17051701347782355,0.05436390532544381
73,0.1,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragility of the esophageal mucosa a key endoscopic sign of primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, where the mucosas lack of durability causes tearing or a crepe-paper esophagus during endoscopy, indicating elevated eosinophil counts.",2.6054570009253947e-07,0.19822261759510873,0.04354659763313615,0.0199476911126006,0.22498419904278455,0.007100000000000009,0.019918816950481533,0.21813908415486116,0.00038469622606600307,2.6054570009253947e-07,0.21054087530402876,0.009012431402541314
73,0.1,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can the fragile esophageal mucosa be used as a pathognomonic endoscopic marker for primary eosinophilic esophagitis? Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, showing a delicate lining that tears easily or appears like crepe paper during endoscopy, signifying high eosinophil levels.",2.1317375462116866e-07,0.03375181017914386,0.12560956790123456,0.016320838183036854,0.030484713522985984,0.09957609778180171,0.0162972138685758,0.05142780678224401,0.08842752787389467,2.1317375462116866e-07,0.10307573268229131,0.05436390532544381
73,0.1,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is mucosal fragility in the esophagus a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Yes, the fragile nature of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, characterized by a lining that lacks resilience and may tear or look like crepe paper during endoscopy, indicating a high eosinophil concentration.",1.4211583641411244e-07,0.02111854475399033,0.09317567212770424,0.010880558788691236,0.07689017105772056,0.023519092627599228,0.0108648092457172,0.10045595195374757,0.009032442807732105,1.4211583641411244e-07,0.12477199602728284,0.006600177850359566
73,0.1,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the fragility of the esophageal mucosa represent a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, manifesting as a delicate mucosal lining prone to tearing or a crepe-paper appearance during endoscopy, which reflects a significant eosinophil presence.",1.6580180914979784e-07,0.15240201269241105,0.022183182959878395,0.012693985253473108,0.1825886842585831,0.033795011337868455,0.012675610786670066,0.17950544031472315,0.03163737207202205,1.6580180914979784e-07,0.17604064835681887,0.028280722773729762
74,0.1,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering required before scoliosis correction in a patient with myelomeningocele? The study indicates that spinal cord untethering might not be needed for MM patients undergoing scoliosis surgery if they show no clinical signs of tethered cord, despite radiographic evidence of tethering.",2.1317375462116866e-07,0.19845093872383757,0.0,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
74,0.1,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a patient with myelomeningocele, is spinal cord untethering necessary prior to scoliosis correction? According to the study, untethering may be unnecessary in MM patients having scoliosis surgery who lack clinical symptoms of tethered cord, even if imaging shows tethering.",2.6054570009253936e-07,0.248461359298501,0.0,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
74,0.1,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele need untethering before scoliosis correction? The study suggests that spinal cord untethering may not be required in MM patients undergoing scoliosis correction who do not exhibit clinical signs of tethered cord, despite radiographic tethering.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.1,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele, is untethering essential before scoliosis surgery? Study findings suggest that spinal cord untethering might be unnecessary for MM patients undergoing scoliosis correction if they have no clinical symptoms of tethered cord, even when tethering is seen on imaging.",2.1317375462116866e-07,0.19845093872383757,0.0,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
74,0.1,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to perform untethering before scoliosis correction in myelomeningocele patients? The study results imply that spinal cord untethering may not be needed in MM patients undergoing scoliosis surgery who do not show clinical signs of tethered cord, despite radiographic evidence.",2.1317375462116866e-07,0.19845093872383757,0.0,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
74,0.1,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should untethering be done prior to scoliosis correction in patients with myelomeningocele? The study suggests that spinal cord untethering might be unnecessary in MM patients undergoing scoliosis correction if they lack clinical symptoms of tethered cord, even if tethering is visible on radiographs.",1.8948778188548325e-07,0.20736039574286913,0.023795359904818555,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
74,0.1,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For myelomeningocele patients, is untethering required before scoliosis correction? The study indicates that spinal cord untethering may not be necessary in MM patients undergoing scoliosis surgery who do not present clinical symptoms of tethered cord, despite radiographic tethering.",3.0791764556390996e-07,0.30110509278391984,0.0,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
74,0.1,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering necessary before scoliosis correction in a patient with myelomeningocele? According to the study, untethering may be unnecessary in MM patients undergoing scoliosis correction who show no clinical signs of tethered cord, even if tethering is detected radiographically.",2.3685972735685406e-07,0.25780091034220565,0.02498356344510192,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
74,0.1,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does spinal cord untethering need to be performed before scoliosis correction in myelomeningocele patients? The study suggests that untethering might not be required in MM patients undergoing scoliosis surgery who do not have clinical symptoms of tethered cord, despite radiographic evidence of tethering.",1.8948778188548325e-07,0.17435338714477755,0.0,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
74,0.1,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering mandatory prior to scoliosis correction in patients with myelomeningocele? The study results suggest that spinal cord untethering may be unnecessary in MM patients undergoing scoliosis correction who lack clinical symptoms of tethered cord, even when tethering is shown on imaging.",2.1317375462116866e-07,0.23226299631212743,0.024375,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
75,0.1,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What is the clinical importance of bile duct sludge compared to bile duct stones? Answer: Although bile duct sludge and stones are alike, their clinical implications differ. Bile duct sludge, which is thickened bile fluid, typically leads to temporary blockage and usually clears on its own. However, bile duct",1.4211583641411244e-07,0.12524404565620362,0.02628660189849008,0.010880558788691236,0.1046502601011925,0.020823902218198284,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.1,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How does the clinical significance of bile duct sludge differ from that of bile duct stones? Answer: Bile duct sludge and stones share similarities but differ in clinical impact. Bile duct sludge, a concentrated bile fluid, often causes transient obstruction and tends to resolve without intervention. However, bile duct",1.4211583641411244e-07,0.09695232400069598,0.00060234773385337,0.010880558788691236,0.07576912757786136,0.04158790170132326,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.1,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Can you explain the clinical differences between bile duct sludge and bile duct stones? Answer: While bile duct sludge and stones are similar, their clinical significance varies. Bile duct sludge, characterized by thickened bile fluid, frequently results in temporary blockage and resolves spontaneously. However, bile duct",7.105791820705622e-08,0.019372652701599602,0.027762984878369423,0.005440279394345618,0.007379788770512263,0.04434829637641968,0.0054324046228586,0.03911087718850137,0.02271498107084911,7.105791820705622e-08,0.07232066157962613,0.0
75,0.1,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What distinguishes the clinical significance of bile duct sludge from bile duct stones? Answer: Bile duct sludge and stones are comparable but have distinct clinical meanings. Bile duct sludge, a viscous bile fluid, commonly causes short-term obstruction and usually resolves on its own. However, bile duct",7.105791820705622e-08,0.04950948663898824,2.5031279321130473e-05,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.1,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: Though bile duct sludge and stones are similar, their clinical significance is different. Bile duct sludge, which is thickened bile fluid, often leads to temporary obstruction and typically resolves spontaneously. However, bile duct",7.105791820705622e-08,0.04950948663898824,2.5031279321130473e-05,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.1,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: Bile duct sludge and stones, while similar, differ in their clinical importance. Bile duct sludge, a thickened bile fluid, often causes temporary blockage and resolves on its own. However, bile duct",9.474389094274162e-08,0.04588338071831277,0.017871551207935044,0.0072537058591274906,0.030698110330948936,0.043388429752066124,0.007243206163811466,0.06228388170779198,0.02221074380165289,9.474389094274162e-08,0.09531017980432566,0.0
75,0.1,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Describe the clinical significance of bile duct sludge versus bile duct stones. Answer: Bile duct sludge and stones are alike but have different clinical implications. Bile duct sludge, a thickened bile fluid, frequently causes transient obstruction and tends to resolve spontaneously. However, bile duct",2.3685972735685406e-08,0.004263900361972439,0.019723865877711633,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
75,0.1,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How does bile duct sludge's clinical significance compare to that of bile duct stones? Answer: Although bile duct sludge and stones are similar, their clinical significance is distinct. Bile duct sludge, a thickened bile fluid, often results in temporary obstruction and usually resolves on its own. However, bile duct",1.4211583641411244e-07,0.12524404565620362,0.02628660189849008,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.1,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What clinical differences exist between bile duct sludge and bile duct stones? Answer: Bile duct sludge and stones share similarities but differ clinically. Bile duct sludge, a thickened bile fluid, commonly causes temporary obstruction and resolves spontaneously. However, bile duct",7.105791820705622e-08,0.15567117538359243,0.09853288107214098,0.005440279394345618,0.14519999067269174,0.05113221329437545,0.0054324046228586,0.11246733753370775,0.026296566837107373,7.105791820705622e-08,0.07796154146971057,0.0
75,0.1,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Explain the clinical significance of bile duct sludge in contrast to bile duct stones. Answer: While bile duct sludge and stones are similar, their clinical significance is not the same. Bile duct sludge, a thickened bile fluid, often leads to temporary blockage and typically resolves on its own. However, bile duct",1.8948778188548325e-07,0.14561694495645927,0.017514792899408604,0.014507411718254981,0.14662749992237956,0.019991670137442734,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
76,0.1,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Is it possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Answer: The findings indicate that quantitative real-time PCR assays for BCRABL detection can yield comparable results across different laboratories despite methodological differences, provided the same positive control cell line and quality control gene are utilized. It is crucial to implement some degree of assay standardization between laboratories, not only for",4.737194547137081e-08,0.010701837840094264,0.013750231139053264,0.0036268529295637453,0.030941994437290177,0.00045891263487144764,0.003621603081905733,0.0307716586667528,0.0,4.737194547137081e-08,0.03125254350410156,0.0
76,0.1,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Can homebrew assays produce correlated results in BCRABL transcript detection via quantitative real-time PCR? Answer: These findings imply that quantitative real-time PCR assays for detecting BCRABL can be consistent between labs even with significant methodological variations, as long as the same positive control cell line and quality control gene are employed. Establishing some assay standardization among laboratories is essential, not only for",9.474389094274162e-08,0.042871023417073495,0.014148739838081154,0.0072537058591274906,0.04218580016663509,0.015380859375,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
76,0.1,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Are correlated results achievable from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? Answer: The data suggest that quantitative real-time PCR assays for BCRABL detection can be comparable across laboratories despite methodological differences if the same positive control cell line and quality control gene are used. It is vital to adopt some level of assay standardization between labs, not only for",7.105791820705622e-08,0.026515767999681472,0.01440455092351716,0.005440279394345618,0.025925279294853887,0.015380859375,0.0054324046228586,0.04800921918636103,0.0,7.105791820705622e-08,0.04879016416943571,0.0
76,0.1,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Is it feasible to get correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Answer: Results indicate that quantitative real-time PCR assays for BCRABL detection can be comparable between labs despite significant methodological differences, provided the same positive control cell line and quality control gene are applied. Some assay standardization between laboratories is imperative, not only for",1.1842986367842703e-07,0.10495036902179589,0.018775313986325794,0.009067132323909363,0.08182000813651058,0.0012810193954682567,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
76,0.1,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Can quantitative real-time PCR homebrew assays yield correlated results for BCRABL transcript detection? Answer: These results suggest that despite methodological differences, quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories if the same positive control cell line and quality control gene are used. It is essential to adopt some assay standardization between labs, not only for",1.6580180914979784e-07,0.1405979218725264,0.020428093112244902,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
76,0.1,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Are consistent results possible from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? Answer: The findings suggest that quantitative real-time PCR assays for BCRABL detection can be comparable across laboratories despite significant methodological differences, as long as the same positive control cell line and quality control gene are utilized. It is important to implement assay standardization between laboratories, not only for",7.105791820705622e-08,0.026515767999681472,0.01440455092351716,0.005440279394345618,0.025925279294853887,0.015380859375,0.0054324046228586,0.04800921918636103,0.0,7.105791820705622e-08,0.04879016416943571,0.0
76,0.1,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Is it possible to achieve correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Answer: The results indicate that quantitative real-time PCR assays for BCRABL detection can be comparable between labs despite methodological differences if the same positive control cell line and quality control gene are used. Some level of assay standardization between laboratories is necessary, not only for",7.105791820705622e-08,0.07052511279713958,0.017226562500000014,0.005440279394345618,0.04828486576453006,0.0007438382869188465,0.0054324046228586,0.04800921918636103,0.0,7.105791820705622e-08,0.04879016416943571,0.0
76,0.1,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Can homebrew quantitative real-time PCR assays produce correlated results for BCRABL transcript detection? Answer: These results suggest that despite significant methodological differences, quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories if the same positive control cell line and quality control gene are employed. It is crucial to adopt some assay standardization between labs, not only for",1.4211583641411244e-07,0.14572088384504767,0.036053093112244874,0.010880558788691236,0.12251524962473148,0.018475711877693125,0.0108648092457172,0.12234169972911246,0.017236072637734686,1.4211583641411244e-07,0.10008345855698497,0.0
76,0.1,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Are correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR achievable? Answer: The data suggest that quantitative real-time PCR assays for BCRABL detection can be comparable across laboratories despite methodological differences, provided the same positive control cell line and quality control gene are used. It is imperative to implement assay standardization between laboratories, not only for",1.4211583641411244e-07,0.14572088384504767,0.036053093112244874,0.010880558788691236,0.12251524962473148,0.018475711877693125,0.0108648092457172,0.0984400728132524,0.0,1.4211583641411244e-07,0.10008345855698497,0.0
76,0.1,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Question: Is it achievable to get correlated results from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? Answer: These findings indicate that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant methodological differences if the same positive control cell line and quality control gene are applied. Some assay standardization between labs is essential, not only for",9.474389094274162e-08,0.042871023417073495,0.014148739838081157,0.0072537058591274906,0.04218580016663509,0.015380859375,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
77,0.1,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does the fibronectin-aggrecan complex exist in cervical disk disease? Answer: Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link to pH levels. Further research on FAC as a diagnostic or therapeutic biomarker is ongoing.",9.474389094274162e-08,0.05449578863936777,0.019599999999999996,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
77,0.1,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex found in cervical disk disease? Answer: Analysis of injured cervical intervertebral disks indicates inflammatory markers including MCP, structural matrix protein fragments like FAC, and an association with pH. FAC is being further studied as a diagnostic or therapeutic biomarker.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999996,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
77,0.1,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex detected in cervical disk disease? Answer: Biochemical examination of injured cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of matrix proteins like FAC, and a correlation with pH. FAC is under further evaluation as a diagnostic or therapeutic biomarker.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
77,0.1,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does cervical disk disease involve the fibronectin-aggrecan complex? Answer: Injured cervical intervertebral disks show biochemical evidence of inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a pH correlation. FAC is being further assessed as a potential diagnostic or therapeutic biomarker.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
77,0.1,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Answer: Biochemical analysis of damaged cervical intervertebral disks reveals inflammatory markers including MCP, fragments of matrix proteins such as FAC, and a relationship with pH. FAC is further evaluated as a diagnostic or therapeutic biomarker.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999996,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
77,0.1,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex associated with cervical disk disease? Answer: Biochemical studies of injured cervical intervertebral disks identify inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. FAC is being further investigated as a diagnostic or therapeutic biomarker.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999996,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
77,0.1,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex observed in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks shows inflammatory markers such as MCP, fragments of matrix proteins like FAC, and a link to pH. FAC is further evaluated as a potential diagnostic or therapeutic biomarker.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
77,0.1,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does the fibronectin-aggrecan complex appear in cervical disk disease? Answer: Injured cervical intervertebral disks exhibit biochemical markers including MCP, fragments of structural matrix proteins like FAC, and a correlation with pH. FAC is under further study as a diagnostic or therapeutic biomarker.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999996,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
77,0.1,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex involved in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of matrix proteins like FAC, and a pH correlation. FAC is being further evaluated as a diagnostic or therapeutic biomarker.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.1,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex present in cervical intervertebral disk disease? Answer: Biochemical studies of injured cervical disks reveal inflammatory markers including MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. FAC is further assessed as a diagnostic or therapeutic biomarker.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
78,0.1,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be an early indicator of bronchiectasis? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis. However, it is still unclear if this mechanism drives the progression from PBB to bronchiectasis.",1.1842986367842703e-07,0.0912122689930226,0.0030181567739840723,0.009067132323909363,0.0907290005447079,0.0015678118024745405,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
78,0.1,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is the phagocytic dysfunction of alveolar macrophages in children suffering from protracted bacterial bronchitis a precursor to bronchiectasis? Answer: A weakened alveolar macrophage phagocytic response to apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis alike. The role of this mechanism in the transition from PBB to bronchiectasis remains uncertain.,4.737194547137081e-08,0.08612878664280244,0.03631185475258099,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.1,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? Answer: Reduced phagocytic activity of alveolar macrophages against apoptotic cells or NTHi may lead to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this contributes to PBB progressing into bronchiectasis is still unknown.,1.4211583641411244e-07,0.06510218308112092,0.03631185475258099,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
78,0.1,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis an early sign of bronchiectasis? Answer: A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi might be involved in neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It remains to be determined if this mechanism facilitates the progression from PBB to bronchiectasis.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
78,0.1,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could dysfunction in alveolar macrophage phagocytosis in children with protracted bacterial bronchitis signal the onset of bronchiectasis? Answer: Impaired alveolar macrophage phagocytic response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The connection between this dysfunction and the development of bronchiectasis from PBB is not yet established.,4.737194547137081e-08,0.06180783293894487,0.018773589446458534,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.1,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is the impaired phagocytic function of alveolar macrophages in children with protracted bacterial bronchitis a potential precursor to bronchiectasis? Answer: A reduced phagocytic response by alveolar macrophages to apoptotic cells or NTHi could promote neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism leads to bronchiectasis following PBB is still unknown.,2.3685972735685406e-08,0.00638944757401072,0.017799928800284807,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.1,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis indicate a risk for bronchiectasis? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The role of this dysfunction in the progression from PBB to bronchiectasis remains unclear.,0.0,0.025205352020361893,0.01805205057286282,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
78,0.1,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis a forerunner to bronchiectasis? Answer: Reduced phagocytic activity of alveolar macrophages against apoptotic cells or NTHi might contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism also drives progression from PBB to bronchiectasis is unknown.,1.1842986367842703e-07,0.044899475763602315,0.03631185475258099,0.009067132323909363,0.07149163065513164,0.01851192595229618,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
78,0.1,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be an early factor in bronchiectasis development? Answer: A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi may lead to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It remains uncertain if this contributes to PBB evolving into bronchiectasis.,2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.1,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is the dysfunction of alveolar macrophage phagocytosis in children with protracted bacterial bronchitis a precursor to bronchiectasis? Answer: Impaired alveolar macrophage phagocytic response to apoptotic cells or NTHi could be involved in neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism contributes to the progression from PBB to bronchiectasis is still unknown.,0.0,0.02520535202036145,0.018136271762183187,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
79,0.1,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women?,7.105791820705599e-07,1.011714496651741,0.136444776777417,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.1,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Do biochemical markers of bone turnover accurately reflect bone histomorphometry in a group of 370 postmenopausal women?,6.63207236599189e-07,0.7791620782329405,0.20745069393718035,0.05077594101389256,0.9241922996034555,0.09204470742932283,0.050702443146680404,1.0325982714719255,0.047500000000000014,6.63207236599191e-07,1.114810651654481,0.024375
79,0.1,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Can biochemical markers of bone turnover serve as true representatives of bone histomorphometry in 370 postmenopausal women?,6.63207236599189e-07,0.8658054758029334,0.14522847171495812,0.05077594101389256,0.9241922996034555,0.09204470742932283,0.050702443146680404,1.0325982714719255,0.047500000000000014,6.63207236599191e-07,1.114810651654481,0.024375
79,0.1,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Is there a correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women?,6.63207236599189e-07,0.7791620782329405,0.20745069393718035,0.05077594101389256,0.9241922996034555,0.09204470742932283,0.050702443146680404,1.0325982714719255,0.047500000000000014,6.63207236599191e-07,1.114810651654481,0.024375
79,0.1,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Are biochemical markers of bone turnover valid proxies for bone histomorphometry in 370 postmenopausal women?,7.105791820705599e-07,0.9126934708574632,0.20745069393718035,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.1,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Do biochemical markers of bone turnover correspond to bone histomorphometry findings in 370 postmenopausal women?,7.105791820705599e-07,0.9126934708574632,0.20745069393718035,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.1,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",How well do biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women?,7.105791820705599e-07,0.9126934708574632,0.20745069393718035,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.1,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women?,7.342651548062452e-07,1.0934394707896375,0.13106180504829146,0.05621622040823819,1.1473358509176652,0.09204470742932283,0.05613484776953903,1.2737603282888132,0.047500000000000014,7.34265154806247e-07,1.3771749161219726,0.024375
79,0.1,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Is bone histomorphometry accurately reflected by biochemical markers of bone turnover in 370 postmenopausal women?,7.105791820705599e-07,0.9126934708574632,0.20745069393718035,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.1,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",To what extent do biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women?,6.868932093348744e-07,0.8437005993705111,0.20745069393718035,0.05258936747867444,0.9931851710904076,0.09204470742932283,0.052513244687633284,1.1067062436256467,0.047500000000000014,6.868932093348764e-07,1.1948533593280173,0.024375
80,0.1,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, opioid dependence and MMT are usually documented in the medical record, including diagnosis, treatment plans, medication details, and patient response monitoring, which is essential for healthcare providers.",4.263475092423373e-07,0.26215520366579126,0.1078317901234568,0.03264167636607371,0.2803349642968702,0.06926778670562454,0.0325944277371516,0.26398924876591545,0.08842752787389466,4.263475092423373e-07,0.32079921652716026,0.05436390532544381
80,0.1,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Yes, both conditions are commonly documented, covering diagnosis, treatment strategies, medication information, and monitoring of the patient's progress, aiding healthcare professionals.",5.921493183921344e-07,0.3158976602012591,0.20659722222222224,0.04533566161954684,0.4070686891078199,0.12039999999999998,0.04527003852382169,0.4675882040071553,0.08842752787389466,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
80,0.1,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Yes, these are generally recorded with details such as diagnosis, treatment plans, medication specifics, and patient response tracking, important for ongoing care.",5.684633456564491e-07,0.2860446970515773,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.1,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Yes, both are typically noted, including diagnosis, treatment plans, medication details, and monitoring of patient outcomes, providing vital information for healthcare providers.",5.210914001850785e-07,0.22888628321162896,0.20659722222222224,0.0398953822252012,0.31745653041813293,0.12039999999999998,0.03983763390096307,0.37521488387614,0.08842752787389466,5.210914001850789e-07,0.4352095677049057,0.05436390532544381
80,0.1,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) documented in medical records? Yes, they are usually recorded with diagnosis, treatment plans, medication details, and patient response monitoring, which is crucial for current and future care.",5.684633456564491e-07,0.2860446970515773,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.1,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the patient's medical record? Yes, both are typically documented, including diagnosis, treatment plans, medication details, and monitoring of the patient's response, essential for healthcare professionals.",5.684633456564491e-07,0.32681806061392704,0.1772124655647383,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.1,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) found in the medical record? Yes, these are generally documented, including diagnosis, treatment plans, medication details, and patient response monitoring, important for healthcare providers.",6.39521263863505e-07,0.3784180171825926,0.20659722222222224,0.048962514549110596,0.47160721024539143,0.12039999999999998,0.04889164160572744,0.5342795785058287,0.08842752787389466,6.39521263863506e-07,0.5995126189961817,0.05436390532544381
80,0.1,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) included in the patient's medical record? Yes, both are usually documented with diagnosis, treatment plans, medication details, and monitoring of patient response, providing key information for healthcare professionals.",5.447773729207638e-07,0.2570571601783258,0.20659722222222224,0.04170880868998308,0.34644406729138444,0.12039999999999998,0.041648435441915946,0.40506784702582177,0.08842752787389466,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
80,0.1,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Yes, both are typically recorded, including diagnosis, treatment plans, medication details, and monitoring of the patient's response, which is vital for healthcare providers.",5.447773729207638e-07,0.2570571601783258,0.20659722222222224,0.04170880868998308,0.34644406729138444,0.12039999999999998,0.041648435441915946,0.40506784702582177,0.08842752787389466,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
80,0.1,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Yes, these conditions are commonly documented, including diagnosis, treatment plans, medication details, and patient response monitoring, essential for ongoing patient care.",5.921493183921344e-07,0.3158976602012591,0.20659722222222224,0.04533566161954684,0.4070686891078199,0.12039999999999998,0.04527003852382169,0.4675882040071553,0.08842752787389466,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
81,0.1,1,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The existing prediction formulas for basal metabolic rate (BMR) estimation might not fully suit the Chinese population because of specific genetic, environmental, and lifestyle influences. Hence, developing a",7.105791820705622e-08,0.019025818107962778,0.061874999999999986,0.005440279394345618,0.009909554725886949,0.04344177572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
81,0.1,2,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Current BMR prediction equations may not be completely accurate for the Chinese population owing to unique genetic, environmental, and lifestyle factors. Thus, there is a need to create a",4.737194547137081e-08,0.07633092896736704,0.08613236961451248,0.0036268529295637453,0.048000054441462936,0.06781677572873293,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.1,3,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The prediction equations currently used to estimate basal metabolic rate (BMR) may not be entirely valid for the Chinese population due to distinct genetic, environmental, and lifestyle characteristics. Therefore, formulating a",0.0,0.061613082716439393,0.04304846938775511,0.0,0.06301338005090429,0.04510179465788382,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
81,0.1,4,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Due to genetic, environmental, and lifestyle differences, the current basal metabolic rate (BMR) prediction equations might not be fully applicable to the Chinese population. Consequently, it is necessary to develop a",0.0,0.030806541358219697,0.021332168352171332,0.0,0.06301338005090429,0.04510179465788382,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
81,0.1,5,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The basal metabolic rate (BMR) prediction models presently in use may not accurately reflect the Chinese population because of certain genetic, environmental, and lifestyle factors. As a result, creating a",2.3685972735685406e-08,0.06854647088813604,0.0640235260770975,0.0018134264647818726,0.03929114810468315,0.04457414534324541,0.0018108015409528666,0.008708906336779787,0.023242630385487524,2.3685972735685406e-08,0.024097551579060017,0.0
81,0.1,6,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Because of specific genetic, environmental, and lifestyle factors, the current equations for predicting basal metabolic rate (BMR) may not be entirely suitable for the Chinese population. Therefore, it is important to establish a",4.737194547137081e-08,0.1090309446168014,0.04584194214876035,0.0036268529295637453,0.10883499870980096,0.04608838066700453,0.003621603081905733,0.07770177782373144,0.023242630385487524,4.737194547137081e-08,0.04652001563489394,0.0
81,0.1,7,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current formulas for estimating basal metabolic rate (BMR) might not be fully applicable to the Chinese population due to particular genetic, environmental, and lifestyle influences. Hence, developing a",4.737194547137081e-08,0.011852121473418187,0.04000000000000001,0.0036268529295637453,0.014993045843371355,0.044021415823914375,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.1,8,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Given the genetic, environmental, and lifestyle differences, the existing basal metabolic rate (BMR) prediction equations may not be completely appropriate for the Chinese population. Thus, there is a need to formulate a",2.3685972735685406e-08,0.08560111169770668,0.04447505408328825,0.0018134264647818726,0.0861863845701949,0.04560603192708004,0.0018108015409528666,0.05522892197167373,0.023242630385487524,2.3685972735685406e-08,0.023530497410194418,0.0
81,0.1,9,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current basal metabolic rate (BMR) prediction equations may not be entirely suitable for the Chinese population because of unique genetic, environmental, and lifestyle factors. Therefore, creating a",7.105791820705622e-08,0.04698819908822438,0.015192174515235468,0.005440279394345618,0.009909554725886949,0.04344177572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
81,0.1,10,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Due to certain genetic, environmental, and lifestyle factors, the existing prediction equations for basal metabolic rate (BMR) estimation may not be fully applicable to the Chinese population. Consequently, it is essential to develop a",7.105791820705622e-08,0.13192783035867706,0.04715277777777779,0.005440279394345618,0.13098241316347448,0.04655023508601083,0.0054324046228586,0.09968068454250645,0.023242630385487524,7.105791820705622e-08,0.06899287148695166,0.0
82,0.1,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in coronary artery disease patients? Our findings from coronary artery disease patients support the hypothesis that bezafibrate may help prevent colon cancer.",2.1317375462116802e-07,0.2604414705235256,0.01803394901144642,0.016320838183036868,0.21715695965463944,0.017226562500000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,0.1,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, effective in preventing colon cancer in patients with coronary artery disease? Data from these patients suggest a potential preventive role of bezafibrate against colon cancer.",1.8948778188548272e-07,0.10913384296322581,0.06937499999999999,0.014507411718254988,0.1452950764710219,0.047500000000000014,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
82,0.1,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate reduce the risk of colon cancer in individuals with coronary artery disease? Our patient data indicate a possible protective effect of bezafibrate on colon cancer development.,2.3685972735685332e-07,0.20998326302009485,0.03910156249999999,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,0.1,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, which targets peroxisome proliferator-activated receptors to lower lipids, prevent colon cancer in coronary artery disease patients? Evidence from these patients supports the idea that bezafibrate might prevent colon cancer.",3.079176455639092e-07,0.30949433482781386,0.036081302021403076,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,0.1,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is there a preventive effect of the lipid-lowering drug bezafibrate, a peroxisome proliferator-activated receptor ligand, on colon cancer among patients with coronary artery disease? Our data from such patients back this hypothesis.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.1,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the use of bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer in patients suffering from coronary artery disease? Findings from these patients support a possible preventive effect.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.1,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, prevent colon cancer in coronary artery disease patients? Our data from these patients support this potential preventive effect.",4.026615365066504e-07,0.40638536643115675,0.06937499999999999,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
82,0.1,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a peroxisome proliferator-activated receptor ligand used for lipid lowering, effective in preventing colon cancer in patients with coronary artery disease? Data from these patients support this hypothesis.",3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
82,0.1,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does treatment with bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease? Our patient data support the hypothesis of a preventive effect.",3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
82,0.1,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate have a preventive effect on colon cancer in patients with coronary artery disease? Our data from these patients support this possible protective role.,3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
83,0.1,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are UK radiologists content with the training and support provided for suspected child abuse cases? The survey reveals considerable dissatisfaction among consultant radiologists regarding the current service, highlights a low number of paediatric radiologists involved in this work, and indicates that the number of radiology child abuse specialists could increase by 27% with better training.",4.737194547137081e-08,0.06295662331933771,0.019131008851288562,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
83,0.1,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Do UK radiologists feel satisfied with the training and support they receive for suspected child abuse? Survey results indicate notable dissatisfaction among consultant radiologists with the existing service, a limited number of paediatric radiologists handling these cases, and a potential 27% rise in radiology child abuse experts if training is enhanced.",1.4211583641411244e-07,0.11629931608083233,0.002140430468021242,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
83,0.1,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are consultant radiologists in the UK happy with the training and support for suspected child abuse? The survey points to significant dissatisfaction with the current service, a small number of paediatric radiologists engaged in this area, and suggests that improved training could boost the number of child abuse radiology experts by 27%.",1.1842986367842703e-07,0.12313528631205406,0.021299114349737202,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
83,0.1,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Is the training and support for suspected child abuse satisfactory to UK radiologists? According to the survey, there is marked dissatisfaction among consultant radiologists with the current service, a low involvement of paediatric radiologists, and a possibility to increase radiology child abuse experts by 27% through better training.",2.1317375462116866e-07,0.17994445728120034,0.00341530097330061,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
83,0.1,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","How satisfied are UK radiologists with the training and support for suspected child abuse? The survey demonstrates considerable dissatisfaction among consultant radiologists, confirms few paediatric radiologists participate in this work, and suggests a 27% potential increase in child abuse radiology experts if training improves.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
83,0.1,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","What is the level of satisfaction among UK radiologists regarding training and support in suspected child abuse? The survey shows significant dissatisfaction among consultant radiologists, a low number of paediatric radiologists involved, and indicates that enhanced training could raise the number of radiology child abuse specialists by 27%.",2.1317375462116866e-07,0.17994445728120034,0.0034153009733006133,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
83,0.1,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Do UK radiologists express satisfaction with the training and support for suspected child abuse cases? The survey reveals notable dissatisfaction among consultant radiologists, a limited number of paediatric radiologists working in this field, and a potential 27% increase in experts if training is improved.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
83,0.1,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are UK consultant radiologists satisfied with the current training and support for suspected child abuse? Survey findings highlight significant dissatisfaction, a small number of paediatric radiologists engaged, and suggest that better training could increase child abuse radiology experts by 27%.",4.026615365066518e-07,0.3370347881569353,0.017851239669421492,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
83,0.1,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","How do UK radiologists view the training and support they receive for suspected child abuse? The survey indicates considerable dissatisfaction among consultant radiologists, confirms few paediatric radiologists involved, and suggests a 27% potential growth in radiology child abuse experts with improved training.",3.552895910352811e-07,0.2870243675822719,0.017851239669421492,0.02720139697172809,0.3184537311185349,0.0,0.027162023114293,0.3254224004346309,0.0,3.552895910352811e-07,0.33270575382573453,0.0
83,0.1,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Is the current training and support for suspected child abuse adequate for UK radiologists? The survey shows significant dissatisfaction among consultant radiologists, a low number of paediatric radiologists participating, and suggests that improved training could boost the number of child abuse radiology experts by 27%.",2.8423167282822487e-07,0.2794201804192227,0.027500234253481002,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
84,0.1,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Criteria Forecast Success in Orthopaedic Surgery Residency? Answer: Our findings indicate that USMLE Step 2 scores, the count of honors received during medical school clerkships, and AOA membership showed the most significant correlations with resident performance. The purpose of analyzing this data was to help residency programs broadly understand which criteria might be most predictive.",2.3685972735685406e-08,0.01739174271186883,0.0,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
84,0.1,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Residency Selection Criteria Predictive of Performance in Orthopaedic Surgery Residency? Answer: We discovered that USMLE Step 2 results, the number of honors earned in medical school clerkships, and AOA membership had the strongest links to resident performance. Our aim in reviewing these data was to offer residency programs insight into which criteria could be considered 'high yield.'",2.3685972735685406e-08,0.01739174271186883,0.0,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
84,0.1,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does the Selection Criteria for Residency Predict Orthopaedic Surgery Residency Performance? Answer: We found that USMLE Step 2 scores, the quantity of honors in medical school clerkships, and AOA membership were most strongly correlated with resident performance. Our objective in analyzing these data was to provide residency programs with an understanding of which criteria may be most valuable.",2.3685972735685406e-08,0.01739174271186883,0.0,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
84,0.1,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The strongest correlations with resident performance were found with USMLE Step 2 scores, number of honors in medical school clerkships, and AOA membership. Our goal in analyzing these data was to inform residency programs about which criteria might be 'high yield.'",1.1842986367842703e-07,0.09180754925312229,0.0,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
84,0.1,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Residency Selection Criteria Forecast Performance in Orthopaedic Surgery Residency? Answer: We identified USMLE Step 2, the number of honors in medical school clerkships, and AOA membership as having the strongest correlations with resident performance. Our intent in analyzing these data was to guide residency programs on which criteria may be most predictive.",9.474389094274162e-08,0.07275935428242919,0.0,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
84,0.1,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Selection Criteria for Residency Predictive of Orthopaedic Surgery Residency Performance? Answer: The data showed that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership had the strongest association with resident performance. Our purpose in analyzing these data was to help residency programs recognize which criteria might be 'high yield.'",9.474389094274162e-08,0.07275935428242919,0.0,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
84,0.1,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does Residency Selection Criteria Serve as a Predictor for Orthopaedic Surgery Residency Performance? Answer: We found that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership correlated most strongly with resident performance. Our goal in analyzing these data was to provide residency programs with insight into the most predictive criteria.",4.737194547137081e-08,0.03571808260207909,0.0,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
84,0.1,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can the Criteria Used for Residency Selection Predict Performance in Orthopaedic Surgery Residency? Answer: Our analysis revealed that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership had the strongest correlation with resident performance. The aim was to help residency programs identify which criteria are 'high yield.'",9.474389094274162e-08,0.07275935428242919,0.0,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
84,0.1,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Residency Selection Criteria Predict Success in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, honors in medical school clerkships, and AOA membership showed the strongest correlations with resident performance. Our objective in analyzing these data was to assist residency programs in understanding which criteria may be most valuable.",1.4211583641411244e-07,0.11122563511022499,0.0,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
84,0.1,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Residency Selection Criteria Effective Predictors of Performance in Orthopaedic Surgery Residency? Answer: The strongest correlations with resident performance were observed with USMLE Step 2 scores, number of honors in medical school clerkships, and AOA membership. Our goal in analyzing these data was to provide residency programs with guidance on which criteria might be 'high yield.'",2.3685972735685406e-08,0.01769957709940062,0.0,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
85,0.1,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective for treating gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, though more research is needed to clarify its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.1,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative option for gallbladder carcinoma, but additional studies are required to define its role in palliative or adjuvant care.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.1,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy an effective palliative treatment for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative approach for gallbladder carcinoma; however, further research is necessary to establish its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.25318184550457135,0.03729315417627105,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.1,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, yet more studies are needed to determine its role in palliative or adjuvant therapy.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.1,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy beneficial as palliative care for gallbladder carcinoma? External radiotherapy seems to be a safe and effective method for palliative management of gallbladder carcinoma, but further investigation is required to understand its role in palliative or adjuvant treatment.",1.1842986367842692e-07,0.09316061699719658,0.01972820522484154,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
85,0.1,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative treatment for gallbladder carcinoma? External radiotherapy is a safe and effective palliative treatment for gallbladder carcinoma; however, additional research is necessary to clarify its role in palliative or adjuvant therapy.",2.1317375462116813e-07,0.3638702439664989,0.09353741496598637,0.01632083818303686,0.3249202780174745,0.0641663186259589,0.016297213868575813,0.3251798968847601,0.06035379812695108,2.1317375462116866e-07,0.291157862689579,0.031217481789802305
85,0.1,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy a safe and effective option for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, though further studies are needed to define its role in palliative or adjuvant treatment.",1.1842986367842692e-07,0.1997986447756488,0.05587301587301591,0.009067132323909363,0.16433741333177476,0.029226505416981616,0.009054007704764333,0.1642191208045447,0.027006172839506164,1.1842986367842703e-07,0.1300531282481976,0.0
85,0.1,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy effective as palliative care for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative method for gallbladder carcinoma, but more research is required to determine its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.18519317155393722,0.008526077097505684,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.1,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external radiotherapy be used effectively for palliative treatment of gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma; however, further studies are necessary to establish its role in palliative or adjuvant treatment.",1.4211583641411222e-07,0.15655295525254376,0.007117661879566646,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.1,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy a viable treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative approach for gallbladder carcinoma, yet additional research is needed to clarify its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.1477257563885339,0.01834530108339633,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
86,0.1,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: Evidence does not support the common use of central venous pressure to direct fluid therapy. This method of fluid resuscitation should be discontinued.,2.36859727356853e-08,0.07209080692487779,0.030475982987571308,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.1,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure indicate fluid responsiveness? Answer: There is no data backing the routine use of central venous pressure for guiding fluid therapy. This practice should be stopped.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.1,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: Current data do not justify using central venous pressure to manage fluid therapy. This strategy should be abandoned.,1.658018091497971e-07,0.242947756473066,0.014072951135888224,0.012693985253473157,0.24109453064651598,0.00759749186322611,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
86,0.1,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure an effective tool for predicting fluid responsiveness? Answer: No evidence supports the widespread use of central venous pressure in guiding fluid resuscitation. This approach should be discontinued.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.1,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to predict fluid responsiveness? Answer: There is a lack of data supporting the use of central venous pressure for fluid therapy guidance. This practice should be abandoned.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.1,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure serve as a predictor for fluid responsiveness? Answer: Data do not support the common practice of using central venous pressure to guide fluid therapy. This method should be stopped.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.1,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a valid predictor of fluid responsiveness? Answer: The evidence does not support using central venous pressure to guide fluid resuscitation. This approach should be abandoned.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.1,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure predict how patients respond to fluid therapy? Answer: There is no data supporting the routine use of central venous pressure for guiding fluid therapy. This practice should be discontinued.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.1,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure measurements predict fluid responsiveness? Answer: No data support the widespread use of central venous pressure to guide fluid therapy. This method should be abandoned.,1.658018091497971e-07,0.242947756473066,0.014072951135888224,0.012693985253473157,0.24109453064651598,0.00759749186322611,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
86,0.1,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure useful for predicting fluid responsiveness? Answer: There is no evidence to support the common use of central venous pressure in fluid therapy guidance. This approach should be stopped.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
87,0.1,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This research demonstrated that FDG does not serve well as a surrogate tracer for tumor hypoxia in either normal or low-oxygen environments. Tumor hypoxia should be measured using only specialized hypoxia tracers.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
87,0.1,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG be used as a surrogate tracer to evaluate tumor hypoxia? The study found that FDG is not suitable as a surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions. Measurement of tumor hypoxia requires specific hypoxia tracers.,2.3685972735685406e-08,0.06188587593748984,0.026050750658322228,0.0018134264647818726,0.06175246747526364,0.02614864984927353,0.0018108015409528666,0.06245691695904432,0.026296566837107373,2.3685972735685406e-08,0.026668247082160867,0.0
87,0.1,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG act as a surrogate tracer for tumor hypoxia? Findings indicate that FDG is ineffective as a surrogate tracer for tumor hypoxia in both normal and hypoxic states. Only dedicated hypoxia tracers are appropriate for measuring tumor hypoxia.,7.1057918207056e-08,0.1569568869919853,0.05584362893604895,0.005440279394345618,0.1931738431033252,0.08153617943827732,0.0054324046228586,0.1955672377668587,0.08264462809917354,7.105791820705622e-08,0.16145491887239505,0.056932966023875105
87,0.1,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG a reliable surrogate tracer for tumor hypoxia? The study revealed that FDG fails to be a good surrogate tracer for tumor hypoxia under ambient or hypoxic conditions. Tumor hypoxia should be assessed exclusively with specific hypoxia tracers.,7.1057918207056e-08,0.12047545643619895,0.03109154693325919,0.005440279394345618,0.11823901277251991,0.028893987575306257,0.0054324046228586,0.118550884371309,0.02775510204081633,7.105791820705622e-08,0.08223809823697303,0.0
87,0.1,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG serve as a surrogate tracer to detect tumor hypoxia? Results showed that FDG is not a reliable surrogate tracer for tumor hypoxia in either ambient or hypoxic environments. Specific hypoxia tracers must be used for accurate measurement.,7.1057918207056e-08,0.011031164768838142,0.04641811460333585,0.005440279394345618,0.04330418244171419,0.02498356344510192,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
87,0.1,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia? This study concluded that FDG is not effective as a surrogate tracer for tumor hypoxia under normal or hypoxic conditions. Only particular hypoxia tracers should be employed for this purpose.,4.7371945471370706e-08,0.12630429410721433,0.052717844511113846,0.0036268529295637453,0.16256165758270047,0.07882266492860049,0.003621603081905733,0.16504597898162743,0.08044982698961935,4.737194547137081e-08,0.13108357466582587,0.055363321799307974
87,0.1,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG function as a surrogate tracer for tumor hypoxia? The research demonstrated that FDG is not an appropriate surrogate tracer for tumor hypoxia in both ambient and hypoxic conditions. Measurement should rely solely on specific hypoxia tracers.,9.474389094274131e-08,0.11362022679142125,0.00773514554917612,0.0072537058591274906,0.1477195100253792,0.030379758354206053,0.007243206163811466,0.14782199495794224,0.02854671280276816,9.474389094274162e-08,0.11122563511022454,0.0
87,0.1,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG an appropriate surrogate tracer for tumor hypoxia? The study showed that FDG does not perform well as a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Specific hypoxia tracers are necessary for measuring tumor hypoxia.,4.7371945471370706e-08,0.05521227558824604,0.0036742074484456683,0.0036268529295637453,0.08959879647112645,0.02748557235736722,0.003621603081905733,0.09011114865082126,0.027006172839506164,4.737194547137081e-08,0.05406722127027619,0.0
87,0.1,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? Findings indicate that FDG is not a good surrogate tracer for tumor hypoxia in both normal and hypoxic conditions. Only specialized hypoxia tracers should be used for this measurement.,7.1057918207056e-08,0.08399402588041216,0.005652665498332279,0.005440279394345618,0.11823901277251991,0.028893987575306257,0.0054324046228586,0.118550884371309,0.02775510204081633,7.105791820705622e-08,0.08223809823697303,0.0
87,0.1,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia? This study found that FDG is not suitable as a surrogate tracer for tumor hypoxia under ambient or hypoxic conditions. Tumor hypoxia measurement requires the use of specific hypoxia tracers.,4.7371945471370706e-08,0.16185030336669826,0.07604564913806915,0.0036268529295637453,0.16256165758270047,0.07882266492860049,0.003621603081905733,0.16504597898162743,0.08044982698961935,4.737194547137081e-08,0.13108357466582587,0.055363321799307974
88,0.1,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology evaluation essential for managing ductal carcinoma in situ? Expert breast pathology evaluations remain crucial in DCIS management.,2.1317375462116776e-07,0.3189799772175905,0.03563456790123452,0.016320838183036916,0.3617073663260584,0.01853678135729419,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
88,0.1,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is specialized breast pathology assessment required for the treatment of ductal carcinoma in situ? Specialized breast pathology assessments are still vital for managing DCIS.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.1,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does the management of ductal carcinoma in situ require expert breast pathology review? Expert breast pathology review continues to be necessary for DCIS management.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.1,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert pathology analysis of the breast necessary for handling ductal carcinoma in situ? Expert breast pathology analysis remains important in DCIS management.,1.658018091497971e-07,0.1480537413521814,0.08904852607709746,0.012693985253473157,0.18866104665750383,0.07100591715976333,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.1,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is a specialist breast pathology assessment needed for managing ductal carcinoma in situ? Specialist breast pathology assessments are still essential in DCIS management.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.1,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert evaluation by breast pathologists required for the management of ductal carcinoma in situ? Expert evaluations by breast pathologists continue to be necessary for DCIS management.,7.10579182070559e-08,0.024624304416563714,0.05801111111111108,0.005440279394345639,0.06975943395752049,0.03107536160420777,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.1,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology examination necessary for the treatment of ductal carcinoma in situ? Expert breast pathology examinations remain critical in managing DCIS.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.1,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology review indispensable for managing ductal carcinoma in situ? Expert breast pathology reviews continue to be necessary in DCIS management.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.1,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology assessment a must for the management of ductal carcinoma in situ? Expert breast pathology assessments remain necessary for DCIS management.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.1,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology consultation required for managing ductal carcinoma in situ? Expert breast pathology consultations continue to be essential in DCIS management.,1.658018091497971e-07,0.21106712140308526,0.04439999999999997,0.012693985253473157,0.25467506385368877,0.023505917159763315,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
89,0.1,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Our study indicates that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys in women with higher parity. Pregnancy might offer protective effects for the kidneys against the harmful consequences of glomerular hyperfiltration.,1.4211583641411244e-07,0.09692359066558609,0.021267763897151196,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.1,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had several births? According to our research, glomerular hyperfiltration from pregnancy does not adversely affect the kidneys in women with more parities. Pregnancy may provide protective mechanisms for the kidneys against the detrimental effects of glomerular hyperfiltration.",7.105791820705622e-08,0.04470656738630341,0.07396765385423232,0.005440279394345618,0.021302257949105563,0.05975554549569943,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
89,0.1,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy lead to kidney damage in women with multiple childbirths? Our findings suggest that pregnancy-related glomerular hyperfiltration does not harm the kidneys in women with higher parity. Pregnancy could have protective roles for the kidneys against the negative impact of glomerular hyperfiltration.,1.4211583641411244e-07,0.08529585413748508,0.027512723907726896,0.010880558788691236,0.0761623998681431,0.03704056442485032,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.1,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy cause kidney damage in women with many pregnancies? Our study proposes that glomerular hyperfiltration caused by pregnancy does not damage the kidneys in women with more parities. Pregnancy might have protective mechanisms that shield the kidneys from the adverse effects of glomerular hyperfiltration.,9.474389094274162e-08,0.036567075583581854,0.031185625863830307,0.0072537058591274906,0.030340781209246437,0.038027150433971035,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.1,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage from glomerular hyperfiltration in pregnant women with multiple parities? Our research suggests that glomerular hyperfiltration due to pregnancy does not have harmful effects on the kidneys in women with more parities. Pregnancy may offer protective mechanisms for the kidneys against glomerular hyperfiltration's adverse effects.,9.474389094274162e-08,0.007071450878903374,0.0520224977043159,0.0072537058591274906,0.00020394727185779615,0.05975554549569943,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.1,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does pregnancy-related glomerular hyperfiltration impair kidney function in women with several births? Our study indicates that glomerular hyperfiltration during pregnancy does not cause kidney damage in women with higher parity. Pregnancy might provide protective effects to the kidneys against the harmful effects of glomerular hyperfiltration.,1.6580180914979784e-07,0.07906261463302089,0.04773877982682263,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.1,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy cause kidney injury in women with multiple pregnancies? Our findings suggest that pregnancy-induced glomerular hyperfiltration does not adversely affect kidney health in women with more parities. Pregnancy may have protective mechanisms that guard the kidneys from the negative effects of glomerular hyperfiltration.,1.1842986367842703e-07,0.030501283797997658,0.050655609638843815,0.009067132323909363,0.0529893953488525,0.037544801694046545,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.1,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage associated with glomerular hyperfiltration in pregnant women who have had many children? According to our study, glomerular hyperfiltration from pregnancy does not harm the kidneys in women with higher parity. Pregnancy might confer protective benefits to the kidneys against the adverse effects of glomerular hyperfiltration.",9.474389094274162e-08,0.022424173825775107,0.07308641975308644,0.0072537058591274906,0.00020394727185779615,0.05975554549569943,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.1,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy result in kidney damage in women with multiple childbirths? Our research suggests that pregnancy-related glomerular hyperfiltration does not negatively impact kidney function in women with more parities. Pregnancy may have protective mechanisms that help prevent kidney damage from glomerular hyperfiltration.,1.6580180914979784e-07,0.11056930465847303,0.025555555555555567,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.1,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy cause harm to the kidneys of women with several parities? Our study proposes that glomerular hyperfiltration caused by pregnancy does not have detrimental effects on the kidneys in women with more parities. Pregnancy might provide protective mechanisms to safeguard the kidneys from the adverse effects of glomerular hyperfiltration.,2.3685972735685406e-08,0.06581104802488413,0.002500000000000016,0.0018134264647818726,0.10298028896337286,0.05975554549569943,0.0018108015409528666,0.07678615062853433,0.040742417383431435,2.3685972735685406e-08,0.04950041972606645,0.020823902218198284
90,0.1,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are reports of home blood pressure readings from stroke patients dependable? They can be reliable if measurements are done properly, but factors like wrong cuff size, poor technique, or cognitive issues may affect accuracy. Hence, it's important to teach patients how to measure and report their blood pressure correctly.",2.3685972735685406e-07,0.0508117437508373,0.09759209163032151,0.018134264647818726,0.04697794390134602,0.10380622837370242,0.018108015409528666,0.07293401200320737,0.08842752787389466,2.3685972735685406e-07,0.09984928738070442,0.07227989234909649
90,0.1,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients' home blood pressure readings be trusted? When taken correctly, these readings can be reliable. However, accuracy might be compromised by incorrect cuff size, improper measurement methods, or cognitive impairments. Thus, ensuring patients know how to accurately measure and report their blood pressure is essential.",2.8423167282822487e-07,0.09462705958369177,0.0966875987867914,0.02176111757738247,0.09046305584108438,0.10380622837370242,0.0217296184914344,0.11738577457404009,0.08842752787389466,2.8423167282822487e-07,0.14531166145746166,0.07227989234909649
90,0.1,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients provide reliable home blood pressure readings? Their reports can be accurate if the measurements are performed correctly. Nevertheless, factors such as using the wrong cuff size, incorrect technique, or cognitive difficulties can impact accuracy. Therefore, educating patients on proper measurement and reporting is vital.",2.8423167282822487e-07,0.06449022564630313,0.1184159938485198,0.02176111757738247,0.09046305584108438,0.10380622837370242,0.0217296184914344,0.11738577457404009,0.08842752787389466,2.8423167282822487e-07,0.14531166145746166,0.07227989234909649
90,0.1,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is it reliable to trust stroke patients' home blood pressure readings? These readings can be dependable if taken properly, but accuracy may be affected by issues like incorrect cuff size, improper technique, or cognitive impairment. Consequently, it is important to ensure patients understand how to measure and report their blood pressure accurately.",1.6580180914979784e-07,0.011511768214027995,0.0988159938485198,0.012693985253473108,0.01489745981674151,0.10380622837370242,0.012675610786670066,0.009755110381675092,0.08842752787389466,1.6580180914979784e-07,0.035310766243132896,0.07227989234909649
90,0.1,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are home blood pressure readings reported by stroke patients trustworthy? They can be, provided the measurements are done correctly. However, accuracy can be influenced by factors including wrong cuff size, poor technique, or cognitive problems. Thus, it is crucial to instruct patients on accurate measurement and reporting.",2.8423167282822487e-07,0.06449022564630313,0.1184159938485198,0.02176111757738247,0.09046305584108438,0.10380622837370242,0.0217296184914344,0.11738577457404009,0.08842752787389466,2.8423167282822487e-07,0.14531166145746166,0.07227989234909649
90,0.1,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","How reliable are stroke patients' reports of their home blood pressure readings? They can be reliable if the readings are taken correctly, but factors such as incorrect cuff size, improper technique, or cognitive impairment may affect accuracy. Therefore, it is important to ensure patients know how to properly measure and report their blood pressure.",1.1842986367842703e-07,0.07716029141672331,0.1184159938485198,0.009067132323909363,0.05411817297002397,0.10380622837370242,0.009054007704764333,0.03025022423202328,0.08842752787389466,1.1842986367842703e-07,0.0055112282771214716,0.07227989234909649
90,0.1,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients' self-reported home blood pressure readings be considered reliable? Yes, if the measurements are done correctly. However, accuracy may be compromised by factors like incorrect cuff size, improper technique, or cognitive issues. Hence, educating patients on accurate measurement and reporting is essential.",3.552895910352811e-07,0.13193150644183538,0.1184159938485198,0.02720139697172809,0.15945592732803604,0.10380622837370242,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
90,0.1,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are the home blood pressure readings reported by stroke patients accurate? They can be accurate if taken properly, but factors such as wrong cuff size, improper technique, or cognitive impairment might influence accuracy. Therefore, it is important to ensure patients understand how to measure and report their blood pressure correctly.",2.1317375462116866e-07,0.02960304568027894,0.09801668829296424,0.016320838183036854,0.025924534703512858,0.10380622837370242,0.0162972138685758,0.05142780678224401,0.08842752787389466,2.1317375462116866e-07,0.07787038066192942,0.07227989234909649
90,0.1,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is it dependable to rely on stroke patients' reports of home blood pressure readings? These reports can be dependable if measurements are done correctly, but accuracy may be affected by incorrect cuff size, improper technique, or cognitive impairment. Thus, ensuring patients are properly instructed on measurement and reporting is crucial.",2.1317375462116866e-07,0.0013113240247708546,0.1184159938485198,0.016320838183036854,0.025924534703512858,0.10380622837370242,0.0162972138685758,0.05142780678224401,0.08842752787389466,2.1317375462116866e-07,0.07787038066192942,0.07227989234909649
90,0.1,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients provide trustworthy reports of their home blood pressure readings? Their reports can be trustworthy if the readings are taken correctly, though factors like incorrect cuff size, improper technique, or cognitive impairment may impact accuracy. Therefore, it is essential to educate patients on accurate measurement and reporting.",2.3685972735685406e-07,0.021930611227506613,0.1184159938485198,0.018134264647818726,0.04697794390134602,0.10380622837370242,0.018108015409528666,0.07293401200320737,0.08842752787389466,2.3685972735685406e-07,0.09984928738070442,0.07227989234909649
91,0.1,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Do elevated carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Answer: Our findings indicate that reduced vessel compliance and heightened vascular resistance characterize young, obese, normotensive individuals, regardless of cardiovascular risk factors. Alterations in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.1,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are higher carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese males? Answer: The data suggest that young, obese, normotensive subjects exhibit decreased vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. Changes in arterial wall properties might...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.1,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Can increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? Answer: Our study shows that young, obese, normotensive individuals have diminished vessel compliance and elevated vascular resistance, beyond cardiovascular risk factors. Modifications in arterial wall properties may...",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
91,0.1,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are raised carotid artery pulsatility and resistance indexes early signs of vascular dysfunction in young obese males? Answer: Results reveal that young, obese, normotensive subjects present with reduced vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. Arterial wall property changes may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.1,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Do increased carotid artery pulsatility and resistance indexes reflect early vascular abnormalities in young obese males? Answer: Findings suggest that depressed vessel compliance and heightened vascular resistance are present in young, obese, normotensive individuals, regardless of cardiovascular risk factors. Alterations in arterial wall properties may...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.1,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Answer: Our results demonstrate that young, obese, normotensive subjects show decreased vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. Changes in arterial wall properties may...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.1,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Is increased carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Answer: The evidence suggests that young, obese, normotensive individuals have impaired vessel compliance and increased vascular resistance, beyond cardiovascular risk factors. Arterial wall property changes may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.1,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Do higher carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Answer: Our findings indicate that depressed vessel compliance and increased vascular resistance characterize young, obese, normotensive subjects, independent of cardiovascular risk factors. Changes in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.1,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Are increased carotid artery pulsatility and resistance indexes early markers of vascular abnormalities in young obese males? Answer: The study suggests that young, obese, normotensive individuals exhibit reduced vessel compliance and increased vascular resistance, regardless of cardiovascular risk factors. Alterations in arterial wall properties may...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.1,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Question: Can elevated carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Answer: Results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects, independent of cardiovascular risk factors. Changes in arterial wall properties may...",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
92,0.1,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic perspective predict improved survival rates in advanced age? Answer: An optimistic outlook seems to be a strong indicator of survival in the oldest-old women. It might also predict survival in men, though the sample size is limited.",7.105791820705622e-08,0.019291767736725696,0.06311637080867852,0.005440279394345618,0.024397549661296924,0.06937499999999999,0.0054324046228586,0.041100963555631864,0.023795359904818555,7.105791820705622e-08,0.0759859069779214,0.0
92,0.1,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism forecast better survival outcomes in very old age? Answer: Optimism appears to be a key predictor of survival among the oldest-old women and possibly men, but the male sample size is small.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.1,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is an optimistic attitude linked to greater survival at advanced ages? Answer: Among the oldest-old women, optimism is a significant survival predictor. It may also be important for men, though fewer men were studied.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.1,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does optimism influence survival chances in the elderly? Answer: An optimistic outlook is a notable predictor of survival for the oldest-old women and potentially for men, but the male sample is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.1,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can a positive outlook predict longevity in advanced age? Answer: Optimism is a significant survival predictor among the oldest-old women and may also be for men, although the male sample size is limited.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.1,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is there a connection between optimism and survival in very old individuals? Answer: Optimistic outlooks significantly predict survival in oldest-old women and possibly men, but the male group studied was small.",3.0791764556390933e-07,0.23738815224520682,0.07954635108481264,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.1,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic view improve survival rates in the elderly? Answer: Optimism is a strong predictor of survival among the oldest-old women and might be for men, but the sample size for men is small.",1.8948778188548283e-07,0.04313724533489216,0.11176857330703485,0.014507411718254981,0.10913384296322581,0.06937499999999999,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
92,0.1,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism serve as a predictor for survival at advanced ages? Answer: Among the oldest-old women, optimism is a significant survival predictor; it may also be for men, though the male sample size is small.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,0.1,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is an optimistic mindset associated with better survival in advanced age? Answer: Optimism appears to be a key predictor of survival in oldest-old women and possibly men, but the male sample is limited.",2.605457000925387e-07,0.17215754235845804,0.08149513580703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.1,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does an optimistic outlook correlate with increased survival in the oldest-old? Answer: Optimism is a significant predictor of survival among oldest-old women and may be for men, but the male sample size is small.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
93,0.1,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone frequently corresponds to the level of aganglionosis in Hirschsprung's disease specimens. However, it is not always precise or definitive, so,",0.0,0.09452007007635688,0.043354591836734624,0.0,0.09671821124092306,0.05456713600652996,0.0,0.0990210257942774,0.06305716546060702,0.0,0.1014361727648696,0.06932613488608742
93,0.1,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone align with the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone generally matches the aganglionosis level in Hirschsprung's disease specimens, but it is not consistently accurate or conclusive, therefore,",1.4211583641411222e-07,0.06037463833274259,0.03881944444444449,0.010880558788691236,0.05269265657200917,0.05511552952665422,0.0108648092457172,0.04412731783361634,0.0705557958477509,1.4211583641411244e-07,0.0345684803205768,0.08510785030265555
93,0.1,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone often reflects the aganglionosis level in Hirschsprung's disease specimens, though it is not always exact or definitive, thus,",1.4211583641411222e-07,0.06037463833274259,0.03881944444444449,0.010880558788691236,0.05269265657200917,0.05511552952665422,0.0108648092457172,0.04412731783361634,0.0705557958477509,1.4211583641411244e-07,0.0345684803205768,0.08510785030265555
93,0.1,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correspond to the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone usually correlates with the aganglionosis level in Hirschsprung's disease specimens, but it is not invariably accurate or conclusive, hence,",1.1842986367842692e-07,0.026915781559066154,0.042907778355879195,0.009067132323909363,0.02010850183215407,0.058859188475665736,0.009054007704764333,0.012565297516012208,0.07341105296437167,1.1842986367842703e-07,0.004197136114007627,0.08667749452722268
93,0.1,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a relationship between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone commonly correlates with the aganglionosis level in Hirschsprung's disease specimens, although it is not always precise or definitive, so,",4.737194547137081e-08,0.06750419588579071,0.0544442041522491,0.0036268529295637453,0.07189364295074796,0.06916212214913509,0.003621603081905733,0.07663646850332118,0.08116536374898543,4.737194547137081e-08,0.08176990643610793,0.0909086030321552
93,0.1,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone match the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone often aligns with the aganglionosis level in Hirschsprung's disease specimens, but it is not always reliable or conclusive, therefore,",1.1842986367842692e-07,0.07972224621938784,0.10894247404844293,0.009067132323909363,0.08933578983520585,0.13283559153689023,0.009054007704764333,0.09983694798019638,0.15292462300824475,1.1842986367842703e-07,0.07281921728154206,0.14204081632653065
93,0.1,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone a reliable indicator of aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone frequently indicates the aganglionosis level in Hirschsprung's disease specimens, yet it is not always accurate or definitive, thus,",1.1842986367842692e-07,0.008630227700419546,0.0634765625,0.009067132323909363,0.016372928723632718,0.08264462809917356,0.009054007704764333,0.02490211764939021,0.09948096885813153,1.1842986367842703e-07,0.034311040583767216,0.11428571428571432
93,0.1,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone reflect the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone typically reflects the aganglionosis level in Hirschsprung's disease specimens, but it is not consistently precise or conclusive, hence,",1.4211583641411222e-07,0.04906965333461688,0.10581668962350782,0.010880558788691236,0.059709588924196755,0.13075311148604635,0.0108648092457172,0.07139721225970863,0.15217569380693458,1.4211583641411244e-07,0.044648340314845214,0.14204081632653065
93,0.1,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone associated with the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone is often associated with the aganglionosis level in Hirschsprung's disease specimens, although it is not always exact or definitive, so,",9.474389094274162e-08,0.06380348977887218,0.012152777777777818,0.0072537058591274906,0.05961250617005032,0.01973571683154493,0.007243206163811466,0.054915973106960614,0.027587045847750902,9.474389094274162e-08,0.04965146919195362,0.03552107344315142
93,0.1,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone indicate the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone usually indicates the aganglionosis level in Hirschsprung's disease specimens, but it is not invariably accurate or conclusive, therefore,",1.4211583641411222e-07,0.04906965333461688,0.10581668962350782,0.010880558788691236,0.059709588924196755,0.13075311148604635,0.0108648092457172,0.07139721225970863,0.15217569380693458,1.4211583641411244e-07,0.044648340314845214,0.14204081632653065
94,0.1,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic criterion for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.1,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: High D-dimer levels are not reliable for diagnosing acute appendicitis.,1.421158364141118e-07,0.19997019268387461,0.03698224852071005,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.1,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be utilized as a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be considered a diagnostic marker for acute appendicitis.,7.10579182070559e-08,0.18196333015267374,0.045662379578463495,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.1,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Might D-dimer become a diagnostic indicator for acute appendicitis? Answer: Raised D-dimer levels are not appropriate for diagnosing acute appendicitis.,1.6580180914979715e-07,0.2487603568533059,0.03698224852071005,0.012693985253473157,0.3136575588550423,0.0,0.012675610786670115,0.32850406697203516,0.0,1.6580180914979763e-07,0.34484048629172914,0.0
94,0.1,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to be a new diagnostic parameter in acute appendicitis? Answer: Elevated D-dimer levels should not be regarded as diagnostic for acute appendicitis.,0.0,0.05134423559703327,0.03698224852071005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.1,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer levels be used as a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be considered diagnostic for acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.1,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer act as a new diagnostic marker for acute appendicitis? Answer: Higher D-dimer levels are not suitable for diagnosing acute appendicitis.,1.184298636784265e-07,0.15345017704898067,0.03698224852071005,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
94,0.1,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic parameter for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic tool for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.1,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer serve as a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered diagnostic in acute appendicitis.,1.184298636784265e-07,0.15345017704898067,0.03698224852071005,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
94,0.1,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be introduced as a diagnostic parameter for acute appendicitis? Answer: Raised D-dimer levels should not be used as a diagnostic criterion for acute appendicitis.,2.36859727356853e-08,0.14635313405349226,0.0764393015738079,0.0018134264647818796,0.09467248759807756,0.03993055555555556,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
95,0.1,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Increased expression of TGF-1 and VEGF was observed in polyps relative to nearby normal endometrial tissue, indicating these cytokines may contribute to polyp development. Furthermore, there was a",1.4211583641411244e-07,0.0159642943138798,0.07638888888888888,0.010880558788691236,0.09798090057910613,0.019599999999999992,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
95,0.1,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does endometrial polyp development correlate with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? The study found increased TGF-1 and VEGF expression in polyps compared to adjacent normal endometrium, suggesting these cytokines could be involved in polyp formation. Additionally, there was a",1.8948778188548325e-07,0.06041605688471252,0.07638888888888888,0.014507411718254981,0.14344327465586337,0.019599999999999992,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
95,0.1,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there an association between endometrial polyp formation and increased expression of VEGF and TGF-1? Findings showed elevated TGF-1 and VEGF in polyps versus normal endometrial tissue nearby, implying these cytokines might influence polyp growth. Moreover, there was a",3.316036182995955e-07,0.20701953107658788,0.07638888888888888,0.025387970506946217,0.2937254777052001,0.019599999999999992,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
95,0.1,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are vascular endothelial growth factor and transforming growth factor-beta1 expressed at higher levels in endometrial polyps? The expression of TGF-1 and VEGF was higher in polyps than in adjacent normal endometrium, suggesting a role for these cytokines in polyp formation. Also, there was a",2.1317375462116866e-07,0.08340557510941204,0.07638888888888888,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
95,0.1,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does the formation of endometrial polyps involve increased expression of TGF-1 and VEGF? Polyps exhibited greater TGF-1 and VEGF expression compared to surrounding normal endometrial tissue, indicating these cytokines may be implicated in polyp development. In addition, there was a",3.079176455639102e-07,0.21659005393281383,0.05076562019082793,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
95,0.1,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is increased expression of vascular endothelial growth factor and transforming growth factor-beta1 associated with endometrial polyp formation? Elevated levels of TGF-1 and VEGF were found in polyps relative to adjacent normal tissue, suggesting these cytokines play a role in polyp formation. Furthermore, there was a",1.8948778188548325e-07,0.06041605688471252,0.07638888888888888,0.014507411718254981,0.14344327465586337,0.019599999999999992,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
95,0.1,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the presence of endometrial polyps connected to higher expression of VEGF and TGF-1? The study revealed increased expression of TGF-1 and VEGF in polyps compared to normal endometrial tissue nearby, indicating these cytokines might contribute to polyp formation. Additionally, there was a",2.3685972735685406e-07,0.13994308111769804,0.052593528984070326,0.018134264647818726,0.1910713236451178,0.019599999999999992,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
95,0.1,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are higher levels of vascular endothelial growth factor and transforming growth factor-beta1 found in endometrial polyps? Polyps showed increased TGF-1 and VEGF expression relative to adjacent normal endometrium, suggesting these cytokines could be involved in polyp development. Moreover, there was a",2.8423167282822487e-07,0.15572623668903818,0.07638888888888888,0.02176111757738247,0.24108174421978124,0.019599999999999992,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
95,0.1,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there a link between endometrial polyp formation and elevated expression of TGF-1 and VEGF? Increased expression of these cytokines was observed in polyps compared to normal endometrial tissue nearby, implying a role in polyp formation. Also, there was a",3.079176455639102e-07,0.21659005393281383,0.05076562019082793,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
95,0.1,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does endometrial polyp formation associate with increased levels of vascular endothelial growth factor and transforming growth factor-beta1? The expression of TGF-1 and VEGF was higher in polyps than in adjacent normal endometrium, suggesting these cytokines may play a role in the formation of polyps. In addition, there was a",9.474389094274162e-08,0.02659532010491672,0.07638888888888888,0.0072537058591274906,0.05449578863936777,0.019599999999999992,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
96,0.1,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is sternal fracture in growing children a rare and frequently missed injury? Answer: Yes, sternal fractures are uncommon and frequently overlooked in children who are still growing. They may result from direct chest trauma but are often not detected during initial assessments because they are rare and other injuries may take precedence.",4.737194547137081e-08,0.12453113537604477,0.060365432098765444,0.0036268529295637453,0.0965887779247141,0.040742417383431435,0.003621603081905733,0.06970312704358506,0.020823902218198284,4.737194547137081e-08,0.04167269640056892,0.0
96,0.1,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children rare and commonly unnoticed? Answer: Indeed, sternal fractures are rare and often go unnoticed in growing children. These fractures can happen from direct chest trauma but are frequently missed during early evaluations due to their rarity and the focus on more obvious injuries.",2.3685972735685406e-08,0.03355156382794666,0.03780134892296208,0.0018134264647818726,0.035964156108279965,0.040742417383431435,0.0018108015409528666,0.007827723325497526,0.020823902218198284,2.3685972735685406e-08,0.02150620522096336,0.0
96,0.1,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is a sternal fracture in growing children a rare and often ignored injury? Answer: Yes, sternal fractures are infrequent and commonly ignored in children who are still developing. They can arise from direct trauma to the chest but are often overlooked in initial medical examinations because they are uncommon and other injuries may be more apparent.",1.4211583641411244e-07,0.2519581214189932,0.09876543209876545,0.010880558788691236,0.17209633043286,0.040742417383431435,0.0108648092457172,0.14666416817971495,0.020823902218198284,1.4211583641411244e-07,0.12014431184206309,0.0
96,0.1,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures rare and frequently overlooked in growing children? Answer: Yes, sternal fractures are rare and often missed in growing children. They occur due to direct chest trauma but are commonly not identified during initial evaluations because of their rarity and the presence of other injuries.",7.105791820705622e-08,0.01173284172013389,0.0352323742475258,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.1,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is the sternal fracture in growing children a rare and often missed diagnosis? Answer: Yes, sternal fractures are uncommon and frequently missed in children who are growing. They can result from direct trauma to the chest but are often overlooked during first assessments due to their infrequency and more obvious injuries.",2.3685972735685406e-08,0.15843206340816884,0.09876543209876545,0.0018134264647818726,0.07678615062853433,0.040742417383431435,0.0018108015409528666,0.04950041972606645,0.020823902218198284,2.3685972735685406e-08,0.02105340919783316,0.0
96,0.1,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children uncommon and often overlooked? Answer: Yes, sternal fractures are uncommon and often overlooked in growing children. They may be caused by direct chest trauma but are frequently missed in initial evaluations because they are rare and other injuries may be prioritized.",7.105791820705622e-08,0.07072409112949085,0.006109851347946574,0.005440279394345618,0.036732292247905196,0.019014022321703038,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.1,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is sternal fracture a rare and often unnoticed injury in growing children? Answer: Yes, sternal fractures are rare and often unnoticed in children who are still growing. They can occur from direct trauma to the chest but are often missed during initial medical checks due to their rarity and the presence of more pressing injuries.",1.1842986367842703e-07,0.1583235598552295,0.04440152677332165,0.009067132323909363,0.10240295616763051,0.0037601688627213817,0.009054007704764333,0.10181553778793972,0.0019629554726361513,1.1842986367842703e-07,0.10109611687136999,0.0
96,0.1,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children rare and commonly missed? Answer: Yes, sternal fractures are rare and commonly missed in growing children. They happen due to direct chest trauma but are often overlooked in early evaluations because they are infrequent and other injuries may be more evident.",7.105791820705622e-08,0.04122846642481237,0.014395502407040198,0.005440279394345618,0.036732292247905196,0.019014022321703038,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.1,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is sternal fracture in growing children a rare and frequently overlooked injury? Answer: Yes, sternal fractures are rare and frequently overlooked in children who are growing. They can occur from direct trauma to the chest but are often missed during initial assessments due to their rarity and the presence of other injuries.",4.737194547137081e-08,0.09787162843143138,0.04128938045361759,0.0036268529295637453,0.04222429317491461,0.0015920633642727416,0.003621603081905733,0.04197723982118706,0.0008322320807555503,4.737194547137081e-08,0.04167269640056892,0.0
96,0.1,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures rare and often missed in growing children? Answer: Yes, sternal fractures are rare and often missed in children who are still growing. They may result from direct chest trauma but are frequently overlooked in initial evaluations because they are uncommon and other injuries may be more obvious.",0.0,0.0,0.0,0.0,0.028291721655508084,0.02022166579237194,0.0,0.028881132523331132,0.020763999483124976,0.0,0.02949562470467848,0.0212665406427221
97,0.1,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women have a higher obesity risk due to needing fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.1,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require fewer calories to maintain their weight? Answer: The data does not support the notion that African American women are more prone to obesity because they need fewer calories to maintain their weight.,1.184298636784265e-07,0.04936352069938632,0.05474286904615165,0.00906713232390937,0.08179116590311031,0.03802357694011063,0.009054007704764347,0.11565214666041834,0.018013548811824424,1.1842986367842703e-07,0.1510362934640943,0.004211308950296141
97,0.1,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower calorie requirements to sustain their weight? Answer: These results do not confirm that African American women face a greater obesity risk because of lower calorie needs for weight maintenance.,0.0,0.03960841031771123,0.027421996943288215,0.0,0.08154672712469857,0.05802419235396247,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.1,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories necessary for African American women to maintain their weight? Answer: The evidence does not support the belief that African American women are at increased risk of obesity due to requiring fewer calories to maintain weight.,7.10579182070559e-08,0.09474601728467036,0.008576706069585785,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.1,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require less caloric intake to keep their weight steady? Answer: The results do not endorse the view that African American women are more susceptible to obesity because they need fewer calories to maintain their weight.,9.47438909427412e-08,0.1955552073921072,0.061250721148912765,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.1,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement lower for African American women to maintain weight? Answer: These findings do not support the idea that African American women have a higher risk of obesity because they require fewer calories to maintain weight.,7.10579182070559e-08,0.13122744784045715,0.03401558750451271,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.1,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to sustain their weight? Answer: The results do not back the claim that African American women are at greater risk for obesity due to lower calorie requirements for weight maintenance.,4.73719454713706e-08,0.13906866209485091,0.05850538342288004,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.1,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,"Question: Are African American women at risk of obesity because they require fewer calories to maintain weight? Answer: The data does not support this perspective, indicating no greater obesity risk from lower calorie needs.",4.73719454713706e-08,0.09959314124791119,0.11238293444328822,0.003626852929563759,0.061695468870612835,0.08740894901144641,0.003621603081905747,0.02149748308653887,0.06035379812695108,4.737194547137081e-08,0.02121682235257394,0.031217481789802305
97,0.1,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require a reduced calorie intake to maintain their weight? Answer: The findings do not support the hypothesis that African American women are more likely to be obese because they need fewer calories to maintain weight.,9.47438909427412e-08,0.16000919813262282,0.03599404555439932,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.1,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it accurate that African American women need fewer calories to maintain their weight? Answer: The results do not uphold the view that African American women have an increased obesity risk due to lower calorie requirements for weight maintenance.,9.47438909427412e-08,0.16000919813262326,0.03599404555439932,0.0072537058591274975,0.1605828646856997,0.03493981320897727,0.00724320616381148,0.16096077608021542,0.03334762528744492,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
98,0.1,1,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Are UK radiologists content with the training and support they get for suspected child abuse cases? Research shows mixed satisfaction levels among UK radiologists about the training and support they receive in suspected child abuse. Some feel well-prepared, while others see a need for more thorough training and support, indicating room for improvement.",9.474389094274162e-08,0.013890703730544463,0.0378081168755397,0.0072537058591274906,0.0058221675106748805,0.04886147698875466,0.007243206163811466,0.029724344386858448,0.03366944444444442,9.474389094274162e-08,0.02829384495814047,0.03600069444444447
98,0.1,2,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Do UK radiologists feel satisfied with the training and support provided for suspected child abuse? Studies reveal varied satisfaction among UK radiologists concerning their training and support in suspected child abuse cases. Some believe they are adequately trained, whereas others call for enhanced training and support, suggesting improvements are necessary.",1.6580180914979784e-07,0.028772253109643486,0.06743290006092892,0.012693985253473108,0.013781194725740242,0.08663132477055638,0.012675610786670066,0.036147973660150434,0.07359999999999998,1.6580180914979784e-07,0.06318102492416466,0.056400000000000027
98,0.1,3,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Is the training and support for suspected child abuse satisfactory to UK radiologists? Research highlights differing satisfaction levels among UK radiologists regarding training and support in suspected child abuse. While some consider their preparation sufficient, others express the need for more extensive training and support, pointing to areas for enhancement.",1.6580180914979784e-07,0.0004805314541354022,0.08817848724591001,0.012693985253473108,0.013781194725740242,0.08663132477055638,0.012675610786670066,0.036147973660150434,0.07359999999999998,1.6580180914979784e-07,0.06318102492416466,0.056400000000000027
98,0.1,4,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Are UK radiologists happy with the training and support they receive for suspected child abuse? Evidence indicates mixed feelings among UK radiologists about the adequacy of training and support in suspected child abuse cases. Some feel prepared, but others emphasize the need for better training and support, showing a need for improvement.",1.1842986367842703e-07,0.009982998446384173,0.05361058601134211,0.009067132323909363,0.02819604509544682,0.08746355685131194,0.009054007704764333,0.005524722740418486,0.07359999999999998,1.1842986367842703e-07,0.020621410505368143,0.056400000000000027
98,0.1,5,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Do UK radiologists feel their training and support in suspected child abuse is adequate? Research suggests varied opinions among UK radiologists on the training and support they receive for suspected child abuse. Some are satisfied with their preparation, while others highlight the necessity for more comprehensive training and support, indicating room for progress.",9.474389094274162e-08,0.03942831015868231,0.07599175396064042,0.0072537058591274906,0.048542317239125055,0.08785522698875467,0.007243206163811466,0.025727430057937095,0.07359999999999998,9.474389094274162e-08,2.1233026323841386e-06,0.056400000000000027
98,0.1,6,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Are UK radiologists satisfied with the level of training and support offered for suspected child abuse? Studies indicate that satisfaction among UK radiologists varies regarding training and support in suspected child abuse. Some feel sufficiently prepared, but others point out the need for improved training and support, signaling a need for development.",1.1842986367842703e-07,0.009982998446384617,0.05361058601134211,0.009067132323909363,0.02819604509544682,0.08746355685131194,0.009054007704764333,0.005524722740418486,0.07359999999999998,1.1842986367842703e-07,0.020621410505368143,0.056400000000000027
98,0.1,7,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","How satisfied are UK radiologists with the training and support in suspected child abuse? Research reveals mixed satisfaction levels among UK radiologists about the training and support they receive in suspected child abuse cases. Some feel adequately equipped, while others call for more robust training and support, highlighting areas for improvement.",1.4211583641411244e-07,0.06097857740044521,0.030809071679270716,0.010880558788691236,0.049155939966197604,0.04649114381295129,0.0108648092457172,0.04397569698564796,0.0527760977818017,1.4211583641411244e-07,0.041674819703201305,0.056400000000000027
98,0.1,8,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Do UK radiologists consider their training and support in suspected child abuse to be sufficient? Evidence shows varied satisfaction among UK radiologists concerning training and support in suspected child abuse. Some feel well-prepared, but others suggest the need for enhanced training and support, indicating a need for better resources.",1.8948778188548325e-07,0.13920446167036715,0.003610586011342093,0.014507411718254981,0.12393597021895664,0.023085297297029406,0.014486412327622933,0.14806468069328016,0.008700054083288236,1.8948778188548325e-07,0.14677301435937906,0.012051703623580344
98,0.1,9,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Are UK radiologists content with the training and support they receive for suspected child abuse cases? Research points to differing satisfaction levels among UK radiologists regarding training and support in suspected child abuse. Some feel adequately trained, while others stress the need for more comprehensive training and support, highlighting the need for improvements.",9.474389094274162e-08,0.013890703730544463,0.0378081168755397,0.0072537058591274906,0.021360074864225087,0.06830487296959598,0.007243206163811466,0.025727430057937095,0.07359999999999998,9.474389094274162e-08,2.1233026323841386e-06,0.056400000000000027
98,0.1,10,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Is the training and support for suspected child abuse cases satisfactory to UK radiologists? Studies show varied satisfaction among UK radiologists about the training and support they receive in suspected child abuse. Some feel prepared, but others indicate a need for more extensive training and support, suggesting improvements are needed.",1.6580180914979784e-07,0.028772253109643486,0.06743290006092895,0.012693985253473108,0.042662327249071375,0.0658673252874314,0.012675610786670066,0.06564359836482891,0.05233345935727789,1.6580180914979784e-07,0.06318102492416466,0.056400000000000027
99,0.1,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Enhancing hospital efficiency by reducing the length of stay does not seem to lead to higher readmission rates or more physician visits within 30 days post-discharge. Further research is necessary to determine the ideal length of stay and anticipated readmission rates.,9.474389094274162e-08,0.10075139533781297,0.020139550918406572,0.0072537058591274906,0.10076747909833506,0.01922337562475971,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
99,0.1,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does early discharge from Winnipeg hospitals compromise care quality? Shortening hospital stays to improve efficiency does not appear to increase readmission rates or physician visits within 30 days after discharge. Additional studies are required to establish optimal stay durations and expected readmission rates.,3.552895910352811e-07,0.28106069584732474,0.01753826530612245,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
99,0.1,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is the quality of care affected by earlier patient discharge from Winnipeg hospitals? Improving hospital efficiency by decreasing length of stay does not seem to cause more readmissions or physician visits within 30 days post-discharge. Research is needed to find the best length of stay and expected readmission rates.,2.1317375462116866e-07,0.20529156826946338,0.02404963639520081,0.016320838183036854,0.20469971372977014,0.021266540642722105,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.1,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients sooner from Winnipeg hospitals harm the quality of care? Reducing hospital stay length to boost efficiency does not seem to raise readmission rates or physician visits within 30 days after discharge. Further investigation is needed to identify optimal stay lengths and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.1,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge from Winnipeg hospitals adversely affect care quality? Shortening hospital stays to improve efficiency does not appear to increase readmission or physician visit rates within 30 days post-discharge. More research is needed to determine ideal lengths of stay and expected readmission rates.,3.316036182995957e-07,0.2575301984371303,0.01753826530612245,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
99,0.1,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is patient care quality compromised by earlier discharge from Winnipeg hospitals? Improving hospital efficiency by shortening stays does not seem to increase readmission rates or physician visits within 30 days after discharge. Research is necessary to identify optimal stay durations and expected readmission rates.,3.316036182995957e-07,0.2575301984371303,0.01753826530612245,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
99,0.1,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients earlier from Winnipeg hospitals negatively impact care quality? Enhancing hospital efficiency by reducing length of stay does not appear to lead to higher readmission or physician visit rates within 30 days post-discharge. Further research is required to find optimal lengths of stay and expected readmission rates.,2.1317375462116866e-07,0.17641043574613224,0.003285636912075833,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.1,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does early discharge from Winnipeg hospitals affect the quality of care? Shortening hospital stays to improve efficiency does not seem to result in increased readmission rates or physician visits within 30 days after discharge. Additional research is needed to determine the best length of stay and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.1,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is the quality of care affected by earlier discharge from Winnipeg hospitals? Improving hospital efficiency by reducing length of stay does not appear to cause more readmissions or physician visits within 30 days post-discharge. Research is needed to establish optimal stay lengths and expected readmission rates.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,0.1,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients sooner from Winnipeg hospitals impact care quality? Shortening hospital stays to enhance efficiency does not seem to increase readmission rates or physician visits within 30 days after discharge. Further studies are necessary to identify optimal lengths of stay and expected readmission rates.,3.079176455639103e-07,0.2345406802124308,0.01753826530612245,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
100,0.1,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect on sleep bruxism? Yes, sleep bruxism does exhibit a 'first night effect,' characterized by an increase in bruxism episodes during the initial night in a new setting, often caused by elevated arousal and anxiety, leading to more teeth grinding or clenching.",2.1317375462116866e-07,0.1282810847026532,0.03631185475258099,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
100,0.1,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism show a first night effect? Indeed, there is a 'first night effect' where bruxism events rise on the first night of sleeping in an unfamiliar environment, typically due to increased arousal and anxiety, resulting in heightened teeth grinding or clenching.",3.079176455639103e-07,0.25225987150647144,0.012516494847762433,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
100,0.1,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is the first night effect present in sleep bruxism? Yes, the 'first night effect' causes an uptick in bruxism occurrences during the first night in a new place, usually because of heightened arousal and anxiety, which may increase teeth grinding or clenching.",3.316036182995957e-07,0.3109745296640196,0.012340347745775353,0.025387970506946217,0.33476195147833554,0.02498356344510192,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
100,0.1,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does the first night effect impact sleep bruxism? Yes, sleep bruxism experiences a 'first night effect,' meaning bruxism events increase on the first night in a novel environment, often due to greater arousal and anxiety, causing more teeth grinding or clenching.",3.552895910352811e-07,0.3373577451338057,0.013549641092294347,0.02720139697172809,0.3609684096941148,0.025623268698060954,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
100,0.1,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect on sleep bruxism? Yes, the 'first night effect' leads to more bruxism episodes during the initial night in a new environment, typically linked to increased arousal and anxiety, resulting in more teeth grinding or clenching.",3.552895910352811e-07,0.2680430270778116,0.03631185475258099,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
100,0.1,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism affected by the first night effect? Yes, the 'first night effect' refers to a rise in bruxism events on the first night sleeping somewhere new, usually due to heightened arousal and anxiety, which can cause increased teeth grinding or clenching.",3.079176455639103e-07,0.2852668801045639,0.011188145247419026,0.023574544042164344,0.3092240374482573,0.024375,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
100,0.1,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism have a first night effect? Yes, there is a 'first night effect' where bruxism events increase during the first night in an unfamiliar environment, often because of elevated arousal and anxiety, leading to more teeth grinding or clenching.",3.552895910352811e-07,0.30270038610580796,0.011328291307479067,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
100,0.1,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect in sleep bruxism? Yes, sleep bruxism shows a 'first night effect' characterized by more bruxism events on the first night in a new setting, typically due to increased arousal and anxiety, resulting in more teeth grinding or clenching.",2.8423167282822487e-07,0.22796176924515965,0.013069224367093464,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
100,0.1,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does the first night effect influence sleep bruxism? Yes, the 'first night effect' causes an increase in bruxism episodes during the first night in a novel environment, usually linked to heightened arousal and anxiety, which may lead to more teeth grinding or clenching.",3.079176455639103e-07,0.2852668801045639,0.011188145247419026,0.023574544042164344,0.3092240374482573,0.024375,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
100,0.1,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is the first night effect observed in sleep bruxism? Yes, there is a 'first night effect' where bruxism events rise on the first night of sleeping in a new place, often due to increased arousal and anxiety, causing more teeth grinding or clenching.",3.079176455639103e-07,0.2852668801045639,0.011188145247419026,0.023574544042164344,0.3092240374482573,0.024375,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
101,0.1,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Grandmultiparous women experienced higher rates of maternal and neonatal complications, as well as increased neonatal mortality, even after adjusting for confounding variables, indicating the necessity for more vigilant monitoring compared to regular multiparous women during labor and delivery.",1.4211583641411244e-07,0.1703875925940399,0.024375,0.010880558788691236,0.13976194237515838,0.0,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
101,0.1,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women with grandmultiparity showed elevated maternal and neonatal morbidity and neonatal death rates despite controlling for confounders, highlighting the importance of closer surveillance than that given to typical multiparous patients during labor and delivery.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,0.1,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Grandmultiparous mothers had greater maternal and neonatal health issues and higher neonatal mortality after accounting for confounding factors, suggesting they require more intensive observation than standard multiparous women during childbirth.",4.7371945471370706e-08,0.01619836298637356,0.024375,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.1,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Can grandmultiparity be considered an independent risk factor for unfavorable perinatal outcomes? Even after adjusting for confounders, grandmultiparous women demonstrated increased maternal and neonatal morbidity and neonatal mortality, implying a need for heightened monitoring compared to regular multiparous patients during labor and delivery.",2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.1,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with adverse perinatal outcomes? Grandmultiparous women showed increased maternal and neonatal complications and neonatal mortality after controlling for confounders, indicating the need for closer observation than that provided to typical multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.1,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently contribute to the risk of adverse perinatal outcomes? After adjusting for confounding factors, grandmultiparous women had higher maternal and neonatal morbidity and neonatal mortality, suggesting the necessity for more careful monitoring than regular multiparous patients during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.1,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of negative perinatal outcomes? Grandmultiparous women experienced increased maternal and neonatal morbidity and neonatal mortality even after controlling for confounders, pointing to the need for closer observation than usual multiparous patients during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.1,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a distinct risk factor for adverse perinatal outcomes? Women with grandmultiparity had elevated maternal and neonatal morbidity and neonatal mortality rates despite adjustment for confounders, indicating a requirement for more vigilant monitoring than regular multiparous women during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.1,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently raise the risk of poor perinatal outcomes? Grandmultiparous women showed increased maternal and neonatal morbidity and neonatal mortality after controlling for confounders, suggesting the need for closer observation compared to typical multiparous patients during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.1,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for negative outcomes in the perinatal period? Even after adjusting for confounding variables, grandmultiparous women had higher maternal and neonatal morbidity and neonatal mortality, implying a need for more intensive monitoring than regular multiparous women during labor and delivery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508943,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
102,0.1,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Several hypotheses explain this dissatisfaction. Physicians might lack interest in assisting caregivers; even if willing to counsel them, they may receive insufficient compensation for the typical counseling sessions caregivers require; furthermore, serving as a professional caregiver to family caregivers is inherently challenging.",1.8948778188548325e-07,0.1671349876081738,0.020857550858791207,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
102,0.1,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians fulfill the needs of family caregivers of frail elderly patients? Possible reasons for dissatisfaction include physicians' disinterest in supporting caregivers; even if open to counseling, they might be poorly paid for the usual caregiver counseling sessions; additionally, being a professional caregiver to family caregivers is itself a demanding role.",2.8423167282822487e-07,0.22047768036966797,0.0038669724755238874,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
102,0.1,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are family caregivers of frail elderly individuals receiving adequate support from physicians? The dissatisfaction may stem from several factors: physicians may be uninterested in aiding caregivers; even if they are willing to provide counseling, they might be undercompensated for the typical sessions caregivers need; and the role of a professional caregiver to family caregivers is inherently taxing.",1.4211583641411244e-07,0.10417836428883565,0.0017265420075026454,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
102,0.1,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Is the medical community meeting the needs of family caregivers for frail elderly patients? Hypotheses for dissatisfaction include physicians' possible lack of interest in helping caregivers; even if receptive to counseling, they may be poorly compensated for the usual caregiver counseling sessions; and the role of professional caregiver to family caregivers is demanding.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
102,0.1,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians addressing the needs of family caregivers of frail elderly individuals? The dissatisfaction might be due to physicians' lack of interest in assisting caregivers; even if they are open to counseling, they may receive inadequate remuneration for typical caregiver counseling sessions; plus, being a professional caregiver to family caregivers is a challenging task.",2.1317375462116866e-07,0.1606393824029153,0.0027362490836432864,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
102,0.1,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians adequately support family caregivers of the frail elderly? Hypotheses for this dissatisfaction include physicians' possible disinterest in helping caregivers; even if willing to counsel, they might be poorly paid for the usual counseling sessions; and the role of professional caregiver to family caregivers is demanding.",3.789755637709665e-07,0.3062702360237095,0.005603697399809551,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
102,0.1,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are the needs of family caregivers for frail elderly patients being met by physicians? Dissatisfaction may arise because physicians might be uninterested in helping caregivers; even if they are receptive to counseling, they could be underpaid for typical caregiver counseling sessions; and being a professional caregiver to family caregivers is itself demanding.",2.6054570009253947e-07,0.20013140822598974,0.003475302338081146,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
102,0.1,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians effectively meeting the needs of family caregivers of frail elderly individuals? The dissatisfaction could be due to physicians' lack of interest in assisting caregivers; even if they are willing to provide counseling, they may be poorly compensated for the usual sessions; and the role of professional caregiver to family caregivers is demanding.",2.1317375462116866e-07,0.1606393824029153,0.0027362490836432864,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
102,0.1,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are family caregivers of frail elderly patients receiving sufficient support from physicians? Hypotheses for dissatisfaction include physicians' possible disinterest in helping caregivers; even if they are open to counseling, they might be undercompensated for typical caregiver counseling sessions; and being a professional caregiver to family caregivers is a demanding role.",3.079176455639103e-07,0.24124622212029667,0.0042746078936367095,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
102,0.1,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians fulfilling the needs of family caregivers of the frail elderly? Possible reasons for dissatisfaction include physicians' lack of interest in assisting caregivers; even if they are receptive to counseling, they may be poorly remunerated for the usual caregiver counseling sessions; and the role of professional caregiver to family caregivers is demanding.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
103,0.1,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Studies suggest that airway surgery may improve serum lipid profiles in obstructive sleep apnea patients, but more research is needed to confirm this due to influencing factors like lifestyle and postoperative conditions.",1.8948778188548325e-07,0.18159563390568279,0.010340724083585065,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
103,0.1,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery decrease serum lipid levels in obstructive sleep apnea patients? Research shows airway surgery might enhance serum lipid profiles in these patients, though definitive conclusions require further study considering factors such as lifestyle and recovery.",3.789755637709661e-07,0.36476261268702714,0.002112729845839892,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
103,0.1,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there a reduction in serum lipid levels after airway surgery in obstructive sleep apnea patients? Evidence points to potential improvements in lipid profiles post-surgery, but more investigation is necessary because of variables like patient lifestyle and postoperative effects.",3.316036182995955e-07,0.23367903802120127,0.057476051645147866,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
103,0.1,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does undergoing airway surgery affect serum lipid levels in obstructive sleep apnea patients? Findings indicate possible benefits to serum lipid profiles, yet conclusive evidence demands additional research due to influencing factors including lifestyle and postoperative care.",4.026615365066514e-07,0.35552554657588553,0.028929338842379707,0.030828249901291842,0.4054651081081633,0.0,0.030783626196198746,0.4155154439616653,0.0,4.026615365066519e-07,0.42608439531090037,0.0
103,0.1,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery lead to lower serum lipid levels in obstructive sleep apnea patients? Research suggests it may improve lipid profiles, but a firm conclusion awaits further studies considering lifestyle and postoperative influences.",4.737194547137073e-07,0.4055292949478613,0.057476051645147866,0.03626852929563748,0.49783842823917857,0.0,0.03621603081905737,0.5108256237659905,0.0,4.737194547137081e-07,0.5245244681241537,0.0
103,0.1,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is airway surgery effective in lowering serum lipid levels among obstructive sleep apnea patients? Studies imply potential improvements, but more research is required to establish a clear link, given the impact of lifestyle and postoperative factors.",4.026615365066514e-07,0.3159171362581743,0.057476051645147866,0.030828249901291842,0.4054651081081633,0.0,0.030783626196198746,0.4155154439616653,0.0,4.026615365066519e-07,0.42608439531090037,0.0
103,0.1,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery have an impact on serum lipid levels in patients with obstructive sleep apnea? Research indicates possible improvements, but definitive conclusions need further investigation due to factors like lifestyle and postoperative recovery.",4.50033481978022e-07,0.3747576362811076,0.057476051645147866,0.0344551028308556,0.46608972992459874,0.0,0.03440522927810449,0.4780358009429988,0.0,4.500334819780227e-07,0.4906229164484719,0.0
103,0.1,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can serum lipid levels be reduced by airway surgery in obstructive sleep apnea patients? Evidence suggests airway surgery might improve lipid profiles, though more research is necessary because of various influencing factors including lifestyle and postoperative conditions.",3.789755637709661e-07,0.3262544359892523,0.029720949604331536,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
103,0.1,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there evidence that airway surgery lowers serum lipid levels in obstructive sleep apnea patients? Studies indicate potential benefits, but further research is needed to confirm this due to the influence of lifestyle and postoperative factors.",4.026615365066514e-07,0.3159171362581743,0.057476051645147866,0.030828249901291842,0.4054651081081633,0.0,0.030783626196198746,0.4155154439616653,0.0,4.026615365066519e-07,0.42608439531090037,0.0
103,0.1,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Research points to possible improvements, but conclusive results require additional investigation considering lifestyle and postoperative variables.",5.447773729207632e-07,0.5039693677611146,0.057476051645147866,0.04170880868998312,0.599621122549121,0.0,0.04164843544191599,0.616186139423816,0.0,5.447773729207643e-07,0.6337237600891443,0.0
104,0.1,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The use of audits to detect maternal mortality is not solely a distinction between wealthy and impoverished areas; it also reveals factors such as care quality, medical protocols, cultural beliefs, and education that impact mortality rates in various environments.",7.816371002776182e-07,0.48104711630642605,0.128662109375,0.059843073337801825,0.5781647139285662,0.042771218534194695,0.0597564508514446,0.6104051208912957,0.028959679215860994,7.816371002776184e-07,0.6437729619055204,0.014702606371129419
104,0.1,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Auditing maternal mortality isn't just about contrasting rich and poor regions; it uncovers influences like healthcare quality, medical standards, cultural perspectives, and educational attainment affecting mortality across different contexts.",1.0184968276344712e-06,0.7864287658576083,0.128662109375,0.0779773379856206,0.8932457605684623,0.042771218534194695,0.07786446626097332,0.9358275213259235,0.028959679215860994,1.0184968276344725e-06,0.9802451985267338,0.014702606371129419
104,0.1,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Maternal mortality audits do more than differentiate between affluent and poor settings; they expose elements including the standard of care, medical procedures, cultural norms, and education levels that influence mortality rates in diverse locations.",9.000669639560447e-07,0.6221257145663324,0.128662109375,0.06891020566171122,0.7233467237730653,0.042771218534194695,0.06881045855620896,0.7599368548622594,0.028959679215860994,9.000669639560454e-07,0.7979236417327789,0.014702606371129419
104,0.1,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Using audits to identify maternal mortality transcends the simple rich-versus-poor divide, highlighting factors such as healthcare quality, medical practices, cultural attitudes, and education that shape mortality outcomes in various settings.",9.948108548987858e-07,0.7513374460463393,0.128662109375,0.07616391152083873,0.8568781163975876,0.042771218534194695,0.07605366472002045,0.8980871933430765,0.028959679215860994,9.94810854898787e-07,0.9410244853734513,0.014702606371129419
104,0.1,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Audits aimed at identifying maternal mortality are not merely about economic disparities; they also bring to light issues like care quality, medical methods, cultural values, and education that affect mortality rates in different environments.",9.000669639560447e-07,0.6221257145663324,0.128662109375,0.06891020566171122,0.7233467237730653,0.042771218534194695,0.06881045855620896,0.7599368548622594,0.028959679215860994,9.000669639560454e-07,0.7979236417327789,0.014702606371129419
104,0.1,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The identification of maternal mortality through audits is not just a matter of economic status; it also reflects the impact of healthcare quality, medical practices, cultural attitudes, and education across different settings.",9.474389094274153e-07,0.6846460715476659,0.128662109375,0.07253705859127496,0.7878852449106368,0.042771218534194695,0.0724320616381147,0.8266282293609328,0.028959679215860994,9.474389094274162e-07,0.8669165132197296,0.014702606371129419
104,0.1,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Auditing maternal mortality rates is more complex than just comparing rich and poor areas; it also involves examining care quality, medical protocols, cultural beliefs, and education levels influencing mortality in diverse settings.",9.474389094274153e-07,0.6846460715476659,0.128662109375,0.07253705859127496,0.7878852449106368,0.042771218534194695,0.0724320616381147,0.8266282293609328,0.028959679215860994,9.474389094274162e-07,0.8669165132197296,0.014702606371129419
104,0.1,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Maternal mortality audits reveal more than economic differences; they highlight the role of healthcare quality, medical practices, cultural attitudes, and education in shaping mortality rates across various contexts.",1.0421828003701566e-06,0.822796410028483,0.128662109375,0.07979076445040248,0.9309860885513093,0.042771218534194695,0.0796752678019262,0.975048234479206,0.028959679215860994,1.0421828003701579e-06,1.0210671930469886,0.014702606371129419
104,0.1,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","The use of audits to identify maternal mortality is not limited to distinguishing between rich and poor settings; it also uncovers factors like quality of care, medical practices, cultural attitudes, and education that affect mortality rates in different environments.",7.816371002776182e-07,0.48104711630642605,0.128662109375,0.059843073337801825,0.5781647139285662,0.042771218534194695,0.0597564508514446,0.6104051208912957,0.028959679215860994,7.816371002776184e-07,0.6437729619055204,0.014702606371129419
104,0.1,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Audits for maternal mortality identification go beyond economic disparities, emphasizing the importance of care quality, medical procedures, cultural perspectives, and education in influencing mortality rates across diverse settings.",1.0421828003701566e-06,0.822796410028483,0.128662109375,0.07979076445040248,0.9309860885513093,0.042771218534194695,0.0796752678019262,0.975048234479206,0.028959679215860994,1.0421828003701579e-06,1.0210671930469886,0.014702606371129419
105,0.1,1,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","What role do hormonal differences play in gender dimorphism after injury and hemorrhagic shock? Evidence indicates that hormonal variations may contribute to gender-specific responses, with estrogen potentially enhancing female resilience. Nonetheless, further detailed studies are required to clarify this connection.",5.210914001850788e-07,0.35640766977350946,0.0652508464142813,0.0398953822252012,0.43365349647704843,0.016661878770468257,0.039837633900963065,0.46661953126149314,0.0,5.210914001850789e-07,0.47692407209030874,0.0
105,0.1,2,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are hormonal differences responsible for gender dimorphism observed after injury and hemorrhagic shock? Research suggests that hormones, particularly estrogen, might provide females with greater protection, but more extensive investigation is necessary to confirm these findings.",6.395212638635053e-07,0.493608791286992,0.0652508464142813,0.048962514549110575,0.5747320947369547,0.016661878770468257,0.04889164160572742,0.6118015411059923,0.0,6.39521263863506e-07,0.6264558060612724,0.0
105,0.1,3,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","How does gender dimorphism manifest after injury and hemorrhagic shock, and are hormones the cause? It appears that hormonal factors, such as estrogen, could influence the increased resilience seen in females, though additional research is essential to fully understand this relationship.",4.974054274493935e-07,0.33108986178921773,0.0652508464142813,0.038081955760419325,0.40767801007379045,0.016661878770468257,0.0380268323600102,0.43995128417933227,0.0,4.974054274493935e-07,0.4495250979021934,0.0
105,0.1,4,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Is the gender dimorphism seen after injury and hemorrhagic shock due to hormonal differences? Studies imply that estrogen may offer protective benefits to females, contributing to their resilience, but comprehensive research is still needed to explore this further.",5.684633456564494e-07,0.4090514032589283,0.0652508464142813,0.04352223515476494,0.4877207177473246,0.016661878770468257,0.0434592369828688,0.5221893824163053,0.0,5.684633456564497e-07,0.5340824859302571,0.0
105,0.1,5,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","To what extent do hormonal differences explain gender dimorphism following injury and hemorrhagic shock? Evidence points to estrogen's protective role in females, yet more thorough research is required to elucidate the physiological mechanisms involved.",6.632072365991906e-07,0.5234617544366738,0.0652508464142813,0.050775941013892455,0.6055037534037084,0.016661878770468257,0.05070244314668029,0.6435502394205721,0.0,6.632072365991914e-07,0.6592456288842641,0.0
105,0.1,6,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are hormonal variations the reason behind gender dimorphism after injury and hemorrhagic shock? Findings suggest that estrogen might enhance female resilience, but further in-depth studies are necessary to fully grasp the hormonal impact.",6.868932093348759e-07,0.5542334131034274,0.0652508464142813,0.052589367478674334,0.6372524517182883,0.016661878770468257,0.052513244687633166,0.6763400622435638,0.0,6.868932093348768e-07,0.6931471805599458,0.0
105,0.1,7,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Does hormonal disparity account for gender dimorphism after injury and hemorrhagic shock? Research indicates that estrogen could be a key factor in female resilience, although more extensive studies are needed to understand the full scope.",6.395212638635053e-07,0.493608791286992,0.0652508464142813,0.048962514549110575,0.5747320947369547,0.016661878770468257,0.04889164160572742,0.6118015411059923,0.0,6.39521263863506e-07,0.6264558060612724,0.0
105,0.1,8,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","What is the influence of hormonal differences on gender dimorphism after injury and hemorrhagic shock? Estrogen's protective effects may contribute to female resilience, but additional research is required to confirm this association.",7.105791820705612e-07,0.5859821114180073,0.0652508464142813,0.054402793943456214,0.67004227454128,0.016661878770468257,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
105,0.1,9,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Can hormonal differences explain the gender dimorphism observed after injury and hemorrhagic shock? Evidence suggests estrogen plays a protective role in females, yet more comprehensive research is essential to understand the physiological responses.",6.868932093348759e-07,0.5542334131034274,0.0652508464142813,0.052589367478674334,0.6372524517182883,0.016661878770468257,0.052513244687633166,0.6763400622435638,0.0,6.868932093348768e-07,0.6931471805599458,0.0
105,0.1,10,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are hormonal factors responsible for the gender dimorphism following injury and hemorrhagic shock? Studies indicate that estrogen may provide females with increased resilience, but further research is necessary to fully comprehend this relationship.",6.868932093348759e-07,0.5542334131034274,0.0652508464142813,0.052589367478674334,0.6372524517182883,0.016661878770468257,0.052513244687633166,0.6763400622435638,0.0,6.868932093348768e-07,0.6931471805599458,0.0
106,0.1,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The programs had a significant effect at multiple levels; graduates were seen as valuable contributors to their workplaces and frequently held influence nationally. The impact aligned closely with the goals of public health education. The qualitative study provided deeper insights into graduates' influence and career trajectories.,2.3685972735685406e-07,0.174532149935545,0.016388888888888897,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
106,0.1,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs contribute to health system strengthening in low- and middle-income countries? There was notable impact across various levels; graduates were recognized for their substantial contributions at work and often had national-level influence. Much of the impact matched the objectives of public health education. The qualitative research offered a detailed understanding of graduates' effects and career paths.,3.079176455639103e-07,0.20223686649489725,0.0,0.023574544042164372,0.2054439742148082,0.0,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
106,0.1,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the role of MPH programs in enhancing health systems in low- and middle-income countries? The impact was significant on many fronts; graduates were perceived as key contributors in their workplaces and frequently influenced national policies. The outcomes were consistent with public health education goals. The qualitative study revealed deeper insights into the graduates' impact and career development.,3.079176455639103e-07,0.20223686649489725,0.0,0.023574544042164372,0.2054439742148082,0.0,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
106,0.1,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs affect health system strengthening in low- and middle-income countries? There was considerable influence at multiple levels; graduates were viewed as important contributors to their workplaces and often had national influence. The impact largely reflected the aims of public health education. The qualitative method study provided a more in-depth understanding of graduates' impact and career progression.,3.079176455639103e-07,0.20223686649489725,0.0,0.023574544042164372,0.2054439742148082,0.0,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
106,0.1,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What impact do MPH programs have on health system strengthening in low- and middle-income countries? The programs showed significant effects at various levels; graduates were seen as making meaningful contributions to their workplaces and often held sway at the national level. Much of the impact aligned with public health educational goals. The qualitative study gave deeper insights into graduates' impact and career paths.,2.1317375462116866e-07,0.13554549199622468,0.0,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
106,0.1,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How significant is the impact of MPH programs on health system strengthening in low- and middle-income countries? There was a notable impact at many levels; graduates were perceived as valuable contributors to their workplaces and often influenced national health policies. The impact corresponded with the aims of public health education. The qualitative research provided a deeper understanding of graduates' influence and career development.,2.1317375462116866e-07,0.15790507846590085,0.016124697661918846,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
106,0.1,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What contributions do MPH programs make to health system strengthening in low- and middle-income countries? The impact was considerable across multiple levels; graduates were recognized for their significant workplace contributions and often had national influence. The impact was consistent with public health education objectives. The qualitative study revealed more detailed insights into graduates' impact and career trajectories.,3.552895910352811e-07,0.2868386992033063,0.03566529492455417,0.027201396971728117,0.2663674088372492,0.0181755829903978,0.027162023114293,0.24512245803298693,0.0,3.552895910352811e-07,0.24921579162398766,0.0
106,0.1,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs influence health system strengthening in low- and middle-income countries? There was substantial impact at various levels; graduates were seen as key contributors to their workplaces and frequently had influence at the national level. The impact aligned with the goals of public health education. The qualitative method study provided a deeper understanding of graduates' impact and career progression.,2.6054570009253947e-07,0.16833531481921682,0.0,0.019947691112600627,0.17095779814363965,0.0,0.019918816950481533,0.17366349405084325,0.0,2.6054570009253947e-07,0.17645643734155847,0.0
106,0.1,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What effect do MPH programs have on strengthening health systems in low- and middle-income countries? The programs had a considerable impact on many levels; graduates were perceived as significant contributors to their workplaces and often influenced national health systems. Much of the impact was in line with public health educational aims. The qualitative study offered deeper insights into graduates' impact and career development.,2.1317375462116866e-07,0.13554549199622468,0.0,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
106,0.1,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs contribute to the strengthening of health systems in low- and middle-income countries? There was a significant impact at multiple levels; graduates were viewed as important contributors to their workplaces and often had influence nationally. The impact corresponded with public health education goals. The qualitative research revealed a more in-depth understanding of graduates' impact and career paths.,2.8423167282822487e-07,0.18514243313559753,0.0,0.0217611175773825,0.18805223150293937,0.0,0.0217296184914344,0.19105523676271208,0.0,2.8423167282822487e-07,0.1941560144409591,0.0
107,0.1,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can neoadjuvant chemotherapy alter the scope of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged by NACT, with clinical non-responders exhibiting more affected lymph nodes. Therefore, a thorough and systemic lymphadenectomy is recommended for patients undergoing NACT followed by surgery, irrespective of their response to NACT.",7.105791820705622e-08,0.03148629604143327,0.01851192595229618,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
107,0.1,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it possible to adjust the extent of lymphadenectomy based on neoadjuvant chemotherapy in cervical cancer? NACT does not change the frequency or distribution of lymph node metastases, and patients who do not respond clinically have more involved lymph nodes. Hence, an extensive lymphadenectomy should be conducted in patients treated with NACT plus surgery regardless of their response.",7.105791820705622e-08,0.07973933906879171,0.01851192595229618,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
107,0.1,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer? The rate and anatomical spread of lymph node metastases are unaffected by NACT, with clinical non-responders showing a higher number of involved lymph nodes. Consequently, a comprehensive lymphadenectomy is advised for patients receiving NACT and surgery, no matter their response.",9.474389094274162e-08,0.051288923337613035,0.01851192595229618,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
107,0.1,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can the scope of lymphadenectomy be altered by neoadjuvant chemotherapy in cervical cancer? The frequency and distribution of lymph node metastases do not change with NACT, and patients who do not respond clinically have more involved lymph nodes. Therefore, systemic and extensive lymphadenectomy should be performed in all patients treated with NACT plus surgery regardless of response.",4.737194547137081e-08,0.0372845055208213,0.0006606862828746896,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
107,0.1,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is the extent of lymphadenectomy modifiable by neoadjuvant chemotherapy in cervical cancer? NACT does not affect the frequency or topographic distribution of lymph node metastases, and clinical non-responders have more involved lymph nodes. Thus, a systemic and extensive lymphadenectomy is necessary for patients treated with NACT and surgery, irrespective of their response.",7.105791820705622e-08,0.03148629604143327,0.01851192595229618,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
107,0.1,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain consistent despite NACT, with clinical non-responders having more involved lymph nodes. As a result, a thorough lymphadenectomy should be performed in patients undergoing NACT plus surgery regardless of response.",1.4211583641411244e-07,0.0921109178578674,0.01851192595229618,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
107,0.1,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it feasible to modify lymphadenectomy extent through neoadjuvant chemotherapy in cervical cancer? The frequency and distribution of lymph node metastases are not altered by NACT, and clinical non-responders present with more involved lymph nodes. Therefore, extensive lymphadenectomy should be carried out in patients treated with NACT and surgery regardless of response.",7.105791820705622e-08,0.03148629604143327,0.01851192595229618,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
107,0.1,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can neoadjuvant chemotherapy affect the extent of lymphadenectomy in cervical cancer? The frequency and topographic distribution of lymph node metastases remain unchanged by NACT, with clinical non-responders showing more involved lymph nodes. Hence, a systemic and extensive lymphadenectomy is recommended for patients treated with NACT plus surgery regardless of their response.",9.474389094274162e-08,0.051288923337613035,0.01851192595229618,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
107,0.1,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it possible for neoadjuvant chemotherapy to modify lymphadenectomy extent in cervical cancer? NACT does not modify the frequency or distribution of lymph node metastases, and clinical non-responders have more involved lymph nodes. Therefore, systemic and extensive lymphadenectomy should be performed in patients treated with NACT and surgery regardless of response.",9.474389094274162e-08,0.051288923337613035,0.01851192595229618,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
107,0.1,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could the extent of lymphadenectomy be influenced by neoadjuvant chemotherapy in cervical cancer? The frequency and topographic distribution of lymph node metastases are not changed by NACT, and clinical non-responders exhibit more involved lymph nodes. Thus, a systemic and extensive lymphadenectomy is advised for patients undergoing NACT plus surgery regardless of their response.",4.737194547137081e-08,0.012068210184330574,0.01851192595229618,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
108,0.1,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are doctors effectively supporting family caregivers of frail elderly patients? Although some physicians do meet these needs well, this is not universally true. Constraints such as limited appointment time, insufficient resources, and knowledge gaps often hinder their capacity to fully assist caregivers. Improvements in training and policy are necessary.",3.316036182995957e-07,0.14413544178882143,0.08002462296091106,0.025387970506946217,0.19254785126063512,0.049048751486325794,0.025351221573340132,0.2194933536956758,0.033293697978596916,3.316036182995957e-07,0.24737843954014682,0.01694411414982164
108,0.1,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians adequately address the needs of family caregivers for frail elderly individuals? While some do, this support is inconsistent. Factors like time limitations during visits, lack of resources, and knowledge deficiencies can prevent physicians from fully meeting caregivers' needs. Enhanced training and policy reforms are needed.",3.789755637709665e-07,0.18669505620761795,0.08002462296091106,0.029014823436509962,0.23603296320037348,0.049048751486325794,0.028972824655245866,0.2639451162665085,0.033293697978596916,3.789755637709665e-07,0.29284081361690406,0.01694411414982164
108,0.1,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are family caregivers of frail elderly patients receiving sufficient support from physicians? Some physicians provide adequate care, but this is not consistent. Challenges including limited consultation time, resource shortages, and knowledge gaps restrict their ability to support caregivers fully. Training improvements and policy changes are essential.",4.026615365066519e-07,0.20867396292639295,0.08002462296091106,0.030828249901291835,0.2585058190524312,0.049048751486325794,0.030783626196198732,0.28693463449120804,0.033293697978596916,4.026615365066519e-07,0.3163713110270985,0.01694411414982164
108,0.1,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","To what extent are physicians meeting the needs of family caregivers for the frail elderly? Some physicians do so adequately, but it is not consistent across all cases. Issues such as time constraints during appointments, inadequate resources, and knowledge gaps limit their ability to support caregivers effectively. There is a need for better training and policy adjustments.",1.4211583641411244e-07,0.010015238038437069,0.08002462296091106,0.010880558788691236,0.03536226773822193,0.049048751486325794,0.0108648092457172,0.059150703620495015,0.033293697978596916,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164
108,0.1,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are the needs of family caregivers for frail elderly patients being met by physicians? While some physicians address these needs well, it is not consistent. Barriers like limited time in appointments, lack of resources, and insufficient knowledge can hinder full support. Training and policy enhancements are required.",3.789755637709665e-07,0.18669505620761795,0.08002462296091106,0.029014823436509962,0.23603296320037348,0.049048751486325794,0.028972824655245866,0.2639451162665085,0.033293697978596916,3.789755637709665e-07,0.29284081361690406,0.01694411414982164
108,0.1,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians consistently meet the needs of family caregivers of frail elderly individuals? Some do, but this is not uniform. Challenges such as appointment time restrictions, resource inadequacies, and knowledge gaps can limit their support. Policy changes and improved training are necessary.",4.974054274493935e-07,0.3017643859924046,0.08002462296091106,0.038081955760419325,0.35381599885675685,0.049048751486325794,0.0380268323600102,0.3845731040551259,0.033293697978596916,4.974054274493935e-07,0.4164547695840799,0.01694411414982164
108,0.1,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians fulfilling the needs of family caregivers for the frail elderly? Although some physicians do so adequately, this is not consistent. Constraints like limited time during visits, lack of resources, and gaps in knowledge can restrict their ability to support caregivers fully. Training and policy reforms are needed.",3.316036182995957e-07,0.14413544178882143,0.08002462296091106,0.025387970506946217,0.19254785126063512,0.049048751486325794,0.025351221573340132,0.2194933536956758,0.033293697978596916,3.316036182995957e-07,0.24737843954014682,0.01694411414982164
108,0.1,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are family caregivers of frail elderly patients receiving adequate support from physicians? Some physicians meet these needs, but not consistently. Factors such as time limitations, insufficient resources, and knowledge gaps can impede their ability to provide full support. Enhanced training and policy changes are essential.",4.263475092423373e-07,0.23114681877845067,0.08002462296091106,0.03264167636607371,0.2814953372771307,0.049048751486325794,0.0325944277371516,0.31046513190140246,0.033293697978596916,4.263475092423373e-07,0.3404688626061585,0.01694411414982164
108,0.1,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","How well do physicians meet the needs of family caregivers for the frail elderly? Some physicians address these needs adequately, but this is not consistent. Challenges including limited appointment time, inadequate resources, and knowledge gaps can limit their support. Training and policy improvements are necessary.",4.263475092423373e-07,0.23114681877845067,0.08002462296091106,0.03264167636607371,0.2814953372771307,0.049048751486325794,0.0325944277371516,0.31046513190140246,0.033293697978596916,4.263475092423373e-07,0.3404688626061585,0.01694411414982164
108,0.1,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are the needs of family caregivers for frail elderly patients being adequately met by physicians? While some physicians do meet these needs, it is not consistent. Barriers such as time constraints, lack of resources, and knowledge deficiencies can hinder full support. Policy reforms and better training are required.",3.552895910352811e-07,0.1651888509866546,0.08002462296091106,0.02720139697172809,0.21405405648159848,0.049048751486325794,0.027162023114293,0.2414722604144508,0.033293697978596916,3.552895910352811e-07,0.26985129539220454,0.01694411414982164
109,0.1,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain linked to a decline in health-related quality of life six months afterward? Our findings indicate that neck pain adversely affects physical health-related quality of life but does not impact mental health-related quality of life. This suggests that neck pain could be a factor leading to poorer physical health-related quality of life in the future. Increasing awareness about the potential long-term effects of neck pain is important.,3.079176455639103e-07,0.011372203503410727,0.43263665278135255,0.023574544042164344,0.0680433319278384,0.21787696293659264,0.023540420032387266,0.14842144624514875,0.07709750566893428,3.079176455639103e-07,0.20181594575851758,0.015380859375
109,0.1,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does neck pain correlate with a reduced health-related quality of life half a year later? We discovered that neck pain is associated with worse physical health-related quality of life, though it does not affect mental health-related quality of life. Our study implies that neck pain might contribute to future declines in physical health-related quality of life among the population. It is crucial to raise awareness about the possible future consequences of neck pain.",4.026615365066519e-07,0.12209746061333249,0.2658223466652946,0.030828249901291876,0.16269103943275187,0.1575827486039168,0.030783626196198746,0.2385949181795266,0.028546712802768156,4.026615365066519e-07,0.28286278601583437,0.0
109,0.1,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is there an association between neck pain and poorer health-related quality of life six months later? Our research shows that neck pain negatively impacts physical health-related quality of life but not mental health-related quality of life. This analysis indicates that neck pain may be a factor in future poor physical health-related quality of life. Promoting awareness of the potential future effects of neck pain is essential.,2.3685972735685406e-07,0.0638525935325358,0.4221582675302399,0.018134264647818726,0.022284359453927483,0.19447668592828254,0.018108015409528666,0.10682879564322834,0.04750000000000001,2.3685972735685406e-07,0.1758906664636637,0.0
109,0.1,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Does experiencing neck pain relate to worse health-related quality of life after six months? We found that neck pain is linked to a decline in physical health-related quality of life but does not influence mental health-related quality of life. Our findings suggest that neck pain could contribute to future poor physical health-related quality of life in the general population. Raising awareness about the possible long-term impact of neck pain is important.,3.552895910352811e-07,0.007350606329340259,0.43314727851925083,0.027201396971728103,0.08239026577579711,0.22658347850887028,0.027162023114293,0.18036092063686615,0.07479289940828401,3.552895910352811e-07,0.23275794019580776,0.014921946740128554
109,0.1,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain associated with a decrease in health-related quality of life six months later? Our analysis revealed that neck pain negatively affects physical health-related quality of life but not mental health-related quality of life. This suggests that neck pain may be a contributor to future poor physical health-related quality of life. Increasing awareness of the potential future impact of neck pain is necessary.,1.8948778188548325e-07,0.1059382065252441,0.44090442137639374,0.014507411718254981,0.015054235478073164,0.201653363303902,0.014486412327622933,0.07240353941857203,0.049048751486325794,1.8948778188548325e-07,0.14310084364067155,0.0
109,0.1,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is there a link between neck pain and diminished health-related quality of life six months afterward? We observed that neck pain is negatively associated with physical health-related quality of life but not with mental health-related quality of life. Our study suggests that neck pain might lead to poorer physical health-related quality of life in the future. It is important to raise awareness about the possible future effects of neck pain.,3.316036182995957e-07,0.040664600448432786,0.3354111619119431,0.025387970506946217,0.08540749651735347,0.214221210301399,0.025351221573340132,0.16451815021012495,0.075927734375,3.316036182995957e-07,0.2174065634280291,0.01514792899408284
109,0.1,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Does neck pain predict worse health-related quality of life six months later? Our findings indicate that neck pain is associated with poorer physical health-related quality of life but does not affect mental health-related quality of life. This analysis implies that neck pain may contribute to future declines in physical health-related quality of life. Raising awareness about the potential long-term consequences of neck pain is vital.,2.1317375462116866e-07,0.10634953084992205,0.4501044213763936,0.016320838183036854,0.018219253962779014,0.21487650379977008,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.1596301455918825,0.0
109,0.1,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain connected to reduced health-related quality of life six months later? We found that neck pain negatively impacts physical health-related quality of life but not mental health-related quality of life. Our research suggests that neck pain could be a factor in future poor physical health-related quality of life. Promoting awareness of the possible future impact of neck pain is important.,1.4211583641411244e-07,0.1497425034444393,0.4609870602652827,0.010880558788691236,0.05380661469297676,0.20932716269134943,0.0108648092457172,0.036755986567840626,0.0507015306122449,1.4211583641411244e-07,0.10919929196499112,0.0
109,0.1,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain related to worse health-related quality of life six months later? Our analysis shows that neck pain is linked to poorer physical health-related quality of life but does not affect mental health-related quality of life. This suggests that neck pain may contribute to future declines in physical health-related quality of life. Raising awareness about the potential future effects of neck pain is essential.,2.1317375462116866e-07,0.10634953084992205,0.4501044213763937,0.016320838183036854,0.018219253962779014,0.21487650379977014,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.1596301455918825,0.0
109,0.1,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain associated with poorer health-related quality of life six months later? We discovered that neck pain negatively influences physical health-related quality of life but not mental health-related quality of life. Our findings imply that neck pain might be a contributor to future poor physical health-related quality of life. Increasing awareness of the possible long-term impact of neck pain is necessary.,1.4211583641411244e-07,0.1497425034444393,0.4609870602652827,0.010880558788691236,0.05380661469297676,0.20932716269134943,0.0108648092457172,0.036755986567840626,0.0507015306122449,1.4211583641411244e-07,0.10919929196499112,0.0
110,0.1,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical importance of bile duct sludge compared to bile duct stones? Answer: The results suggest that symptomatic bile duct sludge has clinical significance comparable to common bile duct stones. Bile duct sludge appears to represent an initial phase of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.1,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical relevance of bile duct sludge differ from that of bile duct stones? Answer: Findings show that symptomatic bile duct sludge shares similar clinical significance with common bile duct stones. Bile duct sludge may be an early form of choledocholithiasis.,0.0,0.12266513581234229,0.3786271844328172,0.0,0.0454652977353458,0.07478796844181462,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.1,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical impact of bile duct sludge distinct from bile duct stones? Answer: The evidence indicates that symptomatic bile duct sludge has clinical significance akin to that of common bile duct stones. Bile duct sludge likely represents an early stage of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.1,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: The data reveal that symptomatic bile duct sludge is clinically similar to common bile duct stones. Bile duct sludge seems to be a precursor stage of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.1,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge have a different clinical significance than bile duct stones? Answer: The findings demonstrate that symptomatic bile duct sludge has clinical significance comparable to common bile duct stones. Bile duct sludge appears to be an early stage in the development of choledocholithiasis.,4.737194547137081e-08,0.06404584102313615,0.3518005540166206,0.0036268529295637453,0.0376286495127971,0.04547052154195008,0.003621603081905733,0.0814401065775443,0.024375,4.737194547137081e-08,0.048790164169431716,0.0
110,0.1,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: The results indicate that symptomatic bile duct sludge holds clinical significance similar to that of common bile duct stones. Bile duct sludge seems to represent an early phase of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.1,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What clinical importance does bile duct sludge have relative to bile duct stones? Answer: The findings suggest that symptomatic bile duct sludge is clinically equivalent to common bile duct stones. Bile duct sludge appears to be an initial stage of choledocholithiasis.,4.737194547137081e-08,0.15092164994648316,0.3751433094013228,0.0036268529295637453,0.06517206862335545,0.0549930747922438,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,0.1,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is there a difference in clinical significance between bile duct sludge and bile duct stones? Answer: The evidence shows that symptomatic bile duct sludge has clinical significance similar to common bile duct stones. Bile duct sludge likely constitutes an early stage of choledocholithiasis.,0.0,0.12266513581234229,0.3786271844328172,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.1,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical significance of symptomatic bile duct sludge compare to bile duct stones? Answer: The findings indicate that symptomatic bile duct sludge is clinically similar to common bile duct stones. Bile duct sludge seems to be an early phase of choledocholithiasis.,0.0,0.12266513581234229,0.3786271844328172,0.0,0.0454652977353458,0.07478796844181461,0.0,0.0,0.0,0.0,0.0,0.0
110,0.1,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical relevance of bile duct sludge versus bile duct stones? Answer: The data suggest that symptomatic bile duct sludge shares clinical significance with common bile duct stones. Bile duct sludge appears to be an early stage of choledocholithiasis.,4.737194547137081e-08,0.15092164994648272,0.3751433094013229,0.0036268529295637453,0.06517206862335545,0.0549930747922438,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
111,0.1,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy forecast the results for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy does not directly determine the outcome for patients treated with radical perineal prostatectomy, although it offers useful patient information.",7.1057918207056e-08,0.08239688909354115,0.09834220912629757,0.005440279394345618,0.1271725565608679,0.1401196306499337,0.0054324046228586,0.09768733862388634,0.12543252595155707,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
111,0.1,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can a history of benign prostate biopsy predict outcomes in patients receiving radical perineal prostatectomy? A prior benign prostate biopsy does not directly predict the outcome for those treated with radical perineal prostatectomy, but it can provide important patient insights.",4.7371945471370706e-08,0.1476600699414936,0.1257595486111111,0.0036268529295637453,0.15482678825264484,0.1408292366523325,0.003621603081905733,0.12508631281200167,0.12543252595155707,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
111,0.1,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is prior benign prostate biopsy a predictor of outcomes for patients treated with radical perineal prostatectomy? Prior benign prostate biopsy does not directly influence the outcome for patients undergoing radical perineal prostatectomy, though it may supply valuable patient data.",7.1057918207056e-08,0.045915458537754805,0.07359012712350782,0.005440279394345618,0.0897051413954646,0.1132482524690317,0.0054324046228586,0.0591791619261115,0.09767742391074075,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
111,0.1,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does having a benign prostate biopsy before surgery predict the results of radical perineal prostatectomy? A previous benign prostate biopsy does not directly forecast the outcome for patients treated with radical perineal prostatectomy, but it can offer useful information about the patient.",0.0,0.20287234552973965,0.12943375605955676,0.0,0.2079441541679845,0.14214224004433795,0.0,0.1777300462974205,0.12543252595155707,0.0,0.10944429166736036,0.0783673469387755
111,0.1,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can prior benign prostate biopsy outcomes predict the success of radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy, yet it provides valuable patient information.",1.421158364141119e-07,0.051957538508839995,0.06325954861111113,0.010880558788691243,0.0014641434264932585,0.10853205348943987,0.010864809245717214,0.031332958399679534,0.09515908845155707,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
111,0.1,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a benign prostate biopsy done earlier predict the outcome for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy does not directly determine the outcome for patients treated with radical perineal prostatectomy, although it can provide important patient details.",2.3685972735685406e-08,0.07167175153625482,0.056819717776816575,0.0018134264647818726,0.11064567743323694,0.09073691460055097,0.0018108015409528666,0.11527312933837619,0.0991359591144497,2.3685972735685406e-08,0.08277604458519949,0.0783673469387755
111,0.1,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is the outcome of radical perineal prostatectomy influenced by a previous benign prostate biopsy? Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy, but it can give valuable information about the patient.",4.7371945471370706e-08,0.14766006994149405,0.1257595486111111,0.0036268529295637453,0.19130821880843119,0.16712580348943987,0.003621603081905733,0.12508631281200167,0.12543252595155707,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
111,0.1,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a prior benign prostate biopsy serve as a predictor for patients treated with radical perineal prostatectomy? A previous benign prostate biopsy does not directly predict the outcome for patients undergoing radical perineal prostatectomy, though it can provide useful patient information.",2.3685972735685406e-08,0.1409864695922498,0.10338300540123455,0.0018134264647818726,0.18173769595220524,0.14150253479137892,0.0018108015409528666,0.15175455989416253,0.12543252595155707,2.3685972735685406e-08,0.08277604458519949,0.0783673469387755
111,0.1,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can the results of a prior benign prostate biopsy predict the outcome of radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy, but it may offer valuable insights about the patient.",0.0,0.10143617276487005,0.06010762117346935,0.0,0.13862943611198997,0.09261886411763563,0.0,0.14218403703793658,0.09980925725349613,0.0,0.10944429166736036,0.0783673469387755
111,0.1,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is prior benign prostate biopsy an indicator of outcomes for patients treated with radical perineal prostatectomy? A prior benign prostate biopsy does not directly predict the outcome for patients undergoing radical perineal prostatectomy, although it can provide important information about the patient.",0.0,0.13524823035316036,0.08254967206790119,0.0,0.1732867951399868,0.11726430764456452,0.0,0.14218403703793658,0.09980925725349613,0.0,0.10944429166736036,0.0783673469387755
112,0.1,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy still be recommended? Answer: Second-look laparotomy does not improve overall or disease-free survival. Tumor grade remains the sole independent prognostic factor for patient survival.,1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.1,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still advisable? Answer: Second-look laparotomy shows no beneficial effect on overall or disease-free survival. Tumor grade is the only independent predictor of survival.",1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.1,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy continue to be offered to Thai women with advanced epithelial ovarian carcinoma? Answer: The procedure does not positively affect overall or disease-free survival rates. Tumor grade is the only independent prognostic indicator for survival.,9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,0.1,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In Thai women with advanced epithelial ovarian carcinoma, is it appropriate to keep offering second-look laparotomy? Answer: Second-look laparotomy does not improve overall or disease-free survival outcomes. Tumor grade is the only independent factor predicting survival.",1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.1,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still warranted? Answer: There is no favorable impact of second-look laparotomy on overall or disease-free survival. Tumor grade is the sole independent prognostic variable for survival.,1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.1,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy be continued for advanced epithelial ovarian carcinoma in Thai women? Answer: The procedure does not enhance overall or disease-free survival. Tumor grade is the only independent prognostic factor for patient survival.,1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.1,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For advanced epithelial ovarian carcinoma in Thai women, is second-look laparotomy still beneficial? Answer: Second-look laparotomy does not improve overall or disease-free survival. Tumor grade is the only independent prognostic variable for survival.",1.894877818854825e-07,0.25907342527176347,0.0302734375,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.1,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Is it advisable to continue second-look laparotomy in Thai women with advanced epithelial ovarian carcinoma? Answer: Second-look laparotomy has no positive effect on overall or disease-free survival. Tumor grade is the only independent prognostic factor for survival.,9.474389094274131e-08,0.1401215692254847,0.027006172839506164,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,0.1,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy remain a treatment option for advanced epithelial ovarian carcinoma in Thai women? Answer: The procedure does not favorably impact overall or disease-free survival. Tumor grade is the only independent prognostic variable for patient survival.,9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,0.1,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In the case of advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy still be performed? Answer: Second-look laparotomy does not improve overall or disease-free survival. Tumor grade is the only independent prognostic factor for survival.",9.474389094274131e-08,0.1401215692254847,0.027006172839506164,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
113,0.1,1,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment alone reliably rule out aspiration after an acute stroke?,9.948108548987845e-07,1.4677706512352682,0.07496876301541024,0.07616391152083879,1.5953396116981557,0.03840000000000001,0.07605366472002058,1.7074188130132062,0.019599999999999992,9.948108548987864e-07,1.8325814637483098,0.0
113,0.1,2,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment sufficient to exclude aspiration following an acute stroke?,1.01849682763447e-06,1.5630808310395934,0.07496876301541024,0.07797733798562068,1.7007001273559816,0.03840000000000001,0.07786446626097344,1.82520184866959,0.019599999999999992,1.0184968276344718e-06,1.9661128563728316,0.0
113,0.1,3,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Does bedside assessment reliably detect the absence of aspiration post-acute stroke?,1.01849682763447e-06,1.5630808310395934,0.07496876301541024,0.07797733798562068,1.7007001273559816,0.03840000000000001,0.07786446626097344,1.82520184866959,0.019599999999999992,1.0184968276344718e-06,1.9661128563728316,0.0
113,0.1,4,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can aspiration be confidently excluded using only bedside assessment after an acute stroke?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.1,5,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment a dependable method to rule out aspiration after an acute stroke?,9.474389094274138e-07,1.3007165665721017,0.07496876301541024,0.07253705859127504,1.4130180549042004,0.03840000000000001,0.07243206163811483,1.506748117551055,0.019599999999999992,9.474389094274156e-07,1.6094379124341,0.0
113,0.1,6,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside evaluation alone confirm the absence of aspiration following an acute stroke?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.1,7,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment enough to reliably exclude aspiration in patients after an acute stroke?,9.474389094274138e-07,1.3007165665721017,0.07496876301541024,0.07253705859127504,1.4130180549042004,0.03840000000000001,0.07243206163811483,1.506748117551055,0.019599999999999992,9.474389094274156e-07,1.6094379124341,0.0
113,0.1,8,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Does bedside assessment provide a reliable exclusion of aspiration after an acute stroke?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.1,9,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can aspiration be reliably ruled out by bedside assessment alone following an acute stroke?,9.474389094274138e-07,1.3007165665721017,0.07496876301541024,0.07253705859127504,1.4130180549042004,0.03840000000000001,0.07243206163811483,1.506748117551055,0.019599999999999992,9.474389094274156e-07,1.6094379124341,0.0
113,0.1,10,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment a reliable standalone tool to exclude aspiration after an acute stroke?,9.474389094274138e-07,1.3007165665721017,0.07496876301541024,0.07253705859127504,1.4130180549042004,0.03840000000000001,0.07243206163811483,1.506748117551055,0.019599999999999992,9.474389094274156e-07,1.6094379124341,0.0
114,0.1,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call impact polio vaccination rates in Kenya in 2015? Yes, their boycott call notably reduced polio vaccination coverage in Kenya that year, causing lower immunization rates and increased vaccine skepticism, which contributed to a public health crisis.",3.552895910352811e-07,0.1161527194128773,0.12563242599757324,0.02720139697172809,0.11681091495564155,0.14124038026256222,0.027162023114293,0.17138969364353063,0.109375,3.552895910352811e-07,0.2280797643072523,0.07496876301541025
114,0.1,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott call? Indeed, the boycott call by Catholic bishops significantly lowered polio vaccination coverage in Kenya in 2015, resulting in decreased immunization and greater vaccine hesitancy, leading to a public health emergency.",2.6054570009253947e-07,0.07565883037309407,0.08897210743801648,0.0199476911126006,0.14752749525312492,0.051240380262562224,0.019918816950481533,0.17046943532053582,0.04000000000000001,2.6054570009253947e-07,0.19401032294645493,0.027468763015410236
114,0.1,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott influence polio vaccine coverage in Kenya during 2015? Yes, the boycott call by Catholic bishops had a major impact on polio vaccination coverage in Kenya in 2015, causing a drop in immunization rates and increased doubts about vaccines, which contributed to a health crisis.",1.8948778188548325e-07,0.08515013250891412,0.15675920573669322,0.014507411718254981,0.014961607935801702,0.11997383961984012,0.014486412327622933,0.006309943284080521,0.109375,1.8948778188548325e-07,0.05900343426331922,0.07496876301541025
114,0.1,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' boycott call affect polio vaccination coverage in Kenya? Yes, the boycott call by Catholic bishops substantially affected polio vaccination coverage in Kenya in 2015, leading to reduced immunization rates and heightened vaccine skepticism, which fueled a public health crisis.",2.8423167282822487e-07,0.10163242956131224,0.08657853413098163,0.02176111757738247,0.10896906086996383,0.09483942844816601,0.0217296184914344,0.13028873008789876,0.08557964009518144,2.8423167282822487e-07,0.1520938573293309,0.07496876301541025
114,0.1,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the 2015 polio vaccination coverage in Kenya impacted by the Catholic bishops' boycott? Yes, the boycott call from Catholic bishops significantly influenced polio vaccination coverage in Kenya in 2015, resulting in lower immunization rates and increased vaccine hesitancy, contributing to a public health crisis.",2.8423167282822487e-07,0.07012573953586232,0.10834710743801648,0.02176111757738247,0.14120846461693848,0.07186538026256223,0.0217296184914344,0.16329573868599123,0.061874999999999986,2.8423167282822487e-07,0.18590591491762076,0.05059376301541025
114,0.1,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' call for boycott affect Kenya's polio vaccination coverage in 2015? Yes, the boycott call by Catholic bishops greatly affected polio vaccination coverage in Kenya in 2015, causing a decline in immunization rates and increased skepticism about vaccines, which led to a public health crisis.",2.1317375462116866e-07,0.03337211424370734,0.13481404958677684,0.016320838183036854,0.0373226404552609,0.0978519505104961,0.0162972138685758,0.05909539136107522,0.08716425619834711,2.1317375462116866e-07,0.08147629011537694,0.07496876301541025
114,0.1,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the boycott called by Catholic bishops impact polio vaccination coverage in Kenya in 2015? Yes, the boycott call by Catholic bishops had a significant effect on polio vaccination coverage in Kenya in 2015, leading to decreased immunization rates and increased vaccine doubts, contributing to a public health crisis.",1.8948778188548325e-07,0.08813666263107267,0.03834710743801642,0.014507411718254981,0.10302089088291222,0.03636509681585019,0.014486412327622933,0.09672044509624689,0.04447505408328825,1.8948778188548325e-07,0.12061651697975861,0.030620466638990568
114,0.1,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' boycott call influence polio vaccination coverage in Kenya? Yes, the boycott call by Catholic bishops notably impacted polio vaccination coverage in Kenya in 2015, causing a reduction in immunization rates and heightened skepticism towards vaccines, which contributed to a public health crisis.",2.1317375462116866e-07,0.02561913516564962,0.09347182399130445,0.016320838183036854,0.0373226404552609,0.0978519505104961,0.0162972138685758,0.05909539136107522,0.08716425619834711,2.1317375462116866e-07,0.08147629011537694,0.07496876301541025
114,0.1,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call affect polio vaccination rates in Kenya in 2015? Yes, the boycott call by Catholic bishops significantly reduced polio vaccination coverage in Kenya in 2015, leading to lower immunization rates and increased vaccine hesitancy, which contributed to a public health crisis.",2.6054570009253947e-07,0.04485228901487437,0.11030427579018781,0.0199476911126006,0.053007425176768486,0.11852539919171311,0.019918816950481533,0.07375122407961276,0.109375,2.6054570009253947e-07,0.12799630575027088,0.07496876301541025
114,0.1,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the polio vaccination coverage in Kenya in 2015 influenced by the Catholic bishops' boycott call? Yes, the boycott call by Catholic bishops had a significant impact on polio vaccination coverage in Kenya in 2015, resulting in decreased immunization rates and increased skepticism about vaccines, contributing to a public health crisis.",1.4211583641411244e-07,0.04510495596384123,0.09958167533925102,0.010880558788691236,0.02703695758098279,0.06025272594157456,0.0108648092457172,0.05039372643527695,0.04715277777777778,1.4211583641411244e-07,0.07450957173293782,0.03249962721294112
115,0.1,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy feasible? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically possible. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.1,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy in a porcine model is technically achievable. Additional experiments focusing on long-term survival are planned.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.1,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to perform transgastric endoscopic splenectomy? Answer: In a pig model, transgastric endoscopic splenectomy appears to be technically feasible. More long-term survival tests are intended.",9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
115,0.1,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: is it achievable? Answer: The procedure seems technically feasible in a porcine model. Further long-term survival experiments will be conducted.,0.0,0.06027366787477817,0.04338842975206613,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
115,0.1,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be performed? Answer: It appears technically feasible in a porcine model. Additional long-term survival studies are planned.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.1,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy technically possible? Answer: In a pig model, the procedure seems feasible. Further long-term survival experiments are planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.1,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy doable? Answer: The technique appears feasible in a porcine model. Additional long-term survival research is planned.,7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
115,0.1,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it feasible to perform transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy in a pig model appears technically possible. More long-term survival experiments are planned.,4.73719454713706e-08,0.08820350236903352,0.0034578741965105714,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.1,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: can it be done? Answer: It seems technically feasible in a porcine model. Further long-term survival studies are planned.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.1,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy possible? Answer: The procedure appears technically feasible in a porcine model. Additional long-term survival experiments are planned.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
116,0.1,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Is fondaparinux used in perioperative bridging? Its role in perioperative bridge therapy remains unestablished, with notable limitations preventing its routine use.",3.7897556377096486e-07,0.5800850295625648,0.005501825954432639,0.029014823436510073,0.571300672005262,0.02854671280276816,0.028972824655245977,0.635988766719997,0.0,3.789755637709663e-07,0.6632942174102641,0.0
116,0.1,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Does fondaparinux have a role in perioperative bridging? The use of fondaparinux for perioperative bridging is not well established and has significant limitations for routine application.,2.605457000925383e-07,0.28762676019236055,0.055363321799307974,0.019947691112600675,0.337685820823757,0.02854671280276816,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
116,0.1,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",What is the role of fondaparinux in perioperative bridging? Fondaparinux's role in perioperative bridge therapy is unclear and it has important restrictions that limit its routine use.,2.36859727356853e-07,0.30172506092830487,0.016963321799307964,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.1,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Can fondaparinux be used for perioperative bridging? The role of fondaparinux in perioperative bridging has not been defined and there are key limitations to its regular use.,2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.1,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Is fondaparinux indicated for perioperative bridging? Its role in perioperative bridge therapy is not established, with important constraints on its routine use.",3.552895910352795e-07,0.461980147337139,0.055363321799307974,0.027201396971728194,0.5200073776177119,0.02854671280276816,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
116,0.1,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Does fondaparinux serve a purpose in perioperative bridging? The role of fondaparinux in perioperative bridging is not established and it has significant limitations for routine use.,2.605457000925383e-07,0.34307853463715565,0.015432766243752415,0.019947691112600675,0.337685820823757,0.02854671280276816,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
116,0.1,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Is there an established role for fondaparinux in perioperative bridging? Fondaparinux's role in perioperative bridge therapy is not established and it has important limitations for routine bridging.,2.36859727356853e-07,0.30172506092830487,0.016963321799307964,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.1,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","What role does fondaparinux play in perioperative bridging? The role of fondaparinux in perioperative bridging remains unestablished, with notable limitations for routine use.",3.316036182995942e-07,0.47847351175314934,0.010011847876405466,0.025387970506946314,0.4712172134482806,0.02854671280276816,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
116,0.1,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Is fondaparinux recommended for perioperative bridging? Its role in perioperative bridge therapy is not established and there are important limitations to its routine use.,3.079176455639089e-07,0.371008369131411,0.055363321799307974,0.023574544042164434,0.42469719781338666,0.02854671280276816,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
116,0.1,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Is fondaparinux effective in perioperative bridging? The role of fondaparinux in perioperative bridging has not been established and it has significant limitations for routine use.,2.842316728282236e-07,0.38621101975927585,0.013775420097984714,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
117,0.1,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do individuals with episodic migraines focus specifically on visual stimuli related to headaches? Studies suggest that those with episodic migraines tend to pay more attention to headache-related visual cues. This selective attention is linked to a cognitive bias towards such stimuli, which might influence the occurrence and severity of migraine attacks. Nonetheless, personal experiences differ widely.",1.4211583641411244e-07,0.2065607913586609,0.06441128574328674,0.010880558788691236,0.17875431542786036,0.043710296269926036,0.0108648092457172,0.17913556125142005,0.04246913580246913,1.4211583641411244e-07,0.152739156029722,0.021728395061728398
117,0.1,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraine sufferers more likely to notice headache-related visual stimuli? Research shows that episodic migraineurs often exhibit selective attention to visual cues associated with headaches. This tendency stems from a cognitive bias that may affect how frequently and intensely migraines occur. However, the degree of this effect varies among individuals.",2.3685972735685406e-08,0.16166131559505859,0.10072314049586772,0.0018134264647818726,0.10726268477272871,0.06222222222222222,0.0018108015409528666,0.08004465860719012,0.04246913580246913,2.3685972735685406e-08,0.051643039158352,0.021728395061728398
117,0.1,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people experiencing episodic migraines selectively focus on headache-related visual information? Evidence suggests that episodic migraineurs have a cognitive bias that leads them to attend more to headache-related visual stimuli, potentially impacting the frequency and intensity of their migraines. Individual responses, however, can be quite diverse.",9.474389094274162e-08,0.025494258579012996,0.07851239669421484,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
117,0.1,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is there selective attention to headache-related visual stimuli among episodic migraine patients? Findings indicate that episodic migraineurs may demonstrate a cognitive bias that causes them to focus on headache-related visual cues, which could contribute to migraine frequency and severity. Still, experiences differ from person to person.",9.474389094274162e-08,0.025494258579012996,0.07851239669421484,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
117,0.1,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraine sufferers show a preference for attending to headache-related visual stimuli? Research points to a cognitive bias in episodic migraineurs that makes them more likely to notice headache-related visual information, possibly influencing migraine episodes' frequency and intensity. Individual variability is significant, though.",1.4211583641411244e-07,0.02140097788649875,0.07748051011038021,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
117,0.1,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are headache-related visual stimuli selectively attended to by those with episodic migraines? Studies suggest that episodic migraineurs possess a cognitive bias toward such stimuli, which may play a role in the frequency and intensity of their migraine attacks. However, individual experiences vary considerably.",1.6580180914979784e-07,0.012692071549718964,0.10072314049586772,0.012693985253473108,0.07098554663359025,0.06222222222222222,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.13494291642206147,0.021728395061728398
117,0.1,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraine patients selectively attend to visual stimuli linked to headaches? Research indicates a cognitive bias in episodic migraineurs that leads to increased attention to headache-related visual cues, potentially affecting migraine frequency and severity. Nonetheless, individual experiences can differ greatly.",2.1317375462116866e-07,0.06148223571915068,0.10072314049586772,0.016320838183036854,0.12099596720825367,0.06222222222222222,0.0162972138685758,0.15357019257431448,0.04246913580246913,2.1317375462116866e-07,0.1875866499074803,0.021728395061728398
117,0.1,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is selective attention to headache-related visual stimuli present in episodic migraineurs? Evidence shows that episodic migraine sufferers may have a cognitive bias toward these stimuli, which might contribute to how often and how severely migraines occur. However, there is considerable individual variation.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
117,0.1,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do individuals with episodic migraines exhibit selective attention to headache-related visual cues? Research suggests that a cognitive bias causes episodic migraineurs to focus more on headache-related visual stimuli, potentially influencing migraine frequency and intensity. Yet, individual experiences can vary widely.",2.3685972735685396e-07,0.12234605296292633,0.07509987179780678,0.018134264647818726,0.14697145361151165,0.06222222222222222,0.018108015409528666,0.18023843965647535,0.04246913580246913,2.3685972735685406e-07,0.21498562409559563,0.021728395061728398
117,0.1,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraineurs more likely to selectively attend to headache-related visual stimuli? Studies indicate that a cognitive bias toward headache-related cues exists in episodic migraineurs, which may affect the frequency and severity of migraine episodes. However, personal experiences differ significantly.",2.3685972735685396e-07,0.08680004370344241,0.10072314049586772,0.018134264647818726,0.14697145361151165,0.06222222222222222,0.018108015409528666,0.18023843965647535,0.04246913580246913,2.3685972735685406e-07,0.21498562409559563,0.021728395061728398
118,0.1,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is a surgeon's prior experience a factor in their ability to perform transurethral resection of the prostate? Yes, previous experience significantly impacts a surgeon's skill in performing transurethral resection of the prostate, with increased practice resulting in better proficiency, fewer complications, and improved patient outcomes. Hence, prior experience is essential for successful surgeries.",1.6580180914979784e-07,0.022366915095670237,0.09506564056133997,0.012693985253473108,0.05603440658670822,0.12578020153639685,0.012675610786670066,0.035813480002059084,0.11661807580174927,1.6580180914979784e-07,0.01500014606689426,0.10560000000000003
118,0.1,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does a surgeon's experience affect their capability to carry out transurethral resection of the prostate? Indeed, the surgeon's previous experience plays a crucial role in their ability to perform this procedure effectively, as skill improves with practice, reducing complications and enhancing patient results. Therefore, prior experience is vital for successful operations.",2.1317375462116866e-07,0.11644373666545382,0.19013128112267996,0.016320838183036854,0.07039355672280934,0.16493055555555555,0.0162972138685758,0.02271737270420271,0.136609745939192,2.1317375462116866e-07,0.02667255033367466,0.10560000000000003
118,0.1,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the skill to perform transurethral resection of the prostate dependent on the surgeon's past experience? Yes, the surgeon's previous experience influences their proficiency in this procedure, with more practice leading to fewer complications and better patient outcomes, making prior experience important for success.",3.789755637709665e-07,0.06661855681610351,0.16688865073719245,0.029014823436509962,0.0837571231044496,0.16493055555555555,0.028972824655245866,0.1349115714993805,0.136609745939192,3.789755637709665e-07,0.1879406979297964,0.10560000000000003
118,0.1,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's previous experience influence their ability to perform transurethral resection of the prostate? Yes, experience gained from prior procedures improves the surgeon's skill, resulting in fewer complications and better outcomes for patients, thus making prior experience critical for successful surgeries.",4.263475092423373e-07,0.11581925964667361,0.16575628112267995,0.03264167636607371,0.13254728727388132,0.16493055555555555,0.0325944277371516,0.18492199207404392,0.136609745939192,4.263475092423373e-07,0.2392339923173461,0.10560000000000003
118,0.1,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the ability to conduct transurethral resection of the prostate affected by the surgeon's earlier experience? Yes, a surgeon's earlier experience enhances their proficiency in this operation, which leads to reduced complications and improved patient outcomes, highlighting the importance of prior experience for success.",3.789755637709665e-07,0.06661855681610351,0.16688865073719245,0.029014823436509962,0.0837571231044496,0.16493055555555555,0.028972824655245866,0.1349115714993805,0.136609745939192,3.789755637709665e-07,0.1879406979297964,0.10560000000000003
118,0.1,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does prior experience impact a surgeon's ability to perform transurethral resection of the prostate? Yes, the surgeon's skill in this procedure improves with experience, leading to fewer complications and better patient outcomes, making previous experience essential for successful operations.",4.974054274493933e-07,0.15799310903630515,0.19013128112267996,0.038081955760419325,0.2105088287435919,0.16493055555555555,0.0380268323600102,0.2649646997475781,0.136609745939192,4.974054274493935e-07,0.32147209055431913,0.10560000000000003
118,0.1,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon's capability to perform transurethral resection of the prostate influenced by their previous experience? Yes, prior experience is a key factor that improves proficiency, decreases complications, and enhances patient outcomes in this procedure, thus being critical for success.",4.73719454713708e-07,0.13201762263304717,0.19013128112267996,0.03626852929563745,0.18384058166143102,0.16493055555555555,0.03621603081905733,0.23756572555946276,0.136609745939192,4.737194547137081e-07,0.2933012135876223,0.10560000000000003
118,0.1,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the ability to perform transurethral resection of the prostate depend on the surgeon's past experience? Yes, the surgeon's previous experience positively affects their skill level, resulting in fewer complications and improved outcomes, making prior experience crucial for successful surgeries.",4.73719454713708e-07,0.1675636318925311,0.16450801242461902,0.03626852929563745,0.18384058166143102,0.16493055555555555,0.03621603081905733,0.23756572555946276,0.136609745939192,4.737194547137081e-07,0.2933012135876223,0.10560000000000003
118,0.1,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon's previous experience a determinant in their ability to perform transurethral resection of the prostate? Yes, experience gained from earlier procedures enhances proficiency, reduces complications, and improves patient outcomes, underscoring the importance of prior experience for success.",4.974054274493933e-07,0.15799310903630515,0.19013128112267996,0.038081955760419325,0.2105088287435919,0.16493055555555555,0.0380268323600102,0.2649646997475781,0.136609745939192,4.974054274493935e-07,0.32147209055431913,0.10560000000000003
118,0.1,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the skill to perform transurethral resection of the prostate influenced by the surgeon's prior experience? Yes, the surgeon's previous experience plays a significant role in improving proficiency, minimizing complications, and achieving better patient outcomes, making it critical for successful operations.",4.500334819780227e-07,0.14135717367675182,0.16514771767757805,0.03445510283085558,0.15786509525817305,0.16493055555555555,0.034405229278104466,0.2108974784773019,0.136609745939192,4.500334819780227e-07,0.26590223939950697,0.10560000000000003
119,0.1,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
119,0.1,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the link between marital status, living arrangement, and mortality differ by gender? Answer: Yes, gender influences the relationship between marital status, living arrangement, and mortality. Research indicates that men living alone or unmarried generally experience higher mortality rates, whereas women often exhibit higher",1.1842986367842703e-07,0.15199722769759205,0.030780918986047193,0.009067132323909363,0.21007737767889445,0.07122080521112455,0.009054007704764333,0.21149900922096876,0.0710059171597633,1.1842986367842703e-07,0.1826934449613664,0.04865220249835634
119,0.1,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is there a gender difference in how marital status and living arrangements relate to mortality? Answer: Yes, the connection between marital status, living arrangement, and mortality varies by gender. Findings suggest men have increased mortality risks when unmarried or living alone, while women tend to have higher",4.737194547137081e-08,0.07149419022146297,0.08098765432098766,0.0036268529295637453,0.013678481895465833,0.020823902218198284,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
119,0.1,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does gender affect the association between marital status, living arrangement, and mortality? Answer: Gender does affect the association between marital status, living arrangement, and mortality. Studies show men face higher mortality rates when unmarried or living alone, whereas women frequently demonstrate higher",1.4211583641411244e-07,0.27536852577082627,0.09533887629125724,0.010880558788691236,0.3356993202878411,0.13917609778180173,0.0108648092457172,0.3394478805354897,0.14204081632653065,1.4211583641411244e-07,0.31304873751514384,0.12244897959183673
119,0.1,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender modify the relationship between marital status, living arrangement, and mortality? Answer: Yes, the relationship between marital status, living arrangement, and mortality is influenced by gender. Evidence reveals men are more likely to have higher mortality rates if unmarried or living alone, while women often have higher",2.3685972735685406e-08,0.13850146076735248,0.0790123456790124,0.0018134264647818726,0.16914602490257336,0.10410173728209918,0.0018108015409528666,0.17219037490790745,0.10707911957168353,2.3685972735685406e-08,0.1452050721516538,0.08804283164782867
119,0.1,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is the association between marital status, living arrangement, and mortality different for men and women? Answer: Yes, this association varies by gender. Research has found that men living alone or unmarried tend to have higher mortality rates, while women often show higher",1.6580180914979784e-07,0.04098379320522705,0.08098765432098766,0.012693985253473108,0.1287478116802525,0.020823902218198284,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
119,0.1,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the impact of marital status and living arrangement on mortality differ by gender? Answer: Yes, gender differences exist in how marital status and living arrangement affect mortality. Men generally have higher mortality rates when unmarried or living alone, whereas women often exhibit higher",1.1842986367842703e-07,0.12049053767214213,0.009012345679012337,0.009067132323909363,0.17783797393192113,0.04855109778180171,0.009054007704764333,0.17849200062287407,0.047500000000000014,1.1842986367842703e-07,0.14888138737307655,0.024375
119,0.1,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Are there gender differences in the link between marital status, living arrangement, and mortality? Answer: Yes, gender differences are present in the association between marital status, living arrangement, and mortality. Studies indicate men have higher mortality rates when living alone or unmarried, while women often show higher",4.737194547137081e-08,0.1349751827112864,0.06338734567901234,0.0036268529295637453,0.13422581764502128,0.06534389823531647,0.003621603081905733,0.13590473601439745,0.06632653061224489,4.737194547137081e-08,0.10746514262173745,0.045351473922902494
119,0.1,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does the association between marital status, living arrangement, and mortality vary by gender? Answer: The association does vary by gender. Research suggests men experience higher mortality rates when unmarried or living alone, while women often have higher",2.6054570009253926e-07,0.2140301128737816,0.02851851851851852,0.0199476911126006,0.23140196574033478,0.020823902218198284,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
119,0.1,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the correlation between marital status, living arrangement, and mortality change with gender? Answer: Yes, the correlation between marital status, living arrangement, and mortality changes depending on gender. Studies have found men tend to have higher mortality rates when living alone or unmarried, while women often show higher",2.3685972735685406e-08,0.13850146076735248,0.0790123456790124,0.0018134264647818726,0.19864164960725184,0.12355109778180172,0.0018108015409528666,0.20232720884529654,0.1275,2.3685972735685406e-08,0.1760116135098735,0.109375
120,0.1,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the timing of living in an urban environment affect non-communicable disease risk in Thailand? Answer: Urban living was linked to higher behavioral and physiological risk factors, but these links might not directly cause increases in biological risk factors. These biological risks probably stem from a complex interplay involving long-term accumulation.",1.8948778188548325e-07,0.07522226739563642,0.0507015306122449,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
120,0.1,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How does living in an urban area impact non-communicable disease risk in Thailand over time? Answer: Urbanicity correlated with rises in behavioral and physiological risk factors, yet these connections may not directly lead to higher biological risk factors. The biological risks likely result from a complex interaction involving prolonged accumulation.",2.1317375462116866e-07,0.09502489469181619,0.0507015306122449,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
120,0.1,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Is the timing of urban living important for non-communicable disease risk in Thailand? Answer: Urban living was associated with increased behavioral and physiological risk factors, but these may not directly cause increases in biological risk factors. The biological risks are probably due to a complex interaction involving long-term accumulation.",2.3685972735685406e-07,0.14351932366484288,0.030302225056689346,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
120,0.1,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the timing of residing in urban areas influence non-communicable disease risk in Thailand? Answer: Urbanicity was linked to elevated behavioral and physiological risk factors; however, these associations might not directly increase biological risk factors. The biological risks likely arise from a complex interaction of long-term accumulation.",2.8423167282822487e-07,0.15690029840990372,0.0507015306122449,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
120,0.1,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How does urban living timing relate to non-communicable disease risk in Thailand? Answer: Urban living correlated with increased behavioral and physiological risk factors, though these may not directly translate into higher biological risk factors. The biological risks probably result from a complex interplay involving long-term accumulation.",3.079176455639103e-07,0.20854333756825572,0.028973135550516504,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
120,0.1,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does living in an urban environment at certain times affect non-communicable disease risk in Thailand? Answer: Urbanicity was associated with rises in behavioral and physiological risk factors, but these may not directly cause increases in biological risk factors. The biological risk factors likely stem from a complex interaction involving long-term accumulation.",1.8948778188548325e-07,0.10240450977053595,0.031101530612244906,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
120,0.1,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Is the timing of urban residence significant for non-communicable disease risk in Thailand? Answer: Urban living was linked to increased behavioral and physiological risk factors; however, these may not directly lead to higher biological risk factors. The biological risks probably result from a complex interaction involving long-term accumulation.",2.6054570009253947e-07,0.13584688921207055,0.0507015306122449,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
120,0.1,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How does the timing of urban living impact non-communicable disease risk in Thailand? Answer: Urbanicity correlated with increases in behavioral and physiological risk factors, but these associations might not directly cause increases in biological risk factors. The biological risks likely arise from a complex interaction involving long-term accumulation.",2.6054570009253947e-07,0.16472802173540124,0.029877628394046618,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
120,0.1,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the timing of living in urban areas matter for non-communicable disease risk in Thailand? Answer: Urban living was associated with increased behavioral and physiological risk factors, though these may not directly translate into higher biological risk factors. The biological risk factors probably result from a complex interplay involving long-term accumulation.",1.8948778188548325e-07,0.10240450977053595,0.031101530612244906,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
120,0.1,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Is timing important in the relationship between urban living and non-communicable disease risk in Thailand? Answer: Urbanicity was linked to rises in behavioral and physiological risk factors, but these may not directly increase biological risk factors. The biological risks likely stem from a complex interaction involving long-term accumulation.",2.6054570009253947e-07,0.13584688921207055,0.0507015306122449,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
121,0.1,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex affect the response to intravenous thrombolysis in ischemic stroke? Yes, sex can impact the response to intravenous thrombolysis in ischemic stroke. Research shows women might face a greater risk of symptomatic intracranial hemorrhage after treatment. Nonetheless, males and females typically experience comparable functional outcomes following thrombolysis. More studies are required for a thorough understanding.",7.105791820705622e-08,0.03703054902509706,0.010960766859765131,0.005440279394345618,0.036502088039712444,0.012177740243756535,0.0054324046228586,0.035909484458663155,0.01345876485848442,7.105791820705622e-08,0.03524657940343623,0.01480384070394862
121,0.1,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Indeed, sex can influence the response to intravenous thrombolysis in ischemic stroke. Evidence suggests women may have an increased risk of symptomatic intracranial hemorrhage post-treatment. However, functional outcomes after thrombolysis are generally similar between men and women. Additional research is necessary for a complete understanding.",4.737194547137081e-08,0.016311470091665115,0.012815993848519752,0.0036268529295637453,0.01581912048074141,0.013806228373702434,0.003621603081905733,0.015279833122093578,0.014827527873894672,4.737194547137081e-08,0.014689355737764753,0.01587989234909646
121,0.1,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex play a role in the response to intravenous thrombolysis in ischemic stroke? Yes, sex does play a role in the response to intravenous thrombolysis in ischemic stroke. Studies have found that women may be at higher risk for symptomatic intracranial hemorrhage following treatment. Despite this, both sexes usually show similar functional recovery after thrombolysis. Further investigation is needed to fully understand this relationship.",1.4211583641411244e-07,0.04914296729929202,0.03247563852459413,0.010880558788691236,0.04796712919157553,0.03508266051518645,0.0108648092457172,0.04668228479538339,0.03777274647452783,1.4211583641411244e-07,0.04527912754951169,0.040545896402618256
121,0.1,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can sex influence the effectiveness of intravenous thrombolysis in ischemic stroke? Yes, sex can influence the effectiveness of intravenous thrombolysis in ischemic stroke. Research indicates that women might have a higher likelihood of symptomatic intracranial hemorrhage after treatment. Still, functional outcomes post-thrombolysis are largely alike in men and women. More research is needed to gain a comprehensive insight.",2.3685972735685406e-08,0.020327030227851317,0.0019840061514801582,0.0018134264647818726,0.02030539356767136,0.0017937716262976244,0.0018108015409528666,0.020268983361639403,0.001572472126105326,2.3685972735685406e-08,0.020216201780815624,0.0013201076509034987
121,0.1,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke affected by sex? Yes, sex affects the response to intravenous thrombolysis in ischemic stroke. Studies suggest women have a greater risk of symptomatic intracranial hemorrhage following treatment. However, functional outcomes after thrombolysis are generally comparable between males and females. Further studies are required for a deeper understanding.",7.105791820705622e-08,0.03703054902509706,0.010960766859765131,0.005440279394345618,0.036502088039712,0.012177740243756507,0.0054324046228586,0.035909484458663155,0.01345876485848442,7.105791820705622e-08,0.03524657940343623,0.01480384070394862
121,0.1,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does gender impact the response to intravenous thrombolysis in ischemic stroke? Yes, gender can impact the response to intravenous thrombolysis in ischemic stroke. Research shows that women may face a higher risk of symptomatic intracranial hemorrhage post-treatment. Nevertheless, both genders tend to have similar functional outcomes after thrombolysis. Additional research is needed for a full understanding.",7.105791820705622e-08,0.06223590104545895,0.006149978373702403,0.005440279394345618,0.0621742058382293,0.005568771626297583,0.0054324046228586,0.0620659818382836,0.004888444348327553,7.105791820705622e-08,0.061906086348049616,0.004108996539792395
121,0.1,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is there a sex difference in response to intravenous thrombolysis in ischemic stroke? Yes, there is a sex difference in response to intravenous thrombolysis in ischemic stroke. Studies reveal women might have an elevated risk of symptomatic intracranial hemorrhage after treatment. Yet, functional outcomes post-thrombolysis are usually alike in men and women. More research is essential for comprehensive knowledge.",0.0,0.04780325383172013,0.031521532182300735,0.0,0.04864190740771557,0.03280351756548962,0.0,0.0495105128971387,0.03402145171794212,0.0,0.05041070404072334,0.035175334639658176
121,0.1,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does intravenous thrombolysis response in ischemic stroke vary by sex? Yes, the response to intravenous thrombolysis in ischemic stroke can vary by sex. Evidence points to women having a higher risk of symptomatic intracranial hemorrhage following treatment. However, functional outcomes are generally similar between sexes after thrombolysis. Further research is needed to fully understand this variation.",7.105791820705622e-08,0.013380155015626283,0.04613610149942331,0.005440279394345618,0.06618638315435454,0.08529430242140623,0.0054324046228586,0.06871650505981908,0.08842752787389466,7.105791820705622e-08,0.04473194143040393,0.07227989234909649
121,0.1,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can sex differences affect outcomes of intravenous thrombolysis in ischemic stroke? Yes, sex differences can affect outcomes of intravenous thrombolysis in ischemic stroke. Studies indicate women may be at increased risk for symptomatic intracranial hemorrhage post-treatment. Despite this, functional recovery after thrombolysis is typically comparable between men and women. More research is necessary for a complete understanding.",4.737194547137081e-08,0.041066726540234466,0.00403298574331698,0.0036268529295637453,0.01581912048074141,0.013806228373702434,0.003621603081905733,0.015279833122093578,0.014827527873894672,4.737194547137081e-08,0.014689355737764753,0.01587989234909646
121,0.1,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the efficacy of intravenous thrombolysis in ischemic stroke influenced by sex? Yes, the efficacy of intravenous thrombolysis in ischemic stroke is influenced by sex. Research suggests women might have a higher chance of symptomatic intracranial hemorrhage after treatment. Nonetheless, functional outcomes after thrombolysis are generally similar across sexes. Further studies are needed for a thorough understanding.",4.737194547137081e-08,0.06582198298880426,0.020472895040369074,0.0036268529295637453,0.041024472501103304,0.0036489986150522458,0.003621603081905733,0.04095195092060999,0.0032009602560512523,4.737194547137081e-08,0.0408458531173852,0.00268887066631375
122,0.1,1,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal-induced anxiety in alcoholism linked to a deficiency in beta-endorphin? Yes, anxiety caused by withdrawal in alcoholism is connected to a lack of beta-endorphin. Beta-endorphin is a peptide that helps regulate stress and pain. When alcohol",7.10579182070559e-08,0.13602178369588858,0.034636678200692064,0.005440279394345639,0.17625555625968126,0.06222222222222223,0.005432404622858621,0.1370924930703663,0.0322222222222222,7.105791820705622e-08,0.09531017980432521,0.0
122,0.1,2,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does withdrawal-induced anxiety in alcoholism stem from beta-endorphin deficiency? Indeed, anxiety during withdrawal in alcoholism is related to beta-endorphin deficiency. Beta-endorphin is a peptide that plays a role in controlling stress and pain. When alcohol",2.36859727356853e-08,0.11510635968914018,0.0606152433425161,0.0018134264647818796,0.11741505623674797,0.06222222222222223,0.0018108015409528735,0.07646787125393084,0.0322222222222222,2.3685972735685406e-08,0.0327898228229917,0.0
122,0.1,3,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety experienced during alcohol withdrawal due to a shortage of beta-endorphin? Yes, withdrawal anxiety in alcoholism is associated with a deficiency of beta-endorphin. Beta-endorphin is a peptide responsible for managing stress and pain. When alcohol",7.10579182070559e-08,0.21303813709143826,0.09000000000000004,0.005440279394345639,0.17625555625968126,0.06222222222222223,0.005432404622858621,0.1370924930703663,0.0322222222222222,7.105791820705622e-08,0.09531017980432521,0.0
122,0.1,4,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is beta-endorphin deficiency the cause of withdrawal-induced anxiety in alcoholism? Yes, anxiety induced by withdrawal in alcoholism is linked to a deficiency in beta-endorphin. Beta-endorphin is a peptide involved in the regulation of stress and pain. When alcohol",9.47438909427412e-08,0.24043711127955358,0.09000000000000004,0.007253705859127511,0.2044264332263781,0.06222222222222223,0.007243206163811494,0.1660800299436178,0.0322222222222222,9.474389094274162e-08,0.125163142954007,0.0
122,0.1,5,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal anxiety in alcoholism caused by a lack of beta-endorphin? Yes, the anxiety that occurs during withdrawal in alcoholism is indeed related to beta-endorphin deficiency. Beta-endorphin is a peptide that helps manage stress and pain. When alcohol",9.47438909427412e-08,0.20296969611415117,0.06299382716049387,0.007253705859127511,0.2044264332263781,0.06222222222222223,0.007243206163811494,0.1660800299436178,0.0322222222222222,9.474389094274162e-08,0.125163142954007,0.0
122,0.1,6,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety from alcohol withdrawal due to beta-endorphin deficiency? Yes, withdrawal-induced anxiety in alcoholism is connected to a deficiency in beta-endorphin. Beta-endorphin is a peptide that regulates stress and pain. When alcohol",2.36859727356853e-08,0.09525510143505445,0.09000000000000004,0.0018134264647818796,0.05489469925541446,0.06222222222222223,0.0018108015409528735,0.011929350116359316,0.0322222222222222,2.3685972735685406e-08,0.03390155167568176,0.0
122,0.1,7,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is beta-endorphin deficiency responsible for withdrawal-induced anxiety in alcoholism? Yes, anxiety during withdrawal in alcoholism is associated with a lack of beta-endorphin. Beta-endorphin is a peptide that helps control stress and pain. When alcohol",0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
122,0.1,8,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety linked to alcohol withdrawal caused by beta-endorphin deficiency? Yes, withdrawal anxiety in alcoholism is indeed related to beta-endorphin deficiency. Beta-endorphin is a peptide involved in stress and pain management. When alcohol",0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
122,0.1,9,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety experienced during alcoholism withdrawal due to beta-endorphin deficiency? Yes, withdrawal-induced anxiety in alcoholism is connected to a deficiency of beta-endorphin. Beta-endorphin is a peptide that regulates stress and pain. When alcohol",0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
122,0.1,10,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal-induced anxiety in alcoholism a result of beta-endorphin deficiency? Yes, anxiety caused by withdrawal in alcoholism is associated with a lack of beta-endorphin. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol",4.73719454713706e-08,0.1452588498070302,0.06145328719723188,0.003626852929563759,0.14726801938642975,0.06222222222222223,0.003621603081905747,0.10723952992068453,0.0322222222222222,4.737194547137081e-08,0.06453852113757153,0.0
123,0.1,1,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are we adhering to guidelines when preparing high-risk fall patients for discharge home after rehabilitation? Compliance with these guidelines varies, emphasizing the importance of thorough assessments, individualized care plans, patient education, and home safety measures. Nonetheless, research indicates inconsistent application, pointing to areas needing enhancement.",4.500334819780227e-07,0.35894509247327333,0.0,0.03445510283085558,0.3659342693515293,0.0,0.034405229278104466,0.3732042458899425,0.0,4.500334819780227e-07,0.3807724955177916,0.0
123,0.1,2,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we follow the recommended guidelines for discharging patients at high risk of falls after rehabilitation? While it is essential to conduct comprehensive evaluations, tailor care plans, provide education, and ensure home safety, adherence to these protocols is inconsistent according to studies, indicating room for improvement.",4.263475092423373e-07,0.3364722366212156,0.0,0.03264167636607371,0.34294475112682976,0.0,0.0325944277371516,0.3496737484797481,0.0,4.263475092423373e-07,0.35667494393873156,0.0
123,0.1,3,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is the preparation of high fall-risk patients for home discharge after rehabilitation aligned with established guidelines? Ensuring detailed assessments, customized care strategies, patient education, and home safety is vital, yet evidence shows variable compliance, suggesting the need for better implementation.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
123,0.1,4,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","When discharging patients at high risk of falls post-rehabilitation, do we meet the guidelines? Proper preparation involves thorough assessments, personalized care plans, education, and home safety precautions, but studies reveal inconsistent adherence, highlighting the necessity for improvement.",6.395212638635055e-07,0.5596157879354249,0.0,0.04896251454911056,0.5717863235556782,0.0,0.048891641605727405,0.5845133395571485,0.0,6.39521263863506e-07,0.5978370007556193,0.0
123,0.1,5,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are guidelines being met in preparing high-risk fall patients for discharge home following rehabilitation? Comprehensive assessments, individualized care, education, and home safety are critical, but research points to inconsistent guideline application, underscoring the need for enhanced practices.",6.395212638635055e-07,0.5596157879354249,0.0,0.04896251454911056,0.5717863235556782,0.0,0.048891641605727405,0.5845133395571485,0.0,6.39521263863506e-07,0.5978370007556193,0.0
123,0.1,6,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we comply with guidelines for preparing patients at high risk of falls for home discharge after rehabilitation? It is crucial to have complete assessments, tailored care plans, patient education, and home safety measures, yet studies show inconsistent implementation, indicating a need for improvement.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.1,7,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is guideline compliance achieved when preparing high-risk fall patients for discharge home post-rehabilitation? Ensuring thorough assessments, personalized care, education, and home safety is essential, but evidence suggests inconsistent adherence, highlighting areas for improvement.",7.342651548062467e-07,0.6773988235918087,0.0,0.05621622040823808,0.693147180559945,0.0,0.0561348477695389,0.7096764825111554,0.0,7.342651548062476e-07,0.7270487322356263,0.0
123,0.1,8,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are the guidelines followed when preparing patients at high risk of falls for discharge home after rehabilitation? Comprehensive assessments, individualized care plans, education, and home safety are necessary, but studies indicate inconsistent compliance, pointing to the need for better implementation.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
123,0.1,9,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we meet the standards for preparing high-risk fall patients for home discharge after rehabilitation? It is vital to conduct thorough assessments, develop personalized care plans, provide education, and ensure home safety, yet research shows inconsistent adherence, emphasizing the need for improvement.",5.210914001850789e-07,0.4295626596872273,0.0,0.0398953822252012,0.4382549309311554,0.0,0.039837633900963065,0.44731221804366594,0.0,5.210914001850789e-07,0.456758402495713,0.0
123,0.1,10,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is the preparation of patients at high risk of falls for discharge home after rehabilitation consistent with guidelines? While comprehensive assessments, tailored care plans, education, and home safety are critical, studies reveal variable compliance, highlighting the need for enhanced implementation.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
124,0.1,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage appears to be both effective and safe for preventing CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, as well as for treating existing CSF leaks.",1.8948778188548325e-07,0.1880977832986206,0.004159661226903637,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
124,0.1,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistulas after spine surgery? Evidence suggests lumbar drainage is a safe and effective approach to prevent CSF fistulas in cases involving large dural tears and compromised patients, and it also helps in treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.1,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a reliable treatment for cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to be a safe and effective option for preventing CSF fistulas in patients with significant dural tears or those who are debilitated or irradiated, and it is also useful in managing CSF leaks.",1.8948778188548325e-07,0.1880977832986206,0.004159661226903637,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
124,0.1,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Can lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage is considered both safe and effective in preventing CSF fistulas in patients with large dural tears or weakened conditions and in treating CSF leaks.,2.36859727356853e-08,0.02620645821577927,0.000639705252959033,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
124,0.1,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage effective and safe for postoperative cerebrospinal fluid fistulas after spine surgery? It appears to be effective in preventing CSF fistulas in cases of large dural tears and in debilitated or irradiated patients, as well as in treating CSF leaks.",2.3685972735685406e-08,0.05934997161836808,0.02498356344510192,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.1,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Does lumbar drainage provide effective management for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is regarded as a safe and effective method to prevent CSF fistulas in patients with large dural tears or compromised health and to treat CSF leaks.,2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.1,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a beneficial intervention for postoperative cerebrospinal fluid fistulas after spine surgery? It seems to be both effective and safe in preventing CSF fistulas in patients with extensive dural tears or those debilitated or irradiated, and in treating CSF leaks.",2.3685972735685406e-08,0.05934997161836808,0.02498356344510192,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.1,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How effective is lumbar drainage in managing postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage appears to be a safe and effective technique for preventing CSF fistulas in cases of large dural tears and in debilitated or irradiated patients, as well as for treating CSF leaks.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,0.1,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage a safe and effective approach for postoperative cerebrospinal fluid fistulas after spine surgery? It seems to prevent CSF fistulas in patients with large dural tears or compromised conditions and is also effective in treating CSF leaks.,4.73719454713706e-08,0.016635935359553322,0.02498356344510192,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
124,0.1,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage safely and effectively prevent and treat postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered effective and safe for preventing CSF fistulas in cases of large dural tears and debilitated or irradiated patients, as well as for treating CSF leaks.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
125,0.1,1,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? The simultaneous use of a neuroendoscope does not directly impact the incidence of ventriculoperitoneal shunt infection. However, it allows for",9.47438909427412e-08,0.14056572735479023,0.14433673469387753,0.007253705859127518,0.1548139535074613,0.17972405350069295,0.007243206163811494,0.12284178872360929,0.1728395061728395,9.474389094274162e-08,0.039755402515464944,0.12244897959183673
125,0.1,2,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is the incidence of ventriculoperitoneal shunt infection influenced by the concurrent use of a neuroendoscope? The concurrent use of a neuroendoscope does not directly affect the incidence of ventriculoperitoneal shunt infection. However, it allows for",2.36859727356853e-08,0.04090965780506162,0.026982248520710128,0.0018134264647818796,0.04428042514549979,0.04017824530645034,0.0018108015409528735,0.04799506639687534,0.05039052658100278,2.3685972735685406e-08,0.05209975094670494,0.05823970491882842
125,0.1,3,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does employing a neuroendoscope at the same time alter the frequency of ventriculoperitoneal shunt infections? Using a neuroendoscope simultaneously does not directly change the incidence of ventriculoperitoneal shunt infection. However, it allows for",7.10579182070559e-08,0.176506848132433,0.14725326991676574,0.005440279394345639,0.18909441542843153,0.18079552925706766,0.005432404622858621,0.15674334039929105,0.1728395061728395,7.105791820705622e-08,0.07484672232673395,0.12244897959183673
125,0.1,4,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the simultaneous application of a neuroendoscope impact the occurrence of ventriculoperitoneal shunt infections? The simultaneous application of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",4.73719454713706e-08,0.04318116291662477,0.0432544378698225,0.003626852929563759,0.04895379275737888,0.062126119106175964,0.003621603081905747,0.05537564440422882,0.07717624086671702,4.737194547137081e-08,0.016328649927756622,0.05612244897959186
125,0.1,5,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is there an effect on ventriculoperitoneal shunt infection rates when a neuroendoscope is used simultaneously? Using a neuroendoscope simultaneously does not directly affect the incidence of ventriculoperitoneal shunt infection. However, it allows for",7.10579182070559e-08,0.2198285469174297,0.17777777777777776,0.005440279394345639,0.23381358836778254,0.21301775147928986,0.005432404622858621,0.15674334039929105,0.1728395061728395,7.105791820705622e-08,0.07484672232673395,0.12244897959183673
125,0.1,6,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the use of a neuroendoscope at the same time affect the incidence of ventriculoperitoneal shunt infection? The use of a neuroendoscope at the same time does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",9.47438909427412e-08,0.07774557670353088,0.006913580246913603,0.0072537058591274975,0.07259823805115628,0.016574085255404047,0.00724320616381148,0.06672455005814193,0.026922681698741957,9.474389094274162e-08,0.060020770609722884,0.0375510204081633
125,0.1,7,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does simultaneous neuroendoscope use influence the rate of ventriculoperitoneal shunt infections? Simultaneous neuroendoscope use does not directly impact the incidence of ventriculoperitoneal shunt infection. However, it allows for",1.894877818854824e-07,0.06880403469610474,0.09633270321361062,0.014507411718255037,0.04871510587433514,0.13662886259040097,0.014486412327622988,0.025578216394663844,0.1728395061728395,1.8948778188548325e-07,0.114395277311794,0.12244897959183673
125,0.1,8,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the concurrent use of a neuroendoscope affect the incidence of ventriculoperitoneal shunt infection? The concurrent use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",4.73719454713706e-08,0.040836677151246725,0.005624999999999991,0.003626852929563759,0.03768960481261363,0.011417751479289834,0.003621603081905747,0.0340627014744741,0.01751406238585726,4.737194547137081e-08,0.029881162109573367,0.023683547493071277
125,0.1,9,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the simultaneous employment of a neuroendoscope change the incidence of ventriculoperitoneal shunt infection? The simultaneous employment of a neuroendoscope does not directly affect the incidence of ventriculoperitoneal shunt infection. However, it allows for",4.73719454713706e-08,0.040836677151246725,0.005624999999999991,0.003626852929563759,0.03768960481261363,0.011417751479289834,0.003621603081905747,0.0340627014744741,0.01751406238585726,4.737194547137081e-08,0.029881162109573367,0.023683547493071277
125,0.1,10,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is the incidence of ventriculoperitoneal shunt infection altered by the simultaneous use of a neuroendoscope? The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for",2.36859727356853e-08,0.04090965780506162,0.026982248520710128,0.0018134264647818796,0.04428042514549979,0.04017824530645034,0.0018108015409528735,0.04799506639687534,0.05039052658100278,2.3685972735685406e-08,0.05209975094670494,0.05823970491882842
126,0.1,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does using an automatic transmission enhance driving habits in elderly drivers? Switching to an automatic transmission might be advised for older drivers to help preserve safe driving and maintain their transportation quality.,9.47438909427412e-08,0.17119079256525804,0.03566256187024015,0.007253705859127518,0.17137295499133653,0.033293697978596916,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
126,0.1,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can automatic transmissions lead to better driving behavior among senior drivers? It is often suggested that older drivers switch to automatic transmissions to ensure safer driving and sustain their mobility quality.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.1,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is driving behavior improved in older drivers by using automatic transmissions? Recommending automatic transmissions for elderly drivers can support safer driving and uphold the quality of their transport mobility.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.1,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Do automatic transmissions contribute to improved driving in older adults? Older drivers may benefit from switching to automatic transmissions to maintain safe driving and the quality of their transportation.,1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.1,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does the use of automatic transmission positively affect driving behavior in senior drivers? Advising older drivers to switch to automatic transmissions can help them drive safely and preserve their transport mobility quality.,9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
126,0.1,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can switching to automatic transmission enhance the driving performance of older drivers? It is recommended for elderly drivers to use automatic transmissions to maintain safety and the quality of their mobility.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.1,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is automatic transmission beneficial for improving driving behavior in older drivers? Older drivers might be encouraged to adopt automatic transmissions to keep their driving safe and maintain transport mobility quality.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.1,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does automatic transmission improve the driving habits of elderly drivers? Switching to automatic transmission is often recommended for older drivers to ensure safe driving and sustain their transportation quality.,1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.1,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can older drivers improve their driving behavior by using automatic transmissions? It is suggested that older drivers switch to automatic transmissions to maintain safety and the quality of their transport mobility.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.1,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is the use of automatic transmission advisable for enhancing driving behavior in older drivers? Older drivers may be advised to switch to automatic transmissions to promote safe driving and preserve the quality of their mobility.,2.36859727356853e-08,0.010620873444459722,0.02854671280276816,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
127,0.1,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact outcomes in colon and rectal surgery? Answer: Analysis of a large multicenter database indicates that severe, moderate, and even mild preoperative anemia independently increase the risk of complications and prolong hospital stays following colon surgery.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.1,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia associated with worse outcomes in colon and rectal surgery? Answer: Findings from a large multicenter database study show that severe, moderate, and mild preoperative anemia are independent risk factors for postoperative complications and extended hospitalization after colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.1,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having anemia before surgery affect the results of colon and rectal operations? Answer: This extensive multicenter database analysis reveals that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays after colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.1,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia a risk factor for poor outcomes in colon and rectal surgery? Answer: According to a large multicenter database analysis, severe, moderate, and even mild anemia before surgery independently increase the likelihood of complications and lengthen hospital stays post-colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.1,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does anemia prior to surgery worsen outcomes in colon and rectal procedures? Answer: The analysis of a large multicenter database suggests that severe, moderate, and mild preoperative anemia independently raise the risk of complications and prolong hospitalization after colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.1,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia adversely influence colon and rectal surgery results? Answer: Data from a large multicenter database analysis indicate that severe, moderate, and mild anemia before surgery are independent predictors of complications and longer hospital stays following colon surgery.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.1,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia linked to poorer outcomes in colon and rectal surgery? Answer: This large multicenter database study suggests that severe, moderate, and mild anemia present before surgery independently increase the risk of postoperative complications and extended hospital stays after colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.1,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does the presence of anemia before surgery affect colon and rectal surgery outcomes? Answer: Analysis from a large multicenter database shows that severe, moderate, and mild preoperative anemia independently elevate the risk of complications and lengthen hospital stays after colon surgery.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.1,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia impact the success of colon and rectal surgeries? Answer: Evidence from a large multicenter database analysis demonstrates that severe, moderate, and mild anemia before surgery independently contribute to higher complication rates and longer hospital stays post-colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.1,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia an independent risk factor for complications in colon and rectal surgery? Answer: This large multicenter database analysis indicates that severe, moderate, and mild anemia prior to surgery independently increase the risk of complications and prolong hospital stays after colon surgery.",2.3685972735685406e-08,0.008517171800753065,0.02271498107084911,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
128,0.1,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? Research suggests that the first urinary ACR in these women could be a prognostic indicator for negative outcomes in both mother and newborn.,1.6580180914979784e-07,0.3268085883163767,0.2490234375,0.012693985253473108,0.27558804364638245,0.24793388429752067,0.012675610786670066,0.2221749735646985,0.23615916955017302,1.6580180914979784e-07,0.1664254229518276,0.21551020408163268
128,0.1,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predict maternal and neonatal adverse outcomes? Studies show that the initial urinary ACR may act as a prognostic factor for unfavorable maternal and neonatal results.,3.0791764556390986e-07,0.09564155509356942,0.19366011570069203,0.023574544042164344,0.07775562811377679,0.2193871714947525,0.023540420032387273,0.05965604406692426,0.23615916955017302,3.079176455639103e-07,0.0006286617113366866,0.21551020408163268
128,0.1,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic marker for adverse outcomes in mothers and newborns? Evidence indicates that the initial urinary ACR might predict maternal and neonatal complications.,3.0791764556390986e-07,0.1726579084891191,0.2490234375,0.023574544042164344,0.11736403843148802,0.24793388429752067,0.023540420032387273,0.05965604406692426,0.23615916955017302,3.079176455639103e-07,0.0006286617113366866,0.21551020408163268
128,0.1,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a useful prognostic factor for maternal and neonatal adverse events? Research findings suggest that the first urinary ACR could forecast negative outcomes for both mother and child.,2.6054570009253926e-07,0.2267251297593953,0.2490234375,0.0199476911126006,0.17293388958630018,0.24793388429752067,0.019918816950481533,0.11681445790687262,0.23615916955017302,2.6054570009253947e-07,0.0582118383115966,0.21551020408163268
128,0.1,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia have prognostic value for maternal and neonatal adverse outcomes? Studies indicate that the initial urinary ACR may be predictive of poor outcomes in mothers and infants.,2.8423167282822456e-07,0.20005688267723443,0.2490234375,0.02176111757738247,0.14553491539818486,0.24793388429752067,0.0217296184914344,0.08864358094017577,0.23615916955017302,2.8423167282822487e-07,0.02922430143834509,0.21551020408163268
128,0.1,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia an indicator of potential adverse maternal and neonatal outcomes? Research supports that the initial urinary ACR might serve as a prognostic factor for such outcomes.,3.0791764556390986e-07,0.1726579084891191,0.2490234375,0.023574544042164344,0.11736403843148802,0.24793388429752067,0.023540420032387273,0.05965604406692426,0.23615916955017302,3.079176455639103e-07,0.0006286617113366866,0.21551020408163268
128,0.1,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict adverse outcomes in mothers and newborns? Evidence suggests that the first urinary ACR may be a prognostic marker for maternal and neonatal complications.,3.3160361829959516e-07,0.14448703152242226,0.2490234375,0.025387970506946224,0.08837650155823651,0.24793388429752067,0.025351221573340146,0.029803080917242486,0.23615916955017302,3.316036182995957e-07,0.031400320378090374,0.21551020408163268
128,0.1,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia linked to prognosis for maternal and neonatal adverse outcomes? Research indicates that this initial urinary ACR could be a predictor of negative outcomes for mother and baby.,2.6054570009253926e-07,0.2267251297593953,0.2490234375,0.0199476911126006,0.17293388958630018,0.24793388429752067,0.019918816950481533,0.11681445790687262,0.23615916955017302,2.6054570009253947e-07,0.0582118383115966,0.21551020408163268
128,0.1,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic factor for adverse maternal and neonatal outcomes? Studies show that the first urinary ACR may forecast complications in both mother and newborn.,2.8423167282822456e-07,0.20005688267723443,0.2490234375,0.02176111757738247,0.14553491539818486,0.24793388429752067,0.0217296184914344,0.08864358094017577,0.23615916955017302,2.8423167282822487e-07,0.02922430143834509,0.21551020408163268
128,0.1,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic indicator for maternal and neonatal adverse outcomes? Research suggests that the initial urinary ACR might predict unfavorable outcomes for mother and child.,3.3160361829959516e-07,0.14448703152242226,0.2490234375,0.025387970506946224,0.08837650155823651,0.24793388429752067,0.025351221573340146,0.029803080917242486,0.23615916955017302,3.316036182995957e-07,0.031400320378090374,0.21551020408163268
129,0.1,1,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT truly enhance multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Yes, PET/CT offers valuable metabolic insights that improve tumor extent assessment, reveal additional lesions, and support better treatment planning.",7.579511275419321e-07,0.47653868663496324,0.15089163237311393,0.05802964687301995,0.5331101427165614,0.124297520661157,0.057945649310491766,0.5694198980952057,0.11107438016528923,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
129,0.1,2,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In preoperative staging of liver metastases from colorectal cancer, does PET/CT contribute beyond multidetector CT? Indeed, PET/CT provides crucial metabolic data that refines tumor evaluation, uncovers more lesions, and aids in optimal treatment strategy.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.1,3,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is there added benefit of PET/CT over multidetector CT for preoperative staging of colorectal carcinoma liver metastases? Yes, PET/CT delivers enhanced metabolic information, enabling more precise tumor mapping, detection of extra lesions, and improved treatment guidance.",6.868932093348762e-07,0.38692652794527627,0.15089163237311393,0.05258936747867431,0.44073682258554614,0.124297520661157,0.052513244687633145,0.47410971829088044,0.11107438016528923,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
129,0.1,4,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For patients with colorectal carcinoma liver metastases, does PET/CT add value to multidetector CT in preoperative staging? Absolutely, PET/CT supplies detailed metabolic details that help accurately define tumor spread, identify additional lesions, and inform treatment decisions.",6.868932093348762e-07,0.38692652794527627,0.15089163237311393,0.05258936747867431,0.44073682258554614,0.124297520661157,0.052513244687633145,0.47410971829088044,0.11107438016528923,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
129,0.1,5,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT improve upon multidetector CT in preoperative staging of liver metastases from colorectal cancer? Yes, it provides significant metabolic insights that enhance tumor extent determination, detect further lesions, and guide effective therapy planning.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.1,6,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In staging liver metastases of colorectal carcinoma preoperatively, does PET/CT offer advantages over multidetector CT? Yes, PET/CT adds important metabolic information that aids in precise tumor assessment, reveals more lesions, and supports treatment planning.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.1,7,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is PET/CT beneficial beyond multidetector CT for preoperative staging of colorectal cancer liver metastases? Yes, it contributes valuable metabolic data that improves tumor extent evaluation, uncovers additional lesions, and assists in treatment planning.",7.579511275419321e-07,0.47653868663496324,0.15089163237311393,0.05802964687301995,0.5331101427165614,0.124297520661157,0.057945649310491766,0.5694198980952057,0.11107438016528923,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
129,0.1,8,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT provide additional benefits to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Yes, it offers enhanced metabolic insights that allow for more accurate tumor extent assessment, detection of extra lesions, and better treatment guidance.",6.158352911278203e-07,0.30468842970830323,0.15089163237311393,0.04714908808432869,0.35617943455748247,0.124297520661157,0.04708084006477453,0.3870983413012503,0.11107438016528923,6.158352911278206e-07,0.41916898027866134,0.09719008264462808
129,0.1,9,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For preoperative staging of colorectal carcinoma liver metastases, does PET/CT add value to multidetector CT? Yes, PET/CT delivers detailed metabolic information that improves tumor mapping, identifies additional lesions, and aids in effective treatment planning.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.1,10,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In the preoperative staging of liver metastases from colorectal cancer, does PET/CT add to multidetector CT? Yes, PET/CT provides significant metabolic data that enhances tumor extent determination, detects further lesions, and guides treatment planning.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
130,0.1,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? A history of PIPE might increase the risk of IPE, but multivariate analysis shows it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How significant are postictal psychotic episodes II in the long term? Are they indicative of interictal psychotic episodes? While a history of PIPE could be a risk factor for IPE, multivariate analysis suggests it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.1,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the lasting impact of postictal psychotic episodes II? Can they forecast interictal psychotic episodes? A history of PIPE may raise the risk for IPE, but multivariate analysis reveals it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term relevance of postictal psychotic episodes II? Do they serve as predictors for interictal psychotic episodes? Although PIPE history might be a risk factor for IPE, multivariate analysis indicates it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.1,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How important are postictal psychotic episodes II over time? Are they predictive of interictal psychotic episodes? A history of PIPE could be a risk factor for IPE, yet multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.1,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the enduring significance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? A history of PIPE may pose a risk for IPE, but multivariate analysis demonstrates it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.1,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term significance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? A history of PIPE might be linked to IPE risk, but multivariate analysis shows it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the lasting significance of postictal psychotic episodes II? Are they indicators of interictal psychotic episodes? While PIPE history may be a risk factor for IPE, multivariate analysis indicates it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term impact of postictal psychotic episodes II? Can they predict interictal psychotic episodes? A history of PIPE may increase IPE risk, but multivariate analysis reveals it is not an independent predictor.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
130,0.1,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the significance over time of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Although a history of PIPE may be a risk factor for IPE, multivariate analysis shows it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
131,0.1,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a previous benign prostate biopsy forecast results for patients undergoing radical perineal prostatectomy? Answer: Having a prior benign prostate biopsy might independently correlate with better surgical and biochemical outcomes post-prostatectomy. Further research is required to validate these results.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.1,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a history of benign prostate biopsy influence outcomes in patients treated with radical perineal prostatectomy? Answer: A previous benign prostate biopsy could be independently linked to improved surgical and biochemical outcomes following prostatectomy. More studies are necessary to confirm these observations.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.1,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is prior benign prostate biopsy predictive of outcomes for patients receiving radical perineal prostatectomy? Answer: Prior benign prostate biopsy may independently predict more favorable surgical and biochemical results after prostatectomy. Additional research is needed to verify these findings.,7.1057918207056e-08,0.08399402588041172,0.005652665498332279,0.005440279394345618,0.0835816537445222,0.004016055175532843,0.0054324046228586,0.08300487511182508,0.002131833342755376,7.105791820705622e-08,0.08223809823697303,0.0
131,0.1,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does having a benign prostate biopsy before surgery affect the outcomes of radical perineal prostatectomy? Answer: A prior benign prostate biopsy might be independently associated with better surgical and biochemical outcomes after prostatectomy. Further studies are needed to confirm this association.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.1,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can prior benign prostate biopsy serve as a predictor for outcomes in radical perineal prostatectomy patients? Answer: A history of benign prostate biopsy may independently relate to more favorable surgical and biochemical outcomes post-prostatectomy. Additional investigations are required to substantiate these findings.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.1,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a previous benign prostate biopsy impact the results of radical perineal prostatectomy? Answer: Prior benign prostate biopsy could be independently associated with improved surgical and biochemical outcomes after prostatectomy. More research is needed to confirm these results.,7.1057918207056e-08,0.047512595324624485,0.020245545637974087,0.005440279394345618,0.046114238579118894,0.02285532300536917,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
131,0.1,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is the outcome of radical perineal prostatectomy influenced by a prior benign prostate biopsy? Answer: A prior benign prostate biopsy may independently correlate with better surgical and biochemical outcomes following prostatectomy. Further studies are necessary to validate these findings.,4.7371945471370706e-08,0.055212275588245596,0.0036742074484456683,0.0036268529295637453,0.05494143744312874,0.0026076399575938047,0.003621603081905733,0.054565139391337336,0.0013829041414452105,4.737194547137081e-08,0.05406722127027619,0.0
131,0.1,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does prior benign prostate biopsy predict surgical and biochemical outcomes in patients treated with radical perineal prostatectomy? Answer: Having a previous benign prostate biopsy might be independently linked to more favorable outcomes after prostatectomy. Additional research is needed to confirm this.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.1,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a benign prostate biopsy done previously predict the outcome for patients undergoing radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with improved surgical and biochemical outcomes post-prostatectomy. Further studies are required to confirm these findings.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.1,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a history of benign prostate biopsy predict the prognosis for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy might independently predict better surgical and biochemical outcomes after prostatectomy. Additional research is necessary to verify these results.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
132,0.1,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? Yes, it might. Neoadjuvant chemotherapy can potentially shrink the tumor and reduce lymph node involvement, thereby limiting the extent of lymphadenectomy needed. However, further studies are necessary.",4.026615365066516e-07,0.39957520558907733,0.014891254753433364,0.030828249901291835,0.3853198363526986,0.0010366782006920386,0.030783626196198732,0.4088445604651123,0.00932333717800845,4.026615365066519e-07,0.4054651081081633,0.0
132,0.1,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it possible for neoadjuvant chemotherapy to change the extent of lymphadenectomy in cervical cancer? Yes, neoadjuvant chemotherapy may decrease tumor size and lymph node involvement, which could reduce the extent of lymphadenectomy. More research is still needed.",4.026615365066516e-07,0.3621077904236749,0.01117866114032652,0.030828249901291835,0.3468116596549238,0.028644897959183683,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
132,0.1,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can neoadjuvant chemotherapy influence how extensive lymphadenectomy is in cervical cancer? Yes, it can potentially reduce tumor burden and lymph node involvement, thus modifying the surgical scope. Additional research is required to confirm this.",4.974054274493928e-07,0.3641158961052118,0.09162848812994587,0.038081955760419346,0.42608651861353275,0.05640000000000001,0.038026832360010226,0.4905970071516679,0.01922337562475971,4.974054274493935e-07,0.5306282510621703,0.0
132,0.1,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy have the potential to modify the extent of lymphadenectomy in cervical cancer? Yes, by reducing tumor size and the number of affected lymph nodes, it may decrease the extent of lymphadenectomy, though more research is needed.",3.789755637709663e-07,0.2960001589568786,0.03915935232747673,0.029014823436509962,0.31837192393443603,0.029393827160493848,0.028972824655245866,0.34106527318070423,0.01922337562475971,3.789755637709665e-07,0.37647757123491177,0.0
132,0.1,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could the use of neoadjuvant chemotherapy affect the extent of lymphadenectomy in cervical cancer? Yes, it might reduce tumor size and lymph node involvement, potentially limiting the surgical extent. Further investigation is necessary.",5.210914001850781e-07,0.39488755477196547,0.09162848812994587,0.039895382225201226,0.4578352169281126,0.05640000000000001,0.0398376339009631,0.5233868299746596,0.01922337562475971,5.210914001850789e-07,0.564529802737852,0.0
132,0.1,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? Yes, neoadjuvant chemotherapy could shrink tumors and reduce lymph node involvement, thereby decreasing the surgical extent. More studies are required to validate this.",4.737194547137075e-07,0.33426293295553,0.09162848812994587,0.03626852929563747,0.39531485994677906,0.05640000000000001,0.03621603081905735,0.45884830883708805,0.01922337562475971,4.737194547137081e-07,0.49783842823917857,0.0
132,0.1,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can neoadjuvant chemotherapy modify the extent of lymphadenectomy in cervical cancer? Yes, it may reduce both tumor size and lymph node involvement, which could lessen the extent of lymphadenectomy. However, additional research is needed.",4.974054274493928e-07,0.44813373617308416,0.031274690002994786,0.038081955760419346,0.46940821739853034,0.025182518210197707,0.038026832360010226,0.4905970071516679,0.01922337562475971,4.974054274493935e-07,0.5306282510621703,0.0
132,0.1,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy potentially change the extent of lymphadenectomy in cervical cancer? Yes, by reducing tumor size and lymph node involvement, it may decrease the surgical scope, but further research is necessary.",5.447773729207634e-07,0.4266362530865453,0.09162848812994587,0.041708808689983105,0.4906250397511043,0.05640000000000001,0.041648435441915974,0.5572883816503413,0.01922337562475971,5.447773729207643e-07,0.599621122549121,0.0
132,0.1,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it feasible that neoadjuvant chemotherapy modifies lymphadenectomy extent in cervical cancer? Yes, it could reduce tumor and lymph node involvement, thus limiting surgery extent, though more research is required.",5.92149318392134e-07,0.49332762758521875,0.09162848812994587,0.045335661619546865,0.559617911238055,0.05640000000000001,0.04527003852382172,0.628747345632485,0.01922337562475971,5.921493183921352e-07,0.6737290947028427,0.0
132,0.1,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could neoadjuvant chemotherapy impact the extent of lymphadenectomy in cervical cancer? Yes, it may shrink tumors and reduce lymph node involvement, potentially decreasing the extent of lymphadenectomy, but more research is needed.",5.447773729207634e-07,0.5160745989652478,0.027419213456937555,0.041708808689983105,0.5368348517884338,0.023106302021403097,0.041648435441915974,0.5572883816503413,0.01922337562475971,5.447773729207643e-07,0.599621122549121,0.0
133,0.1,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors play a role in primary systemic vasculitis? Answer: For the first time, a strong link between farming and PSV has been discovered. The findings also confirm earlier reported connections with silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.1,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental influences significant in primary systemic vasculitis? Answer: A notable association between farming and PSV has been identified for the first time. The results also reinforce previously reported links with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.1,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an importance of environmental factors in primary systemic vasculitis? Answer: A significant correlation between farming and PSV has been found for the first time. The data also support earlier reported associations with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.1,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors matter in primary systemic vasculitis? Answer: A strong association between farming and PSV has been established for the first time. The results also back previously reported connections with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.1,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors relevant to primary systemic vasculitis? Answer: For the first time, a significant link between farming and PSV has been identified. The findings also uphold earlier reported associations with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.1,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there a role of environmental factors in primary systemic vasculitis? Answer: A significant association between farming and PSV has been discovered for the first time. The results also confirm previously reported links with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.1,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: How important are environmental factors in primary systemic vasculitis? Answer: A notable connection between farming and PSV has been found for the first time. The findings also support earlier reported associations with silica, solvents, and allergies.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.1,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors influential in primary systemic vasculitis? Answer: For the first time, a strong association between farming and PSV has been identified. The results also reinforce previously reported links with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.1,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors have significance in primary systemic vasculitis? Answer: A significant link between farming and PSV has been established for the first time. The data also back earlier reported associations with silica, solvents, and allergies.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.1,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is the impact of environmental factors notable in primary systemic vasculitis? Answer: A strong correlation between farming and PSV has been discovered for the first time. The findings also confirm previously reported connections with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
135,0.1,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a valid substitute for thrombolysis? Yes, primary angioplasty is recognized as an acceptable and frequently better alternative to thrombolysis, typically linked to lower death rates, decreased reinfarction risk, and reduced intracranial hemorrhage chances.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.1,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty be used instead of thrombolysis? Indeed, primary angioplasty is considered a suitable and often superior option compared to thrombolysis, usually resulting in lower mortality, fewer reinfarctions, and less intracranial bleeding.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
135,0.1,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty an appropriate alternative to thrombolysis? Yes, it is regarded as an acceptable and often preferable alternative, generally associated with decreased mortality, reduced reinfarction risk, and a lower likelihood of intracranial hemorrhage.",2.3685972735685332e-07,0.20021374673313375,0.046400951814396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
135,0.1,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Yes, primary angioplasty is often seen as an acceptable and superior alternative, commonly linked to lower death rates, fewer reinfarctions, and less risk of brain hemorrhage.",1.8948778188548272e-07,0.2601984776633337,0.038559985685603794,0.014507411718254988,0.2520824572295557,0.029384756657483937,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.1,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a recommended alternative to thrombolysis? Yes, it is considered an acceptable and frequently better alternative, with benefits including lower mortality, reduced reinfarction, and decreased intracranial hemorrhage risk.",3.316036182995945e-07,0.3294254782131407,0.046400951814396206,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
135,0.1,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty replace thrombolysis effectively? Yes, primary angioplasty is accepted as an alternative and often a better choice than thrombolysis, typically associated with lower mortality, fewer reinfarctions, and less chance of intracranial bleeding.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
135,0.1,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a viable alternative to thrombolysis? Yes, it is viewed as an acceptable and often superior alternative, generally linked to reduced mortality, lower reinfarction rates, and decreased intracranial hemorrhage risk.",2.842316728282239e-07,0.26273410371446726,0.046400951814396206,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
135,0.1,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty an effective alternative to thrombolysis? Yes, it is considered an acceptable and often preferable option, usually resulting in lower death rates, fewer reinfarctions, and less intracranial hemorrhage.",3.316036182995945e-07,0.3294254782131407,0.046400951814396206,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
135,0.1,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty an acceptable substitute for thrombolysis? Yes, it is regarded as an acceptable and often superior alternative, commonly associated with decreased mortality, reduced reinfarction risk, and less chance of intracranial hemorrhage.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
135,0.1,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a suitable alternative to thrombolysis? Yes, primary angioplasty is accepted as an alternative and often a better option, typically linked to lower mortality, fewer reinfarctions, and decreased risk of intracranial hemorrhage.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
136,0.1,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Should Culture, Attitudes, and Faith Be Included? Answer: Absolutely, recovery outcome measures need to take into account culture, attitudes, and faith as these elements greatly affect how individuals perceive recovery and their methods of coping.",4.73719454713706e-08,0.02366602914045357,0.021161600274528874,0.0036268529295637453,0.02024343114171767,0.02533083821764002,0.00362160308190574,0.01865023714217351,0.02775510204081633,4.737194547137081e-08,0.058840500022933284,0.0
136,0.1,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Are Culture, Attitudes, and Faith Relevant in Recovery Outcome Measures? Answer: Yes, incorporating culture, attitudes, and faith into recovery outcome measures is important because they profoundly shape a person's view of recovery and their recovery strategies.",0.0,0.03850817669777484,0.026730371900826458,0.0,0.039608410317710785,0.028386253221106945,0.0,0.04077336356234973,0.029384756657483937,0.0,0.0,0.0
136,0.1,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Do Culture, Attitudes, and Faith Matter? Answer: Indeed, recovery outcome measures should reflect culture, attitudes, and faith since these factors play a crucial role in influencing an individual's recovery perception and approach.",2.36859727356853e-08,0.07107998814421679,0.029738306344114673,0.0018134264647818796,0.07092585368024018,0.03004703719723184,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.1,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Should Recovery Outcome Measures Include Culture, Attitudes, and Faith? Answer: Yes, it is essential to consider culture, attitudes, and faith in recovery outcome measures as they significantly impact how a person understands and approaches recovery.",2.36859727356853e-08,0.07107998814421679,0.029738306344114673,0.0018134264647818796,0.07092585368024018,0.03004703719723184,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.1,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Is There a Role for Culture, Attitudes, and Faith in Recovery Outcome Measures? Answer: Yes, these aspects should be integrated into recovery outcome measures because they strongly affect a person's perception and method of recovery.",2.36859727356853e-08,0.047745242808916455,0.05409791529640538,0.0018134264647818796,0.010620873444459722,0.02854671280276816,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.1,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is Inclusion of Culture, Attitudes, and Faith Necessary? Answer: Yes, including culture, attitudes, and faith in recovery outcome measures is necessary since they influence how individuals perceive and engage with recovery.",4.73719454713706e-08,0.1047273379960223,0.032910927456382036,0.003626852929563759,0.10324992977309444,0.03180708532418292,0.003621603081905747,0.10394632060143305,0.031217481789802305,4.737194547137081e-08,0.06252035698133351,0.0
136,0.1,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Do Culture, Attitudes, and Faith Have a Place in Recovery Outcome Measures? Answer: Yes, these factors must be considered in recovery outcome measures as they significantly shape a person's recovery perspective and approach.",7.10579182070559e-08,0.055504686964177985,0.02229082997222246,0.005440279394345639,0.09332544715697333,0.002670768987034146,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
136,0.1,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Should They Account for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should account for culture, attitudes, and faith because these elements deeply influence a person's recovery perception and behavior.",4.73719454713706e-08,0.14550070155837203,0.06004264895195603,0.003626852929563759,0.1452588498070302,0.06145328719723188,0.003621603081905747,0.14726801938642975,0.06222222222222223,4.737194547137081e-08,0.10723952992068453,0.0322222222222222
136,0.1,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Is It Important to Consider Culture, Attitudes, and Faith in Recovery Outcome Measures? Answer: Yes, it is important to consider culture, attitudes, and faith in recovery outcome measures since they affect how a person views and approaches recovery.",4.73719454713706e-08,0.15874112363847903,0.1313862874775209,0.0036268529295637453,0.2045610598506964,0.17121547506881327,0.00362160308190574,0.21239882304447466,0.18311533888228293,4.737194547137081e-08,0.17880996188333365,0.16409036860879903
136,0.1,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Can Culture, Attitudes, and Faith Be Included? Answer: Yes, culture, attitudes, and faith can and should be included in recovery outcome measures as they play a significant role in shaping recovery perceptions and approaches.",2.36859727356853e-08,0.0069461563801711534,0.02387511478420569,0.0018134264647818726,0.009237066111141612,0.026816608996539815,0.0018108015409528735,0.010620873444459722,0.02854671280276816,2.3685972735685406e-08,0.029852963149681777,0.0
137,0.1,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is cholecystectomy truly a reason to perform splenectomy simultaneously in mild hereditary spherocytosis? No, cholecystectomy alone does not automatically warrant a concurrent splenectomy in mild hereditary spherocytosis. Both surgeries can treat hereditary spherocytosis, but their application depends on the patient's specific condition. Splenectomy is generally reserved for more severe cases. Treatment decisions should be individualized.",2.3685972735685406e-08,0.15044337907246463,0.0920347647118041,0.0018134264647818726,0.15284873925875164,0.09456060334895587,0.0018108015409528666,0.1553292977316021,0.09688090737240077,2.3685972735685406e-08,0.13070617618577085,0.07939508506616257
137,0.1,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does cholecystectomy justify a simultaneous splenectomy in mild hereditary spherocytosis? No, undergoing cholecystectomy does not necessarily mean a splenectomy must be done at the same time in mild hereditary spherocytosis. Both procedures are options for managing hereditary spherocytosis, but splenectomy is usually reserved for severe presentations. Treatment choices depend on the patient's unique clinical picture.",2.3685972735685406e-08,0.15044337907246463,0.0920347647118041,0.0018134264647818726,0.15284873925875164,0.09456060334895587,0.0018108015409528666,0.1553292977316021,0.09688090737240077,2.3685972735685406e-08,0.13070617618577085,0.07939508506616257
137,0.1,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is it necessary to perform splenectomy along with cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy is not an automatic indication for a concomitant splenectomy in mild hereditary spherocytosis. While both surgeries can be used to treat hereditary spherocytosis, splenectomy is typically reserved for severe cases. The decision should be based on the individual patient's condition.",2.3685972735685406e-08,0.15044337907246463,0.0920347647118041,0.0018134264647818726,0.15284873925875164,0.09456060334895587,0.0018108015409528666,0.1553292977316021,0.09688090737240077,2.3685972735685406e-08,0.13070617618577085,0.07939508506616257
137,0.1,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Should splenectomy be done together with cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy does not inherently require a simultaneous splenectomy in mild hereditary spherocytosis. Both are treatment options, but splenectomy is generally indicated only in severe cases. Treatment plans should be tailored to the patient's specific needs.",1.6580180914979784e-07,0.018828703280460157,0.08562858348044804,0.012693985253473108,0.015430728501648616,0.09121080629286511,0.012675610786670066,0.01172478693156398,0.09688090737240077,1.6580180914979784e-07,0.039919340844992046,0.07939508506616257
137,0.1,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is concomitant splenectomy indicated when performing cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy alone is not an indication for concurrent splenectomy in mild hereditary spherocytosis. Both procedures may be used in treatment, but splenectomy is usually reserved for more severe disease. Decisions should be individualized.",2.1317375462116866e-07,0.06602017802741988,0.08366553930961167,0.016320838183036854,0.06232596496716036,0.09017891970903047,0.0162972138685758,0.05824480256645792,0.09688090737240077,2.1317375462116866e-07,0.08754738983424648,0.07939508506616257
137,0.1,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does mild hereditary spherocytosis require splenectomy alongside cholecystectomy? No, cholecystectomy is not necessarily an indication for splenectomy in mild hereditary spherocytosis. Both surgeries can be considered, but splenectomy is typically reserved for severe cases. Treatment decisions depend on the patient's condition.",3.079176455639103e-07,0.1329743368088372,0.10403344978741225,0.023574544042164344,0.12772503078410402,0.113421550094518,0.023540420032387266,0.15832826112343934,0.09688090737240077,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
137,0.1,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is splenectomy mandatory with cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy does not mandate a concomitant splenectomy in mild hereditary spherocytosis. Both are treatment options, but splenectomy is generally reserved for severe disease. The choice should be individualized.",3.789755637709662e-07,0.2512133495813571,0.07513946221210599,0.029014823436509962,0.24627591515541303,0.08566644805370167,0.028972824655245866,0.24056635936041237,0.09688090737240077,3.789755637709665e-07,0.2747589319223924,0.07939508506616257
137,0.1,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","In mild hereditary spherocytosis, does cholecystectomy require simultaneous splenectomy? No, cholecystectomy is not necessarily an indication for splenectomy in mild hereditary spherocytosis. Both procedures can be used depending on the patient's condition, with splenectomy usually reserved for severe cases. Treatment should be personalized.",2.6054570009253947e-07,0.11554083080759314,0.08151701323251415,0.0199476911126006,0.11152666779773046,0.089046550094518,0.019918816950481533,0.10703496673588964,0.09688090737240077,2.6054570009253947e-07,0.1375578104089099,0.07939508506616257
137,0.1,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is performing splenectomy alongside cholecystectomy indicated in mild hereditary spherocytosis? No, cholecystectomy alone does not indicate the need for a concurrent splenectomy in mild hereditary spherocytosis. Both surgeries are treatment options, but splenectomy is typically reserved for severe cases. Decisions should be based on individual patient factors.",1.6580180914979784e-07,0.018828703280460157,0.08562858348044804,0.012693985253473108,0.015430728501648616,0.09121080629286511,0.012675610786670066,0.01172478693156398,0.09688090737240077,1.6580180914979784e-07,0.039919340844992046,0.07939508506616257
137,0.1,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does cholecystectomy in mild hereditary spherocytosis require a concomitant splenectomy? No, cholecystectomy is not necessarily an indication for splenectomy in mild hereditary spherocytosis. While both procedures can be used to treat the condition, splenectomy is generally reserved for severe cases. Treatment decisions should be individualized.",2.1317375462116866e-07,0.06602017802741988,0.08366553930961167,0.016320838183036854,0.06232596496716036,0.09017891970903047,0.0162972138685758,0.05824480256645792,0.09688090737240077,2.1317375462116866e-07,0.08754738983424648,0.07939508506616257
138,0.1,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Is aneurysm repair appropriate for patients aged 80 or above following aneurysmal subarachnoid hemorrhage?,9.474389094274138e-07,1.196090577053619,0.14617283950617282,0.07253705859127504,1.3063800271257477,0.113421550094518,0.07243206163811483,1.3980191480514552,0.09688090737240077,9.474389094274156e-07,1.498534363544509,0.07939508506616257
138,0.1,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Should aneurysm repair be performed on patients 80 years or older after aneurysmal subarachnoid hemorrhage?,9.237529366917285e-07,1.1219826048998978,0.14617283950617282,0.07072363212649317,1.2263373194522114,0.113421550094518,0.07062126009716195,1.311007771061825,0.09688090737240077,9.237529366917303e-07,1.4032241837401838,0.07939508506616257
138,0.1,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Is it justified to conduct aneurysm repair in patients aged 80 or older post-aneurysmal subarachnoid hemorrhage?,9.000669639560431e-07,1.0529897334129457,0.14617283950617282,0.0689102056617113,1.1522293472984901,0.113421550094518,0.06881045855620908,1.2309650633882887,0.09688090737240077,9.00066963956045e-07,1.3162128067505536,0.07939508506616257
138,0.1,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Can aneurysm repair be recommended for patients aged 80 and above after aneurysmal subarachnoid hemorrhage?,9.237529366917285e-07,1.1219826048998978,0.14617283950617282,0.07072363212649317,1.2263373194522114,0.113421550094518,0.07062126009716195,1.311007771061825,0.09688090737240077,9.237529366917303e-07,1.4032241837401838,0.07939508506616257
138,0.1,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Is aneurysm repair warranted for patients 80 years or older following aneurysmal subarachnoid hemorrhage?,9.474389094274138e-07,1.196090577053619,0.14617283950617282,0.07253705859127504,1.3063800271257477,0.113421550094518,0.07243206163811483,1.3980191480514552,0.09688090737240077,9.474389094274156e-07,1.498534363544509,0.07939508506616257
138,0.1,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Does aneurysm repair make sense for patients aged 80 or older after aneurysmal subarachnoid hemorrhage?,9.237529366917285e-07,1.1219826048998978,0.14617283950617282,0.07072363212649317,1.2263373194522114,0.113421550094518,0.07062126009716195,1.311007771061825,0.09688090737240077,9.237529366917303e-07,1.4032241837401838,0.07939508506616257
138,0.1,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Is aneurysm repair considered appropriate for patients aged 80+ after aneurysmal subarachnoid hemorrhage?,9.711248821630991e-07,1.2761332847271554,0.14617283950617282,0.07435048505605692,1.3933914041153779,0.113421550094518,0.0742428631790677,1.4933293278557804,0.09688090737240077,9.71124882163101e-07,1.6038948792023349,0.07939508506616257
138,0.1,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Is it reasonable to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage?,8.763809912203577e-07,0.988451212275375,0.14617283950617282,0.06709677919692941,1.083236475811538,0.113421550094518,0.0669996570152562,1.1568570912345675,0.09688090737240077,8.763809912203596e-07,1.2361700990770172,0.07939508506616257
138,0.1,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Is aneurysm repair justified in patients aged 80 or older after aneurysmal subarachnoid hemorrhage?,9.474389094274138e-07,1.196090577053619,0.14617283950617282,0.07253705859127504,1.3063800271257477,0.113421550094518,0.07243206163811483,1.3980191480514552,0.09688090737240077,9.474389094274156e-07,1.498534363544509,0.07939508506616257
138,0.1,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits",Should aneurysm repair be justified for patients aged 80 or older following aneurysmal subarachnoid hemorrhage?,9.237529366917285e-07,1.1219826048998978,0.14617283950617282,0.07072363212649317,1.2263373194522114,0.113421550094518,0.07062126009716195,1.311007771061825,0.09688090737240077,9.237529366917303e-07,1.4032241837401838,0.07939508506616257
139,0.1,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does blood pressure vary in treated hypertensive patients based on whether a physician or a nurse takes the measurement? Systolic BP readings taken by nurses are significantly lower than those by physicians and closely match ambulatory BP monitoring. Nurse-measured blood pressure is preferred for diagnosis and control assessment.,5.210914001850789e-07,0.2451414401611034,0.1254682080807394,0.0398953822252012,0.3297062633434886,0.044023668639053264,0.039837633900963065,0.3773391690069161,0.014921946740128552,5.210914001850789e-07,0.4054651081081624,0.0
139,0.1,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Nurse-measured systolic BP is notably lower than physician measurements and aligns closely with ambulatory BP monitoring, making nurse measurements valuable for diagnosis and control evaluation.",6.868932093348768e-07,0.37691396305254665,0.1467347487234615,0.052589367478674306,0.49478601370293873,0.044023668639053264,0.05251324468763313,0.5464154990508492,0.014921946740128552,6.868932093348768e-07,0.5787368293821986,0.0
139,0.1,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Is there a difference in blood pressure readings in treated hypertensive patients depending on if a physician or nurse measures it? Systolic BP recorded by nurses is significantly lower than that by physicians and nearly identical to ambulatory monitoring, supporting nurse measurements for diagnosis and control.",5.684633456564497e-07,0.2591309273961633,0.1467347487234615,0.04352223515476494,0.37415802591432135,0.044023668639053264,0.0434592369828688,0.42280154308367335,0.014921946740128552,5.684633456564497e-07,0.4519851237430563,0.0
139,0.1,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For treated hypertensive patients, does blood pressure change based on whether a physician or nurse measures it? Nurse-measured systolic BP is significantly lower than physician readings and closely matches ambulatory BP monitoring, making nurse measurements desirable for diagnosis and control.",7.105791820705621e-07,0.4022317710368384,0.1467347487234615,0.05440279394345618,0.5207615001061967,0.044023668639053264,0.054324046228586,0.57308374613301,0.014921946740128552,7.105791820705622e-07,0.6061358035703139,0.0
139,0.1,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Does the blood pressure of treated hypertensive patients differ when measured by a physician compared to a nurse? Systolic BP taken by nurses is significantly lower than physician readings and almost identical to ambulatory BP monitoring, suggesting nurse measurements are preferable for diagnosis and control assessment.",5.684633456564497e-07,0.2591309273961633,0.1467347487234615,0.04352223515476494,0.37415802591432135,0.044023668639053264,0.0434592369828688,0.42280154308367335,0.014921946740128552,5.684633456564497e-07,0.4519851237430563,0.0
139,0.1,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, is there a difference in blood pressure readings depending on whether a physician or nurse measures it? Nurse-measured systolic BP is significantly lower than physician measurements and closely resembles ambulatory BP monitoring, indicating nurse measurements are beneficial for diagnosis and control evaluation.",5.684633456564497e-07,0.2591309273961633,0.1467347487234615,0.04352223515476494,0.37415802591432135,0.044023668639053264,0.0434592369828688,0.42280154308367335,0.014921946740128552,5.684633456564497e-07,0.4519851237430563,0.0
139,0.1,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Does blood pressure in treated hypertensive patients vary depending on whether it is measured by a physician or a nurse? Systolic BP measured by nurses is significantly lower than physician readings and nearly matches ambulatory BP monitoring, making nurse measurements desirable for diagnosis and control.",5.921493183921352e-07,0.3131104732736736,0.1240197676526124,0.045335661619546816,0.39714754413902087,0.044023668639053264,0.045270038523821665,0.44633204049386777,0.014921946740128552,5.921493183921352e-07,0.47608267532211634,0.0
139,0.1,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Is blood pressure in treated hypertensive patients affected by whether a physician or nurse takes the measurement? Nurse-measured systolic BP is significantly lower than physician measurements and closely aligns with ambulatory BP monitoring, supporting the use of nurse measurements for diagnosis and control.",6.39521263863506e-07,0.32812379888311494,0.1467347487234615,0.04896251454911056,0.4447755931282753,0.044023668639053264,0.0488916416057274,0.4951222046632995,0.014921946740128552,6.39521263863506e-07,0.5260930958967798,0.0
139,0.1,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Systolic BP recorded by nurses is significantly lower than physician readings and almost identical to ambulatory BP monitoring, making nurse measurements preferable for diagnosis and control evaluation.",6.39521263863506e-07,0.32812379888311494,0.1467347487234615,0.04896251454911056,0.4447755931282753,0.044023668639053264,0.0488916416057274,0.4951222046632995,0.014921946740128552,6.39521263863506e-07,0.5260930958967798,0.0
139,0.1,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Does blood pressure change in treated hypertensive patients depending on whether a physician or nurse measures it? Systolic BP measured by nurses is significantly lower than physician readings and closely matches ambulatory BP monitoring, indicating nurse measurements are desirable for diagnosis and control.",6.39521263863506e-07,0.32812379888311494,0.1467347487234615,0.04896251454911056,0.4447755931282753,0.044023668639053264,0.0488916416057274,0.4951222046632995,0.014921946740128552,6.39521263863506e-07,0.5260930958967798,0.0
140,0.1,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The use of audits to detect maternal mortality across various settings: is it merely a disparity between wealth and poverty? Differences in maternal mortality extend beyond just economic status. Recognizing the scale of maternal mortality and leveraging strong political commitment are crucial. Nonetheless, there is no universal solution to lower maternal mortality, and problem identification is key.",3.552895910352811e-07,0.19118636043139992,0.02761906381435003,0.027201396971728117,0.2015536464991765,0.02854671280276816,0.027162023114293,0.22503123540805614,0.014489619377162637,3.552895910352811e-07,0.24921579162398766,0.0
140,0.1,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to identify maternal mortality in different contexts: is it simply a matter of rich versus poor? Maternal mortality differences involve more than economic divides. Understanding the extent of maternal mortality and applying strong political will are vital. However, no single solution exists to reduce maternal mortality, and pinpointing issues is essential.",4.500334819780227e-07,0.2698215810274345,0.02192139577594128,0.03445510283085561,0.2770611990073224,0.02854671280276816,0.034405229278104466,0.30199227654418603,0.014489619377162637,4.500334819780227e-07,0.32768740706548183,0.0
140,0.1,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Auditing maternal mortality in diverse environments: is it only a gap between the affluent and the impoverished? The variations in maternal mortality surpass just wealth differences. Acknowledging the severity of maternal mortality and mobilizing political will are important. Still, there is no one-size-fits-all solution to decrease maternal mortality, and identifying problems is necessary.",4.500334819780227e-07,0.2698215810274345,0.02192139577594128,0.03445510283085561,0.2770611990073224,0.02854671280276816,0.034405229278104466,0.30199227654418603,0.014489619377162637,4.500334819780227e-07,0.32768740706548183,0.0
140,0.1,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is the use of audits to identify maternal mortality in various settings just a reflection of the rich-poor divide? Maternal mortality disparities are more complex than economic status alone. Recognizing the magnitude of the problem and fostering strong political will are critical. Yet, no single solution can reduce maternal mortality, and problem identification remains crucial.",4.026615365066519e-07,0.22004401044922917,0.06333914725523118,0.030828249901291863,0.2385949181795266,0.02854671280276816,0.030783626196198732,0.2627715633909036,0.014489619377162637,4.026615365066519e-07,0.28768207245178345,0.0
140,0.1,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The role of audits in identifying maternal mortality across settings: is it merely a rich versus poor issue? Differences in maternal mortality go beyond economic status. Acknowledging the scale of maternal mortality and harnessing political will are key factors. However, there is no universal fix to reduce maternal mortality, and identifying the problems is important.",4.026615365066519e-07,0.22973379088931356,0.024877608793692718,0.030828249901291863,0.2385949181795266,0.02854671280276816,0.030783626196198732,0.2627715633909036,0.014489619377162637,4.026615365066519e-07,0.28768207245178345,0.0
140,0.1,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to uncover maternal mortality in different settings: is it just a matter of wealth disparity? Maternal mortality differences are more than just rich and poor distinctions. Recognizing the extent of maternal mortality and applying strong political will are essential. Still, no single solution exists to reduce maternal mortality, and problem identification is vital.",4.026615365066519e-07,0.22973379088931356,0.024877608793692718,0.030828249901291863,0.2385949181795266,0.02854671280276816,0.030783626196198732,0.2627715633909036,0.014489619377162637,4.026615365066519e-07,0.28768207245178345,0.0
140,0.1,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Auditing maternal mortality in various contexts: is it simply a difference between the wealthy and the poor? The disparities in maternal mortality exceed economic differences. Acknowledging the magnitude of maternal mortality and leveraging political will are important. However, no one solution can reduce maternal mortality, and identifying issues is necessary.",5.210914001850789e-07,0.3331255001630753,0.017025786903148127,0.039895382225201226,0.33768582082375653,0.02854671280276816,0.039837633900963065,0.36386768026227356,0.014489619377162637,5.210914001850789e-07,0.3908663086870141,0.0
140,0.1,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is the use of audit to detect maternal mortality in different settings just a rich-poor divide? Differences in maternal mortality are more complex than wealth alone. Recognizing the scale of maternal mortality and mobilizing strong political will are crucial. Yet, there is no single solution to reduce maternal mortality, and problem identification is key.",4.263475092423373e-07,0.2495775091097152,0.02342789327690241,0.032641676366073735,0.2576431131502197,0.02854671280276816,0.0325944277371516,0.28218964924800627,0.014489619377162637,4.263475092423373e-07,0.3074846997479632,0.0
140,0.1,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The application of audits to identify maternal mortality in various settings: is it only a difference between rich and poor? Maternal mortality differences involve more than economic status. Acknowledging the severity of maternal mortality and harnessing political will are important. However, no universal solution exists to reduce maternal mortality, and identifying problems is essential.",4.263475092423373e-07,0.2495775091097152,0.02342789327690241,0.032641676366073735,0.2576431131502197,0.02854671280276816,0.0325944277371516,0.28218964924800627,0.014489619377162637,4.263475092423373e-07,0.3074846997479632,0.0
140,0.1,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to identify maternal mortality in different environments: is it just a disparity between the rich and the poor? Differences in maternal mortality go beyond economic divides. Recognizing the magnitude of maternal mortality and applying strong political will are vital. Nonetheless, there is no single solution to reduce maternal mortality, and problem identification remains crucial.",3.789755637709665e-07,0.21027494283862458,0.026273691966756524,0.02901482343650999,0.21990278516737227,0.02854671280276816,0.028972824655245866,0.24372336842021047,0.014489619377162637,3.789755637709665e-07,0.26826398659468076,0.0
141,0.1,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is it possible for a single-level measurement of visceral adipose tissue area to represent the total visceral adipose tissue volume? Measuring VAT area at a single level 3 cm above the lower edge of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. New insights: VAT area on a CT slice 3 cm above the lower margin of L3...,9.474389094274162e-08,0.15268243797280778,0.09227454601415822,0.0072537058591274906,0.09506116586716251,0.020818974570557147,0.007243206163811466,0.06977545539104124,0.0022165532879818844,9.474389094274162e-08,0.06941741297507864,0.0011493764172335608
141,0.1,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can the visceral adipose tissue area measured at one level accurately represent the visceral adipose tissue volume? Measuring VAT area at a single level 3 cm above the lower border of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Knowledge update: VAT area on a CT slice 3 cm above the lower margin of L3...,0.0,0.05493061443340519,0.06982248520710058,0.0,4.440892098500626e-16,0.0,0.0,0.023901626915860952,0.017131472423680218,0.0,0.0,3.469446951953614e-18
141,0.1,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does measuring visceral adipose tissue area at a single level correspond to visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is achievable and can mirror changes in VAT volume and body weight. Advances: VAT area at a CT slice 3 cm above the lower margin of L3...,2.3685972735685406e-08,0.11485707267336931,0.05876543209876539,0.0018134264647818726,0.11472650262578066,0.06591832164124584,0.0018108015409528666,0.09119325739943829,0.052469508513464574,2.3685972735685406e-08,0.067644392741252,0.03586152109473195
141,0.1,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can a single-level measurement of visceral adipose tissue area represent the total volume of visceral adipose tissue? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. New knowledge: VAT area on a CT slice 3 cm above the lower margin of L3...,9.474389094274162e-08,0.05202031694135245,0.04517881394296061,0.0072537058591274906,0.10395379781915715,0.02343602259917997,0.007243206163811466,0.1263441813444901,0.03916122448979591,9.474389094274162e-08,0.1269078927174334,0.03886173469387756
141,0.1,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is a single-level visceral adipose tissue area measurement indicative of visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Advances in understanding: VAT area at a CT slice 3 cm above the lower margin of L3...,2.3685972735685406e-08,0.03549891628143298,0.02335069444444443,0.0018134264647818726,0.04302162187820047,0.01805180152758505,0.0018108015409528666,0.06687230369558028,0.035336945386912316,2.3685972735685406e-08,0.067644392741252,0.03586152109473195
141,0.1,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can visceral adipose tissue area measured at one level serve as a proxy for visceral adipose tissue volume? Measuring VAT area at a single level 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Knowledge advancement: VAT area on a CT slice 3 cm above the lower margin of L3...,2.3685972735685406e-08,0.051763930926082224,0.05687869822485203,0.0018134264647818726,0.004339744819346514,0.014746227709190762,0.0018108015409528666,0.029088371189988305,0.03299924101872154,2.3685972735685406e-08,0.029992184331855132,0.034031982627761845
141,0.1,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is it feasible to use visceral adipose tissue area at a single level to represent visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. New insights: VAT area at a CT slice 3 cm above the lower margin of L3...,2.3685972735685406e-08,0.035498916281433424,0.02335069444444443,0.0018134264647818726,0.06692324879406053,0.03439678945894509,0.0018108015409528666,0.06687230369558028,0.0353369453869123,2.3685972735685406e-08,0.067644392741252,0.03586152109473195
141,0.1,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can a single-level VAT area measurement reflect visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and can mirror changes in VAT volume and body weight. Advances: VAT area on a CT slice 3 cm above the lower margin of L3...,2.3685972735685406e-07,0.17482375486570412,0.0018140589569160814,0.018134264647818726,0.20969318109637136,0.016703936106293032,0.018108015409528666,0.2569632759001319,0.04820585258896948,2.3685972735685406e-07,0.25706958653467016,0.045994792545117194
141,0.1,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is measuring visceral adipose tissue area at a single level sufficient to represent visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Knowledge update: VAT area at a CT slice 3 cm above the lower margin of L3...,0.0,0.09241962407465909,0.055198487712665445,0.0,0.09398605838101082,0.06358079561042532,0.0,0.07170488074758152,0.05100088273116295,0.0,0.04864190740771601,0.03493087049634666
141,0.1,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can VAT area measured at a single level serve as an indicator of visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Advances in knowledge: VAT area on a CT slice 3 cm above the lower margin of L3...,4.737194547137081e-08,0.00563377586008329,0.02560000000000004,0.0036268529295637453,0.03860837161419761,0.0028890796340940023,0.003621603081905733,0.08630909177382762,0.03656714164955922,4.737194547137081e-08,0.08701318495930677,0.03682564001932134
142,0.1,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition impact quality of life? Yes, it does. This phase is commonly linked to physical symptoms including hot flashes and sleep problems, as well as psychological challenges like mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.1,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life affected by the menopausal transition? Indeed, it is. Menopausal transition often brings physical symptoms such as hot flashes and sleep disturbances, along with psychological issues like mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.1,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does going through menopause influence quality of life? Yes, menopausal transition influences it. It is frequently accompanied by physical symptoms like hot flashes and sleep disruptions, plus psychological effects such as mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.1,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Can the menopausal transition affect a person's quality of life? Yes, it can. This transition is typically associated with physical symptoms including hot flashes and sleep problems, as well as psychological concerns like mood swings and depression.",1.1842986367842661e-07,0.0051951021049618795,0.09642074506939374,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
142,0.1,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is the quality of life impacted during menopausal transition? Yes, it is affected. Menopausal transition often involves physical symptoms such as hot flashes and sleep disturbances, along with psychological issues like mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.1,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the transition through menopause alter quality of life? Yes, it does. This period is often marked by physical symptoms like hot flashes and sleep difficulties, as well as psychological problems such as mood swings and depression.",1.1842986367842661e-07,0.0051951021049618795,0.09642074506939374,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
142,0.1,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does menopausal transition have an effect on quality of life? Yes, it has an effect. It is commonly linked to physical symptoms including hot flashes and sleep disturbances, and psychological issues like mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.1,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life influenced by menopausal transition? Yes, it is influenced. Menopausal transition is often associated with physical symptoms such as hot flashes and sleep problems, along with psychological challenges like mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.1,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition change quality of life? Yes, it changes it. This phase is frequently accompanied by physical symptoms like hot flashes and sleep disturbances, as well as psychological effects such as mood swings and depression.",1.1842986367842661e-07,0.0051951021049618795,0.09642074506939374,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
142,0.1,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does going through the menopausal transition affect quality of life? Yes, it does affect it. It is often linked to physical symptoms including hot flashes and sleep problems, and psychological issues like mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
143,0.1,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafnessdoes it always lead to Meniere's disease? Our findings indicate that not every patient with low-tone sudden deafness (SD) experiences endolymphatic hydrops, even if vertigo occurs at onset, and that electrocochleography (ECochG) serves as a valuable prognostic indicator.",4.737194547137081e-08,0.015684784721507583,0.020673448681217014,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
143,0.1,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably progress to Meniere's disease? We conclude that some patients with low-tone sudden deafness (SD) do not develop endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) is a useful tool for prognosis.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.1,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the prognosis of low-tone sudden deafness always progression to Meniere's disease? Our study shows that not all low-tone sudden deafness (SD) patients have endolymphatic hydrops even if vertigo is present initially, and electrocochleography (ECochG) is helpful for prognosis.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.1,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily lead to Meniere's disease? We found that not all patients with low-tone sudden deafness (SD) suffer from endolymphatic hydrops, even when vertigo attacks occur at onset, and that electrocochleography (ECochG) is a useful prognostic method.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.1,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease inevitable in low-tone sudden deafness? Our conclusion is that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients, even with initial vertigo attacks, and electrocochleography (ECochG) provides valuable prognostic information.",2.1317375462116834e-07,0.19491723113549364,0.01638225691255996,0.016320838183036854,0.19233700995598957,0.02221074380165289,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.1,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? We conclude that endolymphatic hydrops does not affect all low-tone sudden deafness (SD) patients, even those with vertigo at onset, and that electrocochleography (ECochG) is a useful prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.1,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease an inevitable outcome of low-tone sudden deafness? Our findings suggest that not all low-tone sudden deafness (SD) patients have endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) is a helpful prognostic tool.",2.3685972735685364e-07,0.2233569668559814,0.015633327711249794,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.1,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably develop into Meniere's disease? We conclude that endolymphatic hydrops is not present in every low-tone sudden deafness (SD) patient, even if vertigo occurs initially, and electrocochleography (ECochG) is useful for prognosis.",2.6054570009253894e-07,0.2922364877603254,0.013544536271808981,0.019947691112600606,0.29026878735828765,0.007174012855831045,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
143,0.1,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the progression from low-tone sudden deafness to Meniere's disease unavoidable? Our results indicate that not all patients with low-tone sudden deafness (SD) have endolymphatic hydrops, even with vertigo attacks at onset, and electrocochleography (ECochG) is a valuable prognostic tool.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.1,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always lead to Meniere's disease? We conclude that endolymphatic hydrops is not found in all low-tone sudden deafness (SD) patients, even those experiencing vertigo at onset, and that electrocochleography (ECochG) is a useful prognostic tool.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
144,0.1,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a connection between a resident's leadership abilities and their technical skill ratings? Answer: Yes, a resident's leadership abilities can be linked to their technical skill ratings. Strong leaders often possess excellent technical skills because they must comprehend and manage the tasks at hand. Their technical expertise can impact their credibility, decision-making, and leadership effectiveness.",2.3685972735685406e-08,0.011375362080493279,0.0381447730112454,0.0018134264647818726,0.04542155380117752,0.019236094674556177,0.0018108015409528666,0.04533300997287881,0.019165890272232835,2.3685972735685406e-08,0.04570770191530649,0.01922337562475971
144,0.1,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do leadership skills of residents correlate with their technical skill evaluations? Answer: Yes, residents' leadership skills may correlate with their technical skill evaluations. Effective leadership usually requires solid technical knowledge to understand and supervise work. This technical competence can affect their credibility, decision-making, and ability to lead.",1.8948778188548325e-07,0.15343159492363512,0.002579943542042634,0.014507411718254981,0.1480646806932806,0.008700054083288236,0.014486412327622933,0.1729295117389995,0.006670480151890666,1.8948778188548325e-07,0.17190126774400527,0.0034916054460894
144,0.1,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are residents' leadership skills associated with their technical skill ratings? Answer: Yes, residents' leadership skills are often associated with their technical skill ratings. Good leaders tend to have strong technical skills since they need to grasp and oversee the work. Their technical ability can influence their credibility, decisions, and leadership capacity.",9.474389094274162e-08,0.1248109045350696,0.07178031020132801,0.0072537058591274906,0.08517611883165399,0.005795085066162581,0.007243206163811466,0.08274206399326856,0.003064601158902419,9.474389094274162e-08,0.08226433325225413,0.001600526593438574
144,0.1,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Does a resident's leadership skill impact their technical skill rating? Answer: Yes, a resident's leadership skill can impact their technical skill rating. Effective leaders typically have strong technical skills to understand and manage tasks. Their technical proficiency can affect their credibility, decision-making, and guidance abilities.",2.3685972735685406e-07,0.27671210937562085,0.09545336026886302,0.018134264647818726,0.22813270155375553,0.016400000000000012,0.018108015409528666,0.22125761059326576,0.00872313558986719,2.3685972735685406e-07,0.18691459335344662,0.01922337562475971
144,0.1,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a relationship between residents' leadership skills and their technical skill ratings? Answer: Yes, there is a relationship between residents' leadership skills and their technical skill ratings. Leaders who are effective often demonstrate strong technical skills as they must understand and oversee the work. Their technical expertise can influence their credibility, decision-making, and leadership.",0.0,0.11033501069534735,0.10982872362852932,0.0,0.10268847119406521,0.0700672967863895,0.0,0.13078248689810268,0.09133919700798515,0.0,0.13329753472306605,0.09419817446975828
144,0.1,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Can residents' leadership skills influence their technical skill ratings? Answer: Yes, residents' leadership skills can influence their technical skill ratings. Effective leadership often requires a solid grasp of technical skills to supervise and understand the work. This technical proficiency can impact their credibility, decision-making, and ability to lead.",1.6580180914979784e-07,0.12930572481906477,0.004696979287294442,0.012693985253473108,0.12463484777418588,0.010066942148760333,0.012675610786670066,0.11947435624117375,0.01594942116280062,1.6580180914979784e-07,0.11792172186649497,0.01922337562475971
144,0.1,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do residents' leadership abilities affect their technical skill ratings? Answer: Yes, residents' leadership abilities can affect their technical skill ratings. Effective leaders usually possess strong technical skills necessary to comprehend and oversee tasks. Their technical competence can influence their credibility, decision-making, and leadership effectiveness.",2.6054570009253947e-07,0.2728435826121265,0.07814034087828138,0.0199476911126006,0.2218136709175691,0.004224999999999993,0.019918816950481533,0.21331630910760335,0.01388245631971046,2.6054570009253947e-07,0.21101214493250664,0.01922337562475971
144,0.1,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are leadership skills of residents related to their technical skill ratings? Answer: Yes, leadership skills of residents are related to their technical skill ratings. Effective leaders often have strong technical skills because they need to understand and manage the work. Their technical proficiency can impact their credibility, decision-making, and leadership capabilities.",9.474389094274162e-08,0.15199314690996912,0.0904896080572161,0.0072537058591274906,0.11290200605405198,0.02516543209876547,0.007243206163811466,0.11103378564877664,0.023286266951274358,9.474389094274162e-08,0.08226433325225413,0.001600526593438574
144,0.1,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a link between a resident's leadership skills and their technical skill ratings? Answer: Yes, there is a link between a resident's leadership skills and their technical skill ratings. Effective leaders tend to excel in technical skills as they must understand and oversee the work. Their technical ability can influence their credibility, decision-making, and leadership.",2.3685972735685406e-08,0.11240092016235392,0.1216805754803812,0.0018134264647818726,0.10581055832099251,0.08377240075614363,0.0018108015409528666,0.13437181461673653,0.10598948056186047,2.3685972735685406e-08,0.13738777974203753,0.10979363760775446
144,0.1,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do residents' leadership skills correspond with their technical skill ratings? Answer: Yes, residents' leadership skills correspond with their technical skill ratings. Effective leaders often have strong technical skills since they need to understand and supervise the work. Their technical proficiency can affect their credibility, decision-making, and ability to guide.",1.4211583641411244e-07,0.20129308178995275,0.09837463618792584,0.010880558788691236,0.18838135960230362,0.048848979591836775,0.0108648092457172,0.21530944060621415,0.067197467222183,1.4211583641411244e-07,0.2164901508972754,0.06694442482875504
145,0.1,1,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Can student examiners serve as reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be regarded as suitable substitutes for faculty in an undergraduate OSCE on medical emergencies. They offer valuable peer review and assessment. However, they might",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.3877787807814457e-17
145,0.1,2,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Are student examiners acceptable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can act as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They contribute meaningful peer review and assessment. Nonetheless, they may",9.474389094274162e-08,0.1509466104948629,0.03268167343864131,0.0072537058591274906,0.14887155284759457,0.03416181456977224,0.007243206163811466,0.14971750638595172,0.034494402600673116,9.474389094274162e-08,0.1504625769435437,0.03437548489172766
145,0.1,3,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Is it reasonable for student examiners to replace faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered reasonable replacements for faculty in an undergraduate OSCE on medical emergencies. They provide important peer review and assessment. However, they might",4.737194547137081e-08,0.02468586943981821,0.012830961592222911,0.0036268529295637453,0.02251491847264564,0.016090358532523746,0.003621603081905733,0.021679260607543327,0.017845182908445514,4.737194547137081e-08,0.02073420686105143,0.019675886112960284
145,0.1,4,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: May student examiners be used as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners are reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They offer valuable peer review and assessment. However, they may",7.105791820705622e-08,0.15261062660211877,0.04537698593864131,0.005440279394345618,0.1520738877675618,0.0506907401896069,0.0054324046228586,0.15372515604073644,0.05285987551160061,7.105791820705622e-08,0.15535599331825667,0.054577505093747855
145,0.1,5,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Can student examiners reasonably substitute for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can reasonably substitute for faculty in an undergraduate OSCE on medical emergencies. They provide useful peer review and assessment. However, they may",1.4211583641411233e-07,0.25210860536975943,0.05645475793626312,0.010880558788691236,0.24941477848545635,0.06259156663588789,0.0108648092457172,0.2513570904722835,0.06462296091104959,1.4211583641411244e-07,0.25317170562153457,0.06581717451523551
145,0.1,6,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Are student examiners reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They offer valuable peer review and assessment. However, they may",1.1842986367842703e-07,0.21790429507059716,0.052755458160863467,0.009067132323909363,0.2159559217117799,0.05850323272445318,0.009054007704764333,0.21778695112281143,0.060551970045053596,1.1842986367842703e-07,0.2195281622391856,0.06190458346424697
145,0.1,7,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Is it appropriate for student examiners to act as substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may serve as appropriate substitutes for faculty in an undergraduate OSCE on medical emergencies. They provide beneficial peer review and assessment. However, they might",2.3685972735685406e-08,0.0028002678519669644,0.014609203798392922,0.0018134264647818726,0.004132793502769072,0.017313019390581663,0.0018108015409528666,0.0048536031931418755,0.018698060941828368,2.3685972735685406e-08,0.005638486932304954,0.02008310249307474
145,0.1,8,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Could student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners could be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They contribute valuable peer review and assessment. However, they may",4.737194547137081e-08,0.1858828881746888,0.06778609754113876,0.0036268529295637453,0.18754996146310754,0.08187976108033237,0.003621603081905733,0.19073954854899355,0.08788250952216074,4.737194547137081e-08,0.19402100200103867,0.09331717451523548
145,0.1,9,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Should student examiners be allowed to substitute for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners should be allowed as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They provide important peer review and assessment. However, they might",2.3685972735685406e-08,0.05958073521536811,0.021553644101906688,0.0018134264647818726,0.027385800553832773,0.0029016064053871693,0.0018108015409528666,0.027368521665787515,0.0026077024093046214,2.3685972735685406e-08,0.02731774753984828,0.002237919584629225
145,0.1,10,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Question: Would student examiners make reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners would make reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They offer valuable peer review and assessment. However, they may",9.474389094274162e-08,0.21857072567144353,0.06275545816086348,0.0072537058591274906,0.21818627090358822,0.0730713908930275,0.007243206163811466,0.22080952490492178,0.07720129366628155,9.474389094274162e-08,0.2234254380551164,0.08063507253812834
146,0.1,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy could be an important new tool for enhancing population health, particularly among lower-income groups. Although the results are strong, additional studies are necessary to verify their accuracy. Future investigations should explore various types of income support.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.1,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies providing income support may serve as a crucial mechanism for improving health outcomes in the population, especially for those with lower incomes. Despite the robustness of the findings, more research is required to confirm their validity. Subsequent studies should assess different forms of income support.",9.474389094274162e-08,0.07064322191685513,0.0011893608989532352,0.0072537058591274906,0.07020425867324764,0.0,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
146,0.1,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies might represent a valuable approach to boosting public health, particularly for low-income individuals. While the findings are compelling, further analysis is needed to ensure their reliability. Future research should investigate a range of income support programs.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.1,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support could be a key strategy for enhancing the health of populations, especially those with lower incomes. Although the evidence is strong, additional research is necessary to confirm these results. Future studies should consider various income support options.",4.737194547137081e-08,0.0372845055208213,0.000660686282874693,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
146,0.1,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies may offer a significant opportunity to improve health outcomes, particularly among economically disadvantaged groups. Despite robust findings, further examination is needed to validate them. Future research should explore multiple income support interventions.",1.6580180914979784e-07,0.13706785783146103,0.002548065886134064,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
146,0.1,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support could be an effective lever for advancing population health, especially for lower-income populations. Even though the findings are solid, more research is required to confirm their dependability. Future studies should analyze different income support mechanisms.",1.1842986367842703e-07,0.09595304393715409,0.0017487603305785006,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
146,0.1,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies aimed at income support might be a powerful tool for improving health, particularly in lower-income communities. While the findings are robust, further investigation is necessary to verify their accuracy. Future research should examine diverse income support strategies.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
146,0.1,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives may play a crucial role in enhancing health outcomes, especially for those with limited income. Although the results are strong, additional studies are needed to confirm their reliability. Future research should evaluate various income support programs.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.1,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies have the potential to significantly improve population health, particularly among lower-income individuals. Despite the robustness of the findings, further research is necessary to validate them. Future studies should investigate a variety of income support approaches.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
146,0.1,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support might be an important strategy for improving health outcomes in the population, especially for low-income groups. Even though the findings are compelling, more research is needed to confirm their reliability. Future research should explore different types of income support.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
147,0.1,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the radiographic transition zone correspond to the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between the radiographic transition zone on contrast enema and the length of aganglionosis is minimal. Systematic preoperative biopsy via coelioscopy or umbilical incision is essential.,7.105791820705622e-08,0.07983903746530441,0.006420745069393746,0.005440279394345618,0.10939597588864602,0.02661886545938781,0.0054324046228586,0.10965398141320737,0.025623268698060954,7.105791820705622e-08,0.0759859069779214,0.0
147,0.1,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease specimens? The link between the radiographic transition zone on contrast enema and aganglionosis length is weak. Preoperative biopsy through coelioscopy or umbilical incision is mandatory.,7.105791820705622e-08,0.07983903746530441,0.006420745069393746,0.005440279394345618,0.14405333491664285,0.05126430898631671,0.0054324046228586,0.14519999067269174,0.05113221329437545,7.105791820705622e-08,0.11246733753370775,0.026296566837107373
147,0.1,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the radiographic transition zone on contrast enema align with the aganglionosis level in Hirschsprung's disease specimens? The correlation remains low between these two measures. A systematic preoperative biopsy by coelioscopy or umbilical incision is required.,2.1317375462116813e-07,0.10281481232703937,0.09,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
147,0.1,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease specimens? The correlation between the transition zone on contrast enema and aganglionosis length is limited. Preoperative biopsy using coelioscopy or umbilical incision is necessary.,1.8948778188548283e-07,0.11315211205811737,0.06224489795918367,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
147,0.1,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the level of the radiographic transition zone match the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between these factors is low. Systematic preoperative biopsy by coelioscopy or umbilical incision is mandatory.,2.605457000925387e-07,0.16165531234997266,0.09,0.01994769111260062,0.26322480914686164,0.023242630385487524,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
147,0.1,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is there a strong correlation between the radiographic transition zone and the length of aganglionosis in Hirschsprung's disease? The association remains low. Preoperative biopsy via coelioscopy or umbilical incision is essential.,3.3160361829959463e-07,0.25696549215429787,0.09,0.02538797050694626,0.3616648819601149,0.023242630385487524,0.02535122157334018,0.4054651081081637,0.0,3.316036182995957e-07,0.4177352006999784,0.0
147,0.1,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the radiographic transition zone on contrast enema correlate well with the aganglionosis level in Hirschsprung's disease specimens? The correlation is weak. Systematic preoperative biopsy by coelioscopy or umbilical incision is required.,3.0791764556390933e-07,0.22417566933130617,0.09,0.02357454404216438,0.32776333028443316,0.023242630385487524,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
147,0.1,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is the radiographic transition zone a reliable indicator of aganglionosis length in Hirschsprung's disease? The correlation remains low. Preoperative biopsy through coelioscopy or umbilical incision is mandatory.,4.2634750924233583e-07,0.4000663357949703,0.09,0.03264167636607378,0.5100848870783881,0.023242630385487524,0.032594427737151675,0.5596157879354227,0.0,4.263475092423373e-07,0.5780778507751583,0.0
147,0.1,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the radiographic transition zone correspond closely to the aganglionosis level in Hirschsprung's disease specimens? The correlation is minimal. Systematic preoperative biopsy by coelioscopy or umbilical incision is necessary.,3.7897556377096523e-07,0.32595836364124864,0.09,0.029014823436510018,0.4331238459422586,0.023242630385487524,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
147,0.1,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is the radiographic transition zone on contrast enema correlated with the level of aganglionosis in Hirschsprung's disease? The correlation remains low. Preoperative biopsy by coelioscopy or umbilical incision is essential.,3.5528959103527993e-07,0.29086704382997963,0.09,0.027201396971728138,0.39675620177138393,0.023242630385487524,0.027162023114293055,0.4418327522790384,0.0,3.552895910352811e-07,0.45547552868282537,0.0
148,0.1,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children are uncommon and frequently missed injuries, typically resulting from age-specific trauma. Ultrasound is effective for detecting these fractures, while X-rays are preferred to assess the degree of displacement.",4.5003348197802176e-07,0.4503099137206008,0.01999167013744273,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
148,0.1,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In growing children, isolated sternal fractures are rare and often go unnoticed, usually caused by trauma related to their age. Ultrasonography serves as a valuable diagnostic method, and radiography is the preferred technique to visualize the fracture displacement.",3.0791764556390996e-07,0.27337920556152184,0.01999167013744273,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
148,0.1,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in pediatric patients are infrequent and commonly overlooked, often stemming from typical traumatic events for their age group. Ultrasound is helpful for identifying fractures, whereas radiography is the best approach to evaluate the extent of dislocation.",2.8423167282822466e-07,0.24671095847936098,0.01999167013744273,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
148,0.1,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children are a rare occurrence and frequently missed, generally caused by trauma typical for their developmental stage. Ultrasonography is a useful tool for detecting fractures, and radiography is the standard for visualizing dislocation severity.",3.3160361829959526e-07,0.30077817974963716,0.01999167013744273,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
148,0.1,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In children, isolated sternal fractures are uncommon and often not diagnosed promptly, usually due to trauma typical of their age. Ultrasonography aids in fracture detection, while radiography is the preferred method to determine the extent of displacement.",3.3160361829959526e-07,0.30077817974963716,0.01999167013744273,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
148,0.1,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Growing children rarely suffer isolated sternal fractures, which are often overlooked and typically result from age-related trauma. Ultrasonography is effective for diagnosing these fractures, and radiography is the method of choice to assess dislocation extent.",3.7897556377096586e-07,0.3579365935895855,0.01999167013744273,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
148,0.1,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in the pediatric population are rare and frequently missed, commonly caused by trauma typical for their age. Ultrasonography is a valuable diagnostic tool, and radiography is preferred for visualizing the degree of dislocation.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
148,0.1,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in growing children are infrequent and often overlooked injuries, usually due to trauma associated with their age. Ultrasound is useful for detecting fractures, while radiography is the preferred method to visualize dislocation.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.1,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In childhood, isolated sternal fractures are rare and often go undetected, typically resulting from age-specific traumatic incidents. Ultrasonography is helpful for fracture detection, and radiography is the method of choice for assessing dislocation extent.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.1,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in children are uncommon and frequently missed, generally caused by trauma typical for their developmental stage. Ultrasonography is a useful diagnostic tool, and radiography is preferred to visualize the extent of fracture displacement.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
149,0.1,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a novel risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might account for the development of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.1,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated alongside existing case reports. The dopamine partial agonist mechanism of aripiprazole may explain the emergence of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.1,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: does it represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed in relation to other published case reports. The dopamine partial agonist effect of aripiprazole could clarify the occurrence of pathological gambling.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
149,0.1,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is pathological gambling a potential new risk associated with aripiprazole? Answer: Adverse drug reactions were reviewed with reference to other case reports. The dopamine partial agonist property of aripiprazole might explain the onset of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.1,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be linked as a new risk factor to pathological gambling? Answer: Adverse drug reactions were compared with previously documented case reports. The dopamine partial agonist mechanism of aripiprazole could be responsible for pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.1,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Does aripiprazole pose a new risk for pathological gambling? Answer: Adverse drug reactions were confronted with other published case reports. The dopamine partial agonist action of aripiprazole may explain pathological gambling occurrence.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
149,0.1,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole associated with a new risk factor for pathological gambling? Answer: Adverse drug reactions were examined alongside other case reports. The dopamine partial agonist mechanism of aripiprazole could explain pathological gambling.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
149,0.1,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole as a new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with existing case reports. The dopamine partial agonist effect of aripiprazole might explain pathological gambling.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
149,0.1,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be considered a new risk factor for pathological gambling? Answer: Adverse drug reactions were reviewed in the context of other case reports. The dopamine partial agonist mechanism of aripiprazole could explain the pathological gambling occurrence.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
149,0.1,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Is aripiprazole a novel risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other published case reports. The dopamine partial agonist mechanism of aripiprazole might explain pathological gambling.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
150,0.1,1,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Yes, studies show that preoperative statins help decrease postoperative atrial fibrillation rates.",2.36859727356853e-08,0.04168988456723399,0.0027888888888888963,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.1,2,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Can taking statins before coronary artery bypass surgery reduce atrial fibrillation? Answer: Yes, evidence suggests preoperative statins reduce the occurrence of atrial fibrillation after surgery.",2.36859727356853e-08,0.06741731462517109,0.07638888888888888,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.1,3,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Are preoperative statins effective in preventing atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research supports that preoperative statins reduce postoperative atrial fibrillation.",4.73719454713706e-08,0.031166944941744212,0.03480098718756562,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.1,4,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do statins administered before coronary artery bypass grafting lessen atrial fibrillation risk? Answer: Yes, data indicates that preoperative statins lower the chance of postoperative atrial fibrillation.",0.0,0.10663802777845355,0.07638888888888888,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.1,5,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Is there a reduction in atrial fibrillation after coronary artery bypass grafting with preoperative statin use? Answer: Yes, studies confirm that preoperative statins decrease postoperative atrial fibrillation incidence.",4.73719454713706e-08,0.13123548703503607,0.040723593964334705,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
150,0.1,6,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Does the use of statins before coronary artery bypass surgery reduce atrial fibrillation occurrence? Answer: Yes, research demonstrates that preoperative statins reduce atrial fibrillation after surgery.",0.0,0.0,0.0,0.0,0.0554517744447951,0.03993055555555556,0.0,0.0,0.0,0.0,0.0,0.0
150,0.1,7,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Can preoperative statins prevent atrial fibrillation following coronary artery bypass grafting? Answer: Yes, evidence shows preoperative statins reduce postoperative atrial fibrillation rates.",9.47438909427412e-08,0.18644281698652154,0.013611111111111115,0.007253705859127518,0.17435338714477844,0.0,0.007243206163811494,0.1823215567939549,0.0,9.474389094274152e-08,0.1910552367627094,0.0
150,0.1,8,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Are preoperative statins associated with a lower rate of atrial fibrillation after coronary artery bypass grafting? Answer: Yes, studies indicate that preoperative statins reduce postoperative atrial fibrillation.",2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.1,9,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do preoperative statins contribute to reducing atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins help lower postoperative atrial fibrillation.",2.36859727356853e-08,0.011965540180375989,0.03645833333333332,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.1,10,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Does administering statins before coronary artery bypass grafting reduce the risk of atrial fibrillation? Answer: Yes, evidence suggests that preoperative statins decrease postoperative atrial fibrillation.",2.36859727356853e-08,0.06741731462517109,0.07638888888888888,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
151,0.1,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a disagreement between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Significant differences exist between clinicians and clinical pathologists regarding the clinical importance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the best method to guarantee that RBC morphology changes are understood as intended by clinical pathologists. Reporting methods should be carefully reviewed.,1.1842986367842703e-07,0.037387496562156564,0.03073822121441168,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
151,0.1,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? There are notable differences in how clinicians and clinical pathologists view the clinical relevance of specific RBC morphology terminology. Including explanatory notes on CBC reports is the most effective way to ensure RBC morphology changes are interpreted correctly by clinical pathologists. Reporting procedures need to be critically assessed.,7.105791820705622e-08,0.004780819371978495,0.03171190540177372,0.005440279394345618,0.04959694113937285,0.0,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
151,0.1,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a mismatch between clinicians and clinical pathologists in reporting and interpreting red blood cell morphology? Important discrepancies exist between clinicians and clinical pathologists concerning the clinical significance of certain RBC morphology terms. The clearest approach to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices warrant critical evaluation.,2.3685972735685406e-08,0.12840535887639426,0.13355371900826446,0.0018134264647818726,0.052507599739611166,0.049861495844875335,0.0018108015409528666,0.02989859583120502,0.033856571252693125,2.3685972735685406e-08,0.006509884203991234,0.017236072637734686
151,0.1,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians differ in their approach to reporting and interpreting red blood cell morphology? There are key differences between clinicians and clinical pathologists about the clinical relevance of some RBC morphology terms. The inclusion of interpretive comments on CBC reports is the most straightforward way to ensure RBC morphology changes are understood as clinical pathologists intend. Reporting practices should be scrutinized carefully.,9.474389094274162e-08,0.008619779286243023,0.07954850846546627,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
151,0.1,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there discordance between clinicians and clinical pathologists in the reporting and interpretation of red blood cell morphology? Clinicians and clinical pathologists hold differing views on the clinical importance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically examined.,0.0,0.12424533248939928,0.1190082644628099,0.0,0.04699302919050474,0.033856571252693125,0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0
151,0.1,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are there differences between clinical pathologists and clinicians in how red blood cell morphology is reported and interpreted? Significant differences exist regarding the clinical relevance of certain RBC morphology terms between clinicians and clinical pathologists. The best way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically reviewed.,7.105791820705622e-08,0.004780819371978495,0.03171190540177372,0.005440279394345618,0.04959694113937285,0.0,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
151,0.1,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a lack of agreement between clinicians and clinical pathologists in reporting and interpreting red blood cell morphology? Important differences about the clinical relevance of certain RBC morphology terms exist between clinicians and clinical pathologists. Including interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically analyzed.,4.737194547137081e-08,0.07900810952538695,0.08002462296091106,0.0036268529295637453,0.012115853867486592,0.03274920999712727,0.003621603081905733,0.01079664565701588,0.016661878770468257,4.737194547137081e-08,0.03448617607116855,0.0
151,0.1,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinicians and clinical pathologists disagree on the reporting and interpretation of red blood cell morphology? There are significant differences between clinicians and clinical pathologists regarding the clinical relevance of some RBC morphology terms. The inclusion of interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices should be critically assessed.,7.105791820705622e-08,0.03922852542547872,0.06320022981901754,0.005440279394345618,0.004877768200021393,0.0322222222222222,0.0054324046228586,0.02770471655935225,0.016388888888888897,7.105791820705622e-08,0.05129329438754926,0.0
151,0.1,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a divergence between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists differ in their views on the clinical importance of certain RBC morphology terms. Including interpretive comments on CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically reviewed.,0.0,0.07803552045206796,0.084949215143121,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.1,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are clinical pathologists and clinicians in disagreement about the reporting and interpretation of red blood cell morphology? There are important differences between clinicians and clinical pathologists concerning the clinical relevance of specific RBC morphology terms. The clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically examined.,7.105791820705622e-08,0.02552937911825115,0.08083333333333335,0.005440279394345618,0.04959694113937285,0.0,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
152,0.1,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections contribute to benign paroxysmal positional vertigo? Yes, viral infections can influence benign paroxysmal positional vertigo (BPPV). Viruses might induce inflammation or harm the inner ear, causing calcium crystals to dislodge and result in BPPV. However, this is only one factor.",2.1317375462116866e-07,0.10290134361093717,0.0627750745757739,0.016320838183036854,0.12135944742253635,0.055020085066162565,0.0162972138685758,0.11806567903016685,0.060964083175803374,2.1317375462116866e-07,0.1498770997315848,0.04158790170132326
152,0.1,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections be involved in benign paroxysmal positional vertigo? Indeed, viral infections may have a role in benign paroxysmal positional vertigo (BPPV). They can cause inflammation or damage within the inner ear, leading to the displacement of calcium crystals that trigger BPPV. Still, this is just one possible cause.",4.737194547137081e-08,0.03710347538856862,0.05279333741454954,0.0036268529295637453,0.012319289322674898,0.037807183364839306,0.003621603081905733,0.013706843861276408,0.039697542533081276,4.737194547137081e-08,0.0152026506278653,0.04158790170132326
152,0.1,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections linked to benign paroxysmal positional vertigo? Yes, viral infections can contribute to benign paroxysmal positional vertigo (BPPV). Such infections might cause inner ear inflammation or injury, which dislodges calcium crystals and causes BPPV. Nonetheless, this is only one aspect.",2.3685972735685406e-07,0.16322609974887792,0.03736024666614346,0.018134264647818726,0.18155472048061227,0.02953358922128723,0.018108015409528666,0.1789294962739425,0.03534081447774242,2.3685972735685406e-07,0.17585258613484278,0.04158790170132326
152,0.1,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is there a connection between viral infections and benign paroxysmal positional vertigo? Yes, viral infections can play a part in benign paroxysmal positional vertigo (BPPV). Viruses may lead to inflammation or damage in the inner ear, resulting in the displacement of calcium crystals that cause BPPV. However, this is just one factor among others.",4.737194547137081e-08,0.12411598793361289,0.05881222872012695,0.0036268529295637453,0.12346475509826016,0.060171709441402856,0.003621603081905733,0.12488049958022218,0.060964083175803374,4.737194547137081e-08,0.09858425956691619,0.04158790170132326
152,0.1,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections have an impact on benign paroxysmal positional vertigo? Yes, viral infections can influence benign paroxysmal positional vertigo (BPPV). They may cause inflammation or injury to the inner ear, which can dislodge calcium crystals and lead to BPPV. Still, this is only one contributing factor.",1.1842986367842703e-07,0.0033190414230985787,0.06888104581882545,0.009067132323909363,0.025263508126454504,0.05718434126450968,0.009054007704764333,0.02275549922584119,0.060964083175803374,1.1842986367842703e-07,0.052238630167666944,0.04158790170132326
152,0.1,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can benign paroxysmal positional vertigo be caused by viral infections? Yes, viral infections can be involved in benign paroxysmal positional vertigo (BPPV). They might cause inflammation or damage to the inner ear, causing calcium crystals to become dislodged and trigger BPPV. However, this is just one possible cause.",9.474389094274162e-08,0.02011079149599615,0.07024793388429755,0.0072537058591274906,0.03275172792423753,0.03600665531409644,0.007243206163811466,0.031089184732003172,0.038753339374150486,9.474389094274162e-08,0.02924911194296742,0.04158790170132326
152,0.1,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections a factor in benign paroxysmal positional vertigo? Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). They may cause inflammation or harm to the inner ear, leading to the displacement of calcium crystals that cause BPPV. Nonetheless, this is only one factor.",7.105791820705622e-08,0.014754587808790465,0.031022744034076982,0.005440279394345618,0.009963104237853404,0.036925949263693435,0.0054324046228586,0.008440570592397112,0.039235688114074976,7.105791820705622e-08,0.006776256090909705,0.04158790170132326
152,0.1,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections contribute to the development of benign paroxysmal positional vertigo? Yes, viral infections can contribute to benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage in the inner ear, resulting in the dislodgement of calcium crystals that cause BPPV. However, this is just one of several causes.",2.3685972735685406e-08,0.03184363321613004,0.03501555963677175,0.0018134264647818726,0.06240911991656439,0.05899577951060701,0.0018108015409528666,0.06425587776378805,0.060964083175803374,2.3685972735685406e-08,0.03670885584882866,0.04158790170132326
152,0.1,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is benign paroxysmal positional vertigo associated with viral infections? Yes, viral infections can be associated with benign paroxysmal positional vertigo (BPPV). They might cause inflammation or injury to the inner ear, which dislodges calcium crystals and leads to BPPV. Still, this is only one contributing factor.",1.4211583641411244e-07,0.05811361176258556,0.04573816008770855,0.010880558788691236,0.07994320267119726,0.03404361114326007,0.0108648092457172,0.07798442119751492,0.03772145279031585,1.4211583641411244e-07,0.07576912757786136,0.04158790170132326
152,0.1,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections trigger benign paroxysmal positional vertigo? Yes, viral infections can trigger benign paroxysmal positional vertigo (BPPV). They may cause inflammation or damage to the inner ear, causing calcium crystals to dislodge and result in BPPV. However, this is just one possible cause.",1.8948778188548325e-07,0.10930743539436039,0.04173628430621437,0.014507411718254981,0.1294638554513705,0.03189508506616255,0.014486412327622933,0.12718512402808502,0.03658908317580337,1.8948778188548325e-07,0.12455929174729308,0.04158790170132326
153,0.1,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes be involved in transient tachypnea of the newborn (TTN)? Answer: Studies indicate a possible involvement of polymorphisms in the ADRB genes in TTN.,1.421158364141118e-07,0.1457725127816465,0.179873565563678,0.01088055878869127,0.11804222144868781,0.18892852424362527,0.010864809245717241,0.08920664072103746,0.1875,1.4211583641411244e-07,0.009710803370790444,0.14268727705112957
153,0.1,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is there a connection between beta-adrenergic receptor (ADRB) gene polymorphisms and transient tachypnea of the newborn (TTN)? Answer: Research points to a potential role of ADRB gene polymorphisms in TTN.,1.658018091497971e-07,0.15621122380002772,0.21078914225808942,0.01269398525347315,0.1303504818103356,0.22222222222222218,0.012675610786670115,0.05411532090976845,0.1875,1.6580180914979784e-07,0.026656840800084236,0.14268727705112957
153,0.1,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Do polymorphisms in the beta-adrenergic receptor (ADRB) genes contribute to transient tachypnea of the newborn (TTN)? Answer: Evidence suggests that ADRB gene polymorphisms may play a role in TTN.,1.894877818854824e-07,0.1685194841616755,0.24408284023668633,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
153,0.1,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): could polymorphisms in beta-adrenergic receptor (ADRB) genes be a factor? Answer: Research supports a possible role for ADRB gene polymorphisms in TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.1,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: Studies suggest a potential link between ADRB gene polymorphisms and TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.1,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes influence transient tachypnea of the newborn (TTN)? Answer: Research indicates a possible influence of ADRB gene polymorphisms on TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.1,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: What role do polymorphisms in the beta-adrenergic receptor (ADRB) genes play in transient tachypnea of the newborn (TTN)? Answer: Research suggests these polymorphisms may be involved in TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.1,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Are polymorphisms in the beta-adrenergic receptor (ADRB) genes implicated in transient tachypnea of the newborn (TTN)? Answer: Studies indicate a potential implication of ADRB gene polymorphisms in TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.1,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): is there a role for polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: Research suggests a possible role for these polymorphisms in TTN.,1.894877818854824e-07,0.07291297649823525,0.17549573461254367,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
153,0.1,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Evidence points to a potential involvement of ADRB gene polymorphisms in TTN.,1.894877818854824e-07,0.12071623032995538,0.20964406472648223,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
154,0.1,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.1,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Indeed, parents, their children, and the children's doctors may have varying perceptions of body image. Parents might be shaped by cultural or personal beliefs, children by their self-esteem and peer pressure, and physicians by clinical criteria and health concerns. Therefore, each group",4.737194547137081e-08,0.038371277551590754,0.0018947695229746889,0.0036268529295637453,0.012529249072251503,0.017153368972257988,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
154,0.1,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, the way body image is perceived can vary between parents, their children, and the children's physicians. Parents' opinions may be influenced by cultural or personal values, children by their self-confidence and social circles, and doctors by medical guidelines and health factors. Thus, each group",1.1842986367842703e-07,0.07020780897605539,0.011962625286801087,0.009067132323909363,0.06723248594945552,0.015344645300396944,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
154,0.1,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Certainly, perceptions of body image differ among parents, children, and their physicians. Parents' perspectives might be shaped by cultural or personal beliefs, children by their self-esteem and peer influences, and physicians by medical standards and health considerations. Consequently, each group",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.1,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, parents, children, and their children's doctors often perceive body image differently. Parents' views may stem from cultural or personal beliefs, children from self-esteem and peer influence, and physicians from medical criteria and health implications. Hence, each group",4.737194547137081e-08,0.09220770251736754,0.03895206689677841,0.0036268529295637453,0.09204673101817074,0.03896412569285168,0.003621603081905733,0.06564852320269532,0.019599999999999992,4.737194547137081e-08,0.03922071315328246,0.0
154,0.1,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, there are differences in how parents, children, and their children's physicians view body image. Parents' perceptions can be influenced by cultural or personal beliefs, children by their self-esteem and peer groups, and physicians by medical standards and health concerns. Therefore, each group",7.105791820705622e-08,0.033119373711592015,0.014223200298698849,0.005440279394345618,0.006776477957218141,0.033957209850172934,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
154,0.1,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Indeed, body image perceptions vary among parents, their children, and the children's physicians. Parents may be influenced by cultural or personal beliefs, children by self-esteem and peer pressure, and physicians by medical guidelines and health factors. Thus, each group",2.3685972735685406e-08,0.04542155380117752,0.019236094674556198,0.0018134264647818726,0.04533300997287881,0.019165890272232835,0.0018108015409528666,0.04570770191530649,0.01922337562475971,2.3685972735685406e-08,0.019418085857102696,0.0
154,0.1,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, parents, children, and physicians each perceive body image differently. Parents' views might be shaped by cultural or personal beliefs, children by their self-esteem and peer influences, and physicians by medical standards and health considerations. Hence, each group",4.737194547137081e-08,0.0660512051377471,0.02060485768996645,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
154,0.1,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Certainly, perceptions of body image among parents, children, and their physicians can differ. Parents' opinions may be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical criteria and health implications. Therefore, each group",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.1,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, the perception of body image varies between parents, children, and their children's physicians. Parents' views could be shaped by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health concerns. Thus, each group",2.3685972735685406e-08,0.005386464230514587,0.016642011834319514,0.0018134264647818726,0.00638944757401072,0.017799928800284807,0.0018108015409528666,0.006979984786362525,0.01851192595229618,2.3685972735685406e-08,0.0190481949706931,0.0
155,0.1,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain linked to a decline in health-related quality of life six months afterward? Yes, studies indicate that neck pain correlates with poorer health-related quality of life six months later. Ongoing neck pain may lead to emotional distress, reduced physical function, and impaired daily activities, affecting overall health and wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.1,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain result in a worse health-related quality of life after six months? Research shows that neck pain is connected to a diminished health-related quality of life six months later. Chronic neck pain can cause emotional strain, limited physical capabilities, and difficulty performing daily tasks, impacting overall health and wellbeing.",1.1842986367842703e-07,0.03324816001481157,0.04058369520871416,0.009067132323909363,0.05105872057059724,0.03285758261656855,0.009054007704764333,0.04950254302869883,0.03557609778180174,1.1842986367842703e-07,0.047777102982143216,0.03840000000000001
155,0.1,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there an association between neck pain and poorer health-related quality of life six months later? Yes, evidence suggests neck pain is linked to a decline in health-related quality of life six months afterward. Persistent neck pain can lead to emotional distress, decreased physical function, and challenges in daily activities, affecting overall health and wellbeing.",2.3685972735685406e-08,0.0034126750788989746,0.014486192847442458,0.0018134264647818726,0.020629651336569577,0.0013687630154102515,0.0018108015409528666,0.020557223665671476,0.0010760516451478394,2.3685972735685406e-08,0.020463556717675413,0.0007503540191586833
155,0.1,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Can neck pain lead to a reduced health-related quality of life six months later? Research supports that neck pain is associated with worse health-related quality of life six months later. Long-lasting neck pain may contribute to emotional difficulties, limited physical function, and decreased ability to carry out daily activities, impacting overall health and wellbeing.",4.737194547137081e-08,0.01885294104702373,0.011298297649844719,0.0036268529295637453,0.04168988456723399,0.0027888888888888963,0.003621603081905733,0.041543515813633025,0.0021937499999999735,4.737194547137081e-08,0.04135347370885123,0.0015305555555555558
155,0.1,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain related to a decline in health-related quality of life six months later? Yes, studies suggest that neck pain is associated with poorer health-related quality of life six months afterward. Chronic neck pain can cause emotional distress, reduced physical functionality, and hinder daily activities, affecting overall health and wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.1,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does experiencing neck pain affect health-related quality of life six months later? Research indicates that neck pain is linked to a worsened health-related quality of life six months later. Persistent neck pain may result in emotional distress, limited physical function, and decreased capacity for daily activities, impacting overall health and wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526155,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.1,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain connected to a worse health-related quality of life six months later? Yes, research finds that neck pain is associated with a decline in health-related quality of life six months afterward. Ongoing neck pain can contribute to emotional distress, reduced physical functionality, and difficulty performing daily tasks, affecting overall health and wellbeing.",4.737194547137081e-08,0.01885294104702373,0.011298297649844719,0.0036268529295637453,0.04168988456723399,0.0027888888888888963,0.003621603081905733,0.041543515813633025,0.0021937499999999735,4.737194547137081e-08,0.04135347370885123,0.0015305555555555558
155,0.1,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there a relationship between neck pain and poorer health-related quality of life six months later? Studies show that neck pain correlates with a worsened health-related quality of life six months later. Chronic neck pain may lead to emotional distress, limited physical function, and decreased ability to manage daily activities, impacting overall health and wellbeing.",2.3685972735685406e-08,0.0034126750788989746,0.014486192847442458,0.0018134264647818726,0.020629651336569577,0.0013687630154102515,0.0018108015409528666,0.020557223665671476,0.0010760516451478394,2.3685972735685406e-08,0.020463556717675413,0.0007503540191586833
155,0.1,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain influence health-related quality of life six months later? Research suggests that neck pain is linked to a decline in health-related quality of life six months afterward. Persistent neck pain can cause emotional distress, reduced physical functionality, and hinder daily activities, affecting overall health and wellbeing.",1.8948778188548325e-07,0.16363147690740076,0.010581428248075953,0.014507411718254981,0.17820151463066924,0.012567800453514771,0.014486412327622933,0.17757955571759876,0.009926530612244862,1.8948778188548325e-07,0.17674845082484403,0.006951473922902483
155,0.1,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain associated with a decline in health-related quality of life six months later? Yes, evidence indicates that neck pain correlates with worse health-related quality of life six months later. Long-term neck pain may contribute to emotional distress, limited physical function, and decreased ability to perform daily activities, impacting overall health and wellbeing.",4.737194547137081e-08,0.01885294104702373,0.011298297649844719,0.0036268529295637453,0.04168988456723399,0.0027888888888888963,0.003621603081905733,0.04154351581363347,0.0021937499999999735,4.737194547137081e-08,0.04135347370885123,0.0015305555555555558
156,0.1,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG used as a surrogate tracer for tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia; it primarily measures glucose metabolism in tissues. Specialized tracers like (18)F-fluoromisonidazole are employed instead.",1.421158364141119e-07,0.1406315614257938,0.06029478458049889,0.010880558788691243,0.18698294763518453,0.016790123456790124,0.010864809245717214,0.1864428169865202,0.013611111111111143,1.4211583641411244e-07,0.18553079338508116,0.009753086419753088
156,0.1,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG act as a surrogate tracer to assess tumor hypoxia? No, (18)F-FDG is not suitable for measuring tumor hypoxia. Its main function is to evaluate glucose metabolism, while other tracers such as (18)F-fluoromisonidazole are used for hypoxia detection.",7.1057918207056e-08,0.13964858839973449,0.19918367346938776,0.005440279394345618,0.06066789464227762,0.09876543209876547,0.0054324046228586,0.026595320104918052,0.0763888888888889,7.105791820705622e-08,0.009275237125399904,0.05246913580246914
156,0.1,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a surrogate tracer for detecting tumor hypoxia? No, (18)F-FDG is not used to measure tumor hypoxia; it is primarily utilized to assess glucose metabolism rates in tissues. Other tracers like (18)F-fluoromisonidazole are designed for hypoxia imaging.",9.474389094274131e-08,0.11298034131757362,0.19918367346938776,0.0072537058591274906,0.0332689204541623,0.09876543209876547,0.007243206163811466,0.001575556861778793,0.0763888888888889,9.474389094274162e-08,0.03826277399865141,0.05246913580246914
156,0.1,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG serve as a surrogate tracer to measure tumor hypoxia? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia. It mainly measures tissue glucose metabolism, whereas tracers such as (18)F-fluoromisonidazole are used for hypoxia assessment.",1.1842986367842661e-07,0.00856501373390861,0.14382035167007978,0.009067132323909363,0.034510366830245776,0.07021871929599731,0.00905400770476434,0.0305630937350303,0.0763888888888889,1.1842986367842703e-07,0.06811573714833319,0.05246913580246914
156,0.1,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG employed as a surrogate tracer for tumor hypoxia measurement? No, (18)F-FDG is not used for tumor hypoxia measurement; it primarily tracks glucose metabolism. Specialized tracers like (18)F-fluoromisonidazole are preferred for hypoxia evaluation.",1.894877818854825e-07,0.08544784992804422,0.13882987534243668,0.014507411718255002,0.1278358139872191,0.06754795030896316,0.01448641232762296,0.12293641386604559,0.0763888888888889,1.8948778188548325e-07,0.1634259169526584,0.05246913580246914
156,0.1,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG be used as a surrogate tracer to measure tumor hypoxia? No, (18)F-FDG does not measure tumor hypoxia but is mainly used to evaluate glucose metabolism in tissues. Other tracers such as (18)F-fluoromisonidazole are utilized for hypoxia detection.",7.1057918207056e-08,0.10316715784394814,0.17288710663228038,0.005440279394345618,0.06066789464227762,0.09876543209876547,0.0054324046228586,0.026595320104918052,0.0763888888888889,7.105791820705622e-08,0.009275237125399904,0.05246913580246914
156,0.1,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not intended for tumor hypoxia measurement; it is mainly used to assess glucose metabolism. Hypoxia-specific tracers like (18)F-fluoromisonidazole are used instead.",2.368597273568531e-07,0.10866953978085636,0.16696145124716555,0.01813426464781876,0.14905263633979304,0.09876543209876547,0.018108015409528708,0.18962778836471905,0.0763888888888889,2.3685972735685406e-07,0.23241878843960917,0.05246913580246914
156,0.1,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG function as a surrogate tracer to measure tumor hypoxia? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia. It is primarily used to measure glucose metabolism rates, while other tracers such as (18)F-fluoromisonidazole are used for hypoxia imaging.",2.3685972735685406e-08,0.08696980570329327,0.12467673409758352,0.0018134264647818726,0.07776561886821254,0.07314216340070451,0.0018108015409528666,0.08066254137519424,0.0763888888888889,2.3685972735685406e-08,0.04629461402941226,0.05246913580246914
156,0.1,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia measurement? No, (18)F-FDG is not suitable for measuring tumor hypoxia; it mainly measures glucose metabolism. Specialized tracers like (18)F-fluoromisonidazole are used for hypoxia detection.",1.894877818854825e-07,0.0014300098601718325,0.19918367346938776,0.014507411718255002,0.08451411520222152,0.09876543209876547,0.01448641232762296,0.12293641386604559,0.0763888888888889,1.8948778188548325e-07,0.1634259169526584,0.05246913580246914
156,0.1,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a surrogate tracer to assess tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia. It is primarily used to measure glucose metabolism, with other tracers such as (18)F-fluoromisonidazole employed for hypoxia assessment.",7.1057918207056e-08,0.06668572728816136,0.1467145376669186,0.005440279394345618,0.023200479476875202,0.0717592592592593,0.0054324046228586,0.026595320104918052,0.0763888888888889,7.105791820705622e-08,0.009275237125399904,0.05246913580246914
157,0.1,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain considered a clinically significant issue in general adult psychiatry? Our findings indicate that pain is indeed a notable clinical concern among psychiatric patients, often underestimated within psychiatry. Patients in general adult psychiatry exhibit particular risk factors.",1.8948778188548293e-07,0.17825978338224058,0.01244897959183671,0.014507411718254981,0.2076721821344738,0.00504012096996722,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
157,0.1,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Does pain represent a clinically relevant problem in general adult psychiatry? Evidence suggests that pain is a substantial clinical issue for psychiatric patients and is frequently underrecognized in psychiatric practice. The patients studied in general adult psychiatry show distinct risk factors.,1.1842986367842703e-07,0.09467812963771838,0.016465034767369553,0.009067132323909363,0.12466730702264872,0.002908287627211844,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
157,0.1,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically important problem in the field of general adult psychiatry? Research shows that pain can be a major clinical challenge for psychiatric patients, which appears to be undervalued in psychiatry. The patients examined in general adult psychiatry possess specific risk factors.",4.737194547137081e-08,0.014717846250927646,0.043083900226757364,0.0036268529295637453,0.015013325609441353,0.02271498107084911,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
157,0.1,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a significant clinical concern in general adult psychiatry? We discovered that pain is a considerable clinical problem among psychiatric patients and tends to be underestimated in psychiatric care. The patients assessed in general adult psychiatry have unique risk factors.,1.1842986367842703e-07,0.09467812963771838,0.016465034767369553,0.009067132323909363,0.12466730702264872,0.002908287627211844,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
157,0.1,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a relevant clinical issue in general adult psychiatry? Our study found that pain is a meaningful clinical problem in psychiatric patients, often overlooked in psychiatry. The patients involved in general adult psychiatry are marked by particular risk factors.",1.4211583641411233e-07,0.1217732380849843,0.015194317317869438,0.010880558788691236,0.15157821472220911,0.0035815857662582634,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.1,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically relevant issue within general adult psychiatry? Evidence reveals that pain can be a critical clinical problem for psychiatric patients, which seems to be underestimated in the psychiatric field. The patients studied in general adult psychiatry are characterized by specific risk factors.",2.3685972735685406e-08,0.038440078197148786,0.043611549541395775,0.0018134264647818726,0.008517171800753065,0.02271498107084911,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
157,0.1,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically significant problem in general adult psychiatry? Findings indicate that pain is an important clinical issue among psychiatric patients and is often underestimated in psychiatry. The patients investigated in general adult psychiatry have distinct risk factors.,1.6580180914979763e-07,0.14961956708084712,0.013857394809775749,0.012693985253473108,0.17923244641398606,0.004291191768657054,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
157,0.1,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically pertinent problem in general adult psychiatry? We found that pain constitutes a significant clinical problem in psychiatric patients, which appears to be underappreciated in psychiatry. The patients examined in general adult psychiatry show specific risk factors.",1.4211583641411233e-07,0.15731924734446823,0.010062358276644007,0.010880558788691236,0.15157821472220911,0.0035815857662582634,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.1,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically relevant challenge in general adult psychiatry? Our research indicates that pain can be a major clinical problem in psychiatric patients and is frequently underestimated in psychiatry. The patients studied in general adult psychiatry are characterized by particular risk factors.,7.105791820705622e-08,0.042587264608476616,0.018826530612244874,0.005440279394345618,0.07292293477679124,0.0016600189291508909,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
157,0.1,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically important concern in general adult psychiatry? Evidence suggests that pain is a significant clinical problem among psychiatric patients, often underestimated in psychiatry. The patients involved in general adult psychiatry possess specific risk factors.",2.1317375462116823e-07,0.20774028063509986,0.010963208812936914,0.016320838183036854,0.23694329272110703,0.005831731731919049,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
158,0.1,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors sufficient for detecting cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors might not be fully reliable for identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms.,9.47438909427412e-08,0.11337160161350601,0.0008081632653060833,0.007253705859127504,0.10873347009207857,0.0030166257414039332,0.007243206163811487,0.10815599148194055,0.005600545982874655,9.474389094274162e-08,0.10730625979475672,0.008764924821816789
158,0.1,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,"Question: In geriatric blunt trauma patients with low-energy mechanisms, are clinical predictors effective for diagnosing cervical spine fractures? Answer: Clinical predictors may fall short in accurately identifying cervical spine fractures in these patients.",4.73719454713706e-08,0.21969225267471781,0.16817777777777776,0.003626852929563759,0.2315420832562194,0.1967455621301775,0.003621603081905747,0.19539167157240822,0.17751479289940827,4.737194547137081e-08,0.1569044901980834,0.15532544378698224
158,0.1,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Can clinical predictors adequately identify cervical spine fractures in elderly patients experiencing blunt trauma from low-energy mechanisms? Answer: Clinical predictors may not be completely adequate for this purpose.,1.421158364141118e-07,0.12329374472305066,0.19473470507544582,0.010880558788691277,0.09339174477540224,0.1967455621301775,0.010864809245717241,0.052290827931735784,0.17751479289940827,1.4211583641411244e-07,0.008484485079810256,0.15532544378698224
158,0.1,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors reliable for detecting cervical spine fractures in geriatric blunt trauma cases involving low-energy mechanisms? Answer: Clinical predictors might not be entirely sufficient for identifying such fractures.,1.184298636784265e-07,0.16009232359973868,0.19596122448979592,0.009067132323909398,0.12975938894627692,0.1967455621301775,0.009054007704764368,0.09003115591458277,0.17751479289940827,1.1842986367842703e-07,0.047705198233092716,0.15532544378698224
158,0.1,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Do clinical predictors provide adequate identification of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not fully suffice for accurate detection.,1.421158364141118e-07,0.12329374472305066,0.19473470507544582,0.010880558788691277,0.09339174477540224,0.1967455621301775,0.010864809245717241,0.052290827931735784,0.17751479289940827,1.4211583641411244e-07,0.008484485079810256,0.15532544378698224
158,0.1,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Is the use of clinical predictors adequate for diagnosing cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be entirely dependable for this diagnosis.,7.10579182070559e-08,0.22986777899078126,0.19817777777777779,0.005440279394345639,0.1987522604332277,0.1967455621301775,0.005432404622858621,0.16149011989672646,0.17751479289940827,7.105791820705622e-08,0.12181317038681438,0.15532544378698224
158,0.1,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors enough to detect cervical spine fractures in elderly patients with blunt trauma from low-energy mechanisms? Answer: Clinical predictors might not be wholly adequate for identification.,1.421158364141118e-07,0.12329374472305066,0.19473470507544582,0.010880558788691277,0.09339174477540224,0.1967455621301775,0.010864809245717241,0.052290827931735784,0.17751479289940827,1.4211583641411244e-07,0.008484485079810256,0.15532544378698224
158,0.1,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: How effective are clinical predictors in identifying cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: They may not be completely adequate for this identification.,1.421158364141118e-07,0.1728042576201898,0.2304,0.010880558788691277,0.09339174477540224,0.1967455621301775,0.010864809245717241,0.052290827931735784,0.17751479289940827,1.4211583641411244e-07,0.008484485079810256,0.15532544378698224
158,0.1,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors sufficient to identify cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not fully identify these fractures.,1.894877818854824e-07,0.04537727157724136,0.19199999999999998,0.014507411718255037,0.016430703639272792,0.1967455621301775,0.014486412327622988,0.02775187974180149,0.17751479289940827,1.8948778188548325e-07,0.07489712385924019,0.15532544378698224
158,0.1,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Can clinical predictors alone adequately detect cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be entirely adequate for this detection.,1.421158364141118e-07,0.12329374472305066,0.19473470507544582,0.010880558788691277,0.09339174477540224,0.1967455621301775,0.010864809245717241,0.052290827931735784,0.17751479289940827,1.4211583641411244e-07,0.008484485079810256,0.15532544378698224
159,0.1,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the interfractional motion of the prostate bed target, defined by RTOG consensus and monitored via daily CT on rails, vary between the superior and inferior parts of the clinical target volume? Answer: No significant motion differences are observed between the superior (SUP-CTV) and inferior (INF-CTV) clinical target volume regions. The existing uniform planning target volume (PTV) margins sufficiently cover both areas.",1.1842986367842703e-07,0.0014324941997974072,0.06062194299207286,0.009067132323909363,0.0875512928191915,0.001462350780532598,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
159,0.1,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior sections of the prostate bed clinical target volume? Answer: There is no statistically significant difference in motion between the superior (SUP-CTV) and inferior (INF-CTV) portions. Current uniform planning target volume (PTV) margins adequately encompass both regions.",0.0,0.07296286111157357,0.051866961709619096,0.0,0.024755256448569796,0.017814055255132685,0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0
159,0.1,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the prostate bed target exhibit different interfractional motion in the superior versus inferior parts of the clinical target volume when assessed by RTOG consensus and daily CT on rails? Answer: No statistically significant motion difference exists between the superior (SUP-CTV) and inferior (INF-CTV) parts. The uniform planning target volume (PTV) margins currently used are sufficient for both.,2.3685972735685406e-08,0.018230396287864714,0.0006025468038455273,0.0018134264647818726,0.042454833547970416,0.017851239669421492,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
159,0.1,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When using RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior clinical target volume areas of the prostate bed? Answer: No statistically significant motion difference is found between the superior (SUP-CTV) and inferior (INF-CTV) areas. The uniform planning target volume (PTV) margins adequately cover both.",2.3685972735685406e-08,0.0680786954859629,0.03596459484571372,0.0018134264647818726,0.01846860107447057,0.0003243433209763093,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
159,0.1,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does interfractional motion differ between the superior and inferior portions of the prostate bed clinical target volume based on RTOG consensus and daily CT on rails? Answer: There are no statistically significant differences in motion between the superior (SUP-CTV) and inferior (INF-CTV) portions. Current uniform planning target volume (PTV) margins are sufficient to cover both.,4.737194547137081e-08,0.08789758327581021,0.0372385700350469,0.0036268529295637453,0.0372845055208213,0.0006606862828746896,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.1,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: According to RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume? Answer: No statistically significant motion difference is observed between the superior (SUP-CTV) and inferior (INF-CTV) parts. The existing uniform planning target volume (PTV) margins adequately cover both.",0.0,0.024320953703857562,0.017427813488419513,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
159,0.1,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using daily CT on rails and RTOG consensus definitions, does the interfractional motion of the prostate bed target differ between its superior and inferior clinical target volume portions? Answer: There is no statistically significant difference in motion between the superior (SUP-CTV) and inferior (INF-CTV) portions. The current uniform planning target volume (PTV) margins sufficiently cover both.",2.3685972735685406e-08,0.0185681825888242,0.0006239726105045779,0.0018134264647818726,0.006736750945891323,0.017851239669421492,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
159,0.1,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Is there a difference in interfractional motion between the superior and inferior regions of the prostate bed clinical target volume as defined by RTOG consensus and assessed with daily CT on rails? Answer: No statistically significant motion difference exists between the superior (SUP-CTV) and inferior (INF-CTV) regions. The uniform planning target volume (PTV) margins currently used are adequate for both.,7.105791820705622e-08,0.0075155777206070695,0.031285208298195276,0.005440279394345618,0.053444495023886596,0.0009071255195998509,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
159,0.1,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the interfractional motion of the prostate bed clinical target volume vary between its superior and inferior parts according to RTOG consensus and daily CT on rails? Answer: No statistically significant difference in motion is found between the superior (SUP-CTV) and inferior (INF-CTV) parts. The uniform planning target volume (PTV) margins are sufficient to cover both.,2.3685972735685406e-08,0.0185681825888242,0.0006239726105045709,0.0018134264647818726,0.006736750945891323,0.017851239669421492,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
159,0.1,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Based on RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior portions of the prostate bed clinical target volume? Answer: There are no statistically significant differences in motion between the superior (SUP-CTV) and inferior (INF-CTV) portions. Current uniform planning target volume (PTV) margins adequately cover both.",0.0,0.04864190740771557,0.03473439858306681,0.0,0.024755256448569796,0.017814055255132685,0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0
160,0.1,1,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are laboratories accurately reporting serum quantitative hCG results? The precision of serum quantitative hCG results reported by laboratories depends significantly on the individual lab and its compliance with testing standards. Although numerous labs deliver dependable and precise outcomes, inconsistencies may arise from factors such as equipment calibration, reagent quality, and staff expertise. Consistent audits and quality control measures are crucial to maintain accuracy.",4.737194547137081e-08,0.03183637570855957,0.04534169619202657,0.0036268529295637453,0.03303169030915054,0.04681134093012865,0.003621603081905733,0.03428893658603549,0.048261993679977015,4.737194547137081e-08,0.012115853867486592,0.03274920999712727
160,0.1,2,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories report serum quantitative hCG results correctly? The correctness of serum quantitative hCG results from laboratories is largely influenced by the specific laboratory's adherence to testing protocols. Many labs produce reliable and accurate data, but discrepancies can happen due to equipment calibration, reagent quality, and technician training. Regular quality control and audits are vital to ensure accuracy.",1.6580180914979784e-07,0.08049042967420394,0.025094782611779658,0.012693985253473108,0.07927485895861075,0.027534934894463375,0.012675610786670066,0.07792779242395476,0.030086410689579214,1.6580180914979784e-07,0.07643754347395681,0.03274920999712727
160,0.1,3,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results reported accurately by laboratories? The accuracy of these results depends on the lab's compliance with testing procedures. While many laboratories provide trustworthy and precise results, errors may occur because of equipment calibration issues, reagent quality, or technician skill levels. Ongoing audits and quality control are necessary to guarantee correctness.",2.6054570009253947e-07,0.08028692284505956,0.07756391841424877,0.0199476911126006,0.10387231821519283,0.06320022981901754,0.019918816950481533,0.12822999291173875,0.048261993679977015,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.1,4,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting of serum quantitative hCG results by laboratories accurate? The reliability of serum quantitative hCG results is contingent on the laboratory and its adherence to established testing protocols. Although many labs offer accurate and dependable results, discrepancies can arise from factors like equipment calibration, reagent quality, and technician training. Regular quality checks and audits are essential for ensuring accuracy.",9.474389094274162e-08,0.04865389824973754,0.011237387802003895,0.0072537058591274906,0.0480681366766591,0.012498699206772643,0.007243206163811466,0.04741586892136507,0.013823218169772923,9.474389094274162e-08,0.04669127590753952,0.015210944691004816
160,0.1,5,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do labs report serum quantitative hCG results with accuracy? The accuracy of serum quantitative hCG reporting depends on the specific laboratory and how well it follows testing protocols. Many labs provide accurate and reliable results, but discrepancies may occur due to equipment calibration, reagent quality, and technician expertise. Regular audits and quality control are important to maintain correctness.",1.6580180914979784e-07,0.05616947597034638,0.042522596100199164,0.012693985253473108,0.054519602510040954,0.04534899014959605,0.012675610786670066,0.05272244040359286,0.048261993679977015,1.6580180914979784e-07,0.07643754347395681,0.03274920999712727
160,0.1,6,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results from laboratories reported correctly? The accuracy of these results largely depends on the laboratory's adherence to testing standards. While many labs produce reliable and accurate results, discrepancies can happen due to factors such as equipment calibration, reagent quality, and technician training. Consistent quality control and audits are necessary to ensure accuracy.",2.1317375462116866e-07,0.043245651164709464,0.07756391841424877,0.016320838183036854,0.0661319902323454,0.06320022981901754,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.11417787145680425,0.03274920999712727
160,0.1,7,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the accuracy of serum quantitative hCG results reported by laboratories reliable? The precision of these results depends on the lab and its compliance with testing protocols. Many laboratories provide accurate and dependable results, but discrepancies may occur due to equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to maintain correctness.",1.6580180914979784e-07,0.007527568562630371,0.07756391841424877,0.012693985253473108,0.02976434606147116,0.06320022981901754,0.012675610786670066,0.05272244040359286,0.048261993679977015,1.6580180914979784e-07,0.07643754347395681,0.03274920999712727
160,0.1,8,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are laboratories providing accurate serum quantitative hCG results? The accuracy of serum quantitative hCG results depends on the specific lab and its adherence to testing protocols. While many labs deliver reliable and precise results, discrepancies can arise from equipment calibration, reagent quality, and technician training. Regular quality control and audits are crucial to ensure accuracy.",2.3685972735685406e-07,0.11293902542993894,0.040581669893538716,0.018134264647818726,0.11098062062412062,0.044339283073455416,0.018108015409528666,0.10881190705463606,0.048261993679977015,2.3685972735685406e-07,0.13359595731390694,0.03274920999712727
160,0.1,9,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories consistently report serum quantitative hCG results accurately? The accuracy of these results is largely dependent on the laboratory's compliance with testing protocols. Many labs offer reliable and accurate results, but discrepancies may occur due to factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control measures are vital for ensuring correctness.",1.8948778188548325e-07,0.025227145662030992,0.07756391841424877,0.014507411718254981,0.04778285156414963,0.06320022981901754,0.014486412327622933,0.07107157907178863,0.048261993679977015,1.8948778188548325e-07,0.09512967648611115,0.03274920999712727
160,0.1,10,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results reported by laboratories dependable? The accuracy of these results depends on the specific laboratory and its adherence to testing protocols. While many labs provide reliable and accurate outcomes, discrepancies can arise from equipment calibration, reagent quality, and technician training. Regular quality control checks and audits are essential to maintain accuracy.",2.3685972735685406e-07,0.06159478983290523,0.07756391841424877,0.018134264647818726,0.08482412324449973,0.06320022981901754,0.018108015409528666,0.10881190705463606,0.048261993679977015,2.3685972735685406e-07,0.13359595731390694,0.03274920999712727
161,0.1,1,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome (HRS) prognosis mainly depends on the severity of liver disease and kidney function, but emerging evidence indicates that additional factors like systemic inflammation, infections, circulatory issues, and genetic predispositions may also play a role, warranting further investigation.",3.789755637709663e-07,0.35139788683788886,0.0,0.029014823436509962,0.3593740009078954,0.0,0.028972824655245866,0.3677247801253176,0.0,3.789755637709665e-07,0.37647757123491177,0.0
161,0.1,2,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The prognosis of hepatorenal syndrome is largely determined by liver disease severity and renal function, yet research suggests that other elements such as systemic inflammation, infections, circulatory dysfunction, and genetic factors might be overlooked and require more study.",4.026615365066516e-07,0.37806613392004973,0.0,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
161,0.1,3,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","While the prognosis for hepatorenal syndrome is typically based on liver and kidney health, there is growing recognition that systemic inflammation, infections, circulatory problems, and genetic predispositions could be important prognostic factors that need further exploration.",4.500334819780222e-07,0.4336359850748619,0.0,0.03445510283085559,0.44393138893595907,0.0,0.03440522927810448,0.45473615711494775,0.0,4.500334819780227e-07,0.46608972992459874,0.0
161,0.1,4,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis is traditionally assessed by liver disease severity and kidney function, but studies imply that systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be missing components that deserve additional research.",5.210914001850781e-07,0.5232481437645489,0.0,0.039895382225201226,0.5363047090669744,0.0,0.0398376339009631,0.550046336919273,0.0,5.210914001850789e-07,0.564529802737852,0.0
161,0.1,5,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The current prognostic evaluation of hepatorenal syndrome focuses on liver and renal status, though evidence points to potential overlooked factors such as systemic inflammation, infections, circulatory dysfunction, and genetic predispositions, highlighting the need for more research.",4.500334819780222e-07,0.4336359850748619,0.0,0.03445510283085559,0.44393138893595907,0.0,0.03440522927810448,0.45473615711494775,0.0,4.500334819780227e-07,0.46608972992459874,0.0
161,0.1,6,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Prognosis in hepatorenal syndrome is primarily linked to liver disease severity and renal function; however, systemic inflammation, infections, circulatory dysfunction, and genetic predispositions may also influence outcomes and require further study.",5.684633456564487e-07,0.5877866649021204,0.0,0.043522235154764985,0.6029960835656478,0.0,0.04345923698286885,0.6190392084062237,0.0,5.684633456564497e-07,0.6359887667199957,0.0
161,0.1,7,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis is based on liver and kidney function, but emerging data suggest that systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be missing prognostic factors that need further investigation.",5.447773729207634e-07,0.5549968420791287,0.0,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
161,0.1,8,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The prognosis of hepatorenal syndrome depends on liver disease severity and renal function, yet additional factors like systemic inflammation, infections, circulatory dysfunction, and genetic predispositions may be overlooked and should be studied further.",5.210914001850781e-07,0.5232481437645489,0.0,0.039895382225201226,0.5363047090669744,0.0,0.0398376339009631,0.550046336919273,0.0,5.210914001850789e-07,0.564529802737852,0.0
161,0.1,9,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","In hepatorenal syndrome, prognosis is mainly determined by liver and kidney health, but systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be missing factors that require more research.",6.158352911278193e-07,0.6567795363890712,0.0,0.047149088084328744,0.6744550475477915,0.0,0.047080840064774594,0.6931471805599454,0.0,6.158352911278206e-07,0.7129498078561252,0.0
161,0.1,10,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis relies on liver disease severity and renal function, but studies indicate that systemic inflammation, infections, circulatory dysfunction, and genetic predispositions could be important yet under-recognized factors needing further research.",5.447773729207634e-07,0.5549968420791287,0.0,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
162,0.1,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction using oversized cups ensure initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most acetabular components in this group remained stable despite limited contact between the component and pelvic bone. However, 3 out of 10 showed migration beyond thresholds that indicate potential loosening later on in primary cases.",2.3685972735685406e-08,0.0190481949706931,0.0,0.0018134264647818726,0.019418085857102696,0.0,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
162,0.1,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? In this cohort, the majority of acetabular components were stable even though the contact area between the component and pelvic bone was minimal. Yet, 3 of 10 components migrated beyond limits that suggest future loosening in primary procedures.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
162,0.1,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does using oversized cups in cup-cage reconstruction provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Most acetabular components in this study were stable despite the small contact surface with the pelvic bone. Still, 3 out of 10 migrated beyond the thresholds that predict later loosening in primary surgeries.",7.105791820705622e-08,0.05826890812397556,0.0,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
162,0.1,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can cup-cage reconstruction with oversized cups offer initial stability in THA for osteoporotic acetabular fractures? The majority of acetabular components in this cohort maintained stability despite limited contact with the pelvic bone. However, 3 of 10 migrated beyond the limits that forecast loosening in primary cases.",1.8948778188548325e-07,0.16362942378180145,0.0,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
162,0.1,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction using oversized cups provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Most acetabular components were stable despite the small contact surface with pelvic bone in this cohort. Nonetheless, 3 out of 10 migrated beyond the limits that predict future loosening in primary procedures.",1.1842986367842703e-07,0.09909090264422993,0.0,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
162,0.1,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability in THA for osteoporotic acetabular fractures achieved through cup-cage reconstruction with oversized cups? The majority of acetabular components remained stable despite minimal contact with pelvic bone. However, 3 of 10 migrated beyond thresholds indicating potential loosening later in primary cases.",2.6054570009253947e-07,0.2326222952687531,0.0,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
162,0.1,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction with oversized cups ensure initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Most acetabular components in this cohort were stable despite limited contact between the component and pelvic bone. Yet, 3 out of 10 migrated beyond limits that predict later loosening in primary surgeries.",1.1842986367842703e-07,0.09909090264422993,0.0,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
162,0.1,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can initial stability be provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? The majority of acetabular components were stable despite the small contact surface with pelvic bone. However, 3 of 10 migrated beyond the limits that suggest future loosening in primary cases.",1.6580180914979784e-07,0.14165051706302645,0.0,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
162,0.1,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does the use of oversized cups in cup-cage reconstruction provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Most acetabular components remained stable despite minimal contact with pelvic bone in this cohort. Still, 3 out of 10 migrated beyond thresholds that predict later loosening in primary procedures.",1.1842986367842703e-07,0.09909090264422993,0.0,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
162,0.1,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability achieved in THA for osteoporotic acetabular fractures by using cup-cage reconstruction with oversized cups? The majority of acetabular components were stable despite the small contact surface with pelvic bone. However, 3 of 10 migrated beyond limits that indicate potential loosening later in primary surgeries.",1.6580180914979784e-07,0.14165051706302645,0.0,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
163,0.1,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study data indicates a potential link between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does a relationship exist between cervical cord plaques and discopathy in patients with multiple sclerosis? The study findings suggest a possible association between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.1,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques related to discopathy in individuals with multiple sclerosis? The study data points to a possible correlation between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.09689103160334289,0.033293697978596916,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.1,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any association between cervical cord plaques and discopathy in multiple sclerosis patients? The study results imply a potential connection between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Can cervical cord plaques be linked to discopathy in patients suffering from multiple sclerosis? The study data suggests a possible relationship between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.059150703620495904,0.033293697978596916,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a correlation between cervical cord plaques and discopathy in multiple sclerosis patients? The study findings indicate a potential association between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Do cervical cord plaques have any relation to discopathy in patients with multiple sclerosis? The study data suggests a possible link between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.059150703620495904,0.033293697978596916,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any connection between cervical cord plaques and discopathy among multiple sclerosis patients? The study results suggest a potential correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques associated with discopathy in patients with multiple sclerosis? The study data indicates a possible relationship between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.1,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a link between cervical cord plaques and discopathy in multiple sclerosis patients? The study findings suggest a potential connection between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
164,0.1,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? The study shows improved outcomes when ruptured aneurysms are surgically repaired in elderly patients compared to conservative treatment. Therefore, definitive surgery should be considered for elderly patients with aSAH without hesitation.",2.1317375462116866e-07,0.16529597490007042,0.014962835153679917,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
164,0.1,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be performed on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The findings indicate that elderly patients have a better prognosis with surgical repair of ruptured aneurysms than with conservative management. Hence, definitive surgery is recommended for elderly aSAH patients.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.1,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it justified to repair aneurysms in patients aged 80+ after aneurysmal subarachnoid hemorrhage? This study demonstrates that elderly patients achieve better outcomes with surgical repair of ruptured aneurysms than with conservative treatment, supporting the use of definitive surgery in this group.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.1,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair appropriate? Results reveal that elderly patients fare better when ruptured aneurysms are repaired surgically rather than treated conservatively, suggesting definitive surgery should be offered.",4.026615365066515e-07,0.3344599803367694,0.03767781622452902,0.030828249901291835,0.39589565709201446,0.0,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
164,0.1,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 and above after aneurysmal subarachnoid hemorrhage? The study found that elderly patients have improved prognosis with surgical repair compared to conservative care, indicating that definitive surgery should not be withheld.",4.026615365066515e-07,0.3344599803367694,0.03767781622452902,0.030828249901291835,0.39589565709201446,0.0,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
164,0.1,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is surgical repair of aneurysms justified in patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Evidence shows better outcomes with repair than conservative treatment in the elderly, so definitive surgery should be considered.",4.737194547137074e-07,0.4214713573263995,0.03767781622452902,0.036268529295637474,0.48550781578170144,0.0,0.03621603081905736,0.49783842823917857,0.0,4.737194547137081e-07,0.5108256237659905,0.0
164,0.1,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should elderly patients aged 80+ with aneurysmal subarachnoid hemorrhage undergo aneurysm repair? The study results suggest that surgical repair leads to better prognosis than conservative management, supporting definitive surgery for these patients.",5.21091400185078e-07,0.483991714307733,0.03767781622452902,0.03989538222520123,0.550046336919273,0.0,0.03983763390096311,0.564529802737852,0.0,5.210914001850789e-07,0.5798184952529413,0.0
164,0.1,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Findings indicate that elderly patients benefit more from surgical repair than conservative treatment, thus definitive surgery is advisable.",4.500334819780221e-07,0.39161839417671773,0.03767781622452902,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
164,0.1,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified for octogenarians after aneurysmal subarachnoid hemorrhage? The study shows that repairing ruptured aneurysms in elderly patients results in better outcomes than conservative treatment, so definitive surgery should be offered.",4.974054274493927e-07,0.4522430159931532,0.03767781622452902,0.03808195576041935,0.5172565140962813,0.0,0.03802683236001023,0.5306282510621703,0.0,4.974054274493935e-07,0.5447271754416723,0.0
164,0.1,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is definitive aneurysm repair warranted? The data demonstrate improved prognosis with surgical repair over conservative care in the elderly, supporting the use of definitive surgery.",4.500334819780221e-07,0.39161839417671773,0.03767781622452902,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
165,0.1,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do individuals with episodic migraines specifically focus on headache-related visual cues? Answer: Considering the substantial sample size and previous pilot testing of the images shown, the findings indicate that episodic migraine sufferers do not show selective attention to headache-related facial stimuli. While there is limited evidence of attentional biases in chronic headache groups, these results suggest otherwise.",1.8948778188548325e-07,0.23610613469044717,0.060964083175803374,0.014507411718254981,0.18303181235058918,0.020823902218198284,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
165,0.1,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are episodic migraine patients more likely to attend to headache-associated visual stimuli? Answer: Based on the large sample and earlier pilot studies of the images used, the data imply that episodic migraineurs do not preferentially focus on headache-related facial images. Although some modest evidence exists for attentional biases in chronic headache populations, these findings do not support that for episodic cases.",2.8423167282822487e-07,0.28120259396166825,0.04457519428691448,0.02176111757738247,0.25202468383753907,0.020823902218198284,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
165,0.1,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do people with episodic migraines selectively notice headache-related visual stimuli? Answer: Given the extensive sample size and prior pilot testing of the images, results indicate that episodic migraine sufferers do not exhibit selective attention to headache-related facial stimuli. There is only limited evidence of attentional biases in chronic headache sufferers, making these findings notable.",1.1842986367842703e-07,0.1820389134201723,0.060964083175803374,0.009067132323909363,0.12797203516756062,0.020823902218198284,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
165,0.1,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is selective attention to headache-related visual stimuli present in episodic migraineurs? Answer: With a large sample and previous pilot testing of the images, the results suggest that episodic migraine patients do not differentially attend to headache-related facial stimuli. Although some modest attentional biases have been observed in chronic headache groups, these findings do not confirm that for episodic migraineurs.",2.3685972735685406e-07,0.22359928157111097,0.027107511923110242,0.018134264647818726,0.21812313216185863,0.020823902218198284,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
165,0.1,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine sufferers focus more on headache-related visual cues? Answer: Considering the large sample size and prior pilot testing of the images, the evidence suggests that episodic migraineurs do not selectively attend to headache-related facial stimuli. There is modest evidence of attentional biases in chronic headache samples, but these results do not extend to episodic migraineurs.",1.8948778188548325e-07,0.2117851809865896,0.04342581786968092,0.014507411718254981,0.18303181235058918,0.020823902218198284,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
165,0.1,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are headache-related visual stimuli selectively attended to by episodic migraineurs? Answer: Based on the large sample and earlier pilot testing of the images, findings indicate that episodic migraine patients do not show differential attention to headache-related facial stimuli. While modest attentional biases have been noted in chronic headache sufferers, these findings suggest otherwise for episodic migraineurs.",1.6580180914979784e-07,0.21840655759104655,0.060964083175803374,0.012693985253473108,0.1650133068479107,0.020823902218198284,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
165,0.1,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do individuals with episodic migraines show selective attention to headache-related facial stimuli? Answer: Given the large sample size and prior pilot testing of the images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Although there is modest evidence of attentional biases in chronic headache populations, these findings do not support such biases in episodic migraineurs.",2.6054570009253947e-07,0.19497980500333822,0.005362447436441514,0.0199476911126006,0.21172105092590598,0.0038797880683766432,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
165,0.1,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is there selective attention to headache-related visual stimuli among episodic migraineurs? Answer: Considering the large sample and previous pilot testing of the images, the results imply that episodic migraine sufferers do not preferentially attend to headache-related facial stimuli. Modest evidence of attentional biases exists in chronic headache groups, but these findings do not confirm this for episodic migraineurs.",2.1317375462116866e-07,0.20569462357059587,0.026525307665599282,0.016320838183036854,0.2007313894499898,0.020823902218198284,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
165,0.1,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine patients selectively focus on headache-related visual stimuli? Answer: With a large sample size and prior pilot testing of the images, the data suggest that episodic migraineurs do not show selective attention to headache-related facial stimuli. Although modest attentional biases have been observed in chronic headache samples, these findings do not extend to episodic migraineurs.",1.8948778188548325e-07,0.2117851809865896,0.04342581786968092,0.014507411718254981,0.18303181235058918,0.020823902218198284,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
165,0.1,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are headache-related facial stimuli selectively attended to by episodic migraineurs? Answer: Based on the large sample and earlier pilot testing of the images, findings suggest that episodic migraine patients do not differentially attend to headache-related facial stimuli. While modest evidence of attentional biases is present in chronic headache sufferers, these results do not support such biases in episodic migraineurs.",2.3685972735685406e-07,0.22359928157111097,0.027107511923110242,0.018134264647818726,0.21812313216185863,0.020823902218198284,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
166,0.1,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's distribution of healthcare benefits align with the principles of universal coverage? Although Kenya aims for universal health coverage, the distribution of healthcare benefits encounters major challenges such as regional disparities, resource limitations, and service delivery gaps, meaning it does not yet fully satisfy universal coverage principles.",2.3685972735685406e-07,0.13546481801538146,0.040273170522462765,0.018134264647818726,0.15796293632655445,0.02761748740769719,0.018108015409528666,0.1810665327796479,0.014101110950928097,2.3685972735685406e-07,0.17912229484749664,0.01851192595229618
166,0.1,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of healthcare benefits in Kenya consistent with universal coverage principles? Kenya is working towards universal health coverage, but significant issues like unequal regional access, scarce resources, and service delivery shortcomings prevent it from fully achieving these principles.",4.263475092423372e-07,0.23356389948175948,0.10380622837370242,0.03264167636607371,0.2887445052144848,0.07100591715976332,0.0325944277371516,0.34600456854752215,0.03631185475258099,4.263475092423373e-07,0.3797929903096482,0.01851192595229618
166,0.1,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's healthcare benefits distribution fulfill universal coverage principles? Despite efforts to achieve universal health coverage, Kenya faces challenges including uneven access by region, limited resources, and service delivery gaps, so it does not completely meet universal coverage standards.",4.500334819780225e-07,0.2960208164408038,0.07750966153659504,0.03445510283085558,0.31541275229664567,0.07100591715976332,0.034405229278104466,0.3734035427356375,0.03631185475258099,4.500334819780227e-07,0.40796386727634504,0.01851192595229618
166,0.1,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the allocation of healthcare benefits in Kenya in line with universal coverage principles? Kenya strives for universal health coverage, but disparities in access, resource constraints, and service delivery issues mean it currently falls short of these principles.",4.737194547137078e-07,0.2862076329671783,0.10380622837370242,0.03626852929563745,0.342811726484761,0.07100591715976332,0.03621603081905733,0.4015744197023343,0.03631185475258099,4.737194547137081e-07,0.43695140414959655,0.01851192595229618
166,0.1,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the way healthcare benefits are distributed in Kenya adhere to universal coverage principles? Kenya is progressing towards universal health coverage, yet significant challenges like regional inequality, limited resources, and gaps in service delivery prevent full compliance with these principles.",4.263475092423372e-07,0.23356389948175948,0.10380622837370242,0.03264167636607371,0.2887445052144848,0.07100591715976332,0.0325944277371516,0.34600456854752215,0.03631185475258099,4.263475092423373e-07,0.3797929903096482,0.01851192595229618
166,0.1,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is Kenya's distribution of health care benefits aligned with the principles of universal coverage? While Kenya aims for universal health coverage, challenges such as unequal regional access, resource shortages, and service delivery gaps mean it does not fully meet these principles yet.",3.789755637709665e-07,0.18355347890709606,0.10380622837370242,0.029014823436509962,0.2374512108269351,0.07100591715976332,0.028972824655245866,0.2933608350621033,0.03631185475258099,3.789755637709665e-07,0.325725769039372,0.01851192595229618
166,0.1,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the distribution of healthcare benefits in Kenya satisfy the principles of universal coverage? Kenya is working towards universal health coverage, but issues like regional disparities, limited resources, and service delivery gaps hinder full adherence to these principles.",4.737194547137078e-07,0.2862076329671783,0.10380622837370242,0.03626852929563745,0.342811726484761,0.07100591715976332,0.03621603081905733,0.4015744197023343,0.03631185475258099,4.737194547137081e-07,0.43695140414959655,0.01851192595229618
166,0.1,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Kenya strives for universal health coverage, but unequal access across regions, resource limitations, and service delivery gaps mean it currently does not fully comply with these principles.",4.026615365066519e-07,0.20824609149746776,0.10380622837370242,0.030828249901291835,0.26276901881122683,0.07100591715976332,0.030783626196198732,0.3193363214653613,0.03631185475258099,4.026615365066519e-07,0.35239401612153287,0.01851192595229618
166,0.1,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's healthcare benefits distribution meet the principles of universal coverage? Although Kenya is progressing towards universal health coverage, challenges such as regional inequality, limited resources, and service delivery gaps prevent it from fully meeting these principles.",4.974054274493931e-07,0.31360660715529365,0.10380622837370242,0.038081955760419325,0.37098260345145784,0.07100591715976332,0.038026832360010206,0.4305619565755858,0.03631185475258099,4.974054274493935e-07,0.4668043672992783,0.01851192595229618
166,0.1,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of healthcare benefits in Kenya aligned with universal coverage principles? Kenya aims for universal health coverage, but significant challenges including unequal regional access, resource constraints, and service delivery gaps mean it does not yet fully meet these principles.",4.026615365066519e-07,0.20824609149746776,0.10380622837370242,0.030828249901291835,0.26276901881122683,0.07100591715976332,0.030783626196198732,0.3193363214653613,0.03631185475258099,4.026615365066519e-07,0.35239401612153287,0.01851192595229618
167,0.1,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can a new surgical method for the temporomandibular joint enhance access and minimize complications?,8.290090457489868e-07,1.017440328213043,0.19390581717451527,0.06346992626736568,1.1292759542846293,0.16305062458908606,0.0633780539333505,1.2499251200663908,0.1275,8.290090457489886e-07,1.3808512313433954,0.08804283164782867
167,0.1,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is it possible for an innovative surgical technique targeting the temporomandibular joint to improve accessibility and lower complication rates?,7.105791820705601e-07,0.6920179277784153,0.19390581717451527,0.054402793943456304,0.780969260016414,0.16305062458908606,0.05432404622858612,0.8752316706249803,0.1275,7.105791820705619e-07,0.9753861232352303,0.08804283164782867
167,0.1,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could a novel approach in temporomandibular joint surgery provide better access and reduce the risk of complications?,7.579511275419307e-07,0.8098009634347991,0.19390581717451527,0.05802964687302005,0.9061324029704196,0.16305062458908606,0.05794564931049187,1.008763063249503,0.1275,7.579511275419326e-07,1.1184869668759037,0.08804283164782867
167,0.1,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Does a new surgical strategy for the temporomandibular joint have the potential to improve access and decrease complications?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,0.1,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Might a fresh surgical technique for the temporomandibular joint enhance surgical access and reduce complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.1,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can advancements in surgical methods for the temporomandibular joint improve access and lessen complications?,8.290090457489868e-07,1.017440328213043,0.19390581717451527,0.06346992626736568,1.1292759542846293,0.16305062458908606,0.0633780539333505,1.2499251200663908,0.1275,8.290090457489886e-07,1.3808512313433954,0.08804283164782867
167,0.1,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is a novel surgical approach to the temporomandibular joint capable of improving access and minimizing complications?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,0.1,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could innovative surgical procedures for the temporomandibular joint lead to better access and fewer complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.1,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Does employing a new surgical approach to the temporomandibular joint improve access and reduce the likelihood of complications?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,0.1,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can a cutting-edge surgical technique for the temporomandibular joint enhance access and lower complication risks?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
168,0.1,1,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the position of the head affect the anterior chamber depth in pseudoexfoliation syndrome? Yes, head positioning can impact the anterior chamber depth in pseudoexfoliation syndrome. Certain positions, like lying flat, may increase the anterior chamber depth, which can complicate managing the condition. Hence, head position should be taken into account during assessment and treatment of this syndrome.",4.737194547137081e-08,0.05861683382314453,0.08390591715976337,0.0036268529295637453,0.07260481124361462,0.05905610852426184,0.003621603081905733,0.038371277551590754,0.0018947695229746958,4.737194547137081e-08,0.03820136687076836,0.0013169535961558843
168,0.1,2,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Indeed, head positioning can alter anterior chamber depth in pseudoexfoliation syndrome. For example, lying flat can deepen the anterior chamber, potentially making management more challenging. Therefore, considering the patient's head position is important in evaluating and treating this syndrome.",2.3685972735685406e-07,0.1344084302503572,0.035506428519249025,0.018134264647818726,0.12251662449841749,0.047763203405944366,0.018108015409528666,0.1199408050129187,0.05246913580246911,2.3685972735685406e-07,0.14719978134891543,0.03566529492455417
168,0.1,3,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can head position affect anterior chamber depth in pseudoexfoliation syndrome? Yes, the depth of the anterior chamber in pseudoexfoliation syndrome can be influenced by head positioning. Specific postures, such as lying flat, may increase anterior chamber depth and complicate condition management. Thus, head position should be factored into assessment and treatment.",2.1317375462116866e-07,0.1501332352980862,0.026715793702973223,0.016320838183036854,0.10130792642785913,0.0481878000685871,0.0162972138685758,0.09888739581508554,0.05246913580246911,2.1317375462116866e-07,0.12569357612795207,0.03566529492455417
168,0.1,4,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does head positioning have an effect on anterior chamber depth in pseudoexfoliation syndrome? Yes, head positioning can affect anterior chamber depth in pseudoexfoliation syndrome. Positions like lying flat can increase the depth, potentially complicating treatment. Therefore, the patient's head position must be considered during diagnosis and management.",3.079176455639103e-07,0.23510461493680257,0.00941496326855315,0.023574544042164344,0.2505936371873174,0.0022605750118977613,0.023540420032387266,0.24891215285561952,0.007117661879566618,3.079176455639103e-07,0.24688046589142187,0.012422664539066645
168,0.1,5,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is the anterior chamber depth in pseudoexfoliation syndrome affected by how the head is positioned? Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Lying flat, for instance, can increase the depth and complicate management. Hence, head position should be accounted for in assessment and treatment.",2.8423167282822487e-07,0.18089673884760815,0.03212415314851143,0.02176111757738247,0.22660560820605014,0.003687159707430901,0.0217296184914344,0.22503899966909646,0.00812083942604943,2.8423167282822487e-07,0.22315823394520073,0.01295031385370506
168,0.1,6,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the anterior chamber depth change with head positioning in pseudoexfoliation syndrome? Yes, head positioning can change anterior chamber depth in pseudoexfoliation syndrome. Certain positions, such as lying flat, may increase the depth and complicate management. Therefore, head position is an important factor in assessment and treatment.",3.079176455639103e-07,0.20496778099941304,0.03032628238672193,0.023574544042164344,0.18898055447087803,0.04637636182248976,0.023540420032387266,0.18589877280471478,0.05246913580246911,3.079176455639103e-07,0.21464106214444767,0.03566529492455417
168,0.1,7,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can the depth of the anterior chamber in pseudoexfoliation syndrome be influenced by head position? Yes, head position can influence anterior chamber depth in pseudoexfoliation syndrome. Lying flat can increase the depth, which may complicate management. Thus, head positioning should be considered during evaluation and treatment.",3.316036182995957e-07,0.168012434685072,0.072145786463817,0.025387970506946217,0.18064686896471605,0.06858710562414265,0.025351221573340132,0.2088882910294143,0.05246913580246911,3.316036182995957e-07,0.2381715595546421,0.03566529492455417
168,0.1,8,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth in pseudoexfoliation syndrome dependent on head positioning? Yes, anterior chamber depth can depend on head positioning in pseudoexfoliation syndrome. Specific positions like lying flat can increase the depth and complicate management. Therefore, head position should be included in the assessment and treatment plan.",3.079176455639103e-07,0.20496778099941304,0.03032628238672193,0.023574544042164344,0.18898055447087803,0.04637636182248976,0.023540420032387266,0.18589877280471478,0.05246913580246911,3.079176455639103e-07,0.21464106214444767,0.03566529492455417
168,0.1,9,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the position of the head impact anterior chamber depth in pseudoexfoliation syndrome? Yes, head position impacts anterior chamber depth in pseudoexfoliation syndrome. Positions such as lying flat can increase the depth and complicate management. Hence, head position must be considered in clinical evaluation and treatment.",3.316036182995957e-07,0.2604320587597311,0.007119082840236685,0.025387970506946217,0.2751669390410729,0.0007703298954097187,0.025351221573340132,0.2733670985233627,0.006068183988072906,3.316036182995957e-07,0.27117856815273367,0.011869935019735614
168,0.1,10,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is the anterior chamber depth in pseudoexfoliation syndrome influenced by the patient's head position? Yes, the anterior chamber depth is influenced by head position in pseudoexfoliation syndrome. Lying flat can increase the depth, potentially complicating management. Therefore, head position should be taken into account during assessment and treatment.",2.8423167282822487e-07,0.2398879882569651,0.008431556660060777,0.02176111757738247,0.19646877426866105,0.025198675872076526,0.0217296184914344,0.19423245831087677,0.03025839200081622,2.8423167282822487e-07,0.19165154391974815,0.03566529492455417
169,0.1,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? It is suggested that CYP2D6*4 poor metabolizers may have reduced activation of procarcinogens, potentially offering protection against carcinogens.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.1,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer risk? Poor metabolizers with the CYP2D6*4 variant might transform fewer procarcinogens, which could provide a protective effect against carcinogens.",9.47438909427412e-08,0.20387177956306823,0.03993055555555556,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.1,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What is the association between the CYP2D6*4 allele and breast cancer risk? The decreased conversion of procarcinogens by CYP2D6*4 poor metabolizers may lead to a protective effect against carcinogens.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
169,0.1,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there any connection between the CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers might have a reduced ability to activate procarcinogens, possibly resulting in protection from carcinogens.",2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
169,0.1,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does carrying the CYP2D6*4 allele affect breast cancer risk? The allele's poor metabolizer status could lower procarcinogen activation, thereby offering some protection against carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.1,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is breast cancer risk associated with the CYP2D6*4 allele? Reduced transformation of procarcinogens by CYP2D6*4 poor metabolizers may confer a protective effect against carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.1,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Can the CYP2D6*4 allele impact breast cancer risk? Poor metabolizers with this allele might have decreased procarcinogen activation, which could protect against carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.1,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there an association between CYP2D6*4 allele and breast cancer risk? The allele's poor metabolizer phenotype may reduce procarcinogen transformation, potentially providing protection against carcinogens.",1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.1,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,How does the CYP2D6*4 allele relate to breast cancer risk? A possible decrease in procarcinogen activation by CYP2D6*4 poor metabolizers might result in a protective effect against carcinogens.,4.73719454713706e-08,0.07145896398214369,0.0,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
169,0.1,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What role does the CYP2D6*4 allele play in breast cancer risk? CYP2D6*4 poor metabolizers may have diminished procarcinogen transformation, which could lead to protection from carcinogens.",9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
170,0.1,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call impact polio vaccination coverage in Kenya in 2015? The boycott call did not significantly affect the campaign. However, if repeated in the future, it could negatively impact polio eradication efforts. Hence, it is crucial to ensure that",3.316036182995957e-07,0.15237814394916382,0.19739795918367342,0.025387970506946217,0.17391250521891477,0.1507112648981161,0.025351221573340132,0.2390705764132215,0.07544378698224853,3.316036182995957e-07,0.30673026742247655,0.0
170,0.1,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' call for a boycott? The boycott call did not have a major effect on the campaign. Nevertheless, if such calls recur, they could pose serious risks to polio eradication. Therefore, it is important to ensure that",1.6580180914979784e-07,0.06778655307427917,0.24489795918367344,0.012693985253473108,0.01628356101533157,0.1507112648981161,0.012675610786670066,0.07780242881709976,0.07544378698224853,1.6580180914979784e-07,0.14165051706302645,0.0
170,0.1,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the 2015 boycott call by Catholic bishops influence polio vaccination rates in Kenya? The boycott did not significantly impact the campaign. Still, if repeated, it might have serious negative consequences for polio eradication. Thus, it is essential to ensure that",3.789755637709665e-07,0.1351542909224115,0.24489795918367344,0.029014823436509962,0.2239229257935782,0.1507112648981161,0.028972824655245866,0.2903638708007712,0.07544378698224853,3.789755637709665e-07,0.3593740009078954,0.0
170,0.1,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","In 2015, did the Catholic bishops' boycott call affect polio vaccination coverage in Kenya? The boycott did not substantially affect the campaign. However, future repetitions could harm polio eradication efforts. Therefore, it is important to ensure that",4.737194547137077e-07,0.24051480658023738,0.24489795918367344,0.03626852929563745,0.3321365104338092,0.1507112648981161,0.03621603081905734,0.40158950591099574,0.07544378698224853,4.737194547137081e-07,0.47378435208564085,0.0
170,0.1,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call in 2015 impact Kenya's polio vaccination coverage? The boycott did not significantly disrupt the campaign. But if repeated, it could have serious negative effects on polio eradication. Hence, it is vital to ensure that",4.026615365066518e-07,0.16047209890670322,0.24489795918367344,0.030828249901291835,0.24989841219683617,0.1507112648981161,0.030783626196198732,0.31703211788293206,0.07544378698224853,4.026615365066519e-07,0.3867729750960107,0.0
170,0.1,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the polio vaccination campaign in Kenya in 2015 significantly affected by the Catholic bishops' boycott call? The boycott did not greatly impact the campaign. However, if repeated, it could negatively affect polio eradication. Therefore, it is important to ensure that",3.789755637709665e-07,0.1351542909224115,0.24489795918367344,0.029014823436509962,0.2239229257935782,0.1507112648981161,0.028972824655245866,0.2903638708007712,0.07544378698224853,3.789755637709665e-07,0.3593740009078954,0.0
170,0.1,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the call for boycott by Catholic bishops in 2015 affect polio vaccination coverage in Kenya? The boycott did not have a significant effect on the campaign. Yet, if repeated, it could pose serious challenges to polio eradication. Thus, it is important to ensure that",2.8423167282822487e-07,0.039844111118085834,0.24489795918367344,0.02176111757738247,0.12628445622966034,0.1507112648981161,0.0217296184914344,0.19028041224378978,0.07544378698224853,2.8423167282822487e-07,0.2567198468478131,0.0
170,0.1,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call influence polio vaccination coverage in Kenya during 2015? The boycott did not significantly affect the campaign. However, if repeated, it could have negative implications for polio eradication. Therefore, it is crucial to ensure that",4.026615365066518e-07,0.16047209890670322,0.24489795918367344,0.030828249901291835,0.24989841219683617,0.1507112648981161,0.030783626196198732,0.31703211788293206,0.07544378698224853,4.026615365066519e-07,0.3867729750960107,0.0
170,0.1,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","In 2015, did the boycott call by Catholic bishops impact polio vaccination coverage in Kenya? The boycott did not significantly affect the campaign. But if repeated, it could have serious negative consequences for polio eradication. Hence, it is important to ensure that",3.552895910352811e-07,0.14427373592032966,0.22052295918367343,0.02720139697172809,0.19860511780928647,0.1507112648981161,0.027162023114293,0.2643883843975132,0.07544378698224853,3.552895910352811e-07,0.33270575382573453,0.0
170,0.1,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' call for boycott affect the 2015 polio vaccination coverage in Kenya? The boycott did not significantly impact the campaign. However, if repeated in the future, it could negatively affect polio eradication efforts. Therefore, it is important to ensure that",3.316036182995957e-07,0.08636412675297978,0.24489795918367344,0.025387970506946217,0.17391250521891477,0.1507112648981161,0.025351221573340132,0.2390705764132215,0.07544378698224853,3.316036182995957e-07,0.30673026742247655,0.0
171,0.1,1,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","The stretch-sensitive KCNQ1 mutation connects genetic and environmental factors in causing atrial fibrillation by influencing the heart's reaction to stress such as hypertension, which may lead to irregular heartbeats.",8.763809912203588e-07,0.4848411279443203,0.3015410245730946,0.06709677919692934,0.6247768740378619,0.16447134211463157,0.06699965701525612,0.686996136781497,0.13888888888888887,8.7638099122036e-07,0.7293818684194853,0.1262002743484225
171,0.1,2,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Yes, the KCNQ1 mutation that is sensitive to stretch links genetic predispositions with environmental influences in the development of atrial fibrillation by affecting how the heart responds to stressors like high blood pressure.",7.816371002776176e-07,0.35130973531979803,0.3015410245730946,0.059843073337801825,0.4866265355570447,0.16447134211463157,0.05975645085144463,0.5438952931408245,0.13888888888888887,7.816371002776184e-07,0.5809618633012121,0.1262002743484225
171,0.1,3,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","This mutation in the stretch-sensitive KCNQ1 gene serves as a bridge between genetic and environmental contributors to atrial fibrillation, impacting the heart's stress response and potentially causing abnormal rhythms.",8.763809912203588e-07,0.4848411279443203,0.3015410245730946,0.06709677919692934,0.6247768740378619,0.16447134211463157,0.06699965701525612,0.686996136781497,0.13888888888888887,8.7638099122036e-07,0.7293818684194853,0.1262002743484225
171,0.1,4,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",The stretch-sensitive KCNQ1 mutation represents a connection between inherited genetic factors and environmental stressors in atrial fibrillation pathogenesis by altering the heart's response to conditions like hypertension.,9.237529366917294e-07,0.558949100098042,0.3015410245730946,0.0707236321264931,0.7017379151739913,0.16447134211463157,0.07062126009716188,0.7670388444550342,0.13888888888888887,9.237529366917308e-07,0.8127634773585357,0.1262002743484225
171,0.1,5,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Indeed, the KCNQ1 mutation sensitive to mechanical stretch links genetic susceptibility and environmental triggers in atrial fibrillation by modifying the heart's reaction to stress, which can provoke arrhythmias.",9.000669639560441e-07,0.521208772115195,0.3015410245730946,0.06891020566171122,0.6625172020207089,0.16447134211463157,0.068810458556209,0.7262168499347794,0.13888888888888887,9.000669639560454e-07,0.7702038629397401,0.1262002743484225
171,0.1,6,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Atrial fibrillation pathogenesis involves the stretch-sensitive KCNQ1 mutation, which ties genetic factors to environmental stress such as hypertension, influencing abnormal heart rhythm development.",1.0184968276344706e-06,0.726003184761209,0.3015410245730946,0.07797733798562062,0.8760913023187697,0.16447134211463157,0.07786446626097338,0.9493604012489891,0.13888888888888887,1.0184968276344723e-06,1.0038187141212451,0.1262002743484225
171,0.1,7,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","The mutation in the stretch-sensitive KCNQ1 gene acts as a link between genetic and environmental elements in atrial fibrillation by affecting how the heart handles stress, potentially triggering irregular heartbeats.",8.526950184846735e-07,0.4497498081330513,0.3015410245730946,0.06528335273214747,0.5884092298669872,0.16447134211463157,0.06518885547430325,0.64925580879865,0.13888888888888887,8.526950184846746e-07,0.6901611552662028,0.1262002743484225
171,0.1,8,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Yes, the stretch-sensitive KCNQ1 mutation connects genetic predisposition with environmental factors in atrial fibrillation by impacting the heart's response to stressors like hypertension, leading to arrhythmias.",9.474389094274147e-07,0.5981698132513245,0.3015410245730946,0.07253705859127499,0.7425599096942461,0.16447134211463157,0.07243206163811475,0.8095984588738299,0.13888888888888887,9.474389094274162e-07,0.8572152399293698,0.1262002743484225
171,0.1,9,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",The KCNQ1 mutation sensitive to stretch bridges genetic and environmental causes of atrial fibrillation by altering the heart's stress response and facilitating abnormal heart rhythms.,9.711248821631e-07,0.6389918077715793,0.3015410245730946,0.07435048505605686,0.7851195241130418,0.16447134211463157,0.07424286317906761,0.8540502214446639,0.13888888888888887,9.711248821631017e-07,0.9037352555642637,0.1262002743484225
171,0.1,10,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","This stretch-sensitive mutation in KCNQ1 links genetic and environmental factors in atrial fibrillation by influencing the heart's reaction to stress, such as hypertension, which may trigger irregular heartbeats.",9.000669639560441e-07,0.521208772115195,0.3015410245730946,0.06891020566171122,0.6625172020207089,0.16447134211463157,0.068810458556209,0.7262168499347794,0.13888888888888887,9.000669639560454e-07,0.7702038629397401,0.1262002743484225
172,0.1,1,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.1,2,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery successfully treat spinal cord sarcoidosis when it is accompanied by compressive cervical myelopathy?,6.158352911278182e-07,0.7688374624840675,0.16349480968858132,0.04714908808432882,0.9805074064426837,0.049861495844875335,0.047080840064774684,1.0630662794086234,0.025623268698060954,6.158352911278201e-07,1.1526795099383857,0.0
172,0.1,3,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Does decompressive surgery work well for spinal cord sarcoidosis associated with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.1,4,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery beneficial for patients with spinal cord sarcoidosis and compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.1,5,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery alleviate symptoms in spinal cord sarcoidosis cases involving compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.1,6,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery a viable option for spinal cord sarcoidosis with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.1,7,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Does decompressive surgery effectively address spinal cord sarcoidosis accompanied by compressive cervical myelopathy?,6.868932093348742e-07,0.9919810137982772,0.16349480968858132,0.052589367478674445,1.2216694632595715,0.049861495844875335,0.0525132446876333,1.3254305438761151,0.025623268698060954,6.868932093348761e-07,1.440361582390167,0.0
172,0.1,8,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery useful in managing spinal cord sarcoidosis with compressive cervical myelopathy?,6.868932093348742e-07,0.9919810137982772,0.16349480968858132,0.052589367478674445,1.2216694632595715,0.049861495844875335,0.0525132446876333,1.3254305438761151,0.025623268698060954,6.868932093348761e-07,1.440361582390167,0.0
172,0.1,9,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery improve outcomes for spinal cord sarcoidosis patients with compressive cervical myelopathy?,6.632072365991889e-07,0.9119383061247408,0.16349480968858132,0.05077594101389257,1.1346580862699414,0.049861495844875335,0.05070244314668043,1.23012036407179,0.025623268698060954,6.632072365991907e-07,1.335001066732341,0.0
172,0.1,10,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery an effective intervention for spinal cord sarcoidosis combined with compressive cervical myelopathy?,6.395212638635036e-07,0.8378303339710196,0.16349480968858132,0.0489625145491107,1.054615378596405,0.049861495844875335,0.04889164160572755,1.1431089870821598,0.025623268698060954,6.395212638635054e-07,1.2396908869280159,0.0
173,0.1,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Does the study support the notion that Indigenous Australians age prematurely? The research on various specific conditions does not strongly back this idea. The aged care sector's current focus and services might not be aligned with this perspective.,1.4211583641411212e-07,0.1502822030493367,0.0,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
173,0.1,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Is premature aging among Indigenous Australians confirmed by this study? The evidence from examining several distinct conditions does not robustly support that claim. The services and focus of aged care may not reflect this assumption.,2.1317375462116802e-07,0.23483959107740038,0.0,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
173,0.1,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Do Indigenous Australians experience premature aging according to this research? The study of multiple discrete conditions does not provide strong support for that belief. The aged care sector's current approach and services might not correspond to this view.,1.4211583641411212e-07,0.18774961821473912,0.027006172839506164,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
173,0.1,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Does the research indicate that Indigenous Australians age earlier than others? This study, which looks at a range of specific conditions, does not strongly endorse that idea. The aged care services currently offered may not be designed with this in mind.",7.105791820705622e-08,0.07232066157962613,0.0,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
173,0.1,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Is there strong evidence that Indigenous Australians age prematurely? The study of various individual conditions does not substantiate this notion well. The aged care sector's present focus and services may not be tailored to this concept.,1.8948778188548272e-07,0.20585205420414887,0.0,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
173,0.1,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Does the data show Indigenous Australians age prematurely? The investigation into several distinct conditions does not convincingly support this theory. The current aged care services and focus might not be aligned with this understanding.,2.3685972735685332e-07,0.26469255422708216,0.0,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
173,0.1,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Is premature aging among Indigenous Australians supported by this study? The research on a series of specific conditions does not strongly confirm this. The aged care sector's existing focus and services may not reflect this idea.,1.8948778188548272e-07,0.20585205420414887,0.0,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
173,0.1,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Does this study confirm that Indigenous Australians age prematurely? The analysis of multiple discrete conditions does not provide strong evidence for this. The aged care services currently provided may not be consistent with this notion.,2.1317375462116802e-07,0.23483959107740038,0.0,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
173,0.1,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Is the concept of premature aging in Indigenous Australians validated by this research? The study of various distinct conditions does not strongly back this claim. The aged care sector's current focus and services might not be appropriate for this belief.,9.474389094274152e-08,0.09763846956391786,0.0,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
173,0.1,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Does the evidence suggest Indigenous Australians age prematurely? The study examining several specific conditions does not strongly support this idea. The aged care sector's present services and focus may not be suited to this perspective.,2.1317375462116802e-07,0.23483959107740038,0.0,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
174,0.1,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate achievable over time? Consistent high-quality training, adherence to evidence-based protocols, and meticulous documentation contribute to major decreases in CLABSIs. Thoughtful organization can enhance comprehension of a unit's capacity to manage peak workloads and maintain exceptional performance long-term.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.1,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be maintained sustainably? Significant reductions in CLABSIs are linked to rigorous training, strict adherence to evidence-based guidelines, and detailed documentation. Careful structuring may improve understanding of how a unit manages peak demands and sustains outstanding performance over time.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.1,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero central line-associated bloodstream infection rate? Effective training, strict compliance with proven guidelines, and comprehensive documentation are associated with notable CLABSI reductions. Mindful organization helps better grasp what enables a unit to handle peak pressures and maintain high performance long-term.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.1,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.",Is a zero central line-associated bloodstream infection rate sustainable? High-quality training combined with strict adherence to evidence-based practices and thorough documentation correlates with significant CLABSI reduction. Thoughtful organization may provide insight into a unit's ability to manage peak demands and sustain exceptional long-term performance.,2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.1,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infections be maintained consistently? Significant CLABSI decreases are linked to quality training, strict guideline compliance, and detailed documentation. Mindful organization may lead to improved understanding of a unit's capacity to handle peak workloads and sustain extraordinary performance over time.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.1,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate feasible? High-quality training, strict compliance with evidence-based protocols, and thorough documentation are associated with major CLABSI reductions. Careful organization may enhance understanding of how a unit manages peak demands and maintains exceptional long-term performance.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
174,0.1,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it sustainable to have zero central line-associated bloodstream infections? Rigorous training, strict adherence to evidence-based guidelines, and comprehensive documentation contribute to significant CLABSI reductions. Mindful organization can improve insight into a unit's ability to handle peak demands and sustain outstanding performance over time.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.1,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is zero central line-associated bloodstream infection rate maintainable in the long run? High-quality training, strict compliance with evidence-based standards, and thorough documentation are linked to significant CLABSI decreases. Thoughtful organization may help better understand a unit's capacity to manage peak demands and sustain exceptional performance.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.1,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained? Effective training, strict adherence to evidence-based guidelines, and detailed documentation are associated with significant reductions in CLABSIs. Mindful organization may lead to a better understanding of a unit's ability to handle peak demands and maintain extraordinary long-term performance.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
174,0.1,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain zero central line-associated bloodstream infections? High-quality training, strict compliance with evidence-based protocols, and thorough documentation correlate with significant CLABSI reductions. Thoughtful organization may enhance understanding of what enables a unit to manage peak demands and sustain exceptional performance over time.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
175,0.1,1,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment with estradiol and antagonists before microdose leuprolide enhance IVF results in poor responders compared to oral contraceptive pills? Research shows no significant improvement, though slight benefits may occur in some cases, warranting further study.",6.632072365991908e-07,0.2577165789211926,0.21484375,0.05077594101389244,0.3324588227928209,0.18240000000000006,0.05070244314668028,0.40983106909897726,0.14312130177514798,6.632072365991914e-07,0.4899792233103848,0.09876543209876548
175,0.1,2,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In poor responders undergoing IVF, does estradiol and antagonist pretreatment before microdose leuprolide improve outcomes versus oral contraceptive pills? Studies suggest no major improvement, but minor advantages might exist in certain situations, needing more research.",6.868932093348761e-07,0.2867041157944441,0.21484375,0.05258936747867432,0.3623117859425027,0.18240000000000006,0.05251324468763315,0.44060272776573095,0.14312130177514798,6.868932093348768e-07,0.5217279216249646,0.09876543209876548
175,0.1,3,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is IVF success in poor responders better with estradiol and antagonist pretreatment prior to microdose leuprolide than with oral contraceptive pills? Evidence indicates no significant benefit, though occasional slight improvements could happen, requiring additional investigation.",6.868932093348761e-07,0.2867041157944441,0.21484375,0.05258936747867432,0.3623117859425027,0.18240000000000006,0.05251324468763315,0.44060272776573095,0.14312130177514798,6.868932093348768e-07,0.5217279216249646,0.09876543209876548
175,0.1,4,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does administering estradiol and antagonists before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Research finds no substantial enhancement, but some marginal benefits may be present, calling for further studies.",6.868932093348761e-07,0.2867041157944441,0.21484375,0.05258936747867432,0.3623117859425027,0.18240000000000006,0.05251324468763315,0.44060272776573095,0.14312130177514798,6.868932093348768e-07,0.5217279216249646,0.09876543209876548
175,0.1,5,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","For poor responders, does pretreatment with estradiol and antagonists before microdose leuprolide yield better IVF outcomes than oral contraceptive pills? Data shows no significant improvement, though minor benefits might be possible in select cases, suggesting more research is needed.",5.921493183921349e-07,0.17547848068421956,0.21484375,0.045335661619546816,0.24790143476475723,0.18240000000000006,0.045270038523821665,0.32281969210934713,0.14312130177514798,5.921493183921352e-07,0.4003670646206978,0.09876543209876548
175,0.1,6,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Research indicates no significant advantage, but slight benefits could occur in specific instances, requiring further study.",6.632072365991908e-07,0.2577165789211926,0.21484375,0.05077594101389244,0.3324588227928209,0.18240000000000006,0.05070244314668028,0.40983106909897726,0.14312130177514798,6.632072365991914e-07,0.4899792233103848,0.09876543209876548
175,0.1,7,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In IVF for poor responders, does pretreatment with estradiol and antagonists before microdose leuprolide outperform oral contraceptive pills? Studies reveal no significant improvement, though marginal benefits may exist in some cases, necessitating additional research.",7.105791820705614e-07,0.3165570789441259,0.21484375,0.0544027939434562,0.39308344460925637,0.18240000000000006,0.054324046228586026,0.4723514260803108,0.14312130177514798,7.105791820705622e-07,0.5545177444479563,0.09876543209876548
175,0.1,8,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is there an improvement in IVF outcomes for poor responders with estradiol and antagonist pretreatment before microdose leuprolide compared to oral contraceptive pills? Research suggests no significant gains, but minor benefits might be seen in certain cases, calling for further investigation.",5.447773729207643e-07,0.12418518629666986,0.21484375,0.04170880868998307,0.1952577012793384,0.18240000000000006,0.04164843544191593,0.26875247083907094,0.14312130177514798,5.447773729207643e-07,0.34479721346588565,0.09876543209876548
175,0.1,9,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment using estradiol and antagonists before microdose leuprolide enhance IVF success in poor responders relative to oral contraceptive pills? Evidence shows no significant improvement, though slight benefits may be possible in specific cases, indicating a need for more studies.",5.684633456564496e-07,0.1495029942809616,0.21484375,0.04352223515476494,0.22123318768259637,0.18240000000000006,0.0434592369828688,0.2954207179212318,0.14312130177514798,5.684633456564497e-07,0.372196187654001,0.09876543209876548
175,0.1,10,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","For poor responders, does estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes compared to oral contraceptive pills? Research finds no significant benefit, but marginal improvements might occur in some cases, warranting further research.",6.632072365991908e-07,0.2577165789211926,0.21484375,0.05077594101389244,0.3324588227928209,0.18240000000000006,0.05070244314668028,0.40983106909897726,0.14312130177514798,6.632072365991914e-07,0.4899792233103848,0.09876543209876548
176,0.1,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count serves as a predictor for long-term survival in ESCC, particularly in patients with positive lymph nodes. We suggest that a platelet count of 205 (10(9)/L) is the optimal cutoff for forecasting survival in ESCC cases.",2.3685972735685406e-08,0.0050462715015138215,0.01777777777777778,0.0018134264647818726,0.007083023584949277,0.01991851516523315,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
176,0.1,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? The preoperative platelet count is a significant prognostic factor for long-term survival in ESCC, especially among nodal-positive individuals. Our findings indicate that 205 (10(9)/L) is the best threshold for platelet count to predict survival in ESCC patients.",7.105791820705622e-08,0.04189644277855509,0.012328318944507893,0.005440279394345618,0.036732292247905196,0.019014022321703038,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,0.1,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, notably in patients with lymph node involvement. We determine that 205 (10(9)/L) is the ideal cutoff value for platelet count in survival prediction for ESCC.",7.105791820705622e-08,0.012400818073876607,0.0342222732374248,0.005440279394345618,0.036732292247905196,0.019014022321703038,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,0.1,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a useful prognostic marker in esophageal squamous cell carcinoma? It is a predictive factor for long-term survival in ESCC, particularly in those with positive lymph nodes. We conclude that a platelet count of 205 (10(9)/L) may serve as the optimal cutoff for survival prediction in ESCC patients.",2.3685972735685406e-08,0.14171478390855974,0.12360987654320992,0.0018134264647818726,0.07678615062853433,0.040742417383431435,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
176,0.1,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? Preoperative platelet count is a prognostic indicator for long-term survival in ESCC, especially in nodal-positive patients. We propose 205 (10(9)/L) as the optimal cutoff point for platelet count to predict survival in ESCC.",1.1842986367842703e-07,0.09112001863152619,0.006386557090503148,0.009067132323909363,0.08255391090680186,0.018027436312582325,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
176,0.1,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? It acts as a predictive factor for long-term survival in ESCC, mainly in patients with positive lymph nodes. We conclude that 205 (10(9)/L) is the optimal platelet count cutoff for predicting survival in ESCC patients.",7.105791820705622e-08,0.028227745859835007,0.10074074074074077,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,0.1,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, particularly in nodal-positive cases. Our conclusion is that 205 (10(9)/L) is the best cutoff point for platelet count in survival prediction for ESCC.",1.4211583641411244e-07,0.08515104586633715,0.026612613009598968,0.010880558788691236,0.106276142853023,0.01749978699794391,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
176,0.1,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? It is a predictive marker for long-term survival in ESCC, especially in patients with lymph node positivity. We find that 205 (10(9)/L) may be the optimal cutoff for platelet count in predicting survival in ESCC.",7.105791820705622e-08,0.028227745859835007,0.10074074074074077,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,0.1,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Preoperative platelet count is a significant prognostic factor for long-term survival in ESCC, particularly in nodal-positive patients. We suggest that 205 (10(9)/L) is the optimal cutoff value for platelet count in survival prediction for ESCC.",1.1842986367842703e-07,0.06031347727330649,0.02926429831191739,0.009067132323909363,0.08255391090680186,0.018027436312582325,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
176,0.1,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? It serves as a predictive factor for long-term survival in ESCC, especially in patients with positive lymph nodes. We conclude that 205 (10(9)/L) may be the optimal cutoff point for platelet count in predicting survival in ESCC patients.",2.3685972735685406e-08,0.07230824835874516,0.10246745915977848,0.0018134264647818726,0.035964156108279965,0.040742417383431435,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
177,0.1,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in cases of mild hereditary spherocytosis? The recommendation to carry out a splenectomy alongside cholecystectomy in children with mild HS who have symptomatic gallstones warrants reconsideration. With the advent of minimally invasive surgery, the decision to remove the spleen in these children should be evaluated independently.",4.737194547137081e-08,0.12538337030533508,0.09639999999999999,0.0036268529295637453,0.06439983492746082,0.01922337562475971,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
177,0.1,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy justify a concurrent splenectomy in mild hereditary spherocytosis? The suggestion to do a splenectomy at the same time as cholecystectomy in children with mild HS and symptomatic gallstones should be reexamined. Given the advances in minimal access surgery, the necessity of splenectomy should be assessed on its own.",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
177,0.1,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is performing a splenectomy alongside cholecystectomy indicated in mild hereditary spherocytosis? The current guidance recommending concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs to be reviewed. In the context of minimally invasive surgery, the decision for splenectomy should be made independently.",1.8948778188548325e-07,0.07528732515681646,0.09639999999999999,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
177,0.1,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy be considered an indication for simultaneous splenectomy in mild hereditary spherocytosis? The advice to perform splenectomy concurrently with cholecystectomy in children with mild HS and symptomatic gallstones requires reevaluation. With minimal access surgical techniques, the need for splenectomy should be judged on its own merits.",1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,0.1,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is a concomitant splenectomy warranted during cholecystectomy in mild hereditary spherocytosis? The recommendation to perform splenectomy alongside cholecystectomy in children with mild HS who have symptomatic gallstones should be reconsidered. In the era of minimally invasive surgery, the indication for splenectomy should be independently assessed.",2.1317375462116866e-07,0.1607735610597789,0.05104852607709749,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.1,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis justify a simultaneous splenectomy when undergoing cholecystectomy? The advice to carry out splenectomy with cholecystectomy in children with mild HS and symptomatic gallstones needs to be revisited. With the rise of minimal access surgery, the necessity of splenectomy should be evaluated on its own.",1.4211583641411244e-07,0.0318022132170781,0.09639999999999999,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
177,0.1,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it necessary to perform splenectomy along with cholecystectomy in mild hereditary spherocytosis? The guidance recommending concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be reviewed. Considering minimal access surgery, the decision for splenectomy should be made independently.",2.6054570009253947e-07,0.1772872052418597,0.07260464009518143,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.1,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should splenectomy be routinely done with cholecystectomy in mild hereditary spherocytosis? The advice to perform a simultaneous splenectomy in children with mild HS and symptomatic gallstones undergoing cholecystectomy needs reconsideration. In the context of minimally invasive surgery, the need for splenectomy should be judged separately.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.1,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is concomitant splenectomy indicated during cholecystectomy for mild hereditary spherocytosis? The recommendation to perform splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones requires reexamination. With minimal access surgical options, the necessity for splenectomy should be assessed on its own merits.",2.6054570009253947e-07,0.14428019664376812,0.09639999999999999,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.1,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does the presence of mild hereditary spherocytosis necessitate splenectomy during cholecystectomy? The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be revisited. In the era of minimal access surgery, the indication for splenectomy should be considered independently.",1.8948778188548325e-07,0.10609386651503616,0.0741892561983471,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
178,0.1,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can measuring visceral adipose tissue area at one level accurately represent the total visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at a single level might offer an estimate but does not fully reflect the total visceral adipose tissue volume, as fat distribution varies across the body and a single measurement may miss this variation.",7.105791820705622e-08,0.028312854414670685,0.20444444444444437,0.005440279394345618,0.016521400659918584,0.020992410569669884,0.0054324046228586,0.03572682392059523,0.01207100591715976,7.105791820705622e-08,0.03379975985039385,0.014412399097808448
178,0.1,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Is a single-level measurement of visceral adipose tissue area sufficient to represent its volume? Answer: A single-level measurement of visceral adipose tissue area can approximate but cannot completely represent the visceral adipose tissue volume due to the heterogeneous distribution of adipose tissue throughout the body.,3.552895910352811e-07,0.21808226326407,0.23401360544217686,0.02720139697172809,0.2673249828852211,0.07743060552137851,0.027162023114293,0.317030152092566,0.012194922060679514,3.552895910352811e-07,0.3401258691281219,0.02440710458764811
178,0.1,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does measuring visceral adipose tissue area at one level accurately indicate the total visceral adipose tissue volume? Answer: While a single-level measurement of visceral adipose tissue area may provide an estimate, it cannot fully capture the total volume because adipose tissue distribution differs across body regions.",3.316036182995957e-07,0.09807329622294336,0.3142669296515452,0.025387970506946217,0.1164606541903832,0.17093572122726636,0.025351221573340132,0.1643503051584485,0.07935602484631063,3.316036182995957e-07,0.1845673373255563,0.06977572089711641
178,0.1,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can visceral adipose tissue area measured at a single level serve as a proxy for its volume? Answer: Measuring visceral adipose tissue area at one level may approximate the volume but cannot fully represent it, given the variable distribution of adipose tissue throughout the body.",3.552895910352811e-07,0.002436473756531221,0.5298433472139599,0.02720139697172809,0.09789952949058556,0.23952982553565638,0.027162023114293,0.18807253710466965,0.07882837553167221,3.552895910352811e-07,0.20809783473575072,0.06977572089711641
178,0.1,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Is a single-level visceral adipose tissue area measurement representative of the entire visceral adipose tissue volume? Answer: A single-level measurement may give an approximation but does not fully represent the visceral adipose tissue volume due to the uneven distribution of adipose tissue in the body.,3.552895910352811e-07,0.0948560978311912,0.33136094674556227,0.02720139697172809,0.10979153275796172,0.1919107779166088,0.027162023114293,0.15583313335769544,0.10207100591715974,3.552895910352811e-07,0.20809783473575072,0.06977572089711641
178,0.1,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does a single-level measurement of visceral adipose tissue area accurately reflect its total volume? Answer: Although it may provide an estimate, a single-level measurement cannot fully represent visceral adipose tissue volume because adipose tissue is distributed variably throughout the body.",4.737194547137081e-07,0.17173360618603395,0.48707482993197276,0.03626852929563745,0.2266061557472665,0.23374908616418344,0.03621603081905733,0.2794470893248713,0.10207100591715974,4.737194547137081e-07,0.334849540374893,0.06977572089711641
178,0.1,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can the visceral adipose tissue area at one level represent the total visceral adipose tissue volume? Answer: The area measurement at a single level might approximate the volume but cannot fully represent it, as adipose tissue distribution varies across different body regions.",4.263475092423373e-07,0.04805475821403293,0.544378698224852,0.03264167636607371,0.13931577424192465,0.2605062994585589,0.0325944277371516,0.22815379493732157,0.10207100591715974,4.263475092423373e-07,0.28220580688947416,0.06977572089711641
178,0.1,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Is measuring visceral adipose tissue area at a single level enough to represent its volume? Answer: Measuring at one level may offer an approximation but cannot fully capture the visceral adipose tissue volume due to the heterogeneous distribution of adipose tissue.,4.500334819780227e-07,0.028297110038142836,0.6180144641683103,0.03445510283085558,0.16485368827200286,0.25989773601345695,0.034405229278104466,0.2534716029216133,0.10207100591715974,4.500334819780227e-07,0.30818129329273214,0.06977572089711641
178,0.1,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Does a single-level visceral adipose tissue area measurement provide an accurate representation of its volume? Answer: It may provide an estimate but cannot fully represent the volume because adipose tissue distribution varies throughout the body.,5.921493183921346e-07,0.19811382071187955,0.6097337006427915,0.04533566161954682,0.2927152587417807,0.2848812994585589,0.04527003852382168,0.4205256875847776,0.10207100591715974,5.921493183921352e-07,0.48003155021939214,0.06977572089711641
178,0.1,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can a single-level measurement of visceral adipose tissue area stand in for the total visceral adipose tissue volume? Answer: While it may approximate the volume, it cannot fully represent it due to the variable distribution of adipose tissue across the body.",4.500334819780227e-07,0.0748713174743485,0.541320406278855,0.03445510283085558,0.16485368827200286,0.25989773601345695,0.034405229278104466,0.2534716029216133,0.10207100591715974,4.500334819780227e-07,0.30818129329273214,0.06977572089711641
179,0.1,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT facilitates localized entry of chemotherapy drugs into brain tissue, which could be promising for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.1,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy locally open the rodent blood-brain barrier for paclitaxel as a novel adjuvant glioma therapy? Answer: LITT enables targeted delivery of chemotherapeutic agents into brain tissue, offering potential benefits for brain tumor therapy.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
179,0.1,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is locoregional opening of the rodent blood-brain barrier via Nd:YAG laser-induced thermo therapy a new approach for adjuvant glioma treatment with paclitaxel? Answer: LITT promotes localized passage of chemotherapy drugs into brain tissue, which may improve brain tumor treatment outcomes.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.1,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy allow locoregional opening of the rodent blood-brain barrier for paclitaxel in glioma therapy? Answer: LITT induces a localized entry of chemotherapeutic agents into brain tissue, presenting a promising strategy for brain tumor treatment.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,0.1,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier using Nd:YAG laser-induced thermo therapy for paclitaxel: a novel adjuvant glioma therapy? Answer: LITT causes localized passage of chemotherapy drugs into brain tissue, which is potentially beneficial for treating brain tumors.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,0.1,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy open the rodent blood-brain barrier locally for paclitaxel as a new glioma adjuvant therapy? Answer: LITT facilitates targeted delivery of chemotherapeutic agents into brain tissue, which may be advantageous for brain tumor treatment.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,0.1,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is the locoregional opening of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy a new concept for adjuvant glioma therapy with paclitaxel? Answer: LITT enables localized passage of chemotherapy drugs into brain tissue, offering potential for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.1,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy provide locoregional opening of the rodent blood-brain barrier for paclitaxel in glioma treatment? Answer: LITT induces localized entry of chemotherapeutic agents into brain tissue, which could be useful for brain tumor therapy.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
179,0.1,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel via Nd:YAG laser-induced thermo therapy: a novel adjuvant glioma treatment? Answer: LITT promotes targeted passage of chemotherapy drugs into brain tissue, potentially benefiting brain tumor therapy.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
179,0.1,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy locally open the rodent blood-brain barrier for paclitaxel as a new adjuvant glioma treatment? Answer: LITT causes localized delivery of chemotherapeutic agents into brain tissue, which may be promising for brain tumor treatment.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
180,0.1,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? Yes, it can. This specialized consultation evaluates an older patient's overall health, functional abilities, and vulnerabilities, enabling doctors to customize treatment plans accordingly.",3.5528959103528056e-07,0.10714195893715184,0.17132659131469363,0.027201396971728097,0.1674177219059092,0.13888888888888887,0.027162023114293013,0.2302877868247557,0.10275824770146022,3.552895910352811e-07,0.295924824796296,0.06353305785123965
180,0.1,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation alter the cancer treatment plan for elderly patients? Yes, it can. By assessing the patient's overall health, functional status, and potential risks, this consultation helps physicians adjust the treatment plan to better suit the elderly patient.",2.3685972735685406e-07,0.008267925340625482,0.14634302786959172,0.018134264647818726,0.030216600392426685,0.13888888888888887,0.018108015409528666,0.08920918856484938,0.10275824770146022,2.3685972735685406e-07,0.15074281495179687,0.06353305785123965
180,0.1,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? Yes, it is. This consultation reviews the older patient's health, functional capacity, and vulnerabilities, allowing for a more personalized treatment approach.",3.7897556377096586e-07,0.13612949581040334,0.17132659131469363,0.029014823436509976,0.19727068505559098,0.13888888888888887,0.028972824655245887,0.2610594454915094,0.10275824770146022,3.789755637709665e-07,0.32767352311087583,0.06353305785123965
180,0.1,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does consulting a geriatric oncologist impact the cancer treatment plan for elderly patients? Yes, it does. The consultation evaluates the patient's overall health and functional status, helping doctors tailor the treatment plan to the individual's needs.",3.5528959103528056e-07,0.14675036925486307,0.14277987851192547,0.027201396971728097,0.1674177219059092,0.13888888888888887,0.027162023114293013,0.2302877868247557,0.10275824770146022,3.552895910352811e-07,0.295924824796296,0.06353305785123965
180,0.1,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation influence the cancer treatment plan for elderly patients? Yes, it can. It assesses the patient's health, functional abilities, and vulnerabilities to help physicians customize the treatment plan.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
180,0.1,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Will a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Yes, it will. This specialized evaluation considers the patient's overall health and functional status to guide treatment adjustments.",4.7371945471370706e-07,0.26129263876441033,0.17132659131469363,0.036268529295637494,0.32648241653559795,0.13888888888888887,0.03621603081905738,0.3945908381160317,0.10275824770146022,4.737194547137081e-07,0.465823861591693,0.06353305785123965
180,0.1,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation affect the cancer treatment plan for elderly patients? Yes, it affects it by assessing the patient's health and vulnerabilities, enabling tailored treatment plans.",5.44777372920763e-07,0.3666531544222358,0.17132659131469363,0.04170880868998313,0.4356817085005886,0.13888888888888887,0.041648435441916,0.5079195234230358,0.10275824770146022,5.447773729207643e-07,0.5836068972480772,0.06353305785123965
180,0.1,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan for elderly patients changed by a geriatric oncology consultation? Yes, it is changed. The consultation examines the patient's overall health and functional status to personalize treatment.",4.7371945471370706e-07,0.26129263876441033,0.17132659131469363,0.036268529295637494,0.32648241653559795,0.13888888888888887,0.03621603081905738,0.3945908381160317,0.10275824770146022,4.737194547137081e-07,0.465823861591693,0.06353305785123965
180,0.1,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation lead to changes in the cancer treatment plan for elderly patients? Yes, it can. It evaluates the patient's health and potential vulnerabilities to help doctors adapt the treatment plan.",4.0266153650665116e-07,0.16598245896008512,0.17132659131469363,0.030828249901291856,0.22804234372234466,0.13888888888888887,0.03078362619619876,0.2928081438060892,0.10275824770146022,4.026615365066519e-07,0.36046334593386753,0.06353305785123965
180,0.1,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation result in modifications to the cancer treatment plan for elderly patients? Yes, it does. This consultation assesses the patient's overall health and functional abilities to tailor the treatment accordingly.",4.0266153650665116e-07,0.16598245896008512,0.17132659131469363,0.030828249901291856,0.22804234372234466,0.13888888888888887,0.03078362619619876,0.2928081438060892,0.10275824770146022,4.026615365066519e-07,0.36046334593386753,0.06353305785123965
181,0.1,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be implemented in community palliative care? Answer: Implementing an advance care planning model is feasible within community palliative care services. Quality audit procedures are a crucial part of the model, with documentation of advance care planning discussions recognized as a key outcome metric.",4.737194547137081e-08,0.051008829110396725,0.010248015873015964,0.0036268529295637453,0.04805637672698815,0.005687674518843333,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,0.1,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it possible to apply an advance care planning model in community palliative care? Answer: The advance care planning model can be effectively applied in community palliative care services. Integral to the model are quality audit processes, with the recording of advance care planning conversations serving as an important outcome indicator.",9.474389094274162e-08,0.09961805073119256,0.019684917355371923,0.0072537058591274906,0.09393539257077954,0.010913502136834563,0.007243206163811466,0.1184791694012386,0.023948990820864127,9.474389094274162e-08,0.11851806701508183,0.02271498107084911
181,0.1,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Does an advance care planning model work in community palliative care? Answer: Yes, an advance care planning model is workable in community palliative care services. Quality audits form a vital element of the model, and documenting advance care planning discussions is considered a significant outcome measure.",2.3685972735685406e-08,0.056615544623371594,0.027093144044321227,0.0018134264647818726,0.055717054641363895,0.02558815192743763,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.1,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the use of an advance care planning model practical in community palliative care? Answer: The use of an advance care planning model is practical for community palliative care services. Quality audit processes are essential to the model, with the documentation of advance care planning discussions being a key outcome measure.",9.474389094274162e-08,0.01807132360649355,0.03760001487209991,0.0072537058591274906,0.010757730903586005,0.04901466625950909,0.007243206163811466,0.005312282779206701,0.05637484411944804,9.474389094274162e-08,0.0029935369217577446,0.059929647028324456
181,0.1,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can community palliative care adopt an advance care planning model? Answer: Community palliative care services can adopt an advance care planning model. Quality audits are a fundamental component of the model, and documenting advance care planning discussions is an important outcome measure.",1.1842986367842703e-07,0.17271537909511947,0.05320285467128033,0.009067132323909363,0.1649694721775412,0.04136747291509199,0.009054007704764333,0.12548467099593807,0.005513199468455653,1.1842986367842703e-07,0.12466730702264872,0.002908287627211844
181,0.1,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model suitable for community palliative care? Answer: An advance care planning model is suitable for use in community palliative care services. The model relies heavily on quality audit processes, with documentation of advance care planning discussions as a critical outcome measure.",2.3685972735685406e-08,0.056615544623371594,0.02709314404432117,0.0018134264647818726,0.024910513283144198,0.003036471380144401,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.1,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it feasible to implement an advance care planning model in community palliative care? Answer: Implementing an advance care planning model in community palliative care services is feasible. Quality audit processes are a key part of the model, with documentation of advance care planning discussions recognized as an important outcome measure.",9.474389094274162e-08,0.04525356598139352,0.0192304421768707,0.0072537058591274906,0.010757730903586005,0.049014666259509065,0.007243206163811466,0.005312282779206701,0.05637484411944804,9.474389094274162e-08,0.0029935369217577446,0.059929647028324456
181,0.1,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be integrated into community palliative care? Answer: Integration of an advance care planning model into community palliative care services is feasible. Quality audit processes are essential, with documentation of advance care planning discussions serving as a vital outcome measure.",4.737194547137081e-08,0.08445766447088454,0.03319987216946674,0.0036268529295637453,0.08195492056885723,0.029263776516523787,0.003621603081905733,0.048328098854266255,0.0020526554379765236,4.737194547137081e-08,0.04802033420753293,0.0010803788339694455
181,0.1,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the advance care planning model applicable in community palliative care? Answer: The advance care planning model is applicable in community palliative care services. Quality audit processes are a necessary component, with documentation of advance care planning discussions considered an important outcome measure.",9.474389094274162e-08,0.1747039913142423,0.0679087370242214,0.0072537058591274906,0.16954982353492332,0.06065759637188206,0.007243206163811466,0.13291351311444233,0.028366385064023544,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
181,0.1,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it viable to use an advance care planning model in community palliative care? Answer: Using an advance care planning model is viable for community palliative care services. Quality audit processes are integral to the model, with documentation of advance care planning discussions established as a key outcome measure.",4.737194547137081e-08,0.051008829110396725,0.010248015873015964,0.0036268529295637453,0.04805637672698815,0.005687674518843333,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
182,0.1,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure indicate fluid responsiveness? Central venous pressure (CVP) is not a reliable predictor of fluid responsiveness. Fluid responsiveness mainly depends on the heart and circulatory system interaction.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.1,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can central venous pressure predict fluid responsiveness? Central venous pressure (CVP) does not consistently predict fluid responsiveness. The key factor for fluid responsiveness is the relationship between the heart and circulation.,1.184298636784265e-07,0.1739548849861139,0.013804494598765454,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.1,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness predicted by central venous pressure? Central venous pressure (CVP) fails to reliably forecast fluid responsiveness. Fluid responsiveness is chiefly influenced by heart and circulatory system dynamics.,1.658018091497971e-07,0.20333934615535476,0.01395502034023667,0.012693985253473157,0.1897502950494827,0.029384756657483937,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
182,0.1,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does measuring central venous pressure help predict fluid responsiveness? Central venous pressure (CVP) is not a dependable indicator of fluid responsiveness. Fluid responsiveness is largely governed by the heart-circulation interplay.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.1,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can fluid responsiveness be predicted using central venous pressure? Central venous pressure (CVP) does not reliably indicate fluid responsiveness. The primary determinant of fluid responsiveness is the interaction between the heart and circulatory system.,4.73719454713706e-08,0.024033109137672426,0.024607139373048918,0.003626852929563759,0.019851258254085735,0.029384756657483937,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.1,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure a reliable predictor of fluid responsiveness? Central venous pressure (CVP) does not consistently predict fluid responsiveness. Fluid responsiveness depends mainly on the heart and circulatory system interaction.,1.184298636784265e-07,0.12774507294878434,0.018634406887755126,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.1,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure serve as a predictor for fluid responsiveness? Central venous pressure (CVP) is not a reliable measure for predicting fluid responsiveness. Fluid responsiveness is primarily influenced by the heart and circulatory system relationship.,0.0,0.03960841031771123,0.028027971476124895,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
182,0.1,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can central venous pressure be used to predict fluid responsiveness? Central venous pressure (CVP) does not reliably predict fluid responsiveness. The main factor in fluid responsiveness is the interaction between the heart and circulation.,4.73719454713706e-08,0.06604202917160817,0.005039062500000038,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.1,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness accurately predicted by central venous pressure? Central venous pressure (CVP) is not a consistent predictor of fluid responsiveness. Fluid responsiveness is mainly determined by the heart and circulatory system interaction.,7.10579182070559e-08,0.057430325306548013,0.022738715277777773,0.005440279394345639,0.05159995656866556,0.029384756657483937,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
182,0.1,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure accurately predict fluid responsiveness? Central venous pressure (CVP) does not reliably forecast fluid responsiveness. Fluid responsiveness is primarily dependent on the heart and circulatory system interaction.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
183,0.1,1,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it essential to routinely place a nasobiliary drainage tube after endoscopic removal of stones from the common bile duct in patients with cholangitis caused by choledocholithiasis? No, routine insertion of a nasobiliary drainage tube is not required after endoscopic clearance of the common bile duct in such patients. The choice should be",0.0,0.2132760555569062,0.0981532496684013,0.0,0.21745793899919885,0.12818834470516155,0.0,0.22180709777918306,0.14274281084881085,0.0,0.22633377324406379,0.15397569444444445
183,0.1,2,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-induced cholangitis? No, it is not necessary to routinely insert a nasobiliary drainage tube after the procedure. The decision ought to be",2.6054570009253947e-07,0.08744428647182279,0.17419889880647044,0.0199476911126006,0.04110825420731512,0.17520775623268697,0.019918816950481533,0.020977390888391234,0.17687508764644932,2.6054570009253947e-07,0.00039135651533150906,0.174375
183,0.1,3,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine placement of a nasobiliary drainage tube mandatory after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? No, routine insertion is not necessary. The decision should be",4.50033481978022e-07,0.028184046001135332,0.24691358024691368,0.0344551028308556,0.1127205790509005,0.22506925207756232,0.03440522927810449,0.17305104149662265,0.20249835634451027,4.500334819780227e-07,0.23599742154890002,0.174375
183,0.1,4,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Do patients with choledocholithiasis-induced cholangitis require routine nasobiliary drainage tube insertion after endoscopic clearance of the common bile duct? No, it is not routinely necessary to insert a nasobiliary drainage tube after the procedure. The decision should be",3.552895910352808e-07,0.011291474845804395,0.1930360292265055,0.02720139697172809,0.03344572009229152,0.197314150036746,0.027162023114293,0.05169018449235585,0.20249835634451027,3.552895910352811e-07,0.11083427859489303,0.174375
183,0.1,5,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it standard practice to insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? No, routine insertion is not required. The decision should be",4.263475092423367e-07,0.001668917148546445,0.24691358024691368,0.03264167636607372,0.0819489203841468,0.22506925207756232,0.03259442773715162,0.14130234318204282,0.20249835634451027,4.263475092423373e-07,0.20320759872590832,0.174375
183,0.1,6,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is the routine use of a nasobiliary drainage tube indicated after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, routine insertion is not indicated. The decision should be",4.737194547137073e-07,0.05895570466788902,0.24691358024691368,0.03626852929563748,0.14446927736548032,0.22506925207756232,0.03621603081905737,0.20584086431961435,0.20249835634451027,4.737194547137081e-07,0.2698989732245818,0.174375
183,0.1,7,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Must a nasobiliary drainage tube be routinely placed after endoscopic clearance of the common bile duct in patients with cholangitis from choledocholithiasis? No, routine placement is not necessary. The decision should be",4.974054274493926e-07,0.09070440298246885,0.24691358024691368,0.03808195576041936,0.17725910018847202,0.22506925207756232,0.03802683236001024,0.2397424159952961,0.20249835634451027,4.974054274493935e-07,0.3049902930358508,0.174375
183,0.1,8,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it necessary to always insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, it is not always necessary. The decision should be",4.737194547137073e-07,0.05895570466788902,0.24691358024691368,0.03626852929563748,0.14446927736548032,0.22506925207756232,0.03621603081905737,0.20584086431961435,0.20249835634451027,4.737194547137081e-07,0.2698989732245818,0.174375
183,0.1,9,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine nasobiliary drainage tube insertion required after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, it is not required routinely. The decision should be",5.447773729207632e-07,0.1573957774811423,0.24691358024691368,0.04170880868998312,0.2462519716754228,0.22506925207756232,0.04164843544191599,0.3112013799774398,0.20249835634451027,5.447773729207643e-07,0.37909826518957246,0.174375
183,0.1,10,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Should a nasobiliary drainage tube be inserted as a routine measure after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? No, routine insertion is not necessary. The decision should be",4.026615365066514e-07,0.030656454021797952,0.24691358024691368,0.030828249901291842,0.05209595723446503,0.22506925207756232,0.030783626196198746,0.11053068451528913,0.20249835634451027,4.026615365066519e-07,0.1714589004113285,0.174375
184,0.1,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the length of psychological treatment for depression linked to the likelihood of returning to treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of returning to mental health services for certain groups. Nonetheless, due to the study's design, no causal conclusions can be made. Additional research, ideally through a randomized controlled trial, is necessary to confirm this.",9.474389094274162e-08,0.07260704624771641,0.0034203843161433184,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
184,0.1,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the duration of psychological therapy for depression influence the probability of re-entering treatment? Answer: The results imply that longer treatment periods could help prevent some groups from returning to mental health care. However, the study design does not allow for causal claims. More research, preferably randomized controlled trials, is required to establish causality.",7.105791820705622e-08,0.018895639841298717,0.05246913580246911,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
184,0.1,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there a relationship between how long psychological treatment for depression lasts and the likelihood of returning to treatment? Answer: The data suggest that longer treatment durations may reduce the risk of returning to mental health care in certain populations. Still, the study's design prevents drawing causal inferences. Further studies, ideally randomized controlled trials, are needed to verify this.",4.737194547137081e-08,0.06045600799223738,0.018612564549775987,0.0036268529295637453,0.011189692895409387,0.017236072637734686,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
184,0.1,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of psychological treatment for depression affect the chance of patients returning to treatment? Answer: Results suggest that prolonged treatment might lower the likelihood of returning to mental health services in some groups. However, due to the study design, no causal relationship can be confirmed. Additional research, preferably randomized controlled trials, is necessary.",4.737194547137081e-08,0.012039426489132588,0.03429355281207131,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
184,0.1,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the duration of psychological treatment for depression associated with the risk of returning to treatment? Answer: Findings indicate that longer treatment duration may help prevent return to mental health care in certain groups. Yet, the study design limits causal interpretation. Further investigation, ideally through randomized controlled trials, is needed.",1.6580180914979784e-07,0.058065401294831176,0.05246913580246911,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
184,0.1,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does longer psychological treatment for depression relate to reduced return to treatment? Answer: The results suggest that extended treatment duration might prevent some groups from returning to mental health care. However, causal conclusions cannot be drawn due to the study design. More research, preferably randomized controlled trials, is required.",1.8948778188548325e-07,0.07826810861234978,0.05246913580246911,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
184,0.1,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the length of psychological treatment for depression connected to the likelihood of re-entering treatment? Answer: The findings suggest that a longer treatment duration may reduce return to mental health care in some groups. Nonetheless, the study design does not support causal inference. Further research, ideally randomized controlled trials, is needed.",1.4211583641411244e-07,0.03826277399865141,0.05246913580246911,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
184,0.1,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there an association between the duration of psychological treatment for depression and returning to treatment? Answer: Results suggest that longer treatment may prevent return to mental health care in certain groups. However, no causal inference can be made due to the study design. Additional research, preferably randomized controlled trials, is necessary.",1.1842986367842703e-07,0.018844688141548716,0.05246913580246911,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
184,0.1,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the duration of psychological treatment for depression impact the chance of returning to treatment? Answer: The findings indicate that longer treatment duration might reduce the likelihood of returning to mental health care in some groups. However, causal conclusions are limited by the study design. Further research, ideally randomized controlled trials, is needed.",9.474389094274162e-08,0.052109487930096954,0.014791319577940096,0.0072537058591274906,0.10076747909833506,0.01922337562475971,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
184,0.1,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the length of psychological treatment for depression related to the risk of returning to treatment? Answer: The results suggest that longer treatment may help prevent return to mental health care in some groups. Yet, the study design prevents causal conclusions. More research, preferably randomized controlled trials, is required.",1.8948778188548325e-07,0.07826810861234978,0.05246913580246911,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
185,0.1,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to predict discordance between TEOAE and AABR results in newborns? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be predicted. Various factors such as ear canal debris or ambient noise can cause variations, making predictions unreliable.",9.474389094274162e-08,0.05560482630764074,0.017576097781801726,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
185,0.1,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in TEOAE and AABR results be anticipated in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is unpredictable. Factors like ear canal debris or background noise contribute to this variability, rendering predictions unreliable.",1.6580180914979784e-07,0.09126221492188158,0.03840000000000001,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
185,0.1,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is the discordance between TEOAE and AABR outcomes in newborns foreseeable? No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns cannot be reliably predicted. Influences such as debris in the ear canal or ambient noise levels cause this unpredictability.",1.4211583641411244e-07,0.09942014214049522,0.016671604938271613,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
185,0.1,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Are discordant results between TEOAE and AABR in newborns predictable? No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes among newborns is not predictable. Various factors including ear canal debris and environmental noise make such predictions unreliable.",2.1317375462116866e-07,0.13672458899863882,0.03840000000000001,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
185,0.1,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can we predict when TEOAE and AABR results will be discordant in newborns? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not predictable. Factors like debris in the ear canal or ambient noise levels can cause variations, making predictions unreliable.",7.105791820705622e-08,0.006104406581574295,0.03840000000000001,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
185,0.1,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it feasible to predict discordance in TEOAE and AABR outcomes in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is unpredictable. This is due to factors such as ear canal debris and background noise, which affect reliability.",9.474389094274162e-08,0.026723693784310054,0.03840000000000001,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
185,0.1,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in TEOAE and AABR outcomes be forecasted in newborns? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be forecasted. Various factors like debris in the ear canal or ambient noise contribute to this unpredictability.",1.6580180914979784e-07,0.09126221492188158,0.03840000000000001,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
185,0.1,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is predicting discordance in TEOAE and AABR results in newborns possible? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not predictable. Factors such as ear canal debris and environmental noise cause variability, making predictions unreliable.",1.6580180914979784e-07,0.12206875628010128,0.01618925619834712,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
185,0.1,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Are TEOAE and AABR discordant outcomes in newborns predictable? No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns cannot be predicted. Influences like debris in the ear canal or ambient noise levels lead to this unpredictability.",2.1317375462116866e-07,0.16896399274561302,0.015157369614512486,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
185,0.1,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to foresee discordance in TEOAE and AABR outcomes in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is not foreseeable. Various factors such as ear canal debris and background noise make predictions unreliable.",1.4211583641411244e-07,0.06928330820310658,0.03840000000000001,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
186,0.1,1,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Current research does not show direct evidence that laparoscopic cholecystectomy impacts peri-sinusoidal cell activity. Since this procedure targets the gallbladder, it is typically not linked to changes in peri-sinusoidal cells found mainly in the liver.",2.1317375462116866e-07,0.1724324293579329,0.053656534486704814,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.1,2,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? There is no direct scientific evidence indicating that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The procedure primarily involves the gallbladder, so its effects are usually unrelated to peri-sinusoidal cells in the liver.",2.6054570009253936e-07,0.19036474401550052,0.07668546828700021,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.1,3,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does the laparoscopic cholecystectomy procedure impact peri-sinusoidal cell activity? Current scientific studies do not provide direct proof that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. Since the surgery focuses on the gallbladder, it generally does not affect peri-sinusoidal cells located in the liver.",2.1317375462116866e-07,0.1724324293579329,0.053656534486704814,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.1,4,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Can laparoscopic cholecystectomy alter peri-sinusoidal cell activity? There is no direct evidence in the scientific literature that laparoscopic cholecystectomy changes peri-sinusoidal cell activity. The procedure is mainly concerned with the gallbladder and is not typically associated with peri-sinusoidal cells in the liver.,2.1317375462116866e-07,0.20624448694622322,0.029594055544617914,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.1,5,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does undergoing laparoscopic cholecystectomy modify peri-sinusoidal cell activity? Scientific literature currently lacks direct evidence that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. Since the operation targets the gallbladder, it is generally not connected to peri-sinusoidal cells in the liver.",3.0791764556390996e-07,0.28239729857224116,0.04843118596465298,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
186,0.1,6,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Present scientific data do not directly link laparoscopic cholecystectomy to changes in peri-sinusoidal cell activity. The procedure mainly involves the gallbladder, so it is not usually related to peri-sinusoidal cells in the liver.",1.6580180914979784e-07,0.12165907268604714,0.05590778517066495,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
186,0.1,7,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does laparoscopic cholecystectomy have an impact on peri-sinusoidal cell activity? Current scientific findings do not provide direct evidence that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The surgery focuses on the gallbladder and is generally not associated with peri-sinusoidal cells in the liver.,2.1317375462116866e-07,0.1724324293579329,0.053656534486704814,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.1,8,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? There is no direct scientific proof that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. Since the procedure is centered on the gallbladder, it typically does not impact peri-sinusoidal cells in the liver.",2.8423167282822466e-07,0.2172756517150609,0.07601217014795378,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
186,0.1,9,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does laparoscopic cholecystectomy influence the activity of peri-sinusoidal cells? Current research does not offer direct evidence that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The procedure mainly targets the gallbladder and is not commonly linked to peri-sinusoidal cells in the liver.,2.6054570009253936e-07,0.19036474401550052,0.07668546828700021,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.1,10,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Can the activity of peri-sinusoidal cells be influenced by laparoscopic cholecystectomy? Scientific literature does not currently provide direct evidence that laparoscopic cholecystectomy impacts peri-sinusoidal cell activity. The procedure is primarily focused on the gallbladder and is generally unrelated to peri-sinusoidal cells in the liver.,1.6580180914979784e-07,0.08941966893907294,0.07906610659957364,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
187,0.1,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? Yes, it does. By incentivizing healthcare providers to organize their services efficiently, case-mix based reimbursement fosters a process-oriented approach, which can enhance patient outcomes and optimize resource use in the health system.",3.316036182995957e-07,0.18040929450797938,0.07494897959183676,0.025387970506946217,0.2015464160146445,0.06562499999999999,0.025351221573340132,0.22308823905478903,0.05536332179930796,3.316036182995957e-07,0.2544172726632352,0.037677816224529016
187,0.1,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? Indeed, case-mix based reimbursement promotes this development by motivating healthcare providers to deliver services in a structured and efficient manner, leading to better patient outcomes and improved allocation of resources.",3.552895910352811e-07,0.17230488647914521,0.09807397959183678,0.02720139697172809,0.19242697101672634,0.08999999999999998,0.027162023114293,0.24840604703908076,0.05536332179930796,3.552895910352811e-07,0.2803927590664932,0.037677816224529016
187,0.1,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix based reimbursement drive the growth of process-oriented care delivery? Yes, it can. This reimbursement model encourages healthcare providers to streamline their services, supporting a process-oriented approach that improves patient outcomes and resource management.",5.210914001850783e-07,0.3257043709790013,0.12244897959183677,0.03989538222520121,0.38479886366418237,0.08999999999999998,0.039837633900963086,0.44623179036899874,0.05536332179930796,5.210914001850789e-07,0.483991714307733,0.037677816224529016
187,0.1,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement promote process-oriented care delivery? Yes, it incentivizes healthcare providers to organize their services effectively, which fosters a process-oriented care model and results in enhanced patient outcomes and more efficient resource allocation.",5.210914001850783e-07,0.366477734541351,0.09306422293435283,0.03989538222520121,0.38479886366418237,0.08999999999999998,0.039837633900963086,0.44623179036899874,0.05536332179930796,5.210914001850789e-07,0.483991714307733,0.037677816224529016
187,0.1,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is process-oriented care delivery encouraged by case-mix based reimbursement? Yes, because it motivates healthcare providers to structure their services efficiently, leading to a process-focused approach that benefits patient outcomes and resource distribution.",5.921493183921342e-07,0.4180776911100166,0.12244897959183677,0.04533566161954685,0.4801090434685076,0.08999999999999998,0.04527003852382171,0.544671863182252,0.05536332179930796,5.921493183921352e-07,0.5857744086176755,0.037677816224529016
187,0.1,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement help develop process-oriented care delivery? Yes, it does by encouraging healthcare providers to deliver services in a more organized and efficient way, which supports process-oriented care and improves patient outcomes and resource use.",4.737194547137077e-07,0.3070541338368278,0.09469387755102045,0.03626852929563745,0.3259583636412491,0.08999999999999998,0.03621603081905734,0.3856071685525633,0.05536332179930796,4.737194547137081e-07,0.4214713573263995,0.037677816224529016
187,0.1,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can the implementation of case-mix based reimbursement stimulate process-oriented care delivery? Yes, it incentivizes healthcare providers to adopt efficient service structures, promoting a process-oriented approach that enhances patient outcomes and optimizes resource allocation.",5.684633456564489e-07,0.38632899279543675,0.12244897959183677,0.04352223515476497,0.4473192206455159,0.08999999999999998,0.04345923698286883,0.5107703115065703,0.05536332179930796,5.684633456564497e-07,0.5506830888064065,0.037677816224529016
187,0.1,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement foster the development of process-oriented care delivery? Yes, it encourages healthcare providers to efficiently structure their services, which supports a process-oriented care model and leads to better patient outcomes and resource management.",4.97405427449393e-07,0.336325244423461,0.09390226678906861,0.03808195576041933,0.3549459005145006,0.08999999999999998,0.03802683236001021,0.41546013170224505,0.05536332179930796,4.974054274493935e-07,0.4522430159931532,0.037677816224529016
187,0.1,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the advancement of process-oriented care delivery influenced by case-mix based reimbursement? Yes, because it motivates healthcare providers to organize their services effectively, fostering a process-oriented approach that improves patient outcomes and resource allocation.",5.447773729207636e-07,0.35555733412868307,0.12244897959183677,0.04170880868998309,0.41557052233093605,0.08999999999999998,0.04164843544191596,0.47798048868357856,0.05536332179930796,5.447773729207643e-07,0.5167815371307247,0.037677816224529016
187,0.1,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement stimulate process-oriented care delivery? Yes, by incentivizing healthcare providers to efficiently structure their services, it promotes a process-oriented approach that can enhance patient outcomes and optimize resource use within the health system.",4.97405427449393e-07,0.2967168341057498,0.12244897959183677,0.03808195576041933,0.3549459005145006,0.08999999999999998,0.03802683236001021,0.41546013170224505,0.05536332179930796,4.974054274493935e-07,0.4522430159931532,0.037677816224529016
188,0.1,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside evaluation dependable for ruling out aspiration after an acute stroke? Answer: Bedside swallowing assessments do not have sufficient sensitivity to serve as a screening tool in acute stroke cases, though the use of videofluoroscopy as the definitive standard is debated. The significance of aspiration and bedside assessment in forecasting complications and",0.0,0.08834209862498499,0.09639999999999999,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
188,0.1,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be reliably excluded through bedside assessment following an acute stroke? Answer: Bedside swallowing assessments lack adequate sensitivity to be effective screening tools in acute stroke, and there are concerns regarding videofluoroscopy as the gold standard. The relative roles of aspiration and bedside assessment in predicting complications and",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
188,0.1,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside assessment effectively rule out aspiration after an acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening instruments in acute stroke, and the use of videofluoroscopy as the gold standard is questioned. The importance of aspiration and bedside assessment in predicting complications and",7.105791820705622e-08,0.0023473032786114345,0.07640832986255724,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
188,0.1,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside swallowing assessment a reliable method to exclude aspiration post-acute stroke? Answer: Bedside assessments lack the sensitivity required for screening in acute stroke, and there are doubts about videofluoroscopy being the gold standard. The relative significance of aspiration and bedside assessment in predicting complications and",1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
188,0.1,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be excluded reliably by bedside assessment following an acute stroke? Answer: Bedside swallowing assessments do not possess the necessary sensitivity for screening in acute stroke, and concerns exist about videofluoroscopy as the gold standard. The importance of aspiration and bedside assessment in predicting complications and",1.4211583641411244e-07,0.06129783792175658,0.07513345935727789,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
188,0.1,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment sufficient to rule out aspiration after an acute stroke? Answer: Bedside swallowing assessments lack the sensitivity needed for screening in acute stroke, and the use of videofluoroscopy as the gold standard is controversial. The relative importance of aspiration and bedside assessment in predicting complications and",1.1842986367842703e-07,0.03962993654257563,0.0755760977818017,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
188,0.1,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can bedside swallowing assessment reliably exclude aspiration in acute stroke patients? Answer: Bedside assessments are not sensitive enough to be used as screening tools in acute stroke, and videofluoroscopy as the gold standard is subject to debate. The significance of aspiration and bedside assessment in predicting complications and",1.1842986367842703e-07,0.03962993654257563,0.0755760977818017,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
188,0.1,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside assessment have the sensitivity to exclude aspiration following acute stroke? Answer: Bedside swallowing assessments lack the necessary sensitivity for screening in acute stroke, and there are concerns about videofluoroscopy as the gold standard. The relative importance of aspiration and bedside assessment in predicting complications and",1.4211583641411244e-07,0.06129783792175658,0.07513345935727789,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
188,0.1,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment a dependable screening tool to exclude aspiration after acute stroke? Answer: Bedside swallowing assessments do not have sufficient sensitivity for screening in acute stroke, and the use of videofluoroscopy as the gold standard is questioned. The importance of aspiration and bedside assessment in predicting complications and",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
188,0.1,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be reliably ruled out by bedside assessment after an acute stroke? Answer: Bedside swallowing assessments lack the sensitivity required for screening in acute stroke, and videofluoroscopy as the gold standard raises concerns. The relative importance of aspiration and bedside assessment in predicting complications and",1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
189,0.1,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Are musculoskeletal symptoms related to aromatase inhibitors best addressed by preventing osteoporosis? Answer: Patients treated with AIs who develop osteoporosis face a higher risk of musculoskeletal symptoms and fractures. Using calcium and bisphosphonates alongside reduces the chance of osteoporosis and these symptoms. Those previously treated with tamoxifen before AIs showed fewer AI-related musculoskeletal symptoms. We advise patients on AIs to...,2.3685972735685406e-08,0.005439297214077321,0.015755053507728885,0.0018134264647818726,0.006297787702283841,0.016661878770468257,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
189,0.1,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is the prevention of osteoporosis crucial to eliminating musculoskeletal symptoms caused by aromatase inhibitors? Answer: Patients on AIs who develop osteoporosis have an increased risk of musculoskeletal symptoms and bone fractures. Co-treatment with calcium and bisphosphonates lowers the risk of osteoporosis and related musculoskeletal symptoms. Patients who used tamoxifen prior to AIs were less prone to AI-related musculoskeletal symptoms. Our recommendation for patients on AIs is...,1.1842986367842703e-07,0.0209325289539235,0.040951248513674196,0.009067132323909363,0.08182000813651058,0.0012810193954682567,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
189,0.1,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Does preventing osteoporosis hold the key to stopping aromatase inhibitor-induced musculoskeletal symptoms? Answer: Osteoporosis in patients on AIs raises the risk of musculoskeletal symptoms and fractures. Supplementing with calcium and bisphosphonates reduces the likelihood of osteoporosis and these symptoms. Patients previously treated with tamoxifen before starting AIs were less likely to experience AI-related musculoskeletal symptoms. We suggest that patients on AIs...,0.0,0.04545227413507824,0.0326598625974369,0.0,0.02310490601866455,0.016661878770468257,0.0,0.0,0.0,0.0,0.0,0.0
189,0.1,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Are aromatase inhibitor-related musculoskeletal symptoms best managed by osteoporosis prevention? Answer: Patients receiving AIs who develop osteoporosis are more susceptible to musculoskeletal symptoms and fractures. Co-administration of calcium and bisphosphonates decreases the risk of osteoporosis and musculoskeletal symptoms. Those who had tamoxifen before AIs showed reduced incidence of AI-related musculoskeletal symptoms. We recommend that patients on AIs...,9.474389094274162e-08,0.04828609254385885,0.014007429172276202,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
189,0.1,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is the key to eliminating musculoskeletal symptoms from aromatase inhibitors the prevention of osteoporosis? Answer: Patients on AIs who develop osteoporosis have a higher chance of musculoskeletal symptoms and bone fractures. Using calcium and bisphosphonates together reduces the risk of osteoporosis and these symptoms. Patients treated with tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We advise patients on AIs to...,7.105791820705622e-08,0.05120508221148512,0.002287128266761168,0.005440279394345618,0.04989039778937254,0.0007929921939854208,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
189,0.1,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Can preventing osteoporosis eliminate musculoskeletal symptoms associated with aromatase inhibitors? Answer: Patients on AIs who develop osteoporosis are at greater risk for musculoskeletal symptoms and fractures. Co-medication with calcium and bisphosphonates lowers the risk of osteoporosis and related symptoms. Patients who received tamoxifen prior to AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend patients on AIs...,4.737194547137081e-08,0.01215103825547903,0.015192180233632675,0.0036268529295637453,0.01079664565701588,0.016661878770468257,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
189,0.1,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is osteoporosis prevention the key to resolving aromatase inhibitor-related musculoskeletal symptoms? Answer: Patients on AIs who develop osteoporosis face increased risk of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates reduces the likelihood of osteoporosis and musculoskeletal symptoms. Patients previously treated with tamoxifen before AIs were less likely to experience AI-related musculoskeletal symptoms. We recommend patients on AIs...,4.737194547137081e-08,0.01215103825547903,0.015192180233632668,0.0036268529295637453,0.01079664565701588,0.016661878770468257,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
189,0.1,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Does stopping osteoporosis prevent musculoskeletal symptoms caused by aromatase inhibitors? Answer: Patients on AIs who develop osteoporosis have an increased risk of musculoskeletal symptoms and bone fractures. Co-administration of calcium and bisphosphonates reduces the risk of osteoporosis and musculoskeletal symptoms. Patients who had tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend patients on AIs...,4.737194547137081e-08,0.059144067445982884,0.018389265042599856,0.0036268529295637453,0.01079664565701588,0.016661878770468257,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
189,0.1,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is the prevention of osteoporosis essential to avoid musculoskeletal symptoms in patients on aromatase inhibitors? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms and fractures. Co-medication with calcium and bisphosphonates decreases the risk of osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend patients on AIs...,4.737194547137081e-08,0.03989428706303233,0.08022179329668434,0.0036268529295637453,0.05589472884165669,0.016661878770468257,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
189,0.1,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Question: Is preventing osteoporosis the main strategy to eliminate musculoskeletal symptoms related to aromatase inhibitors? Answer: Patients on AIs who develop osteoporosis have a higher risk of musculoskeletal symptoms and bone fractures. Using calcium and bisphosphonates alongside reduces the chance of osteoporosis and musculoskeletal symptoms. Patients who were treated with tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend patients on AIs...,9.474389094274162e-08,0.06770900025787263,0.003002965846367417,0.0072537058591274906,0.08764342715623652,0.016661878770468257,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
190,0.1,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Do higher depression rates in women result from differences in symptom reporting? Answer: In this community sample, men and women reported similar depressive symptom patterns. There was no evidence that depressive symptom presentation varies by gender.",9.47438909427412e-08,0.10921133332760435,0.0027715385957144123,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
190,0.1,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the increased depression rate in women explained by different symptom reporting? Answer: Men and women in this community sample showed comparable depressive symptom patterns. No gender differences in symptom presentation were found.,1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.1,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are women's higher depression rates due to differential symptom reporting? Answer: Both men and women in this community sample reported similar depressive symptoms. No gender-based differences in symptom presentation were observed.,2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.1,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Does differential symptom reporting explain higher depression rates in women? Answer: Men and women in this community sample exhibited similar depressive symptom patterns. No evidence indicated gender differences in symptom presentation.,2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.1,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are elevated depression rates in women linked to differences in symptom reporting? Answer: In this community sample, men and women reported depressive symptoms similarly. No gender-related differences in symptom presentation were detected.",1.894877818854824e-07,0.2751295898562076,0.037238658777120306,0.014507411718255009,0.2742936145838488,0.0322222222222222,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.1,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the higher prevalence of depression in women due to reporting differences in symptoms? Answer: Men and women in this community sample showed alike depressive symptom patterns. No evidence suggested gender differences in symptom presentation.,1.184298636784265e-07,0.13848244391423759,0.003563149357666242,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.1,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Could differential symptom reporting account for higher depression rates in women? Answer: Men and women in this community sample reported depressive symptoms in similar ways. No gender differences in symptom presentation were found.,1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.1,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are women's higher depression rates explained by how symptoms are reported? Answer: Men and women in this community sample had similar depressive symptom patterns. No evidence of gender differences in symptom presentation was found.,1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.1,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Does symptom reporting variation explain the higher depression rates in women? Answer: Men and women in this community sample reported depressive symptoms similarly. No gender differences in symptom presentation were identified.,2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.1,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are increased depression rates in women due to differences in symptom reporting? Answer: Men and women in this community sample exhibited comparable depressive symptom patterns. No evidence of gender-based differences in symptom presentation was observed.,1.184298636784265e-07,0.17809085423194837,0.031949402578773184,0.00906713232390937,0.17797448507583224,0.029384756657483937,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
191,0.1,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it possible to implement an advance care planning model in community palliative care? Yes, such a model is feasible in this setting. It supports proactive conversations about care preferences, medical choices, and end-of-life wishes, allowing healthcare providers to deliver patient-focused care. Additionally, it improves the",4.737194547137081e-08,0.162984260993011,0.144375,0.0036268529295637453,0.10623240711611137,0.10707911957168353,0.003621603081905733,0.04695724999790185,0.06632653061224489,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
191,0.1,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be effectively used in community palliative care? The answer is yes; it is feasible. This model encourages early discussions regarding care preferences, medical decisions, and end-of-life wishes, helping healthcare professionals offer care centered on the patient. Furthermore, it enhances the",4.737194547137081e-08,0.162984260993011,0.144375,0.0036268529295637453,0.10623240711611137,0.10707911957168353,0.003621603081905733,0.04695724999790185,0.06632653061224489,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
191,0.1,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model practical within community palliative care? Yes, it is feasible. It promotes proactive dialogue about care preferences, medical decisions, and end-of-life wishes, enabling healthcare workers to provide care tailored to the patient. It also improves the",1.6580180914979784e-07,0.045201225336627626,0.144375,0.012693985253473108,0.014395580672506014,0.10707911957168353,0.012675610786670066,0.07665670596927399,0.06632653061224489,1.6580180914979784e-07,0.14176503124858364,0.02271498107084911
191,0.1,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is the implementation of an advance care planning model viable in community palliative care? Yes, it is. This model facilitates early conversations about care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to focus on patient-centered care. Moreover, it enhances the",1.4211583641411244e-07,0.06989383792699932,0.144375,0.010880558788691236,0.010922227311785715,0.10707911957168353,0.0108648092457172,0.05068121956601601,0.06632653061224489,1.4211583641411244e-07,0.11509678416642277,0.02271498107084911
191,0.1,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can community palliative care adopt an advance care planning model? Yes, it is feasible. The model encourages proactive discussions about care preferences, medical decisions, and end-of-life wishes, which helps healthcare professionals deliver patient-centered care. Additionally, it improves the",2.3685972735685374e-07,0.032760316133082945,0.144375,0.018134264647818726,0.09443828834604018,0.10707911957168353,0.018108015409528666,0.15889480420624702,0.06632653061224489,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
191,0.1,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it feasible to use an advance care planning model in community palliative care? Yes, it is. This approach supports early discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare providers to offer care that centers on the patient. It also enhances the",7.105791820705622e-08,0.14051140514095328,0.144375,0.005440279394345618,0.08324288889141185,0.10707911957168353,0.0054324046228586,0.023426752587707433,0.06632653061224489,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
191,0.1,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model workable in community palliative care? Yes, it is feasible. It facilitates proactive conversations about care preferences, medical decisions, and end-of-life wishes, allowing healthcare professionals to provide care focused on the patient. Furthermore, it improves the",1.6580180914979784e-07,0.045201225336627626,0.144375,0.012693985253473108,0.014395580672506014,0.10707911957168353,0.012675610786670066,0.07665670596927399,0.06632653061224489,1.6580180914979784e-07,0.14176503124858364,0.02271498107084911
191,0.1,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be successfully implemented in community palliative care? Yes, it can. This model promotes early dialogue about care preferences, medical decisions, and end-of-life wishes, helping healthcare providers deliver patient-centered care. Moreover, it enhances the",2.1317375462116844e-07,0.006092069050922078,0.144375,0.016320838183036854,0.06703931415792486,0.10707911957168353,0.0162972138685758,0.13072392723955018,0.06632653061224489,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
191,0.1,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is the use of an advance care planning model achievable in community palliative care? Yes, it is feasible. It encourages proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide care tailored to the patient. Additionally, it improves the",9.474389094274162e-08,0.11752188691625376,0.144375,0.0072537058591274906,0.05971239148121743,0.10707911957168353,0.007243206163811466,0.0006707989913525836,0.06632653061224489,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
191,0.1,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model applicable in community palliative care? Yes, it is feasible. This model supports early conversations about care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to focus on patient-centered care. It also enhances the",1.8948778188548314e-07,0.019883417352335897,0.144375,0.014507411718254981,0.04037106707576399,0.10707911957168353,0.014486412327622933,0.10332495305143485,0.06632653061224489,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
192,0.1,1,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is it still advisable to perform second-look laparotomy? Answer: The use of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women remains controversial. Although it offers important insights into the disease status,",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,0.1,2,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy continue to be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: The role of second-look laparotomy in managing advanced epithelial ovarian carcinoma in Thai women is debated. It can yield critical information regarding the condition,",2.3685972735685406e-08,0.06357647881690554,0.025729954291084614,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,0.1,3,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still recommended? Answer: There is ongoing debate about second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women. It may provide useful data on the disease's progression,",9.474389094274131e-08,0.15839835711104744,0.03648864351691271,0.0072537058591274906,0.12076378633693707,0.010609567901234532,0.007243206163811466,0.12040078781491248,0.008572048611111105,9.474389094274162e-08,0.11980950112335131,0.00612461419753086
192,0.1,4,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy be maintained as a practice? Answer: Second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is controversial. It can offer valuable insights into the current status of the cancer,",0.0,0.033812057588289424,0.023178020362705082,0.0,0.0693147180559941,0.04890393625389013,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914
192,0.1,5,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy justified? Answer: The application of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a matter of discussion. It provides important information about the disease status,",4.7371945471370706e-08,0.09422618819011852,0.02916156514641359,0.0036268529295637453,0.05858958049870866,0.005040796274936948,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.1,6,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy still be performed for advanced epithelial ovarian carcinoma in Thai women? Answer: The decision to use second-look laparotomy in advanced epithelial ovarian carcinoma in Thai women is debated. It can deliver crucial information about the cancer's status,",2.3685972735685406e-08,0.06357647881690554,0.025729954291084614,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,0.1,7,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still a viable option? Answer: The practice of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is under debate. It offers valuable information regarding the disease condition,",4.7371945471370706e-08,0.09422618819011852,0.029161565146413562,0.0036268529295637453,0.05858958049870866,0.005040796274936948,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.1,8,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: In cases of advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy be continued? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women remains a debated topic. It can provide significant insights into the disease status,",4.7371945471370706e-08,0.09422618819011896,0.02916156514641359,0.0036268529295637453,0.05858958049870866,0.005040796274936962,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.1,9,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is it appropriate to continue second-look laparotomy? Answer: The use of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is controversial. It can yield important information about the cancer's progression,",4.7371945471370706e-08,0.012411839588333695,0.043209876543209916,0.0036268529295637453,0.014373280612865358,0.04629629629629633,0.003621603081905733,0.016526879127630956,0.04938271604938273,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
192,0.1,10,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should we persist with second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? Answer: The role of second-look laparotomy in advanced epithelial ovarian carcinoma in Thai women is debated. It can provide valuable data on the status of the disease,",0.0,0.03381205758829031,0.02244205089443184,0.0,0.0,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0
193,0.1,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Yes, it does. The condition lowers maximum aerobic capacity because of repeated sleep disruptions, causing daytime tiredness and reduced endurance for aerobic exercises. Long-term sleep deprivation also harms cardiovascular health, which further decreases aerobic fitness.",1.6580180914979784e-07,0.042104414110259114,0.08264462809917357,0.012693985253473108,0.13177252289144326,0.0212665406427221,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
193,0.1,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness influenced by obstructive sleep apnea? Indeed, obstructive sleep apnea negatively affects aerobic fitness by decreasing the maximum aerobic capacity. This happens due to frequent interruptions in sleep, resulting in fatigue during the day and diminished stamina for aerobic workouts. Additionally, chronic lack of sleep impairs heart health, further reducing aerobic fitness.",1.1842986367842703e-07,0.16230243797831267,0.044966811874644554,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
193,0.1,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can obstructive sleep apnea affect aerobic fitness? Yes, it can. The disorder leads to a reduction in maximum aerobic capacity as a result of frequent sleep disturbances, causing daytime exhaustion and lower endurance for aerobic activities. Persistent sleep deprivation also impacts cardiovascular health, which further lowers aerobic fitness.",2.3685972735685406e-08,0.09447112089549092,0.08264462809917357,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
193,0.1,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea have an effect on aerobic fitness? Yes, it does. It diminishes the maximum aerobic capacity because of repeated sleep interruptions, leading to daytime fatigue and decreased stamina for aerobic exercises. Chronic sleep loss also negatively affects heart health, further impairing aerobic fitness.",7.105791820705622e-08,0.05098600895575256,0.08264462809917357,0.005440279394345618,0.0364623430871176,0.0212665406427221,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
193,0.1,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Yes, obstructive sleep apnea can reduce aerobic fitness. It lowers the maximum aerobic capacity due to frequent disruptions in sleep, causing tiredness during the day and less endurance for aerobic activities. Long-term sleep deprivation also harms heart health, further decreasing aerobic fitness.",2.3685972735685406e-08,0.07956037398504412,0.04190221071574214,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
193,0.1,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea influence aerobic fitness? Yes, it can impact aerobic fitness by reducing the maximum aerobic capacity. This is caused by frequent sleep interruptions, which lead to daytime fatigue and reduced stamina for aerobic exercises. Chronic sleep deprivation also affects cardiovascular health, further diminishing aerobic fitness.",2.3685972735685406e-08,0.09447112089549092,0.08264462809917357,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
193,0.1,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can aerobic fitness be affected by obstructive sleep apnea? Yes, obstructive sleep apnea reduces maximum aerobic capacity due to frequent sleep disruptions, resulting in daytime tiredness and decreased endurance for aerobic activities. Ongoing sleep deprivation also negatively impacts heart health, further lowering aerobic fitness.",1.1842986367842703e-07,0.026715768867978884,0.059401997713686046,0.009067132323909363,0.08298235872201154,0.0212665406427221,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
193,0.1,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is there an effect of obstructive sleep apnea on aerobic fitness? Yes, obstructive sleep apnea lowers maximum aerobic capacity because of frequent sleep interruptions, causing fatigue during the day and reduced stamina for aerobic workouts. Chronic sleep deprivation also impairs cardiovascular health, further reducing aerobic fitness.",7.105791820705622e-08,0.010627073760686834,0.03829633172275389,0.005440279394345618,0.06796903311257019,0.0014484404281270083,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
193,0.1,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea reduce aerobic fitness? Yes, it does by decreasing the maximum aerobic capacity due to frequent sleep disturbances, which cause daytime fatigue and less endurance for aerobic activities. Long-term sleep deprivation also affects heart health, further diminishing aerobic fitness.",1.6580180914979784e-07,0.042104414110259114,0.08264462809917357,0.012693985253473108,0.13177252289144326,0.0212665406427221,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
193,0.1,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness compromised by obstructive sleep apnea? Yes, obstructive sleep apnea can lower maximum aerobic capacity as a result of frequent sleep interruptions, leading to daytime tiredness and reduced stamina for aerobic exercises. Chronic sleep deprivation also negatively impacts cardiovascular health, further decreasing aerobic fitness.",7.105791820705622e-08,0.020179467597532863,0.06043388429752068,0.005440279394345618,0.0364623430871176,0.0212665406427221,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
194,0.1,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for laparoscopic surgery for GERD? No, advanced age itself is not a contraindication for GERD laparoscopic surgery. However, the patient's general health, existing comorbidities, and surgical tolerance are crucial considerations.",1.8948778188548261e-07,0.16859414136379058,0.029464681375697466,0.014507411718254995,0.15763725250689387,0.04244124394044323,0.014486412327622954,0.1538288332582156,0.049861495844875335,1.8948778188548325e-07,0.19402843238501388,0.025623268698060954
194,0.1,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age contraindicate laparoscopic surgery for GERD? No, being elderly is not a contraindication for GERD laparoscopic surgery. Nonetheless, the patient's overall health status, other medical conditions, and capacity to withstand surgery must be evaluated.",1.6580180914979731e-07,0.017286513803490777,0.11687363038714388,0.012693985253473115,0.08577536932327634,0.07271468144044323,0.01267561078667008,0.12305717459146193,0.049861495844875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
194,0.1,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is elderly age a reason to avoid GERD laparoscopic surgery? No, advanced age alone does not contraindicate GERD laparoscopic surgery. Still, the patient's overall health, presence of other illnesses, and ability to tolerate surgery are important factors.",1.42115836414112e-07,0.027623813534568775,0.08911852834632755,0.010880558788691236,0.05678783245002483,0.07271468144044323,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.1,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a barrier to performing laparoscopic surgery for GERD? No, advanced age is not a barrier to GERD laparoscopic surgery. However, the patient's general health, coexisting diseases, and surgical endurance are key factors to consider.",1.42115836414112e-07,0.10464016693011846,0.034229002287970337,0.010880558788691236,0.09639624276773606,0.04416796863767507,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.1,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does being of advanced age prevent GERD laparoscopic surgery? No, advanced age is not a reason to avoid GERD laparoscopic surgery. The patient's overall health condition, other diseases, and ability to handle surgery are important considerations.",1.6580180914979731e-07,0.09650333443891279,0.059940664363268774,0.012693985253473115,0.08577536932327634,0.07271468144044323,0.01267561078667008,0.12305717459146193,0.049861495844875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
194,0.1,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for GERD laparoscopic surgery? No, advanced age itself does not contraindicate GERD laparoscopic surgery. However, the patient's overall health, other medical issues, and surgical tolerance are important factors.",2.3685972735685321e-07,0.19354207006317203,0.05465140816492165,0.018134264647818754,0.17814868945429163,0.07271468144044323,0.0181080154095287,0.21836735439578714,0.049861495844875335,2.3685972735685406e-07,0.26071980688368734,0.025623268698060954
194,0.1,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is old age a contraindication to laparoscopic surgery for GERD? No, old age is not a contraindication for GERD laparoscopic surgery. But the patient's overall health, presence of other conditions, and ability to endure surgery are important factors.",1.1842986367842671e-07,0.036651492979484335,0.06299607936673571,0.009067132323909363,0.028616955483327988,0.07271468144044323,0.009054007704764333,0.06421667456852864,0.049861495844875335,1.1842986367842703e-07,0.10165511225399859,0.025623268698060954
194,0.1,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age rule out GERD laparoscopic surgery? No, advanced age does not rule out GERD laparoscopic surgery. However, the patient's general health, other diseases, and surgical endurance must be considered.",2.842316728282238e-07,0.3562764417800679,0.013303884405755556,0.021761117577382513,0.34044657161640535,0.004127575816300563,0.021729618491434448,0.33687073877987705,0.014196200920321159,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
194,0.1,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a limiting factor for GERD laparoscopic surgery? No, advanced age is not a limiting factor for GERD laparoscopic surgery. The patient's overall health, comorbidities, and ability to tolerate surgery are important considerations.",1.8948778188548261e-07,0.2909142320508402,0.05149371655163171,0.014507411718254995,0.28366401260870244,0.046191382768831474,0.014486412327622954,0.2837939296132066,0.04288523423835892,1.8948778188548325e-07,0.28346677826371636,0.03858600597494736
194,0.1,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for laparoscopic surgery in GERD patients? No, advanced age is not a contraindication for laparoscopic surgery in GERD patients. However, the patient's overall health, other illnesses, and capacity to endure surgery are important factors.",9.474389094274141e-08,0.19041842945702392,0.057944267635748975,0.0072537058591274906,0.1885550571222261,0.05912125605955677,0.007243206163811466,0.19007850439293117,0.059513504155124665,9.474389094274162e-08,0.19149280633388033,0.059337668801939046
195,0.1,1,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT showed strong correlations with traditional cardiovascular risk factors, yet no independent association was found between hsCRP levels and carotid IMT in healthy Korean adults.",0.0,0.07664736897684499,0.09787494194978598,0.0,0.06601401719618716,0.04721055725494473,0.0,0.06762411517657974,0.048652202498356334,0.0,0.03465735902799638,0.02498356344510192
195,0.1,2,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Korean individuals? While hsCRP levels and carotid IMT were closely associated with conventional cardiovascular risk factors, no independent relationship existed between hsCRP and carotid IMT in healthy Korean adults.",1.1842986367842682e-07,0.1405820632024266,0.011761520944379572,0.009067132323909363,0.16867952737185643,0.030082191115589622,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
195,0.1,3,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis among healthy Koreans? Both hsCRP and carotid IMT correlated strongly with standard cardiovascular risk factors, but hsCRP levels did not independently associate with carotid IMT in healthy Korean adults.",1.6580180914979742e-07,0.0872317389473305,0.06428960538850652,0.012693985253473108,0.14931454819586287,0.023795359904818555,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.1,4,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Are hsCRP levels linked to carotid atherosclerosis in healthy Korean adults? Although hsCRP and carotid IMT were strongly related to traditional cardiovascular risk factors, there was no independent association between hsCRP and carotid IMT in this population.",1.6580180914979742e-07,0.16424809234288018,0.009400079330149302,0.012693985253473108,0.2285313688312849,0.03313760611905655,0.012675610786670073,0.22798490565049567,0.029384756657483937,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.1,5,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT were strongly correlated with conventional cardiovascular risk factors, but no independent link was found between hsCRP levels and carotid IMT in healthy Korean adults.",4.737194547137081e-08,0.020106606766228108,0.019330025988879618,0.0036268529295637453,0.05044051459933652,0.0011882035402833654,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
195,0.1,6,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there an association between hsCRP and carotid atherosclerosis in healthy Korean adults? While hsCRP levels and carotid IMT were strongly correlated with traditional cardiovascular risk factors, no independent association was observed between hsCRP and carotid IMT in healthy Koreans.",9.474389094274152e-08,0.19537352920381146,0.11732168375525014,0.0072537058591274906,0.1765207416262502,0.05457198703395695,0.007243206163811466,0.1401215692254847,0.027006172839506164,9.474389094274162e-08,0.10536051565782589,0.0
195,0.1,7,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Korean adults? Both hsCRP and carotid IMT showed strong correlations with conventional cardiovascular risk factors, but no independent association was detected between hsCRP levels and carotid IMT in healthy Koreans.",9.474389094274152e-08,0.0753188823544737,0.01565581854043395,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
195,0.1,8,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does hsCRP correlate with carotid atherosclerosis in healthy Koreans? Although hsCRP levels and carotid IMT were strongly linked to traditional cardiovascular risk factors, no independent association was found between hsCRP and carotid IMT in healthy Korean adults.",1.6580180914979742e-07,0.16424809234288018,0.009400079330149302,0.012693985253473108,0.1889229585135741,0.004751352897949604,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.1,9,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean adults? Both hsCRP and carotid IMT were strongly associated with conventional cardiovascular risk factors, but no independent association existed between hsCRP levels and carotid IMT in healthy Koreans.",4.737194547137081e-08,0.06668081420243333,0.058430091694124844,0.0036268529295637453,0.05044051459933652,0.001188203540283362,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
195,0.1,10,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein independently associated with carotid atherosclerosis in healthy Koreans? While hsCRP levels and carotid IMT correlated strongly with traditional cardiovascular risk factors, no independent association was found between hsCRP and carotid IMT in healthy Korean adults.",1.1842986367842682e-07,0.10410063264663982,0.013677360490547338,0.009067132323909363,0.13121211220645312,0.003210812934687609,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
196,0.1,1,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux used in perioperative bridging? Yes, fondaparinux plays a role in perioperative bridging and is frequently chosen as an alternative to heparin for high-risk patients.",2.605457000925383e-07,0.227554004543832,0.095345198866921,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.1,2,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a role in perioperative bridging? Indeed, fondaparinux is utilized in perioperative bridging, commonly serving as a substitute for heparin in patients at high risk.",2.36859727356853e-07,0.18620053083498123,0.09687575442247653,0.018134264647818796,0.17803859535036892,0.11238293444328822,0.018108015409528735,0.2259866035811684,0.08740894901144641,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.1,3,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux applicable in perioperative bridging? Yes, fondaparinux is involved in perioperative bridging and is often preferred over heparin for patients with elevated risk.",3.079176455639089e-07,0.3157575069128655,0.09188732467041041,0.023574544042164434,0.3058719668602534,0.11238293444328822,0.023540420032387356,0.359517996205692,0.08740894901144641,3.0791764556391023e-07,0.41675744784461743,0.06035379812695108
196,0.1,4,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Can fondaparinux be used for perioperative bridging? Yes, fondaparinux is used in perioperative bridging and is frequently an alternative to heparin for high-risk individuals.",3.079176455639089e-07,0.25548383903808736,0.13527575442247655,0.023574544042164434,0.3058719668602534,0.11238293444328822,0.023540420032387356,0.359517996205692,0.08740894901144641,3.0791764556391023e-07,0.41675744784461743,0.06035379812695108
196,0.1,5,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is there a function for fondaparinux in perioperative bridging? Yes, fondaparinux serves a role in perioperative bridging and is commonly employed instead of heparin for patients at high risk.",1.894877818854824e-07,0.10828405768917193,0.09961045949792238,0.014507411718255037,0.10107755421423947,0.11238293444328822,0.014486412327622988,0.14594389590763113,0.08740894901144641,1.8948778188548325e-07,0.19361389653040773,0.06035379812695108
196,0.1,6,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a place in perioperative bridging? Yes, fondaparinux is part of perioperative bridging strategies and is often used as a heparin alternative for high-risk patients.",2.36859727356853e-07,0.13288151694575445,0.13527575442247655,0.018134264647818796,0.17803859535036892,0.11238293444328822,0.018108015409528735,0.2259866035811684,0.08740894901144641,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.1,7,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux relevant in perioperative bridging? Yes, fondaparinux is relevant and often used as an alternative to heparin in perioperative bridging for patients with significant risk.",2.605457000925383e-07,0.227554004543832,0.095345198866921,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.1,8,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux indicated for perioperative bridging? Yes, fondaparinux is indicated and frequently utilized as a substitute for heparin in high-risk perioperative bridging cases.",3.316036182995942e-07,0.2999356016089214,0.13527575442247655,0.025387970506946314,0.35239198249514736,0.11238293444328822,0.02535122157334023,0.4083081603751233,0.08740894901144641,3.316036182995956e-07,0.4680507422321676,0.06035379812695108
196,0.1,9,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux involved in perioperative bridging? Yes, fondaparinux is involved and commonly chosen over heparin for patients at high risk during perioperative bridging.",3.316036182995942e-07,0.2999356016089214,0.13527575442247655,0.025387970506946314,0.35239198249514736,0.11238293444328822,0.02535122157334023,0.4083081603751233,0.08740894901144641,3.316036182995956e-07,0.4680507422321676,0.06035379812695108
196,0.1,10,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux play a role in perioperative bridging? Yes, fondaparinux plays a role and is often used as an alternative to heparin in patients with a high risk during perioperative bridging.",1.421158364141118e-07,0.03599048534241156,0.10198205644387964,0.010880558788691277,0.029618590232095787,0.11238293444328822,0.010864809245717241,0.07183592375390946,0.08740894901144641,1.4211583641411244e-07,0.11665285539427828,0.06035379812695108
197,0.1,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors significant in primary systemic vasculitis? Yes, they are crucial as exposure to infections, drugs, or harmful substances can provoke an abnormal immune reaction.",2.131737546211677e-07,0.1851646090609136,0.08740894901144641,0.016320838183036916,0.2764448110845992,0.0302734375,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
197,0.1,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors matter in primary systemic vasculitis? Indeed, they do, since contact with specific infections, medications, or toxic materials may initiate an abnormal immune response.",2.131737546211677e-07,0.1851646090609136,0.08740894901144641,0.016320838183036916,0.2764448110845992,0.0302734375,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
197,0.1,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the role of environmental factors important in primary systemic vasculitis? Yes, environmental influences are key, with exposure to certain infections, drugs, or hazardous agents triggering abnormal immune activity.",1.421158364141118e-07,0.07183592375390946,0.08740894901144641,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
197,0.1,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental influences relevant in primary systemic vasculitis? Yes, they significantly contribute, as exposure to infections, medications, or dangerous substances can cause an abnormal immune response.",2.131737546211677e-07,0.1851646090609136,0.08740894901144641,0.016320838183036916,0.2764448110845992,0.0302734375,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
197,0.1,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors have an impact on primary systemic vasculitis? Yes, they play an important role because exposure to infections, medications, or harmful materials can lead to an abnormal immune reaction.",9.47438909427412e-08,0.00284305226695869,0.08740894901144641,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.1,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is exposure to environmental factors important in primary systemic vasculitis? Yes, it is, since certain infections, drugs, or hazardous substances can trigger an abnormal immune response.",2.131737546211677e-07,0.1851646090609136,0.08740894901144641,0.016320838183036916,0.2764448110845992,0.0302734375,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
197,0.1,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors a key element in primary systemic vasculitis? Yes, they are, as contact with infections, medications, or toxic materials can provoke an abnormal immune reaction.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.1,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Does primary systemic vasculitis involve environmental factors? Yes, environmental factors are significant, with exposure to infections, medications, or harmful agents triggering abnormal immune responses.",2.605457000925383e-07,0.26854621799996403,0.08740894901144641,0.019947691112600675,0.36345618807422886,0.0302734375,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
197,0.1,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors influential in primary systemic vasculitis? Yes, they play a vital role because exposure to certain infections, drugs, or hazardous substances can cause abnormal immune activity.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.1,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the involvement of environmental factors important in primary systemic vasculitis? Yes, environmental factors are important, as exposure to infections, medications, or dangerous materials can initiate an abnormal immune response.",1.184298636784265e-07,0.08454785777436058,0.05297017350124232,0.009067132323909398,0.12229413125734023,0.0302734375,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
199,0.1,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Yes, grandmultiparity is recognized as an independent risk factor for adverse perinatal outcomes, potentially causing complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean rates.",1.421158364141119e-07,0.11378530095599926,0.029657881883242435,0.010880558788691243,0.11155222504483708,0.03504003058039032,0.010864809245717214,0.10888788769310054,0.04087069166896732,1.4211583641411244e-07,0.10572766404429723,0.0471498651489732
199,0.1,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Indeed, grandmultiparity is an independent risk factor for negative perinatal outcomes and may lead to issues such as postpartum hemorrhage, gestational diabetes, preeclampsia, and a higher likelihood of cesarean delivery.",4.7371945471370706e-08,0.15286192495507622,0.14204081632653065,0.0036268529295637453,0.12199350075243576,0.12244897959183673,0.003621603081905733,0.0895403035525173,0.1012244897959184,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
199,0.1,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Yes, it is considered an independent risk factor that can result in complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and elevated cesarean section rates.",1.894877818854825e-07,0.05620107974202382,0.11176737882653065,0.014507411718255002,0.04985675617422425,0.12244897959183673,0.01448641232762296,0.08739040460656167,0.1012244897959184,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
199,0.1,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Can grandmultiparity independently contribute to adverse perinatal outcomes? Yes, grandmultiparity is an independent risk factor associated with complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean deliveries.",3.316036182995943e-07,0.21486285517023873,0.14204081632653065,0.02538797050694628,0.2574961209524682,0.12244897959183673,0.025351221573340202,0.30250178422350826,0.1012244897959184,3.316036182995957e-07,0.3500880377110809,0.0783673469387755
199,0.1,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent contributor to adverse perinatal outcomes? Yes, it is regarded as an independent risk factor that may cause complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean rates.",2.131737546211678e-07,0.08828551715983934,0.11082333453672835,0.01632083818303688,0.08160545448880407,0.12244897959183673,0.016297213868575834,0.12018022742955337,0.1012244897959184,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
199,0.1,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity pose an independent risk for adverse perinatal outcomes? Yes, grandmultiparity is an independent risk factor linked to complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean section frequency.",2.605457000925384e-07,0.20192196358707237,0.07571428571428578,0.01994769111260064,0.19610008281919766,0.08801020408163264,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,0.1,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity independently associated with adverse perinatal outcomes? Yes, it is considered an independent risk factor that can lead to postpartum hemorrhage, gestational diabetes, preeclampsia, and a greater incidence of cesarean deliveries.",2.368597273568531e-07,0.07671251668942158,0.14204081632653065,0.01813426464781876,0.11439527731179577,0.12244897959183673,0.018108015409528708,0.15408177910523513,0.1012244897959184,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
199,0.1,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity a risk factor on its own for adverse perinatal outcomes? Yes, grandmultiparity independently increases the risk of complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean rates.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,0.1,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently elevate the risk of adverse perinatal outcomes? Yes, it is an independent risk factor that may result in postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean section rates.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,0.1,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for negative outcomes in the perinatal period? Yes, grandmultiparity is recognized as an independent risk factor that can cause complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and a higher rate of cesarean deliveries.",7.1057918207056e-08,0.017442146884457888,0.06367346938775514,0.005440279394345618,0.020390423339469166,0.06857142857142856,0.0054324046228586,0.023633152666627133,0.07346938775510208,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
200,0.1,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the estimation of basal metabolic rate in Chinese populations accurate with current prediction equations? Answer: Currently, the newly developed Singapore equation stands as the most precise BMR prediction formula for Chinese individuals and is suitable for a wide BMI spectrum, including overweight and obese categories.",2.3685972735685406e-08,0.021978906718775004,0.0,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
200,0.1,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are existing prediction equations valid for estimating basal metabolic rate in Chinese people? Answer: The Singapore equation, recently developed, is the most accurate BMR prediction method for Chinese and works well across a broad BMI range, including overweight and obese individuals.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.1,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Can current prediction equations accurately estimate basal metabolic rate in Chinese populations? Answer: The newly formulated Singapore equation is the most reliable BMR prediction tool for Chinese people and is applicable to a wide BMI range, covering overweight and obese groups.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.1,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How accurate are current basal metabolic rate prediction equations for Chinese individuals? Answer: The Singapore equation, developed recently, provides the most accurate BMR estimates for Chinese and is valid for a large BMI range, including those who are overweight or obese.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.1,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are the current basal metabolic rate prediction equations suitable for Chinese populations? Answer: To date, the Singapore equation is the most precise BMR prediction equation for Chinese and is applicable across a broad BMI range, including overweight and obese individuals.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.1,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the Singapore equation effective for estimating basal metabolic rate in Chinese people? Answer: Yes, it is currently the most accurate BMR prediction equation for Chinese and is valid for a wide BMI range, including overweight and obese categories.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
200,0.1,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Do current BMR prediction equations apply well to Chinese populations? Answer: The newly developed Singapore equation is the most accurate for predicting BMR in Chinese and is suitable for a large BMI range, including overweight and obese individuals.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
200,0.1,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: What is the best equation for estimating basal metabolic rate in Chinese individuals? Answer: The Singapore equation, recently developed, is the most accurate and applicable across a wide BMI range, including overweight and obese populations.",2.3685972735685353e-07,0.29092283859861734,0.02854671280276816,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
200,0.1,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are existing basal metabolic rate prediction formulas applicable to Chinese people? Answer: The Singapore equation is currently the most accurate BMR prediction formula for Chinese and works well for a broad BMI range, including those who are overweight or obese.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.1,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How well do current BMR prediction equations estimate basal metabolic rate in Chinese populations? Answer: The newly developed Singapore equation is the most accurate and applicable across a large BMI range, including overweight and obese individuals.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
201,0.1,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? A routinely placed ENBD tube did not enhance the clinical outcome, although it increased procedure time and patient discomfort, making the insertion unnecessary.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
201,0.1,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine insertion of an ENBD tube did not improve clinical progression and caused longer procedures and more discomfort, thus it is unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.1,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine insertion of a nasobiliary drainage tube required after endoscopic removal of stones from the common bile duct in patients with cholangitis due to choledocholithiasis? Routine ENBD tube placement did not benefit the clinical course and led to longer procedures and increased discomfort, so it is not needed.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
201,0.1,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Do patients with choledocholithiasis-induced cholangitis need a nasobiliary drainage tube routinely inserted after endoscopic clearance of the common bile duct? Routine ENBD tube insertion did not improve clinical outcomes but increased procedure duration and discomfort, making it unnecessary.",3.552895910352808e-07,0.3403258059372023,0.0,0.02720139697172809,0.3483066942682149,0.0,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
201,0.1,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube placement did not improve the clinical course and caused longer procedures and more discomfort, so it is unnecessary.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.1,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely placed after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine insertion of an ENBD tube did not improve clinical outcomes and increased procedure time and discomfort, thus it is unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.1,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine placement of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not enhance clinical outcomes but increased procedure time and discomfort, so it is unnecessary.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
201,0.1,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it required to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? Routine ENBD tube placement did not improve clinical progression and caused longer procedures and discomfort, making it unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.1,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct necessary in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube placement did not improve clinical outcomes and increased procedure time and discomfort, so it is unnecessary.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
201,0.1,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it advisable to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube insertion did not improve the clinical course and resulted in longer procedures and more discomfort, thus it is unnecessary.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
202,0.1,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears showing glandular cell abnormalities are frequently identified as abnormal through rapid prescreening, achieving a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected this way.",4.0266153650665085e-07,0.33096772122918905,0.08436992969172526,0.030828249901291876,0.370935064690455,0.06489994591671175,0.03078362619619878,0.412844896878676,0.04434829637641968,4.026615365066519e-07,0.45684607788847975,0.02271498107084911
202,0.1,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening often flags Pap smears with glandular cell abnormalities as abnormal, with a sensitivity rate of 36.4% at the AGC threshold. Importantly, certain AGC cases are detected during this process.",4.0266153650665085e-07,0.33096772122918905,0.08436992969172526,0.030828249901291876,0.370935064690455,0.06489994591671175,0.03078362619619878,0.412844896878676,0.04434829637641968,4.026615365066519e-07,0.45684607788847975,0.02271498107084911
202,0.1,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears that exhibit glandular cell abnormalities are commonly detected as abnormal by rapid prescreening, yielding a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are identified through this method.",3.5528959103528024e-07,0.2664292000916175,0.08436992969172526,0.027201396971728117,0.30424369019178155,0.06489994591671175,0.027162023114293034,0.3438520253917252,0.04434829637641968,3.552895910352811e-07,0.38538711390633607,0.02271498107084911
202,0.1,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening detects many Pap smears with glandular cell abnormalities as abnormal, with a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are found through this screening.",4.2634750924233615e-07,0.3648692729048708,0.08436992969172526,0.032641676366073756,0.406026384501724,0.06489994591671175,0.032594427737151654,0.44921254104955066,0.04434829637641968,4.263475092423373e-07,0.49458640587132674,0.02271498107084911
202,0.1,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears containing glandular cell abnormalities are often marked abnormal by rapid prescreening, resulting in a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are caught this way.",4.0266153650665085e-07,0.33096772122918905,0.08436992969172526,0.030828249901291876,0.370935064690455,0.06489994591671175,0.03078362619619878,0.412844896878676,0.04434829637641968,4.026615365066519e-07,0.45684607788847975,0.02271498107084911
202,0.1,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening frequently identifies Pap smears with glandular cell abnormalities as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected through this approach.",4.2634750924233615e-07,0.3648692729048708,0.08436992969172526,0.032641676366073756,0.406026384501724,0.06489994591671175,0.032594427737151654,0.44921254104955066,0.04434829637641968,4.263475092423373e-07,0.49458640587132674,0.02271498107084911
202,0.1,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears with glandular cell abnormalities are regularly detected as abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are identified in this manner.",3.7897556377096555e-07,0.29817789840619735,0.08436992969172526,0.029014823436509997,0.33703351301477324,0.06489994591671175,0.028972824655245907,0.377753577067407,0.04434829637641968,3.789755637709665e-07,0.42047843371760507,0.02271498107084911
202,0.1,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening flags many Pap smears with glandular cell abnormalities as abnormal, resulting in a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are detected during this screening.",4.0266153650665085e-07,0.33096772122918905,0.08436992969172526,0.030828249901291876,0.370935064690455,0.06489994591671175,0.03078362619619878,0.412844896878676,0.04434829637641968,4.026615365066519e-07,0.45684607788847975,0.02271498107084911
202,0.1,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Pap smears exhibiting glandular cell abnormalities are often recognized as abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are found through this method.",3.7897556377096555e-07,0.29817789840619735,0.08436992969172526,0.029014823436509997,0.33703351301477324,0.06489994591671175,0.028972824655245907,0.377753577067407,0.04434829637641968,3.789755637709665e-07,0.42047843371760507,0.02271498107084911
202,0.1,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Rapid prescreening commonly detects Pap smears with glandular cell abnormalities as abnormal, yielding a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are identified this way.",4.5003348197802145e-07,0.3999605927161398,0.08436992969172526,0.034455102830855636,0.4423940286725987,0.06489994591671175,0.03440522927810453,0.48695286903239765,0.04434829637641968,4.500334819780227e-07,0.5338071190246092,0.02271498107084911
203,0.1,1,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does treating migraines early reduce the time to peak headache intensity and lessen its severity? Yes, early migraine treatment can shorten the time to headache peak and decrease its severity by allowing medications to act before symptoms worsen.",3.789755637709662e-07,0.25121334958135666,0.07513946221210599,0.029014823436509962,0.2729354221000264,0.06731053852052367,0.028972824655245866,0.29493084411021275,0.05859375,3.789755637709665e-07,0.33021070636718797,0.039930555555555566
203,0.1,2,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early intervention in migraine treatment shorten the duration to headache peak and mitigate its severity? Indeed, early treatment helps by enabling medications to control symptoms more effectively before they escalate.",5.447773729207633e-07,0.3859990502326216,0.12901701323251416,0.04170880868998311,0.4506503538718887,0.09506564056134,0.04164843544191598,0.518074395424422,0.05859375,5.447773729207643e-07,0.5607343649790204,0.039930555555555566
203,0.1,3,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is early migraine treatment effective in reducing the time to headache peak and its severity? Yes, because starting treatment early allows the medication to better manage symptoms before they become intense.",5.447773729207633e-07,0.3859990502326216,0.12901701323251416,0.04170880868998311,0.4506503538718887,0.09506564056134,0.04164843544191598,0.518074395424422,0.05859375,5.447773729207643e-07,0.5607343649790204,0.039930555555555566
203,0.1,4,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does initiating migraine treatment early shorten the time until headache peak and reduce its severity? Yes, early treatment facilitates quicker symptom control, leading to a shorter peak time and less severe headache.",5.21091400185078e-07,0.3532092274096299,0.12901701323251416,0.03989538222520123,0.4167488021962069,0.09506564056134,0.03983763390096311,0.482983075613153,0.05859375,5.210914001850789e-07,0.5243667208081457,0.039930555555555566
203,0.1,5,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Will early migraine treatment decrease the time to headache peak and lessen headache severity? Yes, early intervention helps medications work more efficiently to control symptoms before they intensify.",6.158352911278192e-07,0.49135956589044705,0.12901701323251416,0.04714908808432875,0.5598496458368794,0.09506564056134,0.0470808400647746,0.6314030807314261,0.05859375,6.158352911278206e-07,0.6785174006354047,0.039930555555555566
203,0.1,6,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does early treatment of migraines lead to a shorter time to headache peak and milder severity? Yes, because early medication use can prevent symptoms from becoming severe by acting sooner.",5.684633456564486e-07,0.41990060190830336,0.12901701323251416,0.04352223515476499,0.4857416736831577,0.09506564056134,0.043459236982868854,0.5544420395952967,0.05859375,5.684633456564497e-07,0.5984746929618674,0.039930555555555566
203,0.1,7,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment shorten the time to peak headache and reduce its intensity? Yes, early intervention allows medications to control symptoms more effectively before they worsen.",6.395212638635045e-07,0.529099893873294,0.12901701323251416,0.04896251454911063,0.5990703589901618,0.09506564056134,0.048891641605727475,0.672225075251681,0.05859375,6.39521263863506e-07,0.7210770150542003,0.039930555555555566
203,0.1,8,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is it true that early migraine treatment reduces both the time to headache peak and its severity? Yes, early treatment enables medications to act before symptoms become severe, thus shortening peak time and reducing severity.",4.500334819780221e-07,0.2608359072786146,0.12901701323251416,0.034455102830855594,0.3214386223918817,0.09506564056134,0.034405229278104486,0.3845430027998997,0.05859375,4.500334819780227e-07,0.42258402649820326,0.039930555555555566
203,0.1,9,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does treating migraines at an early stage shorten the time to headache peak and decrease severity? Yes, early treatment allows for better symptom control by medications before they escalate.",5.921493183921339e-07,0.45499192171957237,0.12901701323251416,0.04533566161954687,0.5221093178540324,0.09506564056134,0.04527003852382173,0.5921823675781437,0.05859375,5.921493183921352e-07,0.6376954061151499,0.039930555555555566
203,0.1,10,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment both shorten the time to headache peak and reduce headache severity? Yes, because early intervention helps medications work more effectively to manage symptoms before they become severe.",5.447773729207633e-07,0.3859990502326216,0.12901701323251416,0.04170880868998311,0.4506503538718887,0.09506564056134,0.04164843544191598,0.518074395424422,0.05859375,5.447773729207643e-07,0.5607343649790204,0.039930555555555566
204,0.1,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does using oversized cups in cup-cage reconstruction offer initial stability in THA for osteoporotic acetabular fractures? Yes, employing oversized cups in cup-cage reconstruction can ensure initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, aiding in minimizing implant migration and encouraging bone ingrowth for durable fixation.",1.4211583641411244e-07,0.12070083306290558,0.0003440130188381574,0.010880558788691236,0.113329450111598,0.006342430522834466,0.0108648092457172,0.10522949854574604,0.014245453623580318,1.4211583641411244e-07,0.1316141743129382,0.002723310933406376
204,0.1,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Indeed, cup-cage reconstruction with oversized cups provides initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures by reducing implant migration risk and supporting bone ingrowth for long-term fixation.",1.8948778188548325e-07,0.14386673687275486,0.012429603259998617,0.014507411718254981,0.13312380309729566,0.023421550094518004,0.014486412327622933,0.1535575974000123,0.012192798185603794,1.8948778188548325e-07,0.14662749992237956,0.019991670137442734
204,0.1,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can cup-cage reconstruction using oversized cups ensure initial stability in THA for osteoporotic acetabular fractures? Yes, this technique offers initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, helping to prevent implant migration and facilitating bone ingrowth for sustained fixation.",2.8423167282822487e-07,0.15655960078438724,0.06628586650085416,0.02176111757738247,0.1717219408558064,0.06356005424964267,0.0217296184914344,0.18671725946998174,0.05859375,2.8423167282822487e-07,0.24671095847936098,0.019991670137442734
204,0.1,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction with oversized cups contribute to initial stability in THA for osteoporotic acetabular fractures? Yes, it does; this approach provides initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures by lowering the chance of implant migration and promoting bone ingrowth for long-lasting fixation.",1.6580180914979784e-07,0.026789376395996545,0.07653881111673315,0.012693985253473108,0.04623726985986831,0.06907325371809832,0.012675610786670066,0.06608927168136436,0.05859375,1.6580180914979784e-07,0.12309700251218514,0.019991670137442734
204,0.1,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? Yes, cup-cage reconstruction with oversized cups can deliver initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, reducing implant migration and encouraging bone ingrowth for permanent fixation.",2.1317375462116866e-07,0.17124063339543794,0.009309971687121582,0.016320838183036854,0.15904417620808253,0.02137684266519517,0.0162972138685758,0.17862330451244235,0.011093749999999986,2.1317375462116866e-07,0.20453710908972944,0.004383329862557267
204,0.1,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does the use of oversized cups in cup-cage reconstruction offer initial stability in THA for osteoporotic acetabular fractures? Yes, using oversized cups in cup-cage reconstruction can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, which helps decrease implant migration and supports bone ingrowth for long-term fixation.",9.474389094274162e-08,0.0693969122689726,0.0056572361984454644,0.0072537058591274906,0.06449132862251261,0.01066330239305778,0.007243206163811466,0.05912255329892524,0.01612461419753087,9.474389094274162e-08,0.08579255565404154,0.0017367249242856639
204,0.1,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can initial stability be achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Yes, this method ensures initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures by mitigating implant migration risk and fostering bone ingrowth for lasting fixation.",2.3685972735685406e-07,0.10264093642986971,0.07066190414092506,0.018134264647818726,0.11963107582656463,0.06592155009451799,0.018108015409528666,0.17051889648360818,0.03421875,2.3685972735685406e-07,0.19541766409181127,0.019991670137442734
204,0.1,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is cup-cage reconstruction with oversized cups effective in providing initial stability in THA for osteoporotic acetabular fractures? Yes, it is effective; this technique offers initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures by reducing implant migration and aiding bone ingrowth for durable fixation.",1.8948778188548325e-07,0.051447112798094885,0.07466377992241924,0.014507411718254981,0.07011042304639137,0.0680700761716155,0.014486412327622933,0.08907878990606388,0.05859375,1.8948778188548325e-07,0.14662749992237956,0.019991670137442734
204,0.1,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction using oversized cups help achieve initial stability in THA for osteoporotic acetabular fractures? Yes, it helps; cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures, lowering the risk of implant migration and promoting bone ingrowth for long-term fixation.",9.474389094274162e-08,0.012813468957956875,0.04264171162433118,0.0072537058591274906,0.022152068947480785,0.07183364839319474,0.007243206163811466,0.00013130388956827943,0.05859375,9.474389094274162e-08,0.055655721716652895,0.019991670137442734
204,0.1,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability in THA for osteoporotic acetabular fractures attainable with cup-cage reconstruction and oversized cups? Yes, initial stability is attainable; cup-cage reconstruction with oversized cups provides this stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures by minimizing implant migration and encouraging bone ingrowth for sustained fixation.",1.1842986367842703e-07,0.03696922136763092,0.040257631978411146,0.009067132323909363,0.00013032461304751664,0.07095241429204888,0.009054007704764333,0.05177434304792028,0.0368653549382716,1.1842986367842703e-07,0.0776346284354279,0.019991670137442734
205,0.1,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging required to diagnose appendicitis in children? Yes, imaging is frequently needed to confirm appendicitis in pediatric patients, often involving ultrasound or CT scans to detect appendix inflammation.",4.0266153650665063e-07,0.43154886841759543,0.030661235687690712,0.03082824990129189,0.4253393878630276,0.045351473922902494,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
205,0.1,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do children need imaging for appendicitis diagnosis? Yes, imaging such as ultrasound or CT scans is commonly used to identify inflammation of the appendix in children.",4.7371945471370653e-07,0.4953670408274604,0.06632653061224489,0.03626852929563753,0.5431224235194119,0.045351473922902494,0.036216030819057415,0.5934664960174385,0.023242630385487524,4.737194547137081e-07,0.6466271649250523,0.0
205,0.1,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging essential for diagnosing appendicitis in kids? Yes, diagnostic imaging like ultrasound or CT scans is often utilized to verify appendix inflammation in children.",4.974054274493918e-07,0.5361890353477152,0.06632653061224489,0.03808195576041941,0.5856820379382075,0.045351473922902494,0.03802683236001029,0.6379182585882726,0.023242630385487524,4.974054274493935e-07,0.6931471805599463,0.0
205,0.1,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Should imaging be performed to diagnose appendicitis in children? Yes, imaging tests including ultrasound or CT scans are typically necessary to detect an inflamed appendix in pediatric cases.",4.2634750924233593e-07,0.41840599969133097,0.06632653061224489,0.03264167636607377,0.4630797158458746,0.045351473922902494,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
205,0.1,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is it necessary to use imaging to diagnose appendicitis in children? Yes, imaging methods such as ultrasound or CT scans are often required to confirm inflammation of the appendix in children.",3.5528959103528003e-07,0.3130454840335055,0.06632653061224489,0.02720139697172813,0.3538804238808839,0.045351473922902494,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
205,0.1,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do we rely on imaging to diagnose appendicitis in children? Yes, imaging techniques like ultrasound or CT scans are frequently employed to identify appendix inflammation in children.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
205,0.1,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging a part of diagnosing appendicitis in children? Yes, imaging, including ultrasound or CT scans, is often needed to determine if the appendix is inflamed in children.",4.2634750924233593e-07,0.41840599969133097,0.06632653061224489,0.03264167636607377,0.4630797158458746,0.045351473922902494,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
205,0.1,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Are imaging studies needed to diagnose appendicitis in children? Yes, imaging such as ultrasound or CT scans is commonly necessary to detect inflammation of the appendix in pediatric patients.",4.0266153650665063e-07,0.3820383555204563,0.06632653061224489,0.03082824990129189,0.4253393878630276,0.045351473922902494,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
205,0.1,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Does diagnosing appendicitis in children require imaging? Yes, imaging tests like ultrasound or CT scans are often essential to confirm appendix inflammation in children.",5.210914001850771e-07,0.5787486497665109,0.06632653061224489,0.03989538222520129,0.6301338005090416,0.045351473922902494,0.03983763390096316,0.6844382742231665,0.023242630385487524,5.210914001850789e-07,0.7419373447293776,0.0
205,0.1,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging commonly used to diagnose appendicitis in children? Yes, imaging methods including ultrasound or CT scans are frequently necessary to identify an inflamed appendix in children.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
206,0.1,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function forecast frequency compressed speech recognition in individuals with normal hearing and cognition? Yes, cognitive function indeed forecasts frequency compressed speech recognition in such listeners. Cognitive skills, especially working memory, are crucial for effectively processing frequency-compressed speech, aiding comprehension.",3.316036182995957e-07,0.16532597400812588,0.0816326530612245,0.025387970506946217,0.15180332140472297,0.10208596238206838,0.025351221573340132,0.14668485746509496,0.11302572628514579,3.316036182995957e-07,0.1409171962463036,0.12442703429948786
206,0.1,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is frequency compressed speech recognition in listeners with normal hearing and cognition predicted by cognitive function? Yes, cognitive function predicts this recognition. Working memory and other cognitive abilities significantly influence the effective use of frequency-compressed speech, enhancing understanding.",4.026615365066516e-07,0.07000072033785099,0.20408163265306123,0.030828249901291835,0.12520800129980492,0.17847485127095727,0.030783626196198732,0.15596009459049487,0.16549486208761494,4.026615365066519e-07,0.18800716910896487,0.15143320713899402
206,0.1,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Can cognitive function predict how well listeners with normal hearing and cognition recognize frequency compressed speech? Yes, it can. Cognitive abilities, notably working memory, are key factors in successfully interpreting frequency-compressed speech, leading to improved comprehension.",4.500334819780222e-07,0.12557057149266315,0.20408163265306123,0.03445510283085559,0.18236641513975327,0.17847485127095727,0.03440522927810448,0.21480059461342815,0.16549486208761494,4.500334819780227e-07,0.24863179092540033,0.15143320713899402
206,0.1,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive ability determine frequency compressed speech recognition in people with normal hearing and cognition? Yes, cognitive ability does determine this recognition. Working memory and related cognitive functions play an important role in the effective use of frequency-compressed speech, supporting better understanding.",3.079176455639103e-07,0.0011586238660585835,0.17970663265306122,0.023574544042164344,0.019847485641979024,0.17847485127095727,0.023540420032387266,0.04774650995026386,0.16549486208761494,3.079176455639103e-07,0.07678153399874033,0.15143320713899402
206,0.1,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is there a predictive relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? Yes, cognitive function predicts this ability. Cognitive skills, particularly working memory, are essential for the successful processing of frequency-compressed speech, facilitating comprehension.",3.079176455639103e-07,0.0011586238660585835,0.17970663265306122,0.023574544042164344,0.019847485641979024,0.17847485127095727,0.023540420032387266,0.04774650995026386,0.16549486208761494,3.079176455639103e-07,0.07678153399874033,0.15143320713899402
206,0.1,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function serve as a predictor for frequency compressed speech recognition in individuals with normal hearing and cognition? Yes, it serves as a predictor. Cognitive abilities, especially working memory, significantly contribute to the effective use of frequency-compressed speech, improving understanding.",3.316036182995957e-07,0.026696537896136796,0.17909806920795932,0.025387970506946217,0.04516529362627075,0.17847485127095727,0.025351221573340132,0.07372199635352183,0.16549486208761494,3.316036182995957e-07,0.1034497810809012,0.15143320713899402
206,0.1,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Can cognitive function be used to predict frequency compressed speech recognition in listeners with normal hearing and cognition? Yes, cognitive function can predict this. Working memory and other cognitive faculties play a vital role in the successful interpretation of frequency-compressed speech, aiding comprehension.",2.8423167282822487e-07,0.02374397670319972,0.18028627274824266,0.02176111757738247,0.004845126948392675,0.17847485127095727,0.0217296184914344,0.02242870196597213,0.16549486208761494,2.8423167282822487e-07,0.05080604759548235,0.15143320713899402
206,0.1,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is frequency compressed speech recognition in normal hearing and cognitively normal listeners influenced by cognitive function? Yes, it is influenced by cognitive function. Cognitive abilities, particularly working memory, are important for effectively using frequency-compressed speech, enhancing understanding.",4.263475092423369e-07,0.174416047921516,0.14871831085375325,0.03264167636607371,0.192987288584213,0.14992813846818911,0.032594427737151606,0.18494763146374638,0.16549486208761494,4.263475092423373e-07,0.21786013225864664,0.15143320713899402
206,0.1,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function influence the recognition of frequency compressed speech in listeners with normal hearing and cognition? Yes, cognitive function influences this recognition. Working memory and cognitive skills are key to successfully processing frequency-compressed speech, contributing to better comprehension.",3.789755637709663e-07,0.07981390381147646,0.17778506581595385,0.029014823436509962,0.0978090271116896,0.17847485127095727,0.028972824655245866,0.12778921762379802,0.16549486208761494,3.789755637709665e-07,0.15901963223571336,0.15143320713899402
206,0.1,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is the ability to recognize frequency compressed speech in listeners with normal hearing and normal cognition predicted by cognitive function? Yes, cognitive function predicts this ability. Cognitive capacities, especially working memory, play a significant role in the effective use of frequency-compressed speech, leading to improved understanding.",2.1317375462116866e-07,0.12574385678824296,0.20408163265306123,0.016320838183036854,0.07546269416234663,0.17847485127095727,0.0162972138685758,0.049891959613654,0.16549486208761494,2.1317375462116866e-07,0.023301924558241094,0.15143320713899402
207,0.1,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest correlation with bone turnover parameters in iliac cancellous bone. However, the iliac crest bone may not fully represent overall bone turnover.",4.737194547137081e-08,0.05158725722269075,0.005690704908203684,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.1,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? There was a significant but modest association between bone turnover markers and bone turnover parameters in iliac cancellous bone, though the iliac crest may not perfectly represent total bone turnover.",4.737194547137081e-08,0.018580248624596063,0.019097263533610936,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.1,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"In 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry? Bone turnover markers were significantly but modestly linked to bone turnover parameters in iliac cancellous bone, but the iliac crest might not accurately reflect whole bone turnover.",9.474389094274162e-08,0.10595138713869723,0.011963729892247338,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
207,0.1,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover a good representation of bone histomorphometry in 370 postmenopausal women? Bone turnover markers correlated significantly yet modestly with bone turnover parameters in iliac cancellous bone, though the iliac crest may not fully represent overall bone turnover.",7.105791820705622e-08,0.07840381648300676,0.008748996854200664,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
207,0.1,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant but modest association with bone turnover parameters in iliac cancellous bone, but the iliac crest bone may not perfectly represent total bone turnover.",4.737194547137081e-08,0.018580248624596063,0.019097263533610936,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.1,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? There was a significant yet modest relationship between bone turnover markers and bone turnover parameters in iliac cancellous bone, although the iliac crest may not fully represent whole bone turnover.",2.3685972735685406e-08,0.025464217604785677,0.002777736466389097,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
207,0.1,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"In 370 postmenopausal women, do biochemical markers of bone turnover represent bone histomorphometry? Bone turnover markers were significantly but modestly associated with bone turnover parameters in iliac cancellous bone, but the iliac crest may not be a perfect representation of overall bone turnover.",4.737194547137081e-08,0.018580248624596063,0.019097263533610936,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.1,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant but modest association with bone turnover parameters in iliac cancellous bone, though the iliac crest may not perfectly reflect total bone turnover.",7.105791820705622e-08,0.07840381648300676,0.008748996854200664,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
207,0.1,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly yet modestly linked to bone turnover parameters in iliac cancellous bone, but the iliac crest bone may not fully represent whole bone turnover.",7.105791820705622e-08,0.04459175889471645,0.01666300975320327,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
207,0.1,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant but modest correlation with bone turnover parameters in iliac cancellous bone, although the iliac crest may not perfectly represent overall bone turnover.",7.105791820705622e-08,0.07840381648300676,0.008748996854200664,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
208,0.1,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Can severe hypotensive episodes trigger myocardial ischemic events in patients with coronary disease? Answer: In individuals with ischemic heart disease and low blood pressure, both symptomatic and silent ischemia were observed in a time-related manner with hypotension, especially concerning diastolic pressures, indicating that coronary disease patients might be vulnerable to ischemic events caused by hypotension.",0.0,0.0851296586749859,0.09331999563320849,0.0,0.051344235597033716,0.036982248520710054,0.0,0.0,0.0,0.0,0.0,0.0
208,0.1,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Does profound hypotension lead to myocardial ischemic events in patients with coronary artery disease? Answer: Among patients with ischemic heart disease experiencing hypotension, there was a temporal association between hypotension and both symptomatic and silent ischemia, particularly linked to diastolic blood pressure, suggesting susceptibility to ischemic events due to hypotensive episodes.",9.474389094274162e-08,0.019537026562597593,0.07234522460444759,0.0072537058591274906,0.025616805539096177,0.036982248520710054,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
208,0.1,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Can significant hypotensive events cause myocardial ischemia in coronary disease patients? Answer: In patients with ischemic heart disease and hypotension, symptomatic and silent ischemic episodes occurred in close temporal relation to hypotension, especially with low diastolic pressures, implying that those with coronary disease may be prone to ischemic events triggered by hypotension.",7.105791820705622e-08,0.027586037099691207,0.09227220299884659,0.005440279394345618,0.005814178242916412,0.036982248520710054,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
208,0.1,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Is there a causal link between profound hypotension and myocardial ischemic events in patients with coronary disease? Answer: Patients with ischemic heart disease and hypotension showed symptomatic and silent ischemia temporally associated with hypotension, particularly diastolic hypotension, suggesting that coronary disease patients may be at risk of ischemic events due to hypotensive episodes.",4.737194547137081e-08,0.020980744255756356,0.07381776239907728,0.0036268529295637453,0.013603907614186284,0.036982248520710054,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
208,0.1,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Could severe hypotensive episodes induce myocardial ischemic events in individuals with coronary disease? Answer: In ischemic heart disease patients experiencing hypotension, both symptomatic and silent ischemia were temporally related to hypotensive episodes, especially involving diastolic pressure, indicating a potential susceptibility to ischemic events from hypotension.",2.3685972735685406e-07,0.12114222612502346,0.0892848348219534,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.1,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Are myocardial ischemic events caused by profound hypotension in patients with coronary artery disease? Answer: In patients with ischemic heart disease and hypotension, symptomatic and silent ischemia occurred in a time-dependent manner with hypotension, particularly affecting diastolic pressures, suggesting vulnerability to ischemic events due to hypotensive episodes.",1.8948778188548325e-07,0.13533744694110084,0.04796252077236664,0.014507411718254981,0.1391352484155357,0.015253853458981656,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
208,0.1,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Does hypotension provoke myocardial ischemic events in coronary disease patients? Answer: Symptomatic and silent ischemia were temporally linked to hypotension in patients with ischemic heart disease, especially with low diastolic pressures, indicating that coronary disease patients may be susceptible to ischemic events triggered by hypotension.",2.3685972735685406e-07,0.15194876748324315,0.06714728224718661,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.1,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Can profound hypotensive events result in myocardial ischemia in patients with coronary disease? Answer: In ischemic heart disease patients with hypotension, symptomatic and silent ischemia occurred in a temporal causal relationship with hypotension, particularly diastolic hypotension, suggesting susceptibility to ischemic events caused by hypotension.",2.6054570009253947e-07,0.1758219206697662,0.0661441047007038,0.0199476911126006,0.1764396952736793,0.036982248520710054,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
208,0.1,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Is myocardial ischemia caused by severe hypotension in patients with coronary disease? Answer: Patients with ischemic heart disease and hypotension experienced symptomatic and silent ischemia temporally associated with hypotension, especially diastolic pressure drops, indicating that coronary disease patients may be prone to ischemic events due to hypotension.",1.8948778188548325e-07,0.07634619753174388,0.09022903798088419,0.014507411718254981,0.10899841447814707,0.036982248520710054,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
208,0.1,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Question: Do profound hypotensive events cause myocardial ischemic episodes in coronary disease patients? Answer: In patients with ischemic heart disease and hypotension, symptomatic and silent ischemia were temporally related to hypotension, particularly diastolic hypotension, suggesting that those with coronary disease may be vulnerable to ischemic events resulting from hypotensive episodes.",1.4211583641411244e-07,0.03346959808200456,0.09109627306805074,0.010880558788691236,0.06643880005935054,0.036982248520710054,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
209,0.1,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive ability forecast how well listeners with normal hearing and cognition recognize frequency compressed speech? The link between cognitive function and recognizing frequency compressed speech in noisy environments was not statistically significant. Results might have differed if participants had received training or time to acclimate to frequency-compressed conditions.,1.4211583641411244e-07,0.12099205038119809,0.0023119762659021027,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
209,0.1,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive function a predictor of frequency compressed speech recognition in individuals with normal hearing and cognition? No significant statistical relationship was found between cognitive function and recognition of frequency compressed speech in noise. The outcomes could have changed if participants were given training or time to adapt to frequency-compressed speech.,9.474389094274162e-08,0.16219247222720412,0.06088315911386638,0.0072537058591274906,0.1350550587525099,0.040742417383431435,0.007243206163811466,0.10892384019686752,0.020823902218198284,9.474389094274162e-08,0.0816780310142673,0.0
209,0.1,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive functioning predict how often listeners with normal hearing and cognition recognize frequency compressed speech? The study found no statistically significant correlation between cognitive function and recognition of frequency compressed speech in noise. Different results might have emerged if participants had training or acclimatization time.,2.1317375462116866e-07,0.18745598035365862,0.00369881784935671,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
209,0.1,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive performance influence recognition of frequency compressed speech in listeners with normal hearing and cognition? There was no statistically significant association between cognitive function and frequency compressed speech recognition in noise. The findings might have varied if participants had been trained or allowed time to acclimate.,1.8948778188548325e-07,0.19494420015144165,0.024876503799769942,0.014507411718254981,0.19443596514002115,0.02221074380165289,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
209,0.1,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,"Is there a predictive relationship between cognitive function and frequency compressed speech recognition in normal hearing, cognitively normal listeners? Cognitive function did not significantly predict recognition of frequency compressed speech in noise. The results might have differed if participants had training or time to get used to frequency-compressed conditions.",1.4211583641411244e-07,0.17875431542786036,0.043710296269926036,0.010880558788691236,0.14963993654674157,0.0212665406427221,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
209,0.1,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive ability predict recognition of frequency compressed speech in noise among listeners with normal hearing and cognition? The relationship was not statistically significant. The findings could have been different if participants had training or time to acclimatize to frequency compressed speech.,3.079176455639103e-07,0.28355191964974047,0.005863074047703819,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
209,0.1,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive function predict how well normal hearing and cognitively normal listeners recognize frequency compressed speech? No significant statistical link was found between cognitive function and recognition of frequency compressed speech in noise. The findings might have changed if participants had been given training or time to acclimate.,1.6580180914979784e-07,0.17215557646505752,0.02395720985017295,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
209,0.1,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive functioning a predictor of frequency compressed speech recognition in listeners with normal hearing and cognition? The study showed no statistically significant relationship between cognitive function and recognition of frequency compressed speech in noise. Different outcomes might have resulted if participants had training or acclimatization time.,1.8948778188548325e-07,0.2250810340888303,0.046388019964415564,0.014507411718254981,0.22524250649824085,0.04434829637641968,0.014486412327622933,0.19856077468861866,0.02271498107084911,1.8948778188548325e-07,0.1706255170307629,0.0
209,0.1,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive function forecast recognition of frequency compressed speech in noise in listeners with normal hearing and cognition? There was no significant statistical relationship found. The results might have been different if participants had training or time to acclimate to frequency compressed speech.,2.8423167282822487e-07,0.25864931908048217,0.005283433952522374,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
209,0.1,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,"Is cognitive function linked to frequency compressed speech recognition in normal hearing, cognitively normal listeners? The relationship was not statistically significant. The findings might have differed if participants had been provided training or time to acclimatize to frequency compressed speech.",3.55289591035281e-07,0.3708423011550823,0.032620287342079266,0.02720139697172809,0.36918718438152087,0.026296566837107373,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
210,0.1,1,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Answer: The findings suggest that major blunt trauma boosts the migratory ability of circulating neutrophils. This effect appears within 2 hours of admission and may result from changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who subsequently develop ARDS show initially elevated levels.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
210,0.1,2,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is heightened neutrophil migration after significant trauma a factor in causing acute respiratory distress syndrome? Answer: Data show that major blunt trauma increases the migratory capacity of circulating neutrophils, evident within 2 hours of admission, possibly due to modifications in interleukin-8 receptor expression, affinity, or signaling pathways. Those who develop ARDS later have initially elevated levels.",1.4211583641411244e-07,0.10178269430994202,0.0,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
210,0.1,3,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Could increased neutrophil migration post-major trauma play a role in acute respiratory distress syndrome etiology? Answer: Evidence indicates that major blunt trauma enhances circulating neutrophils' migratory capacity within 2 hours of admission, potentially linked to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients developing ARDS later exhibit initially elevated levels.",2.3685972735685406e-07,0.1758906664636637,0.0,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
210,0.1,4,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does major trauma-induced neutrophil migration contribute to acute respiratory distress syndrome? Answer: The data reveal that major blunt trauma augments the migratory ability of circulating neutrophils within 2 hours of admission, possibly due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS later show initially elevated levels.",2.3685972735685406e-07,0.1758906664636637,0.0,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
210,0.1,5,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is the increase in neutrophil migratory activity after major trauma a factor in acute respiratory distress syndrome development? Answer: Findings indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils within 2 hours of admission, which may be due to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who later develop ARDS have initially elevated levels.",4.737194547137081e-08,0.03278982282299214,0.0,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
210,0.1,6,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does enhanced neutrophil migration following major trauma contribute to the onset of acute respiratory distress syndrome? Answer: Data suggest that major blunt trauma increases the migratory capacity of circulating neutrophils within 2 hours of admission, possibly through alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS later show initially elevated levels.",1.6580180914979784e-07,0.1198011998126205,0.0,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
210,0.1,7,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is increased neutrophil migratory activity after severe trauma involved in the pathogenesis of acute respiratory distress syndrome? Answer: The evidence shows that major blunt trauma boosts the migratory capacity of circulating neutrophils within 2 hours of admission, potentially due to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who develop ARDS later have initially elevated levels.",9.474389094274162e-08,0.06669137449867257,0.0,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
210,0.1,8,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Could the rise in neutrophil migration after major trauma be a factor in acute respiratory distress syndrome? Answer: Findings demonstrate that major blunt trauma enhances the migratory ability of circulating neutrophils within 2 hours of admission, possibly linked to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS later exhibit initially elevated levels.",1.1842986367842703e-07,0.0840831172105414,0.0,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
210,0.1,9,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is the increased migratory activity of neutrophils post-major trauma a contributing factor to acute respiratory distress syndrome? Answer: Data indicate that major blunt trauma increases the migratory capacity of circulating neutrophils within 2 hours of admission, which may be due to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who later develop ARDS show initially elevated levels.",7.105791820705622e-08,0.04959694113937285,0.0,0.005440279394345618,0.05043085362689137,0.0,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
210,0.1,10,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does major blunt trauma-induced neutrophil migration play a role in the etiology of acute respiratory distress syndrome? Answer: The data suggest that major blunt trauma enhances the migratory capacity of circulating neutrophils within 2 hours of admission, possibly due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS later have initially elevated levels.",9.474389094274162e-08,0.09059300141453264,0.017236072637734686,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
211,0.1,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",Master of Public Health (MPH) programs play a crucial role in strengthening health systems in low- and middle-income countries by building capacity among local health workers with vital public health skills.,9.711248821631006e-07,0.751490125881856,0.07756546049960925,0.07435048505605685,0.7623741811097529,0.0849609375,0.07424286317906759,0.8014458812974254,0.072021484375,9.711248821631017e-07,0.8421241120470788,0.05859375
211,0.1,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In low- and middle-income countries, MPH programs significantly bolster health systems by training health professionals in essential public health practices, policy formulation, and disease prevention.",1.1132407185772124e-06,0.9284238651587362,0.11085915847820617,0.08523104384474813,0.9941757951670764,0.0849609375,0.08510767242478481,1.042607938114314,0.072021484375,1.113240718577214e-06,1.0934385403279867,0.05859375
211,0.1,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",MPH programs contribute greatly to health system enhancement in low- and middle-income countries by equipping local health practitioners with necessary skills and supporting policy and management improvements.,1.0658687731058418e-06,0.8483811574851989,0.11085915847820617,0.08160419091518437,0.910794186228026,0.0849609375,0.08148606934287908,0.9555965611246844,0.072021484375,1.0658687731058433e-06,1.0024667621222587,0.05859375
211,0.1,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","The impact of MPH programs in low- and middle-income countries includes strengthening health systems through capacity building, policy development, and improved healthcare management.",1.160612664048583e-06,1.015435242148366,0.11085915847820617,0.08885789677431188,1.0851475733728044,0.0849609375,0.08872927550669057,1.1379181179186393,0.072021484375,1.1606126640485847e-06,1.1935219988849681,0.05859375
211,0.1,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","By providing essential public health training, MPH programs help strengthen health systems in low- and middle-income countries, leading to better health outcomes and reduced disparities.",1.1132407185772124e-06,0.9284238651587362,0.11085915847820617,0.08523104384474813,0.9941757951670764,0.0849609375,0.08510767242478481,1.042607938114314,0.072021484375,1.113240718577214e-06,1.0934385403279867,0.05859375
211,0.1,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",Health system strengthening in low- and middle-income countries is significantly supported by MPH programs that develop local health professionals' skills and aid in policy and disease prevention efforts.,1.0421828003701566e-06,0.810640829502352,0.11085915847820617,0.07979076445040248,0.8715734730747435,0.0849609375,0.0796752678019262,0.9147745666044296,0.072021484375,1.0421828003701579e-06,0.9599071477034631,0.05859375
211,0.1,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","MPH programs enhance health systems in low- and middle-income countries by fostering capacity building, improving healthcare management, and supporting disease prevention strategies.",1.1842986367842682e-06,1.0619552577832598,0.11085915847820617,0.09067132323909377,1.1339377375422357,0.0849609375,0.09054007704764344,1.1892114123061894,0.072021484375,1.18429863678427e-06,1.2475892201552434,0.05859375
211,0.1,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In low- and middle-income countries, MPH programs contribute to health system strengthening by equipping health workers with critical skills and facilitating policy and management advancements.",1.1132407185772124e-06,0.9284238651587362,0.11085915847820617,0.08523104384474813,0.9941757951670764,0.0849609375,0.08510767242478481,1.042607938114314,0.072021484375,1.113240718577214e-06,1.0934385403279867,0.05859375
211,0.1,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","The role of MPH programs in low- and middle-income countries includes capacity building, policy development, and disease prevention, all of which strengthen health systems and improve health equity.",1.0421828003701566e-06,0.810640829502352,0.11085915847820617,0.07979076445040248,0.8715734730747435,0.0849609375,0.0796752678019262,0.9147745666044296,0.072021484375,1.0421828003701579e-06,0.9599071477034631,0.05859375
211,0.1,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",MPH programs are instrumental in strengthening health systems in low- and middle-income countries by training local health professionals and supporting effective healthcare policies and disease control.,1.089554745841527e-06,0.8876018706384814,0.11085915847820617,0.08341761737996625,0.9516161807482808,0.0849609375,0.08329687088383195,0.99815617554348,0.072021484375,1.0895547458415287e-06,1.0469185246930928,0.05859375
212,0.1,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for polymorphisms in the beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: We conclude that homozygosity for beta1Gly49 and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may increase susceptibility to TTN.",1.1842986367842671e-07,0.0937446970410507,0.023795359904818555,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.1,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes contribute to transient tachypnea of the newborn (TTN)? Answer: Our findings suggest that beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, which are loss-of-function genetic variations, might predispose individuals to TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.1,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that the loss-of-function genetic variations beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene may predispose to TTN.,2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.1,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): Are polymorphisms in beta-adrenergic receptor (ADRB) genes implicated? Answer: It appears that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, could predispose to TTN.",4.73719454713706e-08,0.0951782614725234,0.02854671280276816,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
212,0.1,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a genetic role for beta-adrenergic receptor (ADRB) polymorphisms in transient tachypnea of the newborn (TTN)? Answer: We find that beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, both loss-of-function mutations, may increase the risk of TTN.",7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.1,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: Do polymorphisms in the beta-adrenergic receptor (ADRB) genes influence transient tachypnea of the newborn (TTN)? Answer: Our conclusion is that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic changes, may predispose to TTN.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
212,0.1,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Transient tachypnea of the newborn (TTN): Is there a connection to polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We conclude that loss-of-function variants beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene may predispose to TTN.,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.1,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes play a role in transient tachypnea of the newborn (TTN)? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, might predispose to TTN.",7.10579182070559e-08,0.04330418244171419,0.024983563445101917,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.1,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Question: Are polymorphisms in the beta-adrenergic receptor (ADRB) genes involved in transient tachypnea of the newborn (TTN)? Answer: We conclude that the loss-of-function genetic variations beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene may predispose to TTN.,4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
212,0.1,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): Does the beta-adrenergic receptor (ADRB) gene polymorphism have a role? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variants, may predispose to TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
213,0.1,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to diagnostic characteristics of child bipolar I disorder? Generalization of the RCT sample was supported since only 7.8% of Phenomenology subjects did not meet RCT criteria. However, because RCT subjects were more severely ill, it remains uncertain if RCT treatment findings apply to children with milder mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.1,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Regarding diagnostic features of child bipolar I disorder, does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? The RCT sample generalization was supported as only 7.8% of Phenomenology subjects failed to meet RCT criteria. Still, since RCT participants were more severely affected, it is unclear if RCT treatment results are relevant for children with less severe mania.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.1,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Questioning if the ""Treatment of Early Age Mania (TEAM)"" sample generalizes to child bipolar I disorder diagnostic traits: Generalization of the RCT sample was confirmed because only 7.8% of Phenomenology subjects did not fit RCT criteria. Yet, due to greater severity in RCT subjects, applicability of RCT treatment findings to children with milder mania is uncertain.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.1,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize regarding diagnostic characteristics of child bipolar I disorder? The RCT sample generalization was supported since only 7.8% of Phenomenology subjects were excluded by RCT criteria. However, because RCT subjects were more severely ill, it is unclear if RCT treatment findings apply to children with less severe mania.",1.8948778188548325e-07,0.07164325150310002,0.12727103928784791,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.1,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Is the ""Treatment of Early Age Mania (TEAM)"" sample generalizable to diagnostic features of child bipolar I disorder? Generalization of the RCT sample was supported as only 7.8% of Phenomenology subjects did not meet RCT criteria. Nonetheless, since RCT subjects were more severely ill, it is uncertain if RCT treatment findings apply to children with milder mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.1,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Regarding child bipolar I disorder diagnostic characteristics, does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? The RCT sample generalization was supported because only 7.8% of Phenomenology subjects failed to meet RCT criteria. Still, since RCT subjects were more severely ill, it is unclear if treatment findings from the RCT apply to children with less severe mania.",1.6580180914979784e-07,0.05350937165898717,0.12758401365114694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.1,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to child bipolar I disorder diagnostic characteristics? Generalization of the RCT sample was supported as only 7.8% of Phenomenology subjects did not fit RCT criteria. However, because RCT subjects were more severely ill, it is uncertain if RCT treatment findings will be applicable to children with milder mania.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.1,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Is the ""Treatment of Early Age Mania (TEAM)"" sample generalizable to diagnostic characteristics of child bipolar I disorder? The RCT sample generalization was supported since only 7.8% of Phenomenology subjects did not meet RCT criteria. Nevertheless, due to greater severity in RCT subjects, it is unclear if RCT treatment findings apply to children with less severe mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.1,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Regarding diagnostic characteristics of child bipolar I disorder, does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? Generalization of the RCT sample was supported because only 7.8% of Phenomenology subjects did not fit RCT criteria. However, since RCT subjects were more severely ill, it remains unclear if RCT treatment findings will be relevant for children with milder mania.",1.4211583641411244e-07,0.011796675243260779,0.1451222789572694,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.1,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to diagnostic features of child bipolar I disorder? The RCT sample generalization was supported as only 7.8% of Phenomenology subjects failed to meet RCT criteria. Still, because RCT subjects were more severely ill, it is uncertain if treatment findings from the RCT will apply to children with less severe mania.",1.1842986367842703e-07,0.01819875647921343,0.12817816480744776,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
214,0.1,1,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy effective for gallbladder carcinoma? It can help alleviate symptoms like pain and obstruction, but it has limited impact on survival due to the disease's advanced stage.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.1,2,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy work for gallbladder carcinoma? It is useful for symptom relief, including pain and obstruction, though it offers minimal survival benefit because the disease is usually advanced.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.1,3,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy manage gallbladder carcinoma effectively? It aids in symptom control such as pain and obstruction, but its effect on survival is limited given the advanced disease state.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.1,4,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",Is external palliative radiotherapy beneficial for gallbladder carcinoma? It helps manage symptoms like pain and obstruction but has a restricted role in extending survival due to the disease's progression.,3.7897556377096523e-07,0.29445167361579827,0.11176857330703485,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
214,0.1,5,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How effective is external palliative radiotherapy for gallbladder carcinoma? It can relieve symptoms including pain and obstruction, yet it has limited influence on survival because the disease is often advanced.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.1,6,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy provide effective symptom relief in gallbladder carcinoma? Yes, it can reduce pain and obstruction symptoms, but it does not significantly improve survival rates due to advanced disease.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.1,7,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",Is external palliative radiotherapy a good option for gallbladder carcinoma symptom management? It effectively controls pain and obstruction symptoms but has limited survival benefits because of the advanced disease stage.,3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.1,8,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",Can external palliative radiotherapy improve outcomes in gallbladder carcinoma? It is effective for symptom relief such as pain and obstruction but offers limited survival improvement due to the advanced nature of the cancer.,2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
214,0.1,9,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at",Is external palliative radiotherapy useful for gallbladder carcinoma? It helps manage symptoms like pain and obstruction but has a limited role in enhancing survival given the disease's advanced stage.,3.7897556377096523e-07,0.29445167361579827,0.11176857330703485,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
214,0.1,10,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How does external palliative radiotherapy affect gallbladder carcinoma? It can effectively manage symptoms including pain and obstruction, though its impact on survival is limited by the advanced disease condition.",3.7897556377096523e-07,0.29445167361579827,0.11176857330703485,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
215,0.1,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",Antral follicle assessment serves as a superior predictor of IVF outcomes compared to age and FSH levels.,1.3974723914054366e-06,1.334599576415418,0.2532544378698224,0.1069921614221307,1.4952754333267713,0.09619827767275783,0.10683729091621928,1.632411777819161,0.013695987654320991,1.3974723914054385e-06,1.7117167615545172,0.0
215,0.1,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","In predicting IVF success, antral follicle count outperforms maternal age and follicle-stimulating hormone measurements.",1.4685303096124926e-06,1.542238941193662,0.2532544378698224,0.11243244081647633,1.718418984640981,0.09619827767275783,0.11226969553907791,1.8735738346360487,0.013695987654320991,1.4685303096124945e-06,1.974081026022009,0.0
215,0.1,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",The evaluation of antral follicles is a more reliable indicator of in vitro fertilization results than age or FSH.,1.350100445934066e-06,1.2168165407590341,0.2532544378698224,0.10336530849256695,1.3701122903727656,0.09619827767275783,0.10321568783431354,1.4988803851946382,0.013695987654320991,1.350100445934068e-06,1.568615917913844,0.0
215,0.1,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","When forecasting IVF outcomes, antral follicle assessment provides better predictive value than age and FSH.",1.4448443368768074e-06,1.4681309690399407,0.2532544378698224,0.11061901435169445,1.6383762769674446,0.09619827767275783,0.11045889399812503,1.7865624576464185,0.013695987654320991,1.4448443368768091e-06,1.8787708462176838,0.0
215,0.1,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",Antral follicle count is a stronger predictor of IVF success than either maternal age or follicle-stimulating hormone.,1.3974723914054366e-06,1.334599576415418,0.2532544378698224,0.1069921614221307,1.4952754333267713,0.09619827767275783,0.10683729091621928,1.632411777819161,0.013695987654320991,1.3974723914054385e-06,1.7117167615545172,0.0
215,0.1,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Compared to age and FSH, antral follicle assessment more accurately predicts in vitro fertilization outcomes.",1.4448443368768074e-06,1.4681309690399407,0.2532544378698224,0.11061901435169445,1.6383762769674446,0.09619827767275783,0.11045889399812503,1.7865624576464185,0.013695987654320991,1.4448443368768091e-06,1.8787708462176838,0.0
215,0.1,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",Assessing antral follicles offers a better prediction of IVF results than age or follicle-stimulating hormone levels.,1.421158364141122e-06,1.3991380975529886,0.2532544378698224,0.10880558788691258,1.5642683048137234,0.09619827767275783,0.10864809245717216,1.7065197499728821,0.013695987654320991,1.421158364141124e-06,1.7917594692280536,0.0
215,0.1,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",In vitro fertilization outcomes correlate more closely with antral follicle assessment than with age or FSH.,1.421158364141122e-06,1.3991380975529886,0.2532544378698224,0.10880558788691258,1.5642683048137234,0.09619827767275783,0.10864809245717216,1.7065197499728821,0.013695987654320991,1.421158364141124e-06,1.7917594692280536,0.0
215,0.1,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",Antral follicle evaluation is a more effective tool for predicting IVF success than maternal age or follicle-stimulating hormone.,1.3737864186697514e-06,1.273974954598983,0.2532544378698224,0.10517873495734882,1.4307369121892006,0.09619827767275783,0.10502648937526642,1.5634189063322088,0.013695987654320991,1.3737864186697531e-06,1.637608789400796,0.0
215,0.1,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from",The assessment of antral follicles provides a distinct and superior marker for predicting IVF outcomes compared to age and FSH.,1.3264144731983806e-06,1.1627493194887588,0.2532544378698224,0.10155188202778506,1.3129538765328168,0.09619827767275783,0.10140488629336067,1.4382557633782032,0.013695987654320991,1.3264144731983825e-06,1.5040773967762733,0.0
216,0.1,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are the home blood pressure readings reported by stroke patients dependable? This elderly group of stroke patients could reliably measure their blood pressure at home. Any bias was minimal and unlikely to impact treatment decisions. Given that blood pressure readings at a GP's office often do not accurately reflect true blood pressure, GPs might consider relying on hypertensive patients' home measurements.",4.737194547137081e-08,0.06723887479505208,0.10204081632653063,0.0036268529295637453,0.01098966147591618,0.01694411414982164,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
216,0.1,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients be trusted to report their home blood pressure readings accurately? Elderly stroke patients in this study successfully recorded their blood pressure at home with reliability. The bias observed was minor and unlikely to influence clinical management. Since blood pressure readings taken at a GP's clinic frequently fail to represent true blood pressure, GPs may want to use home readings from hypertensive patients.",1.4211583641411244e-07,0.0036209229969390577,0.09555555555555555,0.010880558788691236,0.07807878615825725,0.01586888657648284,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
216,0.1,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are home blood pressure readings from stroke patients reliable? This cohort of elderly stroke patients was capable of accurately recording their blood pressure at home. Any bias present was small and unlikely to affect treatment. Because blood pressure measurements in a GP's office often poorly reflect actual blood pressure, GPs might consider using readings reported by hypertensive patients at home.",2.3685972735685406e-08,0.08576023762788765,0.10380165289256202,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
216,0.1,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Do stroke patients provide reliable home blood pressure readings? The elderly stroke patients studied were able to reliably measure their blood pressure at home. The bias detected was minimal and unlikely to alter management. Since blood pressure readings in general practice settings often do not accurately indicate true blood pressure, GPs might consider utilizing hypertensive patients' home readings.",2.3685972735685406e-08,0.09953439581931178,0.08950617283950614,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
216,0.1,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is it reliable when stroke patients report their home blood pressure readings? This group of elderly stroke patients reliably recorded their blood pressure at home. Any bias was minor and unlikely to affect clinical decisions. Given that blood pressure readings in a GP surgery often poorly represent true blood pressure, GPs might consider using hypertensive patients' home measurements.",2.3685972735685406e-08,0.09953439581931178,0.08950617283950614,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
216,0.1,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are reports of home blood pressure readings by stroke patients trustworthy? Elderly stroke patients in this group were able to reliably record their blood pressure at home. The bias was small and unlikely to impact management. Since blood pressure readings taken in a GP's office often do not accurately reflect true blood pressure, GPs might consider relying on hypertensive patients' home readings.",7.105791820705622e-08,0.0490515330656347,0.10033856571252693,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
216,0.1,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients reliably report their home blood pressure readings? This elderly stroke patient group was capable of accurately recording their blood pressure at home. Any bias was minimal and unlikely to influence treatment. Because blood pressure readings in GP surgeries often poorly indicate true blood pressure, GPs might consider using hypertensive patients' home readings.",9.474389094274162e-08,0.13249298001926135,0.07544378698224853,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
216,0.1,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are home blood pressure readings reported by stroke patients dependable? The elderly stroke patients studied could reliably measure their blood pressure at home. The bias was small and unlikely to affect management. Since blood pressure readings in a GP's office often do not accurately represent true blood pressure, GPs might consider using hypertensive patients' home readings.",7.105791820705622e-08,0.1634448360092957,0.11149557862360629,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
216,0.1,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is the reporting of home blood pressure readings by stroke patients reliable? This group of elderly stroke patients was able to reliably record their blood pressure at home. Any bias was minor and unlikely to influence clinical management. Given that blood pressure readings in GP surgeries often poorly reflect true blood pressure, GPs might consider using hypertensive patients' home measurements.",2.3685972735685406e-08,0.08576023762788765,0.10380165289256203,0.0018134264647818726,0.006509884203991234,0.017236072637734686,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
216,0.1,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are stroke patients' self-reported home blood pressure readings accurate? Elderly stroke patients in this study reliably recorded their blood pressure at home. The bias was small and unlikely to affect treatment decisions. Since blood pressure readings in a GP surgery often do not accurately indicate true blood pressure, GPs might consider using hypertensive patients' home readings.",7.105791820705622e-08,0.13823948398893382,0.09282544378698228,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
217,0.1,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering required before scoliosis correction in a patient with myelomeningocele? Typically, untethering is necessary prior to scoliosis correction to avoid worsening neurological damage. However, the choice depends on the patient's specific condition.",4.2634750924233646e-07,0.3787052525238255,0.048177603276360274,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
217,0.1,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For a patient with myelomeningocele, is untethering needed before scoliosis surgery? Usually, untethering is performed before scoliosis correction to prevent further neurological decline, but the decision varies based on individual patient factors.",4.5003348197802176e-07,0.41185142499275873,0.04717286284394038,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,0.1,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does a patient with myelomeningocele need untethering before scoliosis correction? Generally, untethering is essential before scoliosis surgery to reduce the risk of neurological worsening, though it depends on the patient's unique situation.",4.5003348197802176e-07,0.41185142499275873,0.04717286284394038,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,0.1,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","In patients with myelomeningocele, is untethering necessary before correcting scoliosis? Untethering is commonly required prior to scoliosis correction to prevent additional neurological issues, but the decision should be tailored to each patient.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,0.1,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Should untethering be done before scoliosis correction in myelomeningocele patients? Typically, untethering is needed before scoliosis surgery to avoid exacerbating neurological problems, but it depends on individual patient conditions.",5.210914001850777e-07,0.5184254592604893,0.0437297901416084,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
217,0.1,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is it necessary to untether a patient with myelomeningocele before scoliosis correction? Usually, untethering is performed first to prevent neurological deterioration, although the decision is patient-specific.",5.921493183921336e-07,0.5822436316703543,0.07939508506616258,0.04533566161954689,0.6571830244516659,0.040742417383431435,0.04527003852382175,0.7357067949787415,0.0,5.921493183921352e-07,0.7591051483517424,0.0
217,0.1,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For scoliosis correction in myelomeningocele patients, is untethering required beforehand? Untethering is generally necessary to prevent further neurological damage, but the approach depends on the patient's condition.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.1,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does scoliosis correction in myelomeningocele require prior untethering? Typically, untethering is done first to avoid worsening neurological function, but the decision varies with patient circumstances.",6.158352911278189e-07,0.6230656261906091,0.07939508506616258,0.04714908808432877,0.6997426388704615,0.040742417383431435,0.04708084006477462,0.7801585575495755,0.0,6.158352911278206e-07,0.8056251639866363,0.0
217,0.1,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering a prerequisite for scoliosis correction in patients with myelomeningocele? Usually, yes, to prevent neurological decline, but the choice depends on individual patient factors.",6.158352911278189e-07,0.6230656261906091,0.07939508506616258,0.04714908808432877,0.6997426388704615,0.040742417383431435,0.04708084006477462,0.7801585575495755,0.0,6.158352911278206e-07,0.8056251639866363,0.0
217,0.1,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Before scoliosis correction in myelomeningocele patients, is untethering necessary? It is commonly required to prevent neurological deterioration, though the decision should be individualized.",6.632072365991895e-07,0.7100770031802388,0.07939508506616258,0.05077594101389253,0.7907144170761895,0.040742417383431435,0.05070244314668037,0.8754687373539007,0.0,6.632072365991913e-07,0.9057086225436177,0.0
218,0.1,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair pointless? No, it's essential to prevent spinal cord ischemia and reduce paralysis risk, making it a vital part of the surgery.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
218,0.1,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is crucial, not a waste, as it helps avoid spinal cord ischemia and lowers paralysis chances.",8.763809912203585e-07,0.688000279781765,0.16685147928994074,0.06709677919692936,0.7741010413588367,0.09566326530612247,0.06699965701525615,0.8646416226227478,0.049048751486325794,8.7638099122036e-07,0.9357454402742853,0.016661878770468257
218,0.1,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is important to prevent ischemia and paralysis, thus it is a key surgical step.",9.474389094274144e-07,0.7572835879848712,0.20525147928994075,0.07253705859127499,0.9019344128687212,0.09566326530612247,0.07243206163811476,0.9981730152472714,0.049048751486325794,9.474389094274162e-07,1.0755073826494446,0.016661878770468257
218,0.1,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is a necessary procedure to minimize spinal cord ischemia and paralysis risk, not a waste of time.",8.290090457489879e-07,0.6100838066359557,0.16958618436538658,0.0634699262673656,0.6971400002227073,0.09566326530612247,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8523638313352349,0.016661878770468257
218,0.1,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair plays a vital role in preventing spinal cord ischemia and paralysis, making it an indispensable surgical technique.",8.763809912203585e-07,0.688000279781765,0.16685147928994074,0.06709677919692936,0.7741010413588367,0.09566326530612247,0.06699965701525615,0.8646416226227478,0.049048751486325794,8.7638099122036e-07,0.9357454402742853,0.016661878770468257
218,0.1,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","In thoracic and thoracoabdominal aneurysm repair, reimplantation of spinal cord arteries is a significant procedure that helps prevent ischemia and paralysis, so it is not futile.",9.000669639560438e-07,0.6739019790458207,0.20525147928994075,0.06891020566171124,0.8149230358790915,0.09566326530612247,0.06881045855620901,0.9072012370415434,0.049048751486325794,9.000669639560454e-07,0.9801972028451194,0.016661878770468257
218,0.1,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The process of reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is essential to reduce the risk of spinal cord ischemia and paralysis, thus it is worthwhile.",8.290090457489879e-07,0.6100838066359557,0.16958618436538658,0.0634699262673656,0.6971400002227073,0.09566326530612247,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8523638313352349,0.016661878770468257
218,0.1,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a critical step to avoid spinal cord ischemia and paralysis, and therefore it is not a waste of time.",7.816371002776173e-07,0.5377902342891954,0.17195778131134384,0.05984307333780184,0.6256810362405636,0.09566326530612247,0.05975645085144465,0.7104909427954889,0.049048751486325794,7.816371002776184e-07,0.7754027901991054,0.016661878770468257
218,0.1,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is a key measure to prevent ischemia and paralysis, making it an important part of the surgery.",8.763809912203585e-07,0.6346812658925383,0.20525147928994075,0.06709677919692936,0.7741010413588367,0.09566326530612247,0.06699965701525615,0.8646416226227478,0.049048751486325794,8.7638099122036e-07,0.9357454402742853,0.016661878770468257
218,0.1,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is a vital procedure that helps prevent spinal cord ischemia and paralysis, so it is definitely not a waste of time.",7.342651548062467e-07,0.4703635998992919,0.17403399750013845,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.7039438262169617,0.016661878770468257
219,0.1,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery enhance outcomes of bariatric surgery? MSWM seems to offer no extra advantage over the usual preoperative bariatric surgery protocol regarding weight loss and most behavioral results after LAGB in our patients.,1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.1,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Is there an improvement in bariatric surgery results with a preoperative medically supervised weight loss program? In our patient group, MSWM does not seem to provide additional benefits compared to the standard preoperative protocol for weight loss and behavioral outcomes following LAGB.",9.474389094274162e-08,0.06528939793786215,0.01997329637641968,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.1,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does undergoing a medically supervised weight loss program before surgery improve bariatric surgery outcomes? Our findings indicate that MSWM does not yield more benefits than the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes after LAGB.,1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.1,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Can a preoperative medically supervised weight loss program enhance the results of bariatric surgery? According to our patient data, MSWM does not appear to offer extra benefits over the standard preoperative protocol for weight loss and behavioral outcomes post-LAGB.",1.6580180914979763e-07,0.14394467788328003,0.01805172953931231,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.1,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program prior to surgery improve bariatric surgery outcomes? MSWM does not seem to provide additional advantages compared to the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB in our patients.,9.474389094274162e-08,0.09910145552615202,0.004303906121936658,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.1,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a preoperative medically supervised weight loss program beneficial for improving bariatric surgery outcomes? Our patient population shows that MSWM does not confer extra benefits beyond the standard preoperative protocol in terms of weight loss and behavioral outcomes after LAGB.,1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.1,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participation in a medically supervised weight loss program before surgery improve bariatric surgery results? MSWM appears to offer no additional benefit over the standard preoperative bariatric surgery protocol regarding weight loss and behavioral outcomes after LAGB in our patients.,1.4211583641411233e-07,0.152579779443204,0.006783916917955768,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.1,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does a preoperative medically supervised weight loss program lead to better bariatric surgery outcomes? In our patient group, MSWM does not seem to provide more benefits than the standard preoperative protocol for weight loss and behavioral outcomes following LAGB.",1.6580180914979763e-07,0.14394467788328003,0.01805172953931231,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.1,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before bariatric surgery improve outcomes? Our data suggest that MSWM does not confer additional benefits compared to the standard preoperative protocol in terms of weight loss and behavioral outcomes after LAGB.,1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,0.1,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is there an added benefit to bariatric surgery outcomes from a preoperative medically supervised weight loss program? MSWM does not appear to improve weight loss or most behavioral outcomes beyond the standard preoperative bariatric surgery protocol after LAGB in our patient population.,9.474389094274162e-08,0.09910145552615202,0.0043039061219366515,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
220,0.1,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does receiving birth center care during a woman's initial pregnancy influence her future reproductive outcomes? It appears that in Sweden, the type of care model, including birth center care, during a first pregnancy does not significantly impact later reproduction.",1.8948778188548304e-07,0.1736075960621144,0.012430810114242609,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.1,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is there an effect of birth center care during a woman's first pregnancy on her future reproductive behavior? Evidence from Sweden suggests that the care model, like birth center care, during the first pregnancy is not a major factor influencing subsequent reproduction.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.1,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Can birth center care during a woman's first pregnancy affect her future childbearing? In Sweden, the model of care such as birth center care during the first pregnancy does not seem to play a significant role in later reproduction.",1.8948778188548304e-07,0.24657045717368842,0.03890628245699067,0.014507411718254981,0.27067940745689967,0.05387755102040818,0.014486412327622933,0.2391788721599264,0.02775510204081633,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.1,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does the type of care, specifically birth center care, during a woman's first pregnancy affect her future reproductive patterns? Findings from Sweden indicate that birth center care during the first pregnancy is not a crucial determinant of subsequent reproduction.",1.8948778188548304e-07,0.1736075960621144,0.012430810114242609,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.1,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is birth center care during a woman's first pregnancy linked to changes in her future reproduction? Research in Sweden shows that the care model during the first pregnancy, including birth center care, does not substantially influence later reproductive outcomes.",1.8948778188548304e-07,0.1371261655063276,0.03860337907960437,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.1,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does receiving birth center care in a woman's first pregnancy impact her future reproductive decisions? In Sweden, the model of care during the initial pregnancy, such as birth center care, appears not to significantly affect subsequent reproduction.",2.3685972735685364e-07,0.1932201329185923,0.03714484387589542,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
220,0.1,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does birth center care during a woman's first pregnancy have any bearing on her future reproduction? The evidence from Sweden suggests that the care model during the first pregnancy, including birth center care, is not a significant factor in later reproduction.",1.4211583641411244e-07,0.08400879959098795,0.03991638247160983,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.1,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is there an association between birth center care during a woman's first pregnancy and her future reproduction? In Sweden, the model of care like birth center care during the first pregnancy does not seem to be an important influence on subsequent reproduction.",1.1842986367842703e-07,0.15990705832577934,0.031520799152681994,0.009067132323909363,0.18709775371237747,0.049861495844875335,0.009054007704764333,0.1561739970481013,0.025623268698060954,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.1,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does the care model, such as birth center care, during a woman's first pregnancy influence her future reproductive outcomes? Data from Sweden indicates that birth center care during the first pregnancy is not a key factor affecting later reproduction.",1.8948778188548304e-07,0.1736075960621144,0.012430810114242609,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.1,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Can the experience of birth center care during a woman's first pregnancy affect her future reproduction? In Sweden, the model of care during the first pregnancy, including birth center care, does not appear to significantly impact subsequent reproduction.",2.1317375462116834e-07,0.20224781236350786,0.011022394896303571,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
221,0.1,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia negatively impact the results of colon and rectal surgeries? Yes, having anemia before surgery can worsen the outcomes of colon and rectal operations. Studies indicate it raises the chances of postoperative complications such as infections, extended hospitalization, and increased mortality rates.",2.3685972735685406e-08,0.00631903063618644,0.020625000000000004,0.0018134264647818726,0.05730511085940426,0.02425736961451249,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
221,0.1,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is there a detrimental effect of preoperative anemia on colon and rectal surgery outcomes? Indeed, preoperative anemia can harm the results of colon and rectal surgeries. Research demonstrates it is associated with a higher risk of postoperative issues including infections, prolonged hospital stays, and greater mortality.",2.3685972735685406e-08,0.05607999187920765,0.02367346938775511,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.1,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can preoperative anemia adversely influence the outcomes of colon and rectal surgery? Yes, anemia before surgery can negatively affect colon and rectal surgery outcomes. Evidence shows it contributes to increased postoperative complications, longer hospitalizations, and elevated mortality rates.",1.6580180914979753e-07,0.12217979150303293,0.03612244897959182,0.012693985253473108,0.18394995018825266,0.004512471655328806,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
221,0.1,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does anemia prior to surgery have a negative effect on colon and rectal surgery results? Yes, preoperative anemia can lead to worse outcomes in colon and rectal surgeries. Studies reveal it increases the likelihood of postoperative complications like infections, extended hospital stays, and higher death rates.",2.3685972735685406e-08,0.08688653323742734,0.045651703623580314,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.1,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia linked to poorer outcomes in colon and rectal surgery? Yes, anemia before surgery can adversely affect the success of colon and rectal operations. Research finds it causes a rise in postoperative complications, including infections, longer hospital stays, and increased mortality.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
221,0.1,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does having anemia before surgery negatively affect colon and rectal surgery outcomes? Yes, preoperative anemia can worsen the results of colon and rectal surgeries. Studies show it leads to a higher risk of postoperative complications such as infections, prolonged hospitalization, and increased mortality.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
221,0.1,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can anemia present before surgery impact colon and rectal surgery outcomes negatively? Yes, preoperative anemia is associated with adverse effects on colon and rectal surgery outcomes. Research indicates it results in more postoperative complications, longer hospital stays, and higher mortality rates.",9.474389094274162e-08,0.07325549678650756,0.015493060628195762,0.0072537058591274906,0.13649108433591195,0.027889582908887926,0.007243206163811466,0.13656488911276776,0.026296566837107373,9.474389094274162e-08,0.10265415406008227,0.0
221,0.1,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is there an adverse impact of preoperative anemia on colon and rectal surgery outcomes? Yes, anemia before surgery can negatively influence the outcomes of colon and rectal surgeries. Evidence shows it increases the risk of postoperative complications, including infections, extended hospital stays, and greater mortality.",0.0,0.06301338005090429,0.0446485260770975,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
221,0.1,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia cause worse outcomes in colon and rectal surgery? Yes, anemia prior to surgery can adversely affect colon and rectal surgery results. Research demonstrates it leads to increased postoperative complications, longer hospitalization, and higher mortality rates.",1.6580180914979753e-07,0.12217979150303293,0.03612244897959182,0.012693985253473108,0.18394995018825266,0.004512471655328806,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
221,0.1,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia a factor in poorer colon and rectal surgery outcomes? Yes, having anemia before surgery can negatively impact the outcomes of colon and rectal surgeries. Studies confirm it raises the risk of postoperative complications, longer hospital stays, and increased mortality.",7.105791820705622e-08,0.012214922288724672,0.041347797501643656,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
222,0.1,1,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis an early indicator of bronchiectasis? Yes, this dysfunction can precede bronchiectasis by hindering bacterial clearance in the lungs, causing ongoing infections and inflammation.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.1,2,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis signal the onset of bronchiectasis? Indeed, this dysfunction may act as a forerunner by reducing the lung's ability to eliminate bacteria, leading to chronic infections and inflammation that contribute to bronchiectasis.",3.079176455639103e-07,0.042815398765847945,0.15737240075614362,0.023574544042164344,0.07003503747183526,0.14366729678638948,0.023540420032387266,0.09831697778084081,0.12901701323251416,3.079176455639103e-07,0.12772503078410402,0.113421550094518
222,0.1,3,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Can alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis lead to bronchiectasis? Yes, because this impairment compromises bacterial clearance in the lungs, resulting in persistent infections and inflammation that may progress to bronchiectasis.",4.974054274493929e-07,0.2541244924330539,0.15737240075614362,0.03808195576041934,0.287099542709663,0.14366729678638948,0.03802683236001022,0.3214605290950505,0.12901701323251416,4.974054274493935e-07,0.3572994724286018,0.113421550094518
222,0.1,4,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction a precursor to bronchiectasis in children with protracted bacterial bronchitis? Yes, the dysfunction disrupts bacterial removal from the lungs, causing continuous infections and inflammation that can develop into bronchiectasis.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.1,5,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? Yes, it can be an early sign as it impairs bacterial clearance, leading to ongoing lung infections and inflammation that may cause bronchiectasis.",4.737194547137076e-07,0.2251369555598024,0.15737240075614362,0.03626852929563746,0.2572465795599812,0.14366729678638948,0.036216030819057346,0.29068887042829683,0.12901701323251416,4.737194547137081e-07,0.325550774114022,0.113421550094518
222,0.1,6,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is the phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis an early stage of bronchiectasis? Yes, this dysfunction reduces the lungs' ability to clear bacteria, resulting in persistent infections and inflammation that can eventually cause bronchiectasis.",4.026615365066517e-07,0.14289885732282936,0.15737240075614362,0.030828249901291835,0.17268919153191753,0.14366729678638948,0.030783626196198732,0.2036774934386667,0.12901701323251416,4.026615365066519e-07,0.23593861542433503,0.113421550094518
222,0.1,7,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be an initial step toward bronchiectasis? Yes, because it impairs bacterial clearance, leading to chronic infections and inflammation that may culminate in bronchiectasis.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.1,8,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis a potential precursor to bronchiectasis? Yes, this dysfunction hinders bacterial clearance from the lungs, causing persistent infections and inflammation that can lead to bronchiectasis.",4.974054274493929e-07,0.2541244924330539,0.15737240075614362,0.03808195576041934,0.287099542709663,0.14366729678638948,0.03802683236001022,0.3214605290950505,0.12901701323251416,4.974054274493935e-07,0.3572994724286018,0.113421550094518
222,0.1,9,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis act as a forerunner to bronchiectasis? Yes, it impairs the lung's bacterial clearance ability, resulting in ongoing infections and inflammation that may progress to bronchiectasis.",4.737194547137076e-07,0.2251369555598024,0.15737240075614362,0.03626852929563746,0.2572465795599812,0.14366729678638948,0.036216030819057346,0.29068887042829683,0.12901701323251416,4.737194547137081e-07,0.325550774114022,0.113421550094518
222,0.1,10,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis an early indicator of bronchiectasis development? Yes, because this dysfunction compromises bacterial clearance, causing persistent infections and inflammation that can eventually lead to bronchiectasis.",4.974054274493929e-07,0.2541244924330539,0.15737240075614362,0.03808195576041934,0.287099542709663,0.14366729678638948,0.03802683236001022,0.3214605290950505,0.12901701323251416,4.974054274493935e-07,0.3572994724286018,0.113421550094518
223,0.1,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection required for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? Yes, neck dissection is commonly needed in such cases to manage regional disease, reduce the risk of further metastasis, and enhance survival rates. Nonetheless, individual assessment is crucial to weigh the advantages against possible risks.",3.789755637709665e-07,0.04887641692564815,0.14734403940402238,0.029014823436509962,0.044010487001755916,0.15574022776238844,0.028972824655245866,0.06595738052934319,0.14465989535241613,3.789755637709665e-07,0.0885915964455668,0.13296398891966757
223,0.1,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma involving cervical nodes with an unknown primary site in the head and neck, is neck dissection necessary? Yes, it is often essential to perform neck dissection to control local disease, prevent additional metastases, and improve patient survival, though each patient should be evaluated on a case-by-case basis.",4.737194547137081e-07,0.1294832566430295,0.14580568059402896,0.03626852929563745,0.12405319467529274,0.15574022776238844,0.03621603081905733,0.14763541154361048,0.14465989535241613,4.737194547137081e-07,0.1719732053846177,0.13296398891966757
223,0.1,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Does metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary require neck dissection? Yes, neck dissection is frequently indicated to manage regional disease, limit future metastasis, and increase overall survival, but decisions should be personalized considering risks and benefits.",6.39521263863506e-07,0.25534221481478037,0.1662049861495845,0.04896251454911056,0.28168213887887594,0.15574022776238844,0.0488916416057274,0.3089035591397322,0.14465989535241613,6.39521263863506e-07,0.3370529557440678,0.13296398891966757
223,0.1,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","When metastatic carcinoma affects cervical nodes from an unknown primary in the head and neck, is neck dissection needed? Yes, it is typically necessary to perform neck dissection to control the disease regionally, prevent further spread, and improve survival outcomes, with individual case evaluation recommended.",5.921493183921352e-07,0.240328889205339,0.1434900050787354,0.045335661619546816,0.2340540898896215,0.15574022776238844,0.045270038523821665,0.2601133949703005,0.14465989535241613,5.921493183921352e-07,0.28704253516940437,0.13296398891966757
223,0.1,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection warranted for metastatic carcinoma in cervical nodes originating from an unknown head and neck primary? Yes, it is often required to control regional disease, prevent metastasis, and enhance survival, although each case must be carefully assessed for potential risks and benefits.",6.158352911278206e-07,0.23181171740458595,0.1662049861495845,0.04714908808432869,0.2575845872998159,0.15574022776238844,0.04708084006477453,0.2842109465493605,0.14465989535241613,6.158352911278206e-07,0.31173514775977607,0.13296398891966757
223,0.1,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma to cervical lymph nodes with an unknown primary site in the head and neck, is neck dissection indicated? Yes, neck dissection is generally necessary to manage regional disease, reduce the chance of further metastasis, and improve survival, but individual evaluation is important.",5.921493183921352e-07,0.240328889205339,0.1434900050787354,0.045335661619546816,0.2340540898896215,0.15574022776238844,0.045270038523821665,0.2601133949703005,0.14465989535241613,5.921493183921352e-07,0.28704253516940437,0.13296398891966757
223,0.1,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Should neck dissection be performed for metastatic carcinoma in cervical nodes when the primary head and neck tumor is unknown? Yes, it is commonly needed to control regional disease, prevent future metastases, and improve overall survival, with each case requiring individual assessment.",6.632072365991914e-07,0.2794397663938404,0.1662049861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
223,0.1,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection necessary for metastatic carcinoma to cervical nodes from an unknown head and neck primary site? Yes, it often plays a critical role in controlling regional disease, preventing additional metastasis, and improving survival, though each patient should be evaluated individually.",6.632072365991914e-07,0.2794397663938404,0.1662049861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
223,0.1,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","In cases of metastatic carcinoma to cervical nodes from an unknown primary in the head and neck, is neck dissection required? Yes, neck dissection is frequently necessary to manage regional disease, prevent further metastasis, and enhance survival, with careful individual case evaluation.",6.632072365991914e-07,0.31325182398213025,0.1418299861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
223,0.1,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Does metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary site necessitate neck dissection? Yes, it is often essential for controlling regional disease, preventing future metastasis, and improving overall survival, but each case should be individually assessed.",6.868932093348768e-07,0.3041323789842121,0.1662049861495845,0.052589367478674306,0.33169255945353937,0.15574022776238844,0.05251324468763313,0.3601968535272819,0.14465989535241613,6.868932093348768e-07,0.38969668922948664,0.13296398891966757
224,0.1,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy has a high mortality rate, especially among patients older than 70, highlighting the need for enhanced efforts to improve outcomes, particularly for this age group. This may include boosting acute surgical care staffing and early identification of patients in need.",2.3685972735685406e-08,0.03963420796987549,0.016661878770468257,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
224,0.1,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The mortality rate following emergency laparotomy is notably high, particularly in individuals over 70 years old, indicating a critical need for better outcomes through measures such as increasing acute surgical workforce and prompt patient recognition.",1.8948778188548325e-07,0.16673844800081028,0.018860946745562133,0.014507411718254981,0.14310084364067155,0.0,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
224,0.1,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy is associated with significant mortality, especially in patients above 70 years, necessitating improvements in care, including expanding acute surgical manpower and early detection of those requiring intervention.",3.316036182995957e-07,0.2607262624632525,0.0,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
224,0.1,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: There is a high mortality rate in emergency laparotomy cases, particularly for patients over 70, underscoring the urgent need to enhance outcomes by increasing acute surgical staff and early patient identification.",2.8423167282822487e-07,0.24734528771819164,0.020399305555555556,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
224,0.1,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates following emergency laparotomy remain elevated, especially in the elderly over 70, pointing to the necessity for improved care strategies such as augmenting acute surgical manpower and early recognition of critical patients.",2.3685972735685406e-07,0.17904823144898518,0.0,0.018134264647818726,0.182321556793954,0.0,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
224,0.1,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a significant risk of death, particularly in those older than 70 years, and there is a pressing need to improve outcomes by increasing acute surgical care resources and early patient assessment.",2.1317375462116866e-07,0.1596301455918825,0.0,0.016320838183036854,0.16251892949777424,0.0,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
224,0.1,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The high mortality associated with emergency laparotomy, especially in patients over 70, calls for enhanced efforts to improve outcomes, including expanding acute surgical manpower and early identification of patients needing care.",2.8423167282822487e-07,0.21905356606268356,0.0,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
224,0.1,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy results in a high death rate, particularly among those aged over 70, emphasizing the need for better outcomes through increased acute surgical staffing and early patient recognition.",3.316036182995957e-07,0.29022188716793096,0.0212665406427221,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
224,0.1,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: There is a concerningly high mortality rate in emergency laparotomy, especially in patients older than 70, necessitating improvements such as boosting acute surgical manpower and early detection of patients requiring intervention.",2.8423167282822487e-07,0.24734528771819164,0.020399305555555556,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
224,0.1,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The mortality risk in emergency laparotomy is high, particularly for those over 70 years old, highlighting the need for enhanced outcomes through increased acute surgical care personnel and early patient identification.",2.8423167282822487e-07,0.2756370093736993,0.040742417383431435,0.02176111757738247,0.22314355131420838,0.0,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
225,0.1,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss caused by amblyopia permanent? Answer: Amblyopia, commonly called lazy eye, usually begins in childhood. Without treatment, it may cause lasting vision impairment. Nevertheless, early diagnosis and intervention, such as vision therapy or corrective glasses, can frequently reverse the condition and restore normal or nearly normal sight.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
225,0.1,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia result in permanent vision loss? Answer: Amblyopia, or lazy eye, typically develops in childhood. If untreated, it can cause permanent vision damage. However, early detection and treatment, including vision therapy or corrective lenses, often allow for recovery of normal or near-normal vision.",1.1842986367842703e-07,0.1391373542178176,0.02271498107084911,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.1,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is vision loss from amblyopia irreversible? Answer: Amblyopia, known as lazy eye, often starts in childhood. If not treated, it can lead to permanent vision loss. Early diagnosis and treatment, like vision therapy or corrective eyewear, can often reverse the condition and restore normal or close to normal vision.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
225,0.1,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Can amblyopia cause permanent loss of vision? Answer: Amblyopia, or lazy eye, usually begins during childhood. If left untreated, it may result in permanent vision loss. However, with prompt detection and treatment such as vision therapy or corrective glasses, the condition can often be reversed to regain normal or near-normal vision.",4.737194547137081e-08,0.04000533461369837,0.0,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
225,0.1,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision impairment from amblyopia permanent? Answer: Amblyopia, also called lazy eye, often starts in childhood. Without treatment, it can cause lasting vision loss. But early detection and treatment, including vision therapy or corrective eyewear, can frequently restore normal or nearly normal vision.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.1,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia cause lasting vision loss? Answer: Amblyopia, known as lazy eye, typically begins in childhood. If untreated, it can lead to permanent vision impairment. However, early diagnosis and treatment, such as vision therapy or corrective lenses, often help reverse the condition and restore normal or near-normal vision.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.1,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is vision loss due to amblyopia permanent? Answer: Amblyopia, or lazy eye, often starts in childhood. If left untreated, it can cause permanent vision loss. Early detection and treatment, including vision therapy or corrective eyewear, can often reverse the condition and restore normal or near-normal vision.",7.105791820705622e-08,0.06317890162153228,0.0,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
225,0.1,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Can vision loss from amblyopia be permanent? Answer: Amblyopia, commonly called lazy eye, usually begins in childhood. If untreated, it may cause lasting vision damage. However, early diagnosis and treatment, such as vision therapy or corrective glasses, can often restore normal or near-normal vision.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.1,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is amblyopia-associated vision loss irreversible? Answer: Amblyopia, also known as lazy eye, often starts during childhood. Without treatment, it can lead to permanent vision loss. But with early detection and treatment like vision therapy or corrective eyewear, the condition can often be reversed to regain normal or near-normal vision.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
225,0.1,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does lazy eye cause permanent vision loss? Answer: Amblyopia, or lazy eye, typically begins in childhood. If left untreated, it can result in permanent vision loss. However, early detection and treatment, including vision therapy or corrective lenses, can often reverse the condition and restore normal or near-normal vision.",2.3685972735685406e-08,0.04950041972606645,0.020823902218198284,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
226,0.1,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it acceptable for student examiners to act as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears reasonable and justified to allow medical students to serve as examiners in formative OSCE assessments in emergency medicine, though this may not apply to summative evaluations.",4.737194547137081e-08,0.04348511193973836,0.0,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
226,0.1,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably replace faculty members in an undergraduate OSCE focused on medical emergencies? Encouraging medical students to officiate as examiners in formative emergency medicine OSCEs seems appropriate and justified, but this does not necessarily extend to summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.1,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners suitable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems both permissible and justified to have medical students act as examiners during formative OSCE testing in emergency medicine, but not necessarily for summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.1,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May medical students serve as reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? It appears acceptable and justified to involve medical students as examiners in formative emergency medicine OSCEs, though this may not be appropriate for summative evaluations.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
226,0.1,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable to have student examiners replace faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to officiate in formative OSCE assessments in emergency medicine is justifiable, but this does not necessarily apply to summative assessments.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.1,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems justified and acceptable to allow medical students to act as examiners in formative emergency medicine OSCEs, but not necessarily in summative evaluations.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.1,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners justified as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears reasonable and justified to permit medical students to serve as examiners in formative OSCE testing for emergency medicine, though not necessarily in summative assessments.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
226,0.1,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it appropriate for student examiners to act as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems justified and acceptable to encourage medical students to officiate in formative emergency medicine OSCEs, but this may not extend to summative evaluations.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
226,0.1,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners reasonably substitute for faculty in an undergraduate OSCE on medical emergencies? It appears justified and acceptable to have medical students serve as examiners in formative OSCE assessments in emergency medicine, but not necessarily in summative assessments.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.1,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can medical students reasonably act as substitute examiners for faculty in an undergraduate OSCE on medical emergencies? It seems justified and appropriate to encourage their participation as examiners in formative emergency medicine OSCEs, though this may not be suitable for summative evaluations.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
227,0.1,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Answer: At the gas flow rates examined, HFNC are not louder than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.1,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae greater than that of bubble CPAP for preterm infants? Answer: Based on the studied gas flows, HFNC are not noisier than BCPAP in preterm infants.",1.658018091497971e-07,0.333212129805899,0.07359999999999998,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
227,0.1,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier compared to bubble CPAP for preterm infants? Answer: At the gas flows tested, HFNC do not generate more noise than BCPAP for preterm infants.",7.10579182070559e-08,0.16183917481456245,0.04030630202140307,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.1,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Question: Do high flow nasal cannulae create more noise than bubble CPAP in preterm infants? Answer: The gas flow rates studied show that HFNC are not noisier than BCPAP for preterm infants.,9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.1,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is there more noise from high flow nasal cannulae than from bubble CPAP in preterm infants? Answer: At the gas flows analyzed, HFNC are not louder than BCPAP for preterm infants.",9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.1,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder than bubble CPAP for preterm infants? Answer: According to the gas flow rates studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.1,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce higher noise levels than bubble CPAP in preterm infants? Answer: At the gas flows examined, HFNC are not louder than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.1,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise produced by high flow nasal cannulae greater than that of bubble CPAP for preterm infants? Answer: Based on the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",1.658018091497971e-07,0.29243876624354925,0.04421524334251605,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
227,0.1,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? Answer: At the gas flow rates tested, HFNC are not louder than BCPAP for preterm infants.",2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.1,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Question: Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? Answer: The gas flows studied indicate that HFNC are not noisier than BCPAP for preterm infants.,7.10579182070559e-08,0.16183917481456245,0.04030630202140307,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
228,0.1,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? Yes, the coexistence of these two conditions in adolescents typically worsens depression outcomes. The simultaneous occurrence can intensify depressive symptoms and severity, complicating treatment and potentially causing more severe and enduring effects.",4.263475092423373e-07,0.13229121818436385,0.13488520408163265,0.03264167636607371,0.1786157411230893,0.1077254539858418,0.0325944277371516,0.22644887462757257,0.07877526753864447,4.263475092423373e-07,0.27586599171780213,0.048261993679977015
228,0.1,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is the outcome of depression poorer when major depression and alcohol use disorder co-occur in adolescence? Indeed, adolescents with both major depression and alcohol use disorder often experience worse depression outcomes. The combination of these disorders can amplify symptoms and severity, making treatment more difficult and leading to more significant and lasting impacts.",3.079176455639103e-07,0.1644926360360599,0.03981956352029266,0.023574544042164344,0.18416047438745853,0.029862167430839512,0.023540420032387266,0.20426602063693977,0.01901972204294504,3.079176455639103e-07,0.22481877083645285,0.00751957629654558
228,0.1,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does comorbidity of major depression and alcohol use disorder in adolescence lead to worse depression outcomes? Yes, having both disorders during adolescence frequently results in poorer depression outcomes. The presence of both conditions can worsen symptoms and severity, complicating effective treatment and causing more profound, long-term effects.",4.500334819780227e-07,0.1537974234053272,0.13488520408163265,0.03445510283085558,0.20059464784186432,0.1077254539858418,0.034405229278104466,0.2489217304796303,0.07877526753864447,4.500334819780227e-07,0.29885550994250165,0.048261993679977015
228,0.1,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","When major depression and alcohol use disorder coexist in adolescence, does it lead to poorer depression outcomes? Yes, the comorbidity of these disorders in adolescents often results in more severe depression outcomes. The dual diagnosis can exacerbate symptoms and severity, making treatment more challenging and potentially leading to lasting negative effects.",3.552895910352811e-07,0.07041581446627632,0.13488520408163265,0.02720139697172809,0.11543683950155703,0.1077254539858418,0.027162023114293,0.16191035349000105,0.07877526753864447,3.552895910352811e-07,0.20990802392600605,0.048261993679977015
228,0.1,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is depression outcome negatively affected by the comorbidity of major depression and alcohol use disorder in adolescence? Yes, adolescents suffering from both major depression and alcohol use disorder tend to have poorer depression outcomes. The concurrent disorders may intensify symptoms and severity, complicating treatment and causing more enduring effects.",4.026615365066519e-07,0.2556434716031859,0.03212695638017243,0.030828249901291835,0.2750920347208399,0.02335552429411654,0.030783626196198732,0.29488046972096393,0.013875321621932724,4.026615365066519e-07,0.3150062185821838,0.003913697303557333
228,0.1,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the presence of both major depression and alcohol use disorder in adolescence worsen depression outcomes? Yes, comorbidity of these conditions during adolescence commonly leads to poorer outcomes in depression. The combined disorders can heighten symptom severity, making treatment more difficult and potentially resulting in more lasting consequences.",4.263475092423373e-07,0.13229121818436385,0.13488520408163265,0.03264167636607371,0.1786157411230893,0.1077254539858418,0.0325944277371516,0.22644887462757257,0.07877526753864447,4.263475092423373e-07,0.27586599171780213,0.048261993679977015
228,0.1,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Are depression outcomes poorer when major depression and alcohol use disorder co-occur in adolescence? Yes, adolescents with both major depression and alcohol use disorder often face worse depression outcomes. The coexistence of these disorders can increase symptom severity and complicate treatment, leading to more profound and persistent effects.",4.263475092423373e-07,0.27976934170775625,0.030009920634920625,0.03264167636607371,0.29916307687264476,0.02155765353232704,0.0325944277371516,0.31886849870223166,0.012448736926399584,4.263475092423373e-07,0.33887937176870686,0.0029105197570745214
228,0.1,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder during adolescence cause worse depression outcomes? Yes, the comorbidity of these disorders in adolescence typically leads to poorer depression outcomes. The simultaneous presence can worsen symptoms and severity, making effective treatment more challenging and potentially causing long-lasting effects.",4.500334819780227e-07,0.1537974234053272,0.13488520408163265,0.03445510283085558,0.20059464784186432,0.1077254539858418,0.034405229278104466,0.2489217304796303,0.07877526753864447,4.500334819780227e-07,0.29885550994250165,0.048261993679977015
228,0.1,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is the outcome of depression more severe when major depression and alcohol use disorder are comorbid in adolescence? Yes, adolescents with both major depression and alcohol use disorder usually experience poorer depression outcomes. The dual presence can exacerbate symptoms and severity, complicating treatment and leading to more significant and enduring effects.",3.552895910352811e-07,0.2090452505782654,0.0361197719828672,0.02720139697172809,0.22860372612358892,0.026737799664854137,0.027162023114293,0.248553751059994,0.016553045316422252,3.552895910352811e-07,0.268899273335363,0.005792857877507884
228,0.1,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does comorbidity of major depression and alcohol use disorder in adolescence result in poorer depression outcomes? Yes, the coexistence of these disorders in adolescence often leads to worse depression outcomes. The combined presence may intensify symptoms and severity, making treatment more difficult and potentially causing more lasting and profound effects.",3.789755637709665e-07,0.11891024343930301,0.1144858985260771,0.029014823436509962,0.1360561267042928,0.1077254539858418,0.028972824655245866,0.1829637626878342,0.07877526753864447,3.789755637709665e-07,0.2314142291469694,0.048261993679977015
229,0.1,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Can severe hypotensive episodes in patients with coronary disease lead to myocardial ischemic events? Answer: Yes, severe hypotensive episodes in patients with coronary disease may cause myocardial ischemic events. Hypotension reduces coronary blood flow, raising the risk of myocardial ischemia, where the heart muscle lacks sufficient oxygen and nutrients to operate effectively.",7.105791820705622e-08,0.09292805806541704,0.024194358356290163,0.005440279394345618,0.1175633968952825,0.04195555555555558,0.0054324046228586,0.17074184685634375,0.07990448535320333,7.105791820705622e-08,0.17259030709283296,0.08098765432098766
229,0.1,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Is it possible for profound hypotension in coronary disease patients to trigger myocardial ischemic events? Answer: Yes, profound hypotension in patients with coronary disease can lead to myocardial ischemic events. Low blood pressure diminishes coronary circulation, increasing the likelihood of myocardial ischemia, a condition where the heart muscle is deprived of adequate oxygen and nutrients.",0.0,0.07561605606108524,0.05228607987312571,0.0,0.07701635339555013,0.055088074047703814,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
229,0.1,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Does profound hypotension in individuals with coronary disease cause myocardial ischemic events? Answer: Yes, profound hypotensive episodes in coronary disease patients can cause myocardial ischemic events. Hypotension lowers coronary blood flow, which heightens the risk of myocardial ischemia, where the heart muscle does not get enough oxygen and nutrients to function properly.",7.105791820705622e-08,0.040369476657649006,0.06708992057707434,0.005440279394345618,0.018347814979217336,0.054000000000000006,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
229,0.1,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Can myocardial ischemic events be caused by severe hypotension in patients with coronary artery disease? Answer: Yes, severe hypotension in patients with coronary artery disease can cause myocardial ischemic events. Reduced blood pressure decreases coronary perfusion, increasing the risk of myocardial ischemia due to insufficient oxygen and nutrient supply to the heart muscle.",4.737194547137081e-08,0.043699289195162194,0.004451041010291951,0.0036268529295637453,0.06834939151184649,0.021465640561339996,0.003621603081905733,0.12103875294777477,0.059002339809440155,4.737194547137081e-08,0.12239837482047555,0.05975554549569943
229,0.1,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Are myocardial ischemic events a possible consequence of profound hypotension in coronary disease patients? Answer: Yes, profound hypotension can lead to myocardial ischemic events in patients with coronary disease. Hypotension reduces coronary blood flow, which can cause the heart muscle to receive inadequate oxygen and nutrients, resulting in ischemia.",1.4211583641411244e-07,0.02395058794583571,0.06360188904641884,0.010880558788691236,0.04397569698564796,0.052776097781801715,0.0108648092457172,0.0939878144624422,0.018860946745562133,1.4211583641411244e-07,0.12260232209233335,0.0
229,0.1,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Can significant hypotensive episodes in coronary disease patients result in myocardial ischemic events? Answer: Yes, significant hypotensive episodes in patients with coronary disease can result in myocardial ischemic events. Hypotension decreases coronary blood flow, thereby increasing the risk of myocardial ischemia where the heart muscle is deprived of necessary oxygen and nutrients.",7.105791820705622e-08,0.06626855112080365,0.006792052469135779,0.005440279394345618,0.06319891214548301,0.004263286555002285,0.0054324046228586,0.08756418518915021,0.021069608809993434,7.105791820705622e-08,0.05942342047080107,0.0
229,0.1,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Is there a risk of myocardial ischemic events from profound hypotension in patients with coronary disease? Answer: Yes, profound hypotension poses a risk of myocardial ischemic events in patients with coronary disease. Lowered blood pressure reduces coronary circulation, leading to insufficient oxygen and nutrient delivery to the heart muscle.",1.4211583641411244e-07,0.19370091787888377,0.04980902777777782,0.010880558788691236,0.18838135960230362,0.04884897959183675,0.0108648092457172,0.21197031328115612,0.06550898294616313,1.4211583641411244e-07,0.18287598996711107,0.043388429752066124
229,0.1,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Can profound hypotensive events cause myocardial ischemia in patients with coronary disease? Answer: Yes, profound hypotensive events can cause myocardial ischemia in patients with coronary disease by reducing coronary blood flow and depriving the heart muscle of adequate oxygen and nutrients.",3.316036182995957e-07,0.3878201150919507,0.05908875688705234,0.025387970506946217,0.40536027542425535,0.07172871972318343,0.025351221573340132,0.4227578070807918,0.08236354305035627,3.316036182995957e-07,0.4231018505224018,0.0783673469387755
229,0.1,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Does profound hypotension in coronary disease patients increase the risk of myocardial ischemic events? Answer: Yes, profound hypotension increases the risk of myocardial ischemic events in patients with coronary disease by decreasing coronary blood flow and limiting oxygen and nutrient supply to the heart muscle.",2.3685972735685406e-07,0.20907247946893825,0.005611542570677253,0.018134264647818726,0.1966260115283034,0.005783224271267068,0.018108015409528666,0.2474141079728862,0.027540005068834073,2.3685972735685406e-07,0.2465811088961516,0.023795359904818555
229,0.1,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Question: Are myocardial ischemic events linked to profound hypotension in patients with coronary disease? Answer: Yes, myocardial ischemic events are linked to profound hypotension in patients with coronary disease because hypotension reduces coronary blood flow, causing the heart muscle to receive insufficient oxygen and nutrients.",2.6054570009253947e-07,0.33026629740074576,0.06645443594104317,0.0199476911126006,0.35077128590546547,0.0830358024691358,0.019918816950481533,0.3715008408795959,0.09801268364158175,2.6054570009253947e-07,0.3729198822302795,0.09642074506939374
230,0.1,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was about four times more likely to yield positive results compared to the general population, suggesting that physicians might consider recommending more systematic screening for these patients.",1.6580180914979784e-07,0.0725101167401263,0.03121748178980229,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
230,0.1,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it advisable to screen HIV-infected men older than 52 years who have at least two other cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? The likelihood of a positive SMI screening in this group was approximately four times higher than in the general population, which could encourage physicians to recommend more routine screening.",1.6580180914979784e-07,0.0725101167401263,0.03121748178980229,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
230,0.1,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should screening for silent myocardial ischemia with gated myocardial perfusion SPECT be performed in male HIV-infected patients over 52 years old who have at least two additional cardiovascular risk factors? These patients were about four times more likely to test positive than the general population, potentially prompting physicians to suggest more systematic screening.",2.8423167282822487e-07,0.1643176659932486,0.03121748178980229,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
230,0.1,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","In male HIV-infected patients older than 52 years with at least two other cardiovascular risk factors, is screening for silent myocardial ischemia using gated myocardial perfusion SPECT justified? The screening was roughly four times more likely to be positive compared to the general population, which may lead physicians to recommend more consistent screening.",2.8423167282822487e-07,0.1643176659932486,0.03121748178980229,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
230,0.1,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is screening for silent myocardial ischemia via gated myocardial perfusion SPECT recommended for male HIV-infected patients above 52 years with two or more cardiovascular risk factors? This group showed about a fourfold increase in positive screening results compared to the general population, possibly motivating physicians to advise more systematic screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.1,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should male HIV-infected patients aged over 52 with at least two cardiovascular risk factors undergo screening for silent myocardial ischemia using gated myocardial perfusion SPECT? The chance of a positive screening was about four times higher than in the general population, which might encourage physicians to promote more regular screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.1,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it beneficial to screen male HIV-infected patients older than 52 years with two or more cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was nearly four times more likely to be positive than in the general population, suggesting that physicians may recommend more systematic screening.",2.6054570009253947e-07,0.1452694710225555,0.03121748178980229,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
230,0.1,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","For male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors, should silent myocardial ischemia screening with gated myocardial perfusion SPECT be conducted? This group had about a fourfold higher likelihood of positive results compared to the general population, potentially prompting physicians to advise more thorough screening.",3.079176455639103e-07,0.1837357518503513,0.03121748178980229,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
230,0.1,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should physicians consider screening male HIV-infected patients older than 52 years with two or more cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? The screening was approximately four times more likely to be positive than in the general population, which may motivate more systematic screening recommendations.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.1,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it appropriate to screen male HIV-infected patients above 52 years with at least two cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? These patients were about four times more likely to have positive screening results than the general population, possibly encouraging physicians to suggest more consistent screening.",3.079176455639103e-07,0.1837357518503513,0.03121748178980229,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
231,0.1,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? Yes, it is generally regarded as less invasive than retropubic radical prostatectomy.",9.47438909427412e-08,0.1264088932565297,0.1573553719008265,0.007253705859127518,0.14772276350701796,0.20408163265306126,0.007243206163811494,0.04622197089373836,0.14876033057851235,9.474389094274162e-08,0.06344983825518646,0.0793950850661626
231,0.1,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Does robotically assisted laparoscopic radical prostatectomy involve less invasiveness than retropubic radical prostatectomy? Yes, it is considered to be less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.1,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Yes, it is viewed as less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.1,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than the retropubic approach? Yes, it is typically seen as less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.1,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Yes, it is considered less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.1,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy a minimally invasive alternative to retropubic radical prostatectomy? Yes, it is regarded as less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.1,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is generally accepted as less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.1,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is commonly considered less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
231,0.1,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is thought to be less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.1,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is recognized as less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
232,0.1,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","The Nd:YAG laser-induced thermo therapy represents a new method in glioma treatment, enabling local opening of the rodent blood-brain barrier.",6.158352911278184e-07,0.7081908038127809,0.109375,0.04714908808432881,0.7992978059457401,0.06781677572873293,0.04708084006477466,0.895747367890372,0.023242630385487524,6.158352911278203e-07,0.9650808960435868,0.0
232,0.1,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","In glioma therapy, Nd:YAG laser-induced thermo therapy is an innovative technique that locally disrupts the rodent blood-brain barrier.",6.632072365991891e-07,0.819416438923005,0.109375,0.05077594101389256,0.9170808416021239,0.06781677572873293,0.050702443146680404,1.0209105108443777,0.023242630385487524,6.63207236599191e-07,1.0986122886681096,0.0
232,0.1,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy offers a novel strategy for glioma treatment by locally opening the rodent blood-brain barrier.,6.632072365991891e-07,0.819416438923005,0.109375,0.05077594101389256,0.9170808416021239,0.06781677572873293,0.050702443146680404,1.0209105108443777,0.023242630385487524,6.63207236599191e-07,1.0986122886681096,0.0
232,0.1,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",A new concept in glioma therapy involves Nd:YAG laser-induced thermo therapy to locally open the rodent blood-brain barrier.,6.632072365991891e-07,0.819416438923005,0.109375,0.05077594101389256,0.9170808416021239,0.06781677572873293,0.050702443146680404,1.0209105108443777,0.023242630385487524,6.63207236599191e-07,1.0986122886681096,0.0
232,0.1,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",The use of Nd:YAG laser-induced thermo therapy introduces a fresh approach in glioma therapy through local opening of the rodent blood-brain barrier.,5.684633456564477e-07,0.6081073452557995,0.109375,0.04352223515476505,0.6939372902879146,0.06781677572873293,0.04345923698286891,0.7845217327801479,0.023242630385487524,5.684633456564495e-07,0.847297860387203,0.0
232,0.1,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Glioma therapy has advanced with Nd:YAG laser-induced thermo therapy, which locally opens the rodent blood-brain barrier.",7.105791820705599e-07,0.9445795818770106,0.109375,0.05440279394345631,1.0506122342266466,0.06781677572873293,0.05432404622858615,1.164011354485051,0.023242630385487524,7.105791820705618e-07,1.2527629684953672,0.0
232,0.1,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy is a pioneering glioma treatment method that locally opens the rodent blood-brain barrier.,6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.1,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Locoregional opening of the rodent blood-brain barrier using Nd:YAG laser-induced thermo therapy is a novel glioma treatment concept.,6.632072365991891e-07,0.819416438923005,0.109375,0.05077594101389256,0.9170808416021239,0.06781677572873293,0.050702443146680404,1.0209105108443777,0.023242630385487524,6.63207236599191e-07,1.0986122886681096,0.0
232,0.1,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",The novel glioma therapy concept involves Nd:YAG laser-induced thermo therapy to locally open the rodent blood-brain barrier.,6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.1,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy is a new glioma treatment approach that facilitates local opening of the rodent blood-brain barrier.,6.395212638635038e-07,0.7622580250830562,0.109375,0.048962514549110686,0.8564562197856889,0.06781677572873293,0.04889164160572752,0.956371989706807,0.023242630385487524,6.395212638635056e-07,1.0296194171811575,0.0
233,0.1,1,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Yes, colorectal cancer in young individuals is regarded as a distinct clinical entity. It usually exhibits more aggressive behavior and is frequently detected at advanced stages. Genetic predisposition,",0.0,0.07109201851896829,0.04904363706266818,0.0,0.03648143055578723,0.025898211136306366,0.0,0.0,0.0,0.0,0.0,0.0
233,0.1,2,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Yes, colorectal cancer in young patients is recognized as a distinct clinical entity. It tends to be more aggressive and is often diagnosed at later stages. Genetic predisposition,",2.36859727356853e-08,0.06441841816972405,0.026667093852791618,0.0018134264647818726,0.02878175029216612,0.001978458049886611,0.0018108015409528666,0.008827198864009844,0.025462962962962975,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
233,0.1,3,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in younger patients a distinct clinical condition? Answer: Yes, colorectal cancer in younger patients is considered a unique clinical entity. It often shows more aggressive characteristics and is commonly diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.0058288376710153855,0.021626297577854642,0.0018134264647818726,0.029626200911009093,0.0020824800508438407,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.1,4,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young individuals a separate clinical entity? Answer: Yes, colorectal cancer in young individuals is viewed as a distinct clinical entity. It tends to be more aggressive and is frequently identified at advanced stages. Genetic predisposition,",0.0,0.03554600925948437,0.02420803615563867,0.0,0.0,0.0,0.0,0.037467415165403306,0.026871378180902013,0.0,0.03850817669777484,0.02775510204081633
233,0.1,5,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients classified as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is classified as a distinct clinical entity. It generally presents more aggressively and is often diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.07421101794226592,0.06206747404844293,0.0018134264647818726,0.0778562774862861,0.07039298363973687,0.0018108015409528666,0.08179005997558386,0.07680005553419625,2.3685972735685406e-08,0.0475358561426904,0.05387755102040818
233,0.1,6,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young patients constitute a distinct clinical entity? Answer: Yes, colorectal cancer in young patients constitutes a distinct clinical entity. It tends to be more aggressive and is usually diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.06713402344055774,0.026911224048442928,0.0018134264647818726,0.06709361607641151,0.028152395944603725,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.1,7,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients considered a unique clinical entity? Answer: Yes, colorectal cancer in young patients is considered a unique clinical entity. It often behaves more aggressively and is commonly diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.10361545399634364,0.04938537207133578,0.0018134264647818726,0.10456103124181393,0.053468590561224494,0.0018108015409528666,0.10545608911603743,0.055638455259667374,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.1,8,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients identified as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is identified as a distinct clinical entity. It tends to be more aggressive and is frequently diagnosed at advanced stages. Genetic predisposition,",4.7371945471370706e-08,0.042755993834235895,0.05822220315771748,0.0036268529295637453,0.04720656811307311,0.06696137278440792,0.003621603081905733,0.05207288838711488,0.07421831695641223,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
233,0.1,9,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients regarded as a separate clinical entity? Answer: Yes, colorectal cancer in young patients is regarded as a separate clinical entity. It usually exhibits more aggressive features and is often diagnosed at advanced stages. Genetic predisposition,",4.7371945471370706e-08,0.042755993834235895,0.05822220315771748,0.0036268529295637453,0.04720656811307311,0.06696137278440792,0.003621603081905733,0.05207288838711488,0.07421831695641223,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
233,0.1,10,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients seen as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is seen as a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,",4.7371945471370706e-08,0.042755993834235895,0.05822220315771748,0.0036268529295637453,0.04720656811307311,0.06696137278440792,0.003621603081905733,0.05207288838711488,0.07421831695641223,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
234,0.1,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can analyzing APC mutations aid in making therapeutic choices for familial adenomatous polyposis? Yes, APC mutation analysis can assist in therapeutic decision-making for familial adenomatous polyposis by identifying mutation types, guiding targeted therapy selection, and predicting disease progression to tailor treatments.",2.6054570009253947e-07,0.09480295766718472,0.10157171129411868,0.0199476911126006,0.11765204522359829,0.09214532634326131,0.019918816950481533,0.14106725176220847,0.08098765432098766,2.6054570009253947e-07,0.17363970069367252,0.06222222222222222
234,0.1,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis useful for therapeutic decisions in familial adenomatous polyposis? Indeed, it helps determine the mutation type, informs targeted therapy options, and forecasts disease progression, allowing for personalized treatment strategies.",4.7371945471370717e-07,0.28038048923998016,0.15143320713899402,0.03626852929563749,0.34447030043160387,0.11776859504132227,0.036216030819057374,0.41135758150212176,0.08098765432098766,4.737194547137081e-07,0.45235310316269395,0.06222222222222222
234,0.1,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation analysis play a role in therapy decisions for familial adenomatous polyposis? Yes, it contributes by pinpointing mutation types, directing targeted treatments, and anticipating disease course to customize patient care.",4.7371945471370717e-07,0.28038048923998016,0.15143320713899402,0.03626852929563749,0.34447030043160387,0.11776859504132227,0.036216030819057374,0.41135758150212176,0.08098765432098766,4.737194547137081e-07,0.45235310316269395,0.06222222222222222
234,0.1,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can therapeutic decisions in familial adenomatous polyposis benefit from APC mutation analysis? Yes, this analysis identifies mutation specifics, aids in choosing targeted therapies, and predicts how the disease will progress, facilitating individualized treatment.",4.5003348197802187e-07,0.24863179092540033,0.15143320713899402,0.03445510283085561,0.31168047760861217,0.11776859504132227,0.0344052292781045,0.37745602982644,0.08098765432098766,4.500334819780227e-07,0.41726178335142494,0.06222222222222222
234,0.1,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis valuable for guiding therapy in familial adenomatous polyposis? Yes, it helps detect mutation types, supports targeted therapy selection, and forecasts disease progression, enabling tailored treatment plans.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.1,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does analyzing APC mutations influence therapeutic choices in familial adenomatous polyposis? Yes, it identifies mutation types, guides targeted therapy decisions, and predicts disease progression for personalized treatment.",5.921493183921337e-07,0.4562711557036443,0.15143320713899402,0.045335661619546885,0.5267918572255588,0.11776859504132227,0.04527003852382174,0.6005995811406497,0.08098765432098766,5.921493183921352e-07,0.6490633974087485,0.06222222222222222
234,0.1,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis inform treatment decisions in familial adenomatous polyposis? Yes, it assists in mutation identification, targeted therapy guidance, and disease progression prediction to customize therapy.",5.921493183921337e-07,0.4562711557036443,0.15143320713899402,0.045335661619546885,0.5267918572255588,0.11776859504132227,0.04527003852382174,0.6005995811406497,0.08098765432098766,5.921493183921352e-07,0.6490633974087485,0.06222222222222222
234,0.1,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation testing helpful for therapeutic planning in familial adenomatous polyposis? Yes, it reveals mutation types, directs targeted treatments, and anticipates disease progression, supporting personalized care.",5.921493183921337e-07,0.4562711557036443,0.15143320713899402,0.045335661619546885,0.5267918572255588,0.11776859504132227,0.04527003852382174,0.6005995811406497,0.08098765432098766,5.921493183921352e-07,0.6490633974087485,0.06222222222222222
234,0.1,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis impact therapeutic strategies in familial adenomatous polyposis? Yes, it helps identify mutation types, guides targeted therapy choices, and predicts disease progression for individualized treatment.",5.684633456564484e-07,0.4185308277207973,0.15143320713899402,0.043522235154765006,0.4875711440722763,0.11776859504132227,0.04345923698286887,0.5597775866203949,0.08098765432098766,5.684633456564497e-07,0.6065037829899529,0.06222222222222222
234,0.1,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation analysis contribute to treatment decisions in familial adenomatous polyposis? Yes, it aids in mutation identification, targeted therapy selection, and disease progression prediction, enabling personalized treatment approaches.",5.447773729207631e-07,0.3821631835499226,0.15143320713899402,0.041708808689983126,0.4498308160894293,0.11776859504132227,0.041648435441915994,0.5205568734671124,0.08098765432098766,5.447773729207643e-07,0.5656817884696981,0.06222222222222222
235,0.1,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms might trade off quality of life for experimental therapies.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.1,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered when choosing patients for phase I clinical trials? Answer: Older adults with more symptoms enrolled in PICT may compromise their quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.1,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in patient selection for phase I clinical trials? Answer: Older adults in PICT with increased symptoms might sacrifice quality of life in exchange for experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.1,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence significant when evaluating patients for phase I clinical trials? Answer: Older adults enrolled in PICT who exhibit more symptoms may give up quality of life for experimental therapies.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.1,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor in deciding patient eligibility for phase I clinical trials? Answer: Older adults with more symptoms in PICT might trade quality of life for access to experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.1,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom severity influence patient consideration for phase I clinical trials? Answer: Older adults participating in PICT with greater symptoms may sacrifice quality of life for experimental interventions.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
235,0.1,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom burden be assessed when enrolling patients in phase I clinical trials? Answer: Older adults in PICT with higher symptom levels might compromise quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.1,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms relevant when selecting patients for phase I clinical trials? Answer: Older adults enrolled in PICT who have more symptoms may exchange quality of life for experimental therapies.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.1,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms affect patient selection in phase I clinical trials? Answer: Older adults with increased symptoms in PICT might sacrifice quality of life for experimental treatment.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
235,0.1,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom consideration necessary when choosing patients for phase I clinical trials? Answer: Older adults in PICT with more symptoms may trade off quality of life for experimental treatment.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
236,0.1,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does a surgeon's prior experience affect their skill in performing transurethral resection of the prostate? The senior urologist was able to resect tissue at a rate four times higher than less experienced surgeons, suggesting that experience may be crucial in minimizing the risk of secondary TURP caused by recurring or incompletely removed adenomas.",1.6580180914979784e-07,0.12629372532429084,0.0,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
236,0.1,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the proficiency in transurethral resection of the prostate dependent on the surgeon's previous experience? The senior urologist resected tissue four times faster than inexperienced surgeons, indicating that experience might be key to lowering the chance of secondary TURP due to recurring or partially removed adenomas.",3.316036182995957e-07,0.2708749541353992,0.0,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
236,0.1,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does the surgeon's experience influence their ability to perform transurethral resection of the prostate? The senior urologist resected four times more tissue per unit time compared to less experienced surgeons, implying that experience could be important in reducing secondary TURP risks from recurring or incomplete adenomas.",3.316036182995957e-07,0.2708749541353992,0.0,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
236,0.1,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the capability to perform transurethral resection of the prostate affected by the surgeon's experience? The senior urologist resected tissue at a rate four times greater than that of inexperienced surgeons, suggesting that experience may help decrease the likelihood of secondary TURP caused by recurring or incompletely resected adenomas.",2.6054570009253947e-07,0.20633643299782767,0.0,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
236,0.1,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does prior surgical experience impact the ability to perform transurethral resection of the prostate? The senior urologist was able to resect four times more tissue per time unit than less experienced surgeons, indicating that experience might be vital to prevent secondary TURP due to recurring or incompletely removed adenomas.",2.6054570009253947e-07,0.20633643299782767,0.0,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
236,0.1,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the skill in performing transurethral resection of the prostate influenced by the surgeon's previous experience? The senior urologist resected tissue four times faster than less experienced surgeons, which suggests that experience may be important to reduce the risk of secondary TURP from recurring or incomplete adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.1,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does the surgeon's previous experience affect their ability to perform transurethral resection of the prostate? The senior urologist resected four times more tissue per unit time than less experienced surgeons, implying that experience could be crucial in minimizing secondary TURP caused by recurring or incompletely removed adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.1,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the ability to carry out transurethral resection of the prostate dependent on the surgeon's experience? The senior urologist resected tissue at a rate four times higher than less experienced surgeons, suggesting that experience may be key to lowering the risk of secondary TURP due to recurring or incomplete adenomas.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.1,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does experience influence a surgeon's ability to perform transurethral resection of the prostate? The senior urologist resected four times more tissue per time unit than less experienced surgeons, indicating that experience might be important to reduce secondary TURP risk from recurring or incompletely resected adenomas.",3.552895910352811e-07,0.2933478099874569,0.0,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
236,0.1,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the proficiency in transurethral resection of the prostate affected by the surgeon's prior experience? The senior urologist was capable of resecting tissue four times faster than less experienced surgeons, suggesting that experience may help decrease the chance of secondary TURP caused by recurring or incompletely removed adenomas.",2.8423167282822487e-07,0.22738984219566083,0.0,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
237,0.1,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not seem to enhance IVF results in the microdose leuprolide protocol versus standard OCP in poor responders. Well-powered randomized trials are warranted to determine the best steroid pretreatment method.,1.6580180914979784e-07,0.10678069945702084,0.007769350378881171,0.012693985253473108,0.07508202687326904,0.0322222222222222,0.012675610786670066,0.09916368054149594,0.016388888888888897,1.6580180914979784e-07,0.12405264866997845,0.0
237,0.1,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is estradiol and antagonist pretreatment prior to microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not improve IVF outcomes in the microdose leuprolide protocol when compared to the standard oral contraceptive pill in poor responders. Randomized controlled trials with sufficient power are needed to identify the optimal steroid pretreatment approach.,2.3685972735685406e-08,0.06249408464053108,0.032299112626644755,0.0018134264647818726,0.005732515000031135,0.015833333333333303,0.0018108015409528666,0.006196835116328181,0.016388888888888897,2.3685972735685406e-08,0.01680711831638071,0.0
237,0.1,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does using estradiol and antagonist before microdose leuprolide enhance IVF success in poor responders versus oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not appear to improve IVF outcomes in the microdose leuprolide protocol compared to standard OCP in poor responders. Adequately powered randomized trials are justified to explore the best steroid pretreatment strategy.,1.6580180914979784e-07,0.10678069945702084,0.007769350378881171,0.012693985253473108,0.10028737889363093,0.0140466392318244,0.012675610786670066,0.09916368054149594,0.016388888888888897,1.6580180914979784e-07,0.12405264866997845,0.0
237,0.1,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Estradiol and antagonist pretreatment before microdose leuprolide in IVF: does it improve outcomes in poor responders compared to oral contraceptive pills? Answer: E2 and antagonist pretreatment does not seem to improve IVF outcomes in the microdose leuprolide protocol relative to standard OCP in poor responders. Randomized trials with adequate sample size are needed to study optimal steroid pretreatment methods.,9.474389094274162e-08,0.07305649346843346,0.005243936850930234,0.0072537058591274906,0.04587382847518118,0.014986149584487515,0.007243206163811466,0.04509645927122108,0.016388888888888897,9.474389094274162e-08,0.06899287148694988,0.0
237,0.1,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol and antagonist prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not improve IVF outcomes in the microdose leuprolide protocol when compared to the standard OCP in poor responders. Randomized trials with sufficient power to evaluate steroid pretreatment methods are warranted.,1.4211583641411244e-07,0.1359858187864882,0.02503096083505793,0.010880558788691236,0.10657403426773016,0.0034430727023319688,0.0108648092457172,0.10601989389366206,0.0017866941015089038,1.4211583641411244e-07,0.10536051565782412,0.0
237,0.1,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is estradiol and antagonist pretreatment before microdose leuprolide effective in improving IVF outcomes in poor responders versus oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not appear to enhance IVF outcomes in the microdose leuprolide protocol compared to standard OCP in poor responders. Well-designed randomized trials are justified to determine the best steroid pretreatment.,1.6580180914979784e-07,0.1315359559055902,0.00965226033525017,0.012693985253473108,0.10028737889363093,0.0140466392318244,0.012675610786670066,0.09916368054149594,0.016388888888888897,1.6580180914979784e-07,0.12405264866997845,0.0
237,0.1,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF results in poor responders compared to oral contraceptive pills? Answer: E2 and antagonist pretreatment does not seem to improve IVF outcomes in the microdose leuprolide protocol relative to standard OCP in poor responders. Randomized controlled trials with adequate power are needed to identify optimal steroid pretreatment methods.,1.1842986367842703e-07,0.0921764884307743,0.006664390702722553,0.009067132323909363,0.0636848979750475,0.014683956916099746,0.009054007704764333,0.0627960363706217,0.016388888888888897,1.1842986367842703e-07,0.08701137698962835,0.0
237,0.1,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Estradiol and antagonist pretreatment before microdose leuprolide in IVF: does it enhance outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not improve IVF outcomes in the microdose leuprolide protocol versus standard OCP in poor responders. Randomized trials with sufficient power to study steroid pretreatment approaches are justified.,1.8948778188548325e-07,0.12659958724686815,0.006495375189547986,0.014507411718254981,0.0934311655414648,0.0322222222222222,0.014486412327622933,0.11785581355365027,0.016388888888888897,1.8948778188548325e-07,0.14310084364067155,0.0
237,0.1,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol and antagonist prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not appear to improve IVF outcomes in the microdose leuprolide protocol compared to standard OCP in poor responders. Randomized trials with adequate power are warranted to explore optimal steroid pretreatment methods.,1.1842986367842703e-07,0.11607811534663437,0.023295738378515257,0.009067132323909363,0.08800585167890596,0.002819100091827405,0.009054007704764333,0.0875512928191915,0.0014623507805325946,1.1842986367842703e-07,0.08701137698962835,0.0
237,0.1,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is estradiol and antagonist pretreatment before microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not improve IVF outcomes in the microdose leuprolide protocol relative to standard OCP in poor responders. Well-powered randomized trials are justified to determine the best steroid pretreatment approach.,1.8948778188548325e-07,0.1518049392672296,0.011224732461355497,0.014507411718254981,0.11910328333998166,0.01371029626992602,0.014486412327622933,0.11785581355365027,0.016388888888888897,1.8948778188548325e-07,0.14310084364067155,0.0
238,0.1,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access major surgery in newborns result in less pain? Minimal access major surgery in newborns is typically thought to cause less pain compared to traditional open surgery because,7.10579182070559e-08,0.1641695468318667,0.04248157596371885,0.005440279394345639,0.16566722708044512,0.043225623582766395,0.005432404622858621,0.16697359837426617,0.043048469387755126,7.105791820705622e-08,0.1680340659117241,0.04195011337868479
238,0.1,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is pain reduced with minimal access major surgery in newborns? Minimal access major surgery in newborns usually leads to less pain than conventional open surgery due to,1.421158364141118e-07,0.24762862519516204,0.026311350986675613,0.010880558788691277,0.24730918413328062,0.022105329735199797,0.010864809245717241,0.24624845733287337,0.016318097486928668,1.4211583641411244e-07,0.24427202810038162,0.008949654241862039
238,0.1,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Does minimal access major surgery cause less pain in newborns? Generally, minimal access major surgery in newborns is believed to be less painful than traditional open surgery because",1.184298636784265e-07,0.15064494844650955,0.013073979591836732,0.009067132323909398,0.14837117542406375,0.01927437641723359,0.009054007704764368,0.1453537071640909,0.026395975056689315,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.1,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is there less pain with minimal access major surgery in newborns? Minimal access major surgery in newborns is often considered to produce less pain than open surgery due to,9.47438909427412e-08,0.2077971619702299,0.04768334554994025,0.007253705859127518,0.15802552645386303,0.013711734693877528,0.007243206163811494,0.1573192473444669,0.010062358276644007,9.474389094274162e-08,0.1560685257313481,0.005491780045351467
238,0.1,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access major surgery in newborns hurt less than open surgery? Minimal access major surgery in newborns is generally regarded as less painful than traditional open surgery because,9.47438909427412e-08,0.2077971619702299,0.04768334554994025,0.007253705859127518,0.20936976205089497,0.0480040314802669,0.007243206163811494,0.21063826123369234,0.04709501948227307,9.474389094274162e-08,0.21152030017614498,0.0449563095559585
238,0.1,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is minimal access major surgery less painful for newborns? Minimal access major surgery in newborns tends to cause less pain than conventional open surgery due to,1.658018091497971e-07,0.23992860612592715,0.004680384550514463,0.012693985253473157,0.23730038541247023,0.01301863720694893,0.012675610786670115,0.23355720953312442,0.022938100860178744,1.6580180914979784e-07,0.2284501227964375,0.03443877551020409
238,0.1,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access major surgery reduce pain in newborns? Minimal access major surgery in newborns is commonly thought to cause less pain than traditional open surgery because,1.421158364141118e-07,0.19430961130593571,0.009027429497318787,0.010880558788691277,0.19185740968848464,0.01626818023995988,0.010864809245717241,0.1884861922862111,0.024738628910921615,1.4211583641411244e-07,0.18399836022560345,0.03443877551020409
238,0.1,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is pain less severe with minimal access major surgery in newborns? Minimal access major surgery in newborns is usually considered to be less painful than open surgery due to,9.47438909427412e-08,0.15828664907309165,0.016439909297052135,0.007253705859127518,0.15802552645386303,0.013711734693877528,0.007243206163811494,0.1573192473444669,0.010062358276644007,9.474389094274162e-08,0.1560685257313481,0.005491780045351467
238,0.1,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access major surgery in newborns lead to less pain? Minimal access major surgery in newborns is generally believed to cause less pain than traditional open surgery because,9.47438909427412e-08,0.2077971619702299,0.04768334554994025,0.007253705859127518,0.20936976205089497,0.0480040314802669,0.007243206163811494,0.21063826123369234,0.04709501948227307,9.474389094274162e-08,0.21152030017614498,0.0449563095559585
238,0.1,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is minimal access major surgery associated with less pain in newborns? Minimal access major surgery in newborns is typically seen as less painful than conventional open surgery due to,9.47438909427412e-08,0.10877613617595161,0.01684897959183669,0.007253705859127518,0.10668129085682976,0.022063265306122487,0.007243206163811494,0.10400023345524012,0.027926530612244864,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
239,0.1,1,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in patients with hypertension? Research suggests a possible association between ACE-1 gene polymorphism and chronic kidney disease among hypertensive individuals, though the connection is not fully established.",4.73719454713706e-08,0.20086715966627589,0.10248225415512466,0.0036268529295637453,0.16696738488754592,0.08089647418531828,0.003621603081905733,0.13108357466582587,0.055363321799307974,4.737194547137081e-08,0.0951782614725234,0.02854671280276816
239,0.1,2,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there a connection between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients? Studies show a potential link between ACE-1 gene polymorphism and chronic kidney disease in those with hypertension, but the relationship remains unclear.",0.0,0.0,0.0,0.0,0.03746741516540242,0.02531619461662077,0.0,0.07701635339554969,0.054011678200692026,0.0,0.07921682063542246,0.05641422469723184
239,0.1,3,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in patients suffering from hypertension? Evidence points to a possible association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, although the link is not definitive.",2.36859727356853e-08,0.042350675590948406,0.04582400711662077,0.0018134264647818726,0.045454333077945996,0.05115642108407126,0.0018108015409528666,0.009237066111141612,0.026816608996539815,2.3685972735685406e-08,0.010620873444459722,0.02854671280276816
239,0.1,4,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among individuals with hypertension? Research indicates a potential correlation between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, but the relationship is not completely understood.",4.73719454713706e-08,0.16620980063827906,0.07783681062819577,0.0036268529295637453,0.16696738488754592,0.08089647418531828,0.003621603081905733,0.13108357466582587,0.055363321799307974,4.737194547137081e-08,0.0951782614725234,0.02854671280276816
239,0.1,5,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is angiotensin-converting enzyme-1 (ACE-1) gene polymorphism a factor in the development of chronic kidney disease in hypertensive patients? Studies suggest a possible connection between ACE-1 gene polymorphism and chronic kidney disease in those with hypertension, though the association is not fully confirmed.",7.1057918207056e-08,0.1596262599594822,0.05592300493060626,0.005440279394345618,0.15851648407532748,0.056658247038503896,0.0054324046228586,0.12151305180959993,0.02974005310124702,7.105791820705622e-08,0.12184650855468426,0.02854671280276816
239,0.1,6,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism influence the risk of chronic kidney disease in patients with hypertension? Research points to a potential link between ACE-1 gene polymorphism and chronic kidney disease among hypertensive individuals, but the relationship is not entirely clear.",4.73719454713706e-08,0.16620980063827906,0.07783681062819577,0.0036268529295637453,0.16696738488754592,0.08089647418531828,0.003621603081905733,0.13108357466582587,0.055363321799307974,4.737194547137081e-08,0.0951782614725234,0.02854671280276816
239,0.1,7,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there evidence that angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contributes to chronic kidney disease in hypertensive patients? Studies indicate a possible association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, though the connection is not fully established.",2.36859727356853e-08,0.06713402344055774,0.026911224048442928,0.0018134264647818726,0.06709361607641151,0.028152395944603725,0.0018108015409528666,0.029480497252859283,0.0014857707788997962,2.3685972735685406e-08,0.02927111058663323,0.0007916107619518296
239,0.1,8,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene lead to chronic kidney disease in patients with hypertension? Research suggests a potential link between ACE-1 gene polymorphism and chronic kidney disease among hypertensive individuals, but the relationship is not completely understood.",2.36859727356853e-08,0.17377205121900996,0.10121153670562455,0.0018134264647818726,0.14005647718798553,0.08022317604627185,0.0018108015409528666,0.10441532758366501,0.055363321799307974,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
239,0.1,9,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism have a role in chronic kidney disease development among hypertensive patients? Studies show a possible association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, although the link is not definitive.",0.0,0.10944429166735992,0.0739764030612245,0.0,0.11240224549620859,0.07951357004387306,0.0,0.07701635339554969,0.055363321799307974,0.0,0.03960841031771123,0.02854671280276816
239,0.1,10,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism associated with chronic kidney disease in patients with hypertension? Evidence points to a potential connection between ACE-1 gene polymorphism and chronic kidney disease in hypertensive individuals, but the relationship is not entirely clear.",2.36859727356853e-08,0.10268003270004211,0.0511192602040816,0.0018134264647818726,0.10357504663219874,0.05405060708091009,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
240,0.1,1,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care during a woman's initial pregnancy affect her subsequent reproductive outcomes? Yes, birth center care in a first pregnancy can influence future reproduction by offering thorough prenatal support, encouraging healthy habits, and lowering complication risks.",1.8948778188548304e-07,0.02292342637516942,0.11373585034711531,0.014507411718254981,0.04837274414217729,0.1031713419533933,0.014486412327622933,0.04313724533489216,0.11176857330703485,1.8948778188548325e-07,0.0768944392162525,0.09204470742932283
240,0.1,2,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care in a woman's first pregnancy influence her future reproductive health? Indeed, it can, as it delivers comprehensive prenatal care, fosters healthy pregnancy behaviors, and minimizes complications.",4.0266153650665074e-07,0.22025089500350958,0.16620498614958445,0.030828249901291883,0.2896187314457963,0.13017751479289946,0.030783626196198788,0.33081931778667295,0.11176857330703485,4.026615365066519e-07,0.37414596268418343,0.09204470742932283
240,0.1,3,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an effect of birth center care during a woman's first pregnancy on her later reproductive health? Yes, such care provides extensive prenatal services, promotes healthy habits, and decreases the chance of complications, impacting future reproduction.",2.3685972735685364e-07,0.004027786533872479,0.16620498614958445,0.018134264647818726,0.06647518013158704,0.13017751479289946,0.018108015409528673,0.10029565917484051,0.11176857330703485,2.3685972735685406e-07,0.13573493923918578,0.09204470742932283
240,0.1,4,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does care at a birth center during a woman's first pregnancy impact her future reproductive outcomes? Yes, because it offers complete prenatal care, supports healthy pregnancy practices, and reduces complication risks.",3.7897556377096544e-07,0.18634934332782782,0.16620498614958445,0.029014823436510004,0.2545274116345273,0.13017751479289946,0.028972824655245914,0.29445167361579827,0.11176857330703485,3.789755637709665e-07,0.33640563470133644,0.09204470742932283
240,0.1,5,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care during a woman's initial pregnancy affect her future reproductive health? Yes, it can positively influence future reproduction by providing comprehensive prenatal care, encouraging healthy habits, and lowering the risk of complications.",2.8423167282822424e-07,0.06118620037382083,0.16620498614958445,0.021761117577382486,0.12531568015452033,0.13017751479289946,0.02172961849143442,0.16092028099127598,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
240,0.1,6,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care in a woman's first pregnancy have consequences for her future reproduction? Yes, it does by delivering thorough prenatal care, promoting healthy pregnancy behaviors, and reducing complications.",3.7897556377096544e-07,0.18634934332782782,0.16620498614958445,0.029014823436510004,0.2545274116345273,0.13017751479289946,0.028972824655245914,0.29445167361579827,0.11176857330703485,3.789755637709665e-07,0.33640563470133644,0.09204470742932283
240,0.1,7,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is birth center care during a woman's first pregnancy influential on her future reproductive health? Yes, it is, as it ensures comprehensive prenatal care, supports healthy habits, and decreases complication risks.",3.7897556377096544e-07,0.18634934332782782,0.16620498614958445,0.029014823436510004,0.2545274116345273,0.13017751479289946,0.028972824655245914,0.29445167361579827,0.11176857330703485,3.789755637709665e-07,0.33640563470133644,0.09204470742932283
240,0.1,8,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does birth center care in a first pregnancy impact a woman's future reproductive outcomes? Yes, it provides full prenatal care, encourages healthy pregnancy habits, and lowers the risk of complications.",4.0266153650665074e-07,0.22025089500350958,0.16620498614958445,0.030828249901291883,0.2896187314457963,0.13017751479289946,0.030783626196198788,0.33081931778667295,0.11176857330703485,4.026615365066519e-07,0.37414596268418343,0.09204470742932283
240,0.1,9,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can care at a birth center during a woman's first pregnancy affect her future reproduction? Yes, it can, by offering comprehensive prenatal care, fostering healthy habits, and minimizing complications.",4.2634750924233604e-07,0.2553422148147786,0.16620498614958445,0.03264167636607376,0.325986375616671,0.13017751479289946,0.03259442773715166,0.36855964576951994,0.11176857330703485,4.263475092423373e-07,0.4133666758374659,0.09204470742932283
240,0.1,10,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does birth center care during a woman's first pregnancy have an effect on her future reproductive health? Yes, it does by providing thorough prenatal care, promoting healthy pregnancy behaviors, and reducing the risk of complications.",2.8423167282822424e-07,0.06118620037382083,0.16620498614958445,0.021761117577382486,0.12531568015452033,0.13017751479289946,0.02172961849143442,0.16092028099127598,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
241,0.1,1,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there a link between the CYP2D6*4 allele and breast cancer risk? Yes, multiple studies have shown an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.12425081286987005,0.06977315689981095,0.005440279394345639,0.1925455059424257,0.04861111111111113,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.1,2,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele relate to breast cancer risk? Yes, research has found a connection between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.1,3,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is the CYP2D6*4 allele associated with breast cancer risk? Yes, several studies suggest a relationship between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.1,4,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there any correlation between the CYP2D6*4 allele and breast cancer risk? Yes, numerous studies have reported an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.12425081286987005,0.06977315689981095,0.005440279394345639,0.1925455059424257,0.04861111111111113,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.1,5,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele influence breast cancer risk? Yes, evidence from various studies indicates an association between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.10776005525117771,0.1522731568998109,0.010880558788691277,0.10613338527923633,0.09353741496598636,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.1,6,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is breast cancer risk linked to the CYP2D6*4 allele? Yes, several studies have demonstrated a connection between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.047486387376399986,0.19360535644629617,0.010880558788691277,0.04312000522833204,0.13888888888888887,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.1,7,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there an association between the CYP2D6*4 allele and breast cancer risk? Yes, research has identified a link between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.1762680893565669,0.06370667490535112,0.007253705859127518,0.2449199534720119,0.055016928285626404,0.007243206163811494,0.2987488503802247,0.09260498614958453,9.474389094274162e-08,0.30277521092665216,0.09456398891966755
241,0.1,8,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Can the CYP2D6*4 allele affect breast cancer risk? Yes, multiple studies have found an association between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.1,9,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is the presence of the CYP2D6*4 allele connected to breast cancer risk? Yes, various studies have indicated a relationship between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.03570622879781027,0.16635160680529298,0.005440279394345639,0.02926159183675736,0.09895833333333331,0.005432404622858621,0.015094564462317717,0.07359999999999998,7.105791820705622e-08,0.06928330820310613,0.03840000000000001
241,0.1,10,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there any evidence linking the CYP2D6*4 allele to breast cancer risk? Yes, several studies have shown an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.03570622879781027,0.16635160680529298,0.005440279394345639,0.02926159183675736,0.09895833333333331,0.005432404622858621,0.015094564462317717,0.07359999999999998,7.105791820705622e-08,0.06928330820310613,0.03840000000000001
242,0.1,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Yes, studies indicate a strong correlation between hs-CRP levels and carotid atherosclerosis in this population. Elevated hs-CRP is a dependable marker for carotid disease.",1.4211583641411212e-07,0.10148742981067471,0.03381610098821991,0.010880558788691236,0.13214600742852856,0.015642595360455328,0.0108648092457172,0.1640203579443158,0.0041717128027681585,1.4211583641411244e-07,0.16251892949777424,0.0
242,0.1,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Koreans? Research shows a significant association, with higher hs-CRP levels reliably indicating carotid atherosclerosis.",4.737194547137063e-07,0.46450888102954213,0.11426592797783926,0.03626852929563754,0.5476061391307736,0.0710059171597633,0.03621603081905743,0.6352375713925964,0.024375,4.7371945471370807e-07,0.6931471805599458,0.0
242,0.1,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis among healthy Koreans? Evidence suggests a notable link, where increased hs-CRP levels serve as a reliable sign of carotid atherosclerosis.",3.789755637709651e-07,0.30416623095436224,0.11426592797783926,0.029014823436510025,0.38055205446760665,0.0710059171597633,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
242,0.1,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Are high-sensitivity C-reactive protein levels associated with carotid atherosclerosis in healthy Koreans? Yes, findings reveal a significant relationship, with elevated hs-CRP being a trustworthy marker for carotid atherosclerosis.",3.789755637709651e-07,0.30416623095436224,0.11426592797783926,0.029014823436510025,0.38055205446760665,0.0710059171597633,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
242,0.1,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Does research support an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Yes, elevated hs-CRP levels are significantly linked to carotid atherosclerosis and are considered reliable indicators.",3.316036182995945e-07,0.2805105208039387,0.07982715246763517,0.025387970506946266,0.306444082313885,0.0710059171597633,0.025351221573340188,0.3839231431116885,0.024375,3.316036182995957e-07,0.43078291609245367,0.0
242,0.1,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Studies confirm a significant correlation, with high hs-CRP levels indicating carotid atherosclerosis.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.1,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is high-sensitivity C-reactive protein a marker for carotid atherosclerosis in healthy Koreans? Research suggests a strong association, where elevated hs-CRP reliably indicates the presence of carotid atherosclerosis.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.1,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Do high-sensitivity C-reactive protein levels correlate with carotid atherosclerosis in healthy Koreans? Yes, research supports a significant association, with increased hs-CRP levels serving as a reliable indicator.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.1,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid",Is there a significant relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Evidence shows that elevated hs-CRP is a dependable marker for carotid atherosclerosis.,4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.1,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Are elevated high-sensitivity C-reactive protein levels linked to carotid atherosclerosis in healthy Koreans? Studies suggest a significant association, with hs-CRP being a reliable indicator of carotid atherosclerosis.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
243,0.1,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Primary eosinophilic esophagitis features a delicate esophageal lining that tears easily with minimal trauma during routine endoscopy. This 'crpe-paper' appearance can help endoscopists identify the disease even when other mucosal changes are absent. Dilation proves to be an effective treatment.,1.1842986367842703e-07,0.06850434054219878,0.01557782876464196,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
243,0.1,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Could the fragile nature of the esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? In this condition, the esophageal mucosa is notably fragile and tears easily during minor trauma in diagnostic endoscopy. The 'crpe-paper' sign may help clinicians detect the disease when other mucosal abnormalities are not present. Dilation is a beneficial intervention.",4.737194547137081e-08,0.036798578876688914,0.0012265194143500774,0.0036268529295637453,0.060923434622440986,0.0181755829903978,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
243,0.1,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Does the fragility of the esophageal mucosa represent a characteristic endoscopic sign of primary eosinophilic esophagitis? This disease is marked by an esophageal mucosa that is easily torn by slight trauma during otherwise routine endoscopy. The 'crpe-paper' sign can alert endoscopists to the disease even if other mucosal changes are missing. Dilation is an effective treatment option.,4.737194547137081e-08,0.012043322428119119,0.0165875358407826,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
243,0.1,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the fragile esophageal mucosa a diagnostic endoscopic hallmark of primary eosinophilic esophagitis? The condition is defined by mucosa that tears readily with minor trauma during diagnostic endoscopy. This 'crpe-paper' sign may indicate the disease's presence when other mucosal signs are absent. Dilation is effective in management.,2.8423167282822487e-07,0.18399836022560434,0.03443877551020409,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
243,0.1,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Can fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? The disease is characterized by mucosa that is easily torn during minor trauma in diagnostic endoscopy. The 'crpe-paper' sign may help endoscopists recognize the disease when other mucosal changes are not evident. Dilation is an effective treatment.,1.4211583641411244e-07,0.08805554507788438,0.015215399885444382,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
243,0.1,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the esophageal mucosa's fragility a definitive endoscopic marker of primary eosinophilic esophagitis? This condition involves mucosa that tears easily with slight trauma during routine endoscopy. The 'crpe-paper' sign can alert clinicians to the disease even when other mucosal alterations are absent. Dilation is a useful therapeutic approach.,2.6054570009253947e-07,0.16249215500464098,0.03443877551020409,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
243,0.1,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Does primary eosinophilic esophagitis present with fragile esophageal mucosa as a pathognomonic endoscopic sign? The mucosa in this disease tears easily during minor trauma in diagnostic endoscopy. The 'crpe-paper' sign may help identify the disease when other mucosal changes are lacking. Dilation is effective for treatment.,3.079176455639103e-07,0.20597726694437934,0.03443877551020409,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
243,0.1,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is fragile esophageal mucosa an endoscopic hallmark of primary eosinophilic esophagitis? The disease is characterized by mucosa that tears readily with minimal trauma during diagnostic endoscopy. This 'crpe-paper' sign can alert endoscopists to the disease even if other mucosal abnormalities are absent. Dilation is an effective intervention.,2.8423167282822487e-07,0.21413519416299298,0.012710380448475694,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
243,0.1,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Could the fragile nature of the esophageal mucosa be a pathognomonic sign of primary eosinophilic esophagitis during endoscopy? This condition features mucosa that tears easily with minor trauma during diagnostic procedures. The 'crpe-paper' sign may help detect the disease when other mucosal changes are missing. Dilation is beneficial for treatment.,2.1317375462116866e-07,0.12081945860407206,0.03443877551020409,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
243,0.1,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the fragility of the esophageal mucosa a characteristic endoscopic sign of primary eosinophilic esophagitis? The disease involves mucosa that tears easily during minor trauma in diagnostic endoscopy. The 'crpe-paper' sign may alert endoscopists to the disease's presence when other mucosal alterations are absent. Dilation is an effective treatment.,2.3685972735685406e-07,0.14143874580680782,0.03443877551020409,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
244,0.1,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Early discharge from Winnipeg hospitals might influence care quality, contingent on the patient's health status and the availability of follow-up care. Insufficient home care or post-discharge support could raise readmission rates, suggesting a decline in overall care quality.",1.1842986367842703e-07,0.023521794623059478,0.048508284023668656,0.009067132323909363,0.046442531040014945,0.03379978640085441,0.009054007704764333,0.044899475763602315,0.03631185475258099,1.1842986367842703e-07,0.07149163065513164,0.01851192595229618
244,0.1,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Is the quality of care compromised by earlier patient discharge from Winnipeg hospitals? Answer: The quality of care may be affected by earlier discharge from Winnipeg hospitals, depending on the patient's condition and the support they receive after discharge. Lack of proper home care or follow-up can lead to higher readmission risks, reflecting a potential drop in care standards.",4.737194547137081e-08,0.015111857018945685,0.01348331440993758,0.0036268529295637453,0.03765220840939687,0.001829538466970107,0.003621603081905733,0.06180783293894487,0.018773589446458534,4.737194547137081e-08,0.062039761969391094,0.01851192595229618
244,0.1,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does earlier discharge from Winnipeg hospitals harm the quality of patient care? Answer: Discharging patients sooner from Winnipeg hospitals could impact care quality, based on individual health needs and post-discharge support. Without sufficient home care, the chance of readmission might increase, indicating a possible reduction in care quality.",2.1317375462116866e-07,0.10800775345403135,0.04532038232234541,0.016320838183036854,0.1304339443840612,0.0321332457581323,0.0162972138685758,0.1282810847026532,0.03631185475258099,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
244,0.1,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: How does earlier discharge from Winnipeg hospitals affect the quality of care? Answer: The effect of earlier discharge on care quality in Winnipeg hospitals depends on the patient's condition and the follow-up care provided. Inadequate home or post-discharge care may increase readmission rates, signaling a decrease in overall care quality.",1.6580180914979784e-07,0.06487526833191071,0.0469777284681131,0.012693985253473108,0.059265623278813795,0.0533997864008544,0.012675610786670066,0.08572147028385668,0.03631185475258099,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
244,0.1,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does releasing patients earlier from Winnipeg hospitals reduce the quality of care? Answer: Early patient discharge from Winnipeg hospitals can potentially reduce care quality, depending on the patient's health and the level of follow-up care. Without adequate support at home, the risk of readmission may rise, indicating diminished care quality.",1.6580180914979784e-07,0.06487526833191071,0.0469777284681131,0.012693985253473108,0.08755734493432188,0.033000480845298844,0.012675610786670066,0.08572147028385668,0.03631185475258099,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
244,0.1,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Is patient care quality impacted by earlier discharge from Winnipeg hospitals? Answer: Earlier discharge from Winnipeg hospitals might impact the quality of patient care, influenced by the patient's condition and the post-discharge care available. Insufficient home care support could lead to increased readmissions, suggesting a decline in care quality.",1.8948778188548325e-07,0.11450136617115758,0.025944200847865292,0.014507411718254981,0.13764717552821137,0.011811884699531143,0.014486412327622933,0.13627050418636832,0.015045314109858886,1.8948778188548325e-07,0.13467053227666392,0.01851192595229618
244,0.1,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Can discharging patients earlier from Winnipeg hospitals affect care quality? Answer: Discharging patients earlier from Winnipeg hospitals may affect care quality depending on individual health status and follow-up care. Lack of adequate home or post-discharge support could increase readmission risks, indicating reduced overall care quality.",2.8423167282822487e-07,0.2996232576942601,0.043269230769230796,0.02176111757738247,0.2929230475729878,0.036600213599145594,0.0217296184914344,0.2924405767391085,0.033063145247419004,2.8423167282822487e-07,0.29165632767857463,0.028988074047703833
244,0.1,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does earlier discharge from Winnipeg hospitals lead to poorer quality of care? Answer: Earlier discharge from Winnipeg hospitals could lead to poorer care quality, contingent on the patient's condition and the follow-up care provided. Without sufficient home care, readmission rates may rise, reflecting a decrease in care quality.",2.1317375462116866e-07,0.22353228354735588,0.03554069556816809,0.016320838183036854,0.21892081849809664,0.030970143290870854,0.0162972138685758,0.18855475257743093,0.007076574999485136,2.1317375462116866e-07,0.18745598035365862,0.00369881784935671
244,0.1,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: What is the impact of earlier patient discharge from Winnipeg hospitals on care quality? Answer: The impact depends on the patient's health and the follow-up care after discharge. Early discharge without adequate home support may increase readmissions, indicating a potential decline in care quality.",3.079176455639103e-07,0.16876355542245136,0.06419330295281955,0.023574544042164344,0.18988580569587832,0.0533997864008544,0.023540420032387266,0.21925286290837986,0.03631185475258099,3.079176455639103e-07,0.2497398620614506,0.01851192595229618
244,0.1,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Question: Does discharging patients earlier from Winnipeg hospitals compromise the quality of care? Answer: Discharging patients earlier from Winnipeg hospitals might compromise care quality, depending on individual patient conditions and the availability of post-discharge support. Insufficient home care can raise the risk of readmission, suggesting a reduction in overall care quality.",1.6580180914979784e-07,0.14805292999910424,0.011857148075096788,0.012693985253473108,0.1724325099008457,0.027587867920133256,0.012675610786670066,0.17236486785384963,0.025910367469641232,1.6580180914979784e-07,0.17215557646505752,0.02395720985017295
245,0.1,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a link between androgens and sexual desire in women? The current study found that FT and androstenedione showed a statistically significant correlation with sexual desire across the entire group of women. ADT-G did not show a stronger correlation than circulating androgens and thus is not a better measure than circulating androgens assessed by mass spectrometry.,0.0,0.05885422975007737,0.07459408284023672,0.0,0.02520535202036145,0.01813627176218319,0.0,0.0,0.0,0.0,0.0,0.0
245,0.1,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does a relationship exist between androgens and sexual desire in women? This study demonstrated that FT and androstenedione were significantly correlated with sexual desire in the overall female cohort. ADT-G did not correlate more strongly than circulating androgens, indicating it is not superior to measuring circulating androgens via mass spectrometry.",1.6580180914979784e-07,0.0322395803911828,0.1048575826165686,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.1,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there an association between androgens and sexual desire in women? The present research revealed that FT and androstenedione had a statistically significant correlation with sexual desire among all women studied. ADT-G did not correlate more strongly than circulating androgens, so it is not better than measuring circulating androgens by mass spectrometry.",1.1842986367842703e-07,0.037166955158631776,0.12600000000000006,0.009067132323909363,0.044899475763602315,0.036311854752580995,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.1,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens related to sexual desire in women? In this study, FT and androstenedione were found to be statistically significantly correlated with sexual desire in the total female cohort. ADT-G did not show a stronger correlation than circulating androgens and therefore is not superior to measuring circulating androgens using mass spectrometry.",1.4211583641411244e-07,0.03863109142984156,0.0858444545043006,0.010880558788691236,0.09339390473662901,0.01591254919702544,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.1,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a correlation between androgens and sexual desire in women? The study found that FT and androstenedione were significantly correlated with sexual desire in the entire group of women. ADT-G did not correlate more strongly than circulating androgens, so it is not a better marker than measuring circulating androgens by mass spectrometry.",9.474389094274162e-08,0.03044826950140722,0.10720000000000002,0.0072537058591274906,0.052279090842322073,0.016711854752581003,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.1,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does androgen level correlate with sexual desire in women? The current study showed that FT and androstenedione had a statistically significant correlation with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens and is thus not superior to measuring circulating androgens by mass spectrometry.,1.1842986367842703e-07,0.044379771966069015,0.06773671344499775,0.009067132323909363,0.10035125020839786,0.0036187008029745713,0.009054007704764333,0.12545547010915659,0.020399305555555556,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.1,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is sexual desire in women correlated with androgens? This study found that FT and androstenedione were statistically significantly correlated with sexual desire in the overall female cohort. ADT-G did not show a stronger correlation than circulating androgens and is therefore not better than measuring circulating androgens by mass spectrometry.,1.8948778188548325e-07,0.11179995437622692,0.06295537190082648,0.014507411718254981,0.13627050418636832,0.015045314109858893,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
245,0.1,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a connection between androgens and sexual desire in women? The present study demonstrated that FT and androstenedione were significantly correlated with sexual desire in the total group of women. ADT-G did not correlate more strongly than circulating androgens, indicating it is not superior to measuring circulating androgens by mass spectrometry.",1.1842986367842703e-07,0.009984712783731808,0.10644964598084133,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.1,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are androgens linked to sexual desire in women? The study revealed that FT and androstenedione had a statistically significant correlation with sexual desire in the entire female cohort. ADT-G did not correlate more strongly than circulating androgens and is therefore not a better measure than circulating androgens measured by mass spectrometry.,1.4211583641411244e-07,0.06635697865223955,0.06620491493383746,0.010880558788691236,0.12168562639213665,0.004430562630850433,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.1,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a statistical correlation between androgens and sexual desire in women? The current research found that FT and androstenedione were significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens and thus is not superior to measuring circulating androgens by mass spectrometry.,9.474389094274162e-08,0.022870744387819553,0.06921111111111115,0.0072537058591274906,0.052279090842322073,0.016711854752581003,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
246,0.1,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does participating in a medically supervised weight loss program before surgery enhance the results of bariatric surgery? Yes, engaging in such a program preoperatively can greatly improve the outcomes of bariatric surgery by boosting physical fitness and reducing surgical risks, which results in safer operations, fewer complications, and better overall results.",1.1842986367842703e-07,0.32408695930118636,0.14947509392391595,0.009067132323909363,0.296670804345077,0.13296398891966763,0.009054007704764333,0.23895851020222514,0.09204470742932283,1.1842986367842703e-07,0.21149900922096876,0.0710059171597633
246,0.1,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can a medically supervised weight loss program prior to surgery improve the success of bariatric surgery? Indeed, undergoing a preoperative medically supervised weight loss program significantly benefits bariatric surgery outcomes by improving patients' physical condition and minimizing surgical risks, leading to safer procedures and fewer complications.",0.0,0.12322616543287968,0.08142393241353002,0.0,0.0945200700763551,0.0651472131909347,0.0,0.06447880749394796,0.045643755614926625,0.0,0.06601401719618716,0.047210557254944746
246,0.1,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? Yes, such a program before surgery can markedly enhance outcomes by increasing physical fitness and decreasing surgical risks, resulting in safer surgeries and reduced complications.",1.1842986367842703e-07,0.1286692952093751,0.1694667640613587,0.009067132323909363,0.06841215236409459,0.13296398891966763,0.009054007704764333,0.005343659020720537,0.09204470742932283,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
246,0.1,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a medically supervised weight loss regimen before bariatric surgery improve surgical outcomes? Yes, preoperative participation in a medically supervised weight loss program can substantially improve bariatric surgery results by enhancing physical fitness and lowering the risk of complications, ensuring safer procedures.",9.474389094274162e-08,0.01569838014170255,0.04986799862925988,0.0072537058591274906,0.0102421167356046,0.05845704954786339,0.007243206163811466,0.03977287309498978,0.04091249413494738,9.474389094274162e-08,0.037543863318489024,0.044709350322655925
246,0.1,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Will a preoperative medically supervised weight loss program improve the results of bariatric surgery? Yes, it can significantly enhance outcomes by improving patients' physical fitness and reducing surgical risks, which leads to safer surgeries and fewer complications.",2.1317375462116823e-07,0.023308779551549197,0.1694667640613587,0.016320838183036854,0.03980143227613642,0.13296398891966763,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.1,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does engaging in a medically supervised weight loss program before bariatric surgery improve the surgery's success? Yes, such a program pre-surgery can greatly improve outcomes by boosting physical fitness and lowering surgical risks, resulting in safer procedures and fewer complications.",1.4211583641411233e-07,0.10335148722508336,0.1694667640613587,0.010880558788691236,0.04243666596083662,0.13296398891966763,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,0.1,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can bariatric surgery outcomes be improved by a preoperative medically supervised weight loss program? Yes, this program enhances physical fitness and reduces surgical risks before surgery, leading to safer operations and better results with fewer complications.",2.3685972735685353e-07,0.004862097415147648,0.1694667640613587,0.018134264647818733,0.06878896914938792,0.13296398891966763,0.01810801540952868,0.13573493923918578,0.09204470742932283,2.3685972735685406e-07,0.1729126896893627,0.0710059171597633
246,0.1,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is a preoperative medically supervised weight loss program effective in improving bariatric surgery outcomes? Yes, it significantly improves outcomes by enhancing physical fitness and decreasing surgical risks, which results in safer surgeries and fewer complications.",2.6054570009253883e-07,0.033849634288399155,0.1694667640613587,0.019947691112600613,0.0986419322990697,0.13296398891966763,0.019918816950481553,0.16650659790593947,0.09204470742932283,2.6054570009253947e-07,0.2046613880039425,0.0710059171597633
246,0.1,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a medically supervised weight loss program before bariatric surgery lead to better surgical outcomes? Yes, participating in such a program preoperatively can improve physical fitness and reduce surgical risks, thereby ensuring safer procedures and fewer complications.",2.1317375462116823e-07,0.023308779551549197,0.1694667640613587,0.016320838183036854,0.03980143227613642,0.13296398891966763,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.1,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can the outcomes of bariatric surgery be improved by a preoperative medically supervised weight loss program? Yes, it can enhance patients' physical fitness and lower surgical risks before surgery, leading to safer procedures and improved results with fewer complications.",1.6580180914979763e-07,0.07737600082182539,0.1694667640613587,0.012693985253473108,0.01576841887867575,0.13296398891966763,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
247,0.1,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize the diagnostic features of child bipolar I disorder? Yes, it effectively represents the diagnostic traits of child bipolar I disorder by thoroughly analyzing manic and hypomanic episodes in children, highlighting a wide range of bipolar I symptoms, which aids in early diagnosis and treatment planning.",2.3685972735685406e-07,0.018182611879265842,0.09669782278657763,0.018134264647818726,0.005109083611370746,0.1154015714579203,0.018108015409528666,0.023673481650871242,0.10697689872366278,2.3685972735685406e-07,0.04269140904374957,0.09719008264462808
247,0.1,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample successfully generalizes the diagnostic characteristics of child bipolar I disorder by offering an extensive examination of manic and hypomanic episodes in children, thereby covering a broad spectrum of bipolar I symptoms and facilitating early diagnosis and treatment strategies.",4.500334819780227e-07,0.09326034059877353,0.20693189364548284,0.03445510283085558,0.13889836848598858,0.1530793876824493,0.034405229278104466,0.18705757759412345,0.1262002743484225,4.500334819780227e-07,0.2368474234847069,0.09719008264462808
247,0.1,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample apply to the diagnostic features of child bipolar I disorder? Indeed, it generalizes these characteristics by providing a detailed analysis of manic and hypomanic episodes in children, illustrating a wide array of bipolar I symptoms that support early diagnosis and treatment planning.",3.316036182995957e-07,0.015180829194874068,0.209150967309693,0.025387970506946217,0.03126770429362358,0.1530793876824493,0.025351221573340132,0.07705668237979468,0.1262002743484225,3.316036182995957e-07,0.12436944005801687,0.09719008264462808
247,0.1,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The diagnostic characteristics of child bipolar I disorder are generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which delivers a comprehensive review of manic and hypomanic episodes in children, showcasing a broad range of bipolar I symptoms and aiding in early diagnosis and treatment.",4.500334819780227e-07,0.09326034059877353,0.20693189364548284,0.03445510283085558,0.13889836848598858,0.1530793876824493,0.034405229278104466,0.18705757759412345,0.1262002743484225,4.500334819780227e-07,0.2368474234847069,0.09719008264462808
247,0.1,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample generalizes the diagnostic features of child bipolar I disorder by thoroughly analyzing manic and hypomanic episodes in children, thus presenting a wide spectrum of bipolar I symptoms that assist in early diagnosis and treatment planning.",5.210914001850789e-07,0.16445367932559707,0.20534727754231719,0.0398953822252012,0.20951593569994253,0.1530793876824493,0.039837633900963065,0.2593782391737496,0.1262002743484225,5.210914001850789e-07,0.31095539563843033,0.09719008264462808
247,0.1,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize child bipolar I disorder's diagnostic traits? Yes, it provides a detailed analysis of manic and hypomanic episodes in children, demonstrating a broad spectrum of bipolar I symptoms that facilitate early diagnosis and treatment.",5.210914001850789e-07,0.16445367932559707,0.20534727754231719,0.0398953822252012,0.20951593569994253,0.1530793876824493,0.039837633900963065,0.2593782391737496,0.1262002743484225,5.210914001850789e-07,0.31095539563843033,0.09719008264462808
247,0.1,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample effectively generalizes the diagnostic characteristics of child bipolar I disorder by offering a comprehensive analysis of manic and hypomanic episodes in children, highlighting a wide range of bipolar I symptoms to support early diagnosis and treatment planning.",4.737194547137081e-07,0.11643334511806414,0.20642765637628663,0.03626852929563745,0.1618878867106881,0.1530793876824493,0.03621603081905733,0.21058807500431787,0.1262002743484225,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
247,0.1,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The diagnostic features of child bipolar I disorder are well generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which presents an extensive analysis of manic and hypomanic episodes in children, covering a broad spectrum of bipolar I symptoms and aiding early diagnosis and treatment.",4.500334819780227e-07,0.09326034059877353,0.20693189364548284,0.03445510283085558,0.13889836848598858,0.1530793876824493,0.034405229278104466,0.18705757759412345,0.1262002743484225,4.500334819780227e-07,0.2368474234847069,0.09719008264462808
247,0.1,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample generalizes the diagnostic characteristics of child bipolar I disorder by providing an in-depth analysis of manic and hypomanic episodes in children, showcasing a wide array of bipolar I symptoms that help in early diagnosis and treatment planning.",4.737194547137081e-07,0.11643334511806414,0.20642765637628663,0.03626852929563745,0.1618878867106881,0.1530793876824493,0.03621603081905733,0.21058807500431787,0.1262002743484225,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
247,0.1,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize the diagnostic traits of child bipolar I disorder? Yes, it offers a comprehensive examination of manic and hypomanic episodes in children, illustrating a broad spectrum of bipolar I symptoms that facilitate early diagnosis and treatment.",4.737194547137081e-07,0.11643334511806414,0.20642765637628663,0.03626852929563745,0.1618878867106881,0.1530793876824493,0.03621603081905733,0.21058807500431787,0.1262002743484225,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
248,0.1,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese men? Yes, higher carotid artery pulsatility and resistance indexes may signal early vascular abnormalities in young obese males. These ultrasound-measured indexes reflect blood flow changes and can help predict cardiovascular risk.",1.4211583641411244e-07,0.013013430625915756,0.07495069033530569,0.010880558788691236,0.01980881637879328,0.09000000000000002,0.0108648092457172,0.02717954341533968,0.10350981558596076,1.4211583641411244e-07,0.0029430616775427687,0.09248793707449268
248,0.1,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? Indeed, elevated carotid artery pulsatility and resistance indexes can be early signs of vascular problems in young obese men. These measurements, obtained via ultrasound, reveal blood flow alterations that might indicate cardiovascular risk.",2.3685972735685406e-08,0.10969756542367115,0.07078901508322819,0.0018134264647818726,0.14057260271572858,0.10060956790123457,0.0018108015409528666,0.14445511271753775,0.11036250813889031,2.3685972735685406e-08,0.11966049933915812,0.09730098718756564
248,0.1,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can higher carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes are potential early indicators of vascular abnormalities in young obese males. Ultrasound assessments of these indexes show blood flow changes that may predict cardiovascular risk.",9.474389094274162e-08,0.00660068989645568,0.04470742932281399,0.0072537058591274906,0.010857262176881655,0.05499999999999999,0.007243206163811466,0.015467206375585185,0.06424747174301015,9.474389094274162e-08,0.020464619173589327,0.072562358276644
248,0.1,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese men? Yes, these elevated indexes in the carotid artery can be early signs of vascular abnormalities in young obese males. Ultrasound measurements of these indexes can detect blood flow changes that might forecast cardiovascular risk.",4.737194547137081e-08,0.08554577934750762,0.06802721088435376,0.0036268529295637453,0.08924900157715099,0.07931010005408333,0.003621603081905733,0.06430532786467058,0.06856834361323347,4.737194547137081e-08,0.03838685636927286,0.05451895919716364
248,0.1,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can indicate early vascular abnormalities in young obese men. These ultrasound-derived indexes reflect changes in blood flow that may predict cardiovascular risk.",7.105791820705622e-08,0.032524674909599316,0.04784722222222221,0.005440279394345618,0.03621211664414581,0.05779260856632956,0.0054324046228586,0.040179457760100235,0.06645130786798165,7.105791820705622e-08,0.044452648154857055,0.07398894297217715
248,0.1,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do young obese males with increased carotid artery pulsatility and resistance indexes show early signs of vascular abnormalities? Yes, elevated carotid artery pulsatility and resistance indexes can be early indicators of vascular abnormalities in young obese males. These indexes, measured by ultrasound, reveal blood flow changes that could signal cardiovascular risk.",4.737194547137081e-08,0.11327166656990517,0.08593233579712753,0.0036268529295637453,0.14583244488816716,0.11838734567901237,0.003621603081905733,0.12206759291133285,0.10910436909247147,4.737194547137081e-08,0.09737810577862982,0.09641975308641976
248,0.1,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can serve as early signs of vascular abnormalities in young obese men. These ultrasound measurements reflect changes in blood flow that may predict cardiovascular risk.",7.105791820705622e-08,0.004232953254091676,0.03155818540433919,0.005440279394345618,0.007330984120814676,0.03937499999999999,0.0054324046228586,0.010683833055421754,0.04640095181439623,7.105791820705622e-08,0.01431581421746797,0.05272108843537415
248,0.1,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Yes, elevated carotid artery pulsatility and resistance indexes can indicate early vascular abnormalities in young obese males. These indexes, assessed via ultrasound, show blood flow changes that might predict cardiovascular risk.",9.474389094274162e-08,0.00660068989645568,0.04470742932281399,0.0072537058591274906,0.010857262176880766,0.05500000000000002,0.007243206163811466,0.015467206375585185,0.06424747174301015,9.474389094274162e-08,0.020464619173589327,0.072562358276644
248,0.1,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is there a link between increased carotid artery pulsatility and resistance indexes and early vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can be early markers of vascular abnormalities in young obese males. These ultrasound-measured indexes reflect blood flow changes that may indicate cardiovascular risk.",4.737194547137081e-08,0.030094004902711635,0.03472222222222221,0.0036268529295637453,0.03266555826613571,0.042325624628197556,0.003621603081905733,0.03542419534133945,0.04887761172285694,4.737194547137081e-08,0.03838685636927286,0.05451895919716364
248,0.1,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are increased carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, these increased indexes in the carotid artery can be early signs of vascular abnormalities in young obese males. Ultrasound measurements of these indexes can detect changes in blood flow that might predict cardiovascular risk.",2.3685972735685406e-08,0.1640620501734702,0.10666666666666665,0.0018134264647818726,0.16829848993812657,0.11997991493383746,0.0018108015409528666,0.14445511271753775,0.11036250813889031,2.3685972735685406e-08,0.11966049933915812,0.09730098718756564
249,0.1,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is neck dissection necessary? Answer: Based on our experience, definitive radiotherapy targeting the neck and possible mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially for",2.8423167282822487e-07,0.2037444299995057,0.009080706050402995,0.02176111757738247,0.2189112708895289,0.017851239669421492,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
249,0.1,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: When metastatic carcinoma involves cervical nodes from an unknown head and neck primary, is neck dissection required? Answer: Our experience shows that definitive radiotherapy to the neck and potential mucosal areas, regardless of preceding neck dissection, provides effective local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",3.552895910352811e-07,0.2618651435537571,0.011974892047241843,0.02720139697172809,0.27537228900360855,0.018860946745562133,0.027162023114293,0.25344890080953686,0.0,3.552895910352811e-07,0.257829109302099,0.0
249,0.1,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma in cervical nodes with an unknown head and neck primary, should neck dissection be performed? Answer: We have found that definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The decision to perform neck dissection, especially for",2.3685972735685406e-07,0.1667849366025207,0.007313100860178785,0.018134264647818726,0.1829663215455497,0.017236072637734686,0.018108015409528666,0.16164135155641457,0.0,2.3685972735685406e-07,0.16430305129127465,0.0
249,0.1,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection necessary for metastatic carcinoma to cervical nodes from an unknown head and neck primary site? Answer: Our experience indicates that definitive radiotherapy to the neck and potential mucosal sites, with or without prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",2.3685972735685406e-07,0.1667849366025207,0.007313100860178785,0.018134264647818726,0.1829663215455497,0.017236072637734686,0.018108015409528666,0.16164135155641457,0.0,2.3685972735685406e-07,0.16430305129127465,0.0
249,0.1,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Metastatic carcinoma to cervical nodes from an unknown head and neck primary: Is neck dissection indicated? Answer: According to our experience, definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially for",3.079176455639103e-07,0.2227469153330417,0.010011356648788286,0.023574544042164344,0.23737987196399946,0.0181755829903978,0.023540420032387266,0.21570857282668943,0.0,3.079176455639103e-07,0.21936282847430322,0.0
249,0.1,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should neck dissection be done for metastatic carcinoma to cervical nodes from an unknown head and neck primary? Answer: In our experience, definitive radiotherapy to the neck and potential mucosal sites, regardless of prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",3.316036182995957e-07,0.24211570755109646,0.010975475573377684,0.025387970506946217,0.2561957764103502,0.01851192595229618,0.025351221573340132,0.23440070583884376,0.0,3.316036182995957e-07,0.23841102344499632,0.0
249,0.1,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma in cervical nodes from an unknown head and neck primary, is neck dissection necessary? Answer: Our experience suggests that definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The decision to perform neck dissection, especially for",2.1317375462116866e-07,0.14880299255637652,0.006473066092809225,0.016320838183036854,0.1654667758656423,0.01694411414982164,0.0162972138685758,0.14424960884454574,0.0,2.1317375462116866e-07,0.14660347419187403,0.0
249,0.1,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection required for metastatic carcinoma to cervical nodes from an unknown head and neck primary site? Answer: Based on our experience, definitive radiotherapy to the neck and potential mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",2.8423167282822487e-07,0.2037444299995057,0.009080706050402995,0.02176111757738247,0.2189112708895289,0.017851239669421492,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
249,0.1,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: When metastatic carcinoma affects cervical nodes from an unknown head and neck primary, is neck dissection needed? Answer: We have found that definitive radiotherapy to the neck and possible mucosal sites, regardless of preceding neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially for",3.316036182995957e-07,0.24211570755109602,0.010975475573377684,0.025387970506946217,0.2561957764103502,0.01851192595229618,0.025351221573340132,0.23440070583884376,0.0,3.316036182995957e-07,0.23841102344499632,0.0
249,0.1,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection necessary for metastatic carcinoma to cervical nodes from an unknown head and neck primary? Answer: Our experience demonstrates that definitive radiotherapy to the neck and potential mucosal sites, whether or not preceded by neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",2.3685972735685406e-07,0.1667849366025207,0.007313100860178785,0.018134264647818726,0.1829663215455497,0.017236072637734686,0.018108015409528666,0.16164135155641457,0.0,2.3685972735685406e-07,0.16430305129127465,0.0
250,0.1,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery results in measurable harm to Kupffer and endothelial cells, indicated by increased post-operative HA serum levels. However, the injury to liver hepatocytes and perisinusoidal cells lacks clinical importance, with the laparoscopic technique likely being the cause.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.1,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Laparoscopic methods induce noticeable damage to Kupffer and endothelial cells, as shown by elevated post-operative HA serum levels. The liver hepatocyte and perisinusoidal cell damage is clinically insignificant, and the laparoscopic procedure itself is probably responsible.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.1,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy impact peri-sinusoidal cell function? Laparoscopic interventions cause detectable injury to Kupffer and endothelial cells, reflected by raised post-operative HA serum levels. The damage to liver hepatocytes and perisinusoidal cells holds no clinical relevance, with the laparoscopic approach likely being the cause.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.1,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Can laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Laparoscopic operations lead to observable damage to Kupffer and endothelial cells, as evidenced by increased post-operative HA serum levels. The harm to liver hepatocytes and perisinusoidal cells is clinically insignificant, and the laparoscopic procedure itself is the probable cause.",1.1842986367842703e-07,0.0776346284354279,0.019991670137442734,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.1,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? Laparoscopic surgery causes detectable damage to Kupffer and endothelial cells, indicated by elevated post-operative HA serum levels. The injury to liver hepatocytes and perisinusoidal cells is not clinically significant, with the laparoscopic procedure likely responsible.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.1,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Laparoscopic techniques result in measurable damage to Kupffer and endothelial cells, as shown by increased post-operative HA serum levels. The damage to liver hepatocytes and perisinusoidal cells lacks clinical significance, and the laparoscopic procedure itself is probably the cause.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856639,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
250,0.1,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy influence the activity of peri-sinusoidal cells? Laparoscopic procedures cause detectable injury to Kupffer and endothelial cells, reflected by elevated post-operative HA serum levels. The damage to liver hepatocytes and perisinusoidal cells has no clinical importance, with the laparoscopic procedure likely being responsible.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.1,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Can laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery leads to noticeable damage to Kupffer and endothelial cells, as evidenced by increased post-operative HA serum levels. The injury to liver hepatocytes and perisinusoidal cells is clinically insignificant, and the laparoscopic procedure itself is probably the cause.",1.1842986367842703e-07,0.0776346284354279,0.019991670137442734,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.1,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy impact the function of peri-sinusoidal cells? Laparoscopic interventions cause measurable damage to Kupffer and endothelial cells, indicated by elevated post-operative HA serum levels. The damage to liver hepatocytes and perisinusoidal cells holds no clinical significance, with the laparoscopic procedure likely responsible.",1.6580180914979784e-07,0.15533640625915934,0.0032509602480447902,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.1,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is the activity of peri-sinusoidal cells influenced by laparoscopic cholecystectomy? Laparoscopic methods cause detectable injury to Kupffer and endothelial cells, as shown by increased post-operative HA serum levels. The harm to liver hepatocytes and perisinusoidal cells is clinically insignificant, and the laparoscopic procedure itself is probably the cause.",7.105791820705622e-08,0.034149516495689536,0.019991670137442734,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
251,0.1,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness a predictor of neuropsychological decline following a concussion? Answer: Findings from this research question the significance of LOC in forecasting neuropsychological test outcomes during the early recovery period after mild traumatic brain injury. Neuropsychological assessments have proven effective in detecting cognitive aftereffects.,1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
251,0.1,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Can loss of consciousness forecast neuropsychological impairments post-concussion? Answer: This study's results challenge the role of LOC as a reliable predictor of neuropsychological test performance in the acute recovery phase of mild traumatic brain injury. Neuropsychological tests are sensitive tools for identifying cognitive consequences.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.1,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does experiencing loss of consciousness indicate neuropsychological deficits after a concussion? Answer: The study's findings suggest that LOC may not be a crucial predictor of neuropsychological test results during the initial recovery stage from mild traumatic brain injury. Neuropsychological testing is effective in measuring cognitive impairments.,1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
251,0.1,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness an indicator of neuropsychological decline following concussion? Answer: Results from this study undermine the predictive value of LOC for neuropsychological test performance in the acute phase of mild traumatic brain injury recovery. Neuropsychological assessments are sensitive to cognitive sequelae.,2.6054570009253947e-07,0.22778393087071303,0.0,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
251,0.1,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness predict cognitive deficits after a concussion? Answer: The evidence from this research casts doubt on LOC's importance as a predictor of neuropsychological test outcomes during early recovery from mild traumatic brain injury. Neuropsychological testing reliably measures cognitive effects.,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.1,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness a reliable predictor of neuropsychological impairments post-concussion? Answer: This study's findings question the significance of LOC in predicting neuropsychological test performance during the acute recovery phase of mild traumatic brain injury. Neuropsychological tests are sensitive to cognitive sequelae.,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.1,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness serve as a predictor for neuropsychological decline after concussion? Answer: The results indicate that LOC may not be a significant predictor of neuropsychological test results during the acute phase of mild traumatic brain injury recovery. Neuropsychological testing effectively detects cognitive impairments.,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.1,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Can loss of consciousness predict neuropsychological test performance following a concussion? Answer: Findings from this study cast doubt on the predictive value of LOC during the early recovery period after mild traumatic brain injury. Neuropsychological assessments are sensitive to cognitive sequelae.,3.079176455639103e-07,0.27541197985996746,0.0,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
251,0.1,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness associated with neuropsychological deficits after concussion? Answer: The study's results challenge the importance of LOC as a predictor of neuropsychological test outcomes in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing is sensitive in measuring cognitive effects.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.1,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness forecast neuropsychological impairments after concussion? Answer: This research suggests that LOC is not a key predictor of neuropsychological test performance during the acute recovery phase from mild traumatic brain injury. Neuropsychological assessments effectively measure cognitive sequelae.,3.316036182995957e-07,0.30010459245033916,0.0,0.025387970506946217,0.30673026742247655,0.0,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
252,0.1,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What is the value of PET/CT compared to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? PET/CT plays a limited role in hepatic staging of LMCRC. While PET/CT shows higher sensitivity for detecting extrahepatic disease in certain anatomical sites, its effectiveness is limited by a low positive predictive value. PET/CT offered additional useful information in 8% of cases but also...",4.737194547137081e-08,0.03244743539175943,0.0005036344218079889,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
252,0.1,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In the preoperative staging of colorectal carcinoma liver metastases, does PET/CT add benefits over multidetector CT? PET/CT has a restricted role in staging liver metastases from colorectal cancer. Although it is more sensitive in identifying extrahepatic disease in some areas, its low positive predictive value reduces its reliability. PET/CT contributed extra valuable data in 8% of cases but also...",1.4211583641411244e-07,0.07677922342075583,0.015621063240110858,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
252,0.1,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Does PET/CT improve preoperative staging for patients with colorectal carcinoma liver metastases compared to multidetector CT? PET/CT's role in hepatic staging of LMCRC is limited. It has greater sensitivity for detecting extrahepatic disease in certain locations, but its low positive predictive value limits its usefulness. PET/CT added useful information in 8% of cases but also...",2.3685972735685406e-07,0.1482381874028995,0.015621063240110858,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
252,0.1,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","How effective is PET/CT versus multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? PET/CT has a minor role in hepatic staging of LMCRC. Despite higher sensitivity for extrahepatic disease detection in some anatomical regions, its low positive predictive value diminishes its impact. PET/CT provided additional useful insights in 8% of cases but also...",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
252,0.1,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In staging liver metastases from colorectal carcinoma preoperatively, does PET/CT offer advantages over multidetector CT? PET/CT is of limited use in hepatic staging of LMCRC. It detects extrahepatic disease with higher sensitivity in certain areas but suffers from a low positive predictive value. PET/CT gave extra useful information in 8% of cases but also...",2.6054570009253947e-07,0.16693032041505385,0.015621063240110858,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
252,0.1,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What additional value does PET/CT provide over multidetector CT in preoperative staging of colorectal carcinoma liver metastases? PET/CT has a limited role in hepatic staging of LMCRC. Although it is more sensitive for detecting extrahepatic disease in some anatomical sites, its low positive predictive value restricts its utility. PET/CT contributed additional useful information in 8% of cases but also...",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
252,0.1,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also",Does PET/CT significantly enhance preoperative staging of liver metastases from colorectal carcinoma compared to multidetector CT? PET/CT plays a limited role in hepatic staging of LMCRC. It offers higher sensitivity for extrahepatic disease detection in certain locations but is limited by a low positive predictive value. PET/CT provided extra useful information in 8% of cases but also...,1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.1,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In the context of preoperative staging for colorectal carcinoma liver metastases, how does PET/CT compare to multidetector CT? PET/CT has a restricted role in hepatic staging of LMCRC. While it detects extrahepatic disease with greater sensitivity in some anatomical areas, its low positive predictive value limits its effectiveness. PET/CT added useful information in 8% of cases but also...",1.6580180914979784e-07,0.09417096613262466,0.015621063240110858,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
252,0.1,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What is the contribution of PET/CT to preoperative staging of liver metastases from colorectal carcinoma beyond multidetector CT? PET/CT has a limited role in hepatic staging of LMCRC. Despite higher sensitivity for extrahepatic disease in certain regions, its low positive predictive value hampers its results. PET/CT provided additional useful information in 8% of cases but also...",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
252,0.1,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","How does PET/CT compare to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? PET/CT has a limited role in hepatic staging of LMCRC. Although it shows higher sensitivity for detecting extrahepatic disease in some anatomical locations, its low positive predictive value reduces its reliability. PET/CT offered additional useful information in 8% of cases but also...",1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
253,0.1,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet among patients identified through screening was satisfactory. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Therefore, proactive screening in coeliac risk groups appears to be beneficial rather than detrimental.",2.3685972735685406e-08,0.10507787228404242,0.060964083175803374,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.1,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Does screening for coeliac disease in at-risk populations make sense? Patients detected via screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to non-coeliac subjects and the general population. Hence, active screening in coeliac risk groups seems justified and not harmful.",4.737194547137081e-08,0.04320246856595489,0.060964083175803374,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
253,0.1,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to screen for coeliac disease in risk groups? Screen-detected patients showed good long-term adherence to dietary recommendations. Their quality of life and bone mineral density were comparable to those without coeliac disease and to the general population. Active screening in these risk groups appears reasonable and not harmful.,2.3685972735685406e-08,0.07735198506164442,0.04097241303836064,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.1,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Should coeliac disease screening be conducted in risk groups? Patients identified through screening adhered well to dietary guidelines over the long term. Their quality of life and bone mineral density were on par with non-coeliac individuals and the general population. Active screening in coeliac risk groups seems appropriate rather than harmful.,2.3685972735685406e-08,0.10507787228404242,0.060964083175803374,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.1,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening justified in populations at risk? Long-term dietary compliance among screen-detected patients was strong. Their quality of life and bone mineral density were comparable to those of non-coeliac subjects and the general population. Active screening in coeliac risk groups appears to be a reasonable approach rather than a harmful one.,7.105791820705622e-08,0.14429858543732488,0.060964083175803374,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,0.1,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it reasonable to screen for coeliac disease in risk groups? Patients detected by screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to non-coeliac individuals and the general population. Active screening in coeliac risk groups seems beneficial rather than harmful.,4.737194547137081e-08,0.04320246856595489,0.060964083175803374,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
253,0.1,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does screening for coeliac disease in risk groups have justification? Screen-detected patients exhibited good long-term adherence to diet. Their quality of life and bone mineral density were comparable with non-coeliac subjects and the general population. Active screening in coeliac disease risk groups appears to be a sensible and safe strategy.,0.0,0.028291721655508084,0.02022166579237194,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
253,0.1,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease in at-risk groups justified? Patients identified through screening showed good long-term dietary compliance. Their quality of life and bone mineral density were similar to those without coeliac disease and to the general population. Active screening in these risk groups seems reasonable and not harmful.,2.3685972735685406e-08,0.03537474524045736,0.04014018095760509,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.1,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening warranted in risk groups? Long-term dietary adherence in patients detected by screening was good. Their quality of life and bone mineral density matched those of non-coeliac subjects and the general population. Active screening in coeliac risk groups appears to be a reasonable and safe practice.,2.3685972735685406e-08,0.06425587776378805,0.060964083175803374,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.1,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to conduct coeliac disease screening in risk groups? Patients found through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Active screening in coeliac disease risk groups seems to be a reasonable and non-harmful approach.,4.737194547137081e-08,0.07051601483042269,0.02181372915664468,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
254,0.1,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Our findings indicate that the heightened cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. However, we observe increased sensitivity in NIDDM patients carrying the ACE DD genotype.",4.737194547137081e-08,0.06801298065346462,0.020707179930795856,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.1,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: We determine that the elevated cardiovascular risk in individuals with the DD genotype is not caused by insulin resistance or fibrinolytic dysfunction. On the other hand, NIDDM subjects with the ACE DD genotype show increased sensitivity.",4.737194547137081e-08,0.014693966764237842,0.0175454960895923,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.1,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a potential gene for insulin resistance? Answer: We conclude that the increased cardiovascular risk seen in the DD genotype is not mediated by insulin resistance or fibrinolysis issues. Conversely, NIDDM patients with the ACE DD genotype exhibit heightened sensitivity.",7.105791820705622e-08,0.06541487868264895,0.0025385802469135715,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.1,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: Our conclusion is that the DD genotypes increased cardiovascular risk is not linked to insulin resistance or fibrinolytic abnormalities. In contrast, NIDDM individuals with the ACE DD genotype demonstrate increased sensitivity.",0.0,0.02772588722239755,0.019938885418112832,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.1,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism associated with insulin resistance? Answer: We find that the cardiovascular risk elevation in the DD genotype is not due to insulin resistance or fibrinolysis defects. Conversely, NIDDM subjects with the ACE DD genotype show greater sensitivity.",9.474389094274162e-08,0.08820350236903307,0.0034578741965105506,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.1,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the ACE gene I/D polymorphism insertion allele be a candidate gene for insulin resistance? Answer: We conclude that the DD genotypes higher cardiovascular risk is not mediated by insulin resistance or fibrinolysis abnormalities. However, increased sensitivity is observed in NIDDM patients with the ACE DD genotype.",7.105791820705622e-08,0.03591925397797047,0.018664014912833465,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.1,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism implicated in insulin resistance? Answer: Our results indicate that the increased cardiovascular risk of the DD genotype is not caused by insulin resistance or fibrinolytic abnormalities. Conversely, NIDDM subjects with the ACE DD genotype display increased sensitivity.",7.105791820705622e-08,0.09491050338732743,0.023602502295684086,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.1,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? Answer: We conclude that the DD genotypes elevated cardiovascular risk is not mediated through insulin resistance or fibrinolysis abnormalities. However, NIDDM patients with the ACE DD genotype show increased sensitivity.",1.4211583641411244e-07,0.10388828709054065,0.017215574484706456,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
254,0.1,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism contribute to insulin resistance? Answer: We find that the increased cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM individuals with the ACE DD genotype exhibit increased sensitivity.",7.105791820705622e-08,0.12440612809200591,0.04443937413616969,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.1,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a potential candidate gene for insulin resistance? Answer: Our study concludes that the DD genotypes increased cardiovascular risk is not mediated by insulin resistance or fibrinolytic abnormalities. In contrast, NIDDM subjects with the ACE DD genotype have increased sensitivity.",2.3685972735685406e-08,0.00695734547176885,0.01953125000000001,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
255,0.1,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? Answer: This study found that employing an endoscope during VPS surgeries did not raise the risk of infection.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.1,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is the simultaneous use of a neuroendoscope associated with higher ventriculoperitoneal shunt infection rates? Answer: Our research indicates that using an endoscope during VPS operations does not increase surgical infection risk.,9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
255,0.1,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does simultaneous neuroendoscope use impact the incidence of infections in ventriculoperitoneal shunt procedures? Answer: The current study shows that endoscope use during VPS does not elevate infection risk.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.1,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the concurrent use of a neuroendoscope influence ventriculoperitoneal shunt infection occurrence? Answer: Findings reveal that endoscope application during VPS surgeries does not heighten infection risk.,2.131737546211677e-07,0.2576431131502197,0.02854671280276816,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
255,0.1,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is there an increased risk of ventriculoperitoneal shunt infection when a neuroendoscope is used simultaneously? Answer: The study demonstrates no increased infection risk with endoscope use during VPS procedures.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
255,0.1,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the simultaneous employment of a neuroendoscope affect ventriculoperitoneal shunt infection rates? Answer: Results indicate that using an endoscope during VPS does not increase the likelihood of surgical infection.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
255,0.1,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does using a neuroendoscope at the same time as VPS surgery affect infection incidence? Answer: The present research confirms that endoscope use during VPS does not raise infection risk.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
255,0.1,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is the incidence of ventriculoperitoneal shunt infection influenced by simultaneous neuroendoscope use? Answer: This study concludes that endoscope use during VPS procedures does not increase infection risk.,1.894877818854824e-07,0.21990278516737272,0.02854671280276816,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
255,0.1,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the simultaneous application of a neuroendoscope impact the frequency of ventriculoperitoneal shunt infections? Answer: The findings show no increased risk of infection when an endoscope is used during VPS.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.1,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.","Question: Does the use of a neuroendoscope during VPS surgery affect the rate of shunt infections? Answer: According to this study, endoscope use in VPS does not elevate the risk of surgical infections.",7.10579182070559e-08,0.05000374837197574,0.02854671280276816,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
256,0.1,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can analyzing APC mutations aid in making treatment choices for familial adenomatous polyposis? Since the age of onset and disease progression can vary significantly even among individuals with the same germline mutations, treatment decisions should rely on colonoscopy results for each patient instead of the mutation location.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999992,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
256,0.1,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Because the disease's manifestation age and progression differ widely, even among carriers of identical germline mutations, therapeutic strategies should be determined by colonoscopic findings in each patient rather than mutation site.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.1,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation testing help inform treatment plans in familial adenomatous polyposis? Given that the age at disease onset and its course can vary considerably, even in patients with the same germline mutations, treatment decisions ought to be based on individual colonoscopy findings instead of mutation position.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999992,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
256,0.1,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis influence therapeutic decisions in familial adenomatous polyposis? Since the disease's onset age and progression may vary among carriers of the same germline mutations, therapy should be guided by colonoscopic observations in each patient rather than mutation location.",2.6054570009253947e-07,0.2157639362354895,0.019599999999999992,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
256,0.1,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is it beneficial to use APC mutation analysis for treatment decisions in familial adenomatous polyposis? Because the age at which symptoms appear and disease progression can differ even among those with identical germline mutations, treatment should be based on colonoscopy results for each patient, not the mutation site.",9.474389094274162e-08,0.05449578863936777,0.019599999999999992,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
256,0.1,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis contribute to treatment choices in familial adenomatous polyposis? As the age of manifestation and disease course can be quite variable, even among carriers of the same germline mutations, therapeutic decisions should rely on colonoscopic findings in individual patients rather than mutation location.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999992,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
256,0.1,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does analyzing APC mutations help in therapeutic decision-making for familial adenomatous polyposis? Since the age at onset and disease progression may vary even in individuals with identical germline mutations, treatment should be based on colonoscopic findings for each patient rather than the mutation site.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999992,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
256,0.1,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis guide therapy in familial adenomatous polyposis? Given the variability in age at manifestation and disease course among carriers of identical germline mutations, treatment decisions should be made according to colonoscopic findings in each patient instead of mutation location.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999992,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
256,0.1,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation analysis relevant for therapeutic decisions in familial adenomatous polyposis? Because the age of onset and disease progression can vary widely even among patients with the same germline mutations, therapy should be based on colonoscopic findings rather than mutation site.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999992,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
256,0.1,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis assist in therapeutic decision-making for familial adenomatous polyposis? Since the age at manifestation and disease progression may differ among carriers of identical germline mutations, treatment choices should be guided by colonoscopic findings in individual patients rather than mutation location.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
257,0.1,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Are general practice features linked to the adoption of an IT innovation in primary care? Answer: The analysis indicates that structural features of a practice do not affect the adoption of a new IT tool, but usage might be influenced by post-graduate training in the related clinical area. Specifically for this diabetes system, practice nurses...",7.105791820705622e-08,0.08092262754331303,0.019925129815239702,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
257,0.1,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Do characteristics of general practices affect the uptake of IT innovations in primary care? Answer: Findings reveal that the structural attributes of a practice are not related to the adoption of a new IT system, though its utilization may be impacted by post-graduate education in the pertinent clinical condition. At least for this diabetes system, practice nurses...",2.3685972735685406e-08,0.006090557415993736,0.016900510204081634,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
257,0.1,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Does the nature of general practice impact the adoption of IT innovations in primary care? Answer: The study shows that structural aspects of a practice are not linked to the uptake of new IT facilities, but usage could be influenced by advanced education in the relevant clinical field. For this diabetes system in particular, practice nurses...",4.737194547137081e-08,0.012711934020450677,0.034438775510204085,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
257,0.1,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Are general practice characteristics determinants of IT innovation uptake in primary care? Answer: Analysis demonstrates that structural characteristics of a practice do not correlate with the adoption of new IT technology, but its use may be affected by post-graduate education related to the clinical condition. Regarding this diabetes system, practice nurses...",1.6580180914979784e-07,0.08081412399037369,0.034438775510204085,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
257,0.1,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Do the features of general practices influence the adoption of IT innovations in primary care? Answer: The results suggest that structural features of a practice are not associated with the uptake of new IT facilities, but usage might be influenced by post-graduate clinical education. For this diabetes system, at least, practice nurses...",1.4211583641411244e-07,0.08805554507788438,0.015215399885444375,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
257,0.1,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Is the uptake of IT innovations in primary care affected by general practice characteristics? Answer: The analyses indicate that structural characteristics of a practice are not linked to the adoption of new IT tools, but their use may be influenced by post-graduate education in the relevant clinical area. Specifically for this diabetes system, practice nurses...",7.105791820705622e-08,0.005306571482227795,0.034438775510204085,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
257,0.1,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Do general practice structural features impact the adoption of IT innovations in primary care? Answer: The findings show that structural features of a practice do not influence the uptake of new IT facilities, but usage may be affected by post-graduate education in the related clinical condition. For this diabetes system, practice nurses...",1.4211583641411244e-07,0.08805554507788438,0.015215399885444375,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
257,0.1,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Are the characteristics of general practices related to the uptake of IT innovations in primary care? Answer: The analysis reveals that structural characteristics of a practice are not associated with the adoption of new IT systems, but their use may be influenced by post-graduate education in the relevant clinical field. At least for this diabetes system, practice nurses...",0.0,0.023901626915860064,0.0172027028724694,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
257,0.1,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Does the structure of general practices affect the uptake of IT innovations in primary care? Answer: The study finds that structural characteristics of a practice are not connected to the adoption of new IT facilities, but usage might be influenced by post-graduate education in the clinical condition concerned. For this diabetes system, practice nurses...",9.474389094274162e-08,0.02365571015042356,0.034438775510204085,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
257,0.1,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Question: Are general practice attributes linked to the adoption of IT innovations in primary care? Answer: The analyses show that structural attributes of a practice do not determine the uptake of new IT tools, but their use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system, practice nurses...",1.1842986367842703e-07,0.04234784316257789,0.034438775510204085,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
258,0.1,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in an urban environment affect non-communicable disease risk in Thailand? Yes, it does. Urban living in Thailand raises the risk of such diseases due to pollution, stress, and lifestyle, and rapid urbanization without proper planning worsens this risk, making timing important.",3.316036182995957e-07,0.20769543711261074,0.04522727272727274,0.025387970506946217,0.20454849588057566,0.051570247933884296,0.025351221573340132,0.23320924473327187,0.035041322314049606,3.316036182995957e-07,0.2629268160032119,0.017851239669421492
258,0.1,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing important for the risk of non-communicable diseases when living in urban Thailand? Indeed, timing matters. Urban environments in Thailand increase disease risk because of pollution, stress, and lifestyle factors, and rapid urban growth without sufficient health services amplifies these risks.",4.263475092423373e-07,0.2699793188204027,0.06743801652892563,0.03264167636607371,0.2998586756849013,0.051570247933884296,0.0325944277371516,0.33084771429718973,0.035041322314049606,4.263475092423373e-07,0.3630102745601933,0.017851239669421492
258,0.1,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does living in an urban area in Thailand influence non-communicable disease risk depending on timing? Yes, timing is significant. Urban living exposes individuals to pollution, stress, and lifestyle habits that raise disease risk, and rapid urbanization without proper infrastructure heightens these risks.",4.263475092423373e-07,0.2699793188204027,0.06743801652892563,0.03264167636607371,0.2998586756849013,0.051570247933884296,0.0325944277371516,0.33084771429718973,0.035041322314049606,4.263475092423373e-07,0.3630102745601933,0.017851239669421492
258,0.1,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of urban living relevant to non-communicable disease risk in Thailand? Yes, it is. Factors like pollution, stress, and lifestyle in urban Thailand increase disease risk, and rapid urbanization without adequate health planning makes timing a key factor.",4.73719454713708e-07,0.31998973939506614,0.06743801652892563,0.03626852929563745,0.351151970072451,0.051570247933884296,0.03621603081905733,0.3834914477826086,0.035041322314049606,4.737194547137081e-07,0.4170774958304695,0.017851239669421492
258,0.1,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of residing in an urban environment affect non-communicable disease risk in Thailand? Yes, timing plays a role. Urban living in Thailand can elevate disease risk due to pollution, stress, and lifestyle, and rapid urbanization without proper health services exacerbates this risk.",3.789755637709665e-07,0.2545906735781225,0.044195386143438105,0.029014823436509962,0.2510685115154696,0.051570247933884296,0.028972824655245866,0.2808372937225263,0.035041322314049606,3.789755637709665e-07,0.3117169801726436,0.017851239669421492
258,0.1,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing a factor in the risk of non-communicable diseases for urban residents in Thailand? Yes, timing matters. Urban environments contribute to higher disease risk through pollution, stress, and lifestyle habits, and rapid urbanization without sufficient planning increases these risks.",4.73719454713708e-07,0.31998973939506614,0.06743801652892563,0.03626852929563745,0.351151970072451,0.051570247933884296,0.03621603081905733,0.3834914477826086,0.035041322314049606,4.737194547137081e-07,0.4170774958304695,0.017851239669421492
258,0.1,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in urban Thailand impact non-communicable disease risk? Yes, it does. Urban living raises risks due to pollution, stress, and lifestyle, and rapid urbanization without adequate health infrastructure worsens these risks, making timing crucial.",5.210914001850786e-07,0.372633472880485,0.06743801652892563,0.0398953822252012,0.4052191913427272,0.051570247933884296,0.039837633900963065,0.43906129893742074,0.035041322314049606,5.210914001850789e-07,0.47423590967041784,0.017851239669421492
258,0.1,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing important for non-communicable disease risk among urban dwellers in Thailand? Yes, timing is important. Urban environments increase risk through pollution, stress, and lifestyle factors, and rapid urbanization without proper health services intensifies these risks.",5.684633456564492e-07,0.42820332403529715,0.06743801652892563,0.04352223515476495,0.46237760518267557,0.051570247933884296,0.04345923698286881,0.497901798960354,0.035041322314049606,5.684633456564497e-07,0.5348605314868533,0.017851239669421492
258,0.1,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of urban residence influence non-communicable disease risk in Thailand? Yes, timing is key. Urban living exposes people to pollution, stress, and lifestyle habits that increase disease risk, and rapid urbanization without adequate planning exacerbates these risks.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.1,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of living in an urban area significant for non-communicable disease risk in Thailand? Yes, it is. Urban environments raise disease risk due to pollution, stress, and lifestyle, and rapid urbanization without sufficient health services makes timing a critical factor.",4.263475092423373e-07,0.3037913764086926,0.04306301652892563,0.03264167636607371,0.2998586756849013,0.051570247933884296,0.0325944277371516,0.33084771429718973,0.035041322314049606,4.263475092423373e-07,0.3630102745601933,0.017851239669421492
259,0.1,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal-induced anxiety in alcoholism caused by a deficiency in beta-endorphin? Answer: Our findings provide the first evidence that reduced beta-endorphin levels during alcohol withdrawal might play a role in the anxiety commonly experienced in this condition.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
259,0.1,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Answer: Our results offer initial proof that decreased beta-endorphin during alcohol withdrawal could contribute to the anxiety frequently observed in this state.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.1,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is anxiety during alcohol withdrawal linked to a lack of beta-endorphin in alcoholism? Answer: Our study presents the first evidence that lowered beta-endorphin levels during withdrawal may be a factor in the anxiety commonly seen in this phase.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
259,0.1,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Could beta-endorphin deficiency be responsible for withdrawal-induced anxiety in alcoholism? Answer: Our data provide the first indication that reduced beta-endorphin during alcohol withdrawal may contribute to the anxiety often present in this condition.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.1,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety experienced during alcohol withdrawal due to beta-endorphin deficiency in alcoholism? Answer: Our findings give initial evidence that decreased beta-endorphin levels during withdrawal might be involved in the anxiety commonly associated with this state.,7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.1,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does a deficiency in beta-endorphin cause withdrawal-induced anxiety in alcoholism? Answer: Our results show the first evidence that lowered beta-endorphin during alcohol withdrawal may play a role in the anxiety frequently occurring in this condition.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.1,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal-related anxiety in alcoholism linked to beta-endorphin deficiency? Answer: Our study provides the first evidence that reduced beta-endorphin during alcohol withdrawal could contribute to the anxiety commonly experienced during this state.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
259,0.1,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety seen in alcohol withdrawal due to a lack of beta-endorphin in alcoholism? Answer: Our findings offer initial proof that decreased beta-endorphin levels during withdrawal may be a factor in the anxiety often observed in this phase.,1.421158364141118e-07,0.13150807540368037,0.025623268698060954,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
259,0.1,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Could a beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Answer: Our data present the first evidence that lowered beta-endorphin during alcohol withdrawal might contribute to the anxiety commonly present in this condition.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
259,0.1,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety associated with alcohol withdrawal caused by beta-endorphin deficiency in alcoholism? Answer: Our results provide the first indication that reduced beta-endorphin during withdrawal may play a role in the anxiety frequently seen in this state.,9.47438909427412e-08,0.07694293601234303,0.027006172839506164,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
260,0.1,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts truly exist? Answer: Based on our study findings and international literature, the concept of the globulomaxillary cyst is no longer supported.",9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.1,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a real entity? Answer: Our research and global literature indicate that the globulomaxillary cyst is no longer a valid diagnosis.,1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.1,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a genuine condition? Answer: According to our study and worldwide data, the globulomaxillary cyst is no longer considered a legitimate entity.",7.10579182070559e-08,0.2242322341965961,0.0793950850661626,0.005440279394345639,0.17554530070304475,0.04158790170132326,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.1,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts actually exist? Answer: The results from our study and international sources show that the globulomaxillary cyst is no longer justified as a diagnosis.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.1,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts recognized as real? Answer: Our findings and international literature suggest that the globulomaxillary cyst is no longer a justified entity.,1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.1,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is there evidence for the existence of globulomaxillary cysts? Answer: Both our study and international literature conclude that the globulomaxillary cyst is no longer a valid entity.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.1,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts exist in reality? Answer: According to our research and global literature, the globulomaxillary cyst is no longer justified as a distinct entity.",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.1,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a confirmed medical entity? Answer: The data from our study and international literature indicate that the globulomaxillary cyst is no longer justified.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.1,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a recognized pathological entity? Answer: Our study results and international literature show that the globulomaxillary cyst is no longer justified.,9.47438909427412e-08,0.2696752099205817,0.08264462809917354,0.007253705859127518,0.22061631794995806,0.04338842975206613,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.1,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Can globulomaxillary cysts be considered a valid diagnosis? Answer: Based on our research and international data, the globulomaxillary cyst is no longer justified.",1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
261,0.1,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, OSA generally does not predict reduced aerobic fitness based on cycle ergometry tests. Yet, individuals with an apnea-hypopnea index above 20 show a significant decline in aerobic fitness.",1.8948778188548325e-07,0.09567815922396194,0.06222222222222221,0.014507411718254981,0.1275947061710565,0.04246913580246913,0.014486412327622933,0.16091840282531944,0.021728395061728398,1.8948778188548325e-07,0.19574457712609394,0.0
261,0.1,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is aerobic fitness affected by obstructive sleep apnea? Among US Air Force members, OSA does not typically lead to lower aerobic fitness as measured by cycle ergometry. However, those with an apnea-hypopnea index exceeding 20 experience a statistically significant drop in aerobic fitness.",1.4211583641411244e-07,0.07989500365262181,0.03842686231740365,0.010880558788691236,0.07758428559639308,0.04246913580246913,0.0108648092457172,0.10962510843776974,0.021728395061728398,1.4211583641411244e-07,0.1431008436406751,0.0
261,0.1,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea influence aerobic fitness levels? In a study of US Air Force personnel, OSA was not associated with decreased aerobic fitness via cycle ergometry. Still, patients with an apnea-hypopnea index over 20 demonstrated a significant reduction in aerobic fitness.",1.6580180914979784e-07,0.10479760422188011,0.037847222222222206,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.1,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","How does obstructive sleep apnea affect aerobic fitness? Research in a US Air Force population shows OSA does not predict diminished aerobic fitness measured by cycle ergometry. Nonetheless, individuals with an apnea-hypopnea index greater than 20 have a statistically significant decrease in aerobic fitness.",1.1842986367842703e-07,0.023357497644335812,0.06222222222222221,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.08493249584739804,0.021728395061728398,1.1842986367842703e-07,0.11778303565638337,0.0
261,0.1,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is there an effect of obstructive sleep apnea on aerobic fitness? Overall, OSA does not predict lower aerobic fitness in US Air Force members as assessed by cycle ergometry. However, those with an apnea-hypopnea index above 20 show a significant decline in aerobic fitness.",1.1842986367842703e-07,0.023357497644335812,0.06222222222222221,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.08493249584739804,0.021728395061728398,1.1842986367842703e-07,0.11778303565638337,0.0
261,0.1,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea reduce aerobic fitness? In a US Air Force group, OSA generally does not correlate with decreased aerobic fitness measured by cycle ergometry. Yet, patients with an apnea-hypopnea index higher than 20 have a statistically significant reduction in aerobic fitness.",1.4211583641411244e-07,0.04688799505453023,0.06222222222222221,0.010880558788691236,0.07758428559639308,0.04246913580246913,0.0108648092457172,0.10962510843776974,0.021728395061728398,1.4211583641411244e-07,0.1431008436406751,0.0
261,0.1,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","What is the impact of obstructive sleep apnea on aerobic fitness? Among US Air Force personnel, OSA does not predict a decrease in aerobic fitness based on cycle ergometry results. However, those with an apnea-hypopnea index greater than 20 exhibit a significant decline in aerobic fitness.",7.105791820705622e-08,0.00870166492579827,0.04001147842056932,0.005440279394345618,0.006966718382439119,0.04246913580246913,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
261,0.1,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Can obstructive sleep apnea affect aerobic fitness? In a US Air Force population, OSA overall does not predict reduced aerobic fitness as measured by cycle ergometry. Still, patients with an apnea-hypopnea index over 20 have a statistically significant decrease in aerobic fitness.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222221,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.1,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea have an effect on aerobic fitness? In US Air Force subjects, OSA does not generally predict a decrease in aerobic fitness via cycle ergometry. However, individuals with an apnea-hypopnea index exceeding 20 show a significant reduction in aerobic fitness.",1.4211583641411244e-07,0.07989500365262181,0.03842686231740365,0.010880558788691236,0.07758428559639308,0.04246913580246913,0.0108648092457172,0.10962510843776974,0.021728395061728398,1.4211583641411244e-07,0.1431008436406751,0.0
261,0.1,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is aerobic fitness impacted by obstructive sleep apnea? Overall, OSA does not predict decreased aerobic fitness in a US Air Force population as measured by cycle ergometry. Nevertheless, patients with an apnea-hypopnea index greater than 20 have a statistically significant decline in aerobic fitness.",1.1842986367842703e-07,0.055596901391310016,0.03897959183673468,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.08493249584739804,0.021728395061728398,1.1842986367842703e-07,0.11778303565638337,0.0
262,0.1,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts truly exist? Answer: Globulomaxillary cysts were previously believed to be a distinct cyst type originating from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.1,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts real? Answer: It was once assumed that globulomaxillary cysts were a unique cyst type formed along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.1,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the existence of globulomaxillary cysts confirmed? Answer: Globulomaxillary cysts were historically considered a specific cyst type arising at the fusion line between two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.1,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts actually exist? Answer: These cysts were once thought to be a particular type developing from the fusion line of two embryonic processes. However,",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.1,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts a real entity? Answer: Globulomaxillary cysts were once regarded as a distinct cyst type originating from the fusion line between two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.1,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is there evidence for globulomaxillary cysts? Answer: They were once believed to be a specific cyst type arising from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.1,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts exist in reality? Answer: Globulomaxillary cysts were formerly thought to be a unique cyst type formed along the fusion line between two embryonic processes. However,",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,0.1,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts truly a distinct type? Answer: These cysts were once considered to arise specifically from the fusion line of two embryonic processes. However,",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
262,0.1,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the concept of globulomaxillary cysts valid? Answer: It was once believed that globulomaxillary cysts were a particular cyst type originating from the fusion line between two embryonic processes. However,",4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.1,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts exist as a defined cyst type? Answer: Globulomaxillary cysts were once thought to be a specific cyst type arising from the fusion line of two embryonic processes. However,",7.10579182070559e-08,0.05706352137059145,0.0322222222222222,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
263,0.1,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Among patients undergoing MMT and receiving medical care at various locations, opioid dependence and MMT are documented in most medical records, but a significant portion of patients lack this documentation. Many of these patients are prescribed medications that may interact with...",1.1842986367842703e-07,0.046857584090098214,0.030909289399613633,0.009067132323909363,0.06982514879001966,0.01581794668928989,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
263,0.1,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? For patients on MMT receiving care at different sites, opioid dependence and MMT are documented in the majority of cases, though a considerable number of patients have no such records. Most of these patients are given medications that could potentially interact with...",9.474389094274162e-08,0.052868809714252674,0.01322378382483469,0.0072537058591274906,0.05027394425433407,0.016180375568487466,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
263,0.1,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical records? Among patients treated with MMT and receiving medical care at multiple sites, opioid dependence and MMT are recorded for most, but a notable number of patients lack this documentation. Many of these patients are prescribed drugs that might interact with...",9.474389094274162e-08,0.02719669191573626,0.031604857103432596,0.0072537058591274906,0.05027394425433407,0.016180375568487466,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
263,0.1,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) recorded in patients' medical records? Among those receiving MMT and medical care at various locations, documentation of opioid dependence and MMT is present for the majority, yet a substantial number of patients do not have this recorded. Most of these patients are prescribed medications that could interact with...",7.105791820705622e-08,0.007914021691230122,0.03227525087156166,0.005440279394345618,0.031097431661075703,0.016529396361753417,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
263,0.1,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical records? Among patients receiving MMT and medical care at different sites, opioid dependence and MMT are documented for most patients, but a significant number are missing this information. Many of these patients are prescribed medications that may interact with...",1.8948778188548325e-07,0.10826527189962798,0.028656550068587083,0.014507411718254981,0.13088078397171543,0.014642016758494043,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.1,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Among patients undergoing MMT and receiving care at various sites, documentation of opioid dependence and MMT is found in most records, but a considerable number of patients lack this documentation. Most of these patients are prescribed medications that potentially interact with...",1.1842986367842703e-07,0.046857584090098214,0.030909289399613633,0.009067132323909363,0.06982514879001966,0.01581794668928989,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
263,0.1,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Among patients on MMT and receiving medical care at different locations, opioid dependence and MMT are documented for the majority, but a substantial number of patients have no such records. Many of these patients are prescribed medications that could potentially interact with...",9.474389094274162e-08,0.02719669191573626,0.031604857103432596,0.0072537058591274906,0.05027394425433407,0.016180375568487466,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
263,0.1,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Among patients receiving MMT and medical care at various sites, documentation of opioid dependence and MMT occurs for most, but a significant number of patients lack this documentation. Most of these patients are prescribed medications that may interact with...",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.1,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical records? Among patients treated with MMT and receiving medical care at different sites, opioid dependence and MMT are recorded for the majority, but a notable number of patients do not have this documented. Many of these patients are prescribed medications that potentially interact with...",7.105791820705622e-08,0.007914021691230122,0.03227525087156166,0.005440279394345618,0.031097431661075703,0.016529396361753417,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
263,0.1,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? Among patients receiving MMT and medical care at multiple sites, documentation of opioid dependence and MMT is present for most, but a substantial number of patients lack this information. Most of these patients are prescribed medications that could interact with...",1.4211583641411244e-07,0.06691179819077675,0.03018710562414264,0.010880558788691236,0.0897659700774085,0.015441322314049606,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
264,0.1,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the quantity of needles influence acupuncture treatment for neck pain? Answer: For this condition, whether 5 or 11 needles are used does not appear to significantly affect the therapeutic outcome, provided the stimulation duration is equal in both groups.",1.4211583641411244e-07,0.07948827450038065,0.043388429752066124,0.010880558788691236,0.1122943022824554,0.02221074380165289,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
264,0.1,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In acupuncture for neck pain, is the number of needles significant? Answer: The number of needles, either 5 or 11, does not seem to be a crucial factor in the treatment effect when both groups receive the same stimulation time.",1.4211583641411244e-07,0.14880299255637475,0.006473066092809211,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
264,0.1,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles impact acupuncture therapy for neck pain? Answer: For this ailment, using 5 or 11 needles does not seem to alter the therapeutic effect if the stimulation time is consistent across groups.",2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.1,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is needle count important in acupuncture treatment of neck pain? Answer: The therapeutic effect appears unaffected by whether 5 or 11 needles are used, as long as the stimulation time remains the same in both groups.",2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.1,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In treating neck pain with acupuncture, does needle quantity matter? Answer: The number of needles, 5 versus 11, does not seem to influence the treatment outcome when the stimulation duration is identical in both groups.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,0.1,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does acupuncture needle number affect neck pain treatment results? Answer: For this condition, the therapeutic effect is not significantly influenced by using 5 or 11 needles, assuming equal stimulation time in both groups.",3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
264,0.1,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Question: Is the number of needles a key factor in acupuncture for neck pain? Answer: Using either 5 or 11 needles does not appear to impact the therapeutic effect if the stimulation time is the same for both groups.,1.8948778188548304e-07,0.1672629994437167,0.01709186291495875,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
264,0.1,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the count of needles affect acupuncture efficacy in neck pain? Answer: The therapeutic outcome seems independent of whether 5 or 11 needles are used, provided the stimulation time is equal in both groups.",2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,0.1,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In acupuncture treatment for neck pain, does the number of needles play a role? Answer: The number of needles, whether 5 or 11, does not seem to be a significant variable in the therapeutic effect when stimulation time is consistent.",1.4211583641411244e-07,0.14880299255637475,0.006473066092809211,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
264,0.1,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles used in acupuncture influence neck pain therapy? Answer: For this pathology, the therapeutic effect does not appear to depend on using 5 or 11 needles, as long as the stimulation time is the same in both groups.",9.474389094274162e-08,0.030698110330948936,0.043388429752066124,0.0072537058591274906,0.06228388170779198,0.02221074380165289,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
265,0.1,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Yes, the development of endometrial polyps is connected to increased expression of these growth factors, which promote angiogenesis and fibrosis, key processes in polyp formation.",2.1317375462116866e-07,0.09205117989815825,0.17582127040782594,0.016320838183036854,0.07184164308484853,0.17557964009518146,0.0162972138685758,0.0510820462777426,0.17132659131469363,2.1317375462116866e-07,0.02339292924737313,0.15704937537180244
265,0.1,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does endometrial polyp formation correlate with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Indeed, endometrial polyps are associated with upregulated levels of these factors that drive angiogenesis and fibrosis, crucial for polyp growth.",3.789755637709661e-07,0.021151189845345364,0.22222222222222215,0.029014823436509962,0.07747290511101435,0.19937500000000002,0.028972824655245873,0.13612949581040334,0.17132659131469363,3.789755637709665e-07,0.1689789634000829,0.15704937537180244
265,0.1,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is there an association between endometrial polyp formation and increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, these growth factors are elevated in polyps and contribute to angiogenesis and fibrosis, important in their development.",3.789755637709661e-07,0.021151189845345364,0.22222222222222215,0.029014823436509962,0.07747290511101435,0.19937500000000002,0.028972824655245873,0.13612949581040334,0.17132659131469363,3.789755637709665e-07,0.1689789634000829,0.15704937537180244
265,0.1,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions increased in endometrial polyp formation? Yes, the formation of endometrial polyps involves heightened expression of these factors, which facilitate angiogenesis and fibrosis, essential for polyp development.",4.026615365066514e-07,0.04932206681204221,0.22222222222222215,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.17132659131469363,4.026615365066519e-07,0.19975062206683658,0.15704937537180244
265,0.1,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does the formation of endometrial polyps involve increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Yes, these growth factors are upregulated and play vital roles in angiogenesis and fibrosis during polyp formation.",4.263475092423367e-07,0.07830960368529372,0.22222222222222215,0.03264167636607372,0.13631340513394763,0.19937500000000002,0.03259442773715162,0.1967541176268388,0.17132659131469363,4.263475092423373e-07,0.2314993203814164,0.15704937537180244
265,0.1,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is increased expression of vascular endothelial growth factor and transforming growth factor-beta1 associated with endometrial polyp formation? Yes, these factors contribute to the angiogenesis and fibrosis processes that are key to polyp development.",4.737194547137073e-07,0.13893422550172918,0.22222222222222215,0.03626852929563748,0.19883376211528114,0.19937500000000002,0.03621603081905737,0.26129263876441033,0.17132659131469363,4.737194547137081e-07,0.29819069488008987,0.15704937537180244
265,0.1,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is endometrial polyp formation linked to elevated vascular endothelial growth factor and transforming growth factor-beta1? Yes, increased levels of these growth factors promote angiogenesis and fibrosis, which are important in the formation of polyps.",4.50033481978022e-07,0.1081625668349755,0.22222222222222215,0.0344551028308556,0.16708506380070132,0.19937500000000002,0.03440522927810449,0.22850281594141864,0.17132659131469363,4.500334819780227e-07,0.2642891432044081,0.15704937537180244
265,0.1,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Are higher levels of vascular endothelial growth factor and transforming growth factor-beta1 found in endometrial polyp formation? Yes, these growth factors are increased and play significant roles in angiogenesis and fibrosis during polyp development.",4.50033481978022e-07,0.1081625668349755,0.22222222222222215,0.0344551028308556,0.16708506380070132,0.19937500000000002,0.03440522927810449,0.22850281594141864,0.17132659131469363,4.500334819780227e-07,0.2642891432044081,0.15704937537180244
265,0.1,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is the development of endometrial polyps associated with increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, these growth factors enhance angiogenesis and fibrosis, which are critical in polyp formation.",4.974054274493926e-07,0.170682923816309,0.22222222222222215,0.03808195576041936,0.23162358493827284,0.19937500000000002,0.03802683236001024,0.2951941904400921,0.17132659131469363,4.974054274493935e-07,0.3332820146913589,0.15704937537180244
265,0.1,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does endometrial polyp formation involve upregulation of vascular endothelial growth factor and transforming growth factor-beta1? Yes, these growth factors contribute to angiogenesis and fibrosis, both of which are important in the development of polyps.",4.50033481978022e-07,0.1081625668349755,0.22222222222222215,0.0344551028308556,0.16708506380070132,0.19937500000000002,0.03440522927810449,0.22850281594141864,0.17132659131469363,4.500334819780227e-07,0.2642891432044081,0.15704937537180244
266,0.1,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification account for the birthweight differences between Australian Aborigines and whites? No, it does not completely explain the disparity; other factors like genetics, maternal health, socio-economic status, and access also play roles.",2.3685972735685343e-07,0.0057755890984831915,0.1728395061728395,0.01813426464781874,0.10349553549221158,0.11426592797783926,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
266,0.1,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? No, gestational age misclassification alone does not fully account for the birthweight differences; other influences include genetic factors, maternal health, socio-economic conditions, and access.",1.4211583641411222e-07,0.068968615455955,0.14654293933573212,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
266,0.1,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can gestational age misclassification explain why Australian Aborigines and whites have different birthweights? No, it does not entirely explain the difference; additional factors such as genetics, maternal health, socio-economic disparities, and access contribute.",2.84231672828224e-07,0.06640021091491866,0.1728395061728395,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
266,0.1,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does misclassifying gestational age explain the birthweight gap between Australian Aborigines and whites? No, gestational age misclassification does not fully explain the birthweight differences; other elements like genetic variation, maternal health, socio-economic status, and access are involved.",1.8948778188548283e-07,0.06414170535185937,0.09019487807366595,0.014507411718254981,0.08426344578698952,0.0857192151750711,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
266,0.1,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the birthweight difference between Australian Aborigines and whites caused by gestational age misclassification? No, this misclassification does not completely explain the difference; other factors include genetics, maternal health, socio-economic disparities, and access.",2.84231672828224e-07,0.06640021091491866,0.1728395061728395,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
266,0.1,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification fully explain the birthweight differences between Australian Aborigines and whites? No, it does not; other factors such as genetic differences, maternal health, socio-economic status, and access also contribute.",3.0791764556390933e-07,0.09814890922949848,0.1728395061728395,0.02357454404216438,0.1988057152965368,0.11426592797783926,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
266,0.1,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? No, it does not fully account for the disparity; other factors like genetics, maternal health, socio-economic conditions, and access play a role.",2.1317375462116813e-07,0.016396462542942913,0.14429279337007134,0.01632083818303686,0.0736425723425298,0.11426592797783926,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
266,0.1,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can the difference in birthweights between Australian Aborigines and whites be explained by gestational age misclassification? No, gestational age misclassification alone does not explain the difference; other factors include genetic differences, maternal health, socio-economic disparities, and access.",1.8948778188548283e-07,0.012874648043690318,0.14508440413202317,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
266,0.1,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification explain the birthweight disparity between Australian Aborigines and whites? No, it does not fully explain it; other factors such as genetics, maternal health, socio-economic status, and access are also important.",2.605457000925387e-07,0.03562855224816497,0.1728395061728395,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
266,0.1,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? No, it does not fully explain the difference; other factors like genetic variation, maternal health, socio-economic disparities, and access contribute.",2.605457000925387e-07,0.03562855224816497,0.1728395061728395,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
267,0.1,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the distribution of health care benefits in Kenya align with the principles of universal coverage? Answer: Universal coverage principles dictate that health care benefits should be allocated based on need. However, Kenya's health sector is evidently inequitable, with benefits not distributed according to need. Intentional measures must be taken to restructure the system.",7.105791820705622e-08,0.008127642051876993,0.032793472376406355,0.005440279394345618,0.03170576166550987,0.016804348178992037,0.0054324046228586,0.030884114630681303,0.0181755829903978,7.105791820705622e-08,0.05715841383995013,0.0
267,0.1,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Answer: Universal coverage requires that all individuals receive health care benefits according to their needs. The Kenyan health sector is clearly unequal, and benefits are not allocated based on need. Focused efforts are necessary to reform the system.",1.1842986367842703e-07,0.07450225527153087,0.012299669251968542,0.009067132323909363,0.0711977874885843,0.016065294924554177,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
267,0.1,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does Kenya's health care benefits distribution adhere to universal coverage principles? Answer: The essence of universal coverage is that health care benefits are provided according to need. Kenya's health sector shows clear inequities, with benefits not distributed by need. There should be deliberate initiatives to restructure the sector.",2.1317375462116866e-07,0.19009097220455162,0.012868907202057148,0.016320838183036854,0.15518920083263055,0.014398754281832068,0.0162972138685758,0.15348643672301465,0.0181755829903978,2.1317375462116866e-07,0.18232155679395579,0.0
267,0.1,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Are health care benefits in Kenya distributed in line with universal coverage principles? Answer: Universal coverage principles mandate that health care benefits be given according to need. The Kenyan health sector is evidently inequitable, and benefits are not distributed based on need. Targeted efforts should be made to restructure the system.",1.4211583641411244e-07,0.09548854741949286,0.011181970897116408,0.010880558788691236,0.09154405963226253,0.015673624787111436,0.0108648092457172,0.09030753510148237,0.0181755829903978,1.4211583641411244e-07,0.11778303565638426,0.0
267,0.1,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the Kenyan health care benefits distribution fulfill the principles of universal coverage? Answer: Universal coverage requires that all benefit from health care according to their needs. The Kenyan health sector is clearly inequitable, with benefits not allocated on the basis of need. Deliberate restructuring efforts are needed.",2.1317375462116866e-07,0.1612098396812205,0.007553498674894188,0.016320838183036854,0.15518920083263055,0.014398754281832068,0.0162972138685758,0.15348643672301465,0.0181755829903978,2.1317375462116866e-07,0.18232155679395579,0.0
267,0.1,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya equitable according to universal coverage principles? Answer: Universal coverage principles state that health care benefits should be distributed based on need. Kenya's health sector is evidently inequitable, and benefits are not distributed accordingly. Intentional restructuring is necessary.",2.6054570009253947e-07,0.20753655834219042,0.00487577498040466,0.0199476911126006,0.19998522942591013,0.013454551122901278,0.019918816950481533,0.19793819929384737,0.0181755829903978,2.6054570009253947e-07,0.22778393087071303,0.0
267,0.1,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does Kenya's distribution of health care benefits comply with universal coverage principles? Answer: The principles of universal coverage require health care benefits to be allocated according to need. Kenya's health sector is clearly inequitable, with benefits not distributed on this basis. Deliberate efforts to restructure are essential.",2.3685972735685406e-07,0.18410672542309614,0.006242663045876756,0.018134264647818726,0.17733661528630407,0.013936899862825772,0.018108015409528666,0.17546534344178966,0.0181755829903978,2.3685972735685406e-07,0.2047944126460135,0.0
267,0.1,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Are the principles of universal coverage met by the distribution of health care benefits in Kenya? Answer: Universal coverage demands that health care benefits be provided according to need. The Kenyan health sector is evidently inequitable, with benefits not distributed by need. Focused restructuring efforts should be undertaken.",2.1317375462116866e-07,0.1612098396812205,0.007553498674894202,0.016320838183036854,0.15518920083263055,0.014398754281832068,0.0162972138685758,0.15348643672301465,0.0181755829903978,2.1317375462116866e-07,0.18232155679395579,0.0
267,0.1,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the allocation of health care benefits in Kenya satisfy universal coverage principles? Answer: Universal coverage principles require that health care benefits be distributed according to need. Kenya's health sector is clearly inequitable, and benefits are not allocated based on need. Deliberate restructuring efforts are necessary.",2.6054570009253947e-07,0.20753655834219087,0.00487577498040466,0.0199476911126006,0.19998522942591013,0.013454551122901278,0.019918816950481533,0.19793819929384737,0.0181755829903978,2.6054570009253947e-07,0.22778393087071303,0.0
267,0.1,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the Kenyan health care benefits distribution aligned with the principles of universal coverage? Answer: Universal coverage requires that all individuals benefit from health care according to need. The Kenyan health sector is evidently inequitable, with benefits not distributed on the basis of need. Intentional efforts to restructure the system should be prioritized.",9.474389094274162e-08,0.053945031605859395,0.013375720897116382,0.0072537058591274906,0.051256966201195464,0.01644191929979446,0.007243206163811466,0.050302200487784,0.0181755829903978,9.474389094274162e-08,0.07696104113612989,0.0
268,0.1,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: Postictal psychotic episodes can signal an increased risk of interictal psychotic episodes. Frequent occurrences after seizures imply the patient might also have psychotic episodes during interictal periods.,2.3685972735685406e-08,0.005268824097956593,0.019374999999999948,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
268,0.1,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term relevance of postictal psychotic episodes II? Are they indicative of interictal psychotic episodes? Answer: Postictal psychotic episodes may serve as predictors for interictal psychotic episodes. Regular post-seizure episodes suggest a higher chance of psychotic episodes between seizures.,9.474389094274162e-08,0.07544035994788745,0.008900200876552272,0.0072537058591274906,0.0669541587814173,0.020367910477800573,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
268,0.1,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How significant are postictal psychotic episodes II in the long term? Can they forecast interictal psychotic episodes? Answer: Postictal psychotic episodes often point to a greater probability of interictal psychotic episodes. Frequent post-seizure psychosis indicates potential interictal psychotic events.,1.4211583641411233e-07,0.13304105643029818,0.0010076530612244672,0.010880558788691236,0.12007152469675697,0.01905490708579512,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
268,0.1,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term impact of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: The presence of postictal psychotic episodes can be a marker for increased risk of interictal psychotic episodes. Repeated episodes after seizures suggest the patient may develop psychosis during interictal phases.,4.737194547137081e-08,0.09116305644022393,0.07500507030827473,0.0036268529295637453,0.04719147474695973,0.00196304417083637,0.003621603081905733,0.014655832718537543,0.02221074380165289,4.737194547137081e-08,0.04652001563489394,0.0
268,0.1,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the enduring significance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can be indicative of a higher likelihood of interictal psychotic episodes. Frequent post-seizure episodes imply the patient might experience psychosis between seizures.,4.737194547137081e-08,0.008759545745454123,0.06733029257067714,0.0036268529295637453,0.04952065278017326,0.0021485260770975206,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
268,0.1,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: How do postictal psychotic episodes II relate to long-term outcomes? Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes may predict an increased risk of interictal psychotic episodes. If these episodes occur often after seizures, it suggests possible interictal psychosis.",7.105791820705622e-08,0.035360462560123374,0.06519217451523548,0.005440279394345618,0.07522830233962896,0.003300728575453847,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
268,0.1,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term significance of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Answer: Postictal psychotic episodes can indicate a greater chance of interictal psychotic episodes. Frequent post-seizure episodes suggest the patient may have psychotic episodes during interictal periods.,7.105791820705622e-08,0.047818751697374484,0.012560595567867067,0.005440279394345618,0.04141624475133909,0.020976473922902493,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
268,0.1,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What long-term implications do postictal psychotic episodes II have? Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes often signal a higher risk of interictal psychotic episodes. Recurrent episodes after seizures suggest the patient might experience psychosis between seizures.,9.474389094274162e-08,0.06267821009997165,0.06295425493060626,0.0072537058591274906,0.10161151780941502,0.004510021921972841,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
268,0.1,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term importance of postictal psychotic episodes II? Do they serve as predictors for interictal psychotic episodes? Answer: Postictal psychotic episodes can be a sign of increased likelihood of interictal psychotic episodes. Frequent occurrences post-seizure indicate potential interictal psychosis.,9.474389094274162e-08,0.02886615251168223,0.08666031855955676,0.0072537058591274906,0.0669541587814173,0.020367910477800573,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
268,0.1,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: How significant are postictal psychotic episodes II over the long term? Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes may indicate a higher probability of interictal psychotic episodes. If these episodes happen often after seizures, it suggests the patient could experience psychosis during interictal intervals.",7.105791820705622e-08,0.11467443436344693,0.07673037190082643,0.005440279394345618,0.06998009843334385,0.002882338120433363,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
269,0.1,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness affect microvascular function in healthy adults who are at risk of Type 2 diabetes? Yes, aerobic fitness has a significant impact on microvascular function in these individuals. Engaging in regular aerobic exercise enhances insulin sensitivity and endothelial function, which helps lower the risk of microvascular complications linked to prediabetes or early stages of the disease.",4.737194547137081e-08,0.25041209464488823,0.17792573935166667,0.0036268529295637453,0.2426614479089535,0.14214876033057855,0.003621603081905733,0.24629325071731456,0.14617283950617282,4.737194547137081e-08,0.22435687659514025,0.131358024691358
269,0.1,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is there an influence of aerobic fitness on microvascular function in healthy adults at risk for Type 2 diabetes? Indeed, aerobic fitness plays a crucial role in microvascular function among these adults. Consistent aerobic exercise boosts insulin sensitivity and endothelial health, thereby decreasing the likelihood of microvascular issues related to prediabetes or early Type 2 diabetes.",0.0,0.23636177079715548,0.19333755492333926,0.0,0.23104906018664906,0.16000000000000003,0.0,0.20925197903696446,0.14617283950617282,0.0,0.18661654861229282,0.131358024691358
269,0.1,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness play a role in microvascular function in healthy adults at risk of developing Type 2 diabetes? Yes, it does. Aerobic fitness markedly improves microvascular function by enhancing insulin sensitivity and endothelial function, which reduces the risk of microvascular complications in prediabetic or early-stage individuals.",2.1317375462116866e-07,0.04287553630269736,0.1828015143320713,0.016320838183036854,0.04872750339269327,0.16000000000000003,0.0162972138685758,0.023149699403105295,0.14617283950617282,2.1317375462116866e-07,0.0034270542755727718,0.131358024691358
269,0.1,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness significantly affects microvascular function in these adults. Regular aerobic activity improves insulin sensitivity and endothelial function, helping to prevent microvascular complications associated with prediabetes or early Type 2 diabetes.",2.1317375462116866e-07,0.012738702365308718,0.1615336597952683,0.016320838183036854,0.017920962034473575,0.13778925619834714,0.0162972138685758,0.023149699403105295,0.14617283950617282,2.1317375462116866e-07,0.0034270542755727718,0.131358024691358
269,0.1,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is microvascular function in healthy adults at risk of Type 2 diabetes affected by aerobic fitness? Yes, aerobic fitness has a significant effect. Engaging in regular aerobic exercise improves insulin sensitivity and endothelial function, thereby lowering the risk of microvascular complications linked to prediabetes or early-stage Type 2 diabetes.",1.6580180914979784e-07,0.11808338748699887,0.2061135585474598,0.012693985253473108,0.09221261533243164,0.16000000000000003,0.012675610786670066,0.06760146197393802,0.14617283950617282,1.6580180914979784e-07,0.04203531980118447,0.131358024691358
269,0.1,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness impact microvascular function in healthy adults at risk of Type 2 diabetes? Yes, it does significantly. Regular aerobic exercise enhances insulin sensitivity and endothelial function, which reduces the risk of microvascular complications in individuals with prediabetes or early Type 2 diabetes.",2.8423167282822487e-07,0.0013659498253835167,0.20130050843438685,0.02176111757738247,0.020265368094258385,0.16000000000000003,0.0217296184914344,0.04746786781084866,0.14617283950617282,2.8423167282822487e-07,0.0757477158551989,0.131358024691358
269,0.1,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is there a significant influence of aerobic fitness on microvascular function in healthy adults at risk of developing Type 2 diabetes? Yes, aerobic fitness greatly influences microvascular function by improving insulin sensitivity and endothelial function, thus reducing the risk of microvascular complications in prediabetic or early-stage individuals.",2.1317375462116866e-07,0.04287553630269736,0.1828015143320713,0.016320838183036854,0.04872750339269327,0.16000000000000003,0.0162972138685758,0.023149699403105295,0.14617283950617282,2.1317375462116866e-07,0.0034270542755727718,0.131358024691358
269,0.1,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness affect microvascular function in healthy adults at risk of Type 2 diabetes? Yes, aerobic fitness significantly improves microvascular function. Regular aerobic exercise enhances insulin sensitivity and endothelial function, which helps mitigate the risk of microvascular complications associated with prediabetes or early Type 2 diabetes.",2.1317375462116866e-07,0.04287553630269736,0.1828015143320713,0.016320838183036854,0.04872750339269327,0.16000000000000003,0.0162972138685758,0.023149699403105295,0.14617283950617282,2.1317375462116866e-07,0.0034270542755727718,0.131358024691358
269,0.1,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness improve microvascular function in healthy adults at risk of developing Type 2 diabetes? Yes, it can. Aerobic fitness significantly enhances microvascular function by improving insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications in prediabetic or early-stage individuals.",2.8423167282822487e-07,0.030873453921591132,0.17832646024878307,0.02176111757738247,0.020265368094258385,0.16000000000000003,0.0217296184914344,0.04746786781084866,0.14617283950617282,2.8423167282822487e-07,0.0757477158551989,0.131358024691358
269,0.1,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is aerobic fitness a factor in microvascular function among healthy adults at risk of Type 2 diabetes? Yes, aerobic fitness significantly influences microvascular function. Regular aerobic exercise improves insulin sensitivity and endothelial function, which lowers the risk of microvascular complications related to prediabetes or early Type 2 diabetes.",1.8948778188548325e-07,0.06630536922179209,0.1841684023975434,0.014507411718254981,0.07070641011146828,0.16000000000000003,0.014486412327622933,0.04562255525516301,0.14617283950617282,1.8948778188548325e-07,0.01956246394912675,0.131358024691358
270,0.1,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does treating migraines early reduce the time to reach headache peak and lessen its intensity? Early intervention and triptan use might shorten the time from migraine onset to peak but do not decrease headache severity at the peak. This may lower the overall migraine burden by shortening the total headache duration.,7.105791820705622e-08,0.05983829796675266,0.001130723391880601,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
270,0.1,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Can early migraine treatment shorten the time until the headache peaks and diminish its severity? Early treatment with triptans may reduce the duration from migraine onset to peak but does not lessen the headache's peak severity. This could help reduce the overall migraine burden by decreasing total headache duration.,1.1842986367842703e-07,0.10181553778793972,0.0019629554726361513,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
270,0.1,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Is early treatment of migraines effective in shortening the time to headache peak and reducing its severity? Using triptans early may lead to a quicker peak after migraine onset but does not reduce the severity at the peak. This might reduce the migraine burden by shortening the total headache duration.,9.474389094274162e-08,0.108898561372889,0.021881470637869296,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
270,0.1,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does initiating migraine treatment early shorten the time to headache peak and lower its severity? Early use of triptans can shorten the interval from migraine onset to peak but does not alleviate the headache's peak severity. This may decrease the migraine burden by reducing total headache duration.,1.6580180914979784e-07,0.1456308536207942,0.002867448316166265,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
270,0.1,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Will early migraine treatment reduce the time to headache peak and its severity? Early treatment and triptan use may shorten the time from migraine onset to peak but do not reduce headache severity at the peak. This could lessen the migraine burden by shortening the total headache duration.,1.4211583641411244e-07,0.12348343916712068,0.002405593897159969,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
270,0.1,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does early intervention in migraine treatment shorten the time to headache peak and reduce severity? Early use of triptans might shorten the duration from migraine onset to peak but does not diminish headache severity at peak. This could lower the migraine burden by reducing total headache duration.,1.6580180914979784e-07,0.1456308536207942,0.002867448316166265,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
270,0.1,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Can early migraine treatment shorten the time to headache peak and decrease its severity? Early treatment with triptans may lead to a shorter time from migraine onset to peak but does not reduce headache severity at the peak. This might reduce the migraine burden by shortening the total headache duration.,9.474389094274162e-08,0.05231511806187328,0.018860946745562133,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
270,0.1,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Is early treatment of migraines associated with a shorter time to headache peak and reduced severity? Early use of triptans may shorten the duration from migraine onset to peak but does not lessen headache severity at peak. This could result in a decreased migraine burden by reducing total headache duration.,9.474389094274162e-08,0.05231511806187328,0.018860946745562133,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
270,0.1,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does early migraine treatment affect the time to headache peak and its severity? Early treatment and triptan use may shorten the time from migraine onset to peak but do not alleviate headache severity at the peak. This might reduce the migraine burden by decreasing total headache duration.,1.6580180914979784e-07,0.1456308536207942,0.002867448316166265,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
270,0.1,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Will early treatment of migraines shorten the time to headache peak and reduce its severity? Early use of triptans may lead to a shorter duration from migraine onset to peak but does not reduce headache severity at peak. This could help decrease the migraine burden by shortening total headache duration.,9.474389094274162e-08,0.05231511806187328,0.018860946745562133,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
271,0.1,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? The consultation resulted in changes to the treatment plan in over one third of cases. Additional research is necessary to assess if these changes enhance outcomes for older patients.,2.1317375462116866e-07,0.09363356020013835,0.07439043209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.1,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients altered by a geriatric oncology consultation? More than one third of cases saw modifications to the treatment plan following the consultation. Further studies are required to evaluate whether these adjustments improve patient outcomes.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.1,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncologist affect the cancer treatment plan in elderly patients? The consultation led to treatment plan changes in over one third of cases. More research is needed to determine if these changes benefit older patients.,3.0791764556390996e-07,0.19994307183733318,0.07175925925925929,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.1,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Can a geriatric oncology consultation modify cancer treatment plans for elderly patients? In over one third of cases, the consultation resulted in treatment plan modifications. Additional studies are needed to verify if these changes improve outcomes for older patients.",2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.1,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a consultation in geriatric oncology alter the cancer treatment plan for elderly patients? Treatment plans were modified in more than one third of cases after the consultation. Further research is necessary to see if these modifications improve outcomes.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.1,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? The consultation led to changes in the treatment plan in over one third of cases. More studies are needed to determine if these changes improve patient outcomes.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.1,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation lead to changes in the cancer treatment plan for elderly patients? More than one third of cases experienced modifications to their treatment plans following the consultation. Further research is required to assess if these changes improve outcomes.,2.1317375462116866e-07,0.05982150261184849,0.09876543209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.1,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncologist result in modifications to the cancer treatment plan for elderly patients? The consultation caused treatment plan changes in over one third of cases. Additional studies are needed to evaluate if these modifications improve outcomes.,2.8423167282822466e-07,0.17228884014555623,0.07246886526165808,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.1,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation influence the cancer treatment plan for elderly patients? Treatment plans were altered in more than one third of cases after the consultation. Further research is necessary to determine if these changes benefit older patients.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.1,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? The consultation led to modifications in the treatment plan in over one third of cases. More studies are needed to confirm whether these changes improve outcomes.,2.8423167282822466e-07,0.17228884014555623,0.07246886526165808,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
272,0.1,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is computerised tomography a suitable substitute for bone scintigraphy in identifying bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot completely replace bone scintigraphy in detecting bone metastases from breast cancer. Although CT is useful in spotting,7.10579182070559e-08,0.21982520776165293,0.07398761094674555,0.005440279394345625,0.2575686874683032,0.11159406875798007,0.005432404622858614,0.300556720495472,0.14508440413202317,7.105791820705622e-08,0.30622065261467046,0.1508916323731139
272,0.1,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can CT scans take the place of bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: CT scans cannot entirely substitute bone scintigraphy when it comes to detecting bone metastases from breast cancer. While CT is capable of identifying,1.421158364141119e-07,0.37945146772113514,0.1299106158773518,0.010880558788691243,0.41327511540622597,0.1670603323024975,0.010864809245717214,0.419107604866781,0.1728395061728395,1.4211583641411244e-07,0.3884587508516435,0.1508916323731139
272,0.1,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is it possible for computerised tomography to replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully supplant bone scintigraphy in detecting bone metastases from breast cancer. CT is effective in identifying,1.184298636784265e-07,0.28206293131593974,0.08100264122356213,0.00906713232390937,0.3159766386714784,0.11565500685871052,0.009054007704764347,0.3566506879077367,0.14654293933573212,1.1842986367842703e-07,0.36179050376948263,0.1508916323731139
272,0.1,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can bone scintigraphy be replaced by computerised tomography in the detection of bone metastases from breast cancer? Answer: Bone scintigraphy cannot be completely replaced by computerised tomography (CT) for detecting bone metastases from breast cancer. CT is useful in identifying,1.184298636784265e-07,0.24740557228794202,0.059205557457305685,0.00906713232390937,0.2804306294119945,0.09081940595168105,0.009054007704764347,0.3201692573519499,0.12037037037037035,1.1842986367842703e-07,0.36179050376948263,0.1508916323731139
272,0.1,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Does computerised tomography serve as a replacement for bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot entirely replace bone scintigraphy in the detection of bone metastases from breast cancer. CT is effective in identifying,1.184298636784265e-07,0.28206293131593974,0.08100264122356213,0.00906713232390937,0.3159766386714784,0.11565500685871052,0.009054007704764347,0.3566506879077367,0.14654293933573212,1.1842986367842703e-07,0.36179050376948263,0.1508916323731139
272,0.1,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can CT fully replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: CT cannot completely replace bone scintigraphy for detecting bone metastases from breast cancer. While CT is effective in identifying,0.0,0.15843364127084447,0.08744247205785668,0.0,0.1630934542493998,0.10463494673615299,0.0,0.21004460016968096,0.1425660686728395,0.0,0.2166084939249835,0.1508916323731139
272,0.1,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is computerised tomography an adequate replacement for bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. CT is effective in identifying,4.73719454713706e-08,0.11230622269099255,0.0265691730751641,0.003626852929563752,0.11152289858974829,0.03204389574759939,0.003621603081905747,0.11285196863799474,0.03395061728395063,4.737194547137081e-08,0.11413966149202048,0.03533607681755831
272,0.1,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can computerised tomography be used instead of bone scintigraphy to detect bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot entirely replace bone scintigraphy in detecting bone metastases from breast cancer. CT is effective in identifying,4.73719454713706e-08,0.22470846818719892,0.09449542344674555,0.003626852929563752,0.26555560538084677,0.13668057394829145,0.003621603081905747,0.27128560990883877,0.14429279337007134,4.737194547137081e-08,0.27723311574141896,0.1508916323731139
272,0.1,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Is it feasible for computerised tomography to replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. CT is effective in identifying,1.184298636784265e-07,0.24740557228794202,0.059205557457305685,0.00906713232390937,0.28043062941199404,0.09081940595168103,0.009054007704764347,0.3201692573519499,0.12037037037037035,1.1842986367842703e-07,0.36179050376948263,0.1508916323731139
272,0.1,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Question: Can CT scans replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: CT scans cannot completely replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,2.36859727356853e-08,0.115089332941674,0.043216022064462595,0.0018134264647818796,0.15596744053885514,0.0796609613043112,0.0018108015409528735,0.20035975622859858,0.1142457561728395,2.3685972735685406e-08,0.24738015259173718,0.1508916323731139
273,0.1,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should patients with HIV undergo screening for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, because HIV-infected individuals are at increased risk of cardiovascular disease due to chronic inflammation from the infection and antiretroviral therapy, early detection via gated myocardial perfusion SPECT allows for timely intervention and improved outcomes.",3.552895910352811e-07,0.1070377346350786,0.1101492149896825,0.02720139697172809,0.12477746881714769,0.10347361844295871,0.027162023114293,0.12046967804730269,0.11107438016528923,3.552895910352811e-07,0.14587564527898023,0.09719008264462808
273,0.1,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it advisable to screen HIV-positive patients for silent myocardial ischaemia with gated myocardial perfusion SPECT? Indeed, since HIV infection and its treatment cause chronic inflammation that raises cardiovascular risk, screening with gated myocardial perfusion SPECT helps identify silent ischaemia early for better management.",4.974054274493935e-07,0.27779268498205045,0.08151663237311393,0.038081955760419325,0.29544174611452423,0.07679752066115698,0.0380268323600102,0.2908572706413426,0.08669938016528922,4.974054274493935e-07,0.2856375876541386,0.09719008264462808
273,0.1,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Do HIV-infected patients need screening for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, as the chronic inflammatory effects of HIV and antiretroviral drugs increase cardiovascular disease risk, early screening with gated myocardial perfusion SPECT facilitates prompt treatment and improved prognosis.",5.447773729207643e-07,0.29632663790696157,0.10223942987475759,0.04170880868998307,0.3128752521157683,0.09931395721605507,0.04164843544191593,0.30705563362771615,0.11107438016528923,5.447773729207643e-07,0.3369308820416883,0.09719008264462808
273,0.1,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischaemia screening via gated myocardial perfusion SPECT be performed on HIV-infected individuals? Yes, because the chronic inflammation from HIV infection and antiretroviral therapy elevates cardiovascular risk, early detection through this screening method enables timely therapeutic measures.",6.158352911278203e-07,0.30468842970830323,0.15089163237311393,0.04714908808432869,0.35617943455748247,0.124297520661157,0.04708084006477453,0.3870983413012503,0.11107438016528923,6.158352911278206e-07,0.41916898027866134,0.09719008264462808
273,0.1,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is screening for silent myocardial ischaemia with gated myocardial perfusion SPECT recommended for patients with HIV? Yes, due to the heightened cardiovascular risk from chronic inflammation caused by HIV and its treatment, early screening can lead to earlier intervention and better health outcomes.",5.210914001850789e-07,0.2046049711513218,0.15089163237311393,0.0398953822252012,0.2535252804974002,0.124297520661157,0.039837633900963065,0.2817378256434244,0.11107438016528923,5.210914001850789e-07,0.31095539563843033,0.09719008264462808
273,0.1,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Are HIV-positive patients recommended to be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, since HIV infection and antiretroviral therapy induce chronic inflammation that increases cardiovascular risk, early detection through this screening is beneficial for timely treatment.",5.92149318392135e-07,0.27871294330504526,0.15089163237311393,0.045335661619546816,0.3295111874753216,0.124297520661157,0.045270038523821665,0.359699367113135,0.11107438016528923,5.921493183921352e-07,0.3909981033119645,0.09719008264462808
273,0.1,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should gated myocardial perfusion SPECT be used to screen HIV-infected patients for silent myocardial ischaemia? Yes, because HIV and its treatment cause chronic inflammation that raises cardiovascular disease risk, early screening allows for prompt treatment and improved patient outcomes.",6.158352911278203e-07,0.30468842970830323,0.15089163237311393,0.04714908808432869,0.35617943455748247,0.124297520661157,0.04708084006477453,0.3870983413012503,0.11107438016528923,6.158352911278206e-07,0.41916898027866134,0.09719008264462808
273,0.1,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it necessary to screen HIV-infected patients for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, as the chronic inflammatory state from HIV infection and antiretroviral therapy increases cardiovascular risk, early detection through this method supports timely intervention.",6.158352911278203e-07,0.30468842970830323,0.15089163237311393,0.04714908808432869,0.35617943455748247,0.124297520661157,0.04708084006477453,0.3870983413012503,0.11107438016528923,6.158352911278206e-07,0.41916898027866134,0.09719008264462808
273,0.1,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Do HIV-infected individuals require screening for silent myocardial ischaemia with gated myocardial perfusion SPECT? Yes, given the increased cardiovascular risk from chronic inflammation due to HIV and its treatment, early screening facilitates timely treatment and better outcomes.",6.63207236599191e-07,0.3587556509785794,0.15089163237311393,0.050775941013892434,0.41174928571229463,0.124297520661157,0.05070244314668027,0.44425675514119867,0.11107438016528923,6.632072365991914e-07,0.4780094803015946,0.09719008264462808
273,0.1,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should HIV patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Yes, because the chronic inflammation caused by HIV infection and antiretroviral therapy elevates cardiovascular risk, early detection through this screening method can improve treatment timing and outcomes.",5.684633456564497e-07,0.25339513532075353,0.15089163237311393,0.04352223515476494,0.3035357010720636,0.124297520661157,0.0434592369828688,0.3330311200309741,0.11107438016528923,5.684633456564497e-07,0.3635991291238492,0.09719008264462808
274,0.1,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Is there a link between crime and over-the-counter pharmacy syringe sales? Answer: Although no direct link exists between crime and over-the-counter pharmacy syringe sales, misuse is possible. Syringes may be used for illegal drug activities.",4.73719454713706e-08,0.05518371149775003,0.07853509076193779,0.003626852929563759,0.05914713364796542,0.08433807376575328,0.003621603081905747,0.06350640312047462,0.09000000000000004,4.737194547137081e-08,0.02210487643242276,0.06222222222222223
274,0.1,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Does crime relate to over-the-counter pharmacy syringe sales? Answer: There is no direct connection between crime and over-the-counter pharmacy syringe sales, but misuse can happen. Syringes might be utilized for illicit drug use.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
274,0.1,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Are over-the-counter pharmacy syringe sales connected to crime? Answer: While over-the-counter pharmacy syringe sales are not directly connected to crime, misuse can occur. Syringes can be employed for illegal drug use.",4.73719454713706e-08,0.15737920867086652,0.06584647622147144,0.003626852929563759,0.11363644642723303,0.03510904882244257,0.003621603081905747,0.11449462833039359,0.03443877551020409,4.737194547137081e-08,0.06899287148695077,0.0
274,0.1,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Is crime linked to the sale of syringes over the counter at pharmacies? Answer: There is no direct link between crime and over-the-counter pharmacy syringe sales, though misuse is possible. Syringes may be used in illicit drug consumption.",1.184298636784265e-07,0.2250964383277787,0.06035379812695108,0.009067132323909384,0.18850370862949672,0.031217481789802305,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
274,0.1,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Does selling syringes over the counter at pharmacies associate with crime? Answer: No direct association exists between crime and over-the-counter pharmacy syringe sales, but misuse can take place. Syringes can be used for illegal drug use.",7.10579182070559e-08,0.17102921705750251,0.06035379812695108,0.005440279394345639,0.13293385747468456,0.031217481789802305,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
274,0.1,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Is there an association between crime and over-the-counter pharmacy syringe sales? Answer: While no direct association is found between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes might be used for illicit drug purposes.",7.10579182070559e-08,0.021511666431370813,0.07492195629552548,0.005440279394345639,0.025499783796159914,0.0811654526534859,0.005432404622858621,0.02994677055603301,0.08740894901144641,7.105791820705622e-08,0.011292339736452828,0.06035379812695108
274,0.1,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Are crime rates affected by over-the-counter pharmacy syringe sales? Answer: There is no direct effect of over-the-counter pharmacy syringe sales on crime rates, but misuse is possible. Syringes can be used for illegal drug use.",4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
274,0.1,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Is crime related to the sale of syringes at pharmacies without a prescription? Answer: Although there is no direct relation between crime and over-the-counter pharmacy syringe sales, misuse can happen. Syringes may be used for illicit drug use.",1.184298636784265e-07,0.2250964383277787,0.06035379812695108,0.009067132323909384,0.18850370862949672,0.031217481789802305,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
274,0.1,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Does crime have a connection with over-the-counter pharmacy syringe sales? Answer: There is no direct connection between crime and over-the-counter pharmacy syringe sales, but misuse can occur. Syringes can be used for illegal drug activities.",4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
274,0.1,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Question: Is there a crime association with over-the-counter pharmacy syringe sales? Answer: While no direct crime association exists with over-the-counter pharmacy syringe sales, misuse is possible. Syringes might be used for illicit drug use.",0.0,0.08401784006787194,0.05855226608232362,0.0,0.0433216987849967,0.031004740432419922,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
275,0.1,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer be established as a novel diagnostic marker for acute appendicitis? Answer: Although investigations continue, existing research indicates that D-dimer levels might act as a new",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.1,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: Current studies, while ongoing, imply that D-dimer levels could serve as a novel",7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,0.1,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer be utilized as a new diagnostic parameter in acute appendicitis? Answer: Research is still underway, but current findings suggest D-dimer levels may function as a new",2.36859727356853e-08,0.011309146026370787,0.03402366863905328,0.0018134264647818796,0.013603907614186284,0.03698224852071005,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
275,0.1,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Might D-dimer become a new diagnostic indicator for acute appendicitis? Answer: Although research is in progress, present studies propose that D-dimer levels have potential as a new",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.1,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is it possible for D-dimer to be a new diagnostic marker for acute appendicitis? Answer: While studies continue, current evidence suggests D-dimer levels could be used as a new",4.73719454713706e-08,0.07499994574745683,0.0025434730105059547,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
275,0.1,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer serve as a novel diagnostic parameter for acute appendicitis? Answer: Research is ongoing, yet current data indicate that D-dimer levels might be a new",2.36859727356853e-08,0.013603907614186284,0.03698224852071005,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.1,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer levels be considered a new diagnostic criterion for acute appendicitis? Answer: Although research is ongoing, current studies suggest D-dimer levels may potentially serve as a new",2.36859727356853e-08,0.011309146026370787,0.03402366863905328,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
275,0.1,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer likely to become a new diagnostic marker for acute appendicitis? Answer: While investigations are ongoing, current research points to D-dimer levels as a possible new",0.0,0.05134423559703327,0.03698224852071005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.1,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer act as a new diagnostic parameter for acute appendicitis? Answer: Research continues, and current studies suggest that D-dimer levels might serve as a new",2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.09467248759807756,0.03993055555555556,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.1,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer be introduced as a new diagnostic tool for acute appendicitis? Answer: Although research is still ongoing, current findings indicate that D-dimer levels could potentially be a new",4.73719454713706e-08,0.07499994574745683,0.0025434730105059547,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
276,0.1,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate help prevent colon cancer in patients with coronary artery disease? Current research indicates that bezafibrate, a lipid-lowering PPAR ligand, may possess anti-cancer effects, though definitive studies confirming its role in colon cancer prevention are lacking.",2.3685972735685406e-08,0.13689891647355923,0.11207023542023624,0.0018134264647818726,0.14093749141140366,0.11687363038714388,0.0018108015409528666,0.11055561776278777,0.09642074506939374,2.3685972735685406e-08,0.07865426909969919,0.07450693937180423
276,0.1,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer among coronary artery disease patients? Research to date suggests bezafibrate has potential anti-cancer properties, but conclusive evidence for colon cancer prevention is not yet established.",1.4211583641411212e-07,0.005686804267106105,0.10885942248554863,0.010880558788691236,0.010884363163206068,0.11687363038714388,0.0108648092457172,0.022975774861734966,0.09642074506939374,1.4211583641411244e-07,0.058546852413783323,0.07450693937180423
276,0.1,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Can the lipid-lowering PPAR ligand bezafibrate prevent colon cancer in individuals with coronary artery disease? Existing studies imply bezafibrate might have anti-cancer benefits, but specific proof of its effectiveness in colon cancer prevention remains insufficient.",2.1317375462116802e-07,0.08217653215790488,0.10648083866757085,0.016320838183036868,0.07612701382642406,0.11687363038714388,0.01629721386857582,0.11258793355142194,0.09642074506939374,2.1317375462116866e-07,0.15092017254479861,0.07450693937180423
276,0.1,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does bezafibrate, which lowers lipids via peroxisome proliferator-activated receptors, prevent colon cancer in patients with coronary artery disease? Current findings suggest it may have anti-cancer potential, although targeted studies confirming its preventive effect on colon cancer are still needed.",1.1842986367842682e-07,0.03334103595888305,0.10956902848794742,0.009067132323909363,0.03828333735132139,0.11687363038714388,0.009054007704764333,0.0051951021049618795,0.09642074506939374,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
276,0.1,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, capable of preventing colon cancer in coronary artery disease patients? Research suggests bezafibrate could have anti-cancer properties, but direct evidence for colon cancer prevention is not yet confirmed.",1.4211583641411212e-07,0.005686804267106105,0.10885942248554863,0.010880558788691236,0.010884363163206068,0.11687363038714388,0.0108648092457172,0.022975774861734966,0.09642074506939374,1.4211583641411244e-07,0.058546852413783323,0.07450693937180423
276,0.1,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, prevent colon cancer in patients with coronary artery disease? Studies indicate it may possess anti-cancer effects, but specific research proving its efficacy in colon cancer prevention is lacking.",1.1842986367842682e-07,0.03334103595888305,0.10956902848794742,0.009067132323909363,0.03828333735132139,0.11687363038714388,0.009054007704764333,0.0051951021049618795,0.09642074506939374,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
276,0.1,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Can bezafibrate, a lipid-lowering PPAR ligand, prevent colon cancer in patients suffering from coronary artery disease? Current research points to potential anti-cancer properties of bezafibrate, though definitive studies on colon cancer prevention are absent.",2.3685972735685332e-07,0.11326505177917268,0.1055921578250548,0.018134264647818747,0.10689867249317775,0.11687363038714388,0.018108015409528694,0.14433663186600176,0.09642074506939374,2.3685972735685406e-07,0.1837099953677903,0.07450693937180423
276,0.1,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is there evidence that bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevents colon cancer in coronary artery disease patients? Research suggests it might have anti-cancer benefits, but specific studies confirming colon cancer prevention are not available.",1.8948778188548272e-07,0.05202404204001487,0.10731888252228663,0.014507411718254988,0.046274050676742284,0.11687363038714388,0.014486412327622947,0.08181627488466825,0.09642074506939374,1.8948778188548325e-07,0.11917147423021879,0.07450693937180423
276,0.1,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate have a role in preventing colon cancer among patients with coronary artery disease? Current data imply bezafibrate may have anti-cancer properties, yet conclusive studies on colon cancer prevention are missing.",1.4211583641411212e-07,0.005686804267106105,0.10885942248554863,0.010880558788691236,0.010884363163206068,0.11687363038714388,0.0108648092457172,0.022975774861734966,0.09642074506939374,1.4211583641411244e-07,0.058546852413783323,0.07450693937180423
276,0.1,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, effective in colon cancer prevention for patients with coronary artery disease? Research suggests potential anti-cancer effects, but specific evidence for colon cancer prevention is still lacking.",2.1317375462116802e-07,0.12294989572025505,0.0772718453250548,0.016320838183036868,0.11813593386035981,0.08660019288714388,0.01629721386857582,0.11258793355142194,0.09642074506939374,2.1317375462116866e-07,0.15092017254479861,0.07450693937180423
277,0.1,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These findings indicate that the R14C KCNQ1 mutation by itself does not cause AF. Instead, we propose a model where a ""second hit,"" such as an environmental factor like hypertension that induces atrial stretch, reveals an inherited ion channel defect (the ""first hit"").",1.1842986367842703e-07,0.08182000813651058,0.0012810193954682567,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
277,0.1,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The data imply that the R14C KCNQ1 mutation alone is not enough to trigger AF. We suggest a model where a ""second hit,"" for example, hypertension causing atrial stretch, exposes a genetic ion channel abnormality (the ""first hit"").",2.3685972735685406e-07,0.17093183112783628,0.002794723615397801,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
277,0.1,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Our results suggest that the R14C KCNQ1 mutation by itself cannot cause AF. We propose a model in which an environmental ""second hit,"" such as hypertension leading to atrial stretch, unmasks a hereditary ion channel defect (the ""first hit"").",2.1317375462116866e-07,0.1524632300533657,0.002470380294421492,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
277,0.1,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These results indicate that the R14C KCNQ1 mutation alone is insufficient for AF development. Instead, a ""second hit,"" like hypertension-induced atrial stretch, reveals an inherited ion channel kinetic defect (the ""first hit"").",3.789755637709665e-07,0.28953108788482673,0.005018446180555556,0.029014823436509962,0.28768207245178035,0.0,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
277,0.1,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The evidence suggests that the R14C KCNQ1 mutation by itself does not cause AF. We propose a model where a ""second hit,"" such as hypertension causing atrial stretch, uncovers a genetic ion channel defect (the ""first hit"").",2.6054570009253947e-07,0.189747735574187,0.0031310665772961814,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
277,0.1,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data indicate that the R14C KCNQ1 mutation alone cannot induce AF. Rather, we suggest a model where an environmental ""second hit,"" like hypertension leading to atrial stretch, reveals an inherited ion channel abnormality (the ""first hit"").",2.6054570009253947e-07,0.189747735574187,0.0031310665772961814,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
277,0.1,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Findings suggest that the R14C KCNQ1 mutation alone is not sufficient to cause AF. Instead, a ""second hit,"" such as hypertension-induced atrial stretch, unmasks a genetic defect in ion channel kinetics (the ""first hit"").",3.316036182995957e-07,0.2484162739905198,0.004219140624999992,0.025387970506946217,0.24686007793152598,0.0,0.025351221573340132,0.25131442828090833,0.0,3.316036182995957e-07,0.2559333741372005,0.0
277,0.1,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The data show that the R14C KCNQ1 mutation by itself does not cause AF. We propose a model where a ""second hit,"" like hypertension causing atrial stretch, exposes an inherited ion channel defect (the ""first hit"").",2.8423167282822487e-07,0.20892424816744537,0.003480087370562133,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
277,0.1,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These findings suggest that the R14C KCNQ1 mutation alone is inadequate to cause AF. Instead, a ""second hit,"" such as hypertension leading to atrial stretch, reveals a hereditary ion channel kinetic defect (the ""first hit"").",3.079176455639103e-07,0.22847545270313097,0.00384251624975971,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
277,0.1,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The evidence indicates that the R14C KCNQ1 mutation alone cannot cause AF. We propose a model where an environmental ""second hit,"" like hypertension-induced atrial stretch, unmasks an inherited ion channel defect (the ""first hit"").",3.316036182995957e-07,0.2484162739905198,0.004219140624999992,0.025387970506946217,0.24686007793152598,0.0,0.025351221573340132,0.25131442828090833,0.0,3.316036182995957e-07,0.2559333741372005,0.0
278,0.1,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.1,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,"Question: In geriatric blunt trauma patients with low-energy mechanisms, are clinical predictors reliable for cervical spine fracture assessment? Answer: Clinical predictors are inadequate for evaluating cervical spine injuries in elderly trauma patients with low-energy mechanisms.",0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.1,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors effectively identify cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors do not adequately assess cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.004742618054735637,0.02168367346938782,0.0018134264647818796,0.03339721616887559,0.0018684240952711456,0.0018108015409528735,0.033146172468933255,0.0010047404324198955,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.1,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors adequate for detecting cervical spine fractures in geriatric patients after low-energy blunt trauma? Answer: Clinical predictors appear to be insufficient for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,0.0,0.16309345424939803,0.10977359693877556,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.1,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide reliable evaluation of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for assessing cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.07558566665879374,0.02947845804988669,0.0018134264647818796,0.03232407609285426,0.0017600481269510818,0.0018108015409528735,0.032084437417815526,0.0009440442898023052,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.1,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors sufficient for cervical spine fracture assessment in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are not adequate for evaluating cervical spine injuries in elderly trauma patients with low-energy mechanisms.,9.47438909427412e-08,0.17345866370538898,0.03980903656228338,0.007253705859127504,0.12349336091481211,0.006476247106542911,0.007243206163811487,0.12259655774360656,0.0034623797489859755,9.474389094274162e-08,0.1213608570042668,0.0
278,0.1,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective in evaluating cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear inadequate for cervical spine assessment in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.004742618054735637,0.02168367346938782,0.0018134264647818796,0.03339721616887559,0.0018684240952711456,0.0018108015409528735,0.033146172468933255,0.0010047404324198955,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.1,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately evaluate cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.032592934367321025,0.01747571456566166,0.003626852929563759,0.0679408627921636,0.0038554765460572307,0.003621603081905747,0.06742663438990348,0.0020762161887946107,4.737194547137081e-08,0.06669137449867346,0.0
278,0.1,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate for evaluating cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.1,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the evaluation of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms adequately supported by clinical predictors? Answer: Clinical predictors appear insufficient for cervical spine assessment in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.14776588842294647,0.05899234693877556,0.003626852929563759,0.06364151945538365,0.003420832103075977,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
279,0.1,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the interfractional motion of the prostate bed target, defined by RTOG consensus and monitored with daily CT on rails, vary between the superior and inferior parts of the clinical target volume?",6.158352911278196e-07,0.3132898844347469,0.18735592812931923,0.04714908808432872,0.3270912316901602,0.19834710743801648,0.04708084006477457,0.36277848302201976,0.1875,6.158352911278206e-07,0.4000583584039057,0.17561983471074377
279,0.1,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Is there a difference in interfractional motion between the superior and inferior sections of the clinical target volume in the prostate bed, according to RTOG consensus definitions and daily CT on rails imaging?",5.921493183921343e-07,0.23682201318081608,0.21957815035154143,0.045335661619546844,0.2943014088671685,0.19834710743801648,0.0452700385238217,0.328876931346338,0.1875,5.921493183921352e-07,0.3649670385926367,0.17561983471074377
279,0.1,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using RTOG consensus definitions and daily CT on rails, does the prostate bed target exhibit different interfractional motion in its superior versus inferior clinical target volume regions?",7.342651548062461e-07,0.44446137795906004,0.21957815035154143,0.05621622040823812,0.5094127884841151,0.19834710743801648,0.05613484776953894,0.5520204826605477,0.1875,7.342651548062476e-07,0.5967686526499603,0.17561983471074377
279,0.1,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the prostate bed target's interfractional motion, assessed by RTOG consensus and daily CT on rails, differ between the upper and lower portions of the clinical target volume?",7.105791820705608e-07,0.40672104997621306,0.21957815035154143,0.05440279394345624,0.4701920753308326,0.19834710743801648,0.05432404622858607,0.5111984881402929,0.1875,7.105791820705622e-07,0.5542090382311646,0.17561983471074377
279,0.1,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"According to RTOG consensus and daily CT on rails, is there a variation in interfractional motion between the superior and inferior areas of the prostate bed clinical target volume?",6.868932093348755e-07,0.3703534058053384,0.21957815035154143,0.05258936747867436,0.43245174734798564,0.19834710743801648,0.052513244687633194,0.47197777498701043,0.1875,6.868932093348768e-07,0.5133870437109098,0.17561983471074377
279,0.1,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Is interfractional motion of the prostate bed target, as defined by RTOG consensus and observed with daily CT on rails, different between the superior and inferior parts of the clinical target volume?",6.158352911278196e-07,0.3132898844347469,0.18735592812931923,0.04714908808432872,0.3270912316901602,0.19834710743801648,0.04708084006477457,0.36277848302201976,0.1875,6.158352911278206e-07,0.4000583584039057,0.17561983471074377
279,0.1,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Does the clinical target volume of the prostate bed show differing interfractional motion in its superior compared to inferior portions when evaluated using RTOG consensus definitions and daily CT on rails?,6.395212638635049e-07,0.3013605343183876,0.21957815035154143,0.0489625145491106,0.36099278336584195,0.19834710743801648,0.04889164160572745,0.39786980283328877,0.1875,6.39521263863506e-07,0.43642600257478037,0.17561983471074377
279,0.1,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using daily CT on rails and RTOG consensus definitions, does the prostate bed target's interfractional motion vary between the superior and inferior clinical target volume regions?",7.579511275419314e-07,0.4836820911123425,0.21957815035154143,0.05802964687302,0.5502347830043699,0.19834710743801648,0.057945649310491815,0.5945800970793433,0.1875,7.57951127541933e-07,0.6412204152207943,0.17561983471074377
279,0.1,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Is there a difference in the interfractional motion of the prostate bed target between its superior and inferior clinical target volume portions, based on RTOG consensus and daily CT on rails?",6.395212638635049e-07,0.3013605343183876,0.21957815035154143,0.0489625145491106,0.36099278336584195,0.19834710743801648,0.04889164160572745,0.39786980283328877,0.1875,6.39521263863506e-07,0.43642600257478037,0.17561983471074377
279,0.1,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Does the interfractional motion of the prostate bed target differ between the superior and inferior parts of the clinical target volume when using RTOG consensus definitions and daily CT on rails?,6.395212638635049e-07,0.34757034635571715,0.18628445237294453,0.0489625145491106,0.36099278336584195,0.19834710743801648,0.04889164160572745,0.39786980283328877,0.1875,6.39521263863506e-07,0.43642600257478037,0.17561983471074377
280,0.1,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders? Yes, mental imagery fMRI can potentially predict recovery by evaluating cognitive function and neural activity, assisting in prognosis formulation, though further research is needed for conclusive evidence.",4.026615365066519e-07,0.12129868200617544,0.15696350649818733,0.030828249901291835,0.13899273656837918,0.1548211860570394,0.030783626196198732,0.1933095613635527,0.12456597222222221,4.026615365066519e-07,0.24970554492746588,0.09162848812994587
280,0.1,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it possible for mental imagery functional MRI to predict recovery in patients with disorders of consciousness? Yes, mental imagery fMRI shows promise in predicting recovery by assessing brain function and neural responses, helping to guide prognosis, but more research is necessary for definitive conclusions.",3.079176455639103e-07,0.02283783319930599,0.15923208887244014,0.023574544042164344,0.04135426700446132,0.1548211860570394,0.023540420032387266,0.09322610280657129,0.12456597222222221,3.079176455639103e-07,0.1470513908673836,0.09162848812994587
280,0.1,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can functional MRI using mental imagery predict recovery outcomes in patients with consciousness disorders? Yes, this technique can evaluate cognitive and neural responses to aid prognosis, although more extensive studies are required to confirm its reliability.",5.210914001850784e-07,0.2201727156027018,0.18194706994328924,0.039895382225201205,0.2761938580818617,0.1548211860570394,0.03983763390096308,0.334388159623459,0.12456597222222221,5.210914001850789e-07,0.394887554771965,0.09162848812994587
280,0.1,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery functional magnetic resonance imaging have the ability to predict recovery in patients suffering from disorders of consciousness? Yes, it can assess cognitive functions and neural responses to help predict recovery, but conclusive results depend on further research.",4.263475092423372e-07,0.11195913096247079,0.18194706994328924,0.03264167636607371,0.16496822297163716,0.1548211860570394,0.0325944277371516,0.21997780844571357,0.12456597222222221,4.263475092423373e-07,0.2771045191155812,0.09162848812994587
280,0.1,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI be used to predict recovery in patients with disorders of consciousness? Yes, it has the potential to evaluate cognitive and neural function to assist in prognosis, though more comprehensive research is needed for definitive conclusions.",4.500334819780225e-07,0.13793461736572876,0.18194706994328924,0.03445510283085558,0.19163647005379802,0.1548211860570394,0.034405229278104466,0.2473767826338289,0.12456597222222221,4.500334819780227e-07,0.30527539608227805,0.09162848812994587
280,0.1,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional MRI effective in predicting recovery in patients with consciousness disorders? Yes, it can help assess brain function and neural activity to forecast recovery, but additional research is required for firm conclusions.",5.447773729207637e-07,0.2491602524759533,0.18194706994328924,0.041708808689983085,0.3060468212315435,0.1548211860570394,0.04164843544191595,0.3651598182902127,0.12456597222222221,5.447773729207643e-07,0.42663625308654485,0.09162848812994587
280,0.1,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional magnetic resonance imaging predict recovery in patients with consciousness disorders? Yes, it can evaluate cognitive and neural responses to aid prognosis, but more research is necessary to establish definitive results.",5.68463345656449e-07,0.2790132156256351,0.18194706994328924,0.043522235154764964,0.33681847989829716,0.1548211860570394,0.043459236982868826,0.39690851660479254,0.12456597222222221,5.684633456564497e-07,0.45942607590953655,0.09162848812994587
280,0.1,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI predict recovery in patients with disorders of consciousness? Yes, it has potential to assess cognitive function and neural responses to support prognosis, although further research is essential for conclusive evidence.",5.68463345656449e-07,0.2790132156256351,0.18194706994328924,0.043522235154764964,0.33681847989829716,0.1548211860570394,0.043459236982868826,0.39690851660479254,0.12456597222222221,5.684633456564497e-07,0.45942607590953655,0.09162848812994587
280,0.1,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it feasible for mental imagery functional MRI to predict recovery in patients with disorders of consciousness? Yes, it can help assess cognitive and neural function to inform prognosis, but definitive conclusions await more extensive research.",5.210914001850784e-07,0.2201727156027018,0.18194706994328924,0.039895382225201205,0.2761938580818617,0.1548211860570394,0.03983763390096308,0.334388159623459,0.12456597222222221,5.210914001850789e-07,0.394887554771965,0.09162848812994587
280,0.1,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional MRI predict recovery in patients with consciousness disorders? Yes, it can evaluate cognitive and neural responses to assist in prognosis, but more research is needed to confirm its effectiveness.",5.921493183921343e-07,0.30978487429238877,0.18194706994328924,0.045335661619546844,0.368567178212877,0.1548211860570394,0.0452700385238217,0.42969833942778424,0.12456597222222221,5.921493183921352e-07,0.4933276275852183,0.09162848812994587
281,0.1,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This study shows that hospital management can promote care programme development by integrating case-mix reimbursement into hospital budgeting. Further research is needed to validate this result and to assess if care programmes will eventually be established.,2.3685972735685406e-07,0.07293401200320693,0.08842752787389466,0.018134264647818726,0.12505463940106631,0.05436390532544379,0.018108015409528666,0.17912229484749664,0.01851192595229618,2.3685972735685406e-07,0.2090917978585587,0.0
281,0.1,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does reimbursement based on case-mix foster the growth of process-oriented care delivery? The study indicates that hospital management can drive care programme creation by adopting case-mix reimbursement in budgeting. Additional studies are suggested to confirm these findings and to explore whether care programmes will be implemented over time.,2.1317375462116866e-07,0.05142780678224357,0.08842752787389466,0.016320838183036854,0.10307573268229131,0.05436390532544379,0.0162972138685758,0.15664943899543893,0.01851192595229618,2.1317375462116866e-07,0.18610227963385917,0.0
281,0.1,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is process-oriented care delivery stimulated by case-mix based reimbursement? Findings reveal that hospital management can encourage care programme development through case-mix reimbursement in budgeting. Future research should verify this and examine if care programmes will be established in the long run.,3.789755637709665e-07,0.2126959543783653,0.08842752787389466,0.029014823436509962,0.2681554830417414,0.05436390532544379,0.028972824655245866,0.325725769039372,0.01851192595229618,3.789755637709665e-07,0.3593740009078954,0.0
281,0.1,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the use of case-mix based reimbursement promote process-oriented care delivery? This research demonstrates that hospital management can facilitate care programme development by incorporating case-mix reimbursement into budgeting. Further investigation is recommended to confirm this and to determine if care programmes will eventually be created.,2.8423167282822487e-07,0.11738577457403965,0.08842752787389466,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.1,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Can case-mix based reimbursement stimulate the development of process-oriented care delivery? The study shows hospital management can encourage care programmes by adopting case-mix reimbursement within budgeting processes. Future studies are advised to confirm this and to see if care programmes will be established over time.,2.8423167282822487e-07,0.14889246459949224,0.06571254680304554,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.1,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix reimbursement encourage the development of process-oriented care delivery? The study demonstrates that hospital management can foster care programmes by integrating case-mix reimbursement into budgeting. Additional research is needed to confirm this and to assess whether care programmes will be established in the future.,2.8423167282822487e-07,0.18039915462494438,0.04307605395099216,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.1,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? This study indicates hospital management can promote care programmes by adopting case-mix reimbursement in budgeting. Further research is recommended to validate this and to determine if care programmes will be implemented eventually.,3.079176455639103e-07,0.17261469654571338,0.06518489748840714,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
281,0.1,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement drive the development of process-oriented care delivery? The study finds that hospital management can stimulate care programme development by using case-mix reimbursement in budgeting. Future research should confirm this and explore whether care programmes will be established over time.,3.316036182995957e-07,0.1639057902089336,0.08842752787389466,0.025387970506946217,0.218145062467078,0.05436390532544379,0.025351221573340132,0.2744324746518223,0.01851192595229618,3.316036182995957e-07,0.30673026742247655,0.0
281,0.1,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the adoption of case-mix based reimbursement stimulate process-oriented care delivery development? This study shows hospital management can encourage care programmes by integrating case-mix reimbursement into budgeting. Further studies are needed to confirm this and to determine if care programmes will be created in the future.,2.6054570009253947e-07,0.12571946008020163,0.06621678407224177,0.0199476911126006,0.14752749525312403,0.05436390532544379,0.019918816950481533,0.20211181307219617,0.01851192595229618,2.6054570009253947e-07,0.2326222952687531,0.0
281,0.1,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Can the development of process-oriented care delivery be stimulated by case-mix based reimbursement? The study demonstrates hospital management can promote care programmes through case-mix reimbursement in budgeting. Additional research is recommended to verify this and to assess whether care programmes will be established eventually.,3.079176455639103e-07,0.17261469654571338,0.06518489748840714,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
282,0.1,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy harm the kidneys in women with multiple pregnancies? Glomerular hyperfiltration is a normal physiological change in pregnancy and does not inherently damage the kidneys in women with higher parity. However, in women with existing kidney disease, the increased filtration could worsen their condition. Therefore, regular monitoring is advised.",2.3685972735685406e-08,0.10577666423681942,0.16165316358024692,0.0018134264647818726,0.04373433528341941,0.08048592248880847,0.0018108015409528666,0.00695734547176885,0.01953125000000001,2.3685972735685406e-08,0.007672434452772325,0.020399305555555556
282,0.1,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had several pregnancies? Glomerular hyperfiltration is a typical adaptation in pregnancy and usually does not lead to kidney damage in women with more parities. Yet, if there is an underlying kidney disorder, the elevated filtration rate might aggravate it. Hence, routine check-ups are important.",9.474389094274162e-08,0.10664357559212201,0.022281895247419012,0.0072537058591274906,0.13241281558092544,0.039930555555555566,0.007243206163811466,0.10676333709700225,0.020399305555555556,9.474389094274162e-08,0.08004270767353683,0.0
282,0.1,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy lead to kidney injury in women with multiple childbirths? This physiological increase in filtration is common and generally does not harm the kidneys in women with many pregnancies. But for those with pre-existing kidney issues, the higher filtration rate could worsen their condition. Thus, regular medical supervision is recommended.",4.737194547137081e-08,0.06770001319325392,0.020915933775470984,0.0036268529295637453,0.06801298065346462,0.020707179930795856,0.003621603081905733,0.06829705626920646,0.020399305555555556,4.737194547137081e-08,0.04082199452025437,0.0
282,0.1,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Can glomerular hyperfiltration in pregnancy cause kidney damage in women with several parities? While glomerular hyperfiltration is a normal pregnancy adaptation, it does not typically damage kidneys in women with more pregnancies. However, if kidney disease is present beforehand, the increased filtration may exacerbate it. Therefore, routine monitoring is necessary.",4.737194547137081e-08,0.04333377245552272,0.002370333175803381,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
282,0.1,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does the increased glomerular filtration during pregnancy damage kidneys in women with multiple pregnancies? Glomerular hyperfiltration is a common physiological change and usually does not cause kidney damage in women with higher parity. But in cases of pre-existing kidney disease, the increased filtration rate might worsen the condition. Hence, regular follow-up is advised.",2.3685972735685406e-08,0.020986292147961993,0.001117698354852148,0.0018134264647818726,0.048072159366075784,0.020330555555555574,0.0018108015409528666,0.04849442897302669,0.020399305555555556,2.3685972735685406e-08,0.02061928720273576,0.0
282,0.1,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney harm caused by glomerular hyperfiltration in pregnant women with many parities? Glomerular hyperfiltration is a normal adaptation during pregnancy and generally does not damage kidneys in women with more pregnancies. However, if there is an existing kidney condition, the increased filtration could aggravate it. Therefore, routine monitoring is important.",2.3685972735685406e-08,0.006292325383724151,0.018663194444444434,0.0018134264647818726,0.035249067127276934,0.039930555555555566,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
282,0.1,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does pregnancy-related glomerular hyperfiltration damage the kidneys in women with multiple childbirths? This physiological adaptation typically does not cause kidney damage in women with higher parity. But if a woman has pre-existing kidney disease, the increased filtration rate may worsen the condition. Thus, regular medical evaluation is recommended.",9.474389094274162e-08,0.059122553298924796,0.01612461419753087,0.0072537058591274906,0.058066668431643986,0.01820216049382717,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
282,0.1,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Can the kidney be damaged by glomerular hyperfiltration during pregnancy in women with many parities? Glomerular hyperfiltration is a common physiological change in pregnancy and does not usually harm kidneys in women with more pregnancies. However, if kidney disease exists beforehand, the increased filtration might exacerbate it. Therefore, routine check-ups are advised.",0.0,4.440892098500626e-16,0.0,0.0,0.02772588722239755,0.019938885418112832,0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0
282,0.1,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration in pregnancy cause kidney damage in women with multiple pregnancies? This physiological increase in filtration is common and does not necessarily damage kidneys in women with higher parity. But in the presence of pre-existing kidney conditions, the elevated filtration rate may worsen the disease. Hence, regular monitoring is recommended.",0.0,0.027182242374899968,0.019443395980841306,0.0,0.02772588722239755,0.019938885418112832,0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0
282,0.1,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage a result of glomerular hyperfiltration in pregnant women with several parities? Glomerular hyperfiltration is a normal adaptation during pregnancy and generally does not cause kidney damage in women with more pregnancies. However, if there is an underlying kidney disorder, the increased filtration rate could exacerbate it. Therefore, routine medical supervision is important.",7.105791820705622e-08,0.06168878756909901,0.00323042820069204,0.005440279394345618,0.1137206825687711,0.039930555555555566,0.0054324046228586,0.08771514212630915,0.020399305555555556,7.105791820705622e-08,0.06062462181643413,0.0
283,0.1,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty, which corrects a deviated septum, does not directly affect the size of compensatory hypertrophy in the middle turbinate.",9.47438909427412e-08,0.12244491871651686,0.0012975246361896509,0.007253705859127518,0.12196881423277617,0.003928926969497065,0.007243206163811494,0.1211537644002374,0.007382467757631295,9.474389094274162e-08,0.1199314161721925,0.011658147000592867
283,0.1,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can septoplasty modify the dimensions of compensatory hypertrophy of the middle turbinate? Septoplasty, a surgery to fix a deviated septum, does not directly change the compensatory hypertrophy size in the middle turbinate.",7.10579182070559e-08,0.14437524248908007,0.14880847680628156,0.005440279394345639,0.1987522604332277,0.1967455621301775,0.005432404622858621,0.16149011989672646,0.17751479289940827,7.105791820705622e-08,0.12181317038681394,0.15532544378698224
283,0.1,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is the size of compensatory hypertrophy of the middle turbinate changed by septoplasty? Septoplasty, performed to correct a deviated septum, does not directly alter the dimensions of compensatory hypertrophy in the middle turbinate.",4.73719454713706e-08,0.1355971903273714,0.12027102139605564,0.003626852929563759,0.18682291031686837,0.16452333990795528,0.003621603081905747,0.19539167157240822,0.17751479289940827,4.737194547137081e-08,0.15690449019808295,0.15532544378698224
283,0.1,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does the procedure of septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? Septoplasty, aimed at correcting a deviated septum, does not directly modify the size of compensatory hypertrophy in the middle turbinate.",0.0,0.12232009068704963,0.07033047442816032,0.0,0.12602676010180858,0.07783949792090279,0.0,0.1299650963549892,0.08476806281617402,0.0,0.13415751881805393,0.09111616911397392
283,0.1,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Will septoplasty affect the size of compensatory hypertrophy of the middle turbinate? Septoplasty, a surgical correction for a deviated septum, does not directly change the dimensions of compensatory hypertrophy in the middle turbinate.",4.73719454713706e-08,0.1355971903273714,0.12027102139605564,0.003626852929563759,0.18682291031686837,0.16452333990795528,0.003621603081905747,0.19539167157240822,0.17751479289940827,4.737194547137081e-08,0.15690449019808295,0.15532544378698224
283,0.1,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty influence the dimensions of compensatory hypertrophy in the middle turbinate? Septoplasty, which corrects a deviated septum, does not directly impact the size of compensatory hypertrophy in the middle turbinate.",9.47438909427412e-08,0.03002529464185777,0.05301775147928989,0.007253705859127518,0.02636230656933458,0.06234556213017753,0.007243206163811494,0.0221327386059591,0.07191479289940823,9.474389094274162e-08,0.017242944978127284,0.08172544378698225
283,0.1,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can the dimensions of compensatory hypertrophy of the middle turbinate be changed by septoplasty? Septoplasty, a surgery to correct a deviated septum, does not directly alter the size of compensatory hypertrophy in the middle turbinate.",0.0,0.20386681781174953,0.12560880246784348,0.0,0.25205352020361715,0.1664721246301775,0.0,0.25993019270997975,0.17751479289940827,0.0,0.2235958646967564,0.15532544378698224
283,0.1,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is compensatory hypertrophy of the middle turbinate dimensionally changed by septoplasty? Septoplasty, performed to fix a deviated septum, does not directly affect the size of compensatory hypertrophy in the middle turbinate.",9.47438909427412e-08,0.10860414147013175,0.146691220867045,0.007253705859127518,0.16485070875754593,0.1967455621301775,0.007243206163811494,0.12639880008545745,0.17751479289940827,9.474389094274162e-08,0.08544552621593926,0.15532544378698224
283,0.1,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty cause changes in the size of compensatory hypertrophy of the middle turbinate? Septoplasty, a surgical procedure to correct a deviated septum, does not directly modify the dimensions of compensatory hypertrophy in the middle turbinate.",2.36859727356853e-08,0.19674080410120487,0.10063481703600168,0.0018134264647818796,0.28314203982488495,0.16736080547269355,0.0018108015409528735,0.29070185137673343,0.17751479289940827,2.3685972735685406e-08,0.25534456301133623,0.15532544378698224
283,0.1,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Will the dimensions of compensatory hypertrophy of the middle turbinate be altered by septoplasty? Septoplasty, aimed at correcting a deviated septum, does not directly change the size of compensatory hypertrophy in the middle turbinate.",2.36859727356853e-08,0.17030718524730792,0.12301775147928985,0.0018134264647818796,0.21996908278580163,0.1655280803403752,0.0018108015409528735,0.22818149439539992,0.17751479289940827,2.3685972735685406e-08,0.1908060418737647,0.15532544378698224
284,0.1,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research suggests that Indigenous Australians might face some age-related health problems sooner than non-Indigenous Australians because of socio-economic conditions, lifestyle, and healthcare access, but this does not definitively imply premature aging.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.1,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Studies show that Indigenous Australians could encounter certain health issues linked to aging earlier than their non-Indigenous counterparts, influenced by socio-economic status, lifestyle choices, and healthcare availability; however, this doesn't confirm premature aging.",2.605457000925386e-07,0.26322480914686164,0.023242630385487524,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
284,0.1,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians may develop some age-associated health concerns earlier than non-Indigenous Australians due to factors like socio-economic background, lifestyle, and healthcare access, though this does not necessarily indicate they age prematurely.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.1,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Evidence points to Indigenous Australians experiencing some health problems related to aging earlier than non-Indigenous Australians, driven by socio-economic factors, lifestyle, and healthcare access, but this does not mean they age prematurely.",2.842316728282239e-07,0.29497350746144146,0.023242630385487524,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
284,0.1,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research indicates that due to socio-economic conditions, lifestyle, and healthcare access, Indigenous Australians might show certain age-related health issues earlier than non-Indigenous Australians, yet this does not equate to premature aging.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.1,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians may be prone to certain age-related health challenges earlier than non-Indigenous Australians because of socio-economic and lifestyle factors and healthcare access, but this does not imply they age prematurely.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.1,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Certain age-related health issues may appear earlier in Indigenous Australians compared to non-Indigenous Australians, influenced by socio-economic status, lifestyle, and healthcare access; however, this does not necessarily mean premature aging occurs.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.1,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Due to socio-economic factors, lifestyle, and healthcare availability, Indigenous Australians might experience some age-related health problems earlier than non-Indigenous Australians, but this does not confirm premature aging.",4.026615365066504e-07,0.4708641739251056,0.023242630385487524,0.030828249901291904,0.5187937934151678,0.0,0.03078362619619881,0.5355182363563626,0.0,4.026615365066519e-07,0.5533852381847866,0.0
284,0.1,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians could face earlier onset of some age-related health issues than non-Indigenous Australians, linked to socio-economic, lifestyle, and healthcare factors, though this does not imply premature aging.",3.789755637709651e-07,0.4331238459422586,0.023242630385487524,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
284,0.1,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research shows that Indigenous Australians may encounter certain health issues associated with aging earlier than non-Indigenous Australians because of socio-economic and lifestyle factors and healthcare access, but this does not mean they age prematurely.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
285,0.1,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a disagreement between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Yes, discrepancies often arise due to differences in training, interpretation abilities, and communication, with clinicians sometimes missing subtle changes that experienced pathologists detect.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.1,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Do clinical pathologists and clinicians differ in their reporting and interpretation of red blood cell morphology? Yes, such discordance is common, often caused by varying expertise, interpretative skills, and communication issues, where clinicians may overlook subtle abnormalities noted by pathologists.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.1,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a mismatch between clinical pathologists and clinicians regarding red blood cell morphology interpretation? Yes, frequent discordance occurs because of differences in training, skill levels, and communication, leading clinicians to sometimes miss subtle findings recognized by pathologists.",5.44777372920764e-07,0.27548249540989156,0.14532871972318342,0.04170880868998307,0.32954290328284186,0.11649408284023667,0.04164843544191593,0.38558681447770393,0.08543965824136704,5.447773729207643e-07,0.4437278821068147,0.05246913580246911
285,0.1,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are clinical pathologists and clinicians often at odds when reporting red blood cell morphology? Yes, disagreements can happen due to disparities in training, interpretive skills, and communication gaps, with clinicians occasionally failing to identify subtle changes that pathologists observe.",5.210914001850787e-07,0.2488142483277307,0.14532871972318342,0.0398953822252012,0.30214392909472654,0.11649408284023667,0.039837633900963065,0.3574159375110071,0.08543965824136704,5.210914001850789e-07,0.4147403452335632,0.05246913580246911
285,0.1,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Does discordance exist between clinical pathologists and clinicians in red blood cell morphology reporting? Yes, it is common and may result from differences in education, interpretation expertise, and communication, causing clinicians to sometimes misinterpret or miss subtle alterations seen by pathologists.",4.737194547137081e-07,0.197520953940181,0.14532871972318342,0.03626852929563745,0.2495001956093077,0.11649408284023667,0.03621603081905733,0.3033487162407309,0.08543965824136704,4.737194547137081e-07,0.359170494078751,0.05246913580246911
285,0.1,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there often a difference in how clinical pathologists and clinicians report and interpret red blood cell morphology? Yes, such differences arise from varied training, interpretive skills, and communication, with clinicians potentially overlooking subtle changes detected by pathologists.",5.44777372920764e-07,0.27548249540989156,0.14532871972318342,0.04170880868998307,0.32954290328284186,0.11649408284023667,0.04164843544191593,0.38558681447770393,0.08543965824136704,5.447773729207643e-07,0.4437278821068147,0.05246913580246911
285,0.1,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are clinical pathologists and clinicians frequently discordant in their interpretation of red blood cell morphology? Yes, this can occur due to differences in training, skill, and communication, where clinicians might miss subtle changes that experienced pathologists identify.",5.684633456564493e-07,0.3028814695980069,0.14532871972318342,0.04352223515476494,0.3577137802495387,0.11649408284023667,0.043459236982868805,0.41457435135095544,0.08543965824136704,5.684633456564497e-07,0.47358084525649646,0.05246913580246911
285,0.1,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a frequent discordance between clinical pathologists and clinicians in red blood cell morphology interpretation? Yes, often caused by differences in training, interpretive ability, and communication, leading clinicians to sometimes overlook subtle changes noted by pathologists.",5.684633456564493e-07,0.3028814695980069,0.14532871972318342,0.04352223515476494,0.3577137802495387,0.11649408284023667,0.043459236982868805,0.41457435135095544,0.08543965824136704,5.684633456564497e-07,0.47358084525649646,0.05246913580246911
285,0.1,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Do clinical pathologists and clinicians often disagree in reporting red blood cell morphology? Yes, discrepancies are common due to differences in training, interpretation skills, and communication, with clinicians sometimes missing subtle abnormalities that pathologists detect.",6.158352911278199e-07,0.36003988343795523,0.14532871972318342,0.0471490880843287,0.416554280272472,0.11649408284023667,0.04708084006477455,0.4751989731673909,0.08543965824136704,6.158352911278206e-07,0.53610120223783,0.05246913580246911
285,0.1,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a common discordance between clinical pathologists and clinicians when interpreting red blood cell morphology? Yes, it often arises from differences in training, interpretive skills, and communication gaps, causing clinicians to occasionally misinterpret or overlook subtle changes identified by pathologists.",4.737194547137081e-07,0.197520953940181,0.14532871972318342,0.03626852929563745,0.2495001956093077,0.11649408284023667,0.03621603081905733,0.3033487162407309,0.08543965824136704,4.737194547137081e-07,0.359170494078751,0.05246913580246911
286,0.1,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Is there a link between lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis and better health outcomes? Answer: Individuals diagnosed with type 2 diabetes who have lower initial blood sugar levels, possibly indicating an earlier stage of the disease, tend to experience fewer negative clinical outcomes even though their blood sugar levels progress similarly. Because most of these individuals show no symptoms at diagnosis, proactive case management is important.",4.263475092423373e-07,0.2720227926180572,0.004802866154596783,0.03264167636607378,0.28934127422231004,0.004479595336076808,0.03259442773715161,0.287682072451779,0.0,4.263475092423373e-07,0.29238796348919527,0.0
286,0.1,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Do lower fasting plasma glucose levels at type 2 diabetes diagnosis correlate with improved patient outcomes? Answer: Patients with type 2 diabetes presenting with lower initial glucose levels, suggesting an earlier disease phase, have fewer adverse clinical events despite comparable glycemic progression. Since many are asymptomatic when diagnosed, active case detection is crucial.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.1,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are reduced fasting plasma glucose levels at the diagnosis of type 2 diabetes linked to better clinical outcomes? Answer: People with type 2 diabetes who have lower initial glycemia, possibly indicating an earlier stage of their condition, experience fewer negative clinical outcomes even though their glycemic progression is similar. Most of these patients are asymptomatic at diagnosis, highlighting the need for active case identification.",1.8948778188548325e-07,0.13972020673666652,0.004447813134751875,0.014507411718254981,0.13900222078069824,0.0023066964139149618,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
286,0.1,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Does having lower fasting plasma glucose at the time of type 2 diabetes diagnosis associate with improved outcomes? Answer: Those diagnosed with type 2 diabetes with lower initial blood sugar, potentially earlier in their disease course, show fewer adverse clinical outcomes despite similar progression of glycemia. Since most are asymptomatic at diagnosis, active case finding is important.",2.3685972735685406e-08,0.0185681825888242,0.000623972610504564,0.0018134264647818726,0.01846860107447057,0.0003243433209763093,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
286,0.1,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are lower fasting plasma glucose levels at type 2 diabetes diagnosis connected to better health outcomes? Answer: Individuals presenting with type 2 diabetes with lower initial glycemia, possibly earlier in their disease, have fewer adverse clinical outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active case detection is necessary.",9.474389094274162e-08,0.07791647314580885,0.002734705075445841,0.0072537058591274906,0.07748444286268352,0.0014244170096021913,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
286,0.1,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and improved outcomes? Answer: Patients with type 2 diabetes who have lower initial blood glucose levels, indicating an earlier disease stage, tend to have fewer adverse clinical outcomes despite similar glycemic progression. Most are asymptomatic at diagnosis, so active case finding is essential.",2.3685972735685406e-08,0.0185681825888242,0.000623972610504564,0.0018134264647818726,0.01846860107447057,0.0003243433209763093,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
286,0.1,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis indicative of better outcomes? Answer: People with type 2 diabetes presenting with lower initial glycemia, possibly earlier in their disease course, experience fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case detection is important.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
286,0.1,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Does lower fasting plasma glucose at diagnosis of type 2 diabetes relate to improved clinical outcomes? Answer: Individuals with type 2 diabetes who have lower initial glycemia, potentially earlier in their disease, show fewer adverse clinical outcomes despite similar glycemic progression. Most are asymptomatic at diagnosis, emphasizing the need for active case finding.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.1,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Are lower fasting plasma glucose levels at diagnosis associated with better outcomes in type 2 diabetes? Answer: People diagnosed with type 2 diabetes with lower initial blood sugar, possibly earlier in their disease, have fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case detection is vital.",7.105791820705622e-08,0.03170576166550987,0.016804348178992037,0.005440279394345618,0.030884114630681303,0.0181755829903978,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.1,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Question: Is lower fasting plasma glucose at the time of type 2 diabetes diagnosis linked to improved outcomes? Answer: Patients presenting with type 2 diabetes with lower initial glycemia, likely earlier in their disease course, experience fewer adverse clinical outcomes despite similar glycemic progression. Most are asymptomatic at diagnosis, so active case finding is important.",4.737194547137081e-08,0.03820136687076836,0.0013169535961558843,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
287,0.1,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.1,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A significant number of children did not accurately assess their overweight status. This misjudgment was also common among their parents and the physicians caring for them. The findings highlight the importance of improving physician education to better identify obesity and overweight conditions, enabling effective counseling for children and their families.",2.3685972735685406e-07,0.17093183112783628,0.002794723615397801,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
287,0.1,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children failed to recognize how overweight they were. This misunderstanding was also present among their parents and the doctors treating them. The study underscores the necessity of enhancing physician training to detect obesity and overweight, so they can provide appropriate guidance to children and their families.",1.6580180914979784e-07,0.12264696536330622,0.0020508853284789547,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
287,0.1,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children underestimated their overweight status, a misperception shared by their parents and even their physicians. This research points to the need for better physician education to identify obesity and overweight, allowing them to advise children and their families effectively.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.1,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children did not accurately perceive their overweight condition, and this was also true for their parents and the physicians attending to them. The study highlights the need for enhanced physician education to recognize obesity and overweight, facilitating counseling for children and families.",7.105791820705622e-08,0.07831517733430982,0.0181755829903978,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
287,0.1,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A large number of children underestimated their overweight level, with their parents and doctors sharing this incorrect perception. The study emphasizes the importance of educating physicians to better identify obesity and overweight to counsel children and their families.",4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
287,0.1,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated how overweight they were, a misperception also held by their parents and their physicians. This study reveals the need for improved physician education to recognize obesity and overweight and to provide counseling to children and families.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.1,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children often underestimated their overweight status, and this misperception was common among their parents and the physicians caring for them. The findings suggest a need for better physician training to identify obesity and overweight and to counsel affected children and their families.",4.737194547137081e-08,0.036602480918583424,0.0006373176842753465,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
287,0.1,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children did not fully recognize their overweight condition, a misunderstanding shared by their parents and physicians. This study highlights the necessity of educating physicians to detect obesity and overweight to effectively counsel children and their families.",7.105791820705622e-08,0.05754362157529469,0.001047792634361909,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
287,0.1,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A considerable number of children underestimated their overweight status, with their parents and attending physicians sharing this misperception. The research underscores the need to better educate physicians to identify obesity and overweight and to counsel children and their families accordingly.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
288,0.1,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in high-risk groups warranted? Yes, screening is justified as it facilitates early diagnosis and treatment, helping to avoid complications such as malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are particularly recommended for screening.",2.3685972735685406e-08,0.12083932107480422,0.10072314049586772,0.0018134264647818726,0.09447112089549092,0.08264462809917357,0.0018108015409528666,0.06698066889307208,0.06353305785123965,2.3685972735685406e-08,0.03829476115600272,0.043388429752066124
288,0.1,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should coeliac disease screening be conducted in risk groups? Indeed, screening in these groups is justified because it enables early detection and management, preventing issues like malnutrition, osteoporosis, and lymphoma. People with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially targeted.",7.105791820705622e-08,0.0782797066560077,0.10072314049586772,0.005440279394345618,0.05098600895575256,0.08264462809917357,0.0054324046228586,0.02252890632223936,0.06353305785123965,7.105791820705622e-08,0.007167612920754518,0.043388429752066124
288,0.1,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it appropriate to screen for coeliac disease among risk groups? Yes, screening is justified since it promotes early identification and treatment, reducing the risk of complications including malnutrition, osteoporosis, and lymphoma. Those with family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered.",4.737194547137081e-08,0.09978591187697106,0.10072314049586772,0.0036268529295637453,0.07296491567452756,0.08264462809917357,0.003621603081905733,0.04500176217429708,0.06353305785123965,4.737194547137081e-08,0.015821905303945005,0.043388429752066124
288,0.1,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Does coeliac disease screening in risk groups make sense? Yes, it is justified as it helps in early diagnosis and treatment, thereby preventing complications such as malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are particularly recommended.",7.105791820705622e-08,0.0782797066560077,0.10072314049586772,0.005440279394345618,0.05098600895575256,0.08264462809917357,0.0054324046228586,0.02252890632223936,0.06353305785123965,7.105791820705622e-08,0.007167612920754518,0.043388429752066124
288,0.1,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening justified in groups at risk? Yes, it is justified because it supports early detection and treatment, which prevents complications like malnutrition, osteoporosis, and lymphoma. People with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
288,0.1,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it reasonable to screen for coeliac disease in risk groups? Yes, screening is justified as it allows for early detection and treatment, helping to avoid complications such as malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are particularly targeted.",0.0,0.14145860827753998,0.10072314049586772,0.0,0.11552453009332408,0.08264462809917357,0.0,0.08848687411403544,0.06353305785123965,0.0,0.060273667874777725,0.043388429752066124
288,0.1,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should individuals in risk groups be screened for coeliac disease? Yes, screening is justified since it aids in early diagnosis and treatment, preventing complications like malnutrition, osteoporosis, and lymphoma. People with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered.",9.474389094274162e-08,0.05630079993723269,0.10072314049586772,0.0072537058591274906,0.028513153103694844,0.08264462809917357,0.007243206163811466,0.0004606119024601618,0.06353305785123965,9.474389094274162e-08,0.030698110330948936,0.043388429752066124
288,0.1,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening warranted in risk groups? Yes, it is justified because it facilitates early detection and treatment, which helps prevent complications such as malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are particularly recommended.",9.474389094274162e-08,0.05630079993723269,0.10072314049586772,0.0072537058591274906,0.028513153103694844,0.08264462809917357,0.007243206163811466,0.0004606119024601618,0.06353305785123965,9.474389094274162e-08,0.030698110330948936,0.043388429752066124
288,0.1,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in at-risk groups justified? Yes, it is justified as it promotes early diagnosis and treatment, preventing complications like malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered.",1.4211583641411244e-07,0.010838425860475454,0.10072314049586772,0.010880558788691236,0.018006862531199097,0.08264462809917357,0.0108648092457172,0.048088660891714596,0.06353305785123965,1.4211583641411244e-07,0.07948827450038065,0.043388429752066124
288,0.1,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening in risk groups appropriate? Yes, it is justified because it enables early detection and treatment, thereby preventing complications such as malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are particularly targeted.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
289,0.1,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites mirror community practice? The residency training locations of the Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to those reported in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites representative of community practice? The residency training sites at Northeastern Ohio Universities College of Medicine deliver patient care opportunities akin to those identified in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice reflect the nature of community practice? The residency training sites affiliated with Northeastern Ohio Universities College of Medicine provide patient care experiences similar to those found in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.1,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites correspond to community practice? The residency training locations at Northeastern Ohio Universities College of Medicine offer patient care opportunities that align with those in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is the family practice at residency teaching sites consistent with community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites resemble community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those documented in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.1,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Are family practice residency teaching sites reflective of community practice? The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care experiences that mirror those found in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.1,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites align with community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those reported in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites indicative of community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care experiences similar to those in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.1,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do family practice residency teaching sites reflect the realities of community practice? The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care opportunities akin to those found in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
290,0.1,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week of life? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 can assist in tracking or screening for abnormal PaCO2 levels in ELBW infants in their first week.,2.3685972735685406e-08,0.07506264242172334,0.09166281932902429,0.0018134264647818726,0.04814538629429954,0.04565278787518076,0.0018108015409528666,0.005912492424360316,0.015621063240110858,2.3685972735685406e-08,0.01600034134644357,0.0
290,0.1,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants within the first week of life? End-tidal CO2 shows good correlation and agreement with arterial CO2 in ELBW infants at EtCO2 levels between 30 and 50 mmHg. End-tidal CO2 monitoring is useful for trending or screening abnormal PaCO2 values in these infants during their first week.,7.105791820705622e-08,0.10643878189861633,0.13633980281613947,0.005440279394345618,0.03805753737221629,0.06127385111529162,0.0054324046228586,0.026348369793864457,0.015621063240110858,7.105791820705622e-08,0.04879016416943571,0.0
290,0.1,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does measuring end-tidal carbon dioxide correlate with arterial carbon dioxide in extremely low birth weight infants during their initial week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. End-tidal CO2 monitoring can help in tracking or screening abnormal PaCO2 values in the first week of life.,1.1842986367842703e-07,0.07273499034277053,0.1353024982207859,0.009067132323909363,0.005267714549224145,0.06127385111529162,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.1,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a relationship between end-tidal carbon dioxide and arterial carbon dioxide measurements in extremely low birth weight infants in their first week? End-tidal CO2 correlates well and agrees with arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. Monitoring end-tidal CO2 can be beneficial for trending or screening abnormal PaCO2 in these infants during the first week.,1.4211583641411244e-07,0.055448150489308734,0.13475801023931627,0.010880558788691236,0.011539403767156564,0.06127385111529162,0.0108648092457172,0.07677922342075583,0.015621063240110858,1.4211583641411244e-07,0.10008345855698497,0.0
290,0.1,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement correspond with arterial CO2 in extremely low birth weight infants during their first week? There is good correlation and agreement between end-tidal and arterial CO2 in ELBW infants when EtCO2 is 30-50 mmHg. End-tidal CO2 monitoring is helpful for trending or screening abnormal PaCO2 values in the first week of life.,2.8423167282822487e-07,0.08071890652673686,0.11268838641860522,0.02176111757738247,0.1449414315003752,0.042412904369729484,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
290,0.1,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is end-tidal carbon dioxide measurement correlated with arterial carbon dioxide in extremely low birth weight infants during the first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants at EtCO2 levels of 30 to 50 mmHg. End-tidal CO2 monitoring can aid in trending or screening abnormal PaCO2 values in these infants in their first week.,9.474389094274162e-08,0.08972861241027852,0.13582948599569097,0.0072537058591274906,0.021797016500435085,0.06127385111529162,0.007243206163811466,0.042877671745075396,0.015621063240110858,9.474389094274162e-08,0.06559728248581642,0.0
290,0.1,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement align with arterial CO2 in extremely low birth weight infants in the first week of life? There is good correlation and agreement between end-tidal and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring can be useful for trending or screening abnormal PaCO2 values in the first week.,2.1317375462116866e-07,0.07124010038020101,0.08114342419424452,0.016320838183036854,0.11323566983486533,0.025608556190737444,0.0162972138685758,0.12988904873470375,0.015621063240110858,2.1317375462116866e-07,0.15415067982725983,0.0
290,0.1,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal CO2 and arterial CO2 in extremely low birth weight infants during their first week? End-tidal CO2 shows strong correlation and agreement with arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. Monitoring end-tidal CO2 can help trend or screen abnormal PaCO2 values in these infants in their first week.,1.8948778188548325e-07,0.0607732434484225,0.04487620091994238,0.014507411718254981,0.07034653354218268,0.04373558580916917,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
290,0.1,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in their first week? There is good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants at EtCO2 levels of 30-50 mmHg. End-tidal CO2 monitoring can assist in trending or screening abnormal PaCO2 values in the first week of life.,1.8948778188548325e-07,0.019953157019237278,0.1336129327077091,0.014507411718254981,0.046025579838325115,0.06127385111529162,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
290,0.1,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is end-tidal CO2 measurement correlated with arterial CO2 in extremely low birth weight infants during the first week of life? There is strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring can be helpful for trending or screening abnormal PaCO2 values in these infants during their first week.,1.4211583641411244e-07,0.00923833845198141,0.10172517760566831,0.010880558788691236,0.035035918362408935,0.044329736965469976,0.0108648092457172,0.07677922342075583,0.015621063240110858,1.4211583641411244e-07,0.10008345855698497,0.0
291,0.1,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? Antral follicle count is a valuable predictor for IVF success. Although age and FSH are important markers, the antral follicle count may better reflect ovarian reserve and response, leading to more accurate IVF predictions. Using all three factors together might provide the best overall prediction.",3.789755637709665e-07,0.20644122499639472,0.01795440247075973,0.029014823436510045,0.2300562944082083,0.009770100201771478,0.02897282465524588,0.2474081733138398,0.0,3.789755637709665e-07,0.2513144282809048,0.0
291,0.1,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle assessment predict IVF results better than age and FSH? Antral follicle assessment is an effective method for forecasting IVF outcomes. While age and FSH are significant indicators, the antral follicle count may offer a more precise measure of ovarian reserve and responsiveness, thus improving prediction accuracy. Combining these factors could yield the most reliable prognosis.",4.263475092423373e-07,0.24453633689167686,0.014244485409601534,0.03264167636607379,0.2660012437521875,0.009154933170084673,0.03259442773715161,0.2831262559159189,0.0,4.263475092423373e-07,0.287682072451779,0.0
291,0.1,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle assessment outperform age and FSH in predicting IVF success? Antral follicle count serves as a useful predictor for IVF outcomes. Age and FSH are important, but antral follicle assessment might give a clearer picture of ovarian reserve and response, enhancing prediction accuracy. Integrating all these factors may provide the most thorough prediction.",4.974054274493935e-07,0.330190320783319,0.010688759297236353,0.03808195576041941,0.3486187592458876,0.010671643385022852,0.03802683236001021,0.3392157225669621,0.0,4.974054274493935e-07,0.34484048629172914,0.0
291,0.1,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle count a better predictor of IVF outcomes than age and FSH? Antral follicle assessment is a helpful tool in predicting IVF success. Although age and FSH levels are key indicators, the antral follicle count may more accurately represent ovarian reserve and responsiveness, offering a more precise forecast. Using all three factors together may offer the most comprehensive prediction.",3.552895910352811e-07,0.18791986216356094,0.019715239036791135,0.027201396971728173,0.21255674872830088,0.010062058689684523,0.027162023114293013,0.23001643060197097,0.0,3.552895910352811e-07,0.23361485118150416,0.0
291,0.1,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","How does antral follicle assessment compare to age and FSH in predicting IVF outcomes? Antral follicle count is a valuable predictor for IVF results. While age and FSH are important, antral follicle assessment might better reflect ovarian reserve and responsiveness, leading to more accurate predictions. Combining these indicators could provide the most complete forecast.",5.210914001850789e-07,0.351487177747031,0.013226583525567145,0.03989538222520128,0.3686729733465661,0.011393827160493846,0.03983763390096308,0.3586338084240648,0.0,5.210914001850789e-07,0.3646431135879089,0.0
291,0.1,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment more reliable than age and FSH for predicting IVF outcomes? Antral follicle count is an effective predictor of IVF success. Age and FSH are important markers, but antral follicle assessment may offer a more precise evaluation of ovarian reserve and response, improving prediction accuracy. Using all factors together might yield the best prediction.",4.500334819780227e-07,0.28889230627556284,0.005887158785082738,0.03445510283085566,0.3096751968470195,0.009305681913074824,0.03440522927810448,0.30147539458411465,0.0,4.500334819780227e-07,0.30637420546393335,0.0
291,0.1,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle count better predict IVF success than age and FSH? Antral follicle assessment is a useful tool for forecasting IVF outcomes. Although age and FSH are key indicators, the antral follicle count may provide a more accurate measure of ovarian reserve and responsiveness, enhancing prediction precision. Combining these factors may offer the most comprehensive outlook.",4.500334819780227e-07,0.2641370498269935,0.012288599742019943,0.03445510283085566,0.28446984482665805,0.008830589849108363,0.03440522927810448,0.30147539458411465,0.0,4.500334819780227e-07,0.30637420546393335,0.0
291,0.1,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a more accurate predictor of IVF outcomes than age and FSH? Antral follicle count is a valuable method for predicting IVF success. While age and FSH are important, antral follicle assessment might better indicate ovarian reserve and responsiveness, leading to more precise predictions. Using all three factors together could provide the most thorough forecast.",4.263475092423373e-07,0.24453633689167686,0.014244485409601562,0.03264167636607379,0.2660012437521875,0.009154933170084673,0.03259442773715161,0.2831262559159189,0.0,4.263475092423373e-07,0.287682072451779,0.0
291,0.1,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle assessment provide better IVF outcome predictions than age and FSH? Antral follicle count is a helpful predictor for IVF results. Age and FSH are significant, but antral follicle assessment may more accurately reflect ovarian reserve and responsiveness, improving prediction accuracy. Combining these factors may yield the most comprehensive prediction.",5.684633456564497e-07,0.3682871022149956,0.0013395773189577437,0.04352223515476503,0.3823005598330198,0.0070145027020634305,0.04345923698286881,0.39863914303776316,0.0,5.684633456564497e-07,0.4054651081081633,0.0
291,0.1,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle count superior to age and FSH in predicting IVF outcomes? Antral follicle assessment is an effective tool for forecasting IVF success. Although age and FSH are key indicators, the antral follicle count may offer a more precise evaluation of ovarian reserve and responsiveness, resulting in better prediction accuracy. Using all these factors together might provide the most complete forecast.",3.316036182995957e-07,0.1924586575016809,0.004727994138831959,0.0253879705069463,0.2184629278539969,0.0062875251390907515,0.025351221573340146,0.21292199724267125,0.0,3.316036182995957e-07,0.21622310846963533,0.0
292,0.1,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Patients and their carers found the reorganization of care to provide a primary angioplasty service acceptable. Satisfaction was generally high across all care types, except for discharge and aftercare.",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
292,0.1,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty serve as an acceptable substitute for thrombolysis? The restructuring of care to include primary angioplasty was well received by patients and carers. Satisfaction levels remained high regardless of care type, except in areas of discharge and aftercare.",9.474389094274152e-08,0.10425168058893775,0.004731261479979244,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
292,0.1,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is it acceptable to use primary angioplasty instead of thrombolysis? Patients and carers accepted the care reorganization to offer primary angioplasty. Satisfaction was high across care types, with the exception of discharge and aftercare.",2.3685972735685332e-07,0.20021374673313375,0.046400951814396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.1,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Does primary angioplasty represent an acceptable alternative to thrombolysis? Offering primary angioplasty through care reorganization was acceptable to patients and carers. Satisfaction was high for all care types except discharge and aftercare.,2.842316728282239e-07,0.3074532766538183,0.014178729592174005,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
292,0.1,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable option compared to thrombolysis? Patients and carers accepted the care changes to provide primary angioplasty. Satisfaction was high regardless of care type, except for discharge and aftercare.",2.842316728282239e-07,0.26273410371446726,0.046400951814396206,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
292,0.1,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? The reorganization to provide primary angioplasty was accepted by patients and carers. Satisfaction levels were high across care types, except for discharge and aftercare.",2.842316728282239e-07,0.3074532766538183,0.014178729592174005,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
292,0.1,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be considered an acceptable alternative to thrombolysis? Patients and carers found the reorganization to offer primary angioplasty acceptable. Satisfaction was high regardless of care type, except in discharge and aftercare.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.1,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is primary angioplasty an acceptable replacement for thrombolysis? Patients and carers accepted the reorganization of care to provide primary angioplasty. Satisfaction was high across all care types except discharge and aftercare.,3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.1,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a feasible alternative to thrombolysis? The care reorganization to offer primary angioplasty was acceptable to patients and carers. Satisfaction levels were high regardless of care type, except for discharge and aftercare.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.1,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable alternative treatment to thrombolysis? Patients and carers accepted the reorganization of care to provide primary angioplasty. Satisfaction was high across care types, except for discharge and aftercare.",2.842316728282239e-07,0.26273410371446726,0.046400951814396206,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
293,0.1,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes? Yes, lower fasting plasma glucose levels at diagnosis typically reflect superior glycemic control and correlate with enhanced outcomes, such as fewer diabetes complications and improved overall health, resulting in a more favorable prognosis for patients.",7.105791820705622e-08,0.13737731068132364,0.12337834442260623,0.005440279394345618,0.11598553271873335,0.11536345452769163,0.0054324046228586,0.09385404379838258,0.10451694276723078,7.105791820705622e-08,0.09710068631097046,0.10902534309507142
293,0.1,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there an association between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved clinical outcomes? Indeed, lower fasting plasma glucose at diagnosis usually signifies better glycemic management and is connected to improved outcomes, including reduced diabetes-related complications and better overall health, leading to a more positive patient prognosis.",1.1842986367842703e-07,0.12199029224731062,0.13975335743801648,0.009067132323909363,0.10129156595449551,0.13290895061728392,0.009054007704764333,0.07992147227897561,0.12326799123083393,1.1842986367842703e-07,0.08400457901311409,0.12901701323251416
293,0.1,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes correspond with better outcomes? Yes, generally, lower fasting plasma glucose levels at diagnosis indicate improved glycemic control and are linked to better outcomes, such as fewer complications from diabetes and enhanced overall health, which contribute to a better prognosis.",1.1842986367842703e-07,0.06762580749751068,0.10146620006561571,0.009067132323909363,0.04583979150969997,0.09344442110667693,0.009054007704764333,0.02333802896795989,0.08270321361058611,1.1842986367842703e-07,0.02624231396645227,0.0874291115311909
293,0.1,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are improved outcomes associated with lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis? Yes, lower fasting plasma glucose levels at diagnosis are commonly indicative of better glycemic control and are associated with improved outcomes, including a reduction in diabetes-related complications and enhanced overall health status, leading to a better prognosis.",4.737194547137081e-08,0.1066627264208595,0.08897210743801648,0.0036268529295637453,0.11038625900478438,0.09787074315742926,0.003621603081905733,0.0876580935714446,0.08619124514124162,4.737194547137081e-08,0.09026471607974873,0.08986665921335546
293,0.1,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there a connection between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved patient outcomes? Yes, lower fasting plasma glucose levels at diagnosis generally suggest better glycemic control and are associated with improved outcomes, such as fewer diabetes complications and improved overall health, resulting in a better prognosis.",1.1842986367842703e-07,0.040443565122610714,0.08279155188246091,0.009067132323909363,0.04583979150969997,0.09344442110667693,0.009054007704764333,0.02333802896795989,0.08270321361058611,1.1842986367842703e-07,0.02624231396645227,0.0874291115311909
293,0.1,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do patients diagnosed with type 2 diabetes who have lower fasting plasma glucose levels experience better outcomes? Yes, lower fasting plasma glucose levels at diagnosis typically reflect better glycemic control and are linked to improved outcomes, including fewer diabetes-related complications and enhanced overall health, leading to a more favorable prognosis.",1.6580180914979784e-07,0.05036479813627981,0.11735945311702882,0.012693985253473108,0.029277948309043733,0.11061728395061728,0.012675610786670066,0.007549248124557817,0.10119816098392034,1.6580180914979784e-07,0.011308130656928927,0.10728861817078576
293,0.1,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis indicative of improved outcomes? Yes, lower fasting plasma glucose levels at diagnosis usually indicate better glycemic control and are associated with improved outcomes, such as reduced diabetes complications and better overall health, resulting in a better patient prognosis.",1.1842986367842703e-07,0.06762580749751068,0.10146620006561571,0.009067132323909363,0.04583979150969997,0.09344442110667693,0.009054007704764333,0.02333802896795989,0.08270321361058611,1.1842986367842703e-07,0.02624231396645227,0.0874291115311909
293,0.1,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there an improved prognosis for type 2 diabetes patients with lower fasting plasma glucose levels at diagnosis? Yes, lower fasting plasma glucose levels at diagnosis generally correlate with better glycemic control and improved outcomes, including fewer complications related to diabetes and enhanced overall health status.",2.6054570009253947e-07,0.07565883037309407,0.08897210743801648,0.0199476911126006,0.09711679121240158,0.0828395061728395,0.019918816950481533,0.11912519972350388,0.07429229678638949,2.6054570009253947e-07,0.11554083080759314,0.08151701323251415
293,0.1,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Does a lower fasting plasma glucose level at diagnosis of type 2 diabetes relate to better health outcomes? Yes, lower fasting plasma glucose levels at diagnosis are typically associated with improved glycemic control and better outcomes, such as fewer diabetes-related complications and improved overall health, leading to a better prognosis.",1.6580180914979784e-07,0.05036479813627981,0.11735945311702882,0.012693985253473108,0.058159080832374865,0.13125160447151624,0.012675610786670066,0.0370448728292363,0.12240075614366738,1.6580180914979784e-07,0.04144496459431757,0.12901701323251416
293,0.1,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are better outcomes observed in type 2 diabetes patients diagnosed with lower fasting plasma glucose levels? Yes, lower fasting plasma glucose levels at diagnosis generally indicate superior glycemic control and are linked to improved outcomes, including fewer diabetes complications and enhanced overall health, resulting in a more favorable prognosis.",1.8948778188548325e-07,0.05626899998558299,0.13612488521579424,0.014507411718254981,0.035876687271846563,0.13037037037037036,0.014486412327622933,0.014897458375562778,0.12193890172466108,1.8948778188548325e-07,0.019466057875542564,0.12901701323251416
294,0.1,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the position of the head affect the anterior chamber depth in pseudoexfoliation syndrome? In patients with clinically evident unilateral pseudoexfoliation, the lens appears to be more mobile in the affected eye, causing a shallower anterior chamber when the head is prone. This mobility might potentially cause transient pupillary block during certain activities.",1.6580180914979784e-07,0.13261971002301287,0.004543428747306878,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
294,0.1,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? In cases of clinically obvious unilateral pseudoexfoliation, the lens tends to be more mobile in the affected eye, leading to a shallower anterior chamber when the head is positioned prone. This could possibly result in transient pupillary block during some activities.",1.8948778188548325e-07,0.12590102436578832,0.01425657125269314,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
294,0.1,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head posture impact anterior chamber depth in pseudoexfoliation syndrome? Patients with clinically apparent unilateral pseudoexfoliation show increased lens mobility in the affected eye, which causes a shallower anterior chamber when the head is prone. This may potentially cause transient pupillary block during certain actions.",3.552895910352811e-07,0.27786147082240475,0.011141590181844022,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
294,0.1,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Can head positioning alter anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation that is clinically visible, the lens is more mobile in the affected eye, resulting in a shallower anterior chamber when the head is placed prone. This might lead to transient pupillary block during some activities.",2.3685972735685406e-07,0.16701583826009525,0.013457265697137576,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
294,0.1,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is the anterior chamber depth affected by head position in pseudoexfoliation syndrome? In clinically apparent unilateral pseudoexfoliation, the lens shows greater mobility in the affected eye, causing a shallower anterior chamber when the head is prone. This could potentially cause transient pupillary block during activities.",3.552895910352811e-07,0.27786147082240475,0.011141590181844022,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
294,0.1,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the anterior chamber depth change with head positioning in pseudoexfoliation syndrome? Patients with clinically evident unilateral pseudoexfoliation have a more mobile lens in the affected eye, which results in a shallower anterior chamber when the head is prone. This may lead to transient pupillary block during certain activities.",2.6054570009253947e-07,0.1882245363306536,0.013032669034494848,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
294,0.1,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","How does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation that is clinically apparent, the lens is more mobile in the affected eye, causing a shallower anterior chamber when the head is prone. This might cause transient pupillary block during some activities.",3.316036182995957e-07,0.25468846630311415,0.01164582745104024,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
294,0.1,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head position affect anterior chamber depth in pseudoexfoliation syndrome? In patients with clinically obvious unilateral pseudoexfoliation, the lens mobility is increased in the affected eye, resulting in a shallower anterior chamber when the head is prone. This could potentially cause transient pupillary block during activities.",3.316036182995957e-07,0.25468846630311415,0.01164582745104024,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
294,0.1,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth dependent on head positioning in pseudoexfoliation syndrome? In clinically apparent unilateral pseudoexfoliation, the lens is more mobile in the affected eye, leading to a shallower anterior chamber when the head is prone. This may cause transient pupillary block during certain activities.",3.552895910352811e-07,0.27786147082240475,0.011141590181844022,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
294,0.1,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does changing head position influence anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation that is clinically evident, the lens is more mobile in the affected eye, resulting in a shallower anterior chamber when the head is prone. This might potentially lead to transient pupillary block during activities.",2.3685972735685406e-07,0.16701583826009525,0.013457265697137576,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
295,0.1,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission enhance driving performance in elderly drivers? Yes, automatic transmission can greatly enhance driving performance in elderly drivers by simplifying the driving process and removing the need for manual gear changes.",7.10579182070559e-08,0.1081786010261152,0.012002743484225031,0.005440279394345639,0.10421074826202092,0.008254316294676059,0.005432404622858621,0.10371196381111192,0.005972732485293793,7.105791820705622e-08,0.10292162785997583,0.003221293720401787
295,0.1,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission improve the driving habits of older drivers? Indeed, automatic transmission can improve the driving habits of older drivers by making driving easier and eliminating manual gear shifting.",1.421158364141118e-07,0.2768297029047071,0.05392774627179156,0.010880558788691277,0.26987797534246605,0.051479939877442454,0.010864809245717241,0.2706855621853781,0.04902120187304892,1.4211583641411244e-07,0.2709556937716999,0.045171407099086576
295,0.1,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is driving behavior better in older drivers with automatic transmission? Yes, automatic transmission can improve driving behavior in older drivers by simplifying gear changes and reducing driving complexity.",1.894877818854824e-07,0.2155018506876285,0.029513888888888867,0.014507411718255037,0.1992629097968579,0.0490089490114464,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.1,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does using automatic transmission benefit older drivers' driving behavior? Yes, automatic transmission benefits older drivers by simplifying the driving process and removing the need to manually shift gears.",1.894877818854824e-07,0.11281337949356196,0.10190664036817881,0.014507411718255037,0.14594389590763113,0.08740894901144641,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.1,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission positively affect older drivers' driving skills? Yes, automatic transmission positively affects older drivers' driving skills by making gear changes automatic and easier to manage.",2.131737546211677e-07,0.312485527436281,0.009871441689623478,0.016320838183036916,0.29606815795050556,0.00801386394528382,0.016297213868575862,0.23443589105066254,0.06035379812695108,2.1317375462116866e-07,0.2869199880855793,0.031217481789802305
295,0.1,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission help older drivers drive better? Yes, automatic transmission helps older drivers drive better by simplifying the process and eliminating manual gear changes.",2.605457000925383e-07,0.35253897469289797,0.016439909297052163,0.019947691112600675,0.3288198858747422,0.04402051925938028,0.01991881695048161,0.3214472680402922,0.06035379812695108,2.6054570009253947e-07,0.3778917662913073,0.031217481789802305
295,0.1,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is driving easier for older drivers with automatic transmission? Yes, automatic transmission makes driving easier for older drivers by removing the need to manually change gears.",2.36859727356853e-07,0.3602372828118412,0.015306122448979637,0.018134264647818796,0.3992733987211534,0.03504003058039029,0.018108015409528735,0.39754284121901406,0.025814002326563647,2.3685972735685406e-07,0.3943851307073176,0.014133992133100202
295,0.1,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission improve the way older drivers drive? Yes, automatic transmission improves the way older drivers drive by simplifying gear shifting and reducing driving effort.",2.36859727356853e-07,0.3602372828118412,0.015306122448979637,0.018134264647818796,0.34151113367449115,0.004764320912272871,0.018108015409528735,0.33726917334423634,0.01696536837488495,2.3685972735685406e-07,0.33137175065641333,0.031217481789802305
295,0.1,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission lead to better driving behavior in older adults? Yes, automatic transmission leads to better driving behavior in older adults by simplifying the driving task and eliminating manual gear changes.",9.47438909427412e-08,0.19163384305181985,0.04351111111111111,0.007253705859127518,0.18768230041627731,0.04276856578145302,0.007243206163811494,0.18860365290729497,0.04171720779020869,9.474389094274162e-08,0.18923071963380345,0.039788435369961024
295,0.1,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission make driving simpler for older drivers? Yes, automatic transmission makes driving simpler for older drivers by removing the need for manual gear shifting and easing the driving process.",1.184298636784265e-07,0.14094787638802186,0.008711374095989433,0.009067132323909398,0.1323511116060807,0.01882184338730375,0.009054007704764368,0.12979572412054274,0.024688503202396905,1.1842986367842703e-07,0.1265773380103994,0.031217481789802305
296,0.1,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does the use of provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? The Medicaid Demonstration in Florida seems to lower PMPM expenditures. Demonstration PSNs achieved slightly higher expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for providing care to Medicaid enrollees.,7.105791820705622e-08,0.018595055433633156,0.05157024793388431,0.005440279394345618,0.029746267566417295,0.017538265306122455,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
296,0.1,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with lower spending than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows a decrease in PMPM expenditures. Demonstration PSNs produced marginally greater cost reductions than Demonstration HMOs. PSNs appear to be a promising approach for Medicaid care delivery.,2.3685972735685406e-07,0.14641825141427756,0.030746345715686026,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.1,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks reduce expenditures more than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida indicates lower PMPM costs. Demonstration PSNs resulted in slightly larger expenditure decreases compared to Demonstration HMOs. PSNs seem to be a viable model for Medicaid enrollee care.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.1,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is expenditure lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows reduced PMPM expenditures. Demonstration PSNs led to somewhat greater cost savings than Demonstration HMOs. PSNs appear to be a promising care delivery model for Medicaid enrollees.,2.3685972735685406e-07,0.14641825141427756,0.030746345715686026,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.1,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to lower Medicaid expenditures than HMOs or primary care case management in Florida? The Medicaid Demonstration in Florida appears to reduce PMPM spending. Demonstration PSNs achieved slightly more expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for Medicaid enrollee care.,2.3685972735685406e-07,0.11753711889094687,0.05157024793388431,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.1,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida shows a decline in PMPM expenditures. Demonstration PSNs generated marginally greater reductions than Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.1,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks result in decreased expenditures compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to lower PMPM costs. Demonstration PSNs produced slightly greater expenditure reductions than Demonstration HMOs. PSNs appear to be a promising model for Medicaid care delivery.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.1,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is there a reduction in expenditures with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida indicates lower PMPM expenditures. Demonstration PSNs achieved somewhat greater cost reductions than Demonstration HMOs. PSNs seem to be a promising model for Medicaid enrollee care.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.1,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to lower costs than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration appears to reduce PMPM expenditures. Demonstration PSNs resulted in slightly larger expenditure decreases compared to Demonstration HMOs. PSNs seem to be a promising care delivery model for Medicaid enrollees.,1.8948778188548325e-07,0.1044410115930905,0.031578577796441576,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.1,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with reduced expenditures compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida shows lower PMPM costs. Demonstration PSNs generated slightly greater expenditure reductions than Demonstration HMOs. PSNs appear to be a promising model for providing care to Medicaid enrollees.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
297,0.1,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers release GABA? We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal remains unclear, though it might play a role in development. Additional data imply that this GABAergic signal is",2.3685972735685406e-08,0.07355644462982047,0.0008001435587828842,0.0018134264647818726,0.08548623590296245,0.045351473922902494,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
297,0.1,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers responsible for releasing GABA? Our findings strongly support the existence of a GABAergic signal originating from mossy fibers. The exact physiological purpose of this mossy fiber GABAergic signal is not well understood but could be important during development. Further evidence indicates that this GABAergic signal is,7.105791820705622e-08,0.09022028600536247,0.018623835018837936,0.005440279394345618,0.09947572313802233,0.02408493328018039,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
297,0.1,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Is GABA released by mossy fibers? We have demonstrated convincing evidence for a GABAergic signal associated with mossy fibers. The physiological significance of this mossy fiber GABAergic signal is uncertain, but it may have developmental relevance. Other studies suggest that this GABAergic signal is",4.737194547137081e-08,0.031122981367697644,0.031332168352171355,0.0036268529295637453,0.01651364418208079,0.02155611401808394,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
297,0.1,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers emit GABA? Compelling evidence has been provided showing a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is not fully known but might be crucial during development. Additional findings suggest that this GABAergic signal is,4.737194547137081e-08,0.031122981367697644,0.031332168352171355,0.0036268529295637453,0.01651364418208079,0.02155611401808394,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
297,0.1,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Can mossy fibers release GABA? We have supplied strong evidence supporting the presence of a GABAergic signal in mossy fibers. The physiological role of this mossy fiber GABAergic signal remains uncertain, though it may be significant for development. Other research suggests that this GABAergic signal is",0.0,0.049985346188338386,0.0028170926355677584,0.0,0.06301338005090473,0.045351473922902494,0.0,0.0,0.0,0.0,0.0,0.0
297,0.1,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers a source of GABA release? Evidence strongly indicates a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal is unclear but could be important in developmental processes. Further evidence points to this GABAergic signal being,7.105791820705622e-08,0.02423901238750803,0.009457168352171322,0.005440279394345618,0.007604187163049225,0.045351473922902494,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.1,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers discharge GABA? We have provided persuasive evidence for a GABAergic signal linked to mossy fibers. The physiological role of this mossy fiber GABAergic signal is uncertain, potentially playing a role in development. Additional evidence suggests that this GABAergic signal is",7.105791820705622e-08,0.05724602098560272,0.03424513679398594,0.005440279394345618,0.04141624475133909,0.020976473922902493,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.1,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Is there GABA release from mossy fibers? Our data provide compelling evidence of a GABAergic signal from mossy fibers. The physiological significance of this mossy fiber GABAergic signal is not well defined but may be important during development. Other evidence indicates that this GABAergic signal is,0.0,0.011627736528101007,0.04878048780487808,0.0,0.031506690025452144,0.022636492852053387,0.0,0.0,0.0,0.0,0.0,0.0
297,0.1,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers secrete GABA? We have presented convincing evidence that mossy fibers have a GABAergic signal. The physiological role of this mossy fiber GABAergic signal is uncertain but might be developmentally important. Additional findings suggest that this GABAergic signal is,1.1842986367842703e-07,0.09852894730749506,0.013535892276024447,0.009067132323909363,0.09316061699719658,0.019728205224841543,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.1,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers involved in GABA release? Strong evidence supports the existence of a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is unclear but may be crucial for development. Other evidence suggests that this GABAergic signal is,4.737194547137081e-08,0.031122981367697644,0.031332168352171355,0.0036268529295637453,0.01651364418208079,0.02155611401808394,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
298,0.1,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always lead to Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily progress to Meniere's disease. Although it is a symptom of Meniere's disease, it can also result from other causes such as viral infections.",1.4211583641411244e-07,0.09304984977220432,0.0325721801998793,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.1,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is the prognosis of low-tone sudden deafness inevitably Meniere's disease? Answer: No, low-tone sudden deafness does not inevitably develop into Meniere's disease. It is a symptom associated with Meniere's disease but can also arise from other factors like viral infections.",1.4211583641411244e-07,0.05839249074420749,0.0572176237268082,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.1,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always evolve into Meniere's disease? Answer: No, low-tone sudden deafness does not always progress to Meniere's disease. While it can be a symptom of Meniere's disease, other causes such as viral infections may also be responsible.",1.4211583641411244e-07,0.05839249074420749,0.0572176237268082,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.1,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is Meniere's disease an unavoidable outcome of low-tone sudden deafness? Answer: No, low-tone sudden deafness does not inevitably lead to Meniere's disease. It is one symptom of Meniere's disease but can also be caused by other factors including viral infections.",1.4211583641411244e-07,0.05839249074420749,0.0572176237268082,0.010880558788691236,0.05068121956601601,0.06632653061224489,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.1,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness inevitably indicate progression to Meniere's disease? Answer: No, low-tone sudden deafness does not inevitably indicate progression to Meniere's disease. Although it is a symptom of Meniere's disease, other causes like viral infections can also lead to it.",1.1842986367842703e-07,0.16725750562758135,0.034961696754847116,0.009067132323909363,0.16399284769371247,0.03243890148652058,0.009054007704764333,0.1602133162821331,0.02841723222352634,1.1842986367842703e-07,0.16009538652296218,0.026296566837107373
298,0.1,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Will low-tone sudden deafness always develop into Meniere's disease? Answer: No, low-tone sudden deafness will not always develop into Meniere's disease. It is a symptom of Meniere's disease but can also be caused by other factors such as viral infections.",1.4211583641411244e-07,0.16236456782819886,0.015369860020153198,0.010880558788691236,0.15731924734446823,0.010062358276644007,0.0108648092457172,0.15157821472220911,0.0035815857662582634,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.1,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is the development of Meniere's disease certain after low-tone sudden deafness? Answer: No, the development of Meniere's disease is not certain after low-tone sudden deafness. While it is a symptom of Meniere's disease, other causes like viral infections may also be involved.",9.474389094274162e-08,0.21680196644077387,0.13167520568783214,0.0072537058591274906,0.16973108693280192,0.05327223481985392,0.007243206163811466,0.167775566862864,0.05179195830095512,9.474389094274162e-08,0.1331844788234018,0.025623268698060954
298,0.1,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness necessarily progress to Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily progress to Meniere's disease. It can be a symptom of Meniere's disease but may also result from other causes such as viral infections.",1.4211583641411244e-07,0.16236456782819886,0.015369860020153198,0.010880558788691236,0.15731924734446823,0.010062358276644007,0.0108648092457172,0.15157821472220911,0.0035815857662582634,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.1,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is low-tone sudden deafness a guaranteed precursor to Meniere's disease? Answer: No, low-tone sudden deafness is not a guaranteed precursor to Meniere's disease. Although it is one symptom, other factors like viral infections can also cause it.",2.1317375462116834e-07,0.2918438051503385,0.04900828937732796,0.016320838183036854,0.28475663403064955,0.04304846938775511,0.0162972138685758,0.2765517030388178,0.034217984953026,2.1317375462116866e-07,0.2756129546397501,0.029384756657483937
298,0.1,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always mean Meniere's disease will follow? Answer: No, low-tone sudden deafness does not always mean that Meniere's disease will follow. It is a symptom of Meniere's disease but can also be caused by other factors including viral infections.",9.474389094274162e-08,0.15078794924458894,0.08736532487276086,0.0072537058591274906,0.06829491416793232,0.017674328113888547,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
299,0.1,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders? The fMRI mental imagery paradigm shows strong agreement with the clinical progression of patients in a vegetative state. All five vegetative state patients exhibiting significant ROI activation experienced a positive clinical outcome by the end.,2.1317375462116866e-07,0.12776852833841623,0.03164523358427083,0.016320838183036854,0.15044883257652097,0.01785123966942149,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
299,0.1,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Is it possible for mental imagery fMRI to predict recovery in patients suffering from disorders of consciousness? The mental imagery fMRI paradigm correlates highly with the subsequent clinical trajectory of patients in a vegetative state. Each of the five vegetative state patients who demonstrated notable ROI activation had a favorable clinical progression through to the conclusion.,4.737194547137081e-08,0.013165925531228861,0.016157281049888124,0.0036268529295637453,0.03728450552082041,0.000660686282874693,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
299,0.1,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Does mental imagery functional MRI have predictive value for recovery in patients with consciousness disorders? The mental imagery fMRI paradigm aligns closely with the later clinical course of patients in a vegetative state. All five patients in a vegetative state who showed significant activation in regions of interest had a positive clinical outcome by the end.,4.737194547137081e-08,0.06357662957195265,0.019810756546627374,0.0036268529295637453,0.06295662331933682,0.019131008851288565,0.003621603081905733,0.06319776905997099,0.018860946745562133,4.737194547137081e-08,0.03774032798284743,0.0
299,0.1,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Can functional MRI using mental imagery predict recovery outcomes in patients with disorders of consciousness? The mental imagery fMRI paradigm exhibits strong concordance with the future clinical course of patients in a vegetative state. Every one of the five vegetative state patients with significant ROI activation experienced a favorable clinical progression until the end.,9.474389094274162e-08,0.052109487930096954,0.014791319577940096,0.0072537058591274906,0.049352715705150985,0.01785123966942149,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
299,0.1,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Is mental imagery fMRI capable of predicting recovery in patients with disorders of consciousness? The mental imagery fMRI paradigm demonstrates high agreement with the subsequent clinical course of patients in a vegetative state. All five vegetative state patients who showed significant ROI activation had a positive clinical outcome by the end.,1.6580180914979784e-07,0.11351717573962672,0.012538580246913546,0.012693985253473108,0.13706785783146014,0.0025480658861340676,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
299,0.1,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Can mental imagery-based functional MRI predict recovery in patients with consciousness disorders? The mental imagery fMRI paradigm shows a high level of concordance with the further clinical progression of patients in a vegetative state. All five patients in a vegetative state with significant ROI activation had a favorable clinical course until the end.,1.1842986367842703e-07,0.09882320897538888,0.005006915842678754,0.009067132323909363,0.12313528631205317,0.021299114349737205,0.009054007704764333,0.12303606702672365,0.019991670137442734,1.1842986367842703e-07,0.0971637484536485,0.0
299,0.1,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Does mental imagery functional MRI predict recovery in patients with disorders of consciousness? The mental imagery fMRI paradigm is highly consistent with the later clinical course of patients in a vegetative state. All five vegetative state patients who exhibited significant ROI activation had a positive clinical outcome by the end.,1.8948778188548325e-07,0.10655983026785787,0.03206983024691355,0.014507411718254981,0.1293954233786878,0.01785123966942149,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
299,0.1,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Is it feasible for mental imagery fMRI to predict recovery in patients with consciousness disorders? The mental imagery fMRI paradigm shows strong concordance with the subsequent clinical course of patients in a vegetative state. Each of the five vegetative state patients with significant ROI activation had a favorable clinical progression until the end.,1.1842986367842703e-07,0.09882320897538888,0.005006915842678754,0.009067132323909363,0.0959530439371532,0.001748760330578504,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
299,0.1,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Can mental imagery functional MRI serve as a predictor of recovery in patients with disorders of consciousness? The mental imagery fMRI paradigm aligns well with the further clinical course of patients in a vegetative state. All five vegetative state patients who showed significant activation of ROIs had a positive clinical outcome by the end.,9.474389094274162e-08,0.025952990550476507,0.033608189056906976,0.0072537058591274906,0.049352715705150985,0.01785123966942149,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
299,0.1,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Is mental imagery fMRI a reliable predictor of recovery in patients with disorders of consciousness? The mental imagery fMRI paradigm exhibits high concordance with the future clinical course of patients in a vegetative state. All five patients in a vegetative state who showed significant ROI activation experienced a favorable clinical progression until the end.,9.474389094274162e-08,0.1305789800689583,0.0408468364197531,0.0072537058591274906,0.12933123653899115,0.03962481197572638,0.007243206163811466,0.10268979488304542,0.019599999999999996,9.474389094274162e-08,0.07696104113612989,0.0
